data_2l57_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l57 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.464 ' HB3' HG13 ' A' ' 16' ' ' VAL . 33.4 m . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 121.237 0.541 . . . . 0.0 109.718 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 15' ' ' ASN . 96.1 mt -107.02 146.09 13.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.56 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 84.4 m-20 71.21 13.94 6.68 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.602 0.564 . . . . 0.0 110.159 -174.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.54 HG11 ' HB ' ' A' ' 61' ' ' ILE . 4.5 m -105.4 166.27 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.889 -174.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 23' ' ' ALA . 12.4 m -141.34 147.99 21.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -64.19 -51.09 65.43 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.264 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.852 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 14.5 t-20 -148.36 169.3 20.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.732 -176.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 56.9 mt -60.48 -27.53 67.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.912 0.387 . . . . 0.0 110.305 174.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -57.44 -33.8 68.31 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.79 174.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -91.03 -27.41 18.65 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.972 0.415 . . . . 0.0 110.871 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 17' ' ' VAL . . . -71.9 156.82 38.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.596 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.742 ' HZ2' ' HA ' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -131.89 -177.81 4.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.606 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -103.73 174.96 5.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.622 -175.561 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.69 -62.86 1.93 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.654 HD12 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -77.66 127.69 81.71 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.636 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 1.004 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 85.9 Cg_exo -48.58 143.74 15.51 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.806 2.337 . . . . 0.0 112.1 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.477 HG21 ' OD1' ' A' ' 60' ' ' ASN . 23.8 m -115.64 124.51 51.09 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.225 -171.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.428 HD11 ' N ' ' A' ' 30' ' ' ILE . 2.9 mp -109.22 117.62 54.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.636 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 2.3 mm -105.62 116.43 49.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.063 -175.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.475 ' O ' ' HG3' ' A' ' 32' ' ' MET . 26.5 ptm -110.77 112.3 24.07 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.707 0.765 . . . . 0.0 110.107 174.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.529 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 81.6 m-85 -83.64 128.32 34.43 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.018 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.623 ' HE2' ' CB ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -142.77 142.27 31.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.696 -175.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.442 ' O ' ' HE3' ' A' ' 34' ' ' LYS . 1.2 p -75.0 170.87 15.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 174.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -49.68 -74.55 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 O-C-N 123.358 0.411 . . . . 0.0 110.798 176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -88.88 110.84 21.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.961 0.41 . . . . 0.0 110.316 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 5.9 p -152.73 121.32 3.21 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.037 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.11 -35.97 6.33 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.523 2.149 . . . . 0.0 112.839 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -61.81 -24.37 66.83 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.591 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.621 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 49.7 t -61.95 -50.12 73.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.069 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.5 t -59.49 -44.84 93.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.558 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 5.7 tp10 -55.79 -46.79 77.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.928 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.494 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 23.4 ttt -73.85 -30.49 62.7 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.053 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.621 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 27.8 mt-30 -59.43 -48.44 81.62 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 121.458 -0.097 . . . . 0.0 110.988 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.558 ' HG3' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -65.54 -36.06 82.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.522 0.201 . . . . 0.0 111.196 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -59.03 -44.86 91.81 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.18 0.514 . . . . 0.0 109.812 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.738 HD12 HG22 ' A' ' 61' ' ' ILE . 97.9 mt -62.42 -35.91 80.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.056 178.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -58.89 -40.63 85.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.916 0.389 . . . . 0.0 110.228 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.462 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 20.2 m-85 -65.7 -43.31 89.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.322 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.445 HG23 ' HG3' ' A' ' 105' ' ' LYS . 48.7 t -62.1 -42.66 95.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.464 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.4 m -65.74 -31.69 72.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.13 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -61.24 -40.52 94.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.73 176.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.56 -10.37 54.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.586 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.85 84.3 1.97 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.957 0.408 . . . . 0.0 111.168 -177.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -78.98 123.51 27.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.916 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.42 73.92 0.37 Allowed Glycine 0 C--N 1.332 0.313 0 O-C-N 123.596 0.56 . . . . 0.0 113.297 173.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.884 ' HD2' HG12 ' A' ' 117' ' ' VAL . 9.6 mmtt -144.14 -36.73 0.33 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.987 0.423 . . . . 0.0 110.941 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -144.88 168.87 19.2 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.515 HD21 HG12 ' A' ' 27' ' ' ILE . 8.9 p30 -118.25 137.9 52.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.27 0.557 . . . . 0.0 110.723 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.738 HG22 HD12 ' A' ' 48' ' ' LEU . 52.6 mt -104.08 109.72 28.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.118 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.852 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 2.6 t80 -95.01 118.51 31.96 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.926 0.393 . . . . 0.0 110.559 -178.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.509 ' CE1' ' HG2' ' A' ' 45' ' ' GLN . 81.0 m-85 -83.45 103.26 12.67 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 173.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.529 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -90.8 86.15 6.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.377 0.608 . . . . 0.0 109.968 -173.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.623 ' CB ' ' HE2' ' A' ' 34' ' ' LYS . 17.8 ptt180 -77.49 129.01 35.16 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.508 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.3 tp -73.2 12.32 0.59 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.71 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.585 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 10.4 mt-10 -79.98 -13.63 59.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.574 -175.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -116.88 170.48 8.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.338 -173.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.48 -33.53 25.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.158 -176.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.568 ' HB3' ' HZ3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -61.95 -26.41 68.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.894 0.378 . . . . 0.0 110.702 -177.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.607 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 78.5 m-20 -87.79 3.77 46.89 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.909 -176.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.8 mt -72.17 -58.68 4.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 171.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.461 ' CG ' ' HZ2' ' A' ' 77' ' ' LYS . 6.8 t70 -67.49 -38.8 84.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.137 175.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.607 ' HB2' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -56.09 -46.18 79.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.199 176.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.26 -56.45 19.86 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.686 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -67.56 -33.54 75.25 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.573 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.461 ' HZ2' ' CG ' ' A' ' 73' ' ' ASP . 14.3 ttmm -63.36 -24.6 67.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.983 0.42 . . . . 0.0 110.788 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.558 ' CE1' HD22 ' A' ' 89' ' ' LEU . 95.0 m-85 -122.05 22.48 10.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.884 -176.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 66.95 29.17 8.3 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.523 0.514 . . . . 0.0 111.556 166.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.408 ' HA ' HG23 ' A' ' 85' ' ' THR . . . -87.33 113.56 23.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.885 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.517 ' ND2' HG13 ' A' ' 82' ' ' ILE . 3.8 p-10 -138.71 -2.53 1.73 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.271 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.517 HG13 ' ND2' ' A' ' 81' ' ' ASN . 50.5 mt -136.78 142.22 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.446 HG11 ' HA ' ' A' ' 34' ' ' LYS . 99.5 t -101.15 129.3 27.39 Favored Pre-proline 0 C--N 1.319 -0.729 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.667 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 58.4 Cg_endo -95.11 135.18 5.24 Favored 'Cis proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.423 -1.49 . . . . 0.0 113.42 -0.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.564 HG22 ' HG2' ' A' ' 100' ' ' GLN . 19.9 m -87.73 107.5 18.67 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.2 m -100.94 108.03 19.66 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.636 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 6.8 p -108.2 126.16 64.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.445 0.64 . . . . 0.0 110.128 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 1.005 ' HB3' HD13 ' A' ' 115' ' ' LEU . 89.0 m-85 -99.22 119.4 37.83 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.579 -177.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.558 HD22 ' CE1' ' A' ' 78' ' ' TYR . 5.6 mp -115.31 141.73 47.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.817 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 25.1 t70 -75.15 -164.48 0.31 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.598 ' HZ1' ' CD ' ' A' ' 92' ' ' GLU . 6.1 pttm -53.3 -42.86 67.05 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -168.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.598 ' CD ' ' HZ1' ' A' ' 91' ' ' LYS . 0.5 OUTLIER -99.26 6.06 46.41 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.056 -0.403 . . . . 0.0 111.396 -176.268 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.551 ' HA2' ' HB3' ' A' ' 89' ' ' LEU . . . 94.66 30.2 8.7 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.759 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 10.0 m120 -70.92 106.49 3.65 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.403 -0.469 . . . . 0.0 109.93 173.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.451 ' HG3' ' CG2' ' A' ' 87' ' ' VAL . 39.0 ttpt -64.69 100.41 0.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 176.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -98.45 -50.38 4.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.291 -176.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.499 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 91.7 t80 -137.47 122.0 18.44 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.171 -0.611 . . . . 0.0 111.8 -174.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.458 HG12 HG22 ' A' ' 87' ' ' VAL . 11.5 m -103.14 147.04 10.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 172.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.499 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 15.9 t60 -145.4 119.01 9.12 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.564 ' HG2' HG22 ' A' ' 85' ' ' THR . 39.3 mt-30 -102.93 106.22 16.73 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 143.41 160.84 8.58 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.445 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.482 HD23 ' HG2' ' A' ' 43' ' ' GLU . 45.9 tp -71.56 149.75 45.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.935 0.398 . . . . 0.0 111.243 -176.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 69.9 mtm -141.03 -170.14 2.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.19 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.496 HH12 ' CD ' ' A' ' 43' ' ' GLU . 33.2 mmt180 -131.27 165.97 22.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.378 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.462 ' HD2' ' HB3' ' A' ' 50' ' ' TYR . 55.6 tttm -44.7 -56.83 4.1 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.116 0.885 . . . . 0.0 112.299 -176.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -51.93 -47.31 64.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.345 0.593 . . . . 0.0 111.601 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.597 ' O ' HG12 ' A' ' 111' ' ' ILE . 47.0 m-20 -73.84 -40.45 63.29 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.931 -172.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.528 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 60.9 mt -60.21 -47.02 93.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.577 0.703 . . . . 0.0 109.301 174.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -62.98 -39.95 96.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.219 -175.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 57.9 m -64.42 -35.93 82.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.162 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 107' ' ' ASN . 40.8 mm -70.26 -34.95 60.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.632 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 20.9 mt -60.38 -42.89 96.79 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.714 0.769 . . . . 0.0 108.987 174.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -62.1 -30.39 70.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.901 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.9 m -76.05 -30.25 58.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.977 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 1.005 HD13 ' HB3' ' A' ' 88' ' ' PHE . 51.6 mt -70.58 -59.95 2.54 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 122.185 0.993 . . . . 0.0 109.081 174.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 145.86 -44.95 0.83 Allowed Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.371 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 1.004 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 19.2 t 46.58 61.35 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 122.112 0.958 . . . . 0.0 109.397 -176.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 mttm . . . . . 0 CA--C 1.512 -0.5 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.848 -169.309 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.484 ' O ' HG12 ' A' ' 16' ' ' VAL . 14.9 m . . . . . 0 N--CA 1.444 -0.753 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.7 mt -86.66 2.87 4.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.792 0.806 . . . . 0.0 110.69 -174.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -117.47 16.37 14.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.623 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 13' ' ' SER . 12.6 p -85.01 143.59 11.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -171.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.932 ' HB ' ' HB2' ' A' ' 22' ' ' GLU . 27.5 m -128.34 152.95 37.15 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.222 169.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -75.51 -35.1 60.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.349 -174.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.726 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 51.5 t30 -163.41 -176.09 4.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.692 -177.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.1 mt -61.52 -30.6 70.74 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -56.87 -45.56 82.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.329 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.932 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . 5.4 mm-40 -76.69 -24.76 53.17 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.591 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.91 153.25 43.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.682 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.58 ' NZ ' ' HA ' ' A' ' 24' ' ' LYS . 2.4 tpmp? -145.4 156.26 43.66 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.995 -175.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -73.51 179.88 3.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.049 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.85 -59.82 4.87 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -175.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.414 HG13 ' HB2' ' A' ' 60' ' ' ASN . 6.5 pt -90.32 121.9 68.02 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.525 -0.338 . . . . 0.0 110.165 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.854 ' HG3' ' H ' ' A' ' 117' ' ' VAL . 16.5 Cg_endo -57.26 138.51 86.55 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.64 2.227 . . . . 0.0 111.009 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.2 m -103.52 123.76 47.51 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.256 0.551 . . . . 0.0 111.923 -172.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.595 HD11 HD11 ' A' ' 112' ' ' LEU . 75.2 mt -98.63 113.26 32.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 173.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.737 ' HB ' HG23 ' A' ' 87' ' ' VAL . 58.4 mt -107.03 111.98 37.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.35 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.439 ' HG2' ' HD1' ' A' ' 63' ' ' TYR . 21.8 ptm -109.8 129.63 55.61 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.061 176.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.55 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 92.0 m-85 -94.33 112.78 24.59 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 41' ' ' CYS . 55.6 pttt -117.75 138.73 51.84 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.446 -170.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.466 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 0.7 OUTLIER -71.18 149.67 46.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.969 174.43 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -70.31 -45.12 66.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.98 -177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.2 t -94.75 9.77 37.67 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.466 ' SG ' ' HB ' ' A' ' 35' ' ' THR . 76.6 m -106.72 122.19 42.6 Favored Pre-proline 0 C--N 1.327 -0.409 0 O-C-N 121.845 -0.535 . . . . 0.0 111.065 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 6.3 Cg_exo -78.01 -2.88 12.97 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.391 2.061 . . . . 0.0 113.179 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -65.57 -15.95 63.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.935 0.397 . . . . 0.0 110.796 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.561 ' HB3' ' HB2' ' A' ' 34' ' ' LYS . 24.9 p -68.84 -43.79 74.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.818 175.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.2 t -62.89 -30.63 49.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.279 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.729 ' HA ' ' HZ1' ' A' ' 46' ' ' LYS . 7.5 tp10 -58.69 -51.99 67.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.346 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.9 ttt -75.03 -37.31 61.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.54 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.489 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 16.5 mt-30 -59.2 -43.64 92.23 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.76 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.729 ' HZ1' ' HA ' ' A' ' 43' ' ' GLU . 22.7 pttm -70.13 -41.87 73.35 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.446 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.537 ' O ' HG22 ' A' ' 51' ' ' VAL . 24.1 mm-40 -51.03 -49.91 59.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.898 0.38 . . . . 0.0 110.386 172.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.423 ' HB3' HD11 ' A' ' 61' ' ' ILE . 71.2 mt -60.73 -37.66 82.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.515 177.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.8 m -67.59 -37.35 82.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.782 0.325 . . . . 0.0 110.712 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -65.12 -33.5 76.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.523 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 47' ' ' GLU . 21.7 t -73.2 -40.89 58.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.892 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.2 m -56.84 -30.65 64.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.142 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.752 ' HZ3' ' HB3' ' A' ' 53' ' ' LYS . 4.6 ttpm? -52.49 -36.53 55.28 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.756 176.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -109.84 -18.44 13.41 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.204 0.526 . . . . 0.0 110.756 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.561 ' HB3' ' HB2' ' A' ' 58' ' ' LYS . 11.5 mpt_? -111.96 74.55 0.87 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.367 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.555 ' CD ' ' HZ2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -83.73 116.48 22.7 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.84 35.14 91.58 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.467 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 55' ' ' ARG . 12.7 mptt -101.76 -20.02 15.12 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -165.41 153.99 11.76 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.165 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.414 ' HB2' HG13 ' A' ' 27' ' ' ILE . 39.8 t-20 -103.92 138.1 40.97 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.339 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.423 HD11 ' HB3' ' A' ' 48' ' ' LEU . 11.0 mt -117.34 111.87 36.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.714 0.292 . . . . 0.0 110.943 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.726 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 3.3 t80 -98.84 118.41 35.52 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.489 ' CE1' ' HG2' ' A' ' 45' ' ' GLN . 21.7 m-85 -94.65 103.57 15.5 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.398 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.55 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -80.58 87.16 5.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.163 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.545 ' C ' ' H ' ' A' ' 67' ' ' GLU . 1.8 ptm180 -69.59 123.71 22.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.139 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 34' ' ' LYS . 5.4 tp -69.75 11.2 0.29 Allowed 'General case' 0 C--N 1.322 -0.613 0 O-C-N 122.025 -0.422 . . . . 0.0 110.933 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.545 ' H ' ' C ' ' A' ' 65' ' ' ARG . 21.0 mt-10 -82.47 -19.73 38.28 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.7 -173.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.43 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 46.2 mt-10 -117.04 151.29 37.09 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -59.81 -31.03 69.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.103 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.436 ' HD2' ' OD1' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -58.95 -25.92 63.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.268 -178.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.436 ' OD1' ' HD2' ' A' ' 70' ' ' LYS . 10.4 m120 -91.19 -12.18 36.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.963 -176.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.5 mt -71.16 -48.63 53.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.98 -43.56 92.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.762 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -58.52 -42.88 88.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.403 178.514 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.26 -57.38 12.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.441 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -67.23 -33.25 74.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.608 0.242 . . . . 0.0 111.258 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.465 ' HZ2' ' HB2' ' A' ' 77' ' ' LYS . 3.3 ttmp? -63.01 -28.85 70.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.972 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -112.01 8.23 20.11 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 71.72 26.84 3.0 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.599 0.562 . . . . 0.0 111.877 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.75 103.67 10.75 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.175 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -117.72 -35.45 3.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.823 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 12.4 mt -112.57 130.1 66.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.49 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.8 m -102.35 140.47 21.16 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.67 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -86.82 147.7 35.56 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.34 -1.525 . . . . 0.0 112.085 -0.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.0 t -140.78 149.73 42.46 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.4 t -140.71 142.01 34.88 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.22 0.533 . . . . 0.0 110.606 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.804 HG13 HG13 ' A' ' 98' ' ' VAL . 6.2 m -115.49 127.89 72.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.79 176.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.415 ' CD1' ' HD2' ' A' ' 97' ' ' TYR . 83.0 m-85 -97.56 118.74 34.75 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.485 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.516 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 6.4 mp -108.35 141.51 40.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.79 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.449 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 46.6 t0 -80.18 -179.19 6.94 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.594 ' HZ2' ' CD ' ' A' ' 92' ' ' GLU . 7.9 pttm -49.57 -32.11 11.93 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -175.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.594 ' CD ' ' HZ2' ' A' ' 91' ' ' LYS . 32.6 mp0 -69.26 -29.0 66.81 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 122.087 -0.383 . . . . 0.0 111.338 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.33 30.37 7.01 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.972 -173.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 9.9 p30 -105.59 132.99 51.06 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 175.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.402 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 16.6 ptmt -75.73 117.79 17.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.832 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -106.45 -54.83 2.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.989 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.415 ' HD2' ' CD1' ' A' ' 88' ' ' PHE . 73.0 t80 -109.61 135.17 51.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.105 -174.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.804 HG13 HG13 ' A' ' 87' ' ' VAL . 29.3 m -111.82 148.02 15.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.41 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 38.0 t60 -145.84 131.84 19.25 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -117.9 149.81 40.26 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 176.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.38 -124.0 8.1 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.62 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 103' ' ' MET . 27.3 tp -136.53 167.94 20.43 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 122.731 -0.276 . . . . 0.0 110.336 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.402 ' N ' ' HG ' ' A' ' 102' ' ' LEU . 20.3 ptm -168.6 147.08 4.17 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.401 ' HD3' ' HA ' ' A' ' 104' ' ' ARG . 23.3 mmt180 -89.87 168.67 11.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.18 -177.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -53.07 -41.46 64.9 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.234 -177.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -65.83 -35.37 80.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.876 0.37 . . . . 0.0 110.475 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.506 ' O ' HG12 ' A' ' 111' ' ' ILE . 11.7 m120 -64.48 -47.32 79.4 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.2 mt -59.32 -50.8 78.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.099 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -51.88 -50.14 61.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.746 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.2 m -65.16 -38.15 89.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.659 0.266 . . . . 0.0 111.094 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 107' ' ' ASN . 39.9 mm -63.61 -47.26 92.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 177.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.595 HD11 HD11 ' A' ' 30' ' ' ILE . 83.2 mt -62.66 -39.43 93.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.047 0.451 . . . . 0.0 110.055 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -54.71 -44.85 73.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.239 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.5 m -86.14 -23.87 26.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.878 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.0 tp -91.12 -64.97 1.05 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -175.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.861 ' HA2' ' HZ2' ' A' ' 118' ' ' LYS . . . -139.03 -122.82 2.04 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 119.989 -1.1 . . . . 0.0 113.816 -169.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.854 ' H ' ' HG3' ' A' ' 28' ' ' PRO . 12.7 t 58.44 35.14 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 122.152 0.977 . . . . 0.0 109.075 -173.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.861 ' HZ2' ' HA2' ' A' ' 116' ' ' GLY . 37.2 mtmm . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.223 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.49 ' HB3' HG21 ' A' ' 16' ' ' VAL . 44.8 m . . . . . 0 N--CA 1.441 -0.919 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.9 mt -108.41 -61.21 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.885 0.374 . . . . 0.0 111.092 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 7.2 m-20 -85.25 30.18 0.62 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.662 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.49 HG21 ' HB3' ' A' ' 13' ' ' SER . 20.4 m -91.54 155.56 3.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -166.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.526 HG11 ' HB1' ' A' ' 23' ' ' ALA . 47.1 t -136.21 143.01 37.04 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.441 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -71.97 -45.89 59.39 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.201 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.622 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 19.1 t30 -164.02 176.12 9.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.831 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.673 HD11 HD12 ' A' ' 74' ' ' LEU . 86.2 mt -49.03 -36.7 18.63 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -174.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.546 ' OE2' ' HB3' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -77.24 -27.42 53.32 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -172.329 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -77.73 -10.65 59.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.713 0.292 . . . . 0.0 111.355 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.526 ' HB1' HG11 ' A' ' 17' ' ' VAL . . . -87.9 171.43 10.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.955 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.945 ' HZ1' ' HB3' ' A' ' 24' ' ' LYS . 4.2 mtpm? -136.08 152.89 51.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.011 0.434 . . . . 0.0 111.644 177.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.65 170.77 15.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.542 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.3 -29.02 5.83 Favored Glycine 0 CA--C 1.504 -0.619 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.575 ' HB ' ' HA ' ' A' ' 59' ' ' PHE . 22.9 pt -113.55 131.08 23.17 Favored Pre-proline 0 C--N 1.315 -0.899 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 1.03 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 54.7 Cg_exo -56.59 162.79 7.79 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 123.047 2.498 . . . . 0.0 113.111 -174.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.1 m -122.97 122.66 39.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.179 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.443 ' N ' HD13 ' A' ' 30' ' ' ILE . 2.5 mp -104.61 109.19 26.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 174.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.409 HG22 ' CD2' ' A' ' 62' ' ' TYR . 64.3 mt -105.45 113.85 43.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.468 -177.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.48 ' O ' ' HG3' ' A' ' 32' ' ' MET . 25.1 ptm -108.91 112.99 25.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.639 0.733 . . . . 0.0 110.057 178.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.601 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 90.1 m-85 -76.36 114.12 14.71 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.535 177.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.519 ' HG3' ' SG ' ' A' ' 41' ' ' CYS . 0.1 OUTLIER -138.77 148.99 44.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.133 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.0 t -97.99 -173.2 2.54 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -55.99 -51.44 67.72 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.701 0.625 . . . . 0.0 110.769 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.706 HG22 ' HG ' ' A' ' 38' ' ' CYS . 15.0 t -92.73 -162.52 0.94 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.615 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.706 ' HG ' HG22 ' A' ' 37' ' ' THR . 50.7 m 74.61 106.02 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.491 0 C-N-CA 123.639 0.776 . . . . 0.0 110.993 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 2.7 Cg_exo -74.74 3.45 5.46 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.561 2.174 . . . . 0.0 113.145 -176.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.425 ' HD2' ' HB3' ' A' ' 38' ' ' CYS . 80.0 m-85 -65.3 -27.28 68.5 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.519 ' SG ' ' HG3' ' A' ' 34' ' ' LYS . 42.3 t -64.58 -55.05 22.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.646 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.519 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 12.7 p -63.42 -31.09 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.772 0.32 . . . . 0.0 110.99 -175.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -68.14 -49.49 60.67 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.214 0.53 . . . . 0.0 110.21 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.1 ttt -67.75 -29.4 68.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.174 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 51.8 mt-30 -61.21 -38.7 87.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.128 175.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 81.5 mttt -60.1 -49.34 78.05 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.382 0.611 . . . . 0.0 109.671 175.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.544 ' O ' HG23 ' A' ' 51' ' ' VAL . 9.9 mm-40 -57.06 -48.79 77.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.413 176.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.12 -29.79 68.85 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.29 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 68.6 m -62.12 -47.46 84.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.068 0.461 . . . . 0.0 110.412 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -73.02 -33.56 65.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.28 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 47' ' ' GLU . 57.8 t -67.46 -36.73 77.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.106 0.479 . . . . 0.0 110.167 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.0 m -66.26 -30.74 71.23 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.053 175.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.581 ' HZ2' ' CD ' ' A' ' 56' ' ' GLU . 19.8 tptp -74.03 -28.78 61.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.391 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -70.47 -47.26 61.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.086 174.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.601 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 1.2 ttm180 -123.43 75.18 1.3 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.808 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.581 ' CD ' ' HZ2' ' A' ' 53' ' ' LYS . 39.3 mt-10 -69.79 118.51 12.73 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.749 -172.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.46 50.76 60.61 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.575 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.601 ' HB2' ' HG2' ' A' ' 55' ' ' ARG . 39.0 mmtm -136.03 8.59 3.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.693 0.282 . . . . 0.0 110.79 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.575 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 50.5 p90 -169.93 149.03 3.59 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.486 ' HB3' HG21 ' A' ' 17' ' ' VAL . 15.3 m-80 -88.86 135.19 33.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.484 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.7 mt -114.68 106.18 20.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 168.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.622 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 4.0 t80 -96.32 116.67 29.4 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -76.93 103.95 7.15 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 174.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -77.45 72.82 4.02 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.683 ' HD2' ' OE2' ' A' ' 68' ' ' GLU . 2.6 ptp180 -69.61 109.79 4.5 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 113.624 -1.625 . . . . 0.0 111.515 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.8 tp -72.24 4.67 3.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.729 -177.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.653 ' CD ' ' HB2' ' A' ' 65' ' ' ARG . 5.6 pm0 -83.04 -13.98 54.75 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.121 0.486 . . . . 0.0 110.056 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.683 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 62.1 mt-10 -106.55 144.29 33.44 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.912 175.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -21.38 62.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.034 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HG3' ' HB3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -55.8 -23.25 28.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.221 0.534 . . . . 0.0 112.026 177.099 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.616 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 22.7 m-20 -88.1 8.96 24.31 Favored 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -177.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 77.7 mt -71.47 -50.71 38.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 168.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -68.03 -48.67 65.04 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.52 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.673 HD12 HD11 ' A' ' 20' ' ' LEU . 4.4 mm? -58.4 -41.66 85.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.373 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.448 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -56.76 -56.65 18.83 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 120.501 0.191 . . . . 0.0 111.047 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -65.32 -33.95 77.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.758 0.313 . . . . 0.0 111.042 -176.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.798 ' HZ2' ' HB2' ' A' ' 77' ' ' LYS . 4.1 ttmp? -64.2 -25.61 68.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.112 0.482 . . . . 0.0 110.88 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.662 ' HB3' HG22 ' A' ' 87' ' ' VAL . 89.2 m-85 -120.34 22.71 11.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.015 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 68.44 16.84 9.19 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.334 0.588 . . . . 0.0 111.333 169.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' A' ' 75' ' ' ALA . . . -83.94 140.51 31.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.908 -176.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -151.76 -40.2 0.11 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.65 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 22.8 pt -116.73 160.44 16.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.975 173.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.07 152.52 60.13 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.924 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -91.84 149.57 16.61 Favored 'Cis proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.038 -1.651 . . . . 0.0 112.428 -0.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.8 t -138.06 129.82 28.27 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.1 m -108.5 123.25 48.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.931 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.662 HG22 ' HB3' ' A' ' 78' ' ' TYR . 67.1 t -105.16 117.65 51.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.78 176.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -96.03 111.11 23.22 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.402 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -100.04 138.95 36.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.337 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.8 -172.67 0.53 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.609 ' NZ ' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -67.14 -26.14 66.52 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.068 -0.395 . . . . 0.0 112.056 -176.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.609 ' HG2' ' NZ ' ' A' ' 91' ' ' LYS . 38.6 mm-40 -75.05 -47.11 30.54 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.91 20.99 1.42 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.814 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.427 ' ND2' ' HB2' ' A' ' 92' ' ' GLU . 43.7 m-80 -78.13 133.1 37.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -71.04 86.35 0.73 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.202 176.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -86.73 -51.59 6.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.206 -172.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -137.5 125.91 23.42 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.454 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.6 m -112.14 149.51 14.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 173.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -146.27 122.39 10.8 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.41 115.08 27.73 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 135.37 -168.72 23.69 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.3 tp -90.54 149.85 22.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.77 0.319 . . . . 0.0 110.46 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 56.1 mmm -127.09 161.6 28.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.417 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 10.1 mmm180 -113.37 168.53 9.66 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.401 ' HB2' ' HE2' ' A' ' 105' ' ' LYS . 14.3 ptmm? -57.3 -47.62 81.03 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -172.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.505 ' HA ' ' OE1' ' A' ' 109' ' ' GLU . 14.8 t-20 -64.23 -32.29 73.82 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.97 0.414 . . . . 0.0 111.2 -177.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.522 ' O ' HG12 ' A' ' 111' ' ' ILE . 9.3 m120 -65.03 -45.79 84.01 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.556 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 53.1 mt -62.94 -50.04 81.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.066 175.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.505 ' OE1' ' HA ' ' A' ' 106' ' ' ASN . 43.7 mt-10 -51.28 -49.77 60.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.755 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.5 m -66.69 -43.91 83.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.008 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 107' ' ' ASN . 40.4 mm -60.22 -43.61 93.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.497 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 57.5 mt -59.91 -39.77 86.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 0.0 111.238 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -61.21 -41.14 96.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.325 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.3 m -86.06 -17.43 35.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.912 0.387 . . . . 0.0 111.443 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.9 tp -66.84 -54.39 22.92 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.626 -173.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.672 ' O ' ' HG2' ' A' ' 118' ' ' LYS . . . 136.69 13.29 0.97 Allowed Glycine 0 N--CA 1.442 -0.967 0 C-N-CA 119.862 -1.161 . . . . 0.0 112.872 -177.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 1.03 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 61.9 t -43.14 100.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.152 0.501 . . . . 0.0 111.888 167.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 29.7 pttt . . . . . 0 C--O 1.221 -0.438 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 120.574 0.226 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.0 mt 70.96 -60.1 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.066 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.478 HD22 ' HA2' ' A' ' 57' ' ' GLY . 14.6 m120 -83.3 30.4 0.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.263 0.554 . . . . 0.0 110.749 177.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.567 HG21 ' CE2' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -80.1 126.73 39.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.622 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.515 HG13 ' HB2' ' A' ' 23' ' ' ALA . 73.2 t -119.74 132.97 68.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.943 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -71.24 -54.69 10.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.159 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.644 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 7.0 t30 -155.08 169.56 23.83 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.11 -173.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.1 mt -46.73 -45.16 19.45 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.644 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -77.28 -17.74 58.12 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.282 0.563 . . . . 0.0 110.247 -176.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -87.82 17.88 4.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.035 171.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.515 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -122.59 160.41 25.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.301 176.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.419 ' HG3' ' HG2' ' A' ' 25' ' ' GLU . 11.8 ptmm? -173.86 -168.95 0.45 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.508 ' HB2' HD11 ' A' ' 27' ' ' ILE . 4.6 mm-40 75.55 -170.72 0.09 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.106 0.879 . . . . 0.0 110.789 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.574 ' O ' ' HE2' ' A' ' 91' ' ' LYS . . . -117.4 38.18 3.06 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.198 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.559 HD12 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -100.81 155.56 36.19 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 110.513 -0.18 . . . . 0.0 110.513 -178.651 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.696 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 32.5 Cg_exo -60.09 144.61 99.47 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.444 2.096 . . . . 0.0 111.63 173.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.9 m -110.96 115.13 28.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.683 -176.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.2 mt -98.71 107.98 21.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.648 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 55.4 mt -99.93 111.94 31.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.147 0.498 . . . . 0.0 109.875 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.885 ' HE2' ' HB3' ' A' ' 84' ' ' PRO . 8.3 tpt -109.35 108.93 19.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.27 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.576 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 74.3 m-85 -80.2 152.26 29.24 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.678 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.735 ' HZ1' ' HB3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -159.98 155.74 25.94 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 175.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.552 ' HA ' ' HB2' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -67.72 -173.09 0.31 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 173.66 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.402 ' H ' HG22 ' A' ' 35' ' ' THR . 7.9 p-10 -51.31 -45.55 62.26 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.752 0.31 . . . . 0.0 110.748 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.6 p -137.96 -98.02 0.19 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.33 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.609 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 34.3 m 65.71 130.13 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 123.465 0.706 . . . . 0.0 111.731 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 13.9 Cg_exo -67.96 -33.61 25.65 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.085 1.857 . . . . 0.0 113.143 -177.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -64.66 -28.68 69.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.912 0.387 . . . . 0.0 110.822 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.609 ' SG ' ' HB2' ' A' ' 38' ' ' CYS . 52.3 m -70.26 -36.56 74.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.987 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.476 ' O ' ' HB3' ' A' ' 45' ' ' GLN . 41.4 t -75.38 -33.21 27.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.427 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.98 -51.11 63.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.195 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.535 ' HE3' ' HB2' ' A' ' 103' ' ' MET . 25.5 ttt -68.21 -29.37 68.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.193 0.52 . . . . 0.0 109.717 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.476 ' HB3' ' O ' ' A' ' 42' ' ' VAL . 4.6 tp60 -58.12 -38.99 77.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.575 174.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.676 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -67.81 -42.23 81.87 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.402 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.597 ' O ' HG22 ' A' ' 51' ' ' VAL . 7.6 mm-40 -57.9 -45.27 86.7 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.346 0.404 . . . . 0.0 110.479 173.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.533 HD23 HD13 ' A' ' 108' ' ' ILE . 96.1 mt -58.16 -44.13 87.77 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.897 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.1 m -60.21 -37.9 81.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.662 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.56 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 20.2 m-85 -74.85 -28.55 60.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.993 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 47' ' ' GLU . 68.7 t -65.47 -44.25 94.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.6 m -65.32 -31.54 72.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.369 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 50' ' ' TYR . 41.8 tttm -58.73 -39.25 80.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.809 173.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 50' ' ' TYR . 31.6 mm-40 -85.69 -17.9 34.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.843 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.589 ' NE ' ' HA ' ' A' ' 55' ' ' ARG . 3.0 tpm_? -153.0 88.93 1.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 111.569 -176.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.28 147.07 28.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.348 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.478 ' HA2' HD22 ' A' ' 15' ' ' ASN . . . 59.17 39.86 95.01 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.773 -0.648 . . . . 0.0 114.497 171.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.497 ' O ' ' HD2' ' A' ' 28' ' ' PRO . 69.5 mmtt -133.28 1.52 3.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.207 0.504 . . . . 0.0 110.791 175.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -170.46 153.69 4.39 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.42 ' HB3' HG23 ' A' ' 17' ' ' VAL . 83.1 m-20 -121.28 138.25 54.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.847 0.356 . . . . 0.0 110.428 177.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.404 HD11 ' N ' ' A' ' 61' ' ' ILE . 4.5 mp -101.94 108.26 23.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.212 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.698 ' OH ' ' HG ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -89.55 115.23 26.8 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 177.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.697 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 86.9 m-85 -95.07 104.18 16.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.02 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.601 ' C ' HD22 ' A' ' 71' ' ' ASN . . . -87.77 107.01 18.45 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.677 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 9.7 ptt180 -105.56 130.24 53.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.228 -177.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.713 HD11 HD21 ' A' ' 71' ' ' ASN . 8.0 mp -71.85 7.73 1.45 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.152 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.671 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 44.7 mt-10 -62.14 -34.26 76.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.415 0.626 . . . . 0.0 109.485 169.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.669 ' HB2' ' HD2' ' A' ' 70' ' ' LYS . 35.6 mt-10 -104.58 172.95 6.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.53 -170.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.79 -24.35 17.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.779 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.669 ' HD2' ' HB2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -54.27 -17.55 3.03 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.197 0.522 . . . . 0.0 111.862 176.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.713 HD21 HD11 ' A' ' 66' ' ' LEU . 5.7 m-20 -80.58 -9.76 59.77 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.2 mm -61.56 -58.75 6.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.602 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.469 ' CG ' ' HZ1' ' A' ' 77' ' ' LYS . 10.3 t70 -70.54 -40.87 73.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.627 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.698 ' HG ' ' OH ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -62.93 -46.5 87.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.691 -176.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.576 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -62.49 -49.52 75.05 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.71 0.291 . . . . 0.0 110.916 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -65.92 -33.93 76.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.06 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.469 ' HZ1' ' CG ' ' A' ' 73' ' ' ASP . 16.2 ttmm -61.8 -25.22 67.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.999 0.428 . . . . 0.0 110.878 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 33' ' ' PHE . 90.2 m-85 -124.48 23.05 8.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.911 -176.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 66.03 25.7 10.9 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.595 0.559 . . . . 0.0 111.442 166.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.76 97.53 8.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.851 0.358 . . . . 0.0 111.238 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -106.07 -36.09 7.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.16 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.9 pt -132.74 141.39 45.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.966 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.46 HG13 ' HA ' ' A' ' 34' ' ' LYS . 34.7 m -102.57 157.78 33.04 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.434 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.885 ' HB3' ' HE2' ' A' ' 32' ' ' MET . 20.8 Cg_exo -67.29 150.48 83.01 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.054 -1.227 . . . . 0.0 112.401 -0.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 32' ' ' MET . 1.2 m -135.06 108.35 7.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -176.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.04 109.04 16.97 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.001 0.429 . . . . 0.0 110.822 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.648 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 12.6 p -100.78 123.97 54.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.516 0.674 . . . . 0.0 109.362 175.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.508 ' HB3' HD22 ' A' ' 115' ' ' LEU . 85.4 m-85 -99.01 110.43 23.04 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.497 -176.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.617 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 6.7 mp -102.83 129.65 49.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.734 176.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -68.35 169.83 9.94 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.774 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.574 ' HE2' ' O ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -61.76 -14.33 31.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -175.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.67 -5.39 58.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 111.26 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.81 10.8 71.86 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.604 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 8.6 p30 -86.67 131.32 34.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.806 0.336 . . . . 0.0 110.66 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.617 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 20.5 ptmt -77.28 87.17 3.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.217 0.532 . . . . 0.0 109.859 175.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -74.79 -53.64 8.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.618 -173.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.525 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 63.4 t80 -137.54 114.46 10.65 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.866 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 87' ' ' VAL . 4.4 p -96.66 137.0 25.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 172.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.525 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 48.6 t60 -134.1 134.29 42.1 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -175.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.41 131.91 54.64 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 173.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 122.75 173.38 14.15 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.264 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.8 tp -82.01 141.12 33.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.824 0.345 . . . . 0.0 111.323 -175.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.535 ' HB2' ' HE3' ' A' ' 44' ' ' MET . 78.4 mmm -134.15 161.29 35.29 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.419 ' O ' HG13 ' A' ' 108' ' ' ILE . 17.5 mmm180 -106.86 171.52 7.32 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.489 ' HE2' ' CB ' ' A' ' 50' ' ' TYR . 36.5 ttmt -46.62 -60.29 2.47 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.6 0.562 . . . . 0.0 112.004 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.561 ' HA ' ' OE1' ' A' ' 109' ' ' GLU . 6.7 t-20 -67.66 -27.46 66.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.065 0.46 . . . . 0.0 111.12 -174.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.501 ' HB3' ' HE1' ' A' ' 103' ' ' MET . 13.1 m120 -67.4 -42.76 82.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.533 HD13 HD23 ' A' ' 48' ' ' LEU . 56.7 mt -61.7 -46.15 97.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.369 173.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.561 ' OE1' ' HA ' ' A' ' 106' ' ' ASN . 50.9 mt-10 -52.79 -48.03 67.16 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.539 176.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.1 m -61.27 -37.5 83.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.095 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 107' ' ' ASN . 49.7 mm -69.04 -43.79 81.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.328 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.522 ' HB3' ' CG2' ' A' ' 117' ' ' VAL . 72.8 mt -61.7 -39.22 90.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.907 0.384 . . . . 0.0 110.107 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -58.15 -38.05 75.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.799 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.0 m -86.22 -5.74 59.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.029 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.508 HD22 ' HB3' ' A' ' 88' ' ' PHE . 53.9 tp -93.47 -66.72 0.9 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.704 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 174.9 -72.23 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.78 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.696 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 21.4 t 55.32 29.62 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 122.493 1.14 . . . . 0.0 109.719 -177.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.42 ' O ' ' HD2' ' A' ' 91' ' ' LYS . 17.8 pttm . . . . . 0 N--CA 1.447 -0.575 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.962 -175.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.55 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 6.8 m . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.416 ' HB ' ' O ' ' A' ' 13' ' ' SER . 74.5 mt 74.0 -63.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 123.733 0.645 . . . . 0.0 110.37 -174.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.698 ' HB3' ' HA2' ' A' ' 57' ' ' GLY . 0.5 OUTLIER -87.83 32.08 0.75 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.333 0.587 . . . . 0.0 110.581 174.513 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.657 HG22 ' CE1' ' A' ' 63' ' ' TYR . 1.2 p -86.61 111.35 21.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.789 174.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 22' ' ' GLU . 20.8 m -114.0 136.42 50.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.107 0.479 . . . . 0.0 109.933 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -65.54 -54.46 27.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.894 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.735 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 4.9 t30 -144.87 179.33 7.4 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.295 -174.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.407 HD12 HD22 ' A' ' 74' ' ' LEU . 96.5 mt -48.1 -42.0 27.81 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.261 0.624 . . . . 0.0 112.578 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -58.25 -32.22 68.15 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.557 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . 21.1 mt-10 -84.25 -6.07 59.34 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.49 151.73 26.38 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.188 -0.32 . . . . 0.0 111.136 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -172.41 -171.07 0.77 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.495 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 2.4 tp10 72.26 -174.01 0.16 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.43 1.092 . . . . 0.0 111.215 178.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.495 ' H ' ' HG3' ' A' ' 25' ' ' GLU . . . -106.26 36.81 4.16 Favored Glycine 0 CA--C 1.504 -0.611 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 58' ' ' LYS . 17.6 pt -105.93 150.16 38.91 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 114.45 -0.875 . . . . 0.0 111.228 -170.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 1.065 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 62.5 Cg_exo -57.05 158.94 16.12 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.984 2.456 . . . . 0.0 112.304 175.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.6 m -115.9 121.78 43.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.929 -175.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.517 HD13 HD23 ' A' ' 112' ' ' LEU . 80.0 mt -110.17 108.75 26.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.608 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 61.0 mt -105.57 113.78 43.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.824 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.9 ptm -110.25 120.49 42.62 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.515 0.674 . . . . 0.0 109.474 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.479 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 87.3 m-85 -78.73 125.56 29.53 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.505 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.657 ' HE2' ' HB3' ' A' ' 65' ' ' ARG . 29.2 pttt -116.7 -174.26 2.54 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.755 -171.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.45 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 2.1 m -144.98 154.57 42.7 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.415 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 1.8 t70 -47.58 -51.9 19.55 Favored 'General case' 0 C--N 1.32 -0.674 0 O-C-N 124.239 0.962 . . . . 0.0 111.558 174.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.2 m -116.76 98.74 6.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.64 0.257 . . . . 0.0 111.637 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.45 ' SG ' ' HB ' ' A' ' 35' ' ' THR . 7.3 p -169.46 113.44 0.51 Allowed Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.901 171.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.55 ' O ' HG13 ' A' ' 42' ' ' VAL . 2.4 Cg_endo -80.49 -4.62 13.07 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.533 2.155 . . . . 0.0 113.605 -175.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -74.77 -21.8 59.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.834 0.35 . . . . 0.0 110.477 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 82.5 m -68.53 -43.45 76.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.817 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 39' ' ' PRO . 9.8 p -65.56 -29.31 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 120.93 0.395 . . . . 0.0 110.702 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.631 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -65.14 -48.76 72.45 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.28 0.562 . . . . 0.0 109.68 177.43 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.455 ' HE1' HG23 ' A' ' 86' ' ' THR . 25.2 ttt -67.69 -30.16 69.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.867 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.544 ' HG2' ' CE2' ' A' ' 63' ' ' TYR . 27.0 mt-30 -56.22 -40.76 74.56 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.384 173.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.631 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 3.6 mtpm? -59.1 -53.98 52.21 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.174 0.511 . . . . 0.0 110.259 177.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -62.21 -41.3 98.26 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.971 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.714 HD11 HG21 ' A' ' 61' ' ' ILE . 84.3 mt -62.22 -43.04 99.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.472 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.3 m -53.61 -44.24 69.29 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.73 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -63.73 -61.7 2.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.219 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.8 t -57.08 -32.16 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.2 0.524 . . . . 0.0 111.284 -175.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.537 ' HB3' ' OD1' ' A' ' 15' ' ' ASN . 68.0 m -66.83 -30.48 70.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.789 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -83.49 -31.14 26.66 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.066 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -71.14 -15.4 62.5 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.424 0.631 . . . . 0.0 110.865 174.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.63 ' HA ' HH11 ' A' ' 55' ' ' ARG . 0.5 OUTLIER -141.86 77.62 1.59 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 174.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 1.3 pm0 -58.27 115.63 3.07 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -161.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.698 ' HA2' ' HB3' ' A' ' 15' ' ' ASN . . . 50.69 33.23 26.38 Favored Glycine 0 CA--C 1.52 0.35 0 CA-C-N 115.012 -0.995 . . . . 0.0 114.43 173.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 27.3 mmtp -109.73 14.93 23.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.571 0.701 . . . . 0.0 111.279 -176.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -159.66 111.03 2.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.199 166.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -76.48 131.38 38.99 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.093 -174.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.714 HG21 HD11 ' A' ' 48' ' ' LEU . 30.1 mm -97.87 108.49 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.445 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.735 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 1.4 t80 -95.87 110.97 23.07 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.657 ' CE1' HG22 ' A' ' 16' ' ' VAL . 36.8 m-85 -90.77 102.04 14.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.059 177.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -78.97 103.98 9.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.8 0.333 . . . . 0.0 111.424 -172.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.657 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 13.6 ptp180 -68.29 123.95 22.15 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.307 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.0 tp -79.8 8.15 7.32 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 121.808 -0.557 . . . . 0.0 109.969 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.434 ' OE1' ' HB2' ' A' ' 65' ' ' ARG . 2.4 mp0 -84.07 -28.02 27.87 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.199 -172.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -119.21 -177.52 3.37 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -170.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -36.3 20.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.121 -169.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HD2' ' H ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -57.56 -29.57 64.51 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.876 0.846 . . . . 0.0 110.758 -179.234 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.92 -11.32 58.27 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.032 -174.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.4 mm -67.85 -44.56 85.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.425 ' CG ' ' HZ2' ' A' ' 77' ' ' LYS . 10.4 t70 -67.49 -47.51 69.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.54 176.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.407 HD22 HD12 ' A' ' 20' ' ' LEU . 2.0 tm? -60.31 -46.18 90.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.553 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.88 -43.52 98.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.488 0.185 . . . . 0.0 110.831 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -63.09 -34.19 77.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 0.0 110.805 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.425 ' HZ2' ' CG ' ' A' ' 73' ' ' ASP . 47.8 mttp -60.74 -16.85 44.36 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.367 0.604 . . . . 0.0 111.622 176.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.451 ' CD2' ' HE3' ' A' ' 95' ' ' LYS . 32.4 m-85 -124.3 4.02 8.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.435 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.6 t70 54.29 33.8 19.1 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.952 0.882 . . . . 0.0 110.425 -174.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.69 84.75 7.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.004 -176.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -103.14 5.05 37.63 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.934 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.6 pt -128.68 141.21 47.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.777 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 m -127.97 143.63 48.5 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.738 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -92.54 136.14 7.86 Favored 'Cis proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.579 -1.426 . . . . 0.0 111.983 -1.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.68 128.43 54.9 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.937 0.399 . . . . 0.0 111.022 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.455 HG23 ' HE1' ' A' ' 44' ' ' MET . 4.4 m -109.29 118.07 35.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.425 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.608 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 14.8 p -108.29 135.46 46.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.083 0.468 . . . . 0.0 110.13 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.418 ' HZ ' ' HE1' ' A' ' 103' ' ' MET . 93.9 m-85 -111.0 114.62 28.07 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.551 -177.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.501 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 4.8 mp -117.24 143.14 46.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.829 177.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.526 ' HA ' ' HB3' ' A' ' 28' ' ' PRO . 5.4 t0 -80.73 179.64 7.7 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 170.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.91 ' HZ3' ' HB3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -74.4 -14.19 60.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.92 0.391 . . . . 0.0 110.56 -177.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -70.8 -12.34 61.49 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.713 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.64 11.65 63.65 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.13 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 34.6 m-80 -79.0 113.93 17.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.693 0.283 . . . . 0.0 111.295 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.501 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 57.6 mtpt -71.43 95.47 1.36 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.205 172.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -87.58 -54.46 4.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.626 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -134.24 148.95 50.92 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.561 -172.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.0 m -129.54 147.1 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.599 174.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -140.16 139.02 35.65 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -104.43 122.65 45.94 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.555 0.534 . . . . 0.0 109.767 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.52 -161.78 17.89 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.988 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.412 HD21 ' OE1' ' A' ' 43' ' ' GLU . 44.0 tp -90.03 164.33 14.55 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 122.651 0.38 . . . . 0.0 111.154 -174.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.418 ' HE1' ' HZ ' ' A' ' 88' ' ' PHE . 58.3 mtm -149.45 172.12 15.48 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 122.937 0.495 . . . . 0.0 110.054 174.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 104' ' ' ARG . 8.0 mmt180 -100.95 163.14 12.44 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.452 ' HA ' HD11 ' A' ' 108' ' ' ILE . 6.3 ptpp? -56.1 -40.98 74.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -62.15 -30.6 71.16 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.927 0.394 . . . . 0.0 111.525 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.524 ' O ' HG12 ' A' ' 111' ' ' ILE . 10.3 m120 -67.93 -45.74 73.47 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 176.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.592 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 50.1 mt -58.93 -48.1 87.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.586 174.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -50.13 -50.41 48.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.363 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.9 m -65.47 -40.33 93.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.318 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 107' ' ' ASN . 47.5 mm -67.1 -41.12 86.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.712 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 87.5 mt -59.59 -39.95 85.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.114 0.483 . . . . 0.0 109.942 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -61.21 -36.71 80.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.015 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 62.6 m -85.36 -16.72 38.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.63 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.6 tp -78.38 -81.91 0.1 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.084 0.468 . . . . 0.0 110.039 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.418 ' HA3' ' OD2' ' A' ' 90' ' ' ASP . . . 171.49 -54.95 0.18 Allowed Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 174.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 1.065 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 29.1 t 50.42 78.23 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.059 0 CA-C-O 121.561 0.696 . . . . 0.0 111.308 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.761 ' HB2' ' HZ2' ' A' ' 91' ' ' LYS . 28.3 mtmm . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.753 -175.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.51 ' HB3' HG13 ' A' ' 16' ' ' VAL . 50.4 m . . . . . 0 C--O 1.225 -0.211 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 15' ' ' ASN . 94.9 mt -99.07 146.75 7.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.475 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 82.5 m-20 75.26 14.63 2.98 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.935 0.772 . . . . 0.0 109.985 -173.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.738 HG11 HD12 ' A' ' 61' ' ' ILE . 2.4 m -107.88 157.28 8.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.431 -176.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 p -129.57 149.09 33.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.349 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -64.02 -56.39 15.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.184 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.7 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 3.0 t30 -157.95 177.96 10.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.382 -0.827 . . . . 0.0 108.831 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.417 ' HG ' ' CE2' ' A' ' 62' ' ' TYR . 30.7 mt -59.45 -30.77 68.74 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.08 -38.64 70.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.294 0.569 . . . . 0.0 110.659 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -87.94 -5.5 58.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.28 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.515 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -85.48 162.98 18.72 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -172.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 23' ' ' ALA . 4.6 mtmm -167.21 90.77 0.37 Allowed 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 124.78 1.232 . . . . 0.0 107.883 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.34 107.43 18.26 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -159.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -116.28 12.05 16.67 Favored Glycine 0 CA--C 1.503 -0.673 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 159.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.446 ' C ' ' HA ' ' A' ' 91' ' ' LYS . 3.0 pt -122.18 152.9 61.11 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 113.22 -1.49 . . . . 0.0 108.529 -176.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.535 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 50.3 Cg_exo -55.62 122.68 12.17 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 121.816 1.677 . . . . 0.0 111.719 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.5 m -99.0 115.8 29.77 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.944 -176.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.518 HD11 HD11 ' A' ' 112' ' ' LEU . 2.1 mp -98.42 108.21 21.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 176.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.682 ' HB ' HG23 ' A' ' 87' ' ' VAL . 62.4 mt -108.45 110.72 33.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.289 -176.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.502 ' HB3' HG23 ' A' ' 86' ' ' THR . 5.0 ppp? -117.2 142.7 46.71 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.022 176.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.654 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 82.7 m-85 -102.15 144.49 30.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.68 -174.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.85 ' HE2' ' HB3' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -138.85 135.59 34.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.024 177.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.4 m -81.71 162.09 23.11 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -50.52 -49.69 55.03 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.27 0.356 . . . . 0.0 111.539 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.3 m -109.32 95.79 5.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.628 0.251 . . . . 0.0 111.275 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.3 p -165.54 131.35 2.02 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 111.462 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.557 ' O ' HG11 ' A' ' 42' ' ' VAL . 64.0 Cg_endo -77.86 -19.69 12.34 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.382 2.055 . . . . 0.0 112.809 177.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.555 ' HB3' ' HG3' ' A' ' 84' ' ' PRO . 54.8 m-85 -58.9 -24.03 61.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.064 0.459 . . . . 0.0 110.82 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 45.3 t -64.12 -50.44 68.22 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.641 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.557 HG11 ' O ' ' A' ' 39' ' ' PRO . 10.0 p -68.34 -32.82 57.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.022 -174.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.591 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 16.2 mt-10 -65.87 -49.91 66.41 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 120.667 0.27 . . . . 0.0 110.993 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -36.96 85.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.917 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.529 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 25.8 mt-30 -60.74 -44.73 96.3 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 176.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.582 ' HZ1' ' HB3' ' A' ' 46' ' ' LYS . 9.8 mtpm? -56.58 -53.68 54.8 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.064 0.459 . . . . 0.0 111.042 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 12.3 mm-40 -62.64 -43.86 97.74 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.131 -174.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.568 ' HB3' HD13 ' A' ' 61' ' ' ILE . 47.6 mt -59.68 -43.11 94.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.954 175.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.4 m -58.77 -41.18 86.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.05 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.417 ' CD2' ' HA ' ' A' ' 47' ' ' GLU . 24.6 m-85 -59.79 -48.72 80.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.054 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.69 HG22 ' HG3' ' A' ' 105' ' ' LYS . 3.0 t -60.48 -43.37 94.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.039 0.447 . . . . 0.0 110.539 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -62.75 -30.83 71.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.376 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -56.94 -38.04 72.36 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.163 0.506 . . . . 0.0 110.522 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -94.42 2.53 55.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.458 -172.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.558 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 9.4 ptp180 -156.76 85.49 0.97 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.918 0.866 . . . . 0.0 111.553 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.403 ' HA ' HD22 ' A' ' 15' ' ' ASN . 1.1 pm0 -76.68 128.45 34.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.082 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.32 41.51 98.15 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.667 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.558 ' HG2' ' HB2' ' A' ' 55' ' ' ARG . 13.9 mptt -108.63 -27.4 9.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.227 0.537 . . . . 0.0 110.009 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -158.56 154.58 26.87 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.082 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 15' ' ' ASN . 50.2 t30 -108.84 134.05 52.05 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.907 0.384 . . . . 0.0 110.302 -177.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.738 HD12 HG11 ' A' ' 16' ' ' VAL . 34.0 mt -106.78 108.74 25.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.757 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.7 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -96.94 119.93 36.33 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.85 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 68.6 m-85 -94.4 103.47 15.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.598 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.18 101.18 13.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.069 0.461 . . . . 0.0 110.764 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.57 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 29.0 ptt180 -91.75 131.38 37.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.011 178.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.07 9.79 1.81 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.428 0.632 . . . . 0.0 111.215 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.436 ' HB3' ' HD2' ' A' ' 65' ' ' ARG . 57.1 tt0 -78.43 -22.55 47.5 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.543 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.485 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 45.7 mt-10 -110.39 140.24 44.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.043 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.575 ' HA ' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -59.06 -35.41 73.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.159 0.584 . . . . 0.0 112.516 -174.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HE3' ' HB3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -58.97 -27.99 65.9 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.934 0.397 . . . . 0.0 111.22 -177.611 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.47 ' HA ' ' CB ' ' A' ' 74' ' ' LEU . 87.2 m-20 -92.37 2.68 56.51 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.189 -175.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.575 HD11 ' HA ' ' A' ' 69' ' ' GLU . 1.4 mp -71.09 -52.46 27.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.97 -46.17 89.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.811 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.47 ' CB ' ' HA ' ' A' ' 71' ' ' ASN . 0.5 OUTLIER -55.05 -44.47 74.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.567 179.409 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.654 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -55.93 -56.38 21.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.52 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -70.46 -33.12 70.92 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.577 -176.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 77' ' ' LYS . 21.7 ttmt -67.04 -17.19 64.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.355 0.598 . . . . 0.0 110.737 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.439 ' HB2' ' HZ ' ' A' ' 33' ' ' PHE . 51.1 m-85 -118.61 23.67 11.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.391 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 73.15 10.98 5.15 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.095 166.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.09 93.56 7.04 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.33 0.586 . . . . 0.0 111.034 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -101.8 -12.54 18.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.796 175.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 23.9 pt -136.81 -179.51 2.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.641 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.48 145.1 47.83 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.685 0.279 . . . . 0.0 111.117 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.713 ' HD2' ' HA2' ' A' ' 101' ' ' GLY . 97.9 Cg_endo -93.87 120.14 2.84 Favored 'Cis proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.258 -1.559 . . . . 0.0 112.529 -1.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.428 ' O ' ' HD1' ' A' ' 33' ' ' PHE . 70.0 m -92.36 124.54 36.49 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.502 HG23 ' HB3' ' A' ' 32' ' ' MET . 10.5 m -114.57 116.41 28.74 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.213 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.698 HG11 HG12 ' A' ' 98' ' ' VAL . 13.6 m -100.69 123.09 53.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.296 0.57 . . . . 0.0 110.112 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.751 ' HB3' HD13 ' A' ' 115' ' ' LEU . 86.7 m-85 -99.47 110.3 22.79 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.992 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.658 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 5.8 mp -107.1 143.48 35.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.586 175.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.568 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 13.4 t70 -88.18 -165.45 1.32 Allowed 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.625 175.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.568 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -52.28 -35.52 50.45 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -169.311 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.73 18.85 20.88 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.666 -173.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.37 23.67 50.22 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.832 172.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.658 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 32.0 m-80 -77.06 112.65 13.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 117.391 0.595 . . . . 0.0 110.757 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -68.19 85.38 0.25 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -84.42 -45.21 12.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.296 -173.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.455 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 90.9 t80 -140.23 129.32 23.58 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.365 -176.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.698 HG12 HG11 ' A' ' 87' ' ' VAL . 15.0 m -107.92 148.01 12.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 172.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.455 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 62.6 t60 -136.76 128.81 29.49 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -177.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -99.82 120.57 39.96 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.713 ' HA2' ' HD2' ' A' ' 84' ' ' PRO . . . 101.91 166.71 27.09 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -175.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.1 169.22 10.58 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 117.198 0.499 . . . . 0.0 110.181 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.46 ' HE2' HD13 ' A' ' 111' ' ' ILE . 19.6 ptt? -157.14 168.07 28.52 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.415 ' N ' ' HD2' ' A' ' 104' ' ' ARG . 5.5 mmm180 -91.29 174.11 7.56 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.975 -171.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.69 ' HG3' HG22 ' A' ' 51' ' ' VAL . 55.0 tttm -46.46 -55.19 7.83 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.851 0.719 . . . . 0.0 112.469 -176.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -59.27 -34.78 72.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 0.0 111.334 -175.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -69.31 -50.15 49.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.145 0.498 . . . . 0.0 109.774 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.483 ' O ' HD23 ' A' ' 112' ' ' LEU . 41.7 mt -60.5 -49.56 83.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.933 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.483 ' HA ' HD21 ' A' ' 112' ' ' LEU . 35.0 tt0 -56.31 -47.77 78.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.452 -174.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.6 m -59.91 -31.36 69.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.441 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.552 ' O ' ' HG ' ' A' ' 115' ' ' LEU . 66.6 mt -72.6 -33.8 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.065 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.538 ' HB3' HG21 ' A' ' 117' ' ' VAL . 2.7 mm? -62.53 -38.7 90.99 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.187 172.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -63.81 -27.39 69.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.646 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.6 t -85.75 -14.03 46.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.061 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.751 HD13 ' HB3' ' A' ' 88' ' ' PHE . 95.7 mt -85.17 -73.98 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.383 0.611 . . . . 0.0 109.766 176.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 173.67 -59.81 0.14 Allowed Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.332 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.538 HG21 ' HB3' ' A' ' 112' ' ' LEU . 39.3 t 52.22 41.84 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 122.951 1.358 . . . . 0.0 108.021 -175.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.7 pttm . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 113.901 -1.5 . . . . 0.0 112.58 -165.383 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.443 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 13.2 m . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.619 0.247 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.3 mt 69.06 -68.8 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.881 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.23 59.66 5.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.563 0.697 . . . . 0.0 110.121 174.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.443 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 1.0 OUTLIER -98.26 128.85 49.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.886 177.104 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.542 HG23 ' HG3' ' A' ' 22' ' ' GLU . 2.4 t -124.62 141.6 44.21 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-O 121.633 0.73 . . . . 0.0 112.567 -172.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -76.76 -35.49 57.69 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 113.864 -1.516 . . . . 0.0 112.38 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.756 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 66.0 t30 -172.6 -178.85 2.03 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.437 ' H ' ' CG ' ' A' ' 19' ' ' ASN . 83.5 mt -60.38 -29.66 69.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.756 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -78.57 -31.67 47.38 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.094 0.406 . . . . 0.0 110.988 -178.433 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.542 ' HG3' HG23 ' A' ' 17' ' ' VAL . 3.9 tp10 -72.42 -11.88 60.87 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.679 0.752 . . . . 0.0 109.876 170.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.461 ' HB3' HG11 ' A' ' 17' ' ' VAL . . . -95.14 171.73 8.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.435 -177.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.523 ' NZ ' ' HB3' ' A' ' 24' ' ' LYS . 4.3 mtpm? -135.01 167.32 21.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.125 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -86.44 174.81 8.74 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.267 170.124 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.02 -61.58 1.59 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.662 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -87.79 127.47 57.9 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-O 120.88 0.371 . . . . 0.0 110.047 178.081 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.937 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 50.9 Cg_exo -56.22 145.28 77.79 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.397 2.065 . . . . 0.0 111.118 176.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.5 m -119.54 129.61 54.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.18 0.514 . . . . 0.0 111.979 -172.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.614 HD13 HD21 ' A' ' 112' ' ' LEU . 79.6 mt -98.48 121.51 49.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.714 HG12 ' HB3' ' A' ' 62' ' ' TYR . 61.2 mt -118.58 119.85 62.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.146 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.42 ' O ' ' HG3' ' A' ' 32' ' ' MET . 26.5 ptm -108.0 117.48 34.24 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.983 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.52 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 87.4 m-85 -86.41 114.2 22.99 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.361 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.721 ' HG3' ' SG ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -138.71 145.15 39.96 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.741 -174.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 m -66.92 136.18 54.97 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 164.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -65.03 -39.38 93.3 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.792 -164.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 m -98.18 92.99 6.0 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.822 0.344 . . . . 0.0 111.153 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.637 ' SG ' ' HB2' ' A' ' 41' ' ' CYS . 25.7 p -160.87 142.68 9.12 Favored Pre-proline 0 CA--C 1.519 -0.236 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.351 174.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -64.92 -34.39 48.47 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.499 2.133 . . . . 0.0 112.48 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -68.66 -21.62 64.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 -177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.721 ' SG ' ' HG3' ' A' ' 34' ' ' LYS . 39.7 t -61.33 -53.43 56.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.022 175.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.23 -34.3 69.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.835 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -63.48 -50.24 70.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.403 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -71.74 -31.03 66.24 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.545 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 22.8 mt-30 -63.17 -33.59 75.79 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.543 173.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt -64.66 -46.65 81.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.548 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.594 ' O ' HG21 ' A' ' 51' ' ' VAL . 58.2 mm-40 -52.29 -54.52 30.44 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 123.572 0.545 . . . . 0.0 109.557 175.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.449 HD23 HD12 ' A' ' 108' ' ' ILE . 63.7 mt -57.37 -43.56 83.66 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.792 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.1 t -60.75 -39.94 90.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.164 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -76.36 -30.29 57.52 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.842 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.833 HG23 ' HG3' ' A' ' 105' ' ' LYS . 41.9 t -66.12 -39.54 84.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.254 0.55 . . . . 0.0 109.61 172.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.51 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 31.3 m -64.23 -31.66 72.95 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.889 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.421 ' HD2' ' HA ' ' A' ' 53' ' ' LYS . 4.2 mmmp? -74.44 -10.91 60.03 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.737 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -102.72 -8.72 20.63 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.23 0.538 . . . . 0.0 109.676 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.749 ' CZ ' ' HA ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -158.07 75.7 0.76 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.281 -178.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.51 ' HG3' ' O ' ' A' ' 52' ' ' SER . 20.1 mp0 -79.07 141.34 37.45 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.252 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.5 25.55 60.89 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.991 171.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.609 ' HB3' ' HG3' ' A' ' 55' ' ' ARG . 16.9 tptp -117.07 -21.82 8.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.352 0.596 . . . . 0.0 109.738 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.421 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 43.9 p90 -140.56 161.19 38.32 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 172.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -112.42 151.88 29.33 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 121.128 -0.229 . . . . 0.0 110.681 -174.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.404 HD11 ' HB3' ' A' ' 48' ' ' LEU . 58.3 mt -127.07 111.81 26.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.921 0.391 . . . . 0.0 111.124 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.714 ' HB3' HG12 ' A' ' 31' ' ' ILE . 2.5 t80 -103.24 119.74 39.43 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.545 ' CE1' ' HG2' ' A' ' 45' ' ' GLN . 87.1 m-85 -90.44 103.92 16.55 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.788 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.52 ' HB1' ' HA ' ' A' ' 33' ' ' PHE . . . -80.82 94.35 6.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.406 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.475 ' C ' ' H ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -88.13 116.31 26.23 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.37 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 mp -66.36 11.58 0.08 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.871 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.475 ' H ' ' C ' ' A' ' 65' ' ' ARG . 35.0 tt0 -78.46 -32.09 48.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.757 0.789 . . . . 0.0 109.36 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -98.43 140.75 32.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.976 -172.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -31.48 72.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.886 -175.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.477 ' H ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -57.67 -19.09 24.37 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 178.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.552 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 52.4 m-80 -87.08 -2.51 58.68 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.729 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 84.5 mt -70.3 -56.8 9.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -64.6 -40.04 94.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.219 175.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 71' ' ' ASN . 0.4 OUTLIER -58.89 -47.18 85.88 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.033 178.204 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.429 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -62.71 -45.65 91.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.772 0.32 . . . . 0.0 111.226 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -62.93 -34.56 77.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.314 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -57.58 -31.11 65.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.018 0.437 . . . . 0.0 111.142 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -111.81 1.98 16.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.422 -176.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.3 t70 60.66 48.02 7.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.912 0.863 . . . . 0.0 110.332 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.38 116.13 28.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.364 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -107.81 -57.86 2.05 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.891 -171.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 36.6 pt -119.72 154.2 22.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.088 0.47 . . . . 0.0 111.078 -177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.2 m -102.62 153.7 37.99 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.868 -177.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -89.66 127.91 7.64 Favored 'Cis proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.057 -1.643 . . . . 0.0 112.277 -0.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.0 t -120.81 134.3 55.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.077 0.465 . . . . 0.0 109.995 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.3 m -115.21 125.26 53.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.941 -176.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.426 HG23 HG23 ' A' ' 98' ' ' VAL . 66.3 t -105.24 127.87 59.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.046 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -107.83 114.42 28.36 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.242 0.544 . . . . 0.0 110.224 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.53 ' HB3' ' HA2' ' A' ' 93' ' ' GLY . 58.3 mt -99.16 142.29 30.83 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.69 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 6.4 t70 -71.25 -165.46 0.13 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.938 ' HD3' ' HG3' ' A' ' 118' ' ' LYS . 9.7 pttm -61.58 -31.73 71.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -170.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.535 ' CD ' ' HZ2' ' A' ' 91' ' ' LYS . 4.8 mp0 -96.32 1.88 52.3 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.91 -0.494 . . . . 0.0 110.838 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.53 ' HA2' ' HB3' ' A' ' 89' ' ' LEU . . . 85.93 26.53 34.27 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.061 -176.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.458 ' ND2' ' HB2' ' A' ' 92' ' ' GLU . 63.4 m-80 -85.34 141.06 30.3 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 176.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.3 94.15 5.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.594 -174.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -84.23 -52.33 6.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.108 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.415 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 72.0 t80 -133.86 144.85 49.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 -178.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.426 HG23 HG23 ' A' ' 87' ' ' VAL . 3.4 p -136.47 136.95 48.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.415 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 74.8 t60 -120.18 137.02 54.42 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -174.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -112.67 112.46 23.99 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 123.568 0.542 . . . . 0.0 109.752 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.65 -177.67 16.42 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 44.7 tp -76.63 155.67 33.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.007 0.432 . . . . 0.0 111.042 -177.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.1 ptm -159.73 146.58 16.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 175.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.448 ' O ' HG13 ' A' ' 108' ' ' ILE . 35.2 mmt180 -98.8 174.31 6.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.869 0.366 . . . . 0.0 111.827 -174.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.833 ' HG3' HG23 ' A' ' 51' ' ' VAL . 63.7 tttm -46.23 -54.27 9.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.898 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.51 ' HA ' ' CD ' ' A' ' 109' ' ' GLU . 26.9 t-20 -65.74 -28.46 69.06 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.141 0.496 . . . . 0.0 111.446 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.474 ' O ' HD11 ' A' ' 111' ' ' ILE . 9.7 m120 -67.22 -38.95 86.13 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.537 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 42.0 mt -64.58 -47.08 90.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.528 174.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.55 ' OE2' ' HG2' ' A' ' 105' ' ' LYS . 68.1 mt-10 -49.71 -54.75 17.0 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.446 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.523 ' O ' ' HB3' ' A' ' 113' ' ' ASN . 25.4 m -67.41 -31.3 71.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.052 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.474 HD11 ' O ' ' A' ' 107' ' ' ASN . 1.4 mp -71.58 -41.69 71.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.778 178.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.614 HD21 HD13 ' A' ' 30' ' ' ILE . 56.4 mt -62.74 -33.25 74.74 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.523 ' HB3' ' O ' ' A' ' 110' ' ' THR . 23.2 t-20 -57.8 -44.41 86.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.918 178.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.8 m -85.13 -23.03 28.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.271 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.46 HD21 ' O ' ' A' ' 89' ' ' LEU . 62.6 tp -67.78 -78.49 0.06 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.425 0.631 . . . . 0.0 109.807 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.929 ' HA3' ' HD2' ' A' ' 118' ' ' LYS . . . 172.32 -53.84 0.17 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.96 171.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.937 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 21.6 t 56.4 41.0 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 123.162 1.458 . . . . 0.0 107.545 -174.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.938 ' HG3' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 112.801 -2.0 . . . . 0.0 111.907 -169.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 49' ' ' SER . 21.3 m . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 13' ' ' SER . 97.2 mt 71.19 141.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -175.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 66.79 12.35 8.81 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.298 0.57 . . . . 0.0 110.148 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 p -81.94 135.66 24.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.82 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.71 HG11 ' HG2' ' A' ' 22' ' ' GLU . 92.7 t -134.58 143.71 37.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.123 -176.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.669 ' HG3' ' HB2' ' A' ' 19' ' ' ASN . 1.3 tp10 -69.3 -56.1 8.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.789 0.328 . . . . 0.0 111.199 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.792 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 2.9 t-20 -143.14 170.18 16.21 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.963 -167.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.49 -30.8 71.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.04 171.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.792 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 13.5 pt-20 -71.89 -13.85 61.77 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.335 0.588 . . . . 0.0 110.524 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.71 ' HG2' HG11 ' A' ' 17' ' ' VAL . 22.2 tt0 -110.62 0.65 17.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.703 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.74 162.26 20.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.121 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -154.6 148.93 26.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.649 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 81.94 164.95 0.14 Allowed 'General case' 0 C--N 1.333 -0.109 0 O-C-N 124.401 1.063 . . . . 0.0 112.295 167.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.99 56.89 4.34 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.812 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.2 pt -116.61 146.95 38.74 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.765 -0.218 . . . . 0.0 110.538 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.688 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 49.5 Cg_exo -57.71 135.56 70.06 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.838 2.359 . . . . 0.0 112.089 178.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.459 ' HA ' ' OD1' ' A' ' 60' ' ' ASN . 52.4 m -99.07 114.69 27.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.687 -177.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.549 HD13 ' HB2' ' A' ' 59' ' ' PHE . 2.0 mp -98.74 108.58 22.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.354 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.734 HG12 ' HB3' ' A' ' 62' ' ' TYR . 62.5 mt -103.56 136.81 34.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.302 -177.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.8 ptm -128.15 122.61 32.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.145 0.498 . . . . 0.0 110.279 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.767 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 96.1 m-85 -85.72 113.75 22.15 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.102 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -139.67 149.81 44.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.125 -177.297 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.452 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 9.1 p -85.14 177.46 7.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.715 -0.221 . . . . 0.0 110.5 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.429 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 15.4 t70 -60.92 -80.62 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.982 0.42 . . . . 0.0 110.759 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.5 m -82.19 98.37 8.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.005 0.431 . . . . 0.0 110.631 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.8 p -154.77 135.9 8.95 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.64 176.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.0 -26.81 30.82 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.135 1.89 . . . . 0.0 112.267 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.536 ' HB3' ' HG3' ' A' ' 84' ' ' PRO . 69.7 m-85 -58.58 -35.07 71.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.773 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.526 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 45.9 t -63.55 -53.04 58.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.186 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.485 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 43.5 t -60.89 -44.32 97.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.121 -177.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.878 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 15.0 tp10 -57.93 -50.69 72.49 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.725 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.48 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 8.1 tpt -68.02 -35.9 79.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.417 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.526 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 25.9 mt-30 -61.27 -39.39 90.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.319 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.878 ' HE3' ' HA ' ' A' ' 43' ' ' GLU . 10.1 mtmp? -56.14 -53.36 58.01 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.461 0.648 . . . . 0.0 109.39 175.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.561 ' HG3' ' HA ' ' A' ' 104' ' ' ARG . 24.7 mm-40 -62.36 -42.32 99.31 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.028 -176.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.706 HD12 HG23 ' A' ' 61' ' ' ILE . 96.4 mt -60.22 -43.33 96.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.469 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 13' ' ' SER . 45.4 t -58.2 -43.24 87.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.344 0.593 . . . . 0.0 110.078 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -65.54 -43.28 90.45 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.807 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.689 HG12 ' HG2' ' A' ' 109' ' ' GLU . 92.9 t -65.3 -48.33 83.74 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.047 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.8 m -60.9 -31.62 71.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.803 0.335 . . . . 0.0 111.312 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.884 ' HZ3' ' HB3' ' A' ' 53' ' ' LYS . 4.4 ttpm? -64.0 -24.69 67.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.152 0.501 . . . . 0.0 110.601 175.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -109.11 2.93 21.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.561 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.544 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 10.1 tpp180 -156.36 79.23 0.96 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -176.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.25 125.91 32.09 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -172.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 53.89 30.67 45.59 Favored Glycine 0 C--N 1.33 0.212 0 CA-C-N 115.903 -0.59 . . . . 0.0 113.666 174.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.544 ' HB2' ' HG3' ' A' ' 55' ' ' ARG . 61.4 mmtt -110.93 -6.19 14.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.516 0.674 . . . . 0.0 109.228 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.549 ' HB2' HD13 ' A' ' 30' ' ' ILE . 4.6 p90 -162.49 143.34 10.1 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.385 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.459 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 20.8 p-10 -111.03 136.34 50.19 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.056 0.455 . . . . 0.0 110.82 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.706 HG23 HD12 ' A' ' 48' ' ' LEU . 4.5 mp -96.96 109.5 23.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.536 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.734 ' HB3' HG12 ' A' ' 31' ' ' ILE . 1.1 t80 -89.72 115.32 27.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.247 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -80.21 104.34 10.69 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.732 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 33' ' ' PHE . . . -85.43 85.38 7.44 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.748 ' HB2' ' CD ' ' A' ' 67' ' ' GLU . 6.7 ptt180 -91.42 116.86 29.19 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.963 -170.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.409 ' HA ' HD21 ' A' ' 71' ' ' ASN . 4.1 mm? -72.04 5.82 2.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.625 -176.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.748 ' CD ' ' HB2' ' A' ' 65' ' ' ARG . 7.1 pm0 -84.58 -13.61 51.23 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.564 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 32.6 mt-10 -101.38 128.42 47.57 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.311 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -59.4 -37.39 77.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.06 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.564 ' HD2' ' HB3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -58.99 -24.59 62.86 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 122.084 0.945 . . . . 0.0 110.902 -179.132 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.496 ' N ' ' HD3' ' A' ' 70' ' ' LYS . 12.0 t30 -97.74 3.77 50.05 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.861 -172.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 73.3 mt -71.42 -51.02 36.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 169.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.33 -39.72 89.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.261 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.439 ' CB ' ' HA ' ' A' ' 71' ' ' ASN . 1.6 tm? -57.81 -42.57 84.56 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.913 176.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.767 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -51.68 -56.5 13.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.839 176.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -63.8 -32.54 74.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.504 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -62.31 -14.95 44.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.285 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.563 ' HB3' HG13 ' A' ' 87' ' ' VAL . 57.5 m-85 -127.78 21.54 6.42 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.472 ' CG ' ' HZ3' ' A' ' 95' ' ' LYS . 10.0 m-20 70.25 15.43 7.47 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.006 0.522 . . . . 0.0 111.634 172.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.23 130.05 41.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.038 0.447 . . . . 0.0 110.685 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -133.63 -40.22 0.88 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.167 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.48 HD11 ' HB3' ' A' ' 100' ' ' GLN . 36.9 pt -122.28 179.85 2.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.741 0.305 . . . . 0.0 110.5 177.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.7 m -128.51 139.27 35.05 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.704 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.536 ' HG3' ' HB3' ' A' ' 40' ' ' TYR . 79.3 Cg_endo -93.36 128.15 5.03 Favored 'Cis proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.275 -1.552 . . . . 0.0 112.796 -0.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.424 ' O ' ' HD1' ' A' ' 33' ' ' PHE . 64.6 m -108.31 114.62 28.63 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 174.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.426 ' CG2' ' HB3' ' A' ' 99' ' ' HIS . 5.1 t -108.63 122.36 46.94 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.42 0.628 . . . . 0.0 110.74 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.675 HG21 ' HB ' ' A' ' 31' ' ' ILE . 14.0 m -102.62 120.94 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.226 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.753 ' HB3' HD12 ' A' ' 115' ' ' LEU . 96.6 m-85 -99.09 112.73 24.79 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.586 -177.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.0 mt -104.17 137.32 42.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.527 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 23.8 t0 -71.58 179.13 3.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.51 ' HB2' ' HE3' ' A' ' 91' ' ' LYS . 14.8 ptmt -60.88 -13.8 18.08 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.53 -41.42 15.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.796 0.332 . . . . 0.0 110.515 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.2 -17.04 5.97 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.216 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -57.58 139.71 52.83 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.499 0.666 . . . . 0.0 111.771 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.472 ' HZ3' ' CG ' ' A' ' 79' ' ' ASP . 49.9 mtpt -77.46 90.14 3.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.443 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -78.04 -45.99 22.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -174.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.436 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 87.3 t80 -145.85 136.56 24.3 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.894 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.622 HG12 HG11 ' A' ' 87' ' ' VAL . 16.2 m -118.07 149.75 20.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 173.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.436 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 53.4 t60 -137.12 118.18 14.36 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.48 ' HB3' HD11 ' A' ' 82' ' ' ILE . 1.4 mp0 -101.32 106.43 17.6 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.875 0.734 . . . . 0.0 109.211 176.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 131.55 -176.03 19.36 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.968 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.536 HD22 ' HG2' ' A' ' 43' ' ' GLU . 34.8 tp -92.19 161.3 14.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.753 0.311 . . . . 0.0 111.051 -175.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -171.94 162.49 6.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.561 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 1.8 mpt_? -102.13 177.61 4.84 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -174.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.461 ' HA ' HD11 ' A' ' 108' ' ' ILE . 13.7 ptmm? -49.73 -43.36 47.74 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -171.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -67.05 -32.49 73.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.108 0.48 . . . . 0.0 110.374 -175.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.584 ' O ' HG12 ' A' ' 111' ' ' ILE . 15.8 m120 -67.67 -48.1 67.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.612 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.461 HD11 ' HA ' ' A' ' 105' ' ' LYS . 26.6 mt -58.6 -50.84 77.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.078 177.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.689 ' HG2' HG12 ' A' ' 51' ' ' VAL . 1.2 tm-20 -55.6 -48.93 74.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.318 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.2 m -59.81 -33.43 71.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.978 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.656 ' O ' ' HG ' ' A' ' 115' ' ' LEU . 48.9 mm -69.4 -41.05 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.723 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 8.8 mt -60.21 -45.17 94.1 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -61.16 -26.95 68.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.063 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.6 t -83.82 -25.3 30.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.753 HD12 ' HB3' ' A' ' 88' ' ' PHE . 57.2 mt -72.34 -60.7 2.1 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.746 0.784 . . . . 0.0 109.739 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.405 ' HA3' ' HZ1' ' A' ' 118' ' ' LYS . . . 158.98 -50.48 0.4 Allowed Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.15 177.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.688 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 40.0 t 53.29 42.45 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 122.808 1.289 . . . . 0.0 109.105 -177.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.494 ' O ' ' HD2' ' A' ' 91' ' ' LYS . 35.0 mtmm . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.887 -174.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.557 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 35.3 t . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 69.4 mt 70.96 -69.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.992 175.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.81 HD21 ' HB3' ' A' ' 52' ' ' SER . 54.0 m-80 -83.17 31.91 0.44 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.912 0.387 . . . . 0.0 110.426 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 13' ' ' SER . 8.7 p -97.23 148.66 5.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.283 -173.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.478 HG23 ' HB2' ' A' ' 23' ' ' ALA . 8.8 p -133.3 145.9 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.011 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -66.72 -45.1 79.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.407 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.619 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 16.1 t-20 -160.25 168.83 24.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.242 -175.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.9 mt -62.05 -29.41 70.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.84 0.352 . . . . 0.0 110.439 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -59.78 -32.22 70.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.542 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -97.21 -0.96 45.92 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.546 -177.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.478 ' HB2' HG23 ' A' ' 17' ' ' VAL . . . -107.62 171.64 7.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.371 0.605 . . . . 0.0 112.47 -170.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.639 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -129.84 155.82 45.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.897 177.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -103.54 177.24 4.9 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.772 0.32 . . . . 0.0 110.92 -176.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.578 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . 108.81 -35.53 4.9 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.723 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -105.73 152.93 40.25 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 177.009 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.76 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 63.8 Cg_exo -53.28 135.04 59.2 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.827 2.351 . . . . 0.0 112.194 177.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.8 m -106.0 112.92 26.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.425 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.431 HD13 ' HB2' ' A' ' 59' ' ' PHE . 1.7 mp -97.91 109.32 23.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.44 ' HB ' ' HB ' ' A' ' 87' ' ' VAL . 59.3 mt -103.67 126.23 58.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.598 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.434 ' O ' ' HG3' ' A' ' 32' ' ' MET . 24.3 ptm -118.81 116.97 27.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.66 0.743 . . . . 0.0 110.153 173.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 87.5 m-85 -81.5 119.05 23.25 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.346 174.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HE3' ' HB3' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -139.56 145.15 38.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.968 0.413 . . . . 0.0 111.259 -177.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.551 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 5.3 m -91.52 157.04 17.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.668 175.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.73 ' HB2' ' HG2' ' A' ' 67' ' ' GLU . 12.6 t70 -61.58 -66.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 111.841 -178.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.1 m -82.01 54.32 2.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.616 0.722 . . . . 0.0 111.407 -172.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.551 ' SG ' ' HB ' ' A' ' 35' ' ' THR . 37.4 m -145.24 113.67 4.83 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.514 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.52 -3.46 11.9 Favored 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 122.363 2.042 . . . . 0.0 113.37 -176.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -68.99 -17.33 63.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.667 0.27 . . . . 0.0 110.892 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 26.4 p -74.27 -55.36 6.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.482 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.569 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 12.4 p -60.64 -35.58 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.149 -175.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.539 ' HG2' HD21 ' A' ' 102' ' ' LEU . 24.0 tp10 -57.86 -51.09 71.02 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.055 0.455 . . . . 0.0 110.803 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.48 ' HE2' ' HB2' ' A' ' 103' ' ' MET . 24.0 ttt -74.5 -29.29 61.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.303 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 28.8 mt-30 -63.86 -33.9 76.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.76 176.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.569 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 2.9 mtmm -60.22 -51.9 67.61 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.564 ' HG3' ' HA ' ' A' ' 104' ' ' ARG . 33.2 mm-40 -55.7 -46.4 77.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.804 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.43 HD12 HG22 ' A' ' 61' ' ' ILE . 89.7 mt -59.7 -39.22 83.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.003 178.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.0 t -65.58 -45.22 84.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.088 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.431 ' CB ' ' HD2' ' A' ' 105' ' ' LYS . 20.8 m-85 -58.82 -39.82 82.34 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.653 178.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 47' ' ' GLU . 84.9 t -66.97 -53.29 35.4 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.597 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.81 ' HB3' HD21 ' A' ' 15' ' ' ASN . 21.5 m -59.53 -30.85 68.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.927 0.394 . . . . 0.0 111.473 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.822 ' HZ1' ' HB3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -55.85 -29.45 59.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.896 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -113.53 -34.24 5.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.883 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.658 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 2.5 tpp180 -89.7 75.03 7.46 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 2.2 mm-40 -82.49 128.39 34.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.173 -174.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.96 42.9 82.03 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.987 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.658 ' HB2' ' HG3' ' A' ' 55' ' ' ARG . 38.7 mmtm -126.87 -12.89 5.89 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.751 -0.264 . . . . 0.0 110.895 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.431 ' HB2' HD13 ' A' ' 30' ' ' ILE . 1.2 p90 -160.43 149.86 17.47 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -112.83 129.88 56.29 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.43 HG22 HD12 ' A' ' 48' ' ' LEU . 4.7 mp -97.71 110.97 26.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.947 0.403 . . . . 0.0 110.587 -178.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.619 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 12.5 t80 -96.91 116.06 28.52 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.018 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.564 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 15.0 m-30 -77.91 103.77 8.05 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.005 176.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 33' ' ' PHE . . . -85.13 74.34 10.49 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.61 ' C ' ' H ' ' A' ' 67' ' ' GLU . 23.9 ptt180 -84.03 125.89 32.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.294 -174.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.14 12.25 0.09 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.323 0.582 . . . . 0.0 111.3 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.73 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 25.8 mt-10 -82.33 -26.08 33.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.35 -177.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.492 ' CB ' ' HD2' ' A' ' 70' ' ' LYS . 44.6 mt-10 -118.08 147.31 43.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.654 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -69.19 -18.21 63.89 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -175.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.605 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.6 OUTLIER -62.64 -32.26 73.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.576 0.703 . . . . 0.0 110.034 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.605 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 5.6 m120 -83.58 -9.65 58.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.323 -174.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.0 mm -71.49 -42.6 72.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.16 -45.46 88.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.489 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 71' ' ' ASN . 4.4 mm? -58.11 -39.25 78.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.171 175.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.607 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -55.71 -57.23 12.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.485 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -66.17 -33.69 76.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.022 0.439 . . . . 0.0 110.601 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.441 ' HE3' ' HB2' ' A' ' 77' ' ' LYS . 19.2 ttmt -66.96 -17.44 64.92 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.261 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -122.16 11.4 10.16 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 70.59 24.82 4.32 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.595 0.559 . . . . 0.0 111.272 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.17 101.63 11.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.517 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -94.62 -43.17 8.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.888 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.7 pt -133.46 152.54 35.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.813 0.34 . . . . 0.0 110.682 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.538 ' HB ' ' HA ' ' A' ' 84' ' ' PRO . 23.6 m -101.8 158.88 30.93 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.905 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.538 ' HA ' ' HB ' ' A' ' 83' ' ' VAL . 2.3 Cg_endo -83.01 125.41 10.33 Favored 'Cis proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.755 -1.352 . . . . 0.0 112.101 -0.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.516 ' HB ' ' CD1' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -97.4 112.55 24.33 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.4 m -101.44 111.7 24.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.276 0.56 . . . . 0.0 110.459 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.44 ' HB ' ' HB ' ' A' ' 31' ' ' ILE . 99.5 t -108.19 110.21 31.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.259 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.417 ' CD2' ' HD2' ' A' ' 97' ' ' TYR . 97.4 m-85 -91.79 105.68 17.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.082 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.4 mt -95.62 136.05 36.51 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.432 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.513 ' HB3' HD22 ' A' ' 94' ' ' ASN . 25.7 t70 -72.61 177.37 4.76 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 172.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.674 ' HZ3' ' HB2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -53.58 -27.58 27.34 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -175.361 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.483 ' HG2' ' HG3' ' A' ' 91' ' ' LYS . 4.0 mm-40 -90.93 4.04 53.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.792 0.329 . . . . 0.0 111.166 -175.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.85 14.22 79.98 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.676 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.513 HD22 ' HB3' ' A' ' 90' ' ' ASP . 9.8 p30 -81.63 141.89 33.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.765 0.316 . . . . 0.0 110.507 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -79.31 82.01 5.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.839 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -78.52 -42.59 29.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.878 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.417 ' HD2' ' CD2' ' A' ' 88' ' ' PHE . 69.0 t80 -141.63 113.56 7.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.133 0.492 . . . . 0.0 111.18 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.97 128.74 65.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -137.85 143.18 40.81 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.496 ' HG2' HG22 ' A' ' 85' ' ' THR . 27.1 mt-30 -119.98 124.21 45.37 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.683 0.278 . . . . 0.0 110.447 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 142.75 -167.45 26.25 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.808 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.539 HD21 ' HG2' ' A' ' 43' ' ' GLU . 59.9 tp -106.09 121.6 44.47 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.493 ' HE2' HG13 ' A' ' 111' ' ' ILE . 74.0 mtp -116.06 159.72 21.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.553 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.564 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 3.3 mpt_? -111.09 170.49 8.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.703 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.431 ' HD2' ' CB ' ' A' ' 50' ' ' TYR . 23.5 tttp -46.91 -53.79 11.43 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -176.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -56.86 -39.2 73.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.008 0.432 . . . . 0.0 111.309 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.515 ' O ' HG12 ' A' ' 111' ' ' ILE . 9.2 m120 -70.6 -44.89 66.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.844 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.567 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 62.3 mt -60.26 -48.72 87.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.91 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.493 ' CD ' HH21 ' A' ' 55' ' ' ARG . 5.5 mm-40 -54.5 -47.99 72.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.594 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.437 ' O ' ' HB2' ' A' ' 113' ' ' ASN . 24.0 m -64.59 -38.33 90.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.742 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 107' ' ' ASN . 35.4 mm -65.17 -40.98 90.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.765 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 59.8 mt -62.31 -34.79 77.3 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.844 0.354 . . . . 0.0 110.136 177.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 110' ' ' THR . 9.6 m120 -58.87 -45.24 90.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.853 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.8 m -86.49 -16.99 35.32 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.5 tp -70.7 -71.38 0.25 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.35 0.595 . . . . 0.0 110.381 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -178.39 -73.54 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.554 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.76 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 52.0 t 51.71 73.87 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 122.195 0.998 . . . . 0.0 109.82 -175.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.5 pttm . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.686 -172.656 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.595 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 72.9 m . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.462 0.173 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 69.9 mt 69.42 -74.23 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.15 0.58 . . . . 0.0 111.694 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -86.81 29.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.83 0.348 . . . . 0.0 110.929 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 3.0 p -72.94 129.02 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.504 -176.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.615 HG11 ' HB3' ' A' ' 22' ' ' GLU . 73.0 t -127.41 134.04 66.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.596 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -66.38 -55.2 16.99 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.789 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.558 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 47.2 t30 -153.22 179.58 8.61 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -177.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.33 -31.02 68.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.766 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -59.89 -35.82 75.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.987 0.422 . . . . 0.0 110.465 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.615 ' HB3' HG11 ' A' ' 17' ' ' VAL . 3.7 mm-40 -82.91 -8.03 59.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.413 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.35 107.86 15.34 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 172.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.533 ' HE2' ' O ' ' A' ' 22' ' ' GLU . 17.6 mtmt -131.19 174.03 10.44 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.991 -171.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 66.59 167.61 0.22 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.301 1.0 . . . . 0.0 110.207 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.93 50.95 4.37 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.667 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.41 HG13 ' ND2' ' A' ' 60' ' ' ASN . 18.2 pt -116.45 149.39 43.64 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.727 0.299 . . . . 0.0 110.491 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.736 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 40.8 Cg_exo -60.59 168.92 6.06 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 123.217 2.611 . . . . 0.0 112.655 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.455 ' HB ' HD12 ' A' ' 89' ' ' LEU . 34.9 m -135.89 125.01 24.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.525 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.434 HD13 ' CD2' ' A' ' 59' ' ' PHE . 2.4 mp -105.63 115.04 46.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.816 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.54 ' HB ' ' HB ' ' A' ' 87' ' ' VAL . 67.6 mt -100.46 139.38 22.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.78 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.515 ' HE2' ' HA ' ' A' ' 41' ' ' CYS . 2.1 tmt? -134.48 113.34 11.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.183 0.516 . . . . 0.0 109.887 171.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.513 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 91.6 m-85 -76.93 135.29 38.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.529 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.441 ' HG3' ' SG ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -142.28 153.86 44.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.289 -178.303 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -72.57 164.98 25.58 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 67' ' ' GLU . 6.6 p-10 -58.58 -45.22 89.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.681 0.276 . . . . 0.0 110.968 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -130.92 96.9 4.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.977 0.418 . . . . 0.0 111.275 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 41' ' ' CYS . 11.7 p -150.97 140.7 14.01 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.729 177.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 11.6 Cg_exo -69.94 -29.99 22.15 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.533 2.155 . . . . 0.0 112.273 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.554 ' HB3' ' HG3' ' A' ' 84' ' ' PRO . 90.2 m-85 -60.91 -26.98 67.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.095 0.474 . . . . 0.0 110.561 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.532 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . 21.5 t -60.03 -54.42 46.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.869 177.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.409 ' HA ' ' HG2' ' A' ' 45' ' ' GLN . 8.0 p -73.2 -38.13 53.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.432 -172.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.515 ' HG2' HD21 ' A' ' 102' ' ' LEU . 5.2 tp10 -61.6 -50.64 71.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.071 0.462 . . . . 0.0 110.875 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.505 ' SD ' ' HG3' ' A' ' 32' ' ' MET . 24.1 ttt -69.21 -37.25 77.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.053 0.454 . . . . 0.0 111.216 -175.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.439 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 12.9 pt20 -74.12 -31.49 62.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.354 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.898 ' HE2' ' HA ' ' A' ' 46' ' ' LYS . 8.5 mmpt? -74.26 -29.81 61.85 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.535 176.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.535 ' O ' HG21 ' A' ' 51' ' ' VAL . 13.4 mm-40 -62.03 -44.74 96.06 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 169.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 45' ' ' GLN . 98.1 mt -57.37 -36.99 71.92 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.313 173.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.9 t -66.19 -37.96 86.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.425 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.532 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 13.2 m-30 -65.05 -39.22 93.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.876 0.37 . . . . 0.0 110.177 175.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.556 HG23 ' HG3' ' A' ' 105' ' ' LYS . 44.1 t -65.11 -36.33 77.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.106 176.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.3 m -63.67 -31.8 73.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.824 178.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -66.84 -27.06 67.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.321 0.581 . . . . 0.0 110.738 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -100.77 2.58 41.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.584 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.523 ' HE ' HG11 ' A' ' 117' ' ' VAL . 21.1 tpt180 -161.23 76.63 0.54 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.427 0.632 . . . . 0.0 109.437 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -82.61 125.1 30.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.866 -172.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.4 42.63 99.01 Favored Glycine 0 C--O 1.226 -0.346 0 CA-C-N 115.782 -0.644 . . . . 0.0 113.418 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -125.31 0.56 7.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.902 0.351 . . . . 0.0 110.959 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.434 ' CD2' HD13 ' A' ' 30' ' ' ILE . 52.4 p90 -165.89 140.11 4.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.024 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.548 ' HB3' HG23 ' A' ' 17' ' ' VAL . 46.5 m-80 -82.66 131.22 35.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.375 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.7 mt -101.9 108.11 23.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 175.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.558 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 18.0 t80 -93.49 118.91 31.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.88 0.371 . . . . 0.0 110.067 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 45' ' ' GLN . 11.8 m-85 -87.4 104.05 16.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.258 0.552 . . . . 0.0 110.707 178.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 33' ' ' PHE . . . -96.57 81.54 3.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.531 -175.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.534 ' C ' ' H ' ' A' ' 67' ' ' GLU . 19.7 ptt180 -95.28 130.48 42.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.814 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.2 tp -70.18 7.48 0.98 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.577 0.703 . . . . 0.0 110.546 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.534 ' H ' ' C ' ' A' ' 65' ' ' ARG . 34.6 tt0 -83.03 -17.52 43.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.456 -175.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.423 ' HG3' ' HG3' ' A' ' 65' ' ' ARG . 36.1 mt-10 -103.79 -0.51 29.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -170.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.474 ' HA ' HG12 ' A' ' 72' ' ' ILE . 1.2 mp0 69.23 -36.62 0.34 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.557 0.535 . . . . 0.0 112.202 -177.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.472 ' HD2' ' ND2' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -61.05 -25.04 66.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.323 0.582 . . . . 0.0 110.729 175.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.563 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 44.5 m-80 -86.69 -0.86 57.09 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.816 178.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.474 HG12 ' HA ' ' A' ' 69' ' ' GLU . 45.2 mm -66.66 -45.18 88.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -72.21 -49.57 34.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.425 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' A' ' 71' ' ' ASN . 3.8 mm? -57.18 -38.44 73.62 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.737 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.487 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -63.7 -48.4 77.27 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.055 177.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -62.42 -37.49 86.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.128 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -53.27 -35.85 60.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.481 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -113.35 13.27 19.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.842 -176.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.9 t70 63.35 29.32 15.7 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.693 0.759 . . . . 0.0 110.749 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . -87.77 104.2 16.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.362 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -127.98 -11.22 5.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.49 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.6 mt -114.95 133.4 61.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.061 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.1 m -114.05 145.81 34.36 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.681 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.554 ' HG3' ' HB3' ' A' ' 40' ' ' TYR . 6.0 Cg_endo -85.68 157.71 59.69 Favored 'Cis proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.43 -1.487 . . . . 0.0 111.811 -0.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.6 t -153.56 137.86 16.62 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.5 t -124.83 140.74 52.65 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.425 0.631 . . . . 0.0 110.88 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.54 ' HB ' ' HB ' ' A' ' 31' ' ' ILE . 72.4 t -115.87 110.43 31.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.413 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.527 ' HB3' HD23 ' A' ' 115' ' ' LEU . 97.3 m-85 -89.84 108.34 19.64 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.526 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.52 HD22 ' HA ' ' A' ' 95' ' ' LYS . 67.3 mt -97.47 130.44 44.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.815 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.84 169.62 16.4 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.873 ' HG2' ' HG3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -61.93 -23.88 66.63 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.59 ' HB3' HD21 ' A' ' 94' ' ' ASN . 1.1 tp10 -76.53 -5.82 49.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.113 0.482 . . . . 0.0 110.022 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.65 22.46 50.22 Favored Glycine 0 N--CA 1.453 -0.185 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.599 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.59 HD21 ' HB3' ' A' ' 92' ' ' GLU . 9.0 p30 -107.24 148.64 28.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.52 ' HA ' HD22 ' A' ' 89' ' ' LEU . 4.6 ttpm? -77.19 117.81 19.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -97.37 -50.08 4.68 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.105 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 84.7 t80 -148.87 136.24 20.24 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.606 -175.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.474 HG13 HG23 ' A' ' 87' ' ' VAL . 27.5 m -113.94 148.29 16.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.76 172.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.466 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 36.6 t60 -142.83 141.24 31.57 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -111.16 121.76 46.14 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 145.76 170.78 14.78 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.981 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.515 HD21 ' HG2' ' A' ' 43' ' ' GLU . 43.8 tp -82.09 -61.56 1.87 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.465 0.65 . . . . 0.0 111.224 -177.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.518 ' O ' ' HD2' ' A' ' 104' ' ' ARG . 57.5 mtm 64.18 175.73 0.18 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.176 -1.374 . . . . 0.0 111.091 -175.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.518 ' HD2' ' O ' ' A' ' 103' ' ' MET . 10.7 mmm180 -122.61 178.15 5.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.921 173.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.556 ' HG3' HG23 ' A' ' 51' ' ' VAL . 47.1 tttm -45.53 -59.19 2.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -177.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -66.75 -28.85 68.74 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.399 -173.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -64.0 -47.99 78.15 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.614 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 61.5 mt -59.25 -47.5 90.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.796 174.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -50.57 -48.25 57.61 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.766 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 m -61.93 -41.76 98.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.867 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 63.1 mt -67.83 -37.67 78.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.204 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 87.2 mt -63.19 -35.45 80.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.374 . . . . 0.0 110.433 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.76 -39.8 90.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.674 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.6 m -79.46 -28.19 41.59 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.333 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.527 HD23 ' HB3' ' A' ' 88' ' ' PHE . 45.6 tp -66.25 -70.34 0.25 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.712 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 171.52 -73.54 0.1 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.605 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.736 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 11.6 t 55.61 36.52 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 122.677 1.227 . . . . 0.0 109.399 -176.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.873 ' HG3' ' HG2' ' A' ' 91' ' ' LYS . 8.2 ptmt . . . . . 0 C--N 1.319 -0.718 0 CA-C-N 113.527 -1.669 . . . . 0.0 110.02 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.458 ' HB3' HG21 ' A' ' 16' ' ' VAL . 34.4 m . . . . . 0 N--CA 1.445 -0.679 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.0 mt -93.22 -65.3 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.215 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 14.2 m-80 -81.08 59.21 3.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.02 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.694 ' HB ' ' HE2' ' A' ' 63' ' ' TYR . 16.6 m -131.98 151.4 35.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.085 0.469 . . . . 0.0 111.774 -173.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.461 HG13 ' HB2' ' A' ' 23' ' ' ALA . 4.2 p -146.31 164.24 9.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.114 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -90.94 -54.26 4.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.985 0.422 . . . . 0.0 110.999 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.769 ' HA ' ' CE2' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -130.67 162.89 28.41 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.683 -170.384 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.661 HD22 ' CE2' ' A' ' 62' ' ' TYR . 2.0 mm? -65.36 -35.17 80.15 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.579 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 1.7 pm0 -67.09 -23.52 65.86 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.346 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -87.51 -8.65 56.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.561 172.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.461 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -121.29 172.51 7.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.562 0.696 . . . . 0.0 112.133 -170.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.751 ' NZ ' ' HA ' ' A' ' 24' ' ' LYS . 2.3 tpmp? -140.21 160.39 40.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.522 176.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -87.87 179.3 6.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.985 0.422 . . . . 0.0 110.936 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.69 -29.94 10.17 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -174.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.579 HD12 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -117.95 134.18 23.32 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 172.657 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 1.072 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 75.2 Cg_exo -52.54 136.77 57.62 Favored 'Trans proline' 0 CA--C 1.517 -0.356 0 C-N-CA 123.092 2.528 . . . . 0.0 112.424 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.545 ' HB ' HD13 ' A' ' 89' ' ' LEU . 23.6 m -108.69 119.76 40.47 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.207 0.527 . . . . 0.0 111.199 -174.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.418 HD11 ' N ' ' A' ' 30' ' ' ILE . 4.1 mp -99.32 107.17 20.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.779 HG12 ' HB3' ' A' ' 62' ' ' TYR . 50.0 mt -95.74 111.91 27.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 120.731 0.301 . . . . 0.0 110.75 -177.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 25.2 ptm -118.42 136.65 53.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.157 0.503 . . . . 0.0 109.828 175.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.56 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 37.3 m-85 -91.18 132.3 36.17 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.502 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.609 ' HE2' ' HB3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -130.9 139.53 50.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.158 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.0 m -78.09 161.38 27.45 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.49 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 15.1 t70 -68.54 103.33 1.66 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.2 m 73.51 89.44 0.09 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.92 -175.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.9 p -148.06 127.16 6.28 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.567 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.22 -33.66 5.54 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.285 1.99 . . . . 0.0 114.084 -173.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -67.47 -25.17 65.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.806 0.336 . . . . 0.0 111.165 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.565 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 97.6 m -80.06 -35.98 36.27 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.053 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 65.0 t -64.8 -34.85 72.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.82 176.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -57.01 -45.97 82.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.281 175.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.6 ttt -69.11 -31.19 69.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.737 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.565 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 20.5 mt-30 -59.84 -40.12 87.42 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 110.117 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -56.16 -53.36 57.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.608 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.597 ' O ' HG21 ' A' ' 51' ' ' VAL . 57.2 mm-40 -56.99 -47.23 81.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.77 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.702 HD11 HD13 ' A' ' 61' ' ' ILE . 91.3 mt -58.62 -36.9 74.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.472 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.4 t -66.59 -37.58 85.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.99 0.424 . . . . 0.0 110.13 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.417 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 30.5 m-85 -70.34 -36.44 74.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.517 177.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.597 HG21 ' O ' ' A' ' 47' ' ' GLU . 22.4 t -67.95 -31.82 53.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 175.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.5 m -62.97 -32.92 74.35 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.025 174.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.471 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 27.2 mmtm -73.35 -15.79 61.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.138 0.494 . . . . 0.0 110.725 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -87.51 -40.08 14.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.687 173.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.666 ' HG3' ' HG3' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -133.09 75.39 1.62 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.617 -175.236 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 5.8 tp10 -82.44 134.46 35.23 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 120.905 0.383 . . . . 0.0 111.356 -171.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.57 41.22 95.44 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.255 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.666 ' HG3' ' HG3' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -123.08 -9.1 8.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.776 0.322 . . . . 0.0 110.856 -174.093 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.536 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 10.2 p90 -156.68 -176.84 6.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.6 -177.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 29' ' ' THR . 57.2 t30 -144.83 132.99 21.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.896 178.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.702 HD13 HD11 ' A' ' 48' ' ' LEU . 71.6 mt -105.38 114.24 44.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.565 -176.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.779 ' HB3' HG12 ' A' ' 31' ' ' ILE . 4.5 t80 -84.18 115.82 22.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.694 ' HE2' ' HB ' ' A' ' 16' ' ' VAL . 76.1 m-85 -93.38 110.82 22.36 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.054 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.456 ' HB2' ' HE1' ' A' ' 62' ' ' TYR . . . -86.39 102.72 14.29 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 121.255 -0.178 . . . . 0.0 110.793 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.609 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 8.7 ptm180 -78.01 114.48 16.92 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.876 176.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.4 tp -67.92 10.95 0.17 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.061 0.458 . . . . 0.0 110.836 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.568 ' H ' ' C ' ' A' ' 65' ' ' ARG . 3.8 tp10 -84.34 -42.35 15.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.19 0.519 . . . . 0.0 110.424 -175.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.567 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 30.5 mm-40 -93.54 173.58 7.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.08 -172.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.22 -31.88 21.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.856 -176.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.513 ' HD2' ' H ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -60.15 -33.15 71.78 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.241 0.543 . . . . 0.0 110.371 178.521 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.567 ' OD1' ' HB2' ' A' ' 68' ' ' GLU . 5.0 m120 -80.19 -17.35 52.63 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.416 -178.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 68' ' ' GLU . 75.1 mt -70.88 -42.76 77.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -59.86 -48.95 79.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.626 173.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.424 ' HG ' ' OH ' ' A' ' 62' ' ' TYR . 1.2 tm? -55.77 -47.34 77.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.315 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.56 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -53.9 -52.15 61.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.854 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -73.27 -34.84 66.01 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.527 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.446 ' HB2' ' HE3' ' A' ' 77' ' ' LYS . 27.1 ttmt -63.49 -32.86 74.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.241 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -102.73 -0.53 31.47 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.669 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.1 t70 67.64 40.65 2.47 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.704 0.764 . . . . 0.0 111.095 174.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.48 102.84 4.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.946 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -107.26 -31.95 8.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.351 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.734 ' H ' HD12 ' A' ' 82' ' ' ILE . 0.2 OUTLIER -85.05 159.06 3.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.798 0.332 . . . . 0.0 110.947 -178.65 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.1 m -119.42 145.27 38.37 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.719 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -95.25 118.25 2.03 Favored 'Cis proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.637 -1.401 . . . . 0.0 112.517 -1.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.623 HG22 ' HB3' ' A' ' 100' ' ' GLN . 1.2 p -97.9 143.46 28.47 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 173.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.1 m -135.49 121.05 19.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.179 0.514 . . . . 0.0 111.151 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.678 HG13 HG12 ' A' ' 98' ' ' VAL . 20.3 m -112.6 126.65 70.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.003 176.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.527 ' HB3' HD22 ' A' ' 115' ' ' LEU . 94.8 m-85 -98.48 118.61 35.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.829 -174.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.545 HD13 ' HB ' ' A' ' 29' ' ' THR . 10.4 mt -107.57 139.61 41.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.037 -177.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.42 ' OD2' ' HG2' ' A' ' 92' ' ' GLU . 25.0 t70 -63.51 171.48 2.53 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 171.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.415 ' HD3' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -62.36 -16.45 54.64 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 122.015 -0.428 . . . . 0.0 111.84 -176.261 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.42 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 16.9 mm-40 -72.94 -23.69 60.71 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.954 0.407 . . . . 0.0 110.753 175.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.74 17.53 35.41 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -170.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.431 ' N ' HD21 ' A' ' 94' ' ' ASN . 0.9 OUTLIER -90.15 126.24 35.73 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -179.575 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -72.34 112.87 8.79 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.174 0.296 . . . . 0.0 110.511 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -100.67 -54.58 2.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.746 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.566 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 87.6 t80 -124.84 141.84 51.85 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.195 -175.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.678 HG12 HG13 ' A' ' 87' ' ' VAL . 30.0 m -121.65 139.64 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.553 176.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.566 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 8.2 t60 -151.17 139.86 20.72 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.623 ' HB3' HG22 ' A' ' 85' ' ' THR . 9.1 pt20 -130.04 139.52 50.99 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.014 0.435 . . . . 0.0 110.804 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.48 -172.35 18.16 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.6 tp -93.66 130.17 39.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.908 0.354 . . . . 0.0 110.162 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 71.8 mtm -127.08 165.38 19.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.192 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.462 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 37.3 mmt180 -114.34 175.51 5.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.741 178.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 109' ' ' GLU . 58.0 tttm -45.78 -59.36 2.83 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.106 0.962 . . . . 0.0 112.835 -175.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.547 ' HA ' ' OE1' ' A' ' 109' ' ' GLU . 29.0 t-20 -64.66 -28.88 69.91 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -174.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.489 ' O ' HG12 ' A' ' 111' ' ' ILE . 10.7 m120 -65.4 -45.34 84.35 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.532 HD11 HD23 ' A' ' 48' ' ' LEU . 50.3 mt -64.97 -42.52 94.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.933 176.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 105' ' ' LYS . 81.0 mt-10 -51.91 -48.96 63.94 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.887 176.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.0 m -64.39 -42.24 96.23 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.778 -177.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 107' ' ' ASN . 48.7 mm -67.37 -47.81 79.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.184 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.507 ' HB3' HG21 ' A' ' 117' ' ' VAL . 81.0 mt -65.32 -34.45 78.37 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 110.806 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -60.41 -37.99 82.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.412 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.7 m -85.15 -35.93 21.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.165 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 88' ' ' PHE . 34.7 tp -57.13 -72.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.102 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -176.66 -80.75 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.767 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 1.072 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 22.9 t 53.04 71.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 121.662 0.744 . . . . 0.0 109.537 -175.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.2 pttt . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.373 -168.061 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.637 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . 22.7 m . . . . . 0 N--CA 1.447 -0.597 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.0 mt 69.52 -78.24 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 123.047 0.539 . . . . 0.0 111.042 -171.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -113.98 16.56 18.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.524 0.678 . . . . 0.0 109.265 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.637 ' CG2' ' HA ' ' A' ' 13' ' ' SER . 51.5 t -76.27 125.32 35.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.433 175.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.495 HG22 ' HB2' ' A' ' 22' ' ' GLU . 4.6 p -111.52 134.9 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-O 121.592 0.711 . . . . 0.0 110.374 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -61.47 -54.45 43.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.543 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.535 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -131.69 158.83 40.08 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.369 -177.009 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.65 -29.75 69.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.798 0.332 . . . . 0.0 110.585 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -73.38 -23.51 60.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.405 177.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.495 ' HB2' HG22 ' A' ' 17' ' ' VAL . 29.3 mm-40 -67.01 -18.96 65.62 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.008 0.432 . . . . 0.0 110.492 173.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.498 ' HB3' HD11 ' A' ' 27' ' ' ILE . . . -91.71 113.59 25.9 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -122.38 -6.47 8.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.705 0.764 . . . . 0.0 112.165 -173.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.506 ' HB2' HD12 ' A' ' 27' ' ' ILE . 3.8 mp0 -76.05 170.94 15.31 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.383 178.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.48 55.32 4.99 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.385 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.537 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -114.65 143.41 29.93 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.792 0.33 . . . . 0.0 111.357 -173.277 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 1.01 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 60.5 Cg_exo -56.65 151.36 47.49 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.696 2.264 . . . . 0.0 111.649 170.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.0 m -112.7 111.21 21.84 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.787 -175.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.6 mm -102.99 124.76 57.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.738 HG12 ' HB3' ' A' ' 62' ' ' TYR . 54.3 mt -125.04 115.46 44.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.069 -173.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.456 ' SD ' ' NZ ' ' A' ' 34' ' ' LYS . 2.1 tmt? -112.07 124.36 52.24 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.611 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 53.8 m-85 -87.38 144.57 26.7 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.899 -175.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.943 ' HB3' ' HZ2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -149.44 171.24 16.89 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -178.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.0 t -122.69 -174.44 2.92 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.02 -62.88 1.53 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.229 0.537 . . . . 0.0 110.569 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.2 m -93.76 90.92 6.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.075 -176.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.471 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 20.1 p -158.88 121.15 1.94 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.91 0.386 . . . . 0.0 111.388 175.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 2.9 Cg_exo -75.34 -16.48 19.45 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.53 2.153 . . . . 0.0 112.429 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -64.44 -26.12 68.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.009 0.433 . . . . 0.0 110.637 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.64 ' SG ' ' HD3' ' A' ' 34' ' ' LYS . 53.4 t -67.42 -44.41 78.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.679 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.502 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 7.6 p -74.76 -30.35 24.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.779 0.323 . . . . 0.0 110.756 -176.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -69.7 -49.0 57.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.813 0.339 . . . . 0.0 110.323 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.408 ' HG3' ' OE1' ' A' ' 47' ' ' GLU . 3.5 ttt -69.43 -28.45 66.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.991 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -53.32 -45.02 68.86 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.223 171.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 81.9 mttt -58.12 -53.81 54.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.964 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.421 ' O ' HG21 ' A' ' 51' ' ' VAL . 52.7 mt-10 -57.43 -50.65 72.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.919 -178.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 48.6 mt -61.39 -42.95 99.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.638 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 13.9 t -66.81 -32.94 74.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.369 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.432 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 16.6 m-85 -66.9 -43.08 84.31 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.774 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 47' ' ' GLU . 51.0 t -60.3 -52.22 63.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-O 121.223 0.535 . . . . 0.0 110.016 176.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.8 m -59.4 -29.35 67.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.552 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.707 ' HB2' ' HZ2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -67.51 -16.91 64.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.518 -179.353 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -120.44 8.94 10.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.286 0.565 . . . . 0.0 109.791 177.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.672 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 8.0 ttm-85 -151.38 76.9 1.23 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.356 -175.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -82.32 124.77 30.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.83 -169.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.11 25.92 54.89 Favored Glycine 0 CA--C 1.518 0.249 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.333 176.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.672 ' HB2' ' HG2' ' A' ' 55' ' ' ARG . 55.7 mmtt -96.2 -5.68 39.92 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.719 0.771 . . . . 0.0 108.927 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.529 ' HB3' HG12 ' A' ' 117' ' ' VAL . 28.7 p90 -170.79 136.49 1.18 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.042 175.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -95.05 131.33 41.15 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.7 mt -89.64 107.7 18.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.096 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.738 ' HB3' HG12 ' A' ' 31' ' ' ILE . 3.8 t80 -88.43 112.62 23.14 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.923 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 50.3 m-85 -91.73 102.9 15.52 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.589 178.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.92 93.59 4.43 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.975 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.621 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 11.0 ptt180 -89.3 118.25 28.85 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.27 0.557 . . . . 0.0 111.272 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.466 HD22 HD13 ' A' ' 72' ' ' ILE . 53.4 mt -72.77 11.51 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.02 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.516 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 23.9 tt0 -66.4 -33.64 76.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.871 174.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.487 ' CD ' ' HZ1' ' A' ' 70' ' ' LYS . 17.7 mt-10 -106.85 177.2 4.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.351 -177.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.53 -27.0 22.88 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.1 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.57 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -57.6 -33.5 68.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.423 -176.296 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.57 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 68.6 m-80 -90.23 2.39 55.47 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.983 -174.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.466 HD13 HD22 ' A' ' 66' ' ' LEU . 49.7 mm -71.17 -54.44 17.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 172.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.489 ' CG ' ' HZ3' ' A' ' 77' ' ' LYS . 13.8 t70 -65.23 -41.87 93.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.253 175.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.456 ' HB3' ' HA ' ' A' ' 71' ' ' ASN . 1.3 tm? -57.37 -42.61 82.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.101 177.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.611 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -53.17 -53.16 54.64 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.462 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -67.3 -34.3 77.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.771 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.489 ' HZ3' ' CG ' ' A' ' 73' ' ' ASP . 49.4 mttp -62.76 -21.44 65.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.063 0.458 . . . . 0.0 111.588 178.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.505 ' CD2' HG12 ' A' ' 87' ' ' VAL . 52.3 m-85 -119.73 19.32 12.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.643 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 65.13 17.02 10.88 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.801 0.688 . . . . 0.0 111.37 168.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 75' ' ' ALA . . . -123.91 102.17 7.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.079 0.466 . . . . 0.0 111.605 -171.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -113.61 9.21 17.85 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.207 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.9 pt -125.23 171.36 14.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.875 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.57 136.99 19.39 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.229 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -87.26 150.61 38.32 Favored 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 123.65 -1.396 . . . . 0.0 112.667 -0.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 15.1 m -150.26 124.6 9.53 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 88.3 m -122.15 122.89 40.26 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.314 0.578 . . . . 0.0 110.936 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.62 HG22 ' HB ' ' A' ' 98' ' ' VAL . 11.2 p -100.16 132.32 45.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.635 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.988 ' HB3' HD12 ' A' ' 115' ' ' LEU . 86.2 m-85 -106.04 108.8 20.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.799 -175.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 5.5 mp -111.97 138.82 48.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.786 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -80.65 -176.75 5.94 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.56 ' HE2' ' HE2' ' A' ' 118' ' ' LYS . 0.5 OUTLIER -60.57 -22.22 63.45 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -172.494 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.463 ' CD ' ' HZ3' ' A' ' 91' ' ' LYS . 45.9 mp0 -75.85 -12.54 60.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.72 0.295 . . . . 0.0 111.295 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.413 ' O ' HD22 ' A' ' 89' ' ' LEU . . . 85.42 21.06 55.51 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.784 -176.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 92.0 m-20 -92.27 125.36 36.9 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.971 -0.134 . . . . 0.0 110.703 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.452 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 54.2 mtmt -70.5 93.84 0.93 Allowed 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.448 ' HB3' ' CD2' ' A' ' 115' ' ' LEU . 87.6 t80 -83.58 -39.4 20.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.817 0.342 . . . . 0.0 110.338 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.594 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 71.2 t80 -154.04 127.07 8.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.716 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.62 ' HB ' HG22 ' A' ' 87' ' ' VAL . 7.6 p -114.3 133.42 60.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.594 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 49.5 t60 -139.31 137.76 36.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -172.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -110.41 158.18 18.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.825 0.345 . . . . 0.0 111.075 178.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.1 -173.85 20.15 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.028 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.6 tp -104.17 149.59 25.12 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 16.8 ptm -164.8 125.62 2.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.724 -0.216 . . . . 0.0 110.441 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -58.04 163.77 2.63 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.625 -173.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.432 ' HD2' ' HB3' ' A' ' 50' ' ' TYR . 13.6 ptmm? -50.59 -44.43 56.88 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.237 -174.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -63.48 -34.24 77.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.383 0.611 . . . . 0.0 110.932 -176.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -74.11 -40.18 62.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.394 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.481 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 73.8 mt -59.32 -46.27 92.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.246 171.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -58.05 -35.56 71.51 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.004 178.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.5 m -63.92 -41.46 97.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.001 0.429 . . . . 0.0 110.434 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.9 mm -70.89 -41.91 77.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.179 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.52 ' HB3' HG23 ' A' ' 117' ' ' VAL . 85.8 mt -57.53 -41.97 81.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.446 176.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -59.53 -37.11 77.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.803 176.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.1 m -70.37 -24.89 63.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.101 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.988 HD12 ' HB3' ' A' ' 88' ' ' PHE . 27.1 mt -81.28 -73.62 0.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 122.095 0.95 . . . . 0.0 109.788 175.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 162.87 -63.47 0.26 Allowed Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -175.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 1.01 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 48.8 t 52.85 73.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.579 0.704 . . . . 0.0 111.782 172.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.56 ' HE2' ' HE2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.609 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.717 ' HA ' ' HA ' ' A' ' 49' ' ' SER . 49.0 m . . . . . 0 C--O 1.228 -0.074 0 CA-C-O 121.248 0.546 . . . . 0.0 110.45 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.7 mt -80.85 -20.63 11.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.531 0.681 . . . . 0.0 109.941 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.493 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 47.2 m-80 -94.0 25.06 3.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.606 176.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.87 138.96 22.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.641 -173.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.437 HG22 ' HB3' ' A' ' 60' ' ' ASN . 76.0 t -137.93 123.65 25.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.798 175.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -76.13 -55.52 5.51 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.603 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.772 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 59.0 t30 -140.18 -179.38 5.95 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.543 HD12 HD11 ' A' ' 74' ' ' LEU . 83.7 mt -50.39 -32.6 17.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.417 ' CD ' ' HB3' ' A' ' 19' ' ' ASN . 6.7 pm0 -63.41 -39.64 95.04 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.674 0.249 . . . . 0.0 111.674 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 55.7 mp0 -81.52 4.51 21.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.808 175.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.36 171.04 10.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.941 0.4 . . . . 0.0 111.957 -175.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.504 ' HE2' ' OD1' ' A' ' 60' ' ' ASN . 23.1 mtmm -148.57 173.25 13.36 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -120.51 -179.56 4.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.677 0.275 . . . . 0.0 111.378 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.09 -47.74 2.68 Favored Glycine 0 C--N 1.332 0.355 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.044 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.699 HD12 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -100.19 146.66 32.33 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 175.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 1.06 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 84.2 Cg_exo -51.02 158.66 3.04 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.197 2.598 . . . . 0.0 112.436 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.464 HG23 ' HB2' ' A' ' 60' ' ' ASN . 41.7 m -131.44 126.15 34.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.244 0.545 . . . . 0.0 111.43 -175.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.529 HD12 HD21 ' A' ' 112' ' ' LEU . 63.5 mt -98.76 111.52 28.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.495 176.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.593 ' HB ' ' HB ' ' A' ' 87' ' ' VAL . 6.0 mm -91.01 107.81 19.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.415 ' HA ' ' O ' ' A' ' 85' ' ' THR . 21.0 ttt -111.71 107.74 16.94 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.311 0.576 . . . . 0.0 110.647 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.679 ' CE1' ' HA ' ' A' ' 75' ' ' ALA . 87.0 m-85 -72.64 133.12 44.5 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.179 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 1.044 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 60.1 pttt -133.84 179.88 5.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.147 -176.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -137.39 -174.56 3.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.469 0.176 . . . . 0.0 110.589 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -77.33 -17.94 57.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.507 0.67 . . . . 0.0 110.548 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.4 m -143.64 101.97 3.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.873 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 2.2 p -160.13 101.68 1.41 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.986 0.422 . . . . 0.0 112.021 -176.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.8 -32.99 13.33 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.07 1.846 . . . . 0.0 112.655 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -70.51 -23.12 62.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.964 0.411 . . . . 0.0 110.749 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 79.7 m -79.15 -43.62 23.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.956 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.477 ' HA ' HE21 ' A' ' 45' ' ' GLN . 12.0 p -65.5 -31.03 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.484 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.716 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 8.5 tp10 -58.38 -50.04 75.08 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.347 0.594 . . . . 0.0 110.283 175.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 21.0 ttt -73.62 -29.3 62.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.86 -177.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.546 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 49.1 mt-30 -62.56 -33.75 75.58 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.692 0.282 . . . . 0.0 110.65 175.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.716 ' HE2' ' HA ' ' A' ' 43' ' ' GLU . 47.3 mtmt -65.29 -47.05 77.99 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.631 ' O ' HG21 ' A' ' 51' ' ' VAL . 62.5 mm-40 -56.04 -52.21 65.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.849 177.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.491 ' HB3' HD13 ' A' ' 61' ' ' ILE . 90.0 mt -56.9 -33.58 67.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.171 178.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.717 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 8.7 t -65.83 -43.56 88.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.023 0.44 . . . . 0.0 109.854 177.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -68.03 -34.27 76.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.706 178.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.716 HG23 ' HG3' ' A' ' 105' ' ' LYS . 34.4 t -65.35 -39.54 85.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 175.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.7 m -61.77 -30.57 70.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.691 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -59.3 -43.09 92.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.049 0.452 . . . . 0.0 110.132 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -82.22 -50.5 8.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.757 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.41 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -99.11 74.06 1.95 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.281 0.562 . . . . 0.0 109.761 -175.257 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.67 119.06 25.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.255 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.55 47.09 36.27 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.23 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.452 ' HD3' ' HA ' ' A' ' 58' ' ' LYS . 36.5 mmtm -132.64 -7.43 3.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.657 0.265 . . . . 0.0 111.31 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.493 ' O ' ' HB3' ' A' ' 15' ' ' ASN . 0.9 OUTLIER -163.92 155.55 16.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.667 177.141 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.504 ' OD1' ' HE2' ' A' ' 24' ' ' LYS . 36.9 m-80 -96.39 132.36 42.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 171.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.491 HD13 ' HB3' ' A' ' 48' ' ' LEU . 71.2 mt -107.16 105.32 18.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.533 173.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.772 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 1.1 t80 -101.17 111.75 24.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.133 0.492 . . . . 0.0 110.025 -177.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.611 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 73.1 m-85 -90.77 102.58 15.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.978 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 71' ' ' ASN . . . -85.29 97.0 9.7 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 121.184 -0.206 . . . . 0.0 110.801 -177.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 1.044 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 32.8 ptt180 -76.7 114.86 15.92 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.831 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.5 mp -63.7 11.71 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.141 0.496 . . . . 0.0 111.742 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.632 ' H ' ' C ' ' A' ' 65' ' ' ARG . 62.3 tt0 -77.26 -31.41 54.91 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.185 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -112.77 148.14 35.42 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.749 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -65.65 -20.86 66.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.914 -172.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.586 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -63.45 -33.45 75.59 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.214 0.531 . . . . 0.0 110.485 -178.078 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.586 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 4.1 m120 -85.99 -17.65 34.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.571 -173.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.3 mt -69.85 -42.85 80.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.412 ' CG ' ' HZ1' ' A' ' 77' ' ' LYS . 10.0 t70 -65.08 -40.64 94.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.168 175.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.543 HD11 HD12 ' A' ' 20' ' ' LEU . 2.3 mm? -62.71 -38.86 92.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.896 175.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.679 ' HA ' ' CE1' ' A' ' 33' ' ' PHE . . . -54.41 -52.37 61.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.439 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -64.95 -33.39 75.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.478 -178.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.412 ' HZ1' ' CG ' ' A' ' 73' ' ' ASP . 6.8 mtmm -64.96 -16.27 63.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.964 0.412 . . . . 0.0 111.176 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.626 ' HB3' HG21 ' A' ' 87' ' ' VAL . 60.6 m-85 -119.66 15.48 12.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.664 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 65.57 21.99 11.74 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.666 0.604 . . . . 0.0 110.845 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.41 163.2 14.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.954 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -158.45 -36.97 0.07 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.948 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.1 pt -117.95 -176.14 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.985 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.74 147.08 55.58 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.186 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.65 155.42 80.6 Favored 'Cis proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.648 -1.397 . . . . 0.0 111.802 -0.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.532 HG22 ' HG3' ' A' ' 100' ' ' GLN . 88.3 m -144.12 110.19 5.39 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.8 p -102.12 113.69 27.17 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.082 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.626 HG21 ' HB3' ' A' ' 78' ' ' TYR . 85.1 t -100.65 109.88 26.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.319 176.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -89.67 105.86 18.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.139 0.495 . . . . 0.0 110.492 -178.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.518 HD22 ' HA ' ' A' ' 95' ' ' LYS . 46.8 mt -99.13 148.89 23.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.132 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.428 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 7.3 t70 -83.6 -166.01 1.27 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.428 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 12.2 pttm -59.92 -32.45 70.78 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -170.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -105.81 10.72 32.52 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.01 0.433 . . . . 0.0 110.773 -173.886 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.64 20.15 45.38 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.163 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -68.32 116.93 9.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.012 0.406 . . . . 0.0 110.433 176.258 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.518 ' HA ' HD22 ' A' ' 89' ' ' LEU . 39.7 ttmt -74.1 89.09 1.95 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.601 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -89.27 -47.18 8.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.246 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.512 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 77.9 t80 -144.54 111.26 5.72 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.747 -177.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.18 134.46 44.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 172.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.512 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 17.3 t60 -138.24 126.64 23.21 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -175.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.532 ' HG3' HG22 ' A' ' 85' ' ' THR . 24.1 mp0 -96.63 140.09 31.75 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 123.611 0.569 . . . . 0.0 109.733 174.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.98 162.68 18.01 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.515 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.2 tp -73.95 141.04 45.95 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 122.522 0.329 . . . . 0.0 111.429 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 60.0 mtm -135.63 159.47 41.52 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 171.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -97.14 164.51 12.47 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.716 ' HG3' HG23 ' A' ' 51' ' ' VAL . 61.0 tttm -46.92 -52.37 14.69 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -175.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 25.7 t-20 -58.45 -32.82 69.08 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -177.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.524 ' O ' HG12 ' A' ' 111' ' ' ILE . 10.8 m120 -65.04 -46.35 81.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.428 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 41.5 mt -61.9 -43.93 98.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.836 176.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 105' ' ' LYS . 79.3 mm-40 -49.58 -47.21 49.56 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.015 176.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 m -72.11 -39.47 68.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.087 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 107' ' ' ASN . 48.5 mm -65.1 -44.54 95.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.875 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.626 ' HB3' HG21 ' A' ' 117' ' ' VAL . 82.8 mt -63.52 -38.73 92.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.068 0.461 . . . . 0.0 110.279 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -58.23 -41.15 83.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.892 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.9 m -85.13 -8.38 58.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.712 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 tp -85.01 -86.62 0.13 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.016 0.436 . . . . 0.0 109.842 176.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -179.03 -60.44 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 1.06 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 40.8 t 57.51 64.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 122.028 0.918 . . . . 0.0 110.756 177.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.114 -177.891 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 121.174 0.511 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.516 HG21 ' HB3' ' A' ' 52' ' ' SER . 1.1 tt -74.53 -8.42 11.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.484 -172.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -111.76 37.35 2.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.544 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.491 HG21 ' CD1' ' A' ' 63' ' ' TYR . 8.0 p -82.72 140.54 16.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.684 -176.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.8 p -139.6 159.92 27.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.485 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.486 ' HG3' ' HB2' ' A' ' 19' ' ' ASN . 5.1 tp10 -83.53 -55.89 4.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.207 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.632 ' HA ' ' CE2' ' A' ' 62' ' ' TYR . 5.9 t-20 -142.59 169.07 18.26 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.543 -169.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.77 -32.35 73.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.355 176.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -63.34 -24.39 67.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.72 0.771 . . . . 0.0 109.943 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -97.65 10.28 40.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.645 -177.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -109.58 145.45 36.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.186 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -97.38 154.09 17.68 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 174.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.47 177.34 3.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.661 177.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . 89.53 -55.13 3.84 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.535 174.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 24.9 pt -84.51 134.83 41.78 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.913 0.387 . . . . 0.0 110.495 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 1.0 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 48.2 Cg_exo -59.14 144.49 99.36 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.783 2.322 . . . . 0.0 111.338 176.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.448 ' HB ' HD11 ' A' ' 89' ' ' LEU . 25.1 m -110.55 122.13 47.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.151 0.5 . . . . 0.0 111.185 -175.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.6 mt -104.39 108.67 25.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.745 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.669 ' HB ' HG21 ' A' ' 87' ' ' VAL . 5.4 mp -97.62 128.42 48.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.468 ' HB3' HG23 ' A' ' 86' ' ' THR . 26.2 ptm -121.45 122.74 40.43 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.472 0.653 . . . . 0.0 110.353 178.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.559 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 93.7 m-85 -90.6 122.47 33.43 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.309 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.626 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 14.2 pttp -128.75 133.77 48.22 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.226 -174.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.459 ' HA ' ' HB2' ' A' ' 66' ' ' LEU . 17.8 p -75.1 178.17 5.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.561 0.22 . . . . 0.0 110.68 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.98 -58.94 6.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.053 0.454 . . . . 0.0 109.935 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.9 m -102.71 101.22 11.31 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.685 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 34' ' ' LYS . 4.0 p -136.03 104.21 9.72 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 120.996 0.426 . . . . 0.0 112.016 -177.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -71.62 -29.56 15.91 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.988 1.792 . . . . 0.0 111.889 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -63.31 -30.2 71.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.723 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.635 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 52.8 t -66.27 -51.11 60.74 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.113 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.7 t -57.11 -43.25 81.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.893 0.378 . . . . 0.0 110.912 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.568 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 7.6 tp10 -58.24 -49.03 78.55 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.932 177.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.4 ttt -72.16 -29.34 63.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.967 -177.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.635 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 27.4 mt-30 -57.89 -39.01 76.82 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 110.035 174.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.568 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 42.8 mtpt -60.03 -53.12 61.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.192 176.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.515 ' O ' HG22 ' A' ' 51' ' ' VAL . 63.6 mm-40 -58.7 -45.11 90.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.869 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.92 -33.15 73.72 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.953 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.3 t -64.95 -43.08 93.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.201 0.524 . . . . 0.0 109.682 176.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -66.47 -22.55 66.2 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.229 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.714 HG21 ' HG3' ' A' ' 105' ' ' LYS . 40.5 t -86.47 -41.97 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.005 0.431 . . . . 0.0 110.645 177.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.516 ' HB3' HG21 ' A' ' 14' ' ' ILE . 57.0 m -58.8 -30.83 67.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.341 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . 36.0 ttpt -51.59 -53.18 41.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.423 -178.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -105.9 15.99 25.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.707 0.289 . . . . 0.0 111.713 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 55' ' ' ARG . 12.8 ttm180 -138.68 75.91 1.54 Allowed 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.059 0.933 . . . . 0.0 109.633 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.709 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 1.5 tm-20 -71.39 132.0 44.18 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 113.87 -1.514 . . . . 0.0 110.07 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 41.47 46.86 4.63 Favored Glycine 0 C--N 1.333 0.408 0 O-C-N 124.016 0.822 . . . . 0.0 114.734 169.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.709 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 35.6 mmtm -120.14 -1.45 10.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.642 0.734 . . . . 0.0 109.434 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -158.46 150.61 21.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.453 -1.249 . . . . 0.0 108.723 172.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -114.27 124.75 52.79 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.4 mt -98.61 110.32 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.228 0.537 . . . . 0.0 111.564 -174.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.632 ' CE2' ' HA ' ' A' ' 19' ' ' ASN . 1.3 t80 -85.42 114.75 22.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.14 177.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.491 ' CD1' HG21 ' A' ' 16' ' ' VAL . 12.7 m-85 -89.94 103.26 15.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.223 0.535 . . . . 0.0 110.518 176.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.559 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -88.86 81.63 6.9 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.17 -179.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.626 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 20.3 ptt180 -71.73 108.24 4.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.569 177.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 35' ' ' THR . 9.1 mp -65.87 10.5 0.1 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.185 0.517 . . . . 0.0 111.851 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.524 ' H ' ' C ' ' A' ' 65' ' ' ARG . 30.5 tt0 -64.23 -31.3 72.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.342 172.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -96.87 170.09 9.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.331 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -94.29 -11.96 29.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.339 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -67.28 -11.01 56.42 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.868 0.842 . . . . 0.0 110.826 177.217 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -89.89 -5.99 56.23 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.051 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.9 mt -69.19 -56.34 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -70.73 -38.13 73.55 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.724 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -57.42 -42.22 81.91 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.74 177.107 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.479 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -63.36 -56.57 15.31 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.722 -177.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -65.4 -32.21 73.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.633 -175.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.404 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 14.1 tmtt? -61.95 -18.58 60.84 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.971 0.415 . . . . 0.0 110.595 177.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.545 ' HB3' HG13 ' A' ' 87' ' ' VAL . 58.9 m-85 -127.4 25.48 6.11 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 66.0 15.29 10.01 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.323 0.582 . . . . 0.0 111.527 171.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.67 142.71 31.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.641 -174.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -146.16 -34.16 0.31 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.718 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.1 pt -125.59 -177.72 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.039 0.447 . . . . 0.0 111.3 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.2 p -118.87 137.47 25.03 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.306 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -96.65 126.33 2.92 Favored 'Cis proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.86 -1.308 . . . . 0.0 113.223 -0.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.2 m -100.39 116.99 33.66 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 171.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 2.3 p -115.5 115.23 26.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.999 0.428 . . . . 0.0 111.146 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.692 HG11 ' HB ' ' A' ' 98' ' ' VAL . 2.0 m -100.54 124.47 54.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.482 0.658 . . . . 0.0 110.219 176.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.52 ' HB3' HD22 ' A' ' 115' ' ' LEU . 73.3 m-85 -98.18 106.31 18.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.083 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 44.0 mt -88.19 132.18 34.45 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 174.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.06 171.6 3.51 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 173.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 6.2 pttm -52.86 -25.23 10.96 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.447 0.699 . . . . 0.0 112.455 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.21 -9.6 59.06 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.85 10.05 61.87 Favored Glycine 0 CA--C 1.517 0.207 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.728 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 7.9 p30 -85.78 144.4 27.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.756 -0.261 . . . . 0.0 110.708 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt -81.21 92.41 6.32 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -85.48 -45.12 12.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.062 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.501 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 89.1 t80 -137.3 148.12 46.13 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.194 -176.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.692 ' HB ' HG11 ' A' ' 87' ' ' VAL . 2.2 p -134.76 135.36 53.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.649 173.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.501 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 50.4 t60 -122.42 119.5 31.2 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -109.47 105.67 15.11 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 133.22 179.95 16.8 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -174.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.458 HD21 ' HG2' ' A' ' 43' ' ' GLU . 33.2 tp -87.5 164.9 15.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.715 0.258 . . . . 0.0 110.84 -176.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.658 ' HE1' HG12 ' A' ' 108' ' ' ILE . 27.0 ptt? -172.01 156.36 4.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.613 173.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.405 HH12 ' CD ' ' A' ' 43' ' ' GLU . 32.4 mmt180 -91.84 170.87 9.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.754 -0.203 . . . . 0.0 110.987 -176.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.714 ' HG3' HG21 ' A' ' 51' ' ' VAL . 82.5 tttt -47.23 -49.87 22.25 Favored 'General case' 0 C--O 1.222 -0.346 0 O-C-N 123.63 0.581 . . . . 0.0 112.071 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -56.35 -35.43 67.65 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.158 0.504 . . . . 0.0 111.543 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.439 ' HB2' ' HB2' ' A' ' 103' ' ' MET . 6.5 m120 -73.96 -40.02 63.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.658 HG12 ' HE1' ' A' ' 103' ' ' MET . 61.7 mt -60.77 -46.03 96.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.378 172.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 105' ' ' LYS . 10.6 mm-40 -50.49 -48.41 56.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.317 176.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.4 m -63.86 -43.0 97.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.718 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 107' ' ' ASN . 42.8 mm -65.22 -42.99 95.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.816 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.586 ' HB3' HG21 ' A' ' 117' ' ' VAL . 81.6 mt -60.57 -42.23 96.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.617 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -64.25 -31.36 72.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.157 177.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.6 t -86.13 -9.7 56.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.462 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.52 HD22 ' HB3' ' A' ' 88' ' ' PHE . 45.9 tp -93.11 -73.92 0.54 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.116 0.484 . . . . 0.0 110.231 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 172.2 -61.38 0.15 Allowed Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 1.0 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 41.9 t 50.33 78.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.957 0.884 . . . . 0.0 111.605 178.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.796 -174.722 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.539 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 9.8 m . . . . . 0 N--CA 1.454 -0.253 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.1 mt 70.33 -69.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.911 -175.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.703 HD22 ' HA2' ' A' ' 57' ' ' GLY . 12.9 m120 -92.93 31.28 1.43 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.262 0.553 . . . . 0.0 110.487 177.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 7.7 p -74.69 133.58 31.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.202 -177.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.403 HG21 ' HB3' ' A' ' 60' ' ' ASN . 67.5 t -134.84 136.38 52.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.847 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -65.83 -53.95 33.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.928 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.667 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 35.2 t30 -164.77 174.33 10.81 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -173.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -50.48 -29.4 10.32 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.805 0.336 . . . . 0.0 111.208 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.667 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 10.2 pt-20 -55.83 -37.2 68.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.321 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -103.18 8.3 38.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.625 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.26 139.66 52.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.622 0.249 . . . . 0.0 110.347 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -128.18 154.74 45.46 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.759 -174.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 61.8 -170.36 0.16 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.064 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -110.22 43.99 1.6 Allowed Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.151 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.543 HG13 ' ND2' ' A' ' 60' ' ' ASN . 7.0 pt -100.68 147.25 33.38 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.609 -0.295 . . . . 0.0 111.058 -178.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 1.094 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 88.1 Cg_exo -50.59 160.07 1.88 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.64 2.893 . . . . 0.0 113.227 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.7 m -123.37 128.16 49.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.435 -175.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.491 HD12 HD22 ' A' ' 112' ' ' LEU . 80.0 mt -107.45 109.63 28.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.602 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 42.5 mt -105.15 110.22 30.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.263 -177.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.537 ' SD ' ' NZ ' ' A' ' 34' ' ' LYS . 5.1 ppp? -114.69 139.58 49.55 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.767 0.794 . . . . 0.0 110.058 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -103.87 150.03 24.53 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.016 -170.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.801 ' HZ1' ' HB3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -152.77 161.51 42.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.934 178.565 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.62 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -75.06 -173.8 2.07 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 175.114 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.448 ' HB2' ' OE1' ' A' ' 67' ' ' GLU . 31.6 t70 -60.27 -29.37 68.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.057 0.456 . . . . 0.0 110.725 175.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -158.46 132.49 7.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.546 176.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 12.5 p -165.8 137.35 3.1 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.772 176.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 24.2 Cg_exo -63.14 -29.85 74.61 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.693 2.262 . . . . 0.0 112.811 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -62.94 -31.12 72.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.516 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 46.9 t -71.47 -36.32 71.13 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.111 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.537 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 46.9 t -67.93 -42.0 85.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.835 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -57.96 -50.24 74.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.669 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.461 ' HB2' HD22 ' A' ' 102' ' ' LEU . 21.5 ttt -72.15 -29.0 63.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.664 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.95 ' HG2' ' HH ' ' A' ' 63' ' ' TYR . 23.0 tm0? -61.08 -42.41 98.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 177.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 31.7 mmmt -63.04 -45.45 92.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.934 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.589 ' O ' HG21 ' A' ' 51' ' ' VAL . 72.0 mm-40 -58.06 -47.88 81.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.698 176.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.415 ' HB3' HD13 ' A' ' 61' ' ' ILE . 87.1 mt -61.56 -35.41 77.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.213 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.7 m -59.72 -43.93 93.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.079 0.466 . . . . 0.0 110.176 173.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -66.97 -41.03 87.54 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.615 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.589 HG21 ' O ' ' A' ' 47' ' ' GLU . 55.3 t -60.24 -44.56 95.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.571 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.664 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 m -66.24 -30.85 71.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.969 0.414 . . . . 0.0 111.282 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -77.66 -24.71 49.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.045 0.45 . . . . 0.0 110.557 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -93.39 -38.63 11.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.22 0.533 . . . . 0.0 110.199 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -114.8 79.03 1.21 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.63 120.92 19.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.567 -168.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.703 ' HA2' HD22 ' A' ' 15' ' ' ASN . . . 60.91 57.86 16.64 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.549 -0.75 . . . . 0.0 113.184 173.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.826 ' HE3' HG13 ' A' ' 117' ' ' VAL . 29.1 mmmt -132.67 -3.2 3.31 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.655 -0.32 . . . . 0.0 111.571 -176.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -166.82 153.92 9.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 111.149 -176.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.543 ' ND2' HG13 ' A' ' 27' ' ' ILE . 58.6 m-80 -95.64 129.82 42.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.99 174.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.415 HD13 ' HB3' ' A' ' 48' ' ' LEU . 57.6 mt -98.92 108.76 22.84 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 CA-C-O 120.542 0.211 . . . . 0.0 110.657 178.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.794 ' HH ' ' HG ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -96.28 118.28 32.51 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.338 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.95 ' HH ' ' HG2' ' A' ' 45' ' ' GLN . 31.2 m-85 -97.27 103.74 15.7 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.143 0.497 . . . . 0.0 110.368 173.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.4 ' HB1' HD21 ' A' ' 71' ' ' ASN . . . -94.27 100.62 12.64 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.231 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.558 ' C ' ' H ' ' A' ' 67' ' ' GLU . 3.4 ptp180 -84.61 117.22 23.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.273 172.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.7 mt -66.73 10.51 0.13 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.268 0.556 . . . . 0.0 112.082 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.558 ' H ' ' C ' ' A' ' 65' ' ' ARG . 20.7 tp10 -80.4 -25.19 39.2 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.584 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -96.85 159.01 15.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.951 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -71.5 -22.91 61.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.166 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.486 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.9 OUTLIER -65.16 -25.84 67.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.415 0.626 . . . . 0.0 111.166 -174.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.486 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 7.8 m120 -89.94 -7.49 53.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.76 -168.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.7 mm -69.23 -50.94 48.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.78 -44.25 86.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.143 174.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.794 ' HG ' ' HH ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -60.48 -40.98 93.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.593 -178.414 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.9 -55.87 9.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.349 . . . . 0.0 111.655 -177.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -63.2 -34.23 77.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.676 -174.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 77' ' ' LYS . 26.8 ttmt -64.61 -16.91 63.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.901 0.381 . . . . 0.0 110.912 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.574 ' CE1' HD22 ' A' ' 89' ' ' LEU . 75.7 m-85 -122.02 16.96 10.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.797 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 67.77 23.48 8.55 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.87 0.367 . . . . 0.0 111.535 174.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.427 ' HB1' HG21 ' A' ' 85' ' ' THR . . . -102.34 136.49 42.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.615 -178.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -144.33 -75.55 0.24 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.015 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.0 pt -71.15 142.05 16.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.99 0.424 . . . . 0.0 110.95 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.3 153.08 38.33 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.634 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -87.94 119.75 4.87 Favored 'Cis proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.25 -1.563 . . . . 0.0 112.411 0.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.547 ' HB ' ' HG3' ' A' ' 100' ' ' GLN . 5.1 t -110.31 142.52 41.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.249 177.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.7 m -132.39 127.86 36.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.747 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.602 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 10.8 p -108.89 128.33 64.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.25 0.548 . . . . 0.0 110.342 176.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -101.42 111.79 24.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.441 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.574 HD22 ' CE1' ' A' ' 78' ' ' TYR . 5.7 mp -107.91 146.01 32.97 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.079 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -83.2 -172.48 4.16 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 173.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.917 ' HE3' ' HE2' ' A' ' 118' ' ' LYS . 18.7 pttp -62.79 -33.04 74.36 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -172.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -93.42 18.04 10.43 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.458 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 78.54 25.34 61.07 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.819 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.563 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 81.3 m-20 -78.95 110.07 13.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.563 0.22 . . . . 0.0 110.68 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 78' ' ' TYR . 11.7 ptmm? -72.36 86.78 1.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.53 0.681 . . . . 0.0 109.696 177.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -80.42 -53.09 6.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.374 -172.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.408 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 75.8 t80 -135.76 127.6 29.33 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.768 -173.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 87' ' ' VAL . 33.7 m -111.01 150.69 13.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 172.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.408 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 11.9 t60 -156.3 134.33 11.23 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.547 ' HG3' ' HB ' ' A' ' 85' ' ' THR . 2.3 mp0 -105.01 128.69 53.42 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 173.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 141.4 -161.3 26.94 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.458 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' A' ' 44' ' ' MET . 1.1 tm? -129.87 121.3 26.42 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.64 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 3.3 mpp? -116.25 161.34 19.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.845 0.355 . . . . 0.0 110.202 178.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -93.95 167.97 11.27 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.086 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -50.3 -42.77 53.07 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -62.32 -38.76 90.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.186 0.517 . . . . 0.0 110.855 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.64 ' HB2' ' HB3' ' A' ' 103' ' ' MET . 3.5 m120 -71.05 -43.97 66.74 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.503 -176.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.608 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 48.9 mt -58.72 -50.04 80.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.872 176.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -56.51 -48.76 76.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.337 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.5 m -60.03 -38.17 81.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.067 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 107' ' ' ASN . 80.4 mt -65.35 -40.86 89.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.839 0.352 . . . . 0.0 110.231 176.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 57.4 mt -63.27 -35.83 81.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.183 177.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.86 -30.29 71.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.444 177.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.0 m -85.45 -9.85 56.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.709 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.2 tp -87.52 -88.18 0.14 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.387 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -174.5 -54.05 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 1.094 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 17.4 t 52.97 57.22 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 122.327 1.06 . . . . 0.0 109.871 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.917 ' HE2' ' HE3' ' A' ' 91' ' ' LYS . 19.8 pttm . . . . . 0 C--N 1.321 -0.662 0 CA-C-N 114.266 -1.333 . . . . 0.0 110.486 -173.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.546 ' CB ' HG23 ' A' ' 16' ' ' VAL . 20.3 m . . . . . 0 N--CA 1.45 -0.448 0 CA-C-O 121.099 0.476 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 14' ' ' ILE . 3.3 mp -85.81 -28.66 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.529 0.681 . . . . 0.0 110.1 -176.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -79.45 10.33 3.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.493 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.546 HG23 ' CB ' ' A' ' 13' ' ' SER . 1.0 OUTLIER -64.36 142.28 17.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.675 0.75 . . . . 0.0 112.842 -173.089 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.53 HG23 ' HB3' ' A' ' 60' ' ' ASN . 84.3 t -134.85 124.95 44.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.606 174.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -79.47 -30.92 42.3 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.138 0.495 . . . . 0.0 110.798 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -176.24 176.4 1.69 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -48.87 -34.24 12.23 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.67 -33.73 70.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.642 0.258 . . . . 0.0 111.613 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -99.15 19.94 14.37 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.751 0.31 . . . . 0.0 111.019 -175.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.96 145.33 26.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.906 0.384 . . . . 0.0 111.143 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -116.71 114.42 24.0 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -81.41 168.57 18.2 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.284 -175.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.46 -35.0 5.32 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -172.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.5 pt -113.01 157.39 40.84 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 114.925 -0.638 . . . . 0.0 109.729 176.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.524 ' HG2' HG22 ' A' ' 117' ' ' VAL . 49.0 Cg_exo -57.76 169.71 2.39 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.868 2.379 . . . . 0.0 112.608 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.475 ' HA ' ' HB2' ' A' ' 60' ' ' ASN . 63.1 m -136.38 115.28 12.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.932 0.396 . . . . 0.0 111.063 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.4 mm -101.71 139.45 22.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.589 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 77.2 mt -130.6 118.11 41.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.561 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 24.9 ptm -109.23 120.54 42.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.469 0.652 . . . . 0.0 109.856 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.556 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 87.8 m-85 -90.41 117.36 29.06 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.752 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HG3' ' HB2' ' A' ' 41' ' ' CYS . 0.1 OUTLIER -150.8 149.35 29.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.364 -178.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.4 t -81.7 165.22 21.19 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 170.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.655 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -88.92 9.93 23.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.015 0.436 . . . . 0.0 110.871 -169.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.4 p -108.9 -16.69 14.1 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 65.7 m -83.03 128.53 64.95 Favored Pre-proline 0 C--N 1.33 -0.265 0 O-C-N 122.25 -0.281 . . . . 0.0 111.001 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.91 -25.76 7.29 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 121.938 1.759 . . . . 0.0 113.569 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -62.97 -19.74 64.58 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.798 0.332 . . . . 0.0 110.965 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.625 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 7.3 p -71.73 -34.4 69.53 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.35 -35.79 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.691 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -62.99 -49.53 74.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.135 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.501 ' HE2' ' HB2' ' A' ' 103' ' ' MET . 26.5 ttt -65.84 -32.88 74.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.2 178.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 19.8 mt-30 -63.66 -33.2 75.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.934 175.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -68.42 -41.41 80.43 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.216 176.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.663 ' O ' HG21 ' A' ' 51' ' ' VAL . 18.9 mm-40 -55.72 -54.04 49.17 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 172.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.524 ' HB3' HD11 ' A' ' 61' ' ' ILE . 68.7 mt -58.24 -33.43 69.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.487 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.1 t -65.61 -40.66 92.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.788 0.328 . . . . 0.0 110.58 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.416 ' O ' ' HB3' ' A' ' 53' ' ' LYS . 19.8 m-85 -72.69 -31.74 65.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.06 178.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.894 HG23 ' HG3' ' A' ' 105' ' ' LYS . 16.8 t -68.76 -38.66 79.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.2 t -64.06 -31.11 72.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.925 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 50' ' ' TYR . 16.1 tppt? -68.27 -42.55 79.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.378 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -93.24 -20.88 20.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.63 -176.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.3 76.23 1.71 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.521 0.677 . . . . 0.0 109.507 178.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.439 ' O ' ' HE3' ' A' ' 58' ' ' LYS . 1.2 pm0 -72.14 124.34 24.8 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.738 -173.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.34 40.13 37.39 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.614 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.439 ' HE3' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -113.49 -4.59 13.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.076 0.465 . . . . 0.0 110.059 -174.019 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -171.79 141.93 1.47 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.922 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.53 ' HB3' HG23 ' A' ' 17' ' ' VAL . 50.8 m-80 -77.27 145.78 37.28 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.613 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.524 HD11 ' HB3' ' A' ' 48' ' ' LEU . 21.3 mt -128.09 107.04 15.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 171.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.523 ' CD2' HG23 ' A' ' 31' ' ' ILE . 4.7 t80 -98.92 117.27 33.05 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.465 ' CE2' HG22 ' A' ' 16' ' ' VAL . 25.3 m-85 -90.99 103.59 16.29 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' A' ' 33' ' ' PHE . . . -81.5 78.29 8.27 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.984 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.588 ' C ' ' H ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -69.84 113.14 6.8 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.62 174.059 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.7 tp -64.57 11.43 0.05 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.342 0.591 . . . . 0.0 111.123 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.655 ' HB2' ' HB2' ' A' ' 36' ' ' ASP . 7.8 tp10 -80.62 -25.55 38.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.091 -178.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.413 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 44.2 mt-10 -105.87 -174.39 2.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.247 0.546 . . . . 0.0 112.056 -175.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -90.42 -31.44 16.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.947 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -54.31 -40.61 68.09 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.641 0.734 . . . . 0.0 111.664 -173.389 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.538 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 2.6 p30 -101.51 10.28 40.51 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.875 -172.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.2 mm -67.45 -49.61 69.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 167.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.56 -43.96 62.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.606 174.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.486 ' CB ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -62.78 -43.84 97.75 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.674 -177.018 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.02 -41.83 77.2 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 122.187 -0.321 . . . . 0.0 110.857 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -61.9 -32.96 73.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.461 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -55.91 -33.33 64.56 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.525 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -112.19 8.02 19.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.726 0.298 . . . . 0.0 110.575 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 t0 53.81 50.63 16.52 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.255 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.28 71.04 10.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.326 0.584 . . . . 0.0 110.609 177.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -82.87 -13.66 55.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.836 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 23.1 pt -113.9 155.91 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.189 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.18 148.93 66.52 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.985 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -90.77 121.48 4.4 Favored 'Cis proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.372 -1.512 . . . . 0.0 112.587 -1.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 94.5 m -100.52 117.19 34.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.3 m -110.38 125.78 53.57 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.089 0.471 . . . . 0.0 111.323 -175.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.589 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 10.5 p -108.04 140.81 25.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.551 175.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.919 ' HB3' HD12 ' A' ' 115' ' ' LEU . 52.4 m-85 -118.29 113.74 21.92 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.226 -174.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.437 ' CD2' ' HA ' ' A' ' 95' ' ' LYS . 32.3 mt -107.88 143.75 36.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.673 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.601 ' HB3' ' HB2' ' A' ' 94' ' ' ASN . 24.7 t0 -78.28 172.05 14.16 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -63.71 -18.64 64.22 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -87.69 -0.42 56.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 0.0 110.059 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.51 12.03 67.77 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.441 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.601 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 94.5 m-20 -70.06 117.71 11.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.597 -0.301 . . . . 0.0 111.445 -177.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.437 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -73.0 102.2 3.43 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.582 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -104.35 -72.53 0.7 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.91 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -113.0 141.49 46.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.89 -169.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.1 p -139.48 135.75 40.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 174.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -149.35 137.96 20.98 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -106.72 123.72 48.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.896 0.379 . . . . 0.0 110.611 178.215 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 148.43 179.29 24.25 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.949 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.3 tp -83.0 102.06 11.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.902 0.382 . . . . 0.0 110.352 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.501 ' HB2' ' HE2' ' A' ' 44' ' ' MET . 79.4 mmm -94.98 154.35 17.22 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.418 ' HB2' HD21 ' A' ' 107' ' ' ASN . 8.8 mmm180 -115.36 171.17 7.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.784 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.894 ' HG3' HG23 ' A' ' 51' ' ' VAL . 38.8 ttmt -46.59 -59.34 3.07 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -175.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -61.5 -30.75 70.82 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.935 0.398 . . . . 0.0 111.67 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.531 ' O ' HD13 ' A' ' 111' ' ' ILE . 40.3 m-80 -70.47 -40.5 73.63 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.6 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 41.1 mt -63.11 -51.37 72.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 173.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -50.97 -52.49 42.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.341 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.4 m -60.13 -40.93 91.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.004 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.61 ' O ' ' HG ' ' A' ' 115' ' ' LEU . 1.7 mp -69.06 -38.75 78.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.68 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 86.7 mt -58.01 -43.11 86.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.263 0.554 . . . . 0.0 109.783 176.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -56.7 -40.81 76.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.227 176.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.4 m -75.26 -28.99 60.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.452 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.919 HD12 ' HB3' ' A' ' 88' ' ' PHE . 85.1 mt -68.01 -58.32 4.71 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.481 0.657 . . . . 0.0 109.664 175.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 159.79 -71.3 0.23 Allowed Glycine 0 N--CA 1.438 -1.2 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.165 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.524 HG22 ' HG2' ' A' ' 28' ' ' PRO . 40.9 t 54.97 72.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.908 0.861 . . . . 0.0 109.557 -173.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.45 ' HE3' ' HB2' ' A' ' 118' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.006 -171.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.0 m . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.658 ' HB ' ' CD ' ' A' ' 56' ' ' GLU . 4.2 mp -90.77 -14.71 8.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.999 0.904 . . . . 0.0 108.903 177.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -71.16 7.66 1.19 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.305 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.5 ' H ' ' C ' ' A' ' 14' ' ' ILE . 6.5 p -60.0 129.24 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -173.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -133.17 140.07 47.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.813 170.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.728 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 28.0 tp10 -70.53 -50.56 36.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.335 177.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.869 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 27.9 t-20 -149.13 171.05 17.06 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.275 -174.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -50.05 -29.93 9.78 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.194 0.308 . . . . 0.0 111.061 171.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.869 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 12.9 pt-20 -61.31 -29.95 70.19 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.956 0.408 . . . . 0.0 110.881 175.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.728 ' HG3' ' HB3' ' A' ' 18' ' ' GLU . 13.6 mm-40 -95.24 -0.22 53.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.264 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.17 159.69 25.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.303 0.573 . . . . 0.0 112.145 -172.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.588 ' HB2' HD12 ' A' ' 27' ' ' ILE . 29.7 mtmt -115.39 161.96 17.8 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.688 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.44 166.01 10.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.888 0.375 . . . . 0.0 111.977 -177.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.13 -49.43 3.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.063 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.757 ' H ' HD11 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -91.46 149.59 39.75 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.721 0.296 . . . . 0.0 110.62 178.115 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 1.081 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 52.0 Cg_exo -60.72 171.01 3.89 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 123.264 2.643 . . . . 0.0 112.891 176.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.511 HG21 ' HB2' ' A' ' 60' ' ' ASN . 26.4 m -130.74 131.4 44.72 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.921 -176.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.549 HD11 HD21 ' A' ' 112' ' ' LEU . 65.3 mt -110.0 114.13 46.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.664 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.598 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 9.5 mm -100.39 109.93 26.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 25.5 ptm -111.96 131.83 55.14 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.857 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.634 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 77.3 m-85 -97.53 120.55 38.11 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.217 -176.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.546 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -125.6 162.23 25.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.997 -174.587 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.3 t -135.89 164.92 26.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.061 0.457 . . . . 0.0 110.648 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.482 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . 24.3 t70 -75.79 -27.75 58.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.799 -178.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.1 m -81.82 -66.55 0.87 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.042 -174.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.592 ' HB3' ' HD2' ' A' ' 40' ' ' TYR . 29.9 m -68.69 122.12 83.62 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.223 -176.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -79.01 3.72 7.17 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.437 2.091 . . . . 0.0 113.332 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.592 ' HD2' ' HB3' ' A' ' 38' ' ' CYS . 96.1 m-85 -61.4 -23.94 66.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.996 0.427 . . . . 0.0 110.614 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 9.2 p -64.71 -52.02 59.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.245 177.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.413 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 41.7 t -60.47 -30.99 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.71 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -68.02 -49.89 58.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.438 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.2 ttt -66.02 -30.3 70.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.863 0.363 . . . . 0.0 110.199 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 28.2 mt-30 -60.93 -37.27 81.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.023 176.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 43.7 mttp -64.49 -47.83 77.47 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.853 0.359 . . . . 0.0 110.046 177.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.5 ' O ' HG21 ' A' ' 51' ' ' VAL . 21.0 mm-40 -57.28 -44.27 83.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.299 177.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.5 mt -60.7 -34.1 73.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.971 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.5 m -59.87 -44.57 94.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.075 0.464 . . . . 0.0 110.29 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -70.05 -29.5 66.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.047 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 47' ' ' GLU . 50.9 t -76.22 -47.01 32.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.629 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.6 ' HB3' ' OE2' ' A' ' 56' ' ' GLU . 15.1 m -62.81 -29.17 70.52 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-O 120.881 0.372 . . . . 0.0 110.513 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -50.11 -32.96 17.17 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.184 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -104.32 -48.57 3.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.388 0.613 . . . . 0.0 109.365 171.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.647 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 9.4 tpp85 -91.02 66.52 5.83 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.915 -173.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.658 ' CD ' ' HB ' ' A' ' 14' ' ' ILE . 3.9 mm-40 -90.52 144.73 25.5 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.005 172.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.45 34.2 54.55 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.491 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.647 ' HB2' ' HG3' ' A' ' 55' ' ' ARG . 26.8 mmtp -113.05 -14.09 13.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.251 0.548 . . . . 0.0 109.727 -174.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.547 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 0.8 OUTLIER -165.68 -175.01 3.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.398 179.008 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.511 ' HB2' HG21 ' A' ' 29' ' ' THR . 44.1 m-80 -108.2 129.28 55.2 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.209 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 61' ' ' ILE . 36.3 mm -106.64 107.54 22.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 173.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.85 ' CE2' ' HA ' ' A' ' 19' ' ' ASN . 0.7 OUTLIER -98.2 112.1 24.2 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.448 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.455 ' CE2' HG23 ' A' ' 16' ' ' VAL . 89.7 m-85 -89.8 102.75 15.45 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 173.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.596 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -79.67 91.03 5.2 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.591 ' C ' ' H ' ' A' ' 67' ' ' GLU . 8.0 ptp180 -68.97 104.21 2.04 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.443 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.7 mp -65.42 10.74 0.08 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.092 0.472 . . . . 0.0 110.907 176.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.591 ' H ' ' C ' ' A' ' 65' ' ' ARG . 2.0 mp0 -83.29 -29.44 28.36 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.012 177.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.529 ' CD ' ' HZ1' ' A' ' 70' ' ' LYS . 22.6 mt-10 -102.48 -171.67 2.0 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-O 121.379 0.609 . . . . 0.0 112.48 -175.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -95.17 -35.35 11.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.966 -174.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.529 ' HZ1' ' CD ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -56.33 -28.17 58.13 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.408 0.623 . . . . 0.0 111.144 -176.376 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.524 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 3.6 m120 -87.69 -8.45 56.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.435 -170.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.8 mm -68.3 -57.86 7.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.46 -38.89 91.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.2 174.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.566 ' HG ' ' HH ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -58.86 -38.91 79.85 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.312 179.343 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.634 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -61.14 -48.23 82.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.062 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -65.55 -34.17 77.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.809 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -57.91 -33.8 69.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.041 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.438 ' CD1' HG13 ' A' ' 87' ' ' VAL . 72.6 m-85 -115.81 16.99 16.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.902 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 61.9 35.02 16.6 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.006 170.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.452 ' HB2' HG22 ' A' ' 85' ' ' THR . . . -91.65 146.1 24.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.696 -176.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -154.58 -35.01 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.45 174.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.0 mt -91.94 134.9 28.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.787 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 84' ' ' PRO . 16.1 m -108.34 134.74 20.1 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.568 176.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 63.5 Cg_endo -91.7 141.79 11.14 Favored 'Cis proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.321 -1.533 . . . . 0.0 112.509 -0.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.452 HG22 ' HB2' ' A' ' 80' ' ' ALA . 9.0 t -126.06 147.18 49.63 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.5 t -141.17 130.39 23.52 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.891 0.376 . . . . 0.0 110.462 -177.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.598 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 8.8 p -113.61 128.29 70.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.382 0.611 . . . . 0.0 110.198 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.505 ' HB3' HD23 ' A' ' 115' ' ' LEU . 88.8 m-85 -100.03 118.54 36.62 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.147 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.587 ' O ' ' HB3' ' A' ' 28' ' ' PRO . 7.1 mp -106.12 139.43 40.65 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.159 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -68.77 177.51 2.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 173.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.859 ' HE3' ' HE2' ' A' ' 118' ' ' LYS . 4.5 pttm -63.16 -26.19 68.7 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 122.36 0.264 . . . . 0.0 111.596 -176.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -71.13 -25.56 62.63 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.747 0.308 . . . . 0.0 110.967 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.99 22.29 10.96 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.671 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 59.3 m-80 -86.81 132.09 33.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.687 0.244 . . . . 0.0 110.484 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -71.4 84.3 0.8 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.428 0.633 . . . . 0.0 109.724 173.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -73.03 -47.82 41.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.081 -174.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -145.21 116.68 8.04 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.127 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 87' ' ' VAL . 7.2 p -105.67 137.02 37.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 174.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -124.05 136.04 53.99 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -116.5 110.35 18.48 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 175.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 135.3 158.79 8.4 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -175.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.3 tp -77.9 141.78 38.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.757 0.313 . . . . 0.0 111.131 -176.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.455 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 54.7 mtm -131.63 166.89 20.43 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -102.67 175.03 5.63 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -54.85 -48.43 72.9 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.403 ' HA ' ' CD ' ' A' ' 109' ' ' GLU . 5.0 t-20 -66.51 -28.52 68.63 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.007 0.432 . . . . 0.0 110.811 -176.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.499 ' O ' HG12 ' A' ' 111' ' ' ILE . 11.2 m120 -66.16 -45.48 80.79 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 176.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.511 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 54.2 mt -61.71 -45.5 98.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.597 175.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.403 ' CD ' ' HA ' ' A' ' 106' ' ' ASN . 40.9 mt-10 -50.37 -48.29 55.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.528 176.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.3 m -65.25 -40.09 93.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.068 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 107' ' ' ASN . 49.1 mm -68.27 -43.52 84.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.516 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.549 HD21 HD11 ' A' ' 30' ' ' ILE . 98.2 mt -57.2 -43.54 82.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.18 0.514 . . . . 0.0 110.51 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -60.48 -43.2 97.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.117 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.0 m -86.53 -2.58 58.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.816 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.505 HD23 ' HB3' ' A' ' 88' ' ' PHE . 63.5 tp -82.85 -69.93 0.59 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.971 0.415 . . . . 0.0 111.869 -174.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.773 ' O ' ' HG2' ' A' ' 118' ' ' LYS . . . 149.32 -3.16 0.63 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.547 -172.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 1.081 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 39.0 t -33.86 107.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.141 0.976 . . . . 0.0 113.283 171.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.859 ' HE2' ' HE3' ' A' ' 91' ' ' LYS . 22.5 pttm . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 114.672 -1.149 . . . . 0.0 107.95 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.552 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 5.6 m . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.373 0.13 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.0 mt 64.59 -68.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 O-C-N 123.681 0.613 . . . . 0.0 111.133 -173.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -89.15 45.82 1.33 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.061 0.458 . . . . 0.0 110.641 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.552 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 2.4 p -79.71 123.12 36.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.603 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.546 HG11 ' HB1' ' A' ' 23' ' ' ALA . 41.0 t -109.65 141.93 23.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.104 -175.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -83.14 -33.64 26.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.756 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.802 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 20.1 t-20 -173.33 175.58 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.7 mt -60.58 -29.74 69.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.019 0.438 . . . . 0.0 110.447 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.802 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 12.0 pt-20 -65.13 -32.25 73.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.554 176.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -93.31 7.8 42.96 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.493 0.663 . . . . 0.0 110.122 178.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.546 ' HB1' HG11 ' A' ' 17' ' ' VAL . . . -110.24 158.58 18.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.249 -176.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 50.2 tptt -133.24 135.61 45.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.117 175.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.06 163.63 27.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.785 0.326 . . . . 0.0 110.269 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.58 -35.72 3.23 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.62 ' H ' HD11 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -116.0 145.54 35.06 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.177 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.554 ' HD2' ' O ' ' A' ' 58' ' ' LYS . 99.4 Cg_exo -44.93 133.61 10.82 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.17 2.58 . . . . 0.0 112.757 177.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.4 m -101.4 109.25 21.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.366 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.652 HD13 ' HB2' ' A' ' 59' ' ' PHE . 2.4 mp -98.67 108.19 21.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.692 ' HB ' HG23 ' A' ' 87' ' ' VAL . 67.8 mt -104.35 112.02 36.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.069 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.701 ' HE2' ' HG ' ' A' ' 41' ' ' CYS . 4.5 ppp? -109.55 144.15 38.24 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.492 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 87.5 m-85 -104.84 130.34 52.99 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.776 -177.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.847 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 12.5 pttp -143.98 149.06 36.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.108 -172.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.426 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 1.4 m -74.04 -174.18 1.81 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 168.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.42 ' H ' HG21 ' A' ' 35' ' ' THR . 7.0 t70 -54.12 -75.36 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.798 0.332 . . . . 0.0 110.812 175.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.1 m -110.88 127.17 55.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.861 0.363 . . . . 0.0 110.696 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.617 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 44.0 m -146.3 134.76 10.87 Favored Pre-proline 0 C--O 1.235 0.313 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.325 178.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.28 -31.19 14.67 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.116 1.877 . . . . 0.0 113.044 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -68.74 -28.7 67.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.926 0.393 . . . . 0.0 110.694 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.701 ' HG ' ' HE2' ' A' ' 32' ' ' MET . 58.8 m -74.37 -42.38 59.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.694 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.0 p -70.5 -29.58 39.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.161 0.505 . . . . 0.0 110.19 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -66.02 -46.23 78.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.898 175.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.426 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 23.8 ttt -63.16 -35.28 79.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.518 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.446 ' HG2' ' OH ' ' A' ' 63' ' ' TYR . 37.7 mt-30 -57.78 -40.63 80.28 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.192 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -58.68 -50.5 73.65 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.542 ' HG3' ' HA ' ' A' ' 104' ' ' ARG . 70.0 mm-40 -59.96 -40.26 88.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.098 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.797 HD11 HD11 ' A' ' 61' ' ' ILE . 96.7 mt -60.28 -43.66 96.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.492 177.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.9 t -62.99 -37.07 85.7 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.177 0.513 . . . . 0.0 110.15 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.592 ' HA ' ' HE3' ' A' ' 53' ' ' LYS . 23.0 m-85 -64.05 -23.94 67.52 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.567 177.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.524 HG22 ' HE3' ' A' ' 105' ' ' LYS . 46.3 t -83.15 -43.18 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.8 m -55.41 -31.86 62.2 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.16 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.625 ' HZ1' ' HB2' ' A' ' 53' ' ' LYS . 10.1 mtmp? -62.27 -35.16 78.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.786 0.327 . . . . 0.0 111.103 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.56 ' OE1' ' HB2' ' A' ' 53' ' ' LYS . 1.7 mp0 -103.96 9.0 36.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.554 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -154.83 92.8 1.49 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -172.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.12 116.48 7.26 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.119 0.485 . . . . 0.0 109.698 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 59' ' ' PHE . . . 47.02 -105.75 0.12 Allowed Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.168 -173.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.554 ' O ' ' HD2' ' A' ' 28' ' ' PRO . 0.3 OUTLIER 53.58 8.33 0.13 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.826 -1.187 . . . . 0.0 112.946 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.652 ' HB2' HD13 ' A' ' 30' ' ' ILE . 9.5 p90 -163.21 114.14 1.43 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.565 0.698 . . . . 0.0 110.414 174.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.492 ' HB3' HG22 ' A' ' 17' ' ' VAL . 5.4 m-20 -84.15 116.2 22.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.796 174.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.797 HD11 HD11 ' A' ' 48' ' ' LEU . 26.7 mt -96.33 107.91 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.746 -176.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.559 ' HB3' HG12 ' A' ' 31' ' ' ILE . 4.4 t80 -91.18 117.23 29.45 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.492 ' HD2' ' HD3' ' A' ' 34' ' ' LYS . 44.1 m-85 -91.48 106.46 18.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.782 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' A' ' 33' ' ' PHE . . . -83.13 69.83 9.95 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.775 0.797 . . . . 0.0 109.447 178.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.847 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 26.1 ptt180 -62.52 118.45 7.58 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.965 175.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.64 10.24 0.14 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.873 0.368 . . . . 0.0 111.618 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.533 ' H ' ' C ' ' A' ' 65' ' ' ARG . 17.9 mt-10 -69.05 -40.95 78.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.543 0.687 . . . . 0.0 109.974 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.58 ' HB2' ' HD2' ' A' ' 70' ' ' LYS . 27.0 mt-10 -89.83 151.99 21.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.908 -174.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -70.7 -34.21 71.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.216 0.531 . . . . 0.0 110.173 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.58 ' HD2' ' HB2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -58.15 -27.1 63.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.883 179.02 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.488 ' N ' ' HD3' ' A' ' 70' ' ' LYS . 76.8 m-20 -87.47 -3.41 59.0 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.223 -178.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.4 mm -70.72 -43.1 77.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 171.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -71.77 -41.35 68.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.217 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.401 ' HG ' ' HH ' ' A' ' 62' ' ' TYR . 0.8 OUTLIER -60.85 -47.42 86.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.205 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.492 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -62.93 -48.65 77.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.833 0.349 . . . . 0.0 110.967 178.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -61.42 -34.48 75.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.657 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -57.18 -33.22 67.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.181 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.438 ' CE1' ' HD3' ' A' ' 95' ' ' LYS . 85.3 m-85 -111.66 12.53 21.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.961 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.2 t70 67.33 21.86 9.69 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.433 0.635 . . . . 0.0 111.24 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.73 93.43 4.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.898 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -112.75 -8.15 13.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.454 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.511 HD13 ' H ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -125.17 153.39 32.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.001 178.552 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.7 m -131.27 153.22 81.61 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.455 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -90.59 145.65 16.64 Favored 'Cis proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.282 -1.549 . . . . 0.0 112.662 -0.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.1 t -142.61 149.55 39.13 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.3 m -138.6 131.12 28.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.684 0.278 . . . . 0.0 111.35 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.692 HG23 ' HB ' ' A' ' 31' ' ' ILE . 5.5 m -102.4 120.87 52.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.893 173.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -96.55 118.38 32.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.221 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.457 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 6.6 mp -113.68 145.06 41.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.75 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -63.93 171.66 2.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.949 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.805 ' HZ1' ' HB2' ' A' ' 92' ' ' GLU . 2.2 pptp? -52.04 -25.1 7.79 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.901 0.881 . . . . 0.0 112.756 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.805 ' HB2' ' HZ1' ' A' ' 91' ' ' LYS . 21.6 tt0 -92.1 -4.81 53.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.069 0.462 . . . . 0.0 111.036 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.98 29.07 24.12 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.827 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.499 ' ND2' ' HB3' ' A' ' 92' ' ' GLU . 6.4 p30 -110.06 134.04 52.57 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.457 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 35.1 mtmm -65.56 147.07 54.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.061 0.457 . . . . 0.0 111.202 -175.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -127.58 -46.27 1.45 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.132 173.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.498 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 81.4 t80 -147.45 134.09 19.91 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.466 -175.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.496 ' HB ' HG11 ' A' ' 87' ' ' VAL . 3.1 p -116.85 140.36 39.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 173.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.498 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 31.3 t60 -135.85 146.75 47.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -114.88 135.95 53.64 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.69 -149.04 18.34 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.12 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.3 tp -127.11 144.86 50.93 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.515 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 3.4 mpp? -131.28 165.02 24.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.354 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.542 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 32.3 mmt180 -103.22 168.21 9.32 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 173.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.579 ' HG3' ' N ' ' A' ' 106' ' ' ASN . 5.1 ptmt -54.93 -43.11 73.04 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -171.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.579 ' N ' ' HG3' ' A' ' 105' ' ' LYS . 12.9 t-20 -66.21 -32.23 73.53 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.908 0.385 . . . . 0.0 111.074 -178.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 103' ' ' MET . 9.1 m120 -66.74 -42.89 85.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.562 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 60.5 mt -62.59 -48.47 88.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.825 174.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -49.52 -51.79 34.01 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.109 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 m -63.16 -41.11 99.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.998 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 107' ' ' ASN . 42.9 mm -63.52 -40.9 90.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 91.0 mt -64.98 -37.45 87.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.594 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -60.74 -39.3 88.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.846 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.3 t -85.49 -10.49 56.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.471 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.5 tp -82.96 -56.25 3.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.523 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 168.83 -79.2 0.1 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.279 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.523 HG21 ' HB3' ' A' ' 112' ' ' LEU . 57.5 t 52.43 81.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.774 0.797 . . . . 0.0 111.623 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.506 ' CD ' ' HG2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.866 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.536 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . 8.4 p . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.1 mt 70.81 -74.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 123.322 0.649 . . . . 0.0 111.719 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -97.39 23.33 7.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.658 -174.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.536 ' CG2' ' HB2' ' A' ' 13' ' ' SER . 15.9 m -75.43 138.67 20.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.781 0.8 . . . . 0.0 112.732 -174.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' A' ' 60' ' ' ASN . 48.6 t -121.81 124.84 72.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.558 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.412 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . 6.5 tp10 -59.42 -54.61 44.71 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.221 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.648 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 4.1 t30 -158.9 168.87 25.67 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.49 -29.16 34.74 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -170.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -66.58 -29.13 69.12 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.318 -0.239 . . . . 0.0 111.356 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.412 ' HG2' ' HB3' ' A' ' 18' ' ' GLU . 4.1 mp0 -80.43 -12.11 59.6 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.44 144.93 56.82 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.511 ' HD3' ' H ' ' A' ' 25' ' ' GLU . 5.0 tmtt? -127.9 151.69 48.77 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.356 -173.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.511 ' H ' ' HD3' ' A' ' 24' ' ' LYS . 25.6 mm-40 60.29 -164.11 0.23 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.928 175.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -119.19 47.65 1.01 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.917 -174.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.612 HD12 ' H ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -99.15 158.45 32.26 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 171.687 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -53.95 158.59 8.62 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.936 2.424 . . . . 0.0 112.504 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.5 m -127.21 128.99 46.98 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.063 0.459 . . . . 0.0 110.856 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.736 HD13 HD21 ' A' ' 112' ' ' LEU . 80.9 mt -98.23 108.18 21.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.591 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.828 ' HB ' HG23 ' A' ' 87' ' ' VAL . 22.5 mm -95.82 109.33 22.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 24.8 ptm -121.68 136.14 54.95 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.034 -0.667 . . . . 0.0 111.075 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.807 ' HZ ' ' HB2' ' A' ' 78' ' ' TYR . 47.1 m-85 -96.48 119.9 35.81 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.343 -178.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.611 ' HG3' ' HB3' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -130.87 132.59 45.26 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.509 -170.021 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.692 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 7.3 m -99.96 162.87 12.72 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.96 -49.77 55.08 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.6 m -66.8 -52.55 42.69 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -171.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.718 ' SG ' HG23 ' A' ' 83' ' ' VAL . 2.7 p -70.99 125.55 92.02 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -167.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.635 ' O ' HG23 ' A' ' 42' ' ' VAL . 69.5 Cg_endo -75.79 -9.81 19.78 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.094 2.529 . . . . 0.0 112.653 175.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -59.47 -29.81 68.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.486 0.66 . . . . 0.0 109.768 174.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.611 ' HB3' ' HG3' ' A' ' 34' ' ' LYS . 75.0 m -78.93 -36.9 41.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.649 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 39' ' ' PRO . 2.8 m -68.44 -30.62 48.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.34 -177.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.484 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 1.8 mt-10 -61.97 -48.28 81.05 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.824 0.345 . . . . 0.0 110.78 173.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -37.75 78.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.637 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 27.6 mt-30 -58.3 -49.59 76.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.903 175.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 73.3 mmtt -58.04 -43.31 86.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.162 0.506 . . . . 0.0 110.062 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.577 ' O ' HG22 ' A' ' 51' ' ' VAL . 52.0 mm-40 -62.47 -46.86 86.58 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.199 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.0 mt -59.77 -34.82 73.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.466 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.6 m -57.62 -45.87 84.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.209 0.528 . . . . 0.0 110.271 176.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -76.77 -30.36 56.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.754 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 47' ' ' GLU . 77.9 t -62.9 -41.76 93.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -65.13 -36.6 84.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.338 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -74.38 -15.6 60.92 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -109.82 -1.83 17.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.474 0.654 . . . . 0.0 109.977 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -145.7 75.31 1.42 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.356 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -67.12 118.41 10.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.791 -175.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.09 62.64 5.92 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.292 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -134.93 2.32 3.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.805 0.302 . . . . 0.0 111.086 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -168.65 145.07 3.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.412 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.537 ' HB3' HG21 ' A' ' 17' ' ' VAL . 47.4 m-80 -90.88 128.83 36.9 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.145 176.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.7 mt -103.68 108.0 23.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.648 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 55.0 t80 -92.36 114.98 27.68 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.051 177.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -92.35 105.07 17.34 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.135 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.556 ' HB3' ' CE2' ' A' ' 62' ' ' TYR . . . -88.27 75.78 8.5 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.63 ' C ' ' H ' ' A' ' 67' ' ' GLU . 26.2 ptt180 -68.22 113.78 6.14 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.642 177.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.15 12.0 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.104 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.63 ' H ' ' C ' ' A' ' 65' ' ' ARG . 1.4 mp0 -83.23 -20.88 33.75 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.011 -175.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -112.83 -176.8 2.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.0 0.428 . . . . 0.0 111.083 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.41 -31.45 16.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.097 -175.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.484 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -61.37 -29.53 69.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.572 0.701 . . . . 0.0 110.79 -175.667 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.484 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 3.6 m120 -81.78 -11.61 58.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.705 -174.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.5 mm -72.03 -51.33 31.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.098 0.475 . . . . 0.0 110.181 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -67.19 -37.89 84.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.103 177.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.46 -43.75 98.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.897 177.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.704 ' HA ' ' CE1' ' A' ' 33' ' ' PHE . . . -52.06 -56.01 17.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.385 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -69.3 -33.53 73.32 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.062 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -59.22 -26.57 64.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.124 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.807 ' HB2' ' HZ ' ' A' ' 33' ' ' PHE . 79.7 m-85 -119.92 21.43 11.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.735 -178.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 69.66 33.49 2.98 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 167.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.438 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . . . -71.61 152.9 42.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.002 0.429 . . . . 0.0 110.977 176.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -141.25 -81.15 0.24 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.14 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 34.4 pt -113.23 171.18 3.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.718 HG23 ' SG ' ' A' ' 38' ' ' CYS . 19.4 m -101.9 150.89 37.8 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-O 120.522 0.201 . . . . 0.0 111.34 -176.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -92.78 116.43 2.34 Favored 'Cis proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.617 -1.41 . . . . 0.0 112.654 -1.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.727 HG23 ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -96.04 135.64 37.54 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.59 HG23 ' HB3' ' A' ' 99' ' ' HIS . 6.1 t -144.74 132.12 20.77 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.125 178.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.828 HG23 ' HB ' ' A' ' 31' ' ' ILE . 3.9 m -112.34 116.77 53.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.796 175.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.542 ' HB3' HD23 ' A' ' 115' ' ' LEU . 92.5 m-85 -90.61 116.96 28.9 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.769 -177.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 27.6 mt -102.38 137.4 40.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.721 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -73.07 -171.79 0.96 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.957 ' HG2' ' HB2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -69.99 -24.76 63.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.888 -0.508 . . . . 0.0 111.73 -175.114 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.549 ' HB2' ' ND2' ' A' ' 94' ' ' ASN . 8.3 mm-40 -81.23 -6.25 58.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.397 0.617 . . . . 0.0 109.348 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.46 31.71 40.49 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.21 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.549 ' ND2' ' HB2' ' A' ' 92' ' ' GLU . 35.3 m-80 -93.26 143.19 26.5 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.912 177.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -72.28 85.82 1.09 Allowed 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.865 0.728 . . . . 0.0 109.519 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -85.43 -50.79 7.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.276 -172.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.416 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 73.3 t80 -133.64 126.79 31.6 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.675 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.616 HG13 HG13 ' A' ' 87' ' ' VAL . 3.6 m -103.69 151.53 6.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.59 ' HB3' HG23 ' A' ' 86' ' ' THR . 55.8 t60 -142.8 140.89 31.53 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.727 ' NE2' HG23 ' A' ' 85' ' ' THR . 5.7 tp-100 -127.93 138.35 52.61 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 172.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.97 173.68 29.03 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.717 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.9 tp -75.03 152.31 38.68 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.364 0.602 . . . . 0.0 111.253 -175.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.626 ' SD ' HG12 ' A' ' 108' ' ' ILE . 5.3 ptp -146.42 137.96 24.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.206 172.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.456 ' O ' HG13 ' A' ' 108' ' ' ILE . 18.1 tpp180 -85.99 171.57 11.33 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.535 ' HG3' HG21 ' A' ' 51' ' ' VAL . 47.9 tttm -45.98 -57.33 4.5 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -174.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.41 -36.36 75.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.673 0.273 . . . . 0.0 111.163 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.632 ' O ' HG12 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -62.9 -48.91 76.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.617 178.093 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.626 HG12 ' SD ' ' A' ' 103' ' ' MET . 25.6 mt -59.12 -47.36 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.81 0.814 . . . . 0.0 110.281 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -62.74 -41.32 99.13 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.98 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.483 ' O ' ' HB3' ' A' ' 113' ' ' ASN . 59.5 m -64.23 -30.62 71.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.577 177.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.632 HG12 ' O ' ' A' ' 107' ' ' ASN . 50.6 mm -67.62 -36.64 76.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.513 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.736 HD21 HD13 ' A' ' 30' ' ' ILE . 25.3 mt -60.7 -38.78 86.15 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 110' ' ' THR . 17.1 t30 -59.92 -44.74 94.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.957 176.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.5 p -72.33 -30.14 64.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.736 0.303 . . . . 0.0 111.036 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.542 HD23 ' HB3' ' A' ' 88' ' ' PHE . 3.9 mp -63.2 -55.13 27.62 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.31 0.576 . . . . 0.0 109.93 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 148.2 -53.58 0.53 Allowed Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.245 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.0 t 50.42 75.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -171.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.957 ' HB2' ' HG2' ' A' ' 91' ' ' LYS . 25.4 mtpp . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.616 -162.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.452 ' HB3' HG13 ' A' ' 16' ' ' VAL . 15.5 m . . . . . 0 N--CA 1.446 -0.659 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.8 mt -96.3 137.34 24.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.462 -177.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 94.3 m-20 66.86 24.96 9.63 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.842 0.714 . . . . 0.0 110.971 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.671 HG11 HD13 ' A' ' 61' ' ' ILE . 11.7 m -102.01 157.24 4.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.642 0.258 . . . . 0.0 110.855 -176.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.549 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 5.3 p -146.47 157.45 11.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.083 0.468 . . . . 0.0 111.488 -176.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -82.66 -55.18 4.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.617 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.688 ' HA ' ' CE2' ' A' ' 62' ' ' TYR . 18.7 t-20 -136.72 160.38 39.0 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.854 -173.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.1 mt -53.3 -35.06 59.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.38 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -65.42 -31.54 72.69 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.726 0.298 . . . . 0.0 111.008 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -79.42 -15.5 57.71 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.408 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.09 111.6 6.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 0.0 110.394 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.78 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 10.6 mmpt? -88.08 145.67 25.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.318 0.58 . . . . 0.0 111.928 -177.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 58.13 -166.12 0.16 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.677 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -105.26 72.22 0.23 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.097 -175.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.04 149.9 39.71 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 174.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.802 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 53.3 Cg_exo -54.11 141.55 68.76 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.573 2.182 . . . . 0.0 111.416 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 m -111.68 120.61 42.6 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.875 0.369 . . . . 0.0 111.169 -175.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.436 HD11 ' CD2' ' A' ' 88' ' ' PHE . 17.3 mm -106.85 122.5 60.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.668 ' HB ' ' CG2' ' A' ' 87' ' ' VAL . 69.2 mt -114.69 115.65 50.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.919 -174.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.65 ' HE2' ' HB3' ' A' ' 84' ' ' PRO . 2.5 tpt -109.85 116.5 31.77 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.678 177.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.639 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 85.4 m-85 -83.64 118.28 23.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.347 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.948 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 6.4 pttt -132.39 146.54 52.04 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.416 -169.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m -67.8 138.54 56.24 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 158.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.539 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 18.8 t0 -57.14 -32.63 66.56 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.076 0.465 . . . . 0.0 111.075 -168.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.1 m -124.6 92.35 3.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.428 173.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 18.2 p -138.3 142.01 33.67 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.338 177.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.48 -28.1 62.14 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.383 2.056 . . . . 0.0 112.927 -177.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -66.83 -31.09 71.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.913 0.387 . . . . 0.0 110.291 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 45' ' ' GLN . 53.0 t -71.75 -35.07 69.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.008 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 45.5 t -69.59 -46.11 76.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.558 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.438 ' HG2' HD22 ' A' ' 102' ' ' LEU . 4.4 tp10 -61.64 -49.64 75.76 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.755 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.406 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 19.8 ttt -66.58 -29.12 69.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.197 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' A' ' 41' ' ' CYS . 23.0 tm0? -60.0 -41.78 92.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.016 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -62.82 -47.81 81.81 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.571 ' O ' HG21 ' A' ' 51' ' ' VAL . 16.2 mm-40 -57.84 -47.34 82.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.522 177.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.461 HD12 HD11 ' A' ' 61' ' ' ILE . 97.9 mt -58.67 -41.7 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.731 178.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.9 m -57.17 -41.56 79.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.638 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.517 ' CB ' ' HD2' ' A' ' 105' ' ' LYS . 21.1 m-85 -65.95 -37.04 84.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.737 178.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.571 HG21 ' O ' ' A' ' 47' ' ' GLU . 41.2 t -72.63 -50.68 32.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.931 -177.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.7 m -60.73 -31.54 70.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 0.0 111.121 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -57.65 -29.96 65.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.382 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -110.38 -2.04 16.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.987 -175.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.528 ' HB2' ' HG3' ' A' ' 58' ' ' LYS . 17.1 ptp180 -146.73 97.69 2.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.004 0.906 . . . . 0.0 110.768 174.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -82.24 133.05 35.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.953 -178.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.06 35.95 71.84 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.462 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HG3' ' HB2' ' A' ' 55' ' ' ARG . 41.4 mmtm -112.43 -4.05 14.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.933 0.397 . . . . 0.0 110.963 -178.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 28' ' ' PRO . 6.2 p90 -176.03 138.31 0.34 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.191 173.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.549 ' OD1' ' HB ' ' A' ' 17' ' ' VAL . 7.5 t-20 -105.6 124.04 48.91 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.671 HD13 HG11 ' A' ' 16' ' ' VAL . 40.5 mt -89.22 107.61 18.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.291 0.567 . . . . 0.0 111.207 -175.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.688 ' CE2' ' HA ' ' A' ' 19' ' ' ASN . 10.7 t80 -88.49 106.19 18.12 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.89 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.905 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 75.6 m-85 -78.93 102.29 8.2 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.347 176.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 33' ' ' PHE . . . -85.85 74.48 10.18 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.24 0.543 . . . . 0.0 109.859 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.948 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 12.4 ptt85 -63.55 116.98 6.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.787 175.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.7 tp -74.24 9.57 1.59 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.033 0.444 . . . . 0.0 110.473 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 36' ' ' ASP . 0.3 OUTLIER -82.53 -18.65 40.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.191 -175.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -113.21 154.51 26.61 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.187 0.518 . . . . 0.0 111.128 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -32.55 74.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.207 -172.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -26.56 68.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.021 0.439 . . . . 0.0 111.672 -175.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.467 ' HA ' ' CB ' ' A' ' 74' ' ' LEU . 91.2 m-20 -90.51 1.11 57.01 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.48 -176.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.6 mm -70.69 -50.43 44.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 173.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -72.78 -34.08 66.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.481 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.467 ' CB ' ' HA ' ' A' ' 71' ' ' ASN . 1.1 tm? -60.18 -45.82 91.8 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.639 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -57.59 -49.99 74.57 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.994 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -64.41 -34.76 78.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.927 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -62.44 -20.06 64.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.965 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.544 ' HB3' HG13 ' A' ' 87' ' ' VAL . 77.3 m-85 -124.55 15.95 8.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.076 -177.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.8 t70 65.22 27.3 12.22 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.927 0.87 . . . . 0.0 110.826 172.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.72 104.01 15.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.425 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.456 HD21 HG21 ' A' ' 82' ' ' ILE . 4.2 t30 -107.1 -39.74 5.64 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.75 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.456 HG21 HD21 ' A' ' 81' ' ' ASN . 30.1 pt -107.08 171.93 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.033 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.04 145.02 53.96 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.733 174.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.65 ' HB3' ' HE2' ' A' ' 32' ' ' MET . 74.4 Cg_endo -81.02 157.26 84.09 Favored 'Cis proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.36 -1.517 . . . . 0.0 112.606 -0.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.546 ' OG1' ' HB2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -145.84 129.33 16.94 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.771 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.7 m -123.26 116.38 23.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.224 0.535 . . . . 0.0 111.45 -176.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.668 ' CG2' ' HB ' ' A' ' 31' ' ' ILE . 13.2 m -102.86 135.05 42.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.176 174.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.511 ' HB3' HD22 ' A' ' 115' ' ' LEU . 79.5 m-85 -107.15 112.79 25.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.499 -176.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.461 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 6.2 mp -111.17 145.79 38.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.727 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.539 ' OD1' ' HA3' ' A' ' 116' ' ' GLY . 10.6 t70 -80.11 -165.87 0.92 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.569 ' HZ3' ' CD ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -79.4 8.59 5.93 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -168.463 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.569 ' CD ' ' HZ3' ' A' ' 91' ' ' LYS . 34.7 mt-10 -127.42 21.22 6.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.87 0.367 . . . . 0.0 111.187 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.28 14.32 74.11 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.95 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -85.59 125.38 33.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.063 0.459 . . . . 0.0 109.957 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.481 ' HD3' HG21 ' A' ' 98' ' ' VAL . 5.0 tmmm? -82.68 109.54 16.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.888 -177.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -97.26 -59.72 1.73 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.24 -177.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.426 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 76.8 t80 -119.7 149.21 42.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.651 0.262 . . . . 0.0 110.801 -173.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.587 HG13 HG11 ' A' ' 87' ' ' VAL . 9.6 t -130.74 139.84 50.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.426 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 6.2 t60 -147.86 133.49 18.82 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.459 ' CD ' HG23 ' A' ' 85' ' ' THR . 3.3 mm-40 -106.32 158.37 16.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.623 0.249 . . . . 0.0 110.342 -173.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.96 -153.12 20.74 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.588 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.438 HD22 ' HG2' ' A' ' 43' ' ' GLU . 57.8 tp -114.21 120.98 42.32 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.739 0.304 . . . . 0.0 110.475 -176.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.526 ' HE3' HG13 ' A' ' 111' ' ' ILE . 74.9 mtp -111.21 162.24 15.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.893 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -105.44 171.2 7.46 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.174 -0.21 . . . . 0.0 110.537 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.517 ' HD2' ' CB ' ' A' ' 50' ' ' TYR . 52.5 tttp -47.4 -58.83 3.71 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.726 0.641 . . . . 0.0 111.974 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 3.8 m-20 -53.73 -33.56 56.04 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.081 0.467 . . . . 0.0 111.834 -176.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.514 ' O ' HG12 ' A' ' 111' ' ' ILE . 5.7 m120 -73.72 -46.57 45.29 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.355 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.551 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 57.1 mt -58.78 -43.56 88.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.767 174.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 105' ' ' LYS . 71.6 mm-40 -48.71 -56.37 8.76 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.844 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.5 m -72.4 -37.82 68.58 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.486 -174.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.526 HG13 ' HE3' ' A' ' 103' ' ' MET . 38.8 mm -63.43 -41.62 93.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.839 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 86.5 mt -62.44 -39.03 92.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.92 0.391 . . . . 0.0 110.155 176.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -62.81 -37.4 86.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.745 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.5 t -76.98 -37.51 55.03 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.581 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.511 HD22 ' HB3' ' A' ' 88' ' ' PHE . 51.8 tp -57.94 -70.93 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.614 178.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.539 ' HA3' ' OD1' ' A' ' 90' ' ' ASP . . . -175.44 -74.44 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.01 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.802 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 85.6 t 55.72 76.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.971 0.891 . . . . 0.0 109.847 -174.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 20.6 pttm . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.469 -174.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.404 ' HG3' ' HG ' ' A' ' 3' ' ' LEU . 22.9 ptp . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -76.51 84.07 3.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.994 0.426 . . . . 0.0 110.862 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 3' ' ' LEU . 1.8 pp -159.97 154.45 23.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.795 175.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' HG3' ' NE2' ' A' ' 8' ' ' GLN . 7.7 mm-40 66.34 -64.46 0.22 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 124.012 0.82 . . . . 0.0 111.406 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.3 -35.33 2.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.467 -0.397 . . . . 0.0 113.122 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tt -63.29 -52.81 53.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -162.69 35.5 0.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.117 0.484 . . . . 0.0 110.383 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.468 ' NE2' ' HG3' ' A' ' 4' ' ' GLU . 7.5 tt0 -140.85 25.93 2.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.742 0.782 . . . . 0.0 110.104 -177.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.3 tp -67.96 -26.93 35.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.285 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -80.35 18.3 0.92 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.054 -172.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.587 ' O ' ' HB3' ' A' ' 12' ' ' GLN . 57.7 t80 -74.84 73.25 2.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.262 0.553 . . . . 0.0 110.098 174.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.587 ' HB3' ' O ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER 156.78 -18.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.132 1.773 . . . . 0.0 106.886 178.37 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.464 ' HB3' HG13 ' A' ' 16' ' ' VAL . 33.4 m -104.16 101.14 10.89 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 113.959 -1.473 . . . . 0.0 109.718 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 15' ' ' ASN . 96.1 mt -107.02 146.09 13.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.56 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 84.4 m-20 71.21 13.94 6.68 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.602 0.564 . . . . 0.0 110.159 -174.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.54 HG11 ' HB ' ' A' ' 61' ' ' ILE . 4.5 m -105.4 166.27 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.889 -174.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 23' ' ' ALA . 12.4 m -141.34 147.99 21.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -64.19 -51.09 65.43 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.264 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.852 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 14.5 t-20 -148.36 169.3 20.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.732 -176.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 56.9 mt -60.48 -27.53 67.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.912 0.387 . . . . 0.0 110.305 174.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -57.44 -33.8 68.31 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.79 174.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -91.03 -27.41 18.65 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.972 0.415 . . . . 0.0 110.871 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 17' ' ' VAL . . . -71.9 156.82 38.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.596 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.742 ' HZ2' ' HA ' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -131.89 -177.81 4.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.606 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -103.73 174.96 5.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.622 -175.561 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 119' ' ' GLU . . . 93.69 -62.86 1.93 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.654 HD12 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -77.66 127.69 81.71 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.636 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 1.004 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 85.9 Cg_exo -48.58 143.74 15.51 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.806 2.337 . . . . 0.0 112.1 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.477 HG21 ' OD1' ' A' ' 60' ' ' ASN . 23.8 m -115.64 124.51 51.09 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.225 -171.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.428 HD11 ' N ' ' A' ' 30' ' ' ILE . 2.9 mp -109.22 117.62 54.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.636 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 2.3 mm -105.62 116.43 49.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.063 -175.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.475 ' O ' ' HG3' ' A' ' 32' ' ' MET . 26.5 ptm -110.77 112.3 24.07 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.707 0.765 . . . . 0.0 110.107 174.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.529 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 81.6 m-85 -83.64 128.32 34.43 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.018 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.623 ' HE2' ' CB ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -142.77 142.27 31.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.696 -175.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.442 ' O ' ' HE3' ' A' ' 34' ' ' LYS . 1.2 p -75.0 170.87 15.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 174.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -49.68 -74.55 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 O-C-N 123.358 0.411 . . . . 0.0 110.798 176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -88.88 110.84 21.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.961 0.41 . . . . 0.0 110.316 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 5.9 p -152.73 121.32 3.21 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.037 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.11 -35.97 6.33 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.523 2.149 . . . . 0.0 112.839 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -61.81 -24.37 66.83 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.591 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.621 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 49.7 t -61.95 -50.12 73.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.069 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.5 t -59.49 -44.84 93.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.558 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 5.7 tp10 -55.79 -46.79 77.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.928 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.494 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 23.4 ttt -73.85 -30.49 62.7 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.053 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.621 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 27.8 mt-30 -59.43 -48.44 81.62 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 121.458 -0.097 . . . . 0.0 110.988 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.558 ' HG3' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -65.54 -36.06 82.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.522 0.201 . . . . 0.0 111.196 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -59.03 -44.86 91.81 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.18 0.514 . . . . 0.0 109.812 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.738 HD12 HG22 ' A' ' 61' ' ' ILE . 97.9 mt -62.42 -35.91 80.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.056 178.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -58.89 -40.63 85.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.916 0.389 . . . . 0.0 110.228 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.462 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 20.2 m-85 -65.7 -43.31 89.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.322 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.445 HG23 ' HG3' ' A' ' 105' ' ' LYS . 48.7 t -62.1 -42.66 95.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.464 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.4 m -65.74 -31.69 72.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.13 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -61.24 -40.52 94.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.73 176.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.56 -10.37 54.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.586 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.85 84.3 1.97 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.957 0.408 . . . . 0.0 111.168 -177.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -78.98 123.51 27.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.916 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.42 73.92 0.37 Allowed Glycine 0 C--N 1.332 0.313 0 O-C-N 123.596 0.56 . . . . 0.0 113.297 173.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.884 ' HD2' HG12 ' A' ' 117' ' ' VAL . 9.6 mmtt -144.14 -36.73 0.33 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.987 0.423 . . . . 0.0 110.941 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -144.88 168.87 19.2 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.515 HD21 HG12 ' A' ' 27' ' ' ILE . 8.9 p30 -118.25 137.9 52.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.27 0.557 . . . . 0.0 110.723 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.738 HG22 HD12 ' A' ' 48' ' ' LEU . 52.6 mt -104.08 109.72 28.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.118 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.852 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 2.6 t80 -95.01 118.51 31.96 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.926 0.393 . . . . 0.0 110.559 -178.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.509 ' CE1' ' HG2' ' A' ' 45' ' ' GLN . 81.0 m-85 -83.45 103.26 12.67 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 173.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.529 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -90.8 86.15 6.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.377 0.608 . . . . 0.0 109.968 -173.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.623 ' CB ' ' HE2' ' A' ' 34' ' ' LYS . 17.8 ptt180 -77.49 129.01 35.16 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.508 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.3 tp -73.2 12.32 0.59 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.71 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.585 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 10.4 mt-10 -79.98 -13.63 59.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.574 -175.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -116.88 170.48 8.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.338 -173.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.48 -33.53 25.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.158 -176.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.568 ' HB3' ' HZ3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -61.95 -26.41 68.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.894 0.378 . . . . 0.0 110.702 -177.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.607 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 78.5 m-20 -87.79 3.77 46.89 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.909 -176.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.8 mt -72.17 -58.68 4.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 171.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.461 ' CG ' ' HZ2' ' A' ' 77' ' ' LYS . 6.8 t70 -67.49 -38.8 84.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.137 175.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.607 ' HB2' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -56.09 -46.18 79.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.199 176.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.26 -56.45 19.86 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.686 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -67.56 -33.54 75.25 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.573 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.461 ' HZ2' ' CG ' ' A' ' 73' ' ' ASP . 14.3 ttmm -63.36 -24.6 67.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.983 0.42 . . . . 0.0 110.788 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.558 ' CE1' HD22 ' A' ' 89' ' ' LEU . 95.0 m-85 -122.05 22.48 10.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.884 -176.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 66.95 29.17 8.3 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.523 0.514 . . . . 0.0 111.556 166.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.408 ' HA ' HG23 ' A' ' 85' ' ' THR . . . -87.33 113.56 23.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.885 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.517 ' ND2' HG13 ' A' ' 82' ' ' ILE . 3.8 p-10 -138.71 -2.53 1.73 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.271 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.517 HG13 ' ND2' ' A' ' 81' ' ' ASN . 50.5 mt -136.78 142.22 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.446 HG11 ' HA ' ' A' ' 34' ' ' LYS . 99.5 t -101.15 129.3 27.39 Favored Pre-proline 0 C--N 1.319 -0.729 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.667 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 58.4 Cg_endo -95.11 135.18 5.24 Favored 'Cis proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.423 -1.49 . . . . 0.0 113.42 -0.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.564 HG22 ' HG2' ' A' ' 100' ' ' GLN . 19.9 m -87.73 107.5 18.67 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.2 m -100.94 108.03 19.66 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.636 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 6.8 p -108.2 126.16 64.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.445 0.64 . . . . 0.0 110.128 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 1.005 ' HB3' HD13 ' A' ' 115' ' ' LEU . 89.0 m-85 -99.22 119.4 37.83 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.579 -177.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.558 HD22 ' CE1' ' A' ' 78' ' ' TYR . 5.6 mp -115.31 141.73 47.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.817 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 25.1 t70 -75.15 -164.48 0.31 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.598 ' HZ1' ' CD ' ' A' ' 92' ' ' GLU . 6.1 pttm -53.3 -42.86 67.05 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -168.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.598 ' CD ' ' HZ1' ' A' ' 91' ' ' LYS . 0.5 OUTLIER -99.26 6.06 46.41 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.056 -0.403 . . . . 0.0 111.396 -176.268 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.551 ' HA2' ' HB3' ' A' ' 89' ' ' LEU . . . 94.66 30.2 8.7 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.759 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 10.0 m120 -70.92 106.49 3.65 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.403 -0.469 . . . . 0.0 109.93 173.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.451 ' HG3' ' CG2' ' A' ' 87' ' ' VAL . 39.0 ttpt -64.69 100.41 0.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 176.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -98.45 -50.38 4.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.291 -176.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.499 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 91.7 t80 -137.47 122.0 18.44 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.171 -0.611 . . . . 0.0 111.8 -174.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.458 HG12 HG22 ' A' ' 87' ' ' VAL . 11.5 m -103.14 147.04 10.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 172.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.499 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 15.9 t60 -145.4 119.01 9.12 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.564 ' HG2' HG22 ' A' ' 85' ' ' THR . 39.3 mt-30 -102.93 106.22 16.73 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 143.41 160.84 8.58 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.445 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.482 HD23 ' HG2' ' A' ' 43' ' ' GLU . 45.9 tp -71.56 149.75 45.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.935 0.398 . . . . 0.0 111.243 -176.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 69.9 mtm -141.03 -170.14 2.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.19 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.496 HH12 ' CD ' ' A' ' 43' ' ' GLU . 33.2 mmt180 -131.27 165.97 22.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.378 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.462 ' HD2' ' HB3' ' A' ' 50' ' ' TYR . 55.6 tttm -44.7 -56.83 4.1 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.116 0.885 . . . . 0.0 112.299 -176.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -51.93 -47.31 64.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.345 0.593 . . . . 0.0 111.601 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.597 ' O ' HG12 ' A' ' 111' ' ' ILE . 47.0 m-20 -73.84 -40.45 63.29 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.931 -172.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.528 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 60.9 mt -60.21 -47.02 93.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.577 0.703 . . . . 0.0 109.301 174.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -62.98 -39.95 96.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.219 -175.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 57.9 m -64.42 -35.93 82.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.162 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 107' ' ' ASN . 40.8 mm -70.26 -34.95 60.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.632 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 20.9 mt -60.38 -42.89 96.79 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.714 0.769 . . . . 0.0 108.987 174.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -62.1 -30.39 70.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.901 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.9 m -76.05 -30.25 58.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.977 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 1.005 HD13 ' HB3' ' A' ' 88' ' ' PHE . 51.6 mt -70.58 -59.95 2.54 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 122.185 0.993 . . . . 0.0 109.081 174.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 145.86 -44.95 0.83 Allowed Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.371 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 1.004 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 19.2 t 46.58 61.35 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 122.112 0.958 . . . . 0.0 109.397 -176.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -81.83 -51.57 7.99 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.848 -169.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.535 ' HB3' ' O ' ' A' ' 26' ' ' GLY . 12.2 tp10 -72.99 171.42 12.88 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.438 173.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.443 ' HA3' ' HD3' ' A' ' 58' ' ' LYS . . . 97.3 14.8 40.4 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -170.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -79.21 62.49 3.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.729 0.776 . . . . 0.0 109.891 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -133.47 16.97 4.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.047 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 34.8 t60 -77.1 120.72 22.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.709 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -55.29 128.58 34.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.522 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -72.77 -21.82 60.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.005 0.431 . . . . 0.0 110.24 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 77.9 t60 . . . . . 0 C--O 1.24 0.575 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.165 177.77 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 mmt . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 120.622 0.249 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.999 ' HA ' ' HG3' ' A' ' 18' ' ' GLU . 0.8 OUTLIER -140.03 -179.6 6.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.84 -177.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.645 ' HG ' ' HG3' ' A' ' 4' ' ' GLU . 67.7 tp -57.0 -71.39 0.1 Allowed 'General case' 0 C--N 1.332 -0.154 0 O-C-N 123.54 0.525 . . . . 0.0 110.755 177.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.645 ' HG3' ' HG ' ' A' ' 3' ' ' LEU . 45.2 mt-10 -123.14 -11.84 7.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.439 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.53 -54.61 4.05 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.907 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 7' ' ' LYS . 31.7 pt -106.41 154.46 7.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.518 ' HG2' ' HG3' ' A' ' 8' ' ' GLN . 27.7 ttpt 72.76 -63.69 0.42 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.656 0.598 . . . . 0.0 111.711 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.518 ' HG3' ' HG2' ' A' ' 7' ' ' LYS . 28.0 mt-30 -124.05 137.4 54.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.446 0.641 . . . . 0.0 112.006 -175.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.467 HG13 ' H ' ' A' ' 11' ' ' PHE . 13.3 pt -112.67 -159.15 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.216 175.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.439 ' HB3' HG11 ' A' ' 16' ' ' VAL . 3.6 t-20 -58.1 -24.61 59.33 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.814 0.34 . . . . 0.0 110.855 178.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.467 ' H ' HG13 ' A' ' 9' ' ' ILE . 18.7 t80 72.78 -175.73 0.17 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.319 172.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 69.13 -61.2 0.44 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.739 0.816 . . . . 0.0 109.883 -173.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.484 ' O ' HG12 ' A' ' 16' ' ' VAL . 14.9 m -96.82 129.37 44.27 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.7 mt -86.66 2.87 4.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.792 0.806 . . . . 0.0 110.69 -174.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -117.47 16.37 14.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.623 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 13' ' ' SER . 12.6 p -85.01 143.59 11.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -171.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.932 ' HB ' ' HB2' ' A' ' 22' ' ' GLU . 27.5 m -128.34 152.95 37.15 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.222 169.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.999 ' HG3' ' HA ' ' A' ' 2' ' ' SER . 15.8 mm-40 -75.51 -35.1 60.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.349 -174.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.726 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 51.5 t30 -163.41 -176.09 4.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.692 -177.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.1 mt -61.52 -30.6 70.74 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -56.87 -45.56 82.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.329 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.932 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . 5.4 mm-40 -76.69 -24.76 53.17 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.591 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.91 153.25 43.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.682 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.58 ' NZ ' ' HA ' ' A' ' 24' ' ' LYS . 2.4 tpmp? -145.4 156.26 43.66 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.995 -175.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -73.51 179.88 3.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.049 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 119' ' ' GLU . . . 84.85 -59.82 4.87 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -175.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.414 HG13 ' HB2' ' A' ' 60' ' ' ASN . 6.5 pt -90.32 121.9 68.02 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.525 -0.338 . . . . 0.0 110.165 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.854 ' HG3' ' H ' ' A' ' 117' ' ' VAL . 16.5 Cg_endo -57.26 138.51 86.55 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.64 2.227 . . . . 0.0 111.009 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.2 m -103.52 123.76 47.51 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.256 0.551 . . . . 0.0 111.923 -172.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.595 HD11 HD11 ' A' ' 112' ' ' LEU . 75.2 mt -98.63 113.26 32.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 173.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.737 ' HB ' HG23 ' A' ' 87' ' ' VAL . 58.4 mt -107.03 111.98 37.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.35 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.439 ' HG2' ' HD1' ' A' ' 63' ' ' TYR . 21.8 ptm -109.8 129.63 55.61 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.061 176.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.55 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 92.0 m-85 -94.33 112.78 24.59 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 41' ' ' CYS . 55.6 pttt -117.75 138.73 51.84 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.446 -170.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.466 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 0.7 OUTLIER -71.18 149.67 46.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.969 174.43 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -70.31 -45.12 66.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.98 -177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.2 t -94.75 9.77 37.67 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.466 ' SG ' ' HB ' ' A' ' 35' ' ' THR . 76.6 m -106.72 122.19 42.6 Favored Pre-proline 0 C--N 1.327 -0.409 0 O-C-N 121.845 -0.535 . . . . 0.0 111.065 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 6.3 Cg_exo -78.01 -2.88 12.97 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.391 2.061 . . . . 0.0 113.179 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -65.57 -15.95 63.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.935 0.397 . . . . 0.0 110.796 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.561 ' HB3' ' HB2' ' A' ' 34' ' ' LYS . 24.9 p -68.84 -43.79 74.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.818 175.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.2 t -62.89 -30.63 49.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.279 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.729 ' HA ' ' HZ1' ' A' ' 46' ' ' LYS . 7.5 tp10 -58.69 -51.99 67.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.346 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.9 ttt -75.03 -37.31 61.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.54 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.489 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 16.5 mt-30 -59.2 -43.64 92.23 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.76 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.729 ' HZ1' ' HA ' ' A' ' 43' ' ' GLU . 22.7 pttm -70.13 -41.87 73.35 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.446 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.537 ' O ' HG22 ' A' ' 51' ' ' VAL . 24.1 mm-40 -51.03 -49.91 59.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.898 0.38 . . . . 0.0 110.386 172.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.423 ' HB3' HD11 ' A' ' 61' ' ' ILE . 71.2 mt -60.73 -37.66 82.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.515 177.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.8 m -67.59 -37.35 82.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.782 0.325 . . . . 0.0 110.712 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -65.12 -33.5 76.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.523 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 47' ' ' GLU . 21.7 t -73.2 -40.89 58.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.892 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.2 m -56.84 -30.65 64.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.142 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.752 ' HZ3' ' HB3' ' A' ' 53' ' ' LYS . 4.6 ttpm? -52.49 -36.53 55.28 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.756 176.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -109.84 -18.44 13.41 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.204 0.526 . . . . 0.0 110.756 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.561 ' HB3' ' HB2' ' A' ' 58' ' ' LYS . 11.5 mpt_? -111.96 74.55 0.87 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.367 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.555 ' CD ' ' HZ2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -83.73 116.48 22.7 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.84 35.14 91.58 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.467 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 55' ' ' ARG . 12.7 mptt -101.76 -20.02 15.12 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -165.41 153.99 11.76 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.165 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.414 ' HB2' HG13 ' A' ' 27' ' ' ILE . 39.8 t-20 -103.92 138.1 40.97 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.339 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.423 HD11 ' HB3' ' A' ' 48' ' ' LEU . 11.0 mt -117.34 111.87 36.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.714 0.292 . . . . 0.0 110.943 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.726 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 3.3 t80 -98.84 118.41 35.52 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.489 ' CE1' ' HG2' ' A' ' 45' ' ' GLN . 21.7 m-85 -94.65 103.57 15.5 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.398 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.55 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -80.58 87.16 5.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.163 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.545 ' C ' ' H ' ' A' ' 67' ' ' GLU . 1.8 ptm180 -69.59 123.71 22.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.139 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 34' ' ' LYS . 5.4 tp -69.75 11.2 0.29 Allowed 'General case' 0 C--N 1.322 -0.613 0 O-C-N 122.025 -0.422 . . . . 0.0 110.933 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.545 ' H ' ' C ' ' A' ' 65' ' ' ARG . 21.0 mt-10 -82.47 -19.73 38.28 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.7 -173.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.43 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 46.2 mt-10 -117.04 151.29 37.09 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -59.81 -31.03 69.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.103 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.436 ' HD2' ' OD1' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -58.95 -25.92 63.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.268 -178.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.436 ' OD1' ' HD2' ' A' ' 70' ' ' LYS . 10.4 m120 -91.19 -12.18 36.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.963 -176.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.5 mt -71.16 -48.63 53.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.98 -43.56 92.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.762 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -58.52 -42.88 88.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.403 178.514 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.26 -57.38 12.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.441 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -67.23 -33.25 74.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.608 0.242 . . . . 0.0 111.258 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.465 ' HZ2' ' HB2' ' A' ' 77' ' ' LYS . 3.3 ttmp? -63.01 -28.85 70.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.972 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -112.01 8.23 20.11 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 71.72 26.84 3.0 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.599 0.562 . . . . 0.0 111.877 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.75 103.67 10.75 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.175 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -117.72 -35.45 3.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.823 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 12.4 mt -112.57 130.1 66.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.49 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.8 m -102.35 140.47 21.16 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.67 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -86.82 147.7 35.56 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.34 -1.525 . . . . 0.0 112.085 -0.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.0 t -140.78 149.73 42.46 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.4 t -140.71 142.01 34.88 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.22 0.533 . . . . 0.0 110.606 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.804 HG13 HG13 ' A' ' 98' ' ' VAL . 6.2 m -115.49 127.89 72.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.79 176.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.415 ' CD1' ' HD2' ' A' ' 97' ' ' TYR . 83.0 m-85 -97.56 118.74 34.75 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.485 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.516 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 6.4 mp -108.35 141.51 40.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.79 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.449 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 46.6 t0 -80.18 -179.19 6.94 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.594 ' HZ2' ' CD ' ' A' ' 92' ' ' GLU . 7.9 pttm -49.57 -32.11 11.93 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -175.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.594 ' CD ' ' HZ2' ' A' ' 91' ' ' LYS . 32.6 mp0 -69.26 -29.0 66.81 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 122.087 -0.383 . . . . 0.0 111.338 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.33 30.37 7.01 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.972 -173.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 9.9 p30 -105.59 132.99 51.06 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 175.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.402 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 16.6 ptmt -75.73 117.79 17.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.832 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -106.45 -54.83 2.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.989 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.415 ' HD2' ' CD1' ' A' ' 88' ' ' PHE . 73.0 t80 -109.61 135.17 51.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.105 -174.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.804 HG13 HG13 ' A' ' 87' ' ' VAL . 29.3 m -111.82 148.02 15.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.41 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 38.0 t60 -145.84 131.84 19.25 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -117.9 149.81 40.26 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 176.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.38 -124.0 8.1 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.62 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 103' ' ' MET . 27.3 tp -136.53 167.94 20.43 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 122.731 -0.276 . . . . 0.0 110.336 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.402 ' N ' ' HG ' ' A' ' 102' ' ' LEU . 20.3 ptm -168.6 147.08 4.17 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.401 ' HD3' ' HA ' ' A' ' 104' ' ' ARG . 23.3 mmt180 -89.87 168.67 11.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.18 -177.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -53.07 -41.46 64.9 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.234 -177.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -65.83 -35.37 80.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.876 0.37 . . . . 0.0 110.475 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.506 ' O ' HG12 ' A' ' 111' ' ' ILE . 11.7 m120 -64.48 -47.32 79.4 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.2 mt -59.32 -50.8 78.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.099 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -51.88 -50.14 61.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.746 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.2 m -65.16 -38.15 89.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.659 0.266 . . . . 0.0 111.094 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 107' ' ' ASN . 39.9 mm -63.61 -47.26 92.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 177.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.595 HD11 HD11 ' A' ' 30' ' ' ILE . 83.2 mt -62.66 -39.43 93.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.047 0.451 . . . . 0.0 110.055 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -54.71 -44.85 73.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.239 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.5 m -86.14 -23.87 26.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.878 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.0 tp -91.12 -64.97 1.05 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -175.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.861 ' HA2' ' HZ2' ' A' ' 118' ' ' LYS . . . -139.03 -122.82 2.04 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 119.989 -1.1 . . . . 0.0 113.816 -169.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.854 ' H ' ' HG3' ' A' ' 28' ' ' PRO . 12.7 t 58.44 35.14 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 122.152 0.977 . . . . 0.0 109.075 -173.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.861 ' HZ2' ' HA2' ' A' ' 116' ' ' GLY . 37.2 mtmm -107.56 59.51 0.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.223 -174.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 1.2 tm-20 -119.7 -86.4 0.65 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.66 39.49 1.97 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.738 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.42 ' H ' ' C ' ' A' ' 119' ' ' GLU . 3.2 t60 -88.33 5.43 42.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.269 0.556 . . . . 0.0 109.548 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -68.06 -28.61 67.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.608 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 59.1 t60 70.17 -56.4 0.59 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.585 0.754 . . . . 0.0 112.296 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -76.52 92.35 3.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.732 0.301 . . . . 0.0 110.607 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -98.31 -6.81 30.18 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.4 p80 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 117.648 -1.167 . . . . 0.0 108.164 175.579 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.7 ttm . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 120.925 0.393 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.2 m -150.9 -51.74 0.13 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 84.8 mt -110.47 -153.95 0.53 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 170.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.549 ' OE2' ' HA ' ' A' ' 8' ' ' GLN . 5.1 mp0 -65.14 171.87 3.41 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 172.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.45 ' HA3' ' HG3' ' A' ' 18' ' ' GLU . . . -77.72 47.54 2.79 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.446 -176.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.649 ' O ' ' HB3' ' A' ' 7' ' ' LYS . 8.7 tp 170.28 -19.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 122.969 0.508 . . . . 0.0 111.01 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.649 ' HB3' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER 80.16 103.68 0.07 Allowed 'General case' 0 C--N 1.345 0.389 0 O-C-N 123.551 0.532 . . . . 0.0 109.695 -173.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.911 ' HA ' HE21 ' A' ' 8' ' ' GLN . 0.0 OUTLIER 65.24 89.45 0.1 Allowed 'General case' 0 C--N 1.327 -0.395 0 O-C-N 124.11 0.881 . . . . 0.0 110.955 -176.498 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.401 HG23 ' HG2' ' A' ' 4' ' ' GLU . 9.5 tp -90.79 -27.63 4.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.866 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 13' ' ' SER . 8.2 t-20 -165.07 174.0 10.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.488 ' C ' ' H ' ' A' ' 13' ' ' SER . 91.0 t80 -96.59 -33.82 11.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.805 0.336 . . . . 0.0 110.687 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.514 HE22 HG21 ' A' ' 42' ' ' VAL . 24.4 mt-30 -83.52 25.67 0.74 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.813 0.816 . . . . 0.0 108.948 174.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.49 ' HB3' HG21 ' A' ' 16' ' ' VAL . 44.8 m -145.05 96.18 2.81 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.894 -172.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.9 mt -108.41 -61.21 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.885 0.374 . . . . 0.0 111.092 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 7.2 m-20 -85.25 30.18 0.62 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.662 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.49 HG21 ' HB3' ' A' ' 13' ' ' SER . 20.4 m -91.54 155.56 3.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -166.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.526 HG11 ' HB1' ' A' ' 23' ' ' ALA . 47.1 t -136.21 143.01 37.04 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.441 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.45 ' HG3' ' HA3' ' A' ' 5' ' ' GLY . 31.2 mm-40 -71.97 -45.89 59.39 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.201 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.622 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 19.1 t30 -164.02 176.12 9.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.831 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.673 HD11 HD12 ' A' ' 74' ' ' LEU . 86.2 mt -49.03 -36.7 18.63 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -174.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.546 ' OE2' ' HB3' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -77.24 -27.42 53.32 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -172.329 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -77.73 -10.65 59.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.713 0.292 . . . . 0.0 111.355 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.526 ' HB1' HG11 ' A' ' 17' ' ' VAL . . . -87.9 171.43 10.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.955 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.945 ' HZ1' ' HB3' ' A' ' 24' ' ' LYS . 4.2 mtpm? -136.08 152.89 51.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.011 0.434 . . . . 0.0 111.644 177.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.65 170.77 15.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.542 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.3 -29.02 5.83 Favored Glycine 0 CA--C 1.504 -0.619 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.575 ' HB ' ' HA ' ' A' ' 59' ' ' PHE . 22.9 pt -113.55 131.08 23.17 Favored Pre-proline 0 C--N 1.315 -0.899 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 1.03 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 54.7 Cg_exo -56.59 162.79 7.79 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 123.047 2.498 . . . . 0.0 113.111 -174.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.1 m -122.97 122.66 39.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.179 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.443 ' N ' HD13 ' A' ' 30' ' ' ILE . 2.5 mp -104.61 109.19 26.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 174.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.409 HG22 ' CD2' ' A' ' 62' ' ' TYR . 64.3 mt -105.45 113.85 43.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.468 -177.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.48 ' O ' ' HG3' ' A' ' 32' ' ' MET . 25.1 ptm -108.91 112.99 25.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.639 0.733 . . . . 0.0 110.057 178.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.601 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 90.1 m-85 -76.36 114.12 14.71 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.535 177.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.519 ' HG3' ' SG ' ' A' ' 41' ' ' CYS . 0.1 OUTLIER -138.77 148.99 44.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.133 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.0 t -97.99 -173.2 2.54 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -55.99 -51.44 67.72 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.701 0.625 . . . . 0.0 110.769 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.706 HG22 ' HG ' ' A' ' 38' ' ' CYS . 15.0 t -92.73 -162.52 0.94 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.615 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.706 ' HG ' HG22 ' A' ' 37' ' ' THR . 50.7 m 74.61 106.02 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.491 0 C-N-CA 123.639 0.776 . . . . 0.0 110.993 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 2.7 Cg_exo -74.74 3.45 5.46 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.561 2.174 . . . . 0.0 113.145 -176.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.425 ' HD2' ' HB3' ' A' ' 38' ' ' CYS . 80.0 m-85 -65.3 -27.28 68.5 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.519 ' SG ' ' HG3' ' A' ' 34' ' ' LYS . 42.3 t -64.58 -55.05 22.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.646 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.519 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 12.7 p -63.42 -31.09 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.772 0.32 . . . . 0.0 110.99 -175.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -68.14 -49.49 60.67 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.214 0.53 . . . . 0.0 110.21 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.1 ttt -67.75 -29.4 68.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.174 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 51.8 mt-30 -61.21 -38.7 87.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.128 175.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 81.5 mttt -60.1 -49.34 78.05 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.382 0.611 . . . . 0.0 109.671 175.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.544 ' O ' HG23 ' A' ' 51' ' ' VAL . 9.9 mm-40 -57.06 -48.79 77.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.413 176.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.12 -29.79 68.85 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.29 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 68.6 m -62.12 -47.46 84.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.068 0.461 . . . . 0.0 110.412 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -73.02 -33.56 65.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.28 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 47' ' ' GLU . 57.8 t -67.46 -36.73 77.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.106 0.479 . . . . 0.0 110.167 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.0 m -66.26 -30.74 71.23 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.053 175.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.581 ' HZ2' ' CD ' ' A' ' 56' ' ' GLU . 19.8 tptp -74.03 -28.78 61.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.391 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -70.47 -47.26 61.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.086 174.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.601 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 1.2 ttm180 -123.43 75.18 1.3 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.808 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.581 ' CD ' ' HZ2' ' A' ' 53' ' ' LYS . 39.3 mt-10 -69.79 118.51 12.73 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.749 -172.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.46 50.76 60.61 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.575 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.601 ' HB2' ' HG2' ' A' ' 55' ' ' ARG . 39.0 mmtm -136.03 8.59 3.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.693 0.282 . . . . 0.0 110.79 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.575 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 50.5 p90 -169.93 149.03 3.59 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.486 ' HB3' HG21 ' A' ' 17' ' ' VAL . 15.3 m-80 -88.86 135.19 33.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.484 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.7 mt -114.68 106.18 20.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 168.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.622 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 4.0 t80 -96.32 116.67 29.4 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -76.93 103.95 7.15 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 174.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -77.45 72.82 4.02 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.683 ' HD2' ' OE2' ' A' ' 68' ' ' GLU . 2.6 ptp180 -69.61 109.79 4.5 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 113.624 -1.625 . . . . 0.0 111.515 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.8 tp -72.24 4.67 3.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.729 -177.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.653 ' CD ' ' HB2' ' A' ' 65' ' ' ARG . 5.6 pm0 -83.04 -13.98 54.75 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.121 0.486 . . . . 0.0 110.056 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.683 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 62.1 mt-10 -106.55 144.29 33.44 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.912 175.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -21.38 62.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.034 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HG3' ' HB3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -55.8 -23.25 28.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.221 0.534 . . . . 0.0 112.026 177.099 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.616 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 22.7 m-20 -88.1 8.96 24.31 Favored 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -177.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 77.7 mt -71.47 -50.71 38.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 168.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -68.03 -48.67 65.04 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.52 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.673 HD12 HD11 ' A' ' 20' ' ' LEU . 4.4 mm? -58.4 -41.66 85.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.373 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.448 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -56.76 -56.65 18.83 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 120.501 0.191 . . . . 0.0 111.047 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -65.32 -33.95 77.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.758 0.313 . . . . 0.0 111.042 -176.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.798 ' HZ2' ' HB2' ' A' ' 77' ' ' LYS . 4.1 ttmp? -64.2 -25.61 68.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.112 0.482 . . . . 0.0 110.88 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.662 ' HB3' HG22 ' A' ' 87' ' ' VAL . 89.2 m-85 -120.34 22.71 11.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.015 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 68.44 16.84 9.19 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.334 0.588 . . . . 0.0 111.333 169.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' A' ' 75' ' ' ALA . . . -83.94 140.51 31.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.908 -176.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -151.76 -40.2 0.11 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.65 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 22.8 pt -116.73 160.44 16.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.975 173.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.07 152.52 60.13 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.924 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -91.84 149.57 16.61 Favored 'Cis proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.038 -1.651 . . . . 0.0 112.428 -0.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.8 t -138.06 129.82 28.27 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.1 m -108.5 123.25 48.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.931 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.662 HG22 ' HB3' ' A' ' 78' ' ' TYR . 67.1 t -105.16 117.65 51.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.78 176.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -96.03 111.11 23.22 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.402 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -100.04 138.95 36.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.337 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.8 -172.67 0.53 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.609 ' NZ ' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -67.14 -26.14 66.52 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.068 -0.395 . . . . 0.0 112.056 -176.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.609 ' HG2' ' NZ ' ' A' ' 91' ' ' LYS . 38.6 mm-40 -75.05 -47.11 30.54 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.91 20.99 1.42 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.814 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.427 ' ND2' ' HB2' ' A' ' 92' ' ' GLU . 43.7 m-80 -78.13 133.1 37.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -71.04 86.35 0.73 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.202 176.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -86.73 -51.59 6.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.206 -172.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -137.5 125.91 23.42 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.454 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.6 m -112.14 149.51 14.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 173.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -146.27 122.39 10.8 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.41 115.08 27.73 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 135.37 -168.72 23.69 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.3 tp -90.54 149.85 22.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.77 0.319 . . . . 0.0 110.46 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 56.1 mmm -127.09 161.6 28.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.417 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 10.1 mmm180 -113.37 168.53 9.66 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.401 ' HB2' ' HE2' ' A' ' 105' ' ' LYS . 14.3 ptmm? -57.3 -47.62 81.03 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -172.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.505 ' HA ' ' OE1' ' A' ' 109' ' ' GLU . 14.8 t-20 -64.23 -32.29 73.82 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.97 0.414 . . . . 0.0 111.2 -177.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.522 ' O ' HG12 ' A' ' 111' ' ' ILE . 9.3 m120 -65.03 -45.79 84.01 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.556 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 53.1 mt -62.94 -50.04 81.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.066 175.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.505 ' OE1' ' HA ' ' A' ' 106' ' ' ASN . 43.7 mt-10 -51.28 -49.77 60.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.755 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.5 m -66.69 -43.91 83.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.008 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 107' ' ' ASN . 40.4 mm -60.22 -43.61 93.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.497 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 57.5 mt -59.91 -39.77 86.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 0.0 111.238 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -61.21 -41.14 96.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.325 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.3 m -86.06 -17.43 35.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.912 0.387 . . . . 0.0 111.443 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.9 tp -66.84 -54.39 22.92 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.626 -173.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.672 ' O ' ' HG2' ' A' ' 118' ' ' LYS . . . 136.69 13.29 0.97 Allowed Glycine 0 N--CA 1.442 -0.967 0 C-N-CA 119.862 -1.161 . . . . 0.0 112.872 -177.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 1.03 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 61.9 t -43.14 100.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.152 0.501 . . . . 0.0 111.888 167.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 29.7 pttt 169.66 -178.4 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.57 141.9 37.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 118.767 0.712 . . . . 0.0 109.999 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -146.76 -4.68 0.42 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.264 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.576 ' HE2' ' HA ' ' A' ' 92' ' ' GLU . 49.6 m-70 -74.75 -19.56 60.18 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.78 0.29 . . . . 0.0 111.697 -175.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -64.01 88.0 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.365 0.602 . . . . 0.0 110.578 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.482 ' HA ' ' OXT' ' A' ' 126' ' ' HIS . 7.4 m80 -158.85 36.51 0.22 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.075 177.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -117.45 12.26 14.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.235 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -154.57 -35.84 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.628 175.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.482 ' OXT' ' HA ' ' A' ' 123' ' ' HIS . 65.4 m-70 . . . . . 0 C--O 1.245 0.822 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.395 172.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.514 ' H3 ' ' CD ' ' A' ' 4' ' ' GLU . 38.5 mtt . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 21' ' ' GLU . 49.4 m -153.76 69.94 0.81 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.498 176.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.597 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 60.1 tp 64.67 79.9 0.24 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.529 -175.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.514 ' CD ' ' H3 ' ' A' ' 1' ' ' MET . 7.0 mm-40 -72.09 -45.85 59.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.566 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.33 20.91 65.9 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.784 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 tp -155.05 154.03 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 O-C-N 122.722 -0.281 . . . . 0.0 110.863 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.3 tptp 72.13 -61.39 0.5 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 171.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.637 ' HG3' HG21 ' A' ' 9' ' ' ILE . 12.8 pt20 -96.09 -9.95 29.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.524 0.678 . . . . 0.0 111.234 -175.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.779 HD13 HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -176.27 128.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.695 -177.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -166.24 -71.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.995 0.426 . . . . 0.0 111.822 -176.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -79.95 121.4 25.41 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -170.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 171.5 -67.64 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.94 172.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.4 m -125.14 3.02 7.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.591 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.0 mt 70.96 -60.1 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.066 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.478 HD22 ' HA2' ' A' ' 57' ' ' GLY . 14.6 m120 -83.3 30.4 0.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.263 0.554 . . . . 0.0 110.749 177.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.779 HG23 HD13 ' A' ' 9' ' ' ILE . 0.6 OUTLIER -80.1 126.73 39.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.622 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.515 HG13 ' HB2' ' A' ' 23' ' ' ALA . 73.2 t -119.74 132.97 68.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.943 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -71.24 -54.69 10.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.159 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.644 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 7.0 t30 -155.08 169.56 23.83 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.11 -173.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.1 mt -46.73 -45.16 19.45 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.644 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -77.28 -17.74 58.12 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.282 0.563 . . . . 0.0 110.247 -176.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.597 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 66.4 mm-40 -87.82 17.88 4.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.035 171.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.515 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -122.59 160.41 25.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.301 176.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.419 ' HG3' ' HG2' ' A' ' 25' ' ' GLU . 11.8 ptmm? -173.86 -168.95 0.45 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.508 ' HB2' HD11 ' A' ' 27' ' ' ILE . 4.6 mm-40 75.55 -170.72 0.09 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.106 0.879 . . . . 0.0 110.789 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.574 ' O ' ' HE2' ' A' ' 91' ' ' LYS . . . -117.4 38.18 3.06 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.198 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.689 HG22 ' HG2' ' A' ' 119' ' ' GLU . 0.2 OUTLIER -100.81 155.56 36.19 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 110.513 -0.18 . . . . 0.0 110.513 -178.651 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.696 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 32.5 Cg_exo -60.09 144.61 99.47 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.444 2.096 . . . . 0.0 111.63 173.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.9 m -110.96 115.13 28.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.683 -176.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.2 mt -98.71 107.98 21.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.648 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 55.4 mt -99.93 111.94 31.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.147 0.498 . . . . 0.0 109.875 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.885 ' HE2' ' HB3' ' A' ' 84' ' ' PRO . 8.3 tpt -109.35 108.93 19.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.27 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.576 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 74.3 m-85 -80.2 152.26 29.24 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.678 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.735 ' HZ1' ' HB3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -159.98 155.74 25.94 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 175.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.552 ' HA ' ' HB2' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -67.72 -173.09 0.31 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 173.66 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.402 ' H ' HG22 ' A' ' 35' ' ' THR . 7.9 p-10 -51.31 -45.55 62.26 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.752 0.31 . . . . 0.0 110.748 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.6 p -137.96 -98.02 0.19 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.33 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.609 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 34.3 m 65.71 130.13 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 123.465 0.706 . . . . 0.0 111.731 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 13.9 Cg_exo -67.96 -33.61 25.65 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.085 1.857 . . . . 0.0 113.143 -177.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -64.66 -28.68 69.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.912 0.387 . . . . 0.0 110.822 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.609 ' SG ' ' HB2' ' A' ' 38' ' ' CYS . 52.3 m -70.26 -36.56 74.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.987 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.476 ' O ' ' HB3' ' A' ' 45' ' ' GLN . 41.4 t -75.38 -33.21 27.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.427 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.98 -51.11 63.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.195 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.535 ' HE3' ' HB2' ' A' ' 103' ' ' MET . 25.5 ttt -68.21 -29.37 68.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.193 0.52 . . . . 0.0 109.717 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.476 ' HB3' ' O ' ' A' ' 42' ' ' VAL . 4.6 tp60 -58.12 -38.99 77.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.575 174.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.676 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -67.81 -42.23 81.87 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.402 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.597 ' O ' HG22 ' A' ' 51' ' ' VAL . 7.6 mm-40 -57.9 -45.27 86.7 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.346 0.404 . . . . 0.0 110.479 173.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.533 HD23 HD13 ' A' ' 108' ' ' ILE . 96.1 mt -58.16 -44.13 87.77 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.897 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.1 m -60.21 -37.9 81.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.662 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.56 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 20.2 m-85 -74.85 -28.55 60.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.993 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 47' ' ' GLU . 68.7 t -65.47 -44.25 94.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.6 m -65.32 -31.54 72.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.369 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 50' ' ' TYR . 41.8 tttm -58.73 -39.25 80.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.809 173.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 50' ' ' TYR . 31.6 mm-40 -85.69 -17.9 34.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.843 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.589 ' NE ' ' HA ' ' A' ' 55' ' ' ARG . 3.0 tpm_? -153.0 88.93 1.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 111.569 -176.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.28 147.07 28.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.348 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.478 ' HA2' HD22 ' A' ' 15' ' ' ASN . . . 59.17 39.86 95.01 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.773 -0.648 . . . . 0.0 114.497 171.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.497 ' O ' ' HD2' ' A' ' 28' ' ' PRO . 69.5 mmtt -133.28 1.52 3.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.207 0.504 . . . . 0.0 110.791 175.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -170.46 153.69 4.39 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.42 ' HB3' HG23 ' A' ' 17' ' ' VAL . 83.1 m-20 -121.28 138.25 54.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.847 0.356 . . . . 0.0 110.428 177.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.404 HD11 ' N ' ' A' ' 61' ' ' ILE . 4.5 mp -101.94 108.26 23.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.212 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.698 ' OH ' ' HG ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -89.55 115.23 26.8 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 177.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.697 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 86.9 m-85 -95.07 104.18 16.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.02 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.601 ' C ' HD22 ' A' ' 71' ' ' ASN . . . -87.77 107.01 18.45 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.677 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 9.7 ptt180 -105.56 130.24 53.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.228 -177.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.713 HD11 HD21 ' A' ' 71' ' ' ASN . 8.0 mp -71.85 7.73 1.45 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.152 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.671 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 44.7 mt-10 -62.14 -34.26 76.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.415 0.626 . . . . 0.0 109.485 169.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.669 ' HB2' ' HD2' ' A' ' 70' ' ' LYS . 35.6 mt-10 -104.58 172.95 6.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.53 -170.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.79 -24.35 17.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.779 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.669 ' HD2' ' HB2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -54.27 -17.55 3.03 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.197 0.522 . . . . 0.0 111.862 176.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.713 HD21 HD11 ' A' ' 66' ' ' LEU . 5.7 m-20 -80.58 -9.76 59.77 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.2 mm -61.56 -58.75 6.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.602 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.469 ' CG ' ' HZ1' ' A' ' 77' ' ' LYS . 10.3 t70 -70.54 -40.87 73.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.627 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.698 ' HG ' ' OH ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -62.93 -46.5 87.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.691 -176.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.576 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -62.49 -49.52 75.05 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.71 0.291 . . . . 0.0 110.916 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -65.92 -33.93 76.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.06 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.469 ' HZ1' ' CG ' ' A' ' 73' ' ' ASP . 16.2 ttmm -61.8 -25.22 67.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.999 0.428 . . . . 0.0 110.878 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 33' ' ' PHE . 90.2 m-85 -124.48 23.05 8.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.911 -176.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 66.03 25.7 10.9 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.595 0.559 . . . . 0.0 111.442 166.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.76 97.53 8.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.851 0.358 . . . . 0.0 111.238 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -106.07 -36.09 7.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.16 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.9 pt -132.74 141.39 45.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.966 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.46 HG13 ' HA ' ' A' ' 34' ' ' LYS . 34.7 m -102.57 157.78 33.04 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.434 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.885 ' HB3' ' HE2' ' A' ' 32' ' ' MET . 20.8 Cg_exo -67.29 150.48 83.01 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.054 -1.227 . . . . 0.0 112.401 -0.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 32' ' ' MET . 1.2 m -135.06 108.35 7.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -176.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.04 109.04 16.97 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.001 0.429 . . . . 0.0 110.822 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.648 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 12.6 p -100.78 123.97 54.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.516 0.674 . . . . 0.0 109.362 175.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.508 ' HB3' HD22 ' A' ' 115' ' ' LEU . 85.4 m-85 -99.01 110.43 23.04 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.497 -176.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.617 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 6.7 mp -102.83 129.65 49.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.734 176.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -68.35 169.83 9.94 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.774 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.574 ' HE2' ' O ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -61.76 -14.33 31.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -175.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.67 -5.39 58.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 111.26 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.81 10.8 71.86 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.604 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 8.6 p30 -86.67 131.32 34.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.806 0.336 . . . . 0.0 110.66 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.617 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 20.5 ptmt -77.28 87.17 3.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.217 0.532 . . . . 0.0 109.859 175.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -74.79 -53.64 8.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.618 -173.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.525 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 63.4 t80 -137.54 114.46 10.65 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.866 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 87' ' ' VAL . 4.4 p -96.66 137.0 25.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 172.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.525 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 48.6 t60 -134.1 134.29 42.1 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -175.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.41 131.91 54.64 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 173.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 122.75 173.38 14.15 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.264 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.8 tp -82.01 141.12 33.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.824 0.345 . . . . 0.0 111.323 -175.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.535 ' HB2' ' HE3' ' A' ' 44' ' ' MET . 78.4 mmm -134.15 161.29 35.29 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.419 ' O ' HG13 ' A' ' 108' ' ' ILE . 17.5 mmm180 -106.86 171.52 7.32 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.489 ' HE2' ' CB ' ' A' ' 50' ' ' TYR . 36.5 ttmt -46.62 -60.29 2.47 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.6 0.562 . . . . 0.0 112.004 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.561 ' HA ' ' OE1' ' A' ' 109' ' ' GLU . 6.7 t-20 -67.66 -27.46 66.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.065 0.46 . . . . 0.0 111.12 -174.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.501 ' HB3' ' HE1' ' A' ' 103' ' ' MET . 13.1 m120 -67.4 -42.76 82.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.533 HD13 HD23 ' A' ' 48' ' ' LEU . 56.7 mt -61.7 -46.15 97.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.369 173.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.561 ' OE1' ' HA ' ' A' ' 106' ' ' ASN . 50.9 mt-10 -52.79 -48.03 67.16 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.539 176.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.1 m -61.27 -37.5 83.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.095 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 107' ' ' ASN . 49.7 mm -69.04 -43.79 81.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.328 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.522 ' HB3' ' CG2' ' A' ' 117' ' ' VAL . 72.8 mt -61.7 -39.22 90.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.907 0.384 . . . . 0.0 110.107 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -58.15 -38.05 75.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.799 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.0 m -86.22 -5.74 59.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.029 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.508 HD22 ' HB3' ' A' ' 88' ' ' PHE . 53.9 tp -93.47 -66.72 0.9 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.704 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 174.9 -72.23 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.78 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.696 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 21.4 t 55.32 29.62 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 122.493 1.14 . . . . 0.0 109.719 -177.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.42 ' O ' ' HD2' ' A' ' 91' ' ' LYS . 17.8 pttm -89.45 79.56 6.92 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.962 -175.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.689 ' HG2' HG22 ' A' ' 27' ' ' ILE . 7.6 tp10 -130.41 141.98 50.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.685 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -124.18 -50.67 0.2 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.414 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.49 ' HD1' ' CD ' ' A' ' 119' ' ' GLU . 0.4 OUTLIER 59.88 24.87 13.94 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.936 0.494 . . . . 0.0 111.785 -176.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 72.24 -56.96 0.64 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.411 0.684 . . . . 0.0 111.839 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.437 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 52.7 t60 -120.97 -93.97 0.51 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.425 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' A' ' 123' ' ' HIS . 8.2 t60 174.5 -58.42 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.024 0.44 . . . . 0.0 110.397 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -159.97 -66.12 0.07 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.769 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.7 t60 . . . . . 0 C--O 1.242 0.698 0 CA-C-O 117.607 -1.187 . . . . 0.0 108.939 177.703 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 m -62.23 -43.89 97.8 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.443 0.64 . . . . 0.0 109.646 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.466 ' HB2' HE22 ' A' ' 8' ' ' GLN . 1.4 pp -117.68 175.02 5.84 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.788 173.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.471 ' HB2' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -83.14 -82.16 0.15 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.729 0.3 . . . . 0.0 111.776 -178.491 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.41 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 110.76 21.49 6.75 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -173.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.471 HG12 ' HB2' ' A' ' 4' ' ' GLU . 37.1 pt -106.59 -29.12 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.416 -0.392 . . . . 0.0 111.122 -177.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.05 -1.53 18.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.281 0.563 . . . . 0.0 109.687 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.466 HE22 ' HB2' ' A' ' 3' ' ' LEU . 21.0 pt20 -129.61 -166.73 1.7 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.26 -177.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 16' ' ' VAL . 12.2 tt -43.2 134.24 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.681 0.753 . . . . 0.0 112.113 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -125.36 174.83 7.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.704 -176.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -87.37 0.78 54.95 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.394 -0.192 . . . . 0.0 111.479 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -47.77 -71.48 0.07 Allowed 'General case' 0 C--O 1.236 0.382 0 O-C-N 123.535 0.522 . . . . 0.0 111.762 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.55 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 6.8 m -93.97 -6.18 46.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.172 178.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.416 ' HB ' ' O ' ' A' ' 13' ' ' SER . 74.5 mt 74.0 -63.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 123.733 0.645 . . . . 0.0 110.37 -174.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.698 ' HB3' ' HA2' ' A' ' 57' ' ' GLY . 0.5 OUTLIER -87.83 32.08 0.75 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.333 0.587 . . . . 0.0 110.581 174.513 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.657 HG22 ' CE1' ' A' ' 63' ' ' TYR . 1.2 p -86.61 111.35 21.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.789 174.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 22' ' ' GLU . 20.8 m -114.0 136.42 50.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.107 0.479 . . . . 0.0 109.933 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -65.54 -54.46 27.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.894 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.735 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 4.9 t30 -144.87 179.33 7.4 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.295 -174.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.407 HD12 HD22 ' A' ' 74' ' ' LEU . 96.5 mt -48.1 -42.0 27.81 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.261 0.624 . . . . 0.0 112.578 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -58.25 -32.22 68.15 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.557 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . 21.1 mt-10 -84.25 -6.07 59.34 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.49 151.73 26.38 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.188 -0.32 . . . . 0.0 111.136 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -172.41 -171.07 0.77 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.495 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 2.4 tp10 72.26 -174.01 0.16 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.43 1.092 . . . . 0.0 111.215 178.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.495 ' H ' ' HG3' ' A' ' 25' ' ' GLU . . . -106.26 36.81 4.16 Favored Glycine 0 CA--C 1.504 -0.611 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 58' ' ' LYS . 17.6 pt -105.93 150.16 38.91 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 114.45 -0.875 . . . . 0.0 111.228 -170.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 1.065 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 62.5 Cg_exo -57.05 158.94 16.12 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.984 2.456 . . . . 0.0 112.304 175.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.6 m -115.9 121.78 43.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.929 -175.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.517 HD13 HD23 ' A' ' 112' ' ' LEU . 80.0 mt -110.17 108.75 26.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.608 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 61.0 mt -105.57 113.78 43.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.824 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.9 ptm -110.25 120.49 42.62 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.515 0.674 . . . . 0.0 109.474 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.479 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 87.3 m-85 -78.73 125.56 29.53 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.505 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.657 ' HE2' ' HB3' ' A' ' 65' ' ' ARG . 29.2 pttt -116.7 -174.26 2.54 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.755 -171.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.45 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 2.1 m -144.98 154.57 42.7 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 1.8 t70 -47.58 -51.9 19.55 Favored 'General case' 0 C--N 1.32 -0.674 0 O-C-N 124.239 0.962 . . . . 0.0 111.558 174.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.2 m -116.76 98.74 6.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.64 0.257 . . . . 0.0 111.637 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.45 ' SG ' ' HB ' ' A' ' 35' ' ' THR . 7.3 p -169.46 113.44 0.51 Allowed Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.901 171.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.55 ' O ' HG13 ' A' ' 42' ' ' VAL . 2.4 Cg_endo -80.49 -4.62 13.07 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.533 2.155 . . . . 0.0 113.605 -175.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -74.77 -21.8 59.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.834 0.35 . . . . 0.0 110.477 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 82.5 m -68.53 -43.45 76.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.817 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 39' ' ' PRO . 9.8 p -65.56 -29.31 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 120.93 0.395 . . . . 0.0 110.702 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.631 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -65.14 -48.76 72.45 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.28 0.562 . . . . 0.0 109.68 177.43 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.455 ' HE1' HG23 ' A' ' 86' ' ' THR . 25.2 ttt -67.69 -30.16 69.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.867 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.544 ' HG2' ' CE2' ' A' ' 63' ' ' TYR . 27.0 mt-30 -56.22 -40.76 74.56 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.384 173.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.631 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 3.6 mtpm? -59.1 -53.98 52.21 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.174 0.511 . . . . 0.0 110.259 177.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -62.21 -41.3 98.26 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.971 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.714 HD11 HG21 ' A' ' 61' ' ' ILE . 84.3 mt -62.22 -43.04 99.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.472 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.3 m -53.61 -44.24 69.29 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.73 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -63.73 -61.7 2.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.219 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.8 t -57.08 -32.16 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.2 0.524 . . . . 0.0 111.284 -175.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.537 ' HB3' ' OD1' ' A' ' 15' ' ' ASN . 68.0 m -66.83 -30.48 70.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.789 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -83.49 -31.14 26.66 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.066 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -71.14 -15.4 62.5 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.424 0.631 . . . . 0.0 110.865 174.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.63 ' HA ' HH11 ' A' ' 55' ' ' ARG . 0.5 OUTLIER -141.86 77.62 1.59 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 174.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 1.3 pm0 -58.27 115.63 3.07 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -161.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.698 ' HA2' ' HB3' ' A' ' 15' ' ' ASN . . . 50.69 33.23 26.38 Favored Glycine 0 CA--C 1.52 0.35 0 CA-C-N 115.012 -0.995 . . . . 0.0 114.43 173.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 27.3 mmtp -109.73 14.93 23.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.571 0.701 . . . . 0.0 111.279 -176.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -159.66 111.03 2.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.199 166.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -76.48 131.38 38.99 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.093 -174.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.714 HG21 HD11 ' A' ' 48' ' ' LEU . 30.1 mm -97.87 108.49 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.445 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.735 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 1.4 t80 -95.87 110.97 23.07 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.657 ' CE1' HG22 ' A' ' 16' ' ' VAL . 36.8 m-85 -90.77 102.04 14.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.059 177.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -78.97 103.98 9.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.8 0.333 . . . . 0.0 111.424 -172.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.657 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 13.6 ptp180 -68.29 123.95 22.15 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.307 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.0 tp -79.8 8.15 7.32 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 121.808 -0.557 . . . . 0.0 109.969 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.434 ' OE1' ' HB2' ' A' ' 65' ' ' ARG . 2.4 mp0 -84.07 -28.02 27.87 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.199 -172.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -119.21 -177.52 3.37 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -170.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -36.3 20.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.121 -169.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HD2' ' H ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -57.56 -29.57 64.51 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.876 0.846 . . . . 0.0 110.758 -179.234 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.92 -11.32 58.27 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.032 -174.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.4 mm -67.85 -44.56 85.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.425 ' CG ' ' HZ2' ' A' ' 77' ' ' LYS . 10.4 t70 -67.49 -47.51 69.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.54 176.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.407 HD22 HD12 ' A' ' 20' ' ' LEU . 2.0 tm? -60.31 -46.18 90.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.553 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.88 -43.52 98.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.488 0.185 . . . . 0.0 110.831 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -63.09 -34.19 77.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 0.0 110.805 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.425 ' HZ2' ' CG ' ' A' ' 73' ' ' ASP . 47.8 mttp -60.74 -16.85 44.36 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.367 0.604 . . . . 0.0 111.622 176.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.451 ' CD2' ' HE3' ' A' ' 95' ' ' LYS . 32.4 m-85 -124.3 4.02 8.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.435 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.6 t70 54.29 33.8 19.1 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.952 0.882 . . . . 0.0 110.425 -174.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.69 84.75 7.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.004 -176.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -103.14 5.05 37.63 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.934 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.6 pt -128.68 141.21 47.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.777 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 m -127.97 143.63 48.5 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.738 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -92.54 136.14 7.86 Favored 'Cis proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.579 -1.426 . . . . 0.0 111.983 -1.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.68 128.43 54.9 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.937 0.399 . . . . 0.0 111.022 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.455 HG23 ' HE1' ' A' ' 44' ' ' MET . 4.4 m -109.29 118.07 35.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.425 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.608 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 14.8 p -108.29 135.46 46.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.083 0.468 . . . . 0.0 110.13 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.418 ' HZ ' ' HE1' ' A' ' 103' ' ' MET . 93.9 m-85 -111.0 114.62 28.07 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.551 -177.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.501 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 4.8 mp -117.24 143.14 46.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.829 177.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.526 ' HA ' ' HB3' ' A' ' 28' ' ' PRO . 5.4 t0 -80.73 179.64 7.7 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 170.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.91 ' HZ3' ' HB3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -74.4 -14.19 60.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.92 0.391 . . . . 0.0 110.56 -177.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -70.8 -12.34 61.49 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.713 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.64 11.65 63.65 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.13 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 34.6 m-80 -79.0 113.93 17.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.693 0.283 . . . . 0.0 111.295 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.501 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 57.6 mtpt -71.43 95.47 1.36 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.205 172.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -87.58 -54.46 4.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.626 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -134.24 148.95 50.92 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.561 -172.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.0 m -129.54 147.1 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.599 174.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -140.16 139.02 35.65 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -104.43 122.65 45.94 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.555 0.534 . . . . 0.0 109.767 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.52 -161.78 17.89 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.988 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.412 HD21 ' OE1' ' A' ' 43' ' ' GLU . 44.0 tp -90.03 164.33 14.55 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 122.651 0.38 . . . . 0.0 111.154 -174.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.418 ' HE1' ' HZ ' ' A' ' 88' ' ' PHE . 58.3 mtm -149.45 172.12 15.48 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 122.937 0.495 . . . . 0.0 110.054 174.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 104' ' ' ARG . 8.0 mmt180 -100.95 163.14 12.44 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.452 ' HA ' HD11 ' A' ' 108' ' ' ILE . 6.3 ptpp? -56.1 -40.98 74.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -62.15 -30.6 71.16 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.927 0.394 . . . . 0.0 111.525 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.524 ' O ' HG12 ' A' ' 111' ' ' ILE . 10.3 m120 -67.93 -45.74 73.47 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 176.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.592 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 50.1 mt -58.93 -48.1 87.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.586 174.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -50.13 -50.41 48.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.363 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.9 m -65.47 -40.33 93.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.318 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 107' ' ' ASN . 47.5 mm -67.1 -41.12 86.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.712 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 87.5 mt -59.59 -39.95 85.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.114 0.483 . . . . 0.0 109.942 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -61.21 -36.71 80.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.015 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 62.6 m -85.36 -16.72 38.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.63 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.6 tp -78.38 -81.91 0.1 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.084 0.468 . . . . 0.0 110.039 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.418 ' HA3' ' OD2' ' A' ' 90' ' ' ASP . . . 171.49 -54.95 0.18 Allowed Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 174.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 1.065 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 29.1 t 50.42 78.23 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.059 0 CA-C-O 121.561 0.696 . . . . 0.0 111.308 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.761 ' HB2' ' HZ2' ' A' ' 91' ' ' LYS . 28.3 mtmm -121.01 140.08 52.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.753 -175.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.46 ' HG2' ' HD2' ' A' ' 58' ' ' LYS . 19.9 mt-10 -82.43 96.56 8.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.177 0.513 . . . . 0.0 110.554 175.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.98 -160.54 38.25 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.338 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -104.49 96.98 6.97 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 172.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -71.01 -4.82 26.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.022 -169.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -145.54 93.67 2.39 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -97.9 162.37 13.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.391 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -70.17 135.3 48.97 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 . . . . . 0 C--O 1.245 0.86 0 CA-C-O 117.963 -1.018 . . . . 0.0 108.616 173.836 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.526 ' H1 ' ' CD ' ' A' ' 4' ' ' GLU . 3.8 mpp? . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.661 0.267 . . . . 0.0 110.415 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.3 t -177.32 119.81 0.11 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 47.1 tp 57.16 78.37 0.23 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.559 0.695 . . . . 0.0 109.585 -171.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.526 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 5.3 mm-40 -76.27 100.64 5.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.355 -172.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.17 55.6 4.82 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.374 173.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.757 HG12 ' H ' ' A' ' 7' ' ' LYS . 19.2 tt -160.02 -174.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -174.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.757 ' H ' HG12 ' A' ' 6' ' ' ILE . 44.2 mmtt -69.63 27.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -175.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.699 ' HG2' HG21 ' A' ' 6' ' ' ILE . 15.6 mm100 -84.18 -4.26 58.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.566 0.698 . . . . 0.0 110.462 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.3 tt -92.97 -32.39 4.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.706 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -93.64 77.53 4.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.751 -176.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -123.43 -49.24 1.92 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.027 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 13' ' ' SER . 11.0 pt20 -81.77 154.96 25.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 162.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.51 ' HB3' HG13 ' A' ' 16' ' ' VAL . 50.4 m 67.94 88.48 0.11 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -169.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 15' ' ' ASN . 94.9 mt -99.07 146.75 7.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.475 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 82.5 m-20 75.26 14.63 2.98 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.935 0.772 . . . . 0.0 109.985 -173.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.738 HG11 HD12 ' A' ' 61' ' ' ILE . 2.4 m -107.88 157.28 8.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.431 -176.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 p -129.57 149.09 33.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.349 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -64.02 -56.39 15.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.184 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.7 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 3.0 t30 -157.95 177.96 10.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.382 -0.827 . . . . 0.0 108.831 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.417 ' HG ' ' CE2' ' A' ' 62' ' ' TYR . 30.7 mt -59.45 -30.77 68.74 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.08 -38.64 70.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.294 0.569 . . . . 0.0 110.659 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -87.94 -5.5 58.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.28 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.515 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -85.48 162.98 18.72 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -172.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 23' ' ' ALA . 4.6 mtmm -167.21 90.77 0.37 Allowed 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 124.78 1.232 . . . . 0.0 107.883 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.34 107.43 18.26 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -159.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -116.28 12.05 16.67 Favored Glycine 0 CA--C 1.503 -0.673 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 159.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.446 ' C ' ' HA ' ' A' ' 91' ' ' LYS . 3.0 pt -122.18 152.9 61.11 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 113.22 -1.49 . . . . 0.0 108.529 -176.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.535 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 50.3 Cg_exo -55.62 122.68 12.17 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 121.816 1.677 . . . . 0.0 111.719 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.5 m -99.0 115.8 29.77 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.944 -176.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.518 HD11 HD11 ' A' ' 112' ' ' LEU . 2.1 mp -98.42 108.21 21.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 176.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.682 ' HB ' HG23 ' A' ' 87' ' ' VAL . 62.4 mt -108.45 110.72 33.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.289 -176.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.502 ' HB3' HG23 ' A' ' 86' ' ' THR . 5.0 ppp? -117.2 142.7 46.71 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.022 176.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.654 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 82.7 m-85 -102.15 144.49 30.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.68 -174.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.85 ' HE2' ' HB3' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -138.85 135.59 34.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.024 177.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.4 m -81.71 162.09 23.11 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -50.52 -49.69 55.03 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.27 0.356 . . . . 0.0 111.539 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.3 m -109.32 95.79 5.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.628 0.251 . . . . 0.0 111.275 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.3 p -165.54 131.35 2.02 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 111.462 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.557 ' O ' HG11 ' A' ' 42' ' ' VAL . 64.0 Cg_endo -77.86 -19.69 12.34 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.382 2.055 . . . . 0.0 112.809 177.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.555 ' HB3' ' HG3' ' A' ' 84' ' ' PRO . 54.8 m-85 -58.9 -24.03 61.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.064 0.459 . . . . 0.0 110.82 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 45.3 t -64.12 -50.44 68.22 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.641 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.557 HG11 ' O ' ' A' ' 39' ' ' PRO . 10.0 p -68.34 -32.82 57.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.022 -174.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.591 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 16.2 mt-10 -65.87 -49.91 66.41 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 120.667 0.27 . . . . 0.0 110.993 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -36.96 85.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.917 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.529 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 25.8 mt-30 -60.74 -44.73 96.3 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 176.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.582 ' HZ1' ' HB3' ' A' ' 46' ' ' LYS . 9.8 mtpm? -56.58 -53.68 54.8 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.064 0.459 . . . . 0.0 111.042 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 12.3 mm-40 -62.64 -43.86 97.74 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.131 -174.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.568 ' HB3' HD13 ' A' ' 61' ' ' ILE . 47.6 mt -59.68 -43.11 94.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.954 175.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.4 m -58.77 -41.18 86.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.05 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.417 ' CD2' ' HA ' ' A' ' 47' ' ' GLU . 24.6 m-85 -59.79 -48.72 80.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.054 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.69 HG22 ' HG3' ' A' ' 105' ' ' LYS . 3.0 t -60.48 -43.37 94.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.039 0.447 . . . . 0.0 110.539 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -62.75 -30.83 71.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.376 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -56.94 -38.04 72.36 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.163 0.506 . . . . 0.0 110.522 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -94.42 2.53 55.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.458 -172.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.558 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 9.4 ptp180 -156.76 85.49 0.97 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.918 0.866 . . . . 0.0 111.553 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.403 ' HA ' HD22 ' A' ' 15' ' ' ASN . 1.1 pm0 -76.68 128.45 34.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.082 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.32 41.51 98.15 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.667 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.558 ' HG2' ' HB2' ' A' ' 55' ' ' ARG . 13.9 mptt -108.63 -27.4 9.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.227 0.537 . . . . 0.0 110.009 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -158.56 154.58 26.87 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.082 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 15' ' ' ASN . 50.2 t30 -108.84 134.05 52.05 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.907 0.384 . . . . 0.0 110.302 -177.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.738 HD12 HG11 ' A' ' 16' ' ' VAL . 34.0 mt -106.78 108.74 25.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.757 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.7 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -96.94 119.93 36.33 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.85 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 68.6 m-85 -94.4 103.47 15.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.598 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.18 101.18 13.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.069 0.461 . . . . 0.0 110.764 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.57 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 29.0 ptt180 -91.75 131.38 37.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.011 178.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.07 9.79 1.81 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.428 0.632 . . . . 0.0 111.215 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.436 ' HB3' ' HD2' ' A' ' 65' ' ' ARG . 57.1 tt0 -78.43 -22.55 47.5 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.543 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.485 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 45.7 mt-10 -110.39 140.24 44.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.043 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.575 ' HA ' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -59.06 -35.41 73.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.159 0.584 . . . . 0.0 112.516 -174.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HE3' ' HB3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -58.97 -27.99 65.9 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.934 0.397 . . . . 0.0 111.22 -177.611 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.47 ' HA ' ' CB ' ' A' ' 74' ' ' LEU . 87.2 m-20 -92.37 2.68 56.51 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.189 -175.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.575 HD11 ' HA ' ' A' ' 69' ' ' GLU . 1.4 mp -71.09 -52.46 27.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.97 -46.17 89.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.811 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.47 ' CB ' ' HA ' ' A' ' 71' ' ' ASN . 0.5 OUTLIER -55.05 -44.47 74.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.567 179.409 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.654 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -55.93 -56.38 21.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.52 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -70.46 -33.12 70.92 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.577 -176.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 77' ' ' LYS . 21.7 ttmt -67.04 -17.19 64.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.355 0.598 . . . . 0.0 110.737 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.439 ' HB2' ' HZ ' ' A' ' 33' ' ' PHE . 51.1 m-85 -118.61 23.67 11.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.391 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 73.15 10.98 5.15 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.095 166.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.09 93.56 7.04 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.33 0.586 . . . . 0.0 111.034 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -101.8 -12.54 18.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.796 175.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 23.9 pt -136.81 -179.51 2.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.641 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.48 145.1 47.83 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.685 0.279 . . . . 0.0 111.117 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.713 ' HD2' ' HA2' ' A' ' 101' ' ' GLY . 97.9 Cg_endo -93.87 120.14 2.84 Favored 'Cis proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.258 -1.559 . . . . 0.0 112.529 -1.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.428 ' O ' ' HD1' ' A' ' 33' ' ' PHE . 70.0 m -92.36 124.54 36.49 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.502 HG23 ' HB3' ' A' ' 32' ' ' MET . 10.5 m -114.57 116.41 28.74 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.213 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.698 HG11 HG12 ' A' ' 98' ' ' VAL . 13.6 m -100.69 123.09 53.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.296 0.57 . . . . 0.0 110.112 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.751 ' HB3' HD13 ' A' ' 115' ' ' LEU . 86.7 m-85 -99.47 110.3 22.79 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.992 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.658 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 5.8 mp -107.1 143.48 35.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.586 175.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.568 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 13.4 t70 -88.18 -165.45 1.32 Allowed 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.625 175.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.568 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -52.28 -35.52 50.45 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -169.311 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.73 18.85 20.88 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.666 -173.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.37 23.67 50.22 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.832 172.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.658 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 32.0 m-80 -77.06 112.65 13.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 117.391 0.595 . . . . 0.0 110.757 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -68.19 85.38 0.25 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -84.42 -45.21 12.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.296 -173.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.455 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 90.9 t80 -140.23 129.32 23.58 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.365 -176.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.698 HG12 HG11 ' A' ' 87' ' ' VAL . 15.0 m -107.92 148.01 12.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 172.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.455 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 62.6 t60 -136.76 128.81 29.49 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -177.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -99.82 120.57 39.96 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.713 ' HA2' ' HD2' ' A' ' 84' ' ' PRO . . . 101.91 166.71 27.09 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -175.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.1 169.22 10.58 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 117.198 0.499 . . . . 0.0 110.181 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.46 ' HE2' HD13 ' A' ' 111' ' ' ILE . 19.6 ptt? -157.14 168.07 28.52 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.415 ' N ' ' HD2' ' A' ' 104' ' ' ARG . 5.5 mmm180 -91.29 174.11 7.56 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.975 -171.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.69 ' HG3' HG22 ' A' ' 51' ' ' VAL . 55.0 tttm -46.46 -55.19 7.83 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.851 0.719 . . . . 0.0 112.469 -176.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -59.27 -34.78 72.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 0.0 111.334 -175.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -69.31 -50.15 49.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.145 0.498 . . . . 0.0 109.774 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.483 ' O ' HD23 ' A' ' 112' ' ' LEU . 41.7 mt -60.5 -49.56 83.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.933 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.483 ' HA ' HD21 ' A' ' 112' ' ' LEU . 35.0 tt0 -56.31 -47.77 78.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.452 -174.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.6 m -59.91 -31.36 69.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.441 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.552 ' O ' ' HG ' ' A' ' 115' ' ' LEU . 66.6 mt -72.6 -33.8 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.065 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.538 ' HB3' HG21 ' A' ' 117' ' ' VAL . 2.7 mm? -62.53 -38.7 90.99 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.187 172.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -63.81 -27.39 69.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.646 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.6 t -85.75 -14.03 46.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.061 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.751 HD13 ' HB3' ' A' ' 88' ' ' PHE . 95.7 mt -85.17 -73.98 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.383 0.611 . . . . 0.0 109.766 176.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 173.67 -59.81 0.14 Allowed Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.332 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.538 HG21 ' HB3' ' A' ' 112' ' ' LEU . 39.3 t 52.22 41.84 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 122.951 1.358 . . . . 0.0 108.021 -175.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -93.2 14.89 16.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 113.901 -1.5 . . . . 0.0 112.58 -165.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.515 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . 2.7 tp10 -84.57 -30.17 25.25 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.814 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.04 25.31 1.24 Allowed Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.282 -0.485 . . . . 0.0 113.588 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.407 ' H ' ' C ' ' A' ' 119' ' ' GLU . 13.3 m80 -149.4 22.79 0.93 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.856 0.36 . . . . 0.0 110.444 176.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -105.02 12.79 31.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.851 0.358 . . . . 0.0 111.215 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -76.83 92.76 3.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.051 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -57.57 132.7 53.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.726 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -126.72 -57.52 1.35 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.649 -0.691 . . . . 0.0 109.798 172.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.412 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 m -70.09 -56.4 7.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.157 0.504 . . . . 0.0 110.182 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -94.32 95.21 8.75 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.549 ' HG3' ' HA ' ' A' ' 8' ' ' GLN . 3.9 mm-40 60.76 -167.25 0.19 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.304 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.88 -44.61 94.39 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.108 172.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.44 HG13 ' N ' ' A' ' 7' ' ' LYS . 35.0 pt -135.99 -40.27 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.736 0.303 . . . . 0.0 111.696 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.452 ' HZ1' ' CD ' ' A' ' 22' ' ' GLU . 35.6 ttpt -160.11 -71.28 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.113 0.483 . . . . 0.0 109.751 -174.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.549 ' HA ' ' HG3' ' A' ' 4' ' ' GLU . 19.5 tp60 -135.47 8.24 3.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 122.203 1.001 . . . . 0.0 108.597 172.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.8 mt -124.89 158.09 32.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.541 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -71.84 -178.88 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.267 0.556 . . . . 0.0 111.524 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 12' ' ' GLN . 19.2 p90 -96.49 -148.72 0.31 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.618 -175.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.53 ' HB2' ' O ' ' A' ' 11' ' ' PHE . 16.0 mt-30 76.64 -63.76 0.37 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.634 0.774 . . . . 0.0 111.384 -176.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.443 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 13.2 m -76.13 -34.1 59.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.799 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.3 mt 69.06 -68.8 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.881 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.23 59.66 5.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.563 0.697 . . . . 0.0 110.121 174.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.443 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 1.0 OUTLIER -98.26 128.85 49.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.886 177.104 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.542 HG23 ' HG3' ' A' ' 22' ' ' GLU . 2.4 t -124.62 141.6 44.21 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-O 121.633 0.73 . . . . 0.0 112.567 -172.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -76.76 -35.49 57.69 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 113.864 -1.516 . . . . 0.0 112.38 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.756 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 66.0 t30 -172.6 -178.85 2.03 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.437 ' H ' ' CG ' ' A' ' 19' ' ' ASN . 83.5 mt -60.38 -29.66 69.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.756 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -78.57 -31.67 47.38 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.094 0.406 . . . . 0.0 110.988 -178.433 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.542 ' HG3' HG23 ' A' ' 17' ' ' VAL . 3.9 tp10 -72.42 -11.88 60.87 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.679 0.752 . . . . 0.0 109.876 170.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.461 ' HB3' HG11 ' A' ' 17' ' ' VAL . . . -95.14 171.73 8.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.435 -177.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.523 ' NZ ' ' HB3' ' A' ' 24' ' ' LYS . 4.3 mtpm? -135.01 167.32 21.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.125 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -86.44 174.81 8.74 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.267 170.124 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.02 -61.58 1.59 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.662 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -87.79 127.47 57.9 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-O 120.88 0.371 . . . . 0.0 110.047 178.081 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.937 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 50.9 Cg_exo -56.22 145.28 77.79 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.397 2.065 . . . . 0.0 111.118 176.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.5 m -119.54 129.61 54.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.18 0.514 . . . . 0.0 111.979 -172.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.614 HD13 HD21 ' A' ' 112' ' ' LEU . 79.6 mt -98.48 121.51 49.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.714 HG12 ' HB3' ' A' ' 62' ' ' TYR . 61.2 mt -118.58 119.85 62.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.146 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.42 ' O ' ' HG3' ' A' ' 32' ' ' MET . 26.5 ptm -108.0 117.48 34.24 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.983 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.52 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 87.4 m-85 -86.41 114.2 22.99 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.361 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.721 ' HG3' ' SG ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -138.71 145.15 39.96 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.741 -174.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 m -66.92 136.18 54.97 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 164.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -65.03 -39.38 93.3 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.792 -164.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 m -98.18 92.99 6.0 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.822 0.344 . . . . 0.0 111.153 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.637 ' SG ' ' HB2' ' A' ' 41' ' ' CYS . 25.7 p -160.87 142.68 9.12 Favored Pre-proline 0 CA--C 1.519 -0.236 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.351 174.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -64.92 -34.39 48.47 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.499 2.133 . . . . 0.0 112.48 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -68.66 -21.62 64.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 -177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.721 ' SG ' ' HG3' ' A' ' 34' ' ' LYS . 39.7 t -61.33 -53.43 56.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.022 175.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.23 -34.3 69.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.835 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -63.48 -50.24 70.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.403 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -71.74 -31.03 66.24 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.545 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 22.8 mt-30 -63.17 -33.59 75.79 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.543 173.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt -64.66 -46.65 81.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.548 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.594 ' O ' HG21 ' A' ' 51' ' ' VAL . 58.2 mm-40 -52.29 -54.52 30.44 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 123.572 0.545 . . . . 0.0 109.557 175.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.449 HD23 HD12 ' A' ' 108' ' ' ILE . 63.7 mt -57.37 -43.56 83.66 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.792 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.1 t -60.75 -39.94 90.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.164 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -76.36 -30.29 57.52 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.842 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.833 HG23 ' HG3' ' A' ' 105' ' ' LYS . 41.9 t -66.12 -39.54 84.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.254 0.55 . . . . 0.0 109.61 172.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.51 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 31.3 m -64.23 -31.66 72.95 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.889 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.421 ' HD2' ' HA ' ' A' ' 53' ' ' LYS . 4.2 mmmp? -74.44 -10.91 60.03 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.737 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -102.72 -8.72 20.63 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.23 0.538 . . . . 0.0 109.676 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.749 ' CZ ' ' HA ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -158.07 75.7 0.76 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.281 -178.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.51 ' HG3' ' O ' ' A' ' 52' ' ' SER . 20.1 mp0 -79.07 141.34 37.45 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.252 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.5 25.55 60.89 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.991 171.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.609 ' HB3' ' HG3' ' A' ' 55' ' ' ARG . 16.9 tptp -117.07 -21.82 8.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.352 0.596 . . . . 0.0 109.738 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.421 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 43.9 p90 -140.56 161.19 38.32 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 172.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -112.42 151.88 29.33 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 121.128 -0.229 . . . . 0.0 110.681 -174.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.404 HD11 ' HB3' ' A' ' 48' ' ' LEU . 58.3 mt -127.07 111.81 26.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.921 0.391 . . . . 0.0 111.124 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.714 ' HB3' HG12 ' A' ' 31' ' ' ILE . 2.5 t80 -103.24 119.74 39.43 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.545 ' CE1' ' HG2' ' A' ' 45' ' ' GLN . 87.1 m-85 -90.44 103.92 16.55 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.788 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.52 ' HB1' ' HA ' ' A' ' 33' ' ' PHE . . . -80.82 94.35 6.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.406 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.475 ' C ' ' H ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -88.13 116.31 26.23 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.37 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 mp -66.36 11.58 0.08 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.871 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.475 ' H ' ' C ' ' A' ' 65' ' ' ARG . 35.0 tt0 -78.46 -32.09 48.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.757 0.789 . . . . 0.0 109.36 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -98.43 140.75 32.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.976 -172.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -31.48 72.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.886 -175.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.477 ' H ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -57.67 -19.09 24.37 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 178.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.552 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 52.4 m-80 -87.08 -2.51 58.68 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.729 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 84.5 mt -70.3 -56.8 9.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -64.6 -40.04 94.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.219 175.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 71' ' ' ASN . 0.4 OUTLIER -58.89 -47.18 85.88 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.033 178.204 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.429 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -62.71 -45.65 91.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.772 0.32 . . . . 0.0 111.226 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -62.93 -34.56 77.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.314 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -57.58 -31.11 65.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.018 0.437 . . . . 0.0 111.142 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -111.81 1.98 16.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.422 -176.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.3 t70 60.66 48.02 7.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.912 0.863 . . . . 0.0 110.332 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.38 116.13 28.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.364 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -107.81 -57.86 2.05 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.891 -171.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 36.6 pt -119.72 154.2 22.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.088 0.47 . . . . 0.0 111.078 -177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.2 m -102.62 153.7 37.99 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.868 -177.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -89.66 127.91 7.64 Favored 'Cis proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.057 -1.643 . . . . 0.0 112.277 -0.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.0 t -120.81 134.3 55.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.077 0.465 . . . . 0.0 109.995 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.3 m -115.21 125.26 53.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.941 -176.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.426 HG23 HG23 ' A' ' 98' ' ' VAL . 66.3 t -105.24 127.87 59.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.046 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -107.83 114.42 28.36 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.242 0.544 . . . . 0.0 110.224 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.53 ' HB3' ' HA2' ' A' ' 93' ' ' GLY . 58.3 mt -99.16 142.29 30.83 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.69 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 6.4 t70 -71.25 -165.46 0.13 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.938 ' HD3' ' HG3' ' A' ' 118' ' ' LYS . 9.7 pttm -61.58 -31.73 71.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -170.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.535 ' CD ' ' HZ2' ' A' ' 91' ' ' LYS . 4.8 mp0 -96.32 1.88 52.3 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.91 -0.494 . . . . 0.0 110.838 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.53 ' HA2' ' HB3' ' A' ' 89' ' ' LEU . . . 85.93 26.53 34.27 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.061 -176.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.458 ' ND2' ' HB2' ' A' ' 92' ' ' GLU . 63.4 m-80 -85.34 141.06 30.3 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 176.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.3 94.15 5.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.594 -174.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -84.23 -52.33 6.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.108 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.415 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 72.0 t80 -133.86 144.85 49.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 -178.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.426 HG23 HG23 ' A' ' 87' ' ' VAL . 3.4 p -136.47 136.95 48.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.415 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 74.8 t60 -120.18 137.02 54.42 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -174.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -112.67 112.46 23.99 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 123.568 0.542 . . . . 0.0 109.752 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.65 -177.67 16.42 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 44.7 tp -76.63 155.67 33.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.007 0.432 . . . . 0.0 111.042 -177.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.1 ptm -159.73 146.58 16.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 175.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.448 ' O ' HG13 ' A' ' 108' ' ' ILE . 35.2 mmt180 -98.8 174.31 6.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.869 0.366 . . . . 0.0 111.827 -174.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.833 ' HG3' HG23 ' A' ' 51' ' ' VAL . 63.7 tttm -46.23 -54.27 9.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.898 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.51 ' HA ' ' CD ' ' A' ' 109' ' ' GLU . 26.9 t-20 -65.74 -28.46 69.06 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.141 0.496 . . . . 0.0 111.446 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.474 ' O ' HD11 ' A' ' 111' ' ' ILE . 9.7 m120 -67.22 -38.95 86.13 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.537 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 42.0 mt -64.58 -47.08 90.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.528 174.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.55 ' OE2' ' HG2' ' A' ' 105' ' ' LYS . 68.1 mt-10 -49.71 -54.75 17.0 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.446 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.523 ' O ' ' HB3' ' A' ' 113' ' ' ASN . 25.4 m -67.41 -31.3 71.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.052 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.474 HD11 ' O ' ' A' ' 107' ' ' ASN . 1.4 mp -71.58 -41.69 71.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.778 178.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.614 HD21 HD13 ' A' ' 30' ' ' ILE . 56.4 mt -62.74 -33.25 74.74 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.523 ' HB3' ' O ' ' A' ' 110' ' ' THR . 23.2 t-20 -57.8 -44.41 86.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.918 178.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.8 m -85.13 -23.03 28.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.271 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.46 HD21 ' O ' ' A' ' 89' ' ' LEU . 62.6 tp -67.78 -78.49 0.06 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.425 0.631 . . . . 0.0 109.807 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.929 ' HA3' ' HD2' ' A' ' 118' ' ' LYS . . . 172.32 -53.84 0.17 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.96 171.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.937 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 21.6 t 56.4 41.0 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 123.162 1.458 . . . . 0.0 107.545 -174.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.938 ' HG3' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -77.68 -139.01 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 112.801 -2.0 . . . . 0.0 111.907 -169.35 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.47 ' H ' ' HB2' ' A' ' 118' ' ' LYS . 2.8 tm-20 81.62 146.86 0.08 Allowed 'General case' 0 N--CA 1.47 0.545 0 O-C-N 124.142 0.901 . . . . 0.0 108.915 -175.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.96 -33.16 84.8 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.464 -0.398 . . . . 0.0 113.488 -171.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.528 ' O ' ' HE2' ' A' ' 58' ' ' LYS . 58.9 m-70 -78.26 82.06 4.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.219 0.533 . . . . 0.0 110.632 -177.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -138.08 -49.59 0.57 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.283 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -161.07 133.48 6.04 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -146.84 145.02 29.73 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.629 0.252 . . . . 0.0 110.342 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -121.71 -70.94 0.75 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 173.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 . . . . . 0 C--O 1.243 0.755 0 CA-C-O 118.442 -0.789 . . . . 0.0 109.789 178.293 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 mmt . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 m 67.79 98.69 0.05 Allowed 'General case' 0 N--CA 1.464 0.238 0 O-C-N 124.06 0.85 . . . . 0.0 110.526 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 pp -163.11 17.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.924 -175.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 2.0 mp0 -65.62 -20.84 66.47 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.908 0.385 . . . . 0.0 110.8 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.51 -53.26 4.72 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.399 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.3 pt -52.37 -26.31 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -174.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -135.58 19.96 3.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.266 0.555 . . . . 0.0 110.312 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -104.51 42.15 1.23 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.21 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 28.0 pt -78.36 16.64 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.553 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.5 m120 69.03 97.64 0.06 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.582 0.706 . . . . 0.0 111.091 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -70.74 93.38 0.94 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.242 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -167.26 -64.34 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.62 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 49' ' ' SER . 21.3 m -68.13 -38.69 82.48 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 13' ' ' SER . 97.2 mt 71.19 141.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -175.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 66.79 12.35 8.81 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.298 0.57 . . . . 0.0 110.148 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 p -81.94 135.66 24.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.82 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.71 HG11 ' HG2' ' A' ' 22' ' ' GLU . 92.7 t -134.58 143.71 37.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.123 -176.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.669 ' HG3' ' HB2' ' A' ' 19' ' ' ASN . 1.3 tp10 -69.3 -56.1 8.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.789 0.328 . . . . 0.0 111.199 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.792 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 2.9 t-20 -143.14 170.18 16.21 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.963 -167.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.49 -30.8 71.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.04 171.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.792 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 13.5 pt-20 -71.89 -13.85 61.77 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.335 0.588 . . . . 0.0 110.524 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.71 ' HG2' HG11 ' A' ' 17' ' ' VAL . 22.2 tt0 -110.62 0.65 17.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.703 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.74 162.26 20.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.121 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -154.6 148.93 26.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.649 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.407 ' OE1' ' NE2' ' A' ' 121' ' ' HIS . 3.2 tp10 81.94 164.95 0.14 Allowed 'General case' 0 C--N 1.333 -0.109 0 O-C-N 124.401 1.063 . . . . 0.0 112.295 167.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.99 56.89 4.34 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.812 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.2 pt -116.61 146.95 38.74 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.765 -0.218 . . . . 0.0 110.538 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.688 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 49.5 Cg_exo -57.71 135.56 70.06 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.838 2.359 . . . . 0.0 112.089 178.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.459 ' HA ' ' OD1' ' A' ' 60' ' ' ASN . 52.4 m -99.07 114.69 27.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.687 -177.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.549 HD13 ' HB2' ' A' ' 59' ' ' PHE . 2.0 mp -98.74 108.58 22.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.354 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.734 HG12 ' HB3' ' A' ' 62' ' ' TYR . 62.5 mt -103.56 136.81 34.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.302 -177.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.8 ptm -128.15 122.61 32.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.145 0.498 . . . . 0.0 110.279 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.767 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 96.1 m-85 -85.72 113.75 22.15 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.102 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -139.67 149.81 44.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.125 -177.297 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.452 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 9.1 p -85.14 177.46 7.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.715 -0.221 . . . . 0.0 110.5 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.429 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 15.4 t70 -60.92 -80.62 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.982 0.42 . . . . 0.0 110.759 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.5 m -82.19 98.37 8.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.005 0.431 . . . . 0.0 110.631 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.8 p -154.77 135.9 8.95 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.64 176.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.0 -26.81 30.82 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.135 1.89 . . . . 0.0 112.267 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.536 ' HB3' ' HG3' ' A' ' 84' ' ' PRO . 69.7 m-85 -58.58 -35.07 71.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.773 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.526 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 45.9 t -63.55 -53.04 58.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.186 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.485 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 43.5 t -60.89 -44.32 97.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.121 -177.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.878 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 15.0 tp10 -57.93 -50.69 72.49 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.725 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.48 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 8.1 tpt -68.02 -35.9 79.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.417 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.526 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 25.9 mt-30 -61.27 -39.39 90.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.319 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.878 ' HE3' ' HA ' ' A' ' 43' ' ' GLU . 10.1 mtmp? -56.14 -53.36 58.01 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.461 0.648 . . . . 0.0 109.39 175.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.561 ' HG3' ' HA ' ' A' ' 104' ' ' ARG . 24.7 mm-40 -62.36 -42.32 99.31 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.028 -176.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.706 HD12 HG23 ' A' ' 61' ' ' ILE . 96.4 mt -60.22 -43.33 96.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.469 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 13' ' ' SER . 45.4 t -58.2 -43.24 87.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.344 0.593 . . . . 0.0 110.078 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -65.54 -43.28 90.45 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.807 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.689 HG12 ' HG2' ' A' ' 109' ' ' GLU . 92.9 t -65.3 -48.33 83.74 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.047 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.8 m -60.9 -31.62 71.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.803 0.335 . . . . 0.0 111.312 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.884 ' HZ3' ' HB3' ' A' ' 53' ' ' LYS . 4.4 ttpm? -64.0 -24.69 67.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.152 0.501 . . . . 0.0 110.601 175.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -109.11 2.93 21.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.561 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.544 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 10.1 tpp180 -156.36 79.23 0.96 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -176.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.25 125.91 32.09 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -172.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 53.89 30.67 45.59 Favored Glycine 0 C--N 1.33 0.212 0 CA-C-N 115.903 -0.59 . . . . 0.0 113.666 174.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.544 ' HB2' ' HG3' ' A' ' 55' ' ' ARG . 61.4 mmtt -110.93 -6.19 14.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.516 0.674 . . . . 0.0 109.228 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.549 ' HB2' HD13 ' A' ' 30' ' ' ILE . 4.6 p90 -162.49 143.34 10.1 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.385 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.459 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 20.8 p-10 -111.03 136.34 50.19 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.056 0.455 . . . . 0.0 110.82 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.706 HG23 HD12 ' A' ' 48' ' ' LEU . 4.5 mp -96.96 109.5 23.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.536 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.734 ' HB3' HG12 ' A' ' 31' ' ' ILE . 1.1 t80 -89.72 115.32 27.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.247 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -80.21 104.34 10.69 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.732 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 33' ' ' PHE . . . -85.43 85.38 7.44 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.748 ' HB2' ' CD ' ' A' ' 67' ' ' GLU . 6.7 ptt180 -91.42 116.86 29.19 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.963 -170.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.409 ' HA ' HD21 ' A' ' 71' ' ' ASN . 4.1 mm? -72.04 5.82 2.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.625 -176.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.748 ' CD ' ' HB2' ' A' ' 65' ' ' ARG . 7.1 pm0 -84.58 -13.61 51.23 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.564 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 32.6 mt-10 -101.38 128.42 47.57 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.311 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -59.4 -37.39 77.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.06 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.564 ' HD2' ' HB3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -58.99 -24.59 62.86 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 122.084 0.945 . . . . 0.0 110.902 -179.132 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.496 ' N ' ' HD3' ' A' ' 70' ' ' LYS . 12.0 t30 -97.74 3.77 50.05 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.861 -172.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 73.3 mt -71.42 -51.02 36.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 169.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.33 -39.72 89.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.261 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.439 ' CB ' ' HA ' ' A' ' 71' ' ' ASN . 1.6 tm? -57.81 -42.57 84.56 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.913 176.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.767 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -51.68 -56.5 13.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.839 176.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -63.8 -32.54 74.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.504 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -62.31 -14.95 44.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.285 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.563 ' HB3' HG13 ' A' ' 87' ' ' VAL . 57.5 m-85 -127.78 21.54 6.42 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.472 ' CG ' ' HZ3' ' A' ' 95' ' ' LYS . 10.0 m-20 70.25 15.43 7.47 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.006 0.522 . . . . 0.0 111.634 172.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.23 130.05 41.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.038 0.447 . . . . 0.0 110.685 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -133.63 -40.22 0.88 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.167 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.48 HD11 ' HB3' ' A' ' 100' ' ' GLN . 36.9 pt -122.28 179.85 2.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.741 0.305 . . . . 0.0 110.5 177.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.7 m -128.51 139.27 35.05 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.704 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.536 ' HG3' ' HB3' ' A' ' 40' ' ' TYR . 79.3 Cg_endo -93.36 128.15 5.03 Favored 'Cis proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.275 -1.552 . . . . 0.0 112.796 -0.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.424 ' O ' ' HD1' ' A' ' 33' ' ' PHE . 64.6 m -108.31 114.62 28.63 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 174.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.426 ' CG2' ' HB3' ' A' ' 99' ' ' HIS . 5.1 t -108.63 122.36 46.94 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.42 0.628 . . . . 0.0 110.74 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.675 HG21 ' HB ' ' A' ' 31' ' ' ILE . 14.0 m -102.62 120.94 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.226 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.753 ' HB3' HD12 ' A' ' 115' ' ' LEU . 96.6 m-85 -99.09 112.73 24.79 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.586 -177.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.0 mt -104.17 137.32 42.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.527 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 23.8 t0 -71.58 179.13 3.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.51 ' HB2' ' HE3' ' A' ' 91' ' ' LYS . 14.8 ptmt -60.88 -13.8 18.08 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.53 -41.42 15.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.796 0.332 . . . . 0.0 110.515 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.2 -17.04 5.97 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.216 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -57.58 139.71 52.83 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.499 0.666 . . . . 0.0 111.771 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.472 ' HZ3' ' CG ' ' A' ' 79' ' ' ASP . 49.9 mtpt -77.46 90.14 3.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.443 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -78.04 -45.99 22.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -174.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.436 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 87.3 t80 -145.85 136.56 24.3 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.894 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.622 HG12 HG11 ' A' ' 87' ' ' VAL . 16.2 m -118.07 149.75 20.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 173.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.436 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 53.4 t60 -137.12 118.18 14.36 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.48 ' HB3' HD11 ' A' ' 82' ' ' ILE . 1.4 mp0 -101.32 106.43 17.6 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.875 0.734 . . . . 0.0 109.211 176.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 131.55 -176.03 19.36 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.968 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.536 HD22 ' HG2' ' A' ' 43' ' ' GLU . 34.8 tp -92.19 161.3 14.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.753 0.311 . . . . 0.0 111.051 -175.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -171.94 162.49 6.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.561 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 1.8 mpt_? -102.13 177.61 4.84 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -174.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.461 ' HA ' HD11 ' A' ' 108' ' ' ILE . 13.7 ptmm? -49.73 -43.36 47.74 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -171.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -67.05 -32.49 73.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.108 0.48 . . . . 0.0 110.374 -175.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.584 ' O ' HG12 ' A' ' 111' ' ' ILE . 15.8 m120 -67.67 -48.1 67.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.612 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.461 HD11 ' HA ' ' A' ' 105' ' ' LYS . 26.6 mt -58.6 -50.84 77.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.078 177.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.689 ' HG2' HG12 ' A' ' 51' ' ' VAL . 1.2 tm-20 -55.6 -48.93 74.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.318 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.2 m -59.81 -33.43 71.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.978 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.656 ' O ' ' HG ' ' A' ' 115' ' ' LEU . 48.9 mm -69.4 -41.05 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.723 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 8.8 mt -60.21 -45.17 94.1 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -61.16 -26.95 68.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.063 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.6 t -83.82 -25.3 30.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.753 HD12 ' HB3' ' A' ' 88' ' ' PHE . 57.2 mt -72.34 -60.7 2.1 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.746 0.784 . . . . 0.0 109.739 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.405 ' HA3' ' HZ1' ' A' ' 118' ' ' LYS . . . 158.98 -50.48 0.4 Allowed Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.15 177.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.688 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 40.0 t 53.29 42.45 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 122.808 1.289 . . . . 0.0 109.105 -177.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.494 ' O ' ' HD2' ' A' ' 91' ' ' LYS . 35.0 mtmm -85.88 75.26 10.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.887 -174.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -50.69 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.809 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.0 29.05 35.44 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.776 174.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.407 ' NE2' ' OE1' ' A' ' 25' ' ' GLU . 36.0 m-70 -111.6 -34.64 6.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.39 0.595 . . . . 0.0 111.518 176.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -72.38 74.87 1.02 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.748 0.785 . . . . 0.0 111.62 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -165.54 114.7 1.02 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.796 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -116.14 151.24 36.04 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -171.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -105.01 -6.55 19.93 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 164.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 . . . . . 0 C--O 1.246 0.894 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.546 179.306 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.839 0.352 . . . . 0.0 110.4 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.3 t -153.77 103.69 2.63 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.425 HD22 ' HA ' ' A' ' 3' ' ' LEU . 0.8 OUTLIER 65.05 87.33 0.12 Allowed 'General case' 0 CA--C 1.531 0.245 0 O-C-N 123.737 0.648 . . . . 0.0 109.619 -175.372 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 8' ' ' GLN . 4.5 mp0 -82.76 -25.47 32.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.699 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.31 -54.25 3.94 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.165 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.1 pt -138.37 -32.36 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.789 0.328 . . . . 0.0 111.597 -175.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -85.77 41.78 0.93 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.022 0.439 . . . . 0.0 111.673 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.558 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . 31.8 tt0 -119.1 15.45 13.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.829 0.823 . . . . 0.0 108.846 177.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.1 tp -101.1 95.1 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.809 -172.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -129.17 -3.05 5.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.608 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.501 ' O ' ' HB2' ' A' ' 12' ' ' GLN . 43.7 p90 -142.31 133.34 25.92 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.115 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' A' ' 11' ' ' PHE . 5.4 tp-100 168.63 -61.69 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.557 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 35.3 t -106.73 7.1 30.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.268 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 69.4 mt 70.96 -69.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.992 175.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.81 HD21 ' HB3' ' A' ' 52' ' ' SER . 54.0 m-80 -83.17 31.91 0.44 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.912 0.387 . . . . 0.0 110.426 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 13' ' ' SER . 8.7 p -97.23 148.66 5.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.283 -173.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.478 HG23 ' HB2' ' A' ' 23' ' ' ALA . 8.8 p -133.3 145.9 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.011 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -66.72 -45.1 79.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.407 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.619 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 16.1 t-20 -160.25 168.83 24.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.242 -175.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.9 mt -62.05 -29.41 70.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.84 0.352 . . . . 0.0 110.439 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -59.78 -32.22 70.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.542 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -97.21 -0.96 45.92 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.546 -177.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.478 ' HB2' HG23 ' A' ' 17' ' ' VAL . . . -107.62 171.64 7.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.371 0.605 . . . . 0.0 112.47 -170.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.639 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -129.84 155.82 45.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.897 177.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -103.54 177.24 4.9 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.772 0.32 . . . . 0.0 110.92 -176.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.578 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . 108.81 -35.53 4.9 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.723 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -105.73 152.93 40.25 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 177.009 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.76 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 63.8 Cg_exo -53.28 135.04 59.2 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.827 2.351 . . . . 0.0 112.194 177.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.8 m -106.0 112.92 26.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.425 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.431 HD13 ' HB2' ' A' ' 59' ' ' PHE . 1.7 mp -97.91 109.32 23.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.44 ' HB ' ' HB ' ' A' ' 87' ' ' VAL . 59.3 mt -103.67 126.23 58.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.598 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.434 ' O ' ' HG3' ' A' ' 32' ' ' MET . 24.3 ptm -118.81 116.97 27.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.66 0.743 . . . . 0.0 110.153 173.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 87.5 m-85 -81.5 119.05 23.25 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.346 174.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HE3' ' HB3' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -139.56 145.15 38.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.968 0.413 . . . . 0.0 111.259 -177.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.551 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 5.3 m -91.52 157.04 17.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.668 175.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.73 ' HB2' ' HG2' ' A' ' 67' ' ' GLU . 12.6 t70 -61.58 -66.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 111.841 -178.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.1 m -82.01 54.32 2.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.616 0.722 . . . . 0.0 111.407 -172.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.551 ' SG ' ' HB ' ' A' ' 35' ' ' THR . 37.4 m -145.24 113.67 4.83 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.514 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.52 -3.46 11.9 Favored 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 122.363 2.042 . . . . 0.0 113.37 -176.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -68.99 -17.33 63.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.667 0.27 . . . . 0.0 110.892 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 26.4 p -74.27 -55.36 6.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.482 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.569 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 12.4 p -60.64 -35.58 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.149 -175.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.539 ' HG2' HD21 ' A' ' 102' ' ' LEU . 24.0 tp10 -57.86 -51.09 71.02 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.055 0.455 . . . . 0.0 110.803 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.48 ' HE2' ' HB2' ' A' ' 103' ' ' MET . 24.0 ttt -74.5 -29.29 61.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.303 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 28.8 mt-30 -63.86 -33.9 76.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.76 176.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.569 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 2.9 mtmm -60.22 -51.9 67.61 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.564 ' HG3' ' HA ' ' A' ' 104' ' ' ARG . 33.2 mm-40 -55.7 -46.4 77.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.804 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.43 HD12 HG22 ' A' ' 61' ' ' ILE . 89.7 mt -59.7 -39.22 83.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.003 178.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.0 t -65.58 -45.22 84.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.088 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.431 ' CB ' ' HD2' ' A' ' 105' ' ' LYS . 20.8 m-85 -58.82 -39.82 82.34 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.653 178.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 47' ' ' GLU . 84.9 t -66.97 -53.29 35.4 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.597 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.81 ' HB3' HD21 ' A' ' 15' ' ' ASN . 21.5 m -59.53 -30.85 68.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.927 0.394 . . . . 0.0 111.473 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.822 ' HZ1' ' HB3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -55.85 -29.45 59.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.896 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -113.53 -34.24 5.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.883 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.658 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 2.5 tpp180 -89.7 75.03 7.46 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 2.2 mm-40 -82.49 128.39 34.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.173 -174.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.96 42.9 82.03 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.987 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.658 ' HB2' ' HG3' ' A' ' 55' ' ' ARG . 38.7 mmtm -126.87 -12.89 5.89 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.751 -0.264 . . . . 0.0 110.895 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.431 ' HB2' HD13 ' A' ' 30' ' ' ILE . 1.2 p90 -160.43 149.86 17.47 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -112.83 129.88 56.29 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.43 HG22 HD12 ' A' ' 48' ' ' LEU . 4.7 mp -97.71 110.97 26.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.947 0.403 . . . . 0.0 110.587 -178.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.619 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 12.5 t80 -96.91 116.06 28.52 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.018 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.564 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 15.0 m-30 -77.91 103.77 8.05 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.005 176.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 33' ' ' PHE . . . -85.13 74.34 10.49 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.61 ' C ' ' H ' ' A' ' 67' ' ' GLU . 23.9 ptt180 -84.03 125.89 32.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.294 -174.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.14 12.25 0.09 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.323 0.582 . . . . 0.0 111.3 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.73 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 25.8 mt-10 -82.33 -26.08 33.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.35 -177.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.492 ' CB ' ' HD2' ' A' ' 70' ' ' LYS . 44.6 mt-10 -118.08 147.31 43.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.654 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -69.19 -18.21 63.89 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -175.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.605 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.6 OUTLIER -62.64 -32.26 73.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.576 0.703 . . . . 0.0 110.034 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.605 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 5.6 m120 -83.58 -9.65 58.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.323 -174.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.0 mm -71.49 -42.6 72.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.16 -45.46 88.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.489 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 71' ' ' ASN . 4.4 mm? -58.11 -39.25 78.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.171 175.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.607 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -55.71 -57.23 12.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.485 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -66.17 -33.69 76.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.022 0.439 . . . . 0.0 110.601 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.441 ' HE3' ' HB2' ' A' ' 77' ' ' LYS . 19.2 ttmt -66.96 -17.44 64.92 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.261 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -122.16 11.4 10.16 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 70.59 24.82 4.32 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.595 0.559 . . . . 0.0 111.272 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.17 101.63 11.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.517 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -94.62 -43.17 8.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.888 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.7 pt -133.46 152.54 35.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.813 0.34 . . . . 0.0 110.682 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.538 ' HB ' ' HA ' ' A' ' 84' ' ' PRO . 23.6 m -101.8 158.88 30.93 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.905 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.538 ' HA ' ' HB ' ' A' ' 83' ' ' VAL . 2.3 Cg_endo -83.01 125.41 10.33 Favored 'Cis proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.755 -1.352 . . . . 0.0 112.101 -0.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.516 ' HB ' ' CD1' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -97.4 112.55 24.33 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.4 m -101.44 111.7 24.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.276 0.56 . . . . 0.0 110.459 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.44 ' HB ' ' HB ' ' A' ' 31' ' ' ILE . 99.5 t -108.19 110.21 31.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.259 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.417 ' CD2' ' HD2' ' A' ' 97' ' ' TYR . 97.4 m-85 -91.79 105.68 17.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.082 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.4 mt -95.62 136.05 36.51 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.432 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.513 ' HB3' HD22 ' A' ' 94' ' ' ASN . 25.7 t70 -72.61 177.37 4.76 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 172.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.674 ' HZ3' ' HB2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -53.58 -27.58 27.34 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -175.361 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.483 ' HG2' ' HG3' ' A' ' 91' ' ' LYS . 4.0 mm-40 -90.93 4.04 53.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.792 0.329 . . . . 0.0 111.166 -175.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.85 14.22 79.98 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.676 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.513 HD22 ' HB3' ' A' ' 90' ' ' ASP . 9.8 p30 -81.63 141.89 33.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.765 0.316 . . . . 0.0 110.507 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -79.31 82.01 5.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.839 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -78.52 -42.59 29.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.878 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.417 ' HD2' ' CD2' ' A' ' 88' ' ' PHE . 69.0 t80 -141.63 113.56 7.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.133 0.492 . . . . 0.0 111.18 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.97 128.74 65.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -137.85 143.18 40.81 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.496 ' HG2' HG22 ' A' ' 85' ' ' THR . 27.1 mt-30 -119.98 124.21 45.37 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.683 0.278 . . . . 0.0 110.447 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 142.75 -167.45 26.25 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.808 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.539 HD21 ' HG2' ' A' ' 43' ' ' GLU . 59.9 tp -106.09 121.6 44.47 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.493 ' HE2' HG13 ' A' ' 111' ' ' ILE . 74.0 mtp -116.06 159.72 21.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.553 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.564 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 3.3 mpt_? -111.09 170.49 8.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.703 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.431 ' HD2' ' CB ' ' A' ' 50' ' ' TYR . 23.5 tttp -46.91 -53.79 11.43 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -176.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -56.86 -39.2 73.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.008 0.432 . . . . 0.0 111.309 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.515 ' O ' HG12 ' A' ' 111' ' ' ILE . 9.2 m120 -70.6 -44.89 66.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.844 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.567 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 62.3 mt -60.26 -48.72 87.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.91 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.493 ' CD ' HH21 ' A' ' 55' ' ' ARG . 5.5 mm-40 -54.5 -47.99 72.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.594 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.437 ' O ' ' HB2' ' A' ' 113' ' ' ASN . 24.0 m -64.59 -38.33 90.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.742 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 107' ' ' ASN . 35.4 mm -65.17 -40.98 90.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.765 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 59.8 mt -62.31 -34.79 77.3 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.844 0.354 . . . . 0.0 110.136 177.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 110' ' ' THR . 9.6 m120 -58.87 -45.24 90.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.853 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.8 m -86.49 -16.99 35.32 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.5 tp -70.7 -71.38 0.25 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.35 0.595 . . . . 0.0 110.381 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -178.39 -73.54 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.554 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.76 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 52.0 t 51.71 73.87 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 122.195 0.998 . . . . 0.0 109.82 -175.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -158.97 167.23 29.9 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.686 -172.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 0.3 OUTLIER -141.43 88.39 2.14 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 173.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.64 ' N ' ' HE2' ' A' ' 91' ' ' LYS . . . -66.14 100.72 0.54 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 168.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -53.81 105.95 0.16 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -167.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -74.41 -169.43 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.247 172.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -68.0 85.93 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.589 0.709 . . . . 0.0 111.349 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -114.41 15.98 17.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.122 174.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -100.95 144.54 29.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.427 -175.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 70.8 m80 . . . . . 0 C--O 1.243 0.762 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 171.517 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.0 m -68.03 105.24 1.97 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.971 0.415 . . . . 0.0 110.59 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.64 -13.54 20.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.273 0.558 . . . . 0.0 110.604 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.712 ' HG3' ' H ' ' A' ' 5' ' ' GLY . 5.6 pt-20 -106.46 -74.53 0.65 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.758 -174.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.712 ' H ' ' HG3' ' A' ' 4' ' ' GLU . . . 75.64 -52.79 2.79 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.264 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.699 HG13 ' HG3' ' A' ' 7' ' ' LYS . 29.0 pt -122.33 -162.99 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.699 ' HG3' HG13 ' A' ' 6' ' ' ILE . 85.3 mttt 72.53 -69.96 0.17 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.027 0.531 . . . . 0.0 111.014 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -79.8 -34.52 39.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.892 0.854 . . . . 0.0 110.275 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.659 HG22 HG22 ' A' ' 16' ' ' VAL . 26.7 mt -88.55 100.61 10.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.314 174.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 179.64 -37.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -176.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -141.68 -158.58 0.88 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.031 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 75.3 -50.99 0.65 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.569 0.747 . . . . 0.0 111.739 176.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.595 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 72.9 m -107.55 -5.01 17.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.462 0.173 . . . . 0.0 111.263 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 69.9 mt 69.42 -74.23 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.15 0.58 . . . . 0.0 111.694 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -86.81 29.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.83 0.348 . . . . 0.0 110.929 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.659 HG22 HG22 ' A' ' 9' ' ' ILE . 3.0 p -72.94 129.02 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.504 -176.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.615 HG11 ' HB3' ' A' ' 22' ' ' GLU . 73.0 t -127.41 134.04 66.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.596 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.505 ' OE1' ' HA2' ' A' ' 5' ' ' GLY . 11.9 tp10 -66.38 -55.2 16.99 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.789 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.558 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 47.2 t30 -153.22 179.58 8.61 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -177.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.33 -31.02 68.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.766 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -59.89 -35.82 75.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.987 0.422 . . . . 0.0 110.465 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.615 ' HB3' HG11 ' A' ' 17' ' ' VAL . 3.7 mm-40 -82.91 -8.03 59.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.413 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.35 107.86 15.34 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 172.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.533 ' HE2' ' O ' ' A' ' 22' ' ' GLU . 17.6 mtmt -131.19 174.03 10.44 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.991 -171.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.534 ' OE1' ' HA ' ' A' ' 121' ' ' HIS . 7.4 tp10 66.59 167.61 0.22 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.301 1.0 . . . . 0.0 110.207 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 120' ' ' GLY . . . -81.93 50.95 4.37 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.667 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.41 HG13 ' ND2' ' A' ' 60' ' ' ASN . 18.2 pt -116.45 149.39 43.64 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.727 0.299 . . . . 0.0 110.491 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.736 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 40.8 Cg_exo -60.59 168.92 6.06 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 123.217 2.611 . . . . 0.0 112.655 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.455 ' HB ' HD12 ' A' ' 89' ' ' LEU . 34.9 m -135.89 125.01 24.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.525 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.434 HD13 ' CD2' ' A' ' 59' ' ' PHE . 2.4 mp -105.63 115.04 46.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.816 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.54 ' HB ' ' HB ' ' A' ' 87' ' ' VAL . 67.6 mt -100.46 139.38 22.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.78 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.515 ' HE2' ' HA ' ' A' ' 41' ' ' CYS . 2.1 tmt? -134.48 113.34 11.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.183 0.516 . . . . 0.0 109.887 171.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.513 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 91.6 m-85 -76.93 135.29 38.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.529 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.441 ' HG3' ' SG ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -142.28 153.86 44.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.289 -178.303 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -72.57 164.98 25.58 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 67' ' ' GLU . 6.6 p-10 -58.58 -45.22 89.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.681 0.276 . . . . 0.0 110.968 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -130.92 96.9 4.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.977 0.418 . . . . 0.0 111.275 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 41' ' ' CYS . 11.7 p -150.97 140.7 14.01 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.729 177.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 11.6 Cg_exo -69.94 -29.99 22.15 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.533 2.155 . . . . 0.0 112.273 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.554 ' HB3' ' HG3' ' A' ' 84' ' ' PRO . 90.2 m-85 -60.91 -26.98 67.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.095 0.474 . . . . 0.0 110.561 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.532 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . 21.5 t -60.03 -54.42 46.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.869 177.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.409 ' HA ' ' HG2' ' A' ' 45' ' ' GLN . 8.0 p -73.2 -38.13 53.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.432 -172.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.515 ' HG2' HD21 ' A' ' 102' ' ' LEU . 5.2 tp10 -61.6 -50.64 71.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.071 0.462 . . . . 0.0 110.875 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.505 ' SD ' ' HG3' ' A' ' 32' ' ' MET . 24.1 ttt -69.21 -37.25 77.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.053 0.454 . . . . 0.0 111.216 -175.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.439 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 12.9 pt20 -74.12 -31.49 62.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.354 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.898 ' HE2' ' HA ' ' A' ' 46' ' ' LYS . 8.5 mmpt? -74.26 -29.81 61.85 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.535 176.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.535 ' O ' HG21 ' A' ' 51' ' ' VAL . 13.4 mm-40 -62.03 -44.74 96.06 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 169.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 45' ' ' GLN . 98.1 mt -57.37 -36.99 71.92 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.313 173.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.9 t -66.19 -37.96 86.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.425 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.532 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 13.2 m-30 -65.05 -39.22 93.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.876 0.37 . . . . 0.0 110.177 175.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.556 HG23 ' HG3' ' A' ' 105' ' ' LYS . 44.1 t -65.11 -36.33 77.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.106 176.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.3 m -63.67 -31.8 73.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.824 178.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -66.84 -27.06 67.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.321 0.581 . . . . 0.0 110.738 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -100.77 2.58 41.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.584 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.523 ' HE ' HG11 ' A' ' 117' ' ' VAL . 21.1 tpt180 -161.23 76.63 0.54 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.427 0.632 . . . . 0.0 109.437 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -82.61 125.1 30.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.866 -172.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.4 42.63 99.01 Favored Glycine 0 C--O 1.226 -0.346 0 CA-C-N 115.782 -0.644 . . . . 0.0 113.418 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -125.31 0.56 7.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.902 0.351 . . . . 0.0 110.959 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.434 ' CD2' HD13 ' A' ' 30' ' ' ILE . 52.4 p90 -165.89 140.11 4.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.024 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.548 ' HB3' HG23 ' A' ' 17' ' ' VAL . 46.5 m-80 -82.66 131.22 35.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.375 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.7 mt -101.9 108.11 23.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 175.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.558 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 18.0 t80 -93.49 118.91 31.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.88 0.371 . . . . 0.0 110.067 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 45' ' ' GLN . 11.8 m-85 -87.4 104.05 16.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.258 0.552 . . . . 0.0 110.707 178.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 33' ' ' PHE . . . -96.57 81.54 3.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.531 -175.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.545 HH22 ' CD ' ' A' ' 4' ' ' GLU . 19.7 ptt180 -95.28 130.48 42.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.814 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.2 tp -70.18 7.48 0.98 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.577 0.703 . . . . 0.0 110.546 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.534 ' H ' ' C ' ' A' ' 65' ' ' ARG . 34.6 tt0 -83.03 -17.52 43.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.456 -175.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.423 ' HG3' ' HG3' ' A' ' 65' ' ' ARG . 36.1 mt-10 -103.79 -0.51 29.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -170.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.474 ' HA ' HG12 ' A' ' 72' ' ' ILE . 1.2 mp0 69.23 -36.62 0.34 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.557 0.535 . . . . 0.0 112.202 -177.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.472 ' HD2' ' ND2' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -61.05 -25.04 66.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.323 0.582 . . . . 0.0 110.729 175.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.563 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 44.5 m-80 -86.69 -0.86 57.09 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.816 178.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.474 HG12 ' HA ' ' A' ' 69' ' ' GLU . 45.2 mm -66.66 -45.18 88.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -72.21 -49.57 34.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.425 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' A' ' 71' ' ' ASN . 3.8 mm? -57.18 -38.44 73.62 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.737 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.487 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -63.7 -48.4 77.27 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.055 177.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -62.42 -37.49 86.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.128 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -53.27 -35.85 60.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.481 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -113.35 13.27 19.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.842 -176.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.9 t70 63.35 29.32 15.7 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.693 0.759 . . . . 0.0 110.749 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . -87.77 104.2 16.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.362 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -127.98 -11.22 5.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.49 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.6 mt -114.95 133.4 61.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.061 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.1 m -114.05 145.81 34.36 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.681 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.554 ' HG3' ' HB3' ' A' ' 40' ' ' TYR . 6.0 Cg_endo -85.68 157.71 59.69 Favored 'Cis proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.43 -1.487 . . . . 0.0 111.811 -0.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.6 t -153.56 137.86 16.62 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.5 t -124.83 140.74 52.65 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.425 0.631 . . . . 0.0 110.88 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.54 ' HB ' ' HB ' ' A' ' 31' ' ' ILE . 72.4 t -115.87 110.43 31.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.413 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.527 ' HB3' HD23 ' A' ' 115' ' ' LEU . 97.3 m-85 -89.84 108.34 19.64 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.526 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.52 HD22 ' HA ' ' A' ' 95' ' ' LYS . 67.3 mt -97.47 130.44 44.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.815 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.84 169.62 16.4 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.873 ' HG2' ' HG3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -61.93 -23.88 66.63 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.59 ' HB3' HD21 ' A' ' 94' ' ' ASN . 1.1 tp10 -76.53 -5.82 49.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.113 0.482 . . . . 0.0 110.022 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.65 22.46 50.22 Favored Glycine 0 N--CA 1.453 -0.185 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.599 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.59 HD21 ' HB3' ' A' ' 92' ' ' GLU . 9.0 p30 -107.24 148.64 28.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.52 ' HA ' HD22 ' A' ' 89' ' ' LEU . 4.6 ttpm? -77.19 117.81 19.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -97.37 -50.08 4.68 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.105 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 84.7 t80 -148.87 136.24 20.24 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.606 -175.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.474 HG13 HG23 ' A' ' 87' ' ' VAL . 27.5 m -113.94 148.29 16.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.76 172.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.466 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 36.6 t60 -142.83 141.24 31.57 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -111.16 121.76 46.14 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 145.76 170.78 14.78 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.981 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.515 HD21 ' HG2' ' A' ' 43' ' ' GLU . 43.8 tp -82.09 -61.56 1.87 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.465 0.65 . . . . 0.0 111.224 -177.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.518 ' O ' ' HD2' ' A' ' 104' ' ' ARG . 57.5 mtm 64.18 175.73 0.18 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.176 -1.374 . . . . 0.0 111.091 -175.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.518 ' HD2' ' O ' ' A' ' 103' ' ' MET . 10.7 mmm180 -122.61 178.15 5.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.921 173.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.556 ' HG3' HG23 ' A' ' 51' ' ' VAL . 47.1 tttm -45.53 -59.19 2.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -177.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -66.75 -28.85 68.74 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.399 -173.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -64.0 -47.99 78.15 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.614 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 61.5 mt -59.25 -47.5 90.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.796 174.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -50.57 -48.25 57.61 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.766 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 m -61.93 -41.76 98.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.867 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 63.1 mt -67.83 -37.67 78.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.204 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 87.2 mt -63.19 -35.45 80.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.374 . . . . 0.0 110.433 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.76 -39.8 90.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.674 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.6 m -79.46 -28.19 41.59 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.333 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.527 HD23 ' HB3' ' A' ' 88' ' ' PHE . 45.6 tp -66.25 -70.34 0.25 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.712 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 171.52 -73.54 0.1 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.605 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.736 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 11.6 t 55.61 36.52 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 122.677 1.227 . . . . 0.0 109.399 -176.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.873 ' HG3' ' HG2' ' A' ' 91' ' ' LYS . 8.2 ptmt -101.56 128.0 48.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.527 -1.669 . . . . 0.0 110.02 -177.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -92.81 110.4 21.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.863 -175.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.571 ' O ' ' HA3' ' A' ' 26' ' ' GLY . . . -117.82 93.02 0.56 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.618 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.534 ' HA ' ' OE1' ' A' ' 25' ' ' GLU . 97.6 m-70 -59.96 124.7 21.02 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.04 0.448 . . . . 0.0 110.953 -177.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -82.7 81.11 8.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.938 -173.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 13.2 p80 178.66 170.58 0.83 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.204 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.438 ' HB2' ' H ' ' A' ' 126' ' ' HIS . 6.6 m80 -99.42 -151.59 0.39 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -64.2 -22.6 67.0 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 163.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.438 ' H ' ' HB2' ' A' ' 124' ' ' HIS . 48.9 t-80 . . . . . 0 C--O 1.243 0.755 0 CA-C-N 113.77 -1.559 . . . . 0.0 107.732 168.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.454 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 23.1 mmt . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.502 ' OG ' ' HB3' ' A' ' 22' ' ' GLU . 75.5 m -72.41 78.43 1.03 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.671 0.748 . . . . 0.0 112.733 -173.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -113.36 99.48 7.81 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 166.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.435 ' HB2' ' HG2' ' A' ' 8' ' ' GLN . 15.2 pt-20 -65.54 -38.18 88.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.323 -168.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.82 -60.19 4.41 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.018 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.9 tp -106.97 146.61 13.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.432 ' HA ' ' OE1' ' A' ' 4' ' ' GLU . 12.8 tptp -68.22 99.87 0.96 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.995 0.426 . . . . 0.0 110.751 -176.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.435 ' HG2' ' HB2' ' A' ' 4' ' ' GLU . 17.9 pt20 -124.51 -4.35 7.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.554 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.422 HG12 ' OE1' ' A' ' 4' ' ' GLU . 25.1 pt -113.58 149.76 15.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.858 173.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -106.05 -172.66 2.13 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.064 0.459 . . . . 0.0 111.626 -172.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.501 ' O ' ' HB3' ' A' ' 12' ' ' GLN . 32.1 p90 -88.41 -165.63 1.38 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.393 173.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.501 ' HB3' ' O ' ' A' ' 11' ' ' PHE . 30.6 tt0 72.94 -63.73 0.42 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -175.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.458 ' HB3' HG21 ' A' ' 16' ' ' VAL . 34.4 m -80.44 90.68 5.65 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.421 173.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.0 mt -93.22 -65.3 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.215 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 14.2 m-80 -81.08 59.21 3.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.02 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.694 ' HB ' ' HE2' ' A' ' 63' ' ' TYR . 16.6 m -131.98 151.4 35.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.085 0.469 . . . . 0.0 111.774 -173.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.461 HG13 ' HB2' ' A' ' 23' ' ' ALA . 4.2 p -146.31 164.24 9.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.114 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -90.94 -54.26 4.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.985 0.422 . . . . 0.0 110.999 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.769 ' HA ' ' CE2' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -130.67 162.89 28.41 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.683 -170.384 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.661 HD22 ' CE2' ' A' ' 62' ' ' TYR . 2.0 mm? -65.36 -35.17 80.15 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.579 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 1.7 pm0 -67.09 -23.52 65.86 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.346 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.502 ' HB3' ' OG ' ' A' ' 2' ' ' SER . 21.7 mm-40 -87.51 -8.65 56.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.561 172.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.461 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -121.29 172.51 7.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.562 0.696 . . . . 0.0 112.133 -170.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.751 ' NZ ' ' HA ' ' A' ' 24' ' ' LYS . 2.3 tpmp? -140.21 160.39 40.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.522 176.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -87.87 179.3 6.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.985 0.422 . . . . 0.0 110.936 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.69 -29.94 10.17 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -174.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.579 HD12 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -117.95 134.18 23.32 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 172.657 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 1.072 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 75.2 Cg_exo -52.54 136.77 57.62 Favored 'Trans proline' 0 CA--C 1.517 -0.356 0 C-N-CA 123.092 2.528 . . . . 0.0 112.424 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.545 ' HB ' HD13 ' A' ' 89' ' ' LEU . 23.6 m -108.69 119.76 40.47 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.207 0.527 . . . . 0.0 111.199 -174.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.418 HD11 ' N ' ' A' ' 30' ' ' ILE . 4.1 mp -99.32 107.17 20.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.779 HG12 ' HB3' ' A' ' 62' ' ' TYR . 50.0 mt -95.74 111.91 27.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 120.731 0.301 . . . . 0.0 110.75 -177.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 25.2 ptm -118.42 136.65 53.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.157 0.503 . . . . 0.0 109.828 175.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.56 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 37.3 m-85 -91.18 132.3 36.17 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.502 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.609 ' HE2' ' HB3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -130.9 139.53 50.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.158 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.0 m -78.09 161.38 27.45 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.49 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 15.1 t70 -68.54 103.33 1.66 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.2 m 73.51 89.44 0.09 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.92 -175.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.9 p -148.06 127.16 6.28 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.567 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.22 -33.66 5.54 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.285 1.99 . . . . 0.0 114.084 -173.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -67.47 -25.17 65.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.806 0.336 . . . . 0.0 111.165 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.565 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 97.6 m -80.06 -35.98 36.27 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.053 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 65.0 t -64.8 -34.85 72.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.82 176.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -57.01 -45.97 82.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.281 175.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.6 ttt -69.11 -31.19 69.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.737 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.565 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 20.5 mt-30 -59.84 -40.12 87.42 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 110.117 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -56.16 -53.36 57.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.608 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.597 ' O ' HG21 ' A' ' 51' ' ' VAL . 57.2 mm-40 -56.99 -47.23 81.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.77 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.702 HD11 HD13 ' A' ' 61' ' ' ILE . 91.3 mt -58.62 -36.9 74.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.472 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.4 t -66.59 -37.58 85.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.99 0.424 . . . . 0.0 110.13 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.417 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 30.5 m-85 -70.34 -36.44 74.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.517 177.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.597 HG21 ' O ' ' A' ' 47' ' ' GLU . 22.4 t -67.95 -31.82 53.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 175.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.5 m -62.97 -32.92 74.35 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.025 174.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.471 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 27.2 mmtm -73.35 -15.79 61.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.138 0.494 . . . . 0.0 110.725 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -87.51 -40.08 14.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.687 173.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.666 ' HG3' ' HG3' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -133.09 75.39 1.62 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.617 -175.236 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 5.8 tp10 -82.44 134.46 35.23 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 120.905 0.383 . . . . 0.0 111.356 -171.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.57 41.22 95.44 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.255 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.666 ' HG3' ' HG3' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -123.08 -9.1 8.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.776 0.322 . . . . 0.0 110.856 -174.093 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.536 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 10.2 p90 -156.68 -176.84 6.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.6 -177.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 29' ' ' THR . 57.2 t30 -144.83 132.99 21.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.896 178.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.702 HD13 HD11 ' A' ' 48' ' ' LEU . 71.6 mt -105.38 114.24 44.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.565 -176.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.779 ' HB3' HG12 ' A' ' 31' ' ' ILE . 4.5 t80 -84.18 115.82 22.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.694 ' HE2' ' HB ' ' A' ' 16' ' ' VAL . 76.1 m-85 -93.38 110.82 22.36 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.054 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.456 ' HB2' ' HE1' ' A' ' 62' ' ' TYR . . . -86.39 102.72 14.29 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 121.255 -0.178 . . . . 0.0 110.793 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.609 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 8.7 ptm180 -78.01 114.48 16.92 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.876 176.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.4 tp -67.92 10.95 0.17 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.061 0.458 . . . . 0.0 110.836 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.568 ' H ' ' C ' ' A' ' 65' ' ' ARG . 3.8 tp10 -84.34 -42.35 15.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.19 0.519 . . . . 0.0 110.424 -175.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.567 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 30.5 mm-40 -93.54 173.58 7.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.08 -172.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.22 -31.88 21.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.856 -176.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.513 ' HD2' ' H ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -60.15 -33.15 71.78 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.241 0.543 . . . . 0.0 110.371 178.521 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.567 ' OD1' ' HB2' ' A' ' 68' ' ' GLU . 5.0 m120 -80.19 -17.35 52.63 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.416 -178.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 68' ' ' GLU . 75.1 mt -70.88 -42.76 77.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -59.86 -48.95 79.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.626 173.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.424 ' HG ' ' OH ' ' A' ' 62' ' ' TYR . 1.2 tm? -55.77 -47.34 77.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.315 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.56 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -53.9 -52.15 61.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.854 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -73.27 -34.84 66.01 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.527 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.446 ' HB2' ' HE3' ' A' ' 77' ' ' LYS . 27.1 ttmt -63.49 -32.86 74.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.241 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -102.73 -0.53 31.47 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.669 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.1 t70 67.64 40.65 2.47 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.704 0.764 . . . . 0.0 111.095 174.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.48 102.84 4.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.946 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -107.26 -31.95 8.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.351 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.734 ' H ' HD12 ' A' ' 82' ' ' ILE . 0.2 OUTLIER -85.05 159.06 3.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.798 0.332 . . . . 0.0 110.947 -178.65 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.1 m -119.42 145.27 38.37 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.719 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -95.25 118.25 2.03 Favored 'Cis proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.637 -1.401 . . . . 0.0 112.517 -1.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.623 HG22 ' HB3' ' A' ' 100' ' ' GLN . 1.2 p -97.9 143.46 28.47 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 173.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.1 m -135.49 121.05 19.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.179 0.514 . . . . 0.0 111.151 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.678 HG13 HG12 ' A' ' 98' ' ' VAL . 20.3 m -112.6 126.65 70.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.003 176.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.527 ' HB3' HD22 ' A' ' 115' ' ' LEU . 94.8 m-85 -98.48 118.61 35.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.829 -174.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.545 HD13 ' HB ' ' A' ' 29' ' ' THR . 10.4 mt -107.57 139.61 41.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.037 -177.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.42 ' OD2' ' HG2' ' A' ' 92' ' ' GLU . 25.0 t70 -63.51 171.48 2.53 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 171.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.573 ' HG3' ' HG2' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -62.36 -16.45 54.64 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 122.015 -0.428 . . . . 0.0 111.84 -176.261 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.42 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 16.9 mm-40 -72.94 -23.69 60.71 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.954 0.407 . . . . 0.0 110.753 175.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.74 17.53 35.41 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -170.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.431 ' N ' HD21 ' A' ' 94' ' ' ASN . 0.9 OUTLIER -90.15 126.24 35.73 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -179.575 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -72.34 112.87 8.79 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.174 0.296 . . . . 0.0 110.511 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -100.67 -54.58 2.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.746 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.566 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 87.6 t80 -124.84 141.84 51.85 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.195 -175.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.678 HG12 HG13 ' A' ' 87' ' ' VAL . 30.0 m -121.65 139.64 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.553 176.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.566 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 8.2 t60 -151.17 139.86 20.72 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.623 ' HB3' HG22 ' A' ' 85' ' ' THR . 9.1 pt20 -130.04 139.52 50.99 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.014 0.435 . . . . 0.0 110.804 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.48 -172.35 18.16 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.6 tp -93.66 130.17 39.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.908 0.354 . . . . 0.0 110.162 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 71.8 mtm -127.08 165.38 19.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.192 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.462 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 37.3 mmt180 -114.34 175.51 5.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.741 178.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 109' ' ' GLU . 58.0 tttm -45.78 -59.36 2.83 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.106 0.962 . . . . 0.0 112.835 -175.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.547 ' HA ' ' OE1' ' A' ' 109' ' ' GLU . 29.0 t-20 -64.66 -28.88 69.91 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -174.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.489 ' O ' HG12 ' A' ' 111' ' ' ILE . 10.7 m120 -65.4 -45.34 84.35 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.532 HD11 HD23 ' A' ' 48' ' ' LEU . 50.3 mt -64.97 -42.52 94.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.933 176.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 105' ' ' LYS . 81.0 mt-10 -51.91 -48.96 63.94 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.887 176.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.0 m -64.39 -42.24 96.23 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.778 -177.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 107' ' ' ASN . 48.7 mm -67.37 -47.81 79.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.184 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.507 ' HB3' HG21 ' A' ' 117' ' ' VAL . 81.0 mt -65.32 -34.45 78.37 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 110.806 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -60.41 -37.99 82.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.412 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.7 m -85.15 -35.93 21.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.165 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 88' ' ' PHE . 34.7 tp -57.13 -72.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.102 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -176.66 -80.75 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.767 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 1.072 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 22.9 t 53.04 71.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 121.662 0.744 . . . . 0.0 109.537 -175.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -165.36 146.7 7.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.373 -168.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.573 ' HG2' ' HG3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -174.44 168.13 3.89 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 166.59 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.82 -8.45 49.83 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.866 -176.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -80.05 78.6 6.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.17 0.51 . . . . 0.0 109.881 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -136.99 128.89 29.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.767 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -77.99 88.49 4.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.615 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 36.4 m80 61.31 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 O-C-N 123.762 0.664 . . . . 0.0 110.593 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -161.5 16.54 0.1 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 . . . . . 0 C--O 1.25 1.104 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.174 -176.144 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.4 ttp . . . . . 0 N--CA 1.478 0.954 0 CA-C-O 120.989 0.423 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 m -75.14 -30.72 60.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.369 -174.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 3' ' ' LEU . 3.4 mm? -116.33 136.78 52.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.85 0.357 . . . . 0.0 111.124 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.631 ' OE1' ' HB2' ' A' ' 7' ' ' LYS . 65.5 mt-10 -118.51 -172.72 2.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.997 177.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -119.32 15.13 10.85 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 172.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.8 pt -135.74 -55.26 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.689 ' HZ1' ' HB2' ' A' ' 7' ' ' LYS . 9.4 mtmp? -110.41 -62.5 1.51 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.201 -0.312 . . . . 0.0 111.105 -174.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.457 ' HB2' ' HG3' ' A' ' 4' ' ' GLU . 28.7 mt-30 -74.74 77.1 2.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.241 0.543 . . . . 0.0 111.825 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.407 HD12 ' HB3' ' A' ' 13' ' ' SER . 3.0 pt -135.49 -36.97 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.246 171.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.8 m120 66.9 -139.91 0.14 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.072 171.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' A' ' 12' ' ' GLN . 83.7 m-85 -58.21 155.9 10.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.07 -0.513 . . . . 0.0 112.149 -174.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 11' ' ' PHE . 33.6 mm-40 70.85 -2.93 2.13 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.098 -175.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.637 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . 22.7 m -140.8 -86.99 0.18 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.0 mt 69.52 -78.24 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 123.047 0.539 . . . . 0.0 111.042 -171.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -113.98 16.56 18.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.524 0.678 . . . . 0.0 109.265 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.637 ' CG2' ' HA ' ' A' ' 13' ' ' SER . 51.5 t -76.27 125.32 35.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.433 175.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.495 HG22 ' HB2' ' A' ' 22' ' ' GLU . 4.6 p -111.52 134.9 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-O 121.592 0.711 . . . . 0.0 110.374 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -61.47 -54.45 43.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.543 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.535 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -131.69 158.83 40.08 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.369 -177.009 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.65 -29.75 69.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.798 0.332 . . . . 0.0 110.585 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -73.38 -23.51 60.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.405 177.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.495 ' HB2' HG22 ' A' ' 17' ' ' VAL . 29.3 mm-40 -67.01 -18.96 65.62 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.008 0.432 . . . . 0.0 110.492 173.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.498 ' HB3' HD11 ' A' ' 27' ' ' ILE . . . -91.71 113.59 25.9 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -122.38 -6.47 8.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.705 0.764 . . . . 0.0 112.165 -173.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.506 ' HB2' HD12 ' A' ' 27' ' ' ILE . 3.8 mp0 -76.05 170.94 15.31 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.383 178.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.48 55.32 4.99 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.385 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.537 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -114.65 143.41 29.93 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.792 0.33 . . . . 0.0 111.357 -173.277 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 1.01 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 60.5 Cg_exo -56.65 151.36 47.49 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.696 2.264 . . . . 0.0 111.649 170.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.0 m -112.7 111.21 21.84 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.787 -175.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.6 mm -102.99 124.76 57.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.738 HG12 ' HB3' ' A' ' 62' ' ' TYR . 54.3 mt -125.04 115.46 44.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.069 -173.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.456 ' SD ' ' NZ ' ' A' ' 34' ' ' LYS . 2.1 tmt? -112.07 124.36 52.24 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.611 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 53.8 m-85 -87.38 144.57 26.7 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.899 -175.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.943 ' HB3' ' HZ2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -149.44 171.24 16.89 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -178.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.0 t -122.69 -174.44 2.92 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.02 -62.88 1.53 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.229 0.537 . . . . 0.0 110.569 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.2 m -93.76 90.92 6.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.075 -176.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.471 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 20.1 p -158.88 121.15 1.94 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.91 0.386 . . . . 0.0 111.388 175.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 2.9 Cg_exo -75.34 -16.48 19.45 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.53 2.153 . . . . 0.0 112.429 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -64.44 -26.12 68.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.009 0.433 . . . . 0.0 110.637 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.64 ' SG ' ' HD3' ' A' ' 34' ' ' LYS . 53.4 t -67.42 -44.41 78.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.679 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.502 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 7.6 p -74.76 -30.35 24.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.779 0.323 . . . . 0.0 110.756 -176.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -69.7 -49.0 57.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.813 0.339 . . . . 0.0 110.323 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.408 ' HG3' ' OE1' ' A' ' 47' ' ' GLU . 3.5 ttt -69.43 -28.45 66.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.991 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -53.32 -45.02 68.86 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.223 171.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 81.9 mttt -58.12 -53.81 54.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.964 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.421 ' O ' HG21 ' A' ' 51' ' ' VAL . 52.7 mt-10 -57.43 -50.65 72.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.919 -178.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 48.6 mt -61.39 -42.95 99.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.638 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 13.9 t -66.81 -32.94 74.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.369 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.432 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 16.6 m-85 -66.9 -43.08 84.31 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.774 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 47' ' ' GLU . 51.0 t -60.3 -52.22 63.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-O 121.223 0.535 . . . . 0.0 110.016 176.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.8 m -59.4 -29.35 67.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.552 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.707 ' HB2' ' HZ2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -67.51 -16.91 64.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.518 -179.353 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -120.44 8.94 10.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.286 0.565 . . . . 0.0 109.791 177.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.672 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 8.0 ttm-85 -151.38 76.9 1.23 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.356 -175.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.417 ' OE2' ' HE1' ' A' ' 124' ' ' HIS . 1.7 pm0 -82.32 124.77 30.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.83 -169.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.11 25.92 54.89 Favored Glycine 0 CA--C 1.518 0.249 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.333 176.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.672 ' HB2' ' HG2' ' A' ' 55' ' ' ARG . 55.7 mmtt -96.2 -5.68 39.92 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.719 0.771 . . . . 0.0 108.927 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.529 ' HB3' HG12 ' A' ' 117' ' ' VAL . 28.7 p90 -170.79 136.49 1.18 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.042 175.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -95.05 131.33 41.15 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.7 mt -89.64 107.7 18.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.096 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.738 ' HB3' HG12 ' A' ' 31' ' ' ILE . 3.8 t80 -88.43 112.62 23.14 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.923 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 50.3 m-85 -91.73 102.9 15.52 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.589 178.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.92 93.59 4.43 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.975 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.621 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 11.0 ptt180 -89.3 118.25 28.85 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.27 0.557 . . . . 0.0 111.272 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.466 HD22 HD13 ' A' ' 72' ' ' ILE . 53.4 mt -72.77 11.51 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.02 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.516 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 23.9 tt0 -66.4 -33.64 76.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.871 174.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.487 ' CD ' ' HZ1' ' A' ' 70' ' ' LYS . 17.7 mt-10 -106.85 177.2 4.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.351 -177.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.53 -27.0 22.88 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.1 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.57 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -57.6 -33.5 68.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.423 -176.296 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.57 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 68.6 m-80 -90.23 2.39 55.47 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.983 -174.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.466 HD13 HD22 ' A' ' 66' ' ' LEU . 49.7 mm -71.17 -54.44 17.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 172.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.489 ' CG ' ' HZ3' ' A' ' 77' ' ' LYS . 13.8 t70 -65.23 -41.87 93.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.253 175.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.456 ' HB3' ' HA ' ' A' ' 71' ' ' ASN . 1.3 tm? -57.37 -42.61 82.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.101 177.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.611 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -53.17 -53.16 54.64 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.462 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -67.3 -34.3 77.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.771 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.489 ' HZ3' ' CG ' ' A' ' 73' ' ' ASP . 49.4 mttp -62.76 -21.44 65.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.063 0.458 . . . . 0.0 111.588 178.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.505 ' CD2' HG12 ' A' ' 87' ' ' VAL . 52.3 m-85 -119.73 19.32 12.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.643 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 65.13 17.02 10.88 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.801 0.688 . . . . 0.0 111.37 168.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 75' ' ' ALA . . . -123.91 102.17 7.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.079 0.466 . . . . 0.0 111.605 -171.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -113.61 9.21 17.85 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.207 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.9 pt -125.23 171.36 14.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.875 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.57 136.99 19.39 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.229 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -87.26 150.61 38.32 Favored 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 123.65 -1.396 . . . . 0.0 112.667 -0.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 15.1 m -150.26 124.6 9.53 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 88.3 m -122.15 122.89 40.26 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.314 0.578 . . . . 0.0 110.936 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.62 HG22 ' HB ' ' A' ' 98' ' ' VAL . 11.2 p -100.16 132.32 45.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.635 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.988 ' HB3' HD12 ' A' ' 115' ' ' LEU . 86.2 m-85 -106.04 108.8 20.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.799 -175.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 5.5 mp -111.97 138.82 48.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.786 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -80.65 -176.75 5.94 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.56 ' HE2' ' HE2' ' A' ' 118' ' ' LYS . 0.5 OUTLIER -60.57 -22.22 63.45 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -172.494 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.463 ' CD ' ' HZ3' ' A' ' 91' ' ' LYS . 45.9 mp0 -75.85 -12.54 60.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.72 0.295 . . . . 0.0 111.295 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.413 ' O ' HD22 ' A' ' 89' ' ' LEU . . . 85.42 21.06 55.51 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.784 -176.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 92.0 m-20 -92.27 125.36 36.9 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.971 -0.134 . . . . 0.0 110.703 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.452 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 54.2 mtmt -70.5 93.84 0.93 Allowed 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.448 ' HB3' ' CD2' ' A' ' 115' ' ' LEU . 87.6 t80 -83.58 -39.4 20.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.817 0.342 . . . . 0.0 110.338 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.594 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 71.2 t80 -154.04 127.07 8.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.716 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.62 ' HB ' HG22 ' A' ' 87' ' ' VAL . 7.6 p -114.3 133.42 60.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.594 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 49.5 t60 -139.31 137.76 36.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -172.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -110.41 158.18 18.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.825 0.345 . . . . 0.0 111.075 178.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.1 -173.85 20.15 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.028 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.6 tp -104.17 149.59 25.12 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 16.8 ptm -164.8 125.62 2.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.724 -0.216 . . . . 0.0 110.441 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -58.04 163.77 2.63 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.625 -173.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.432 ' HD2' ' HB3' ' A' ' 50' ' ' TYR . 13.6 ptmm? -50.59 -44.43 56.88 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.237 -174.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -63.48 -34.24 77.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.383 0.611 . . . . 0.0 110.932 -176.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -74.11 -40.18 62.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.394 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.481 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 73.8 mt -59.32 -46.27 92.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.246 171.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -58.05 -35.56 71.51 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.004 178.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.5 m -63.92 -41.46 97.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.001 0.429 . . . . 0.0 110.434 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.9 mm -70.89 -41.91 77.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.179 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.52 ' HB3' HG23 ' A' ' 117' ' ' VAL . 85.8 mt -57.53 -41.97 81.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.446 176.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -59.53 -37.11 77.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.803 176.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.1 m -70.37 -24.89 63.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.101 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.988 HD12 ' HB3' ' A' ' 88' ' ' PHE . 27.1 mt -81.28 -73.62 0.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 122.095 0.95 . . . . 0.0 109.788 175.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 162.87 -63.47 0.26 Allowed Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -175.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 1.01 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 48.8 t 52.85 73.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.579 0.704 . . . . 0.0 111.782 172.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.56 ' HE2' ' HE2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -173.93 154.18 2.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.609 -178.487 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.95 -45.84 6.77 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -123.56 179.16 16.22 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.462 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -78.34 81.8 4.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.998 0.399 . . . . 0.0 110.711 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.0 t60 39.5 85.34 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 O-C-N 124.467 1.105 . . . . 0.0 112.893 169.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -119.1 85.78 2.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.598 0.713 . . . . 0.0 112.293 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.417 ' HE1' ' OE2' ' A' ' 56' ' ' GLU . 8.5 m170 -150.9 13.36 0.7 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.374 -1.284 . . . . 0.0 108.599 172.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -110.44 150.43 28.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.171 -176.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 . . . . . 0 C--O 1.245 0.821 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.022 -179.341 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 m 57.8 45.63 18.33 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.713 0.633 . . . . 0.0 112.133 173.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 pp -106.46 165.5 11.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.796 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -80.65 -90.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.478 ' N ' ' HB2' ' A' ' 10' ' ' ASN . . . 84.31 -10.81 60.2 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.571 ' O ' ' HB3' ' A' ' 7' ' ' LYS . 19.5 pt -154.05 152.21 10.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.571 ' HB3' ' O ' ' A' ' 6' ' ' ILE . 29.5 tttm 72.6 -46.21 0.64 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.653 0.596 . . . . 0.0 109.926 -174.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -135.99 138.81 42.64 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 170.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 9.6 tp -67.42 134.66 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.253 0.549 . . . . 0.0 111.599 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.478 ' HB2' ' N ' ' A' ' 5' ' ' GLY . 0.6 OUTLIER -141.48 161.11 38.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.001 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.6 p90 57.92 -17.74 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.577 1.551 . . . . 0.0 114.889 174.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 13' ' ' SER . 16.2 mm100 -78.84 95.67 5.45 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 171.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.717 ' HA ' ' HA ' ' A' ' 49' ' ' SER . 49.0 m 78.57 134.45 0.06 Allowed 'General case' 0 C--O 1.228 -0.074 0 O-C-N 124.506 1.129 . . . . 0.0 110.45 -172.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.7 mt -80.85 -20.63 11.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.531 0.681 . . . . 0.0 109.941 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.493 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 47.2 m-80 -94.0 25.06 3.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.606 176.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.87 138.96 22.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.641 -173.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.437 HG22 ' HB3' ' A' ' 60' ' ' ASN . 76.0 t -137.93 123.65 25.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.798 175.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -76.13 -55.52 5.51 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.603 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.772 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 59.0 t30 -140.18 -179.38 5.95 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.543 HD12 HD11 ' A' ' 74' ' ' LEU . 83.7 mt -50.39 -32.6 17.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.417 ' CD ' ' HB3' ' A' ' 19' ' ' ASN . 6.7 pm0 -63.41 -39.64 95.04 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.674 0.249 . . . . 0.0 111.674 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 55.7 mp0 -81.52 4.51 21.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.808 175.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.36 171.04 10.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.941 0.4 . . . . 0.0 111.957 -175.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.504 ' HE2' ' OD1' ' A' ' 60' ' ' ASN . 23.1 mtmm -148.57 173.25 13.36 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -120.51 -179.56 4.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.677 0.275 . . . . 0.0 111.378 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.09 -47.74 2.68 Favored Glycine 0 C--N 1.332 0.355 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.044 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.699 HD12 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -100.19 146.66 32.33 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 175.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 1.06 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 84.2 Cg_exo -51.02 158.66 3.04 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.197 2.598 . . . . 0.0 112.436 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.464 HG23 ' HB2' ' A' ' 60' ' ' ASN . 41.7 m -131.44 126.15 34.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.244 0.545 . . . . 0.0 111.43 -175.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.529 HD12 HD21 ' A' ' 112' ' ' LEU . 63.5 mt -98.76 111.52 28.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.495 176.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.593 ' HB ' ' HB ' ' A' ' 87' ' ' VAL . 6.0 mm -91.01 107.81 19.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.415 ' HA ' ' O ' ' A' ' 85' ' ' THR . 21.0 ttt -111.71 107.74 16.94 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.311 0.576 . . . . 0.0 110.647 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.679 ' CE1' ' HA ' ' A' ' 75' ' ' ALA . 87.0 m-85 -72.64 133.12 44.5 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.179 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 1.044 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 60.1 pttt -133.84 179.88 5.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.147 -176.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -137.39 -174.56 3.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.469 0.176 . . . . 0.0 110.589 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -77.33 -17.94 57.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.507 0.67 . . . . 0.0 110.548 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.4 m -143.64 101.97 3.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.873 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 2.2 p -160.13 101.68 1.41 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.986 0.422 . . . . 0.0 112.021 -176.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.8 -32.99 13.33 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.07 1.846 . . . . 0.0 112.655 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -70.51 -23.12 62.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.964 0.411 . . . . 0.0 110.749 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 79.7 m -79.15 -43.62 23.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.956 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.477 ' HA ' HE21 ' A' ' 45' ' ' GLN . 12.0 p -65.5 -31.03 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.484 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.716 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 8.5 tp10 -58.38 -50.04 75.08 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.347 0.594 . . . . 0.0 110.283 175.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 21.0 ttt -73.62 -29.3 62.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.86 -177.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.546 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 49.1 mt-30 -62.56 -33.75 75.58 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.692 0.282 . . . . 0.0 110.65 175.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.716 ' HE2' ' HA ' ' A' ' 43' ' ' GLU . 47.3 mtmt -65.29 -47.05 77.99 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.631 ' O ' HG21 ' A' ' 51' ' ' VAL . 62.5 mm-40 -56.04 -52.21 65.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.849 177.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.491 ' HB3' HD13 ' A' ' 61' ' ' ILE . 90.0 mt -56.9 -33.58 67.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.171 178.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.717 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 8.7 t -65.83 -43.56 88.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.023 0.44 . . . . 0.0 109.854 177.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -68.03 -34.27 76.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.706 178.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.716 HG23 ' HG3' ' A' ' 105' ' ' LYS . 34.4 t -65.35 -39.54 85.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 175.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.7 m -61.77 -30.57 70.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.691 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -59.3 -43.09 92.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.049 0.452 . . . . 0.0 110.132 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -82.22 -50.5 8.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.757 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.41 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -99.11 74.06 1.95 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.281 0.562 . . . . 0.0 109.761 -175.257 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.67 119.06 25.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.255 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.55 47.09 36.27 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.23 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.452 ' HD3' ' HA ' ' A' ' 58' ' ' LYS . 36.5 mmtm -132.64 -7.43 3.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.657 0.265 . . . . 0.0 111.31 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.493 ' O ' ' HB3' ' A' ' 15' ' ' ASN . 0.9 OUTLIER -163.92 155.55 16.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.667 177.141 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.504 ' OD1' ' HE2' ' A' ' 24' ' ' LYS . 36.9 m-80 -96.39 132.36 42.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 171.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.491 HD13 ' HB3' ' A' ' 48' ' ' LEU . 71.2 mt -107.16 105.32 18.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.533 173.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.772 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 1.1 t80 -101.17 111.75 24.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.133 0.492 . . . . 0.0 110.025 -177.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.611 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 73.1 m-85 -90.77 102.58 15.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.978 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 71' ' ' ASN . . . -85.29 97.0 9.7 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 121.184 -0.206 . . . . 0.0 110.801 -177.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 1.044 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 32.8 ptt180 -76.7 114.86 15.92 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.831 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.5 mp -63.7 11.71 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.141 0.496 . . . . 0.0 111.742 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.632 ' H ' ' C ' ' A' ' 65' ' ' ARG . 62.3 tt0 -77.26 -31.41 54.91 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.185 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -112.77 148.14 35.42 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.749 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -65.65 -20.86 66.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.914 -172.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.586 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -63.45 -33.45 75.59 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.214 0.531 . . . . 0.0 110.485 -178.078 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.586 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 4.1 m120 -85.99 -17.65 34.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.571 -173.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.3 mt -69.85 -42.85 80.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.412 ' CG ' ' HZ1' ' A' ' 77' ' ' LYS . 10.0 t70 -65.08 -40.64 94.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.168 175.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.543 HD11 HD12 ' A' ' 20' ' ' LEU . 2.3 mm? -62.71 -38.86 92.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.896 175.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.679 ' HA ' ' CE1' ' A' ' 33' ' ' PHE . . . -54.41 -52.37 61.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.439 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -64.95 -33.39 75.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.478 -178.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.412 ' HZ1' ' CG ' ' A' ' 73' ' ' ASP . 6.8 mtmm -64.96 -16.27 63.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.964 0.412 . . . . 0.0 111.176 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.626 ' HB3' HG21 ' A' ' 87' ' ' VAL . 60.6 m-85 -119.66 15.48 12.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.664 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 65.57 21.99 11.74 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.666 0.604 . . . . 0.0 110.845 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.41 163.2 14.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.954 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -158.45 -36.97 0.07 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.948 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.1 pt -117.95 -176.14 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.985 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.74 147.08 55.58 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.186 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.65 155.42 80.6 Favored 'Cis proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.648 -1.397 . . . . 0.0 111.802 -0.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.532 HG22 ' HG3' ' A' ' 100' ' ' GLN . 88.3 m -144.12 110.19 5.39 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.8 p -102.12 113.69 27.17 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.082 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.626 HG21 ' HB3' ' A' ' 78' ' ' TYR . 85.1 t -100.65 109.88 26.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.319 176.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -89.67 105.86 18.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.139 0.495 . . . . 0.0 110.492 -178.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.518 HD22 ' HA ' ' A' ' 95' ' ' LYS . 46.8 mt -99.13 148.89 23.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.132 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.428 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 7.3 t70 -83.6 -166.01 1.27 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.428 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 12.2 pttm -59.92 -32.45 70.78 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -170.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -105.81 10.72 32.52 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.01 0.433 . . . . 0.0 110.773 -173.886 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.64 20.15 45.38 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.163 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -68.32 116.93 9.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.012 0.406 . . . . 0.0 110.433 176.258 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.518 ' HA ' HD22 ' A' ' 89' ' ' LEU . 39.7 ttmt -74.1 89.09 1.95 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.601 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -89.27 -47.18 8.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.246 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.512 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 77.9 t80 -144.54 111.26 5.72 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.747 -177.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.18 134.46 44.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 172.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.512 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 17.3 t60 -138.24 126.64 23.21 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -175.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.532 ' HG3' HG22 ' A' ' 85' ' ' THR . 24.1 mp0 -96.63 140.09 31.75 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 123.611 0.569 . . . . 0.0 109.733 174.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.98 162.68 18.01 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.515 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.2 tp -73.95 141.04 45.95 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 122.522 0.329 . . . . 0.0 111.429 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 60.0 mtm -135.63 159.47 41.52 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 171.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -97.14 164.51 12.47 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.716 ' HG3' HG23 ' A' ' 51' ' ' VAL . 61.0 tttm -46.92 -52.37 14.69 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -175.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 25.7 t-20 -58.45 -32.82 69.08 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -177.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.524 ' O ' HG12 ' A' ' 111' ' ' ILE . 10.8 m120 -65.04 -46.35 81.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.428 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 41.5 mt -61.9 -43.93 98.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.836 176.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 105' ' ' LYS . 79.3 mm-40 -49.58 -47.21 49.56 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.015 176.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 m -72.11 -39.47 68.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.087 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 107' ' ' ASN . 48.5 mm -65.1 -44.54 95.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.875 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.626 ' HB3' HG21 ' A' ' 117' ' ' VAL . 82.8 mt -63.52 -38.73 92.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.068 0.461 . . . . 0.0 110.279 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -58.23 -41.15 83.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.892 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.9 m -85.13 -8.38 58.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.712 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 tp -85.01 -86.62 0.13 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.016 0.436 . . . . 0.0 109.842 176.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -179.03 -60.44 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 1.06 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 40.8 t 57.51 64.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 122.028 0.918 . . . . 0.0 110.756 177.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -164.14 162.02 22.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.114 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -93.36 145.85 24.17 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 173.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.595 ' O ' ' HB2' ' A' ' 121' ' ' HIS . . . -50.75 -70.01 0.96 Allowed Glycine 0 C--N 1.331 0.301 0 O-C-N 123.372 0.42 . . . . 0.0 112.983 -174.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.595 ' HB2' ' O ' ' A' ' 120' ' ' GLY . 19.2 t-80 163.54 76.37 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.805 0.842 . . . . 0.0 109.24 175.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -57.27 138.33 54.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.092 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 42.9 t60 71.79 90.99 0.09 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.636 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 64.84 104.42 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.451 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -67.98 -42.05 81.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.048 0.451 . . . . 0.0 110.2 178.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 . . . . . 0 C--O 1.245 0.851 0 CA-C-O 118.373 -0.823 . . . . 0.0 109.179 178.423 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.483 1.219 0 CA-C-O 120.545 0.212 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.1 m -104.76 108.14 19.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.839 0.352 . . . . 0.0 110.812 -176.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.45 ' N ' HD13 ' A' ' 3' ' ' LEU . 2.2 mp -111.77 -29.96 7.49 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 8' ' ' GLN . 10.6 mp0 -90.34 33.55 0.89 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.887 -176.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 81.44 -72.41 2.76 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.39 -174.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.558 HG13 ' HG2' ' A' ' 7' ' ' LYS . 8.4 tp -176.42 128.09 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.703 0.287 . . . . 0.0 110.58 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.816 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 10.6 mmpt? 63.76 16.88 10.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.704 176.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.45 ' HA ' ' HB2' ' A' ' 4' ' ' GLU . 79.5 mt-30 56.11 95.55 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.72 0.637 . . . . 0.0 111.969 -177.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 tt -115.37 103.8 15.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.202 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 40.5 t30 71.37 118.08 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.509 0.671 . . . . 0.0 112.534 172.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -100.0 -10.36 21.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.637 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -72.37 -47.26 50.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.948 0.404 . . . . 0.0 110.72 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.7 m -92.91 108.29 19.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.174 0.511 . . . . 0.0 109.71 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.516 HG21 ' HB3' ' A' ' 52' ' ' SER . 1.1 tt -74.53 -8.42 11.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.484 -172.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -111.76 37.35 2.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.544 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.491 HG21 ' CD1' ' A' ' 63' ' ' TYR . 8.0 p -82.72 140.54 16.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.684 -176.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.8 p -139.6 159.92 27.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.485 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.486 ' HG3' ' HB2' ' A' ' 19' ' ' ASN . 5.1 tp10 -83.53 -55.89 4.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.207 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.632 ' HA ' ' CE2' ' A' ' 62' ' ' TYR . 5.9 t-20 -142.59 169.07 18.26 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.543 -169.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.77 -32.35 73.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.355 176.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -63.34 -24.39 67.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.72 0.771 . . . . 0.0 109.943 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -97.65 10.28 40.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.645 -177.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -109.58 145.45 36.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.186 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -97.38 154.09 17.68 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 174.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.47 177.34 3.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.661 177.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . 89.53 -55.13 3.84 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.535 174.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 24.9 pt -84.51 134.83 41.78 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.913 0.387 . . . . 0.0 110.495 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 1.0 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 48.2 Cg_exo -59.14 144.49 99.36 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.783 2.322 . . . . 0.0 111.338 176.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.448 ' HB ' HD11 ' A' ' 89' ' ' LEU . 25.1 m -110.55 122.13 47.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.151 0.5 . . . . 0.0 111.185 -175.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.6 mt -104.39 108.67 25.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.745 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.669 ' HB ' HG21 ' A' ' 87' ' ' VAL . 5.4 mp -97.62 128.42 48.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.468 ' HB3' HG23 ' A' ' 86' ' ' THR . 26.2 ptm -121.45 122.74 40.43 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.472 0.653 . . . . 0.0 110.353 178.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.559 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 93.7 m-85 -90.6 122.47 33.43 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.309 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.626 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 14.2 pttp -128.75 133.77 48.22 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.226 -174.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.459 ' HA ' ' HB2' ' A' ' 66' ' ' LEU . 17.8 p -75.1 178.17 5.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.561 0.22 . . . . 0.0 110.68 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.98 -58.94 6.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.053 0.454 . . . . 0.0 109.935 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.9 m -102.71 101.22 11.31 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.685 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 34' ' ' LYS . 4.0 p -136.03 104.21 9.72 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 120.996 0.426 . . . . 0.0 112.016 -177.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -71.62 -29.56 15.91 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.988 1.792 . . . . 0.0 111.889 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -63.31 -30.2 71.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.723 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.635 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 52.8 t -66.27 -51.11 60.74 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.113 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.7 t -57.11 -43.25 81.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.893 0.378 . . . . 0.0 110.912 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.568 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 7.6 tp10 -58.24 -49.03 78.55 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.932 177.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.4 ttt -72.16 -29.34 63.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.967 -177.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.635 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 27.4 mt-30 -57.89 -39.01 76.82 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 110.035 174.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.568 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 42.8 mtpt -60.03 -53.12 61.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.192 176.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.515 ' O ' HG22 ' A' ' 51' ' ' VAL . 63.6 mm-40 -58.7 -45.11 90.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.869 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.92 -33.15 73.72 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.953 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.3 t -64.95 -43.08 93.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.201 0.524 . . . . 0.0 109.682 176.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -66.47 -22.55 66.2 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.229 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.714 HG21 ' HG3' ' A' ' 105' ' ' LYS . 40.5 t -86.47 -41.97 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.005 0.431 . . . . 0.0 110.645 177.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.516 ' HB3' HG21 ' A' ' 14' ' ' ILE . 57.0 m -58.8 -30.83 67.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.341 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . 36.0 ttpt -51.59 -53.18 41.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.423 -178.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -105.9 15.99 25.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.707 0.289 . . . . 0.0 111.713 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 55' ' ' ARG . 12.8 ttm180 -138.68 75.91 1.54 Allowed 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.059 0.933 . . . . 0.0 109.633 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.709 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 1.5 tm-20 -71.39 132.0 44.18 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 113.87 -1.514 . . . . 0.0 110.07 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 41.47 46.86 4.63 Favored Glycine 0 C--N 1.333 0.408 0 O-C-N 124.016 0.822 . . . . 0.0 114.734 169.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.709 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 35.6 mmtm -120.14 -1.45 10.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.642 0.734 . . . . 0.0 109.434 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -158.46 150.61 21.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.453 -1.249 . . . . 0.0 108.723 172.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -114.27 124.75 52.79 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.4 mt -98.61 110.32 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.228 0.537 . . . . 0.0 111.564 -174.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.632 ' CE2' ' HA ' ' A' ' 19' ' ' ASN . 1.3 t80 -85.42 114.75 22.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.14 177.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.491 ' CD1' HG21 ' A' ' 16' ' ' VAL . 12.7 m-85 -89.94 103.26 15.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.223 0.535 . . . . 0.0 110.518 176.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.559 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -88.86 81.63 6.9 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.17 -179.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.626 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 20.3 ptt180 -71.73 108.24 4.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.569 177.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 35' ' ' THR . 9.1 mp -65.87 10.5 0.1 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.185 0.517 . . . . 0.0 111.851 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.524 ' H ' ' C ' ' A' ' 65' ' ' ARG . 30.5 tt0 -64.23 -31.3 72.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.342 172.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -96.87 170.09 9.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.331 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -94.29 -11.96 29.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.339 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -67.28 -11.01 56.42 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.868 0.842 . . . . 0.0 110.826 177.217 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -89.89 -5.99 56.23 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.051 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.9 mt -69.19 -56.34 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -70.73 -38.13 73.55 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.724 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -57.42 -42.22 81.91 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.74 177.107 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.479 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -63.36 -56.57 15.31 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.722 -177.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -65.4 -32.21 73.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.633 -175.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.404 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 14.1 tmtt? -61.95 -18.58 60.84 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.971 0.415 . . . . 0.0 110.595 177.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.545 ' HB3' HG13 ' A' ' 87' ' ' VAL . 58.9 m-85 -127.4 25.48 6.11 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 66.0 15.29 10.01 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.323 0.582 . . . . 0.0 111.527 171.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.67 142.71 31.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.641 -174.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -146.16 -34.16 0.31 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.718 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.1 pt -125.59 -177.72 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.039 0.447 . . . . 0.0 111.3 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.2 p -118.87 137.47 25.03 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.306 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -96.65 126.33 2.92 Favored 'Cis proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.86 -1.308 . . . . 0.0 113.223 -0.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.2 m -100.39 116.99 33.66 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 171.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 2.3 p -115.5 115.23 26.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.999 0.428 . . . . 0.0 111.146 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.692 HG11 ' HB ' ' A' ' 98' ' ' VAL . 2.0 m -100.54 124.47 54.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.482 0.658 . . . . 0.0 110.219 176.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.52 ' HB3' HD22 ' A' ' 115' ' ' LEU . 73.3 m-85 -98.18 106.31 18.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.083 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 44.0 mt -88.19 132.18 34.45 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 174.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.06 171.6 3.51 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 173.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 6.2 pttm -52.86 -25.23 10.96 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.447 0.699 . . . . 0.0 112.455 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.21 -9.6 59.06 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.85 10.05 61.87 Favored Glycine 0 CA--C 1.517 0.207 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.728 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 7.9 p30 -85.78 144.4 27.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.756 -0.261 . . . . 0.0 110.708 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt -81.21 92.41 6.32 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -85.48 -45.12 12.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.062 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.501 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 89.1 t80 -137.3 148.12 46.13 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.194 -176.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.692 ' HB ' HG11 ' A' ' 87' ' ' VAL . 2.2 p -134.76 135.36 53.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.649 173.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.501 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 50.4 t60 -122.42 119.5 31.2 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -109.47 105.67 15.11 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 133.22 179.95 16.8 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -174.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.458 HD21 ' HG2' ' A' ' 43' ' ' GLU . 33.2 tp -87.5 164.9 15.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.715 0.258 . . . . 0.0 110.84 -176.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.658 ' HE1' HG12 ' A' ' 108' ' ' ILE . 27.0 ptt? -172.01 156.36 4.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.613 173.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.405 HH12 ' CD ' ' A' ' 43' ' ' GLU . 32.4 mmt180 -91.84 170.87 9.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.754 -0.203 . . . . 0.0 110.987 -176.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.714 ' HG3' HG21 ' A' ' 51' ' ' VAL . 82.5 tttt -47.23 -49.87 22.25 Favored 'General case' 0 C--O 1.222 -0.346 0 O-C-N 123.63 0.581 . . . . 0.0 112.071 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -56.35 -35.43 67.65 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.158 0.504 . . . . 0.0 111.543 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.439 ' HB2' ' HB2' ' A' ' 103' ' ' MET . 6.5 m120 -73.96 -40.02 63.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.658 HG12 ' HE1' ' A' ' 103' ' ' MET . 61.7 mt -60.77 -46.03 96.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.378 172.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 105' ' ' LYS . 10.6 mm-40 -50.49 -48.41 56.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.317 176.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.4 m -63.86 -43.0 97.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.718 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 107' ' ' ASN . 42.8 mm -65.22 -42.99 95.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.816 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.586 ' HB3' HG21 ' A' ' 117' ' ' VAL . 81.6 mt -60.57 -42.23 96.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.617 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -64.25 -31.36 72.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.157 177.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.6 t -86.13 -9.7 56.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.462 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.52 HD22 ' HB3' ' A' ' 88' ' ' PHE . 45.9 tp -93.11 -73.92 0.54 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.116 0.484 . . . . 0.0 110.231 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 172.2 -61.38 0.15 Allowed Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 1.0 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 41.9 t 50.33 78.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.957 0.884 . . . . 0.0 111.605 178.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -148.13 178.45 8.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.796 -174.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.8 90.65 1.64 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 167.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -140.51 36.28 1.8 Allowed Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 119.982 -1.104 . . . . 0.0 113.361 -171.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -71.44 -51.04 26.02 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -86.42 79.45 8.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.404 172.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -114.88 125.61 53.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.296 -172.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 67.38 158.59 0.14 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.941 0.776 . . . . 0.0 111.03 176.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -101.4 -21.18 14.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.905 -0.497 . . . . 0.0 110.56 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.8 p80 . . . . . 0 C--O 1.244 0.814 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.905 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.1 mmm . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.1 p -65.48 -49.66 68.24 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.646 0.26 . . . . 0.0 111.0 -176.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 pp -91.44 165.58 13.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.833 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -73.1 132.65 43.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.844 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -121.63 32.67 4.56 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.327 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 tp -138.36 84.85 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.757 0.789 . . . . 0.0 112.179 -177.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.465 ' HZ2' ' CD ' ' A' ' 18' ' ' GLU . 2.7 ttpm? 66.37 2.27 2.36 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.374 168.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 29.8 mm-40 65.45 107.67 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.061 0.458 . . . . 0.0 109.869 -171.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 16' ' ' VAL . 10.8 tp -157.03 16.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.254 0.55 . . . . 0.0 110.966 -175.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -50.61 -41.82 55.21 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.446 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -148.09 97.64 2.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.221 0.534 . . . . 0.0 110.533 -177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -127.57 -53.4 1.35 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.715 173.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.539 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 9.8 m -121.69 16.87 11.14 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.955 176.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.1 mt 70.33 -69.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.911 -175.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.703 HD22 ' HA2' ' A' ' 57' ' ' GLY . 12.9 m120 -92.93 31.28 1.43 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.262 0.553 . . . . 0.0 110.487 177.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 7.7 p -74.69 133.58 31.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.202 -177.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.403 HG21 ' HB3' ' A' ' 60' ' ' ASN . 67.5 t -134.84 136.38 52.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.847 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.465 ' CD ' ' HZ2' ' A' ' 7' ' ' LYS . 6.5 mm-40 -65.83 -53.95 33.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.928 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.667 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 35.2 t30 -164.77 174.33 10.81 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -173.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -50.48 -29.4 10.32 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.805 0.336 . . . . 0.0 111.208 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.667 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 10.2 pt-20 -55.83 -37.2 68.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.321 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -103.18 8.3 38.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.625 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.26 139.66 52.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.622 0.249 . . . . 0.0 110.347 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -128.18 154.74 45.46 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.759 -174.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 61.8 -170.36 0.16 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.064 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -110.22 43.99 1.6 Allowed Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.151 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.543 HG13 ' ND2' ' A' ' 60' ' ' ASN . 7.0 pt -100.68 147.25 33.38 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.609 -0.295 . . . . 0.0 111.058 -178.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 1.094 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 88.1 Cg_exo -50.59 160.07 1.88 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.64 2.893 . . . . 0.0 113.227 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.7 m -123.37 128.16 49.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.435 -175.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.491 HD12 HD22 ' A' ' 112' ' ' LEU . 80.0 mt -107.45 109.63 28.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.602 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 42.5 mt -105.15 110.22 30.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.263 -177.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.537 ' SD ' ' NZ ' ' A' ' 34' ' ' LYS . 5.1 ppp? -114.69 139.58 49.55 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.767 0.794 . . . . 0.0 110.058 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -103.87 150.03 24.53 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.016 -170.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.801 ' HZ1' ' HB3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -152.77 161.51 42.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.934 178.565 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.62 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -75.06 -173.8 2.07 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 175.114 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.448 ' HB2' ' OE1' ' A' ' 67' ' ' GLU . 31.6 t70 -60.27 -29.37 68.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.057 0.456 . . . . 0.0 110.725 175.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -158.46 132.49 7.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.546 176.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 12.5 p -165.8 137.35 3.1 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.772 176.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 24.2 Cg_exo -63.14 -29.85 74.61 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.693 2.262 . . . . 0.0 112.811 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -62.94 -31.12 72.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.516 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 46.9 t -71.47 -36.32 71.13 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.111 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.537 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 46.9 t -67.93 -42.0 85.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.835 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -57.96 -50.24 74.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.669 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.461 ' HB2' HD22 ' A' ' 102' ' ' LEU . 21.5 ttt -72.15 -29.0 63.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.664 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.95 ' HG2' ' HH ' ' A' ' 63' ' ' TYR . 23.0 tm0? -61.08 -42.41 98.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 177.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 31.7 mmmt -63.04 -45.45 92.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.934 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.589 ' O ' HG21 ' A' ' 51' ' ' VAL . 72.0 mm-40 -58.06 -47.88 81.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.698 176.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.415 ' HB3' HD13 ' A' ' 61' ' ' ILE . 87.1 mt -61.56 -35.41 77.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.213 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.7 m -59.72 -43.93 93.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.079 0.466 . . . . 0.0 110.176 173.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -66.97 -41.03 87.54 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.615 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.589 HG21 ' O ' ' A' ' 47' ' ' GLU . 55.3 t -60.24 -44.56 95.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.571 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.664 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 m -66.24 -30.85 71.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.969 0.414 . . . . 0.0 111.282 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -77.66 -24.71 49.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.045 0.45 . . . . 0.0 110.557 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -93.39 -38.63 11.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.22 0.533 . . . . 0.0 110.199 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -114.8 79.03 1.21 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.63 120.92 19.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.567 -168.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.703 ' HA2' HD22 ' A' ' 15' ' ' ASN . . . 60.91 57.86 16.64 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.549 -0.75 . . . . 0.0 113.184 173.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.826 ' HE3' HG13 ' A' ' 117' ' ' VAL . 29.1 mmmt -132.67 -3.2 3.31 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.655 -0.32 . . . . 0.0 111.571 -176.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -166.82 153.92 9.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 111.149 -176.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.543 ' ND2' HG13 ' A' ' 27' ' ' ILE . 58.6 m-80 -95.64 129.82 42.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.99 174.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.415 HD13 ' HB3' ' A' ' 48' ' ' LEU . 57.6 mt -98.92 108.76 22.84 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 CA-C-O 120.542 0.211 . . . . 0.0 110.657 178.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.794 ' HH ' ' HG ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -96.28 118.28 32.51 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.338 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.95 ' HH ' ' HG2' ' A' ' 45' ' ' GLN . 31.2 m-85 -97.27 103.74 15.7 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.143 0.497 . . . . 0.0 110.368 173.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.4 ' HB1' HD21 ' A' ' 71' ' ' ASN . . . -94.27 100.62 12.64 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.231 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.558 ' C ' ' H ' ' A' ' 67' ' ' GLU . 3.4 ptp180 -84.61 117.22 23.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.273 172.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.7 mt -66.73 10.51 0.13 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.268 0.556 . . . . 0.0 112.082 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.558 ' H ' ' C ' ' A' ' 65' ' ' ARG . 20.7 tp10 -80.4 -25.19 39.2 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.584 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -96.85 159.01 15.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.951 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -71.5 -22.91 61.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.166 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.486 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.9 OUTLIER -65.16 -25.84 67.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.415 0.626 . . . . 0.0 111.166 -174.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.486 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 7.8 m120 -89.94 -7.49 53.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.76 -168.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.7 mm -69.23 -50.94 48.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.78 -44.25 86.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.143 174.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.794 ' HG ' ' HH ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -60.48 -40.98 93.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.593 -178.414 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.9 -55.87 9.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.349 . . . . 0.0 111.655 -177.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -63.2 -34.23 77.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.676 -174.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 77' ' ' LYS . 26.8 ttmt -64.61 -16.91 63.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.901 0.381 . . . . 0.0 110.912 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.574 ' CE1' HD22 ' A' ' 89' ' ' LEU . 75.7 m-85 -122.02 16.96 10.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.797 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 67.77 23.48 8.55 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.87 0.367 . . . . 0.0 111.535 174.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.427 ' HB1' HG21 ' A' ' 85' ' ' THR . . . -102.34 136.49 42.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.615 -178.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -144.33 -75.55 0.24 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.015 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.0 pt -71.15 142.05 16.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.99 0.424 . . . . 0.0 110.95 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.3 153.08 38.33 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.634 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -87.94 119.75 4.87 Favored 'Cis proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.25 -1.563 . . . . 0.0 112.411 0.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.547 ' HB ' ' HG3' ' A' ' 100' ' ' GLN . 5.1 t -110.31 142.52 41.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.249 177.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.7 m -132.39 127.86 36.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.747 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.602 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 10.8 p -108.89 128.33 64.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.25 0.548 . . . . 0.0 110.342 176.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -101.42 111.79 24.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.441 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.574 HD22 ' CE1' ' A' ' 78' ' ' TYR . 5.7 mp -107.91 146.01 32.97 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.079 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -83.2 -172.48 4.16 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 173.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.917 ' HE3' ' HE2' ' A' ' 118' ' ' LYS . 18.7 pttp -62.79 -33.04 74.36 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -172.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -93.42 18.04 10.43 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.458 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 78.54 25.34 61.07 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.819 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.563 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 81.3 m-20 -78.95 110.07 13.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.563 0.22 . . . . 0.0 110.68 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 78' ' ' TYR . 11.7 ptmm? -72.36 86.78 1.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.53 0.681 . . . . 0.0 109.696 177.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -80.42 -53.09 6.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.374 -172.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.408 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 75.8 t80 -135.76 127.6 29.33 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.768 -173.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 87' ' ' VAL . 33.7 m -111.01 150.69 13.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 172.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.408 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 11.9 t60 -156.3 134.33 11.23 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.547 ' HG3' ' HB ' ' A' ' 85' ' ' THR . 2.3 mp0 -105.01 128.69 53.42 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 173.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 141.4 -161.3 26.94 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.458 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' A' ' 44' ' ' MET . 1.1 tm? -129.87 121.3 26.42 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.64 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 3.3 mpp? -116.25 161.34 19.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.845 0.355 . . . . 0.0 110.202 178.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -93.95 167.97 11.27 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.086 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -50.3 -42.77 53.07 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -62.32 -38.76 90.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.186 0.517 . . . . 0.0 110.855 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.64 ' HB2' ' HB3' ' A' ' 103' ' ' MET . 3.5 m120 -71.05 -43.97 66.74 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.503 -176.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.608 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 48.9 mt -58.72 -50.04 80.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.872 176.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -56.51 -48.76 76.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.337 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.5 m -60.03 -38.17 81.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.067 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 107' ' ' ASN . 80.4 mt -65.35 -40.86 89.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.839 0.352 . . . . 0.0 110.231 176.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 57.4 mt -63.27 -35.83 81.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.183 177.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.86 -30.29 71.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.444 177.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.0 m -85.45 -9.85 56.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.709 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.2 tp -87.52 -88.18 0.14 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.387 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -174.5 -54.05 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 1.094 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 17.4 t 52.97 57.22 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 122.327 1.06 . . . . 0.0 109.871 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.917 ' HE2' ' HE3' ' A' ' 91' ' ' LYS . 19.8 pttm -123.14 146.85 47.41 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.266 -1.333 . . . . 0.0 110.486 -173.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -98.62 -33.46 10.95 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 172.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 178.93 -113.53 0.41 Allowed Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.623 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -150.63 -175.32 5.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 63.3 t60 66.97 24.16 9.66 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.05 173.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -71.4 -33.59 69.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 171.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -71.49 123.12 21.7 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 170.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -79.28 -60.82 2.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.784 0.325 . . . . 0.0 111.013 -172.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.43 -0.795 . . . . 0.0 109.779 178.342 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 121.0 0.429 . . . . 0.0 110.102 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.4 m -146.27 99.78 3.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.97 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 52.8 tp -124.33 128.36 48.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.399 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.86 87.06 7.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.485 0.66 . . . . 0.0 110.712 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.93 -21.12 78.98 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.954 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 24.6 pt -142.89 172.16 8.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 120.672 0.272 . . . . 0.0 111.125 -177.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? 71.46 -53.29 0.68 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.738 1.215 . . . . 0.0 112.071 177.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -82.09 87.61 6.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.25 0.548 . . . . 0.0 110.272 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.439 HG22 HG13 ' A' ' 16' ' ' VAL . 38.1 pt -83.28 -8.39 11.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.493 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.6 t30 71.37 -80.36 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.085 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.417 ' O ' ' HB3' ' A' ' 12' ' ' GLN . 42.0 t80 -175.07 -166.46 0.23 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -170.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.417 ' HB3' ' O ' ' A' ' 11' ' ' PHE . 10.0 tt0 80.97 -45.7 0.23 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.801 0.84 . . . . 0.0 111.529 172.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.546 ' CB ' HG23 ' A' ' 16' ' ' VAL . 20.3 m -119.86 104.94 10.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.099 0.476 . . . . 0.0 110.302 177.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 14' ' ' ILE . 3.3 mp -85.81 -28.66 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.529 0.681 . . . . 0.0 110.1 -176.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -79.45 10.33 3.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.493 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.546 HG23 ' CB ' ' A' ' 13' ' ' SER . 1.0 OUTLIER -64.36 142.28 17.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.675 0.75 . . . . 0.0 112.842 -173.089 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.53 HG23 ' HB3' ' A' ' 60' ' ' ASN . 84.3 t -134.85 124.95 44.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.606 174.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -79.47 -30.92 42.3 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.138 0.495 . . . . 0.0 110.798 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -176.24 176.4 1.69 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -48.87 -34.24 12.23 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.67 -33.73 70.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.642 0.258 . . . . 0.0 111.613 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -99.15 19.94 14.37 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.751 0.31 . . . . 0.0 111.019 -175.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.96 145.33 26.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.906 0.384 . . . . 0.0 111.143 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -116.71 114.42 24.0 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -81.41 168.57 18.2 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.284 -175.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.46 -35.0 5.32 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -172.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.5 pt -113.01 157.39 40.84 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 114.925 -0.638 . . . . 0.0 109.729 176.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.524 ' HG2' HG22 ' A' ' 117' ' ' VAL . 49.0 Cg_exo -57.76 169.71 2.39 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.868 2.379 . . . . 0.0 112.608 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.475 ' HA ' ' HB2' ' A' ' 60' ' ' ASN . 63.1 m -136.38 115.28 12.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.932 0.396 . . . . 0.0 111.063 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.4 mm -101.71 139.45 22.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.589 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 77.2 mt -130.6 118.11 41.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.561 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 24.9 ptm -109.23 120.54 42.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.469 0.652 . . . . 0.0 109.856 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.556 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 87.8 m-85 -90.41 117.36 29.06 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.752 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HG3' ' HB2' ' A' ' 41' ' ' CYS . 0.1 OUTLIER -150.8 149.35 29.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.364 -178.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.4 t -81.7 165.22 21.19 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 170.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.655 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -88.92 9.93 23.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.015 0.436 . . . . 0.0 110.871 -169.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.4 p -108.9 -16.69 14.1 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 65.7 m -83.03 128.53 64.95 Favored Pre-proline 0 C--N 1.33 -0.265 0 O-C-N 122.25 -0.281 . . . . 0.0 111.001 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.91 -25.76 7.29 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 121.938 1.759 . . . . 0.0 113.569 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -62.97 -19.74 64.58 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.798 0.332 . . . . 0.0 110.965 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.625 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 7.3 p -71.73 -34.4 69.53 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.35 -35.79 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.691 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -62.99 -49.53 74.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.135 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.501 ' HE2' ' HB2' ' A' ' 103' ' ' MET . 26.5 ttt -65.84 -32.88 74.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.2 178.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 19.8 mt-30 -63.66 -33.2 75.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.934 175.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -68.42 -41.41 80.43 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.216 176.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.663 ' O ' HG21 ' A' ' 51' ' ' VAL . 18.9 mm-40 -55.72 -54.04 49.17 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 172.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.524 ' HB3' HD11 ' A' ' 61' ' ' ILE . 68.7 mt -58.24 -33.43 69.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.487 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.1 t -65.61 -40.66 92.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.788 0.328 . . . . 0.0 110.58 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.416 ' O ' ' HB3' ' A' ' 53' ' ' LYS . 19.8 m-85 -72.69 -31.74 65.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.06 178.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.894 HG23 ' HG3' ' A' ' 105' ' ' LYS . 16.8 t -68.76 -38.66 79.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.2 t -64.06 -31.11 72.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.925 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 50' ' ' TYR . 16.1 tppt? -68.27 -42.55 79.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.378 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -93.24 -20.88 20.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.63 -176.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.3 76.23 1.71 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.521 0.677 . . . . 0.0 109.507 178.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.439 ' O ' ' HE3' ' A' ' 58' ' ' LYS . 1.2 pm0 -72.14 124.34 24.8 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.738 -173.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.34 40.13 37.39 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.614 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.439 ' HE3' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -113.49 -4.59 13.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.076 0.465 . . . . 0.0 110.059 -174.019 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -171.79 141.93 1.47 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.922 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.53 ' HB3' HG23 ' A' ' 17' ' ' VAL . 50.8 m-80 -77.27 145.78 37.28 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.613 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.524 HD11 ' HB3' ' A' ' 48' ' ' LEU . 21.3 mt -128.09 107.04 15.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 171.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.523 ' CD2' HG23 ' A' ' 31' ' ' ILE . 4.7 t80 -98.92 117.27 33.05 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.465 ' CE2' HG22 ' A' ' 16' ' ' VAL . 25.3 m-85 -90.99 103.59 16.29 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' A' ' 33' ' ' PHE . . . -81.5 78.29 8.27 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.984 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.588 ' C ' ' H ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -69.84 113.14 6.8 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.62 174.059 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.7 tp -64.57 11.43 0.05 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.342 0.591 . . . . 0.0 111.123 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.655 ' HB2' ' HB2' ' A' ' 36' ' ' ASP . 7.8 tp10 -80.62 -25.55 38.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.091 -178.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.413 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 44.2 mt-10 -105.87 -174.39 2.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.247 0.546 . . . . 0.0 112.056 -175.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -90.42 -31.44 16.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.947 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -54.31 -40.61 68.09 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.641 0.734 . . . . 0.0 111.664 -173.389 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.538 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 2.6 p30 -101.51 10.28 40.51 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.875 -172.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.2 mm -67.45 -49.61 69.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 167.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.56 -43.96 62.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.606 174.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.486 ' CB ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -62.78 -43.84 97.75 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.674 -177.018 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.02 -41.83 77.2 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 122.187 -0.321 . . . . 0.0 110.857 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -61.9 -32.96 73.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.461 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -55.91 -33.33 64.56 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.525 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -112.19 8.02 19.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.726 0.298 . . . . 0.0 110.575 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 t0 53.81 50.63 16.52 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.255 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.28 71.04 10.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.326 0.584 . . . . 0.0 110.609 177.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -82.87 -13.66 55.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.836 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 23.1 pt -113.9 155.91 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.189 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.18 148.93 66.52 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.985 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -90.77 121.48 4.4 Favored 'Cis proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.372 -1.512 . . . . 0.0 112.587 -1.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 94.5 m -100.52 117.19 34.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.3 m -110.38 125.78 53.57 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.089 0.471 . . . . 0.0 111.323 -175.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.589 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 10.5 p -108.04 140.81 25.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.551 175.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.919 ' HB3' HD12 ' A' ' 115' ' ' LEU . 52.4 m-85 -118.29 113.74 21.92 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.226 -174.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.437 ' CD2' ' HA ' ' A' ' 95' ' ' LYS . 32.3 mt -107.88 143.75 36.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.673 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.601 ' HB3' ' HB2' ' A' ' 94' ' ' ASN . 24.7 t0 -78.28 172.05 14.16 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.708 ' HE2' ' HA ' ' A' ' 119' ' ' GLU . 17.4 pttp -63.71 -18.64 64.22 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -174.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -87.69 -0.42 56.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 0.0 110.059 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.51 12.03 67.77 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.441 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.601 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 94.5 m-20 -70.06 117.71 11.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.597 -0.301 . . . . 0.0 111.445 -177.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.437 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -73.0 102.2 3.43 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.582 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -104.35 -72.53 0.7 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.91 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -113.0 141.49 46.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.89 -169.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.1 p -139.48 135.75 40.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 174.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -149.35 137.96 20.98 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -106.72 123.72 48.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.896 0.379 . . . . 0.0 110.611 178.215 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 148.43 179.29 24.25 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.949 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.3 tp -83.0 102.06 11.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.902 0.382 . . . . 0.0 110.352 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.501 ' HB2' ' HE2' ' A' ' 44' ' ' MET . 79.4 mmm -94.98 154.35 17.22 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.418 ' HB2' HD21 ' A' ' 107' ' ' ASN . 8.8 mmm180 -115.36 171.17 7.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.784 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.894 ' HG3' HG23 ' A' ' 51' ' ' VAL . 38.8 ttmt -46.59 -59.34 3.07 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -175.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -61.5 -30.75 70.82 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.935 0.398 . . . . 0.0 111.67 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.531 ' O ' HD13 ' A' ' 111' ' ' ILE . 40.3 m-80 -70.47 -40.5 73.63 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.6 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 41.1 mt -63.11 -51.37 72.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 173.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -50.97 -52.49 42.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.341 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.4 m -60.13 -40.93 91.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.004 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.61 ' O ' ' HG ' ' A' ' 115' ' ' LEU . 1.7 mp -69.06 -38.75 78.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.68 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 86.7 mt -58.01 -43.11 86.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.263 0.554 . . . . 0.0 109.783 176.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -56.7 -40.81 76.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.227 176.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.4 m -75.26 -28.99 60.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.452 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.919 HD12 ' HB3' ' A' ' 88' ' ' PHE . 85.1 mt -68.01 -58.32 4.71 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.481 0.657 . . . . 0.0 109.664 175.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 159.79 -71.3 0.23 Allowed Glycine 0 N--CA 1.438 -1.2 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.165 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.524 HG22 ' HG2' ' A' ' 28' ' ' PRO . 40.9 t 54.97 72.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.908 0.861 . . . . 0.0 109.557 -173.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.45 ' HE3' ' HB2' ' A' ' 118' ' ' LYS . 0.6 OUTLIER -138.95 -172.79 3.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.006 -171.352 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.708 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -175.3 138.47 0.42 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 164.396 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -84.06 -22.49 54.84 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.9 -172.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -79.25 78.61 5.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.273 0.559 . . . . 0.0 111.975 -174.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -94.7 -18.0 21.7 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 170.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.3 m170 -152.63 158.84 42.99 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.271 -1.331 . . . . 0.0 107.528 172.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -101.71 61.26 0.89 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.711 0.767 . . . . 0.0 111.473 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -112.36 13.64 20.32 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 163.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 . . . . . 0 C--O 1.256 1.417 0 CA-C-N 113.208 -1.814 . . . . 0.0 107.143 -179.362 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.627 0.251 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.6 m -151.9 20.13 0.69 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.429 0.633 . . . . 0.0 110.017 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -161.42 83.7 0.62 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -102.79 3.18 36.51 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.834 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.91 -68.29 0.35 Allowed Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.159 -175.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.0 pt -154.79 -48.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 121.044 0.45 . . . . 0.0 110.648 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -111.0 122.24 47.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.711 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -77.11 85.82 3.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.233 0.54 . . . . 0.0 110.681 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.6 pt -116.12 -42.93 3.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.29 176.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -168.41 177.72 5.2 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -145.45 74.54 1.4 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.313 0.578 . . . . 0.0 109.76 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.673 ' HG2' ' HB3' ' A' ' 45' ' ' GLN . 21.8 mp0 -128.6 -68.78 0.74 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.737 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.0 m -100.28 138.12 37.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.888 174.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.658 ' HB ' ' CD ' ' A' ' 56' ' ' GLU . 4.2 mp -90.77 -14.71 8.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.999 0.904 . . . . 0.0 108.903 177.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -71.16 7.66 1.19 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.305 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.5 ' H ' ' C ' ' A' ' 14' ' ' ILE . 6.5 p -60.0 129.24 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -173.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -133.17 140.07 47.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.813 170.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.728 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 28.0 tp10 -70.53 -50.56 36.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.335 177.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.869 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 27.9 t-20 -149.13 171.05 17.06 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.275 -174.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -50.05 -29.93 9.78 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.194 0.308 . . . . 0.0 111.061 171.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.869 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 12.9 pt-20 -61.31 -29.95 70.19 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.956 0.408 . . . . 0.0 110.881 175.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.728 ' HG3' ' HB3' ' A' ' 18' ' ' GLU . 13.6 mm-40 -95.24 -0.22 53.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.264 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.17 159.69 25.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.303 0.573 . . . . 0.0 112.145 -172.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.588 ' HB2' HD12 ' A' ' 27' ' ' ILE . 29.7 mtmt -115.39 161.96 17.8 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.688 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.44 166.01 10.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.888 0.375 . . . . 0.0 111.977 -177.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.13 -49.43 3.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.063 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.757 ' H ' HD11 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -91.46 149.59 39.75 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.721 0.296 . . . . 0.0 110.62 178.115 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 1.081 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 52.0 Cg_exo -60.72 171.01 3.89 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 123.264 2.643 . . . . 0.0 112.891 176.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.511 HG21 ' HB2' ' A' ' 60' ' ' ASN . 26.4 m -130.74 131.4 44.72 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.921 -176.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.549 HD11 HD21 ' A' ' 112' ' ' LEU . 65.3 mt -110.0 114.13 46.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.664 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.598 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 9.5 mm -100.39 109.93 26.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 25.5 ptm -111.96 131.83 55.14 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.857 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.634 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 77.3 m-85 -97.53 120.55 38.11 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.217 -176.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.546 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -125.6 162.23 25.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.997 -174.587 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.3 t -135.89 164.92 26.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.061 0.457 . . . . 0.0 110.648 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.482 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . 24.3 t70 -75.79 -27.75 58.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.799 -178.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.1 m -81.82 -66.55 0.87 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.042 -174.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.592 ' HB3' ' HD2' ' A' ' 40' ' ' TYR . 29.9 m -68.69 122.12 83.62 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.223 -176.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -79.01 3.72 7.17 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.437 2.091 . . . . 0.0 113.332 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.592 ' HD2' ' HB3' ' A' ' 38' ' ' CYS . 96.1 m-85 -61.4 -23.94 66.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.996 0.427 . . . . 0.0 110.614 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 9.2 p -64.71 -52.02 59.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.245 177.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.413 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 41.7 t -60.47 -30.99 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.71 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -68.02 -49.89 58.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.438 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.2 ttt -66.02 -30.3 70.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.863 0.363 . . . . 0.0 110.199 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.673 ' HB3' ' HG2' ' A' ' 12' ' ' GLN . 28.2 mt-30 -60.93 -37.27 81.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.023 176.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 43.7 mttp -64.49 -47.83 77.47 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.853 0.359 . . . . 0.0 110.046 177.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.5 ' O ' HG21 ' A' ' 51' ' ' VAL . 21.0 mm-40 -57.28 -44.27 83.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.299 177.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.5 mt -60.7 -34.1 73.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.971 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.5 m -59.87 -44.57 94.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.075 0.464 . . . . 0.0 110.29 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -70.05 -29.5 66.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.047 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 47' ' ' GLU . 50.9 t -76.22 -47.01 32.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.629 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.6 ' HB3' ' OE2' ' A' ' 56' ' ' GLU . 15.1 m -62.81 -29.17 70.52 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-O 120.881 0.372 . . . . 0.0 110.513 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -50.11 -32.96 17.17 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.184 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -104.32 -48.57 3.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.388 0.613 . . . . 0.0 109.365 171.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.647 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 9.4 tpp85 -91.02 66.52 5.83 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.915 -173.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.658 ' CD ' ' HB ' ' A' ' 14' ' ' ILE . 3.9 mm-40 -90.52 144.73 25.5 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.005 172.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.45 34.2 54.55 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.491 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.647 ' HB2' ' HG3' ' A' ' 55' ' ' ARG . 26.8 mmtp -113.05 -14.09 13.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.251 0.548 . . . . 0.0 109.727 -174.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.547 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 0.8 OUTLIER -165.68 -175.01 3.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.398 179.008 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.511 ' HB2' HG21 ' A' ' 29' ' ' THR . 44.1 m-80 -108.2 129.28 55.2 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.209 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 61' ' ' ILE . 36.3 mm -106.64 107.54 22.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 173.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.85 ' CE2' ' HA ' ' A' ' 19' ' ' ASN . 0.7 OUTLIER -98.2 112.1 24.2 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.448 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.455 ' CE2' HG23 ' A' ' 16' ' ' VAL . 89.7 m-85 -89.8 102.75 15.45 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 173.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.596 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -79.67 91.03 5.2 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.591 ' C ' ' H ' ' A' ' 67' ' ' GLU . 8.0 ptp180 -68.97 104.21 2.04 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.443 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.7 mp -65.42 10.74 0.08 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.092 0.472 . . . . 0.0 110.907 176.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.591 ' H ' ' C ' ' A' ' 65' ' ' ARG . 2.0 mp0 -83.29 -29.44 28.36 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.012 177.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.529 ' CD ' ' HZ1' ' A' ' 70' ' ' LYS . 22.6 mt-10 -102.48 -171.67 2.0 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-O 121.379 0.609 . . . . 0.0 112.48 -175.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -95.17 -35.35 11.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.966 -174.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.529 ' HZ1' ' CD ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -56.33 -28.17 58.13 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.408 0.623 . . . . 0.0 111.144 -176.376 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.524 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 3.6 m120 -87.69 -8.45 56.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.435 -170.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.8 mm -68.3 -57.86 7.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.46 -38.89 91.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.2 174.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.566 ' HG ' ' HH ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -58.86 -38.91 79.85 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.312 179.343 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.634 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -61.14 -48.23 82.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.062 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -65.55 -34.17 77.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.809 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -57.91 -33.8 69.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.041 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.438 ' CD1' HG13 ' A' ' 87' ' ' VAL . 72.6 m-85 -115.81 16.99 16.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.902 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 61.9 35.02 16.6 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.006 170.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.452 ' HB2' HG22 ' A' ' 85' ' ' THR . . . -91.65 146.1 24.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.696 -176.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -154.58 -35.01 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.45 174.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.0 mt -91.94 134.9 28.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.787 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 84' ' ' PRO . 16.1 m -108.34 134.74 20.1 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.568 176.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 63.5 Cg_endo -91.7 141.79 11.14 Favored 'Cis proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.321 -1.533 . . . . 0.0 112.509 -0.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.452 HG22 ' HB2' ' A' ' 80' ' ' ALA . 9.0 t -126.06 147.18 49.63 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.5 t -141.17 130.39 23.52 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.891 0.376 . . . . 0.0 110.462 -177.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.598 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 8.8 p -113.61 128.29 70.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.382 0.611 . . . . 0.0 110.198 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.505 ' HB3' HD23 ' A' ' 115' ' ' LEU . 88.8 m-85 -100.03 118.54 36.62 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.147 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.587 ' O ' ' HB3' ' A' ' 28' ' ' PRO . 7.1 mp -106.12 139.43 40.65 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.159 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -68.77 177.51 2.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 173.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.859 ' HE3' ' HE2' ' A' ' 118' ' ' LYS . 4.5 pttm -63.16 -26.19 68.7 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 122.36 0.264 . . . . 0.0 111.596 -176.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -71.13 -25.56 62.63 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.747 0.308 . . . . 0.0 110.967 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.99 22.29 10.96 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.671 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 59.3 m-80 -86.81 132.09 33.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.687 0.244 . . . . 0.0 110.484 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -71.4 84.3 0.8 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.428 0.633 . . . . 0.0 109.724 173.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -73.03 -47.82 41.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.081 -174.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -145.21 116.68 8.04 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.127 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 87' ' ' VAL . 7.2 p -105.67 137.02 37.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 174.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -124.05 136.04 53.99 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -116.5 110.35 18.48 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 175.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 135.3 158.79 8.4 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -175.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.3 tp -77.9 141.78 38.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.757 0.313 . . . . 0.0 111.131 -176.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.455 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 54.7 mtm -131.63 166.89 20.43 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -102.67 175.03 5.63 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -54.85 -48.43 72.9 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.403 ' HA ' ' CD ' ' A' ' 109' ' ' GLU . 5.0 t-20 -66.51 -28.52 68.63 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.007 0.432 . . . . 0.0 110.811 -176.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.499 ' O ' HG12 ' A' ' 111' ' ' ILE . 11.2 m120 -66.16 -45.48 80.79 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 176.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.511 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 54.2 mt -61.71 -45.5 98.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.597 175.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.403 ' CD ' ' HA ' ' A' ' 106' ' ' ASN . 40.9 mt-10 -50.37 -48.29 55.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.528 176.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.3 m -65.25 -40.09 93.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.068 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 107' ' ' ASN . 49.1 mm -68.27 -43.52 84.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.516 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.549 HD21 HD11 ' A' ' 30' ' ' ILE . 98.2 mt -57.2 -43.54 82.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.18 0.514 . . . . 0.0 110.51 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -60.48 -43.2 97.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.117 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.0 m -86.53 -2.58 58.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.816 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.505 HD23 ' HB3' ' A' ' 88' ' ' PHE . 63.5 tp -82.85 -69.93 0.59 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.971 0.415 . . . . 0.0 111.869 -174.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.773 ' O ' ' HG2' ' A' ' 118' ' ' LYS . . . 149.32 -3.16 0.63 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.547 -172.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 1.081 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 39.0 t -33.86 107.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.141 0.976 . . . . 0.0 113.283 171.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.859 ' HE2' ' HE3' ' A' ' 91' ' ' LYS . 22.5 pttm 176.4 -172.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.672 -1.149 . . . . 0.0 107.95 177.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.26 158.03 24.0 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 174.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.85 74.41 1.99 Allowed Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.335 -172.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -124.2 -3.21 8.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.702 0.287 . . . . 0.0 111.1 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -113.42 109.66 19.05 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -131.33 -47.94 0.99 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -84.26 157.29 21.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.547 0.689 . . . . 0.0 112.565 -168.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -149.14 135.66 19.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.146 175.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.1 p80 . . . . . 0 C--N 1.322 -0.601 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.711 177.688 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 tpt . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.714 0.292 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.5 m 72.85 -58.1 0.61 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.25 0.62 . . . . 0.0 111.351 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.486 HD11 ' H ' ' A' ' 5' ' ' GLY . 0.8 OUTLIER -90.11 85.92 6.42 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.865 ' HG3' ' HG2' ' A' ' 8' ' ' GLN . 2.1 mm-40 -93.22 21.98 5.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.474 -174.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.486 ' H ' HD11 ' A' ' 3' ' ' LEU . . . 79.82 -71.46 2.72 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.845 -177.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.1 pt -146.91 -50.54 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.381 . . . . 0.0 111.065 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -138.25 144.71 40.67 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.865 ' HG2' ' HG3' ' A' ' 4' ' ' GLU . 36.8 mt-30 -78.12 99.47 6.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.908 0.385 . . . . 0.0 110.52 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.5 tp -158.2 154.93 4.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.29 142.43 47.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.209 0.528 . . . . 0.0 111.86 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.434 ' HD1' ' H ' ' A' ' 11' ' ' PHE . 2.9 p90 -88.57 4.0 48.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.232 -177.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -60.47 -33.72 72.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.77 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.552 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 5.6 m -93.94 -18.44 21.92 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.106 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.0 mt 64.59 -68.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 O-C-N 123.681 0.613 . . . . 0.0 111.133 -173.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -89.15 45.82 1.33 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.061 0.458 . . . . 0.0 110.641 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.552 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 2.4 p -79.71 123.12 36.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.603 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.546 HG11 ' HB1' ' A' ' 23' ' ' ALA . 41.0 t -109.65 141.93 23.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.104 -175.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -83.14 -33.64 26.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.756 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.802 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 20.1 t-20 -173.33 175.58 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.7 mt -60.58 -29.74 69.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.019 0.438 . . . . 0.0 110.447 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.802 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 12.0 pt-20 -65.13 -32.25 73.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.554 176.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -93.31 7.8 42.96 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.493 0.663 . . . . 0.0 110.122 178.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.546 ' HB1' HG11 ' A' ' 17' ' ' VAL . . . -110.24 158.58 18.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.249 -176.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 50.2 tptt -133.24 135.61 45.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.117 175.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.06 163.63 27.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.785 0.326 . . . . 0.0 110.269 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.58 -35.72 3.23 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.62 ' H ' HD11 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -116.0 145.54 35.06 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.177 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.554 ' HD2' ' O ' ' A' ' 58' ' ' LYS . 99.4 Cg_exo -44.93 133.61 10.82 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.17 2.58 . . . . 0.0 112.757 177.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.4 m -101.4 109.25 21.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.366 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.652 HD13 ' HB2' ' A' ' 59' ' ' PHE . 2.4 mp -98.67 108.19 21.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.692 ' HB ' HG23 ' A' ' 87' ' ' VAL . 67.8 mt -104.35 112.02 36.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.069 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.701 ' HE2' ' HG ' ' A' ' 41' ' ' CYS . 4.5 ppp? -109.55 144.15 38.24 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.492 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 87.5 m-85 -104.84 130.34 52.99 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.776 -177.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.847 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 12.5 pttp -143.98 149.06 36.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.108 -172.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.426 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 1.4 m -74.04 -174.18 1.81 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 168.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.42 ' H ' HG21 ' A' ' 35' ' ' THR . 7.0 t70 -54.12 -75.36 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.798 0.332 . . . . 0.0 110.812 175.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.1 m -110.88 127.17 55.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.861 0.363 . . . . 0.0 110.696 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.617 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 44.0 m -146.3 134.76 10.87 Favored Pre-proline 0 C--O 1.235 0.313 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.325 178.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.28 -31.19 14.67 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.116 1.877 . . . . 0.0 113.044 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -68.74 -28.7 67.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.926 0.393 . . . . 0.0 110.694 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.701 ' HG ' ' HE2' ' A' ' 32' ' ' MET . 58.8 m -74.37 -42.38 59.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.694 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.0 p -70.5 -29.58 39.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.161 0.505 . . . . 0.0 110.19 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -66.02 -46.23 78.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.898 175.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.426 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 23.8 ttt -63.16 -35.28 79.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.518 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.446 ' HG2' ' OH ' ' A' ' 63' ' ' TYR . 37.7 mt-30 -57.78 -40.63 80.28 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.192 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -58.68 -50.5 73.65 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.542 ' HG3' ' HA ' ' A' ' 104' ' ' ARG . 70.0 mm-40 -59.96 -40.26 88.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.098 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.797 HD11 HD11 ' A' ' 61' ' ' ILE . 96.7 mt -60.28 -43.66 96.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.492 177.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.9 t -62.99 -37.07 85.7 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.177 0.513 . . . . 0.0 110.15 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.592 ' HA ' ' HE3' ' A' ' 53' ' ' LYS . 23.0 m-85 -64.05 -23.94 67.52 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.567 177.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.524 HG22 ' HE3' ' A' ' 105' ' ' LYS . 46.3 t -83.15 -43.18 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.8 m -55.41 -31.86 62.2 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.16 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.625 ' HZ1' ' HB2' ' A' ' 53' ' ' LYS . 10.1 mtmp? -62.27 -35.16 78.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.786 0.327 . . . . 0.0 111.103 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.56 ' OE1' ' HB2' ' A' ' 53' ' ' LYS . 1.7 mp0 -103.96 9.0 36.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.554 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -154.83 92.8 1.49 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -172.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.12 116.48 7.26 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.119 0.485 . . . . 0.0 109.698 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 59' ' ' PHE . . . 47.02 -105.75 0.12 Allowed Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.168 -173.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.554 ' O ' ' HD2' ' A' ' 28' ' ' PRO . 0.3 OUTLIER 53.58 8.33 0.13 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.826 -1.187 . . . . 0.0 112.946 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.652 ' HB2' HD13 ' A' ' 30' ' ' ILE . 9.5 p90 -163.21 114.14 1.43 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.565 0.698 . . . . 0.0 110.414 174.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.492 ' HB3' HG22 ' A' ' 17' ' ' VAL . 5.4 m-20 -84.15 116.2 22.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.796 174.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.797 HD11 HD11 ' A' ' 48' ' ' LEU . 26.7 mt -96.33 107.91 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.746 -176.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.559 ' HB3' HG12 ' A' ' 31' ' ' ILE . 4.4 t80 -91.18 117.23 29.45 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.492 ' HD2' ' HD3' ' A' ' 34' ' ' LYS . 44.1 m-85 -91.48 106.46 18.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.782 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' A' ' 33' ' ' PHE . . . -83.13 69.83 9.95 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.775 0.797 . . . . 0.0 109.447 178.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.847 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 26.1 ptt180 -62.52 118.45 7.58 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.965 175.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.64 10.24 0.14 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.873 0.368 . . . . 0.0 111.618 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.533 ' H ' ' C ' ' A' ' 65' ' ' ARG . 17.9 mt-10 -69.05 -40.95 78.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.543 0.687 . . . . 0.0 109.974 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.58 ' HB2' ' HD2' ' A' ' 70' ' ' LYS . 27.0 mt-10 -89.83 151.99 21.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.908 -174.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -70.7 -34.21 71.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.216 0.531 . . . . 0.0 110.173 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.58 ' HD2' ' HB2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -58.15 -27.1 63.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.883 179.02 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.488 ' N ' ' HD3' ' A' ' 70' ' ' LYS . 76.8 m-20 -87.47 -3.41 59.0 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.223 -178.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.4 mm -70.72 -43.1 77.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 171.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -71.77 -41.35 68.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.217 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.401 ' HG ' ' HH ' ' A' ' 62' ' ' TYR . 0.8 OUTLIER -60.85 -47.42 86.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.205 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.492 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -62.93 -48.65 77.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.833 0.349 . . . . 0.0 110.967 178.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -61.42 -34.48 75.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.657 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -57.18 -33.22 67.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.181 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.438 ' CE1' ' HD3' ' A' ' 95' ' ' LYS . 85.3 m-85 -111.66 12.53 21.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.961 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.2 t70 67.33 21.86 9.69 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.433 0.635 . . . . 0.0 111.24 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.73 93.43 4.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.898 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -112.75 -8.15 13.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.454 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.511 HD13 ' H ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -125.17 153.39 32.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.001 178.552 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.7 m -131.27 153.22 81.61 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.455 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -90.59 145.65 16.64 Favored 'Cis proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.282 -1.549 . . . . 0.0 112.662 -0.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.1 t -142.61 149.55 39.13 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.3 m -138.6 131.12 28.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.684 0.278 . . . . 0.0 111.35 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.692 HG23 ' HB ' ' A' ' 31' ' ' ILE . 5.5 m -102.4 120.87 52.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.893 173.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -96.55 118.38 32.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.221 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.457 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 6.6 mp -113.68 145.06 41.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.75 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -63.93 171.66 2.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.949 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.805 ' HZ1' ' HB2' ' A' ' 92' ' ' GLU . 2.2 pptp? -52.04 -25.1 7.79 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.901 0.881 . . . . 0.0 112.756 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.805 ' HB2' ' HZ1' ' A' ' 91' ' ' LYS . 21.6 tt0 -92.1 -4.81 53.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.069 0.462 . . . . 0.0 111.036 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.98 29.07 24.12 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.827 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.499 ' ND2' ' HB3' ' A' ' 92' ' ' GLU . 6.4 p30 -110.06 134.04 52.57 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.457 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 35.1 mtmm -65.56 147.07 54.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.061 0.457 . . . . 0.0 111.202 -175.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -127.58 -46.27 1.45 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.132 173.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.498 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 81.4 t80 -147.45 134.09 19.91 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.466 -175.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.496 ' HB ' HG11 ' A' ' 87' ' ' VAL . 3.1 p -116.85 140.36 39.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 173.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.498 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 31.3 t60 -135.85 146.75 47.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -114.88 135.95 53.64 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.69 -149.04 18.34 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.12 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.3 tp -127.11 144.86 50.93 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.515 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 3.4 mpp? -131.28 165.02 24.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.354 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.542 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 32.3 mmt180 -103.22 168.21 9.32 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 173.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.579 ' HG3' ' N ' ' A' ' 106' ' ' ASN . 5.1 ptmt -54.93 -43.11 73.04 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -171.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.579 ' N ' ' HG3' ' A' ' 105' ' ' LYS . 12.9 t-20 -66.21 -32.23 73.53 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.908 0.385 . . . . 0.0 111.074 -178.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 103' ' ' MET . 9.1 m120 -66.74 -42.89 85.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.562 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 60.5 mt -62.59 -48.47 88.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.825 174.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -49.52 -51.79 34.01 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.109 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 m -63.16 -41.11 99.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.998 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 107' ' ' ASN . 42.9 mm -63.52 -40.9 90.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 91.0 mt -64.98 -37.45 87.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.594 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -60.74 -39.3 88.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.846 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.3 t -85.49 -10.49 56.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.471 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.5 tp -82.96 -56.25 3.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.523 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 168.83 -79.2 0.1 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.279 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.523 HG21 ' HB3' ' A' ' 112' ' ' LEU . 57.5 t 52.43 81.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.774 0.797 . . . . 0.0 111.623 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.506 ' CD ' ' HG2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -165.83 -165.36 0.81 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.866 -179.228 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.438 ' HB2' ' CE ' ' A' ' 118' ' ' LYS . 7.8 tp10 80.38 153.15 0.12 Allowed 'General case' 0 C--O 1.234 0.277 0 O-C-N 124.432 1.083 . . . . 0.0 111.576 174.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 177.41 -2.83 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.826 -178.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -89.47 92.07 8.97 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 117.736 0.768 . . . . 0.0 110.619 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -59.36 -34.77 72.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.287 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -127.48 139.52 52.75 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.086 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -98.4 -33.02 11.21 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -86.6 150.91 23.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.949 176.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 . . . . . 0 C--O 1.246 0.918 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.094 173.586 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtm . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.8 p -116.12 103.8 10.91 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.14 -48.72 1.33 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.628 0.728 . . . . 0.0 110.118 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.608 ' CD ' ' H ' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -94.85 -74.89 0.53 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.966 -172.789 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.608 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 116.26 -2.04 20.69 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 -175.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 34.6 pt -126.62 -3.31 4.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.071 0.462 . . . . 0.0 110.854 -177.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.437 ' C ' ' H ' ' A' ' 9' ' ' ILE . 50.9 tptt -111.9 7.76 20.13 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -76.54 29.86 0.12 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.927 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.49 HG12 ' HB3' ' A' ' 13' ' ' SER . 13.9 tt -82.0 50.92 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 122.526 1.155 . . . . 0.0 109.317 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -70.83 -30.24 66.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.131 -176.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.599 ' HD2' ' HG3' ' A' ' 12' ' ' GLN . 30.3 p90 -120.07 168.44 11.18 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.22 -178.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.599 ' HG3' ' HD2' ' A' ' 11' ' ' PHE . 88.1 mt-30 62.46 23.78 14.12 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.875 0.735 . . . . 0.0 110.119 -175.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.536 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . 8.4 p -122.8 -92.15 0.54 Allowed 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -169.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.1 mt 70.81 -74.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 123.322 0.649 . . . . 0.0 111.719 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -97.39 23.33 7.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.658 -174.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.536 ' CG2' ' HB2' ' A' ' 13' ' ' SER . 15.9 m -75.43 138.67 20.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.781 0.8 . . . . 0.0 112.732 -174.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' A' ' 60' ' ' ASN . 48.6 t -121.81 124.84 72.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.558 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.412 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . 6.5 tp10 -59.42 -54.61 44.71 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.221 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.648 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 4.1 t30 -158.9 168.87 25.67 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.49 -29.16 34.74 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -170.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -66.58 -29.13 69.12 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.318 -0.239 . . . . 0.0 111.356 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.412 ' HG2' ' HB3' ' A' ' 18' ' ' GLU . 4.1 mp0 -80.43 -12.11 59.6 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.44 144.93 56.82 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.511 ' HD3' ' H ' ' A' ' 25' ' ' GLU . 5.0 tmtt? -127.9 151.69 48.77 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.356 -173.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.511 ' H ' ' HD3' ' A' ' 24' ' ' LYS . 25.6 mm-40 60.29 -164.11 0.23 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.928 175.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -119.19 47.65 1.01 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.917 -174.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.612 HD12 ' H ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -99.15 158.45 32.26 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 171.687 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -53.95 158.59 8.62 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.936 2.424 . . . . 0.0 112.504 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.5 m -127.21 128.99 46.98 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.063 0.459 . . . . 0.0 110.856 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.736 HD13 HD21 ' A' ' 112' ' ' LEU . 80.9 mt -98.23 108.18 21.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.591 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.828 ' HB ' HG23 ' A' ' 87' ' ' VAL . 22.5 mm -95.82 109.33 22.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 24.8 ptm -121.68 136.14 54.95 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.034 -0.667 . . . . 0.0 111.075 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.807 ' HZ ' ' HB2' ' A' ' 78' ' ' TYR . 47.1 m-85 -96.48 119.9 35.81 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.343 -178.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.611 ' HG3' ' HB3' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -130.87 132.59 45.26 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.509 -170.021 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.692 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 7.3 m -99.96 162.87 12.72 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.96 -49.77 55.08 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.6 m -66.8 -52.55 42.69 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -171.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.718 ' SG ' HG23 ' A' ' 83' ' ' VAL . 2.7 p -70.99 125.55 92.02 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -167.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.635 ' O ' HG23 ' A' ' 42' ' ' VAL . 69.5 Cg_endo -75.79 -9.81 19.78 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.094 2.529 . . . . 0.0 112.653 175.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -59.47 -29.81 68.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.486 0.66 . . . . 0.0 109.768 174.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.611 ' HB3' ' HG3' ' A' ' 34' ' ' LYS . 75.0 m -78.93 -36.9 41.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.649 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 39' ' ' PRO . 2.8 m -68.44 -30.62 48.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.34 -177.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.484 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 1.8 mt-10 -61.97 -48.28 81.05 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.824 0.345 . . . . 0.0 110.78 173.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -37.75 78.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.637 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 27.6 mt-30 -58.3 -49.59 76.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.903 175.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 73.3 mmtt -58.04 -43.31 86.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.162 0.506 . . . . 0.0 110.062 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.577 ' O ' HG22 ' A' ' 51' ' ' VAL . 52.0 mm-40 -62.47 -46.86 86.58 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.199 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.0 mt -59.77 -34.82 73.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.466 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.6 m -57.62 -45.87 84.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.209 0.528 . . . . 0.0 110.271 176.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -76.77 -30.36 56.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.754 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 47' ' ' GLU . 77.9 t -62.9 -41.76 93.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -65.13 -36.6 84.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.338 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -74.38 -15.6 60.92 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -109.82 -1.83 17.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.474 0.654 . . . . 0.0 109.977 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -145.7 75.31 1.42 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.356 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -67.12 118.41 10.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.791 -175.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.09 62.64 5.92 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.292 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -134.93 2.32 3.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.805 0.302 . . . . 0.0 111.086 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -168.65 145.07 3.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.412 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.537 ' HB3' HG21 ' A' ' 17' ' ' VAL . 47.4 m-80 -90.88 128.83 36.9 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.145 176.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.7 mt -103.68 108.0 23.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.648 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 55.0 t80 -92.36 114.98 27.68 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.051 177.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -92.35 105.07 17.34 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.135 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.556 ' HB3' ' CE2' ' A' ' 62' ' ' TYR . . . -88.27 75.78 8.5 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.63 ' C ' ' H ' ' A' ' 67' ' ' GLU . 26.2 ptt180 -68.22 113.78 6.14 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.642 177.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.15 12.0 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.104 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.63 ' H ' ' C ' ' A' ' 65' ' ' ARG . 1.4 mp0 -83.23 -20.88 33.75 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.011 -175.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -112.83 -176.8 2.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.0 0.428 . . . . 0.0 111.083 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.41 -31.45 16.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.097 -175.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.484 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -61.37 -29.53 69.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.572 0.701 . . . . 0.0 110.79 -175.667 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.484 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 3.6 m120 -81.78 -11.61 58.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.705 -174.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.5 mm -72.03 -51.33 31.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.098 0.475 . . . . 0.0 110.181 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -67.19 -37.89 84.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.103 177.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.46 -43.75 98.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.897 177.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.704 ' HA ' ' CE1' ' A' ' 33' ' ' PHE . . . -52.06 -56.01 17.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.385 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -69.3 -33.53 73.32 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.062 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -59.22 -26.57 64.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.124 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.807 ' HB2' ' HZ ' ' A' ' 33' ' ' PHE . 79.7 m-85 -119.92 21.43 11.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.735 -178.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 69.66 33.49 2.98 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 167.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.438 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . . . -71.61 152.9 42.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.002 0.429 . . . . 0.0 110.977 176.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -141.25 -81.15 0.24 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.14 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 34.4 pt -113.23 171.18 3.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.718 HG23 ' SG ' ' A' ' 38' ' ' CYS . 19.4 m -101.9 150.89 37.8 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-O 120.522 0.201 . . . . 0.0 111.34 -176.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -92.78 116.43 2.34 Favored 'Cis proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.617 -1.41 . . . . 0.0 112.654 -1.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.727 HG23 ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -96.04 135.64 37.54 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.59 HG23 ' HB3' ' A' ' 99' ' ' HIS . 6.1 t -144.74 132.12 20.77 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.125 178.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.828 HG23 ' HB ' ' A' ' 31' ' ' ILE . 3.9 m -112.34 116.77 53.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.796 175.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.542 ' HB3' HD23 ' A' ' 115' ' ' LEU . 92.5 m-85 -90.61 116.96 28.9 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.769 -177.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 27.6 mt -102.38 137.4 40.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.721 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -73.07 -171.79 0.96 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.957 ' HG2' ' HB2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -69.99 -24.76 63.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.888 -0.508 . . . . 0.0 111.73 -175.114 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.549 ' HB2' ' ND2' ' A' ' 94' ' ' ASN . 8.3 mm-40 -81.23 -6.25 58.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.397 0.617 . . . . 0.0 109.348 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.46 31.71 40.49 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.21 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.549 ' ND2' ' HB2' ' A' ' 92' ' ' GLU . 35.3 m-80 -93.26 143.19 26.5 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.912 177.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -72.28 85.82 1.09 Allowed 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.865 0.728 . . . . 0.0 109.519 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -85.43 -50.79 7.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.276 -172.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.416 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 73.3 t80 -133.64 126.79 31.6 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.675 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.616 HG13 HG13 ' A' ' 87' ' ' VAL . 3.6 m -103.69 151.53 6.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.59 ' HB3' HG23 ' A' ' 86' ' ' THR . 55.8 t60 -142.8 140.89 31.53 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.727 ' NE2' HG23 ' A' ' 85' ' ' THR . 5.7 tp-100 -127.93 138.35 52.61 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 172.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.97 173.68 29.03 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.717 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.9 tp -75.03 152.31 38.68 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.364 0.602 . . . . 0.0 111.253 -175.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.626 ' SD ' HG12 ' A' ' 108' ' ' ILE . 5.3 ptp -146.42 137.96 24.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.206 172.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.456 ' O ' HG13 ' A' ' 108' ' ' ILE . 18.1 tpp180 -85.99 171.57 11.33 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.535 ' HG3' HG21 ' A' ' 51' ' ' VAL . 47.9 tttm -45.98 -57.33 4.5 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -174.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.41 -36.36 75.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.673 0.273 . . . . 0.0 111.163 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.632 ' O ' HG12 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -62.9 -48.91 76.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.617 178.093 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.626 HG12 ' SD ' ' A' ' 103' ' ' MET . 25.6 mt -59.12 -47.36 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.81 0.814 . . . . 0.0 110.281 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -62.74 -41.32 99.13 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.98 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.483 ' O ' ' HB3' ' A' ' 113' ' ' ASN . 59.5 m -64.23 -30.62 71.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.577 177.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.632 HG12 ' O ' ' A' ' 107' ' ' ASN . 50.6 mm -67.62 -36.64 76.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.513 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.736 HD21 HD13 ' A' ' 30' ' ' ILE . 25.3 mt -60.7 -38.78 86.15 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 110' ' ' THR . 17.1 t30 -59.92 -44.74 94.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.957 176.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.5 p -72.33 -30.14 64.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.736 0.303 . . . . 0.0 111.036 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.542 HD23 ' HB3' ' A' ' 88' ' ' PHE . 3.9 mp -63.2 -55.13 27.62 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.31 0.576 . . . . 0.0 109.93 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 148.2 -53.58 0.53 Allowed Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.245 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.0 t 50.42 75.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -171.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.957 ' HB2' ' HG2' ' A' ' 91' ' ' LYS . 25.4 mtpp -104.59 26.03 9.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.616 -162.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -112.96 128.02 56.38 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.622 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.58 55.92 3.83 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.918 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -92.96 83.61 4.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.352 0.596 . . . . 0.0 110.043 173.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -119.29 41.36 3.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.393 -176.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -55.71 130.69 44.25 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.196 0.522 . . . . 0.0 111.141 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -149.78 138.33 20.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.374 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -64.08 128.17 34.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.781 0.324 . . . . 0.0 110.753 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 . . . . . 0 C--O 1.246 0.887 0 CA-C-O 118.284 -0.865 . . . . 0.0 109.491 174.775 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptm . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.1 t -109.17 149.76 28.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -129.63 101.28 5.84 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.703 ' HG3' ' HE3' ' A' ' 7' ' ' LYS . 0.4 OUTLIER -130.25 150.62 51.41 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.646 177.572 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.673 ' HA3' ' HB3' ' A' ' 18' ' ' GLU . . . -133.89 -28.97 0.48 Allowed Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.594 176.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.405 HG22 ' HB3' ' A' ' 22' ' ' GLU . 32.3 pt -68.98 -21.83 25.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.108 0.48 . . . . 0.0 110.976 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.703 ' HE3' ' HG3' ' A' ' 4' ' ' GLU . 27.5 ttpp -92.32 -11.54 34.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.387 0.613 . . . . 0.0 109.999 177.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -104.68 22.04 15.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.628 -174.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.456 HG13 ' H ' ' A' ' 11' ' ' PHE . 39.4 pt -76.51 -25.93 16.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.869 -177.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.7 t30 67.52 6.26 4.84 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.09 0.556 . . . . 0.0 111.635 176.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.456 ' H ' HG13 ' A' ' 9' ' ' ILE . 22.4 m-85 66.86 177.16 0.23 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.465 -177.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 68.81 -50.6 0.58 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.041 -171.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.452 ' HB3' HG13 ' A' ' 16' ' ' VAL . 15.5 m -67.81 92.62 0.36 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.285 168.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.8 mt -96.3 137.34 24.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.462 -177.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 94.3 m-20 66.86 24.96 9.63 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.842 0.714 . . . . 0.0 110.971 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.671 HG11 HD13 ' A' ' 61' ' ' ILE . 11.7 m -102.01 157.24 4.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.642 0.258 . . . . 0.0 110.855 -176.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.549 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 5.3 p -146.47 157.45 11.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.083 0.468 . . . . 0.0 111.488 -176.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.673 ' HB3' ' HA3' ' A' ' 5' ' ' GLY . 9.7 tp10 -82.66 -55.18 4.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.617 174.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.688 ' HA ' ' CE2' ' A' ' 62' ' ' TYR . 18.7 t-20 -136.72 160.38 39.0 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.854 -173.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.1 mt -53.3 -35.06 59.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.38 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -65.42 -31.54 72.69 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.726 0.298 . . . . 0.0 111.008 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.405 ' HB3' HG22 ' A' ' 6' ' ' ILE . 31.5 mm-40 -79.42 -15.5 57.71 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.408 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.09 111.6 6.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 0.0 110.394 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.78 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 10.6 mmpt? -88.08 145.67 25.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.318 0.58 . . . . 0.0 111.928 -177.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 58.13 -166.12 0.16 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.677 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -105.26 72.22 0.23 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.097 -175.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.04 149.9 39.71 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 174.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.802 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 53.3 Cg_exo -54.11 141.55 68.76 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.573 2.182 . . . . 0.0 111.416 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 m -111.68 120.61 42.6 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.875 0.369 . . . . 0.0 111.169 -175.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.436 HD11 ' CD2' ' A' ' 88' ' ' PHE . 17.3 mm -106.85 122.5 60.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.668 ' HB ' ' CG2' ' A' ' 87' ' ' VAL . 69.2 mt -114.69 115.65 50.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.919 -174.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.65 ' HE2' ' HB3' ' A' ' 84' ' ' PRO . 2.5 tpt -109.85 116.5 31.77 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.678 177.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.639 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 85.4 m-85 -83.64 118.28 23.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.347 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.948 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 6.4 pttt -132.39 146.54 52.04 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.416 -169.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m -67.8 138.54 56.24 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 158.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.539 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 18.8 t0 -57.14 -32.63 66.56 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.076 0.465 . . . . 0.0 111.075 -168.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.1 m -124.6 92.35 3.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.428 173.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 18.2 p -138.3 142.01 33.67 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.338 177.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.48 -28.1 62.14 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.383 2.056 . . . . 0.0 112.927 -177.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -66.83 -31.09 71.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.913 0.387 . . . . 0.0 110.291 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 45' ' ' GLN . 53.0 t -71.75 -35.07 69.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.008 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 45.5 t -69.59 -46.11 76.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.558 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.438 ' HG2' HD22 ' A' ' 102' ' ' LEU . 4.4 tp10 -61.64 -49.64 75.76 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.755 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.406 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 19.8 ttt -66.58 -29.12 69.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.197 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' A' ' 41' ' ' CYS . 23.0 tm0? -60.0 -41.78 92.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.016 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -62.82 -47.81 81.81 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.571 ' O ' HG21 ' A' ' 51' ' ' VAL . 16.2 mm-40 -57.84 -47.34 82.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.522 177.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.461 HD12 HD11 ' A' ' 61' ' ' ILE . 97.9 mt -58.67 -41.7 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.731 178.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.9 m -57.17 -41.56 79.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.638 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.517 ' CB ' ' HD2' ' A' ' 105' ' ' LYS . 21.1 m-85 -65.95 -37.04 84.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.737 178.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.571 HG21 ' O ' ' A' ' 47' ' ' GLU . 41.2 t -72.63 -50.68 32.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.931 -177.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.7 m -60.73 -31.54 70.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 0.0 111.121 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -57.65 -29.96 65.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.382 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -110.38 -2.04 16.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.987 -175.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.528 ' HB2' ' HG3' ' A' ' 58' ' ' LYS . 17.1 ptp180 -146.73 97.69 2.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.004 0.906 . . . . 0.0 110.768 174.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -82.24 133.05 35.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.953 -178.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.06 35.95 71.84 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.462 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HG3' ' HB2' ' A' ' 55' ' ' ARG . 41.4 mmtm -112.43 -4.05 14.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.933 0.397 . . . . 0.0 110.963 -178.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 28' ' ' PRO . 6.2 p90 -176.03 138.31 0.34 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.191 173.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.549 ' OD1' ' HB ' ' A' ' 17' ' ' VAL . 7.5 t-20 -105.6 124.04 48.91 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.671 HD13 HG11 ' A' ' 16' ' ' VAL . 40.5 mt -89.22 107.61 18.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.291 0.567 . . . . 0.0 111.207 -175.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.688 ' CE2' ' HA ' ' A' ' 19' ' ' ASN . 10.7 t80 -88.49 106.19 18.12 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.89 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.905 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 75.6 m-85 -78.93 102.29 8.2 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.347 176.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 33' ' ' PHE . . . -85.85 74.48 10.18 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.24 0.543 . . . . 0.0 109.859 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.948 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 12.4 ptt85 -63.55 116.98 6.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.787 175.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.7 tp -74.24 9.57 1.59 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.033 0.444 . . . . 0.0 110.473 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 36' ' ' ASP . 0.3 OUTLIER -82.53 -18.65 40.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.191 -175.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -113.21 154.51 26.61 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.187 0.518 . . . . 0.0 111.128 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -32.55 74.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.207 -172.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -26.56 68.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.021 0.439 . . . . 0.0 111.672 -175.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.467 ' HA ' ' CB ' ' A' ' 74' ' ' LEU . 91.2 m-20 -90.51 1.11 57.01 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.48 -176.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.6 mm -70.69 -50.43 44.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 173.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -72.78 -34.08 66.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.481 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.467 ' CB ' ' HA ' ' A' ' 71' ' ' ASN . 1.1 tm? -60.18 -45.82 91.8 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.639 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -57.59 -49.99 74.57 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.994 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -64.41 -34.76 78.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.927 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -62.44 -20.06 64.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.965 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.544 ' HB3' HG13 ' A' ' 87' ' ' VAL . 77.3 m-85 -124.55 15.95 8.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.076 -177.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.8 t70 65.22 27.3 12.22 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.927 0.87 . . . . 0.0 110.826 172.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.72 104.01 15.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.425 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.456 HD21 HG21 ' A' ' 82' ' ' ILE . 4.2 t30 -107.1 -39.74 5.64 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.75 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.456 HG21 HD21 ' A' ' 81' ' ' ASN . 30.1 pt -107.08 171.93 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.033 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.04 145.02 53.96 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.733 174.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.65 ' HB3' ' HE2' ' A' ' 32' ' ' MET . 74.4 Cg_endo -81.02 157.26 84.09 Favored 'Cis proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.36 -1.517 . . . . 0.0 112.606 -0.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.546 ' OG1' ' HB2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -145.84 129.33 16.94 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.771 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.7 m -123.26 116.38 23.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.224 0.535 . . . . 0.0 111.45 -176.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.668 ' CG2' ' HB ' ' A' ' 31' ' ' ILE . 13.2 m -102.86 135.05 42.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.176 174.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.511 ' HB3' HD22 ' A' ' 115' ' ' LEU . 79.5 m-85 -107.15 112.79 25.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.499 -176.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.461 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 6.2 mp -111.17 145.79 38.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.727 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.539 ' OD1' ' HA3' ' A' ' 116' ' ' GLY . 10.6 t70 -80.11 -165.87 0.92 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.569 ' HZ3' ' CD ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -79.4 8.59 5.93 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -168.463 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.569 ' CD ' ' HZ3' ' A' ' 91' ' ' LYS . 34.7 mt-10 -127.42 21.22 6.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.87 0.367 . . . . 0.0 111.187 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.28 14.32 74.11 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.95 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -85.59 125.38 33.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.063 0.459 . . . . 0.0 109.957 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.481 ' HD3' HG21 ' A' ' 98' ' ' VAL . 5.0 tmmm? -82.68 109.54 16.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.888 -177.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -97.26 -59.72 1.73 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.24 -177.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.426 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 76.8 t80 -119.7 149.21 42.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.651 0.262 . . . . 0.0 110.801 -173.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.587 HG13 HG11 ' A' ' 87' ' ' VAL . 9.6 t -130.74 139.84 50.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.426 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 6.2 t60 -147.86 133.49 18.82 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.459 ' CD ' HG23 ' A' ' 85' ' ' THR . 3.3 mm-40 -106.32 158.37 16.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.623 0.249 . . . . 0.0 110.342 -173.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.96 -153.12 20.74 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.588 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.438 HD22 ' HG2' ' A' ' 43' ' ' GLU . 57.8 tp -114.21 120.98 42.32 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.739 0.304 . . . . 0.0 110.475 -176.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.526 ' HE3' HG13 ' A' ' 111' ' ' ILE . 74.9 mtp -111.21 162.24 15.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.893 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -105.44 171.2 7.46 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.174 -0.21 . . . . 0.0 110.537 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.517 ' HD2' ' CB ' ' A' ' 50' ' ' TYR . 52.5 tttp -47.4 -58.83 3.71 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.726 0.641 . . . . 0.0 111.974 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 3.8 m-20 -53.73 -33.56 56.04 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.081 0.467 . . . . 0.0 111.834 -176.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.514 ' O ' HG12 ' A' ' 111' ' ' ILE . 5.7 m120 -73.72 -46.57 45.29 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.355 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.551 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 57.1 mt -58.78 -43.56 88.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.767 174.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 105' ' ' LYS . 71.6 mm-40 -48.71 -56.37 8.76 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.844 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.5 m -72.4 -37.82 68.58 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.486 -174.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.526 HG13 ' HE3' ' A' ' 103' ' ' MET . 38.8 mm -63.43 -41.62 93.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.839 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 86.5 mt -62.44 -39.03 92.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.92 0.391 . . . . 0.0 110.155 176.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -62.81 -37.4 86.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.745 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.5 t -76.98 -37.51 55.03 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.581 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.511 HD22 ' HB3' ' A' ' 88' ' ' PHE . 51.8 tp -57.94 -70.93 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.614 178.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.539 ' HA3' ' OD1' ' A' ' 90' ' ' ASP . . . -175.44 -74.44 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.01 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.802 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 85.6 t 55.72 76.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.971 0.891 . . . . 0.0 109.847 -174.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 20.6 pttm -159.34 103.18 1.6 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.469 -174.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -71.25 -40.34 71.07 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.54 8.28 77.51 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.73 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -81.5 93.78 6.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.109 0.48 . . . . 0.0 110.273 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -126.05 108.29 11.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.474 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -83.7 120.96 26.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.127 0.489 . . . . 0.0 110.568 -177.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -90.41 -22.98 21.18 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -76.09 170.6 15.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.367 173.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.08 -174.364 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.628 ' HB3' HG11 ' A' ' 16' ' ' VAL . 33.4 m . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 121.237 0.541 . . . . 0.0 109.718 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 15' ' ' ASN . 96.1 mt -107.02 146.09 13.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.56 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 84.4 m-20 71.21 13.94 6.68 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.602 0.564 . . . . 0.0 110.159 -174.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.628 HG11 ' HB3' ' A' ' 13' ' ' SER . 4.5 m -105.4 166.27 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.889 -174.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.707 HG21 ' HB2' ' A' ' 23' ' ' ALA . 12.4 m -141.34 147.99 21.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.427 ' H ' ' HG2' ' A' ' 18' ' ' GLU . 1.6 mm-40 -64.19 -51.09 65.43 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.264 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.863 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 14.5 t-20 -148.36 169.3 20.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.732 -176.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.631 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 56.9 mt -60.48 -27.53 67.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.912 0.387 . . . . 0.0 110.305 174.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -57.44 -33.8 68.31 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.79 174.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -91.03 -27.41 18.65 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.972 0.415 . . . . 0.0 110.871 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.707 ' HB2' HG21 ' A' ' 17' ' ' VAL . . . -71.9 156.82 38.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.596 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.494 ' HD2' ' O ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -131.89 -177.81 4.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.606 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.501 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -103.73 174.96 5.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.622 -175.561 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.69 -62.86 1.93 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.738 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -77.66 127.69 81.71 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.636 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 1.016 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 85.9 Cg_exo -48.58 143.74 15.51 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.806 2.337 . . . . 0.0 112.1 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.484 HG23 ' OD1' ' A' ' 60' ' ' ASN . 23.8 m -115.64 124.51 51.09 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.225 -171.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 30' ' ' ILE . 2.9 mp -109.22 117.62 54.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.653 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 2.3 mm -105.62 116.43 49.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.063 -175.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.48 ' O ' ' HG3' ' A' ' 32' ' ' MET . 26.5 ptm -110.77 112.3 24.07 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.707 0.765 . . . . 0.0 110.107 174.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 81.6 m-85 -83.64 128.32 34.43 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.018 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.638 ' HE2' ' CB ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -142.77 142.27 31.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.696 -175.002 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.445 ' O ' ' HE3' ' A' ' 34' ' ' LYS . 1.2 p -75.0 170.87 15.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 174.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -49.68 -74.55 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 O-C-N 123.358 0.411 . . . . 0.0 110.798 176.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -88.88 110.84 21.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.961 0.41 . . . . 0.0 110.316 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.499 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 5.9 p -152.73 121.32 3.21 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.037 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 8.0 Cg_exo -72.11 -35.97 6.33 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.523 2.149 . . . . 0.0 112.839 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -61.81 -24.37 66.83 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.591 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.628 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 49.7 t -61.95 -50.12 73.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.069 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.5 t -59.49 -44.84 93.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 5.7 tp10 -55.79 -46.79 77.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.928 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.507 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 23.4 ttt -73.85 -30.49 62.7 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.053 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.628 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 94.2 mt-30 -59.43 -48.44 81.62 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 121.458 -0.097 . . . . 0.0 110.988 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -65.54 -36.06 82.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.522 0.201 . . . . 0.0 111.196 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -59.03 -44.86 91.81 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.18 0.514 . . . . 0.0 109.812 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.806 HD13 HG21 ' A' ' 61' ' ' ILE . 97.9 mt -62.42 -35.91 80.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.056 178.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -58.89 -40.63 85.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.916 0.389 . . . . 0.0 110.228 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.472 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 20.2 m-85 -65.7 -43.31 89.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.322 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.441 HG22 ' HG3' ' A' ' 105' ' ' LYS . 48.7 t -62.1 -42.66 95.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.464 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.4 m -65.74 -31.69 72.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.13 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -61.24 -40.52 94.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.73 176.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.56 -10.37 54.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.586 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.85 84.3 1.97 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.957 0.408 . . . . 0.0 111.168 -177.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -78.98 123.51 27.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.916 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.42 73.92 0.37 Allowed Glycine 0 C--N 1.332 0.313 0 O-C-N 123.596 0.56 . . . . 0.0 113.297 173.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.922 ' HD2' HG12 ' A' ' 117' ' ' VAL . 9.6 mmtt -144.14 -36.73 0.33 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.987 0.423 . . . . 0.0 110.941 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.405 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 39.1 p90 -144.88 168.87 19.2 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.57 HD22 HG12 ' A' ' 27' ' ' ILE . 8.9 p30 -118.25 137.9 52.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.27 0.557 . . . . 0.0 110.723 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.806 HG21 HD13 ' A' ' 48' ' ' LEU . 52.6 mt -104.08 109.72 28.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.118 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.863 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 2.6 t80 -95.01 118.51 31.96 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.926 0.393 . . . . 0.0 110.559 -178.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.521 ' CE1' ' HG2' ' A' ' 45' ' ' GLN . 81.0 m-85 -83.45 103.26 12.67 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 173.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.519 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -90.8 86.15 6.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.377 0.608 . . . . 0.0 109.968 -173.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.638 ' CB ' ' HE2' ' A' ' 34' ' ' LYS . 17.8 ptt180 -77.49 129.01 35.16 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.508 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.3 tp -73.2 12.32 0.59 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.71 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.598 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 10.4 mt-10 -79.98 -13.63 59.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.574 -175.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -116.88 170.48 8.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.338 -173.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.48 -33.53 25.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.158 -176.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.621 ' HD2' ' H ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -61.95 -26.41 68.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.894 0.378 . . . . 0.0 110.702 -177.563 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.648 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 78.5 m-20 -87.79 3.77 46.89 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.909 -176.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.8 mt -72.17 -58.68 4.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 171.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.49 -38.8 84.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.137 175.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.648 ' HB2' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -56.09 -46.18 79.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.199 176.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.26 -56.45 19.86 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.686 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -67.56 -33.54 75.25 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.573 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -63.36 -24.6 67.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.983 0.42 . . . . 0.0 110.788 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.568 ' CE1' HD21 ' A' ' 89' ' ' LEU . 95.0 m-85 -122.05 22.48 10.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.884 -176.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 66.95 29.17 8.3 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.523 0.514 . . . . 0.0 111.556 166.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.402 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -87.33 113.56 23.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.885 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.532 ' ND2' HG13 ' A' ' 82' ' ' ILE . 3.8 p-10 -138.71 -2.53 1.73 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.271 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.532 HG13 ' ND2' ' A' ' 81' ' ' ASN . 50.5 mt -136.78 142.22 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 34' ' ' LYS . 99.5 t -101.15 129.3 27.39 Favored Pre-proline 0 C--N 1.319 -0.729 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.667 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 58.4 Cg_endo -95.11 135.18 5.24 Favored 'Cis proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.423 -1.49 . . . . 0.0 113.42 -0.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.594 HG23 ' HG2' ' A' ' 100' ' ' GLN . 19.9 m -87.73 107.5 18.67 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.2 m -100.94 108.03 19.66 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.653 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 6.8 p -108.2 126.16 64.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.445 0.64 . . . . 0.0 110.128 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 1.005 ' HB3' HD11 ' A' ' 115' ' ' LEU . 89.0 m-85 -99.22 119.4 37.83 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.579 -177.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.568 HD21 ' CE1' ' A' ' 78' ' ' TYR . 5.6 mp -115.31 141.73 47.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.817 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 25.1 t70 -75.15 -164.48 0.31 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.526 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 6.1 pttm -53.3 -42.86 67.05 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -168.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.492 ' OE1' ' HG2' ' A' ' 91' ' ' LYS . 0.5 OUTLIER -99.26 6.06 46.41 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.056 -0.403 . . . . 0.0 111.396 -176.268 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.562 ' HA2' ' HB3' ' A' ' 89' ' ' LEU . . . 94.66 30.2 8.7 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.759 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 90.1 m-20 -70.92 106.49 3.65 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.403 -0.469 . . . . 0.0 109.93 173.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.452 ' HG3' ' CG2' ' A' ' 87' ' ' VAL . 39.0 ttpt -64.69 100.41 0.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 176.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -98.45 -50.38 4.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.291 -176.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.511 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 91.7 t80 -137.47 122.0 18.44 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.171 -0.611 . . . . 0.0 111.8 -174.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.551 HG12 HG23 ' A' ' 87' ' ' VAL . 11.5 m -103.14 147.04 10.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 172.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.511 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 15.9 t60 -145.4 119.01 9.12 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.594 ' HG2' HG23 ' A' ' 85' ' ' THR . 39.3 mt-30 -102.93 106.22 16.73 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 143.41 160.84 8.58 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.445 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.533 HD21 ' HG2' ' A' ' 43' ' ' GLU . 45.9 tp -71.56 149.75 45.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.935 0.398 . . . . 0.0 111.243 -176.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 69.9 mtm -141.03 -170.14 2.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.19 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.491 HH12 ' CD ' ' A' ' 43' ' ' GLU . 33.2 mmt180 -131.27 165.97 22.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.378 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.472 ' HD2' ' HB3' ' A' ' 50' ' ' TYR . 55.6 tttm -44.7 -56.83 4.1 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.116 0.885 . . . . 0.0 112.299 -176.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -51.93 -47.31 64.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.345 0.593 . . . . 0.0 111.601 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.609 ' O ' HG12 ' A' ' 111' ' ' ILE . 47.0 m-20 -73.84 -40.45 63.29 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.931 -172.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.533 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 60.9 mt -60.21 -47.02 93.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.577 0.703 . . . . 0.0 109.301 174.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -62.98 -39.95 96.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.219 -175.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 57.9 m -64.42 -35.93 82.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.162 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 107' ' ' ASN . 40.8 mm -70.26 -34.95 60.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.632 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 20.9 mt -60.38 -42.89 96.79 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.714 0.769 . . . . 0.0 108.987 174.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -62.1 -30.39 70.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.901 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.9 m -76.05 -30.25 58.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.977 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 1.005 HD11 ' HB3' ' A' ' 88' ' ' PHE . 51.6 mt -70.58 -59.95 2.54 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 122.185 0.993 . . . . 0.0 109.081 174.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 145.86 -44.95 0.83 Allowed Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.371 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.016 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 19.2 t 46.58 61.35 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 122.112 0.958 . . . . 0.0 109.397 -176.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 mttm . . . . . 0 CA--C 1.512 -0.5 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.848 -169.309 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.506 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 14.9 m . . . . . 0 N--CA 1.444 -0.753 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.416 ' O ' HG22 ' A' ' 14' ' ' ILE . 46.7 mt -86.66 2.87 4.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.792 0.806 . . . . 0.0 110.69 -174.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -117.47 16.37 14.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.623 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 12.6 p -85.01 143.59 11.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -171.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.952 ' HB ' ' HB2' ' A' ' 22' ' ' GLU . 27.5 m -128.34 152.95 37.15 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.222 169.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -75.51 -35.1 60.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.349 -174.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.732 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 51.5 t30 -163.41 -176.09 4.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.692 -177.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.1 mt -61.52 -30.6 70.74 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.4 mp0 -56.87 -45.56 82.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.329 176.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.952 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . 5.4 mm-40 -76.69 -24.76 53.17 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.591 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.91 153.25 43.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.682 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.589 ' NZ ' ' HA ' ' A' ' 24' ' ' LYS . 2.4 tpmp? -145.4 156.26 43.66 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.995 -175.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -73.51 179.88 3.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.049 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.85 -59.82 4.87 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -175.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.419 HG13 ' HB2' ' A' ' 60' ' ' ASN . 6.5 pt -90.32 121.9 68.02 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.525 -0.338 . . . . 0.0 110.165 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.945 ' HG3' ' H ' ' A' ' 117' ' ' VAL . 16.5 Cg_endo -57.26 138.51 86.55 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.64 2.227 . . . . 0.0 111.009 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.2 m -103.52 123.76 47.51 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.256 0.551 . . . . 0.0 111.923 -172.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.607 HD11 HD11 ' A' ' 112' ' ' LEU . 75.2 mt -98.63 113.26 32.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 173.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.759 ' HB ' HG23 ' A' ' 87' ' ' VAL . 58.4 mt -107.03 111.98 37.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.35 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.458 ' HG2' ' HD1' ' A' ' 63' ' ' TYR . 21.8 ptm -109.8 129.63 55.61 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.061 176.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.554 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 92.0 m-85 -94.33 112.78 24.59 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.605 ' HB2' ' HB3' ' A' ' 41' ' ' CYS . 55.6 pttt -117.75 138.73 51.84 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.446 -170.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.467 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 0.7 OUTLIER -71.18 149.67 46.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.969 174.43 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -70.31 -45.12 66.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.98 -177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.2 t -94.75 9.77 37.67 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.467 ' SG ' ' HB ' ' A' ' 35' ' ' THR . 76.6 m -106.72 122.19 42.6 Favored Pre-proline 0 C--N 1.327 -0.409 0 O-C-N 121.845 -0.535 . . . . 0.0 111.065 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 6.3 Cg_exo -78.01 -2.88 12.97 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.391 2.061 . . . . 0.0 113.179 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -65.57 -15.95 63.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.935 0.397 . . . . 0.0 110.796 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.605 ' HB3' ' HB2' ' A' ' 34' ' ' LYS . 24.9 p -68.84 -43.79 74.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.818 175.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.2 t -62.89 -30.63 49.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.279 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.529 ' HA ' ' NZ ' ' A' ' 46' ' ' LYS . 7.5 tp10 -58.69 -51.99 67.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.346 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.9 ttt -75.03 -37.31 61.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.54 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.498 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 16.5 mt-30 -59.2 -43.64 92.23 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.76 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.529 ' NZ ' ' HA ' ' A' ' 43' ' ' GLU . 22.7 pttm -70.13 -41.87 73.35 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.446 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.542 ' O ' HG23 ' A' ' 51' ' ' VAL . 24.1 mm-40 -51.03 -49.91 59.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.898 0.38 . . . . 0.0 110.386 172.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.435 HD13 HG21 ' A' ' 61' ' ' ILE . 71.2 mt -60.73 -37.66 82.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.515 177.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.8 m -67.59 -37.35 82.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.782 0.325 . . . . 0.0 110.712 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -65.12 -33.5 76.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.523 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 47' ' ' GLU . 21.7 t -73.2 -40.89 58.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.892 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.2 m -56.84 -30.65 64.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.142 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.524 ' HZ3' ' HB3' ' A' ' 53' ' ' LYS . 4.6 ttpm? -52.49 -36.53 55.28 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.756 176.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -109.84 -18.44 13.41 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.204 0.526 . . . . 0.0 110.756 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.58 ' HB3' ' HB2' ' A' ' 58' ' ' LYS . 11.5 mpt_? -111.96 74.55 0.87 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.367 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.73 116.48 22.7 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.84 35.14 91.58 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.467 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.58 ' HB2' ' HB3' ' A' ' 55' ' ' ARG . 12.7 mptt -101.76 -20.02 15.12 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -165.41 153.99 11.76 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.165 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.419 ' HB2' HG13 ' A' ' 27' ' ' ILE . 39.8 t-20 -103.92 138.1 40.97 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.339 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.435 HG21 HD13 ' A' ' 48' ' ' LEU . 11.0 mt -117.34 111.87 36.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.714 0.292 . . . . 0.0 110.943 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.732 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 3.3 t80 -98.84 118.41 35.52 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.498 ' CE1' ' HG2' ' A' ' 45' ' ' GLN . 21.7 m-85 -94.65 103.57 15.5 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.398 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.554 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -80.58 87.16 5.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.163 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.501 ' C ' ' H ' ' A' ' 67' ' ' GLU . 1.8 ptm180 -69.59 123.71 22.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.139 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 34' ' ' LYS . 5.4 tp -69.75 11.2 0.29 Allowed 'General case' 0 C--N 1.322 -0.613 0 O-C-N 122.025 -0.422 . . . . 0.0 110.933 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 65' ' ' ARG . 21.0 mt-10 -82.47 -19.73 38.28 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.7 -173.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.44 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 46.2 mt-10 -117.04 151.29 37.09 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -59.81 -31.03 69.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.103 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.451 ' HD2' ' OD1' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -58.95 -25.92 63.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.268 -178.691 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.451 ' OD1' ' HD2' ' A' ' 70' ' ' LYS . 10.4 m120 -91.19 -12.18 36.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.963 -176.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.5 mt -71.16 -48.63 53.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.98 -43.56 92.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.762 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -58.52 -42.88 88.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.403 178.514 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.26 -57.38 12.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.441 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -67.23 -33.25 74.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.608 0.242 . . . . 0.0 111.258 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.417 ' HB2' ' NZ ' ' A' ' 77' ' ' LYS . 3.3 ttmp? -63.01 -28.85 70.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.972 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -112.01 8.23 20.11 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 71.72 26.84 3.0 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.599 0.562 . . . . 0.0 111.877 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.75 103.67 10.75 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.175 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -117.72 -35.45 3.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.823 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 12.4 mt -112.57 130.1 66.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.49 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.8 m -102.35 140.47 21.16 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.67 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -86.82 147.7 35.56 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.34 -1.525 . . . . 0.0 112.085 -0.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.0 t -140.78 149.73 42.46 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.4 t -140.71 142.01 34.88 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.22 0.533 . . . . 0.0 110.606 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.816 HG12 HG12 ' A' ' 98' ' ' VAL . 6.2 m -115.49 127.89 72.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.79 176.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.416 ' CD1' ' HD2' ' A' ' 97' ' ' TYR . 83.0 m-85 -97.56 118.74 34.75 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.485 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 6.4 mp -108.35 141.51 40.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.79 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 46.6 t0 -80.18 -179.19 6.94 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.463 ' HZ3' ' CD ' ' A' ' 92' ' ' GLU . 7.9 pttm -49.57 -32.11 11.93 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -175.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.463 ' CD ' ' HZ3' ' A' ' 91' ' ' LYS . 32.6 mp0 -69.26 -29.0 66.81 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 122.087 -0.383 . . . . 0.0 111.338 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.33 30.37 7.01 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.972 -173.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 2.5 p-10 -105.59 132.99 51.06 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 175.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.423 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 16.6 ptmt -75.73 117.79 17.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.832 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -106.45 -54.83 2.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.989 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.419 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 73.0 t80 -109.61 135.17 51.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.105 -174.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.816 HG12 HG12 ' A' ' 87' ' ' VAL . 29.3 m -111.82 148.02 15.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.419 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 38.0 t60 -145.84 131.84 19.25 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -117.9 149.81 40.26 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 176.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.38 -124.0 8.1 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.62 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.415 ' HG ' ' N ' ' A' ' 103' ' ' MET . 27.3 tp -136.53 167.94 20.43 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 122.731 -0.276 . . . . 0.0 110.336 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.415 ' N ' ' HG ' ' A' ' 102' ' ' LEU . 20.3 ptm -168.6 147.08 4.17 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.405 ' HD3' ' HA ' ' A' ' 104' ' ' ARG . 23.3 mmt180 -89.87 168.67 11.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.18 -177.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -53.07 -41.46 64.9 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.234 -177.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -65.83 -35.37 80.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.876 0.37 . . . . 0.0 110.475 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.529 ' O ' HG12 ' A' ' 111' ' ' ILE . 11.7 m120 -64.48 -47.32 79.4 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.2 mt -59.32 -50.8 78.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.099 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -51.88 -50.14 61.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.746 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.2 m -65.16 -38.15 89.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.659 0.266 . . . . 0.0 111.094 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 107' ' ' ASN . 39.9 mm -63.61 -47.26 92.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 177.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.607 HD11 HD11 ' A' ' 30' ' ' ILE . 83.2 mt -62.66 -39.43 93.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.047 0.451 . . . . 0.0 110.055 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -54.71 -44.85 73.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.239 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.5 m -86.14 -23.87 26.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.878 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.0 tp -91.12 -64.97 1.05 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -175.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.69 ' HA2' ' HZ3' ' A' ' 118' ' ' LYS . . . -139.03 -122.82 2.04 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 119.989 -1.1 . . . . 0.0 113.816 -169.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.945 ' H ' ' HG3' ' A' ' 28' ' ' PRO . 12.7 t 58.44 35.14 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 122.152 0.977 . . . . 0.0 109.075 -173.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HZ3' ' HA2' ' A' ' 116' ' ' GLY . 37.2 mtmm . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.223 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.806 ' HB3' HG21 ' A' ' 16' ' ' VAL . 44.8 m . . . . . 0 N--CA 1.441 -0.919 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.9 mt -108.41 -61.21 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.885 0.374 . . . . 0.0 111.092 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 7.2 m-20 -85.25 30.18 0.62 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.662 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.806 HG21 ' HB3' ' A' ' 13' ' ' SER . 20.4 m -91.54 155.56 3.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -166.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.55 HG11 ' HB2' ' A' ' 23' ' ' ALA . 47.1 t -136.21 143.01 37.04 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.441 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -71.97 -45.89 59.39 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.201 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.62 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 19.1 t30 -164.02 176.12 9.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.831 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.669 HD11 HD11 ' A' ' 74' ' ' LEU . 86.2 mt -49.03 -36.7 18.63 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -174.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.545 ' OE2' ' HB3' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -77.24 -27.42 53.32 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -172.329 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -77.73 -10.65 59.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.713 0.292 . . . . 0.0 111.355 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.55 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -87.9 171.43 10.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.955 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.721 ' HZ3' ' HB3' ' A' ' 24' ' ' LYS . 4.2 mtpm? -136.08 152.89 51.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.011 0.434 . . . . 0.0 111.644 177.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.65 170.77 15.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.542 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.3 -29.02 5.83 Favored Glycine 0 CA--C 1.504 -0.619 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.598 ' HB ' ' HA ' ' A' ' 59' ' ' PHE . 22.9 pt -113.55 131.08 23.17 Favored Pre-proline 0 C--N 1.315 -0.899 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 1.051 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 54.7 Cg_exo -56.59 162.79 7.79 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 123.047 2.498 . . . . 0.0 113.111 -174.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.1 m -122.97 122.66 39.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.179 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.436 HD12 ' N ' ' A' ' 30' ' ' ILE . 2.5 mp -104.61 109.19 26.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 174.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.423 HG12 ' HB3' ' A' ' 62' ' ' TYR . 64.3 mt -105.45 113.85 43.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.468 -177.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.491 ' O ' ' HG3' ' A' ' 32' ' ' MET . 25.1 ptm -108.91 112.99 25.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.639 0.733 . . . . 0.0 110.057 178.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.744 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 90.1 m-85 -76.36 114.12 14.71 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.535 177.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.523 ' HG3' ' SG ' ' A' ' 41' ' ' CYS . 0.1 OUTLIER -138.77 148.99 44.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.133 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.0 t -97.99 -173.2 2.54 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -55.99 -51.44 67.72 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.701 0.625 . . . . 0.0 110.769 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -92.73 -162.52 0.94 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.615 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.436 ' HB3' ' HD2' ' A' ' 40' ' ' TYR . 50.7 m 74.61 106.02 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.491 0 C-N-CA 123.639 0.776 . . . . 0.0 110.993 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 2.7 Cg_exo -74.74 3.45 5.46 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.561 2.174 . . . . 0.0 113.145 -176.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.436 ' HD2' ' HB3' ' A' ' 38' ' ' CYS . 80.0 m-85 -65.3 -27.28 68.5 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.523 ' SG ' ' HG3' ' A' ' 34' ' ' LYS . 42.3 t -64.58 -55.05 22.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.646 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.531 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 12.7 p -63.42 -31.09 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.772 0.32 . . . . 0.0 110.99 -175.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -68.14 -49.49 60.67 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.214 0.53 . . . . 0.0 110.21 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.1 ttt -67.75 -29.4 68.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.174 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 51.8 mt-30 -61.21 -38.7 87.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.128 175.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.531 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 81.5 mttt -60.1 -49.34 78.05 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.382 0.611 . . . . 0.0 109.671 175.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.551 ' O ' HG23 ' A' ' 51' ' ' VAL . 9.9 mm-40 -57.06 -48.79 77.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.413 176.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.474 HD13 HG21 ' A' ' 61' ' ' ILE . 91.9 mt -60.12 -29.79 68.85 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.29 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 68.6 m -62.12 -47.46 84.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.068 0.461 . . . . 0.0 110.412 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -73.02 -33.56 65.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.28 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 47' ' ' GLU . 57.8 t -67.46 -36.73 77.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.106 0.479 . . . . 0.0 110.167 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.0 m -66.26 -30.74 71.23 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.053 175.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -74.03 -28.78 61.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.391 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -70.47 -47.26 61.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.086 174.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.651 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 1.2 ttm180 -123.43 75.18 1.3 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.808 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -69.79 118.51 12.73 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.749 -172.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.46 50.76 60.61 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.575 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.651 ' HB2' ' HG2' ' A' ' 55' ' ' ARG . 39.0 mmtm -136.03 8.59 3.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.693 0.282 . . . . 0.0 110.79 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.598 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 50.5 p90 -169.93 149.03 3.59 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.488 ' ND2' HG13 ' A' ' 27' ' ' ILE . 15.3 m-80 -88.86 135.19 33.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.484 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.474 HG21 HD13 ' A' ' 48' ' ' LEU . 60.7 mt -114.68 106.18 20.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 168.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.62 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 4.0 t80 -96.32 116.67 29.4 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -76.93 103.95 7.15 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 174.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.744 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -77.45 72.82 4.02 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.699 ' HD2' ' OE2' ' A' ' 68' ' ' GLU . 2.6 ptp180 -69.61 109.79 4.5 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 113.624 -1.625 . . . . 0.0 111.515 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.8 tp -72.24 4.67 3.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.729 -177.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.673 ' CD ' ' HB2' ' A' ' 65' ' ' ARG . 5.6 pm0 -83.04 -13.98 54.75 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.121 0.486 . . . . 0.0 110.056 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.699 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 62.1 mt-10 -106.55 144.29 33.44 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.912 175.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -21.38 62.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.034 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.519 ' HG3' ' HB3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -55.8 -23.25 28.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.221 0.534 . . . . 0.0 112.026 177.099 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.652 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 22.7 m-20 -88.1 8.96 24.31 Favored 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -177.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 77.7 mt -71.47 -50.71 38.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 168.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -68.03 -48.67 65.04 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.52 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.669 HD11 HD11 ' A' ' 20' ' ' LEU . 4.4 mm? -58.4 -41.66 85.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.373 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.458 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -56.76 -56.65 18.83 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 120.501 0.191 . . . . 0.0 111.047 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -65.32 -33.95 77.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.758 0.313 . . . . 0.0 111.042 -176.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.557 ' HZ2' ' HB2' ' A' ' 77' ' ' LYS . 4.1 ttmp? -64.2 -25.61 68.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.112 0.482 . . . . 0.0 110.88 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.688 ' HB3' HG21 ' A' ' 87' ' ' VAL . 89.2 m-85 -120.34 22.71 11.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.015 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 68.44 16.84 9.19 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.334 0.588 . . . . 0.0 111.333 169.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' A' ' 75' ' ' ALA . . . -83.94 140.51 31.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.908 -176.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -151.76 -40.2 0.11 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.65 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 22.8 pt -116.73 160.44 16.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.975 173.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.07 152.52 60.13 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.924 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -91.84 149.57 16.61 Favored 'Cis proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.038 -1.651 . . . . 0.0 112.428 -0.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.8 t -138.06 129.82 28.27 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.1 m -108.5 123.25 48.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.931 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.688 HG21 ' HB3' ' A' ' 78' ' ' TYR . 67.1 t -105.16 117.65 51.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.78 176.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -96.03 111.11 23.22 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.402 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -100.04 138.95 36.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.337 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.8 -172.67 0.53 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.616 ' NZ ' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -67.14 -26.14 66.52 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.068 -0.395 . . . . 0.0 112.056 -176.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.616 ' HG2' ' NZ ' ' A' ' 91' ' ' LYS . 38.6 mm-40 -75.05 -47.11 30.54 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.91 20.99 1.42 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.814 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 92' ' ' GLU . 43.7 m-80 -78.13 133.1 37.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -71.04 86.35 0.73 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.202 176.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -86.73 -51.59 6.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.206 -172.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -137.5 125.91 23.42 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.454 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.6 m -112.14 149.51 14.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 173.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -146.27 122.39 10.8 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.41 115.08 27.73 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 135.37 -168.72 23.69 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.3 tp -90.54 149.85 22.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.77 0.319 . . . . 0.0 110.46 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 56.1 mmm -127.09 161.6 28.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.417 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 10.1 mmm180 -113.37 168.53 9.66 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.4 ' HE2' ' HB2' ' A' ' 105' ' ' LYS . 14.3 ptmm? -57.3 -47.62 81.03 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -172.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.505 ' HA ' ' OE1' ' A' ' 109' ' ' GLU . 14.8 t-20 -64.23 -32.29 73.82 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.97 0.414 . . . . 0.0 111.2 -177.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.543 ' O ' HG12 ' A' ' 111' ' ' ILE . 9.3 m120 -65.03 -45.79 84.01 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.568 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 53.1 mt -62.94 -50.04 81.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.066 175.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.505 ' OE1' ' HA ' ' A' ' 106' ' ' ASN . 43.7 mt-10 -51.28 -49.77 60.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.755 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.5 m -66.69 -43.91 83.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.008 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 107' ' ' ASN . 40.4 mm -60.22 -43.61 93.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.497 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 57.5 mt -59.91 -39.77 86.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 0.0 111.238 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -61.21 -41.14 96.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.325 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.3 m -86.06 -17.43 35.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.912 0.387 . . . . 0.0 111.443 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.9 tp -66.84 -54.39 22.92 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.626 -173.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.681 ' O ' ' HG2' ' A' ' 118' ' ' LYS . . . 136.69 13.29 0.97 Allowed Glycine 0 N--CA 1.442 -0.967 0 C-N-CA 119.862 -1.161 . . . . 0.0 112.872 -177.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.051 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 61.9 t -43.14 100.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.152 0.501 . . . . 0.0 111.888 167.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 29.7 pttt . . . . . 0 C--O 1.221 -0.438 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 120.574 0.226 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.0 mt 70.96 -60.1 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.066 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.525 HD21 ' HA2' ' A' ' 57' ' ' GLY . 14.6 m120 -83.3 30.4 0.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.263 0.554 . . . . 0.0 110.749 177.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.583 HG23 ' CE2' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -80.1 126.73 39.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.622 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.537 HG11 ' HB2' ' A' ' 23' ' ' ALA . 73.2 t -119.74 132.97 68.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.943 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -71.24 -54.69 10.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.159 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.634 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 7.0 t30 -155.08 169.56 23.83 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.11 -173.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.1 mt -46.73 -45.16 19.45 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.634 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -77.28 -17.74 58.12 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.282 0.563 . . . . 0.0 110.247 -176.811 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -87.82 17.88 4.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.035 171.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.537 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -122.59 160.41 25.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.301 176.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.433 ' HG3' ' HG2' ' A' ' 25' ' ' GLU . 11.8 ptmm? -173.86 -168.95 0.45 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.521 ' HB2' HD12 ' A' ' 27' ' ' ILE . 4.6 mm-40 75.55 -170.72 0.09 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.106 0.879 . . . . 0.0 110.789 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.586 ' O ' ' HE2' ' A' ' 91' ' ' LYS . . . -117.4 38.18 3.06 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.198 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.666 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -100.81 155.56 36.19 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 110.513 -0.18 . . . . 0.0 110.513 -178.651 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.722 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 32.5 Cg_exo -60.09 144.61 99.47 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.444 2.096 . . . . 0.0 111.63 173.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.9 m -110.96 115.13 28.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.683 -176.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.2 mt -98.71 107.98 21.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.659 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 55.4 mt -99.93 111.94 31.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.147 0.498 . . . . 0.0 109.875 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.542 ' HA ' ' O ' ' A' ' 85' ' ' THR . 8.3 tpt -109.35 108.93 19.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.27 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.585 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 74.3 m-85 -80.2 152.26 29.24 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.678 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.719 ' HE2' ' HB3' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -159.98 155.74 25.94 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 175.765 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.573 ' HA ' ' HB2' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -67.72 -173.09 0.31 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 173.66 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.405 ' H ' HG22 ' A' ' 35' ' ' THR . 7.9 p-10 -51.31 -45.55 62.26 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.752 0.31 . . . . 0.0 110.748 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.6 p -137.96 -98.02 0.19 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.33 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.622 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 34.3 m 65.71 130.13 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 123.465 0.706 . . . . 0.0 111.731 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 13.9 Cg_exo -67.96 -33.61 25.65 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.085 1.857 . . . . 0.0 113.143 -177.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -64.66 -28.68 69.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.912 0.387 . . . . 0.0 110.822 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 38' ' ' CYS . 52.3 m -70.26 -36.56 74.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.987 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 45' ' ' GLN . 41.4 t -75.38 -33.21 27.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.427 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.98 -51.11 63.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.195 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.461 ' HE3' ' HB2' ' A' ' 103' ' ' MET . 25.5 ttt -68.21 -29.37 68.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.193 0.52 . . . . 0.0 109.717 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' A' ' 42' ' ' VAL . 4.6 tp60 -58.12 -38.99 77.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.575 174.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.692 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -67.81 -42.23 81.87 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.402 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 51' ' ' VAL . 7.6 mm-40 -57.9 -45.27 86.7 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.346 0.404 . . . . 0.0 110.479 173.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.544 HD23 HD13 ' A' ' 108' ' ' ILE . 96.1 mt -58.16 -44.13 87.77 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.897 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.1 m -60.21 -37.9 81.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.662 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.565 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 20.2 m-85 -74.85 -28.55 60.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.993 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 47' ' ' GLU . 68.7 t -65.47 -44.25 94.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.6 m -65.32 -31.54 72.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.369 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 50' ' ' TYR . 41.8 tttm -58.73 -39.25 80.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.809 173.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 50' ' ' TYR . 31.6 mm-40 -85.69 -17.9 34.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.843 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.589 ' NE ' ' HA ' ' A' ' 55' ' ' ARG . 3.0 tpm_? -153.0 88.93 1.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 111.569 -176.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.28 147.07 28.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.348 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.525 ' HA2' HD21 ' A' ' 15' ' ' ASN . . . 59.17 39.86 95.01 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.773 -0.648 . . . . 0.0 114.497 171.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 28' ' ' PRO . 69.5 mmtt -133.28 1.52 3.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.207 0.504 . . . . 0.0 110.791 175.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -170.46 153.69 4.39 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.436 ' HB3' HG21 ' A' ' 17' ' ' VAL . 83.1 m-20 -121.28 138.25 54.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.847 0.356 . . . . 0.0 110.428 177.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.5 mp -101.94 108.26 23.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.212 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.695 ' OH ' ' HG ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -89.55 115.23 26.8 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 177.848 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.719 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 86.9 m-85 -95.07 104.18 16.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.02 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.405 ' HB3' ' CD2' ' A' ' 33' ' ' PHE . . . -87.77 107.01 18.45 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.692 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 9.7 ptt180 -105.56 130.24 53.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.228 -177.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.573 ' HB2' ' HA ' ' A' ' 35' ' ' THR . 8.0 mp -71.85 7.73 1.45 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.152 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.685 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 44.7 mt-10 -62.14 -34.26 76.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.415 0.626 . . . . 0.0 109.485 169.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.698 ' HB2' ' HD2' ' A' ' 70' ' ' LYS . 35.6 mt-10 -104.58 172.95 6.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.53 -170.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.471 ' CD ' ' H ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -94.79 -24.35 17.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.779 -177.848 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.755 ' HD3' HD21 ' A' ' 71' ' ' ASN . 0.0 OUTLIER -54.27 -17.55 3.03 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.197 0.522 . . . . 0.0 111.862 176.796 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.755 HD21 ' HD3' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -80.58 -9.76 59.77 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.629 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.2 mm -61.56 -58.75 6.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.602 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -70.54 -40.87 73.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.627 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.695 ' HG ' ' OH ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -62.93 -46.5 87.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.691 -176.58 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.585 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -62.49 -49.52 75.05 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.71 0.291 . . . . 0.0 110.916 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -65.92 -33.93 76.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.06 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -61.8 -25.22 67.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.999 0.428 . . . . 0.0 110.878 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 33' ' ' PHE . 90.2 m-85 -124.48 23.05 8.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.911 -176.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 66.03 25.7 10.9 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.595 0.559 . . . . 0.0 111.442 166.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.76 97.53 8.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.851 0.358 . . . . 0.0 111.238 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -106.07 -36.09 7.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.16 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.9 pt -132.74 141.39 45.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.966 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 84' ' ' PRO . 34.7 m -102.57 157.78 33.04 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.434 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 83' ' ' VAL . 20.8 Cg_exo -67.29 150.48 83.01 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.054 -1.227 . . . . 0.0 112.401 -0.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 32' ' ' MET . 1.2 m -135.06 108.35 7.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -176.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.04 109.04 16.97 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.001 0.429 . . . . 0.0 110.822 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.659 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 12.6 p -100.78 123.97 54.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.516 0.674 . . . . 0.0 109.362 175.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.534 ' HB3' HD22 ' A' ' 115' ' ' LEU . 85.4 m-85 -99.01 110.43 23.04 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.497 -176.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.629 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 6.7 mp -102.83 129.65 49.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.734 176.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -68.35 169.83 9.94 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.774 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.586 ' HE2' ' O ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -61.76 -14.33 31.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -175.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.67 -5.39 58.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 111.26 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.81 10.8 71.86 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.604 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 2.5 p-10 -86.67 131.32 34.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.806 0.336 . . . . 0.0 110.66 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.629 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 20.5 ptmt -77.28 87.17 3.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.217 0.532 . . . . 0.0 109.859 175.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -74.79 -53.64 8.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.618 -173.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.53 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 63.4 t80 -137.54 114.46 10.65 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.866 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 87' ' ' VAL . 4.4 p -96.66 137.0 25.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 172.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.53 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 48.6 t60 -134.1 134.29 42.1 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -175.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -110.41 131.91 54.64 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 173.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 122.75 173.38 14.15 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.264 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.8 tp -82.01 141.12 33.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.824 0.345 . . . . 0.0 111.323 -175.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.461 ' HB2' ' HE3' ' A' ' 44' ' ' MET . 78.4 mmm -134.15 161.29 35.29 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.413 ' O ' HG13 ' A' ' 108' ' ' ILE . 17.5 mmm180 -106.86 171.52 7.32 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.524 ' HE2' ' HB3' ' A' ' 50' ' ' TYR . 36.5 ttmt -46.62 -60.29 2.47 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.6 0.562 . . . . 0.0 112.004 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.569 ' HA ' ' OE1' ' A' ' 109' ' ' GLU . 6.7 t-20 -67.66 -27.46 66.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.065 0.46 . . . . 0.0 111.12 -174.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.496 ' O ' HG12 ' A' ' 111' ' ' ILE . 13.1 m120 -67.4 -42.76 82.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.544 HD13 HD23 ' A' ' 48' ' ' LEU . 56.7 mt -61.7 -46.15 97.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.369 173.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.569 ' OE1' ' HA ' ' A' ' 106' ' ' ASN . 50.9 mt-10 -52.79 -48.03 67.16 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.539 176.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.1 m -61.27 -37.5 83.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.095 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 107' ' ' ASN . 49.7 mm -69.04 -43.79 81.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.328 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.535 ' HB3' ' CG2' ' A' ' 117' ' ' VAL . 72.8 mt -61.7 -39.22 90.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.907 0.384 . . . . 0.0 110.107 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -58.15 -38.05 75.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.799 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.0 m -86.22 -5.74 59.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.029 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.534 HD22 ' HB3' ' A' ' 88' ' ' PHE . 53.9 tp -93.47 -66.72 0.9 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.704 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 174.9 -72.23 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.78 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.722 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 21.4 t 55.32 29.62 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 122.493 1.14 . . . . 0.0 109.719 -177.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.433 ' O ' ' HD2' ' A' ' 91' ' ' LYS . 17.8 pttm . . . . . 0 N--CA 1.447 -0.575 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.962 -175.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.551 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 6.8 m . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 13' ' ' SER . 74.5 mt 74.0 -63.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 123.733 0.645 . . . . 0.0 110.37 -174.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.717 ' HB3' ' HA2' ' A' ' 57' ' ' GLY . 0.5 OUTLIER -87.83 32.08 0.75 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.333 0.587 . . . . 0.0 110.581 174.513 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.672 HG23 ' CE1' ' A' ' 63' ' ' TYR . 1.2 p -86.61 111.35 21.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.789 174.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.584 ' HB ' ' HB2' ' A' ' 22' ' ' GLU . 20.8 m -114.0 136.42 50.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.107 0.479 . . . . 0.0 109.933 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -65.54 -54.46 27.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.894 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.749 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 4.9 t30 -144.87 179.33 7.4 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.295 -174.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.414 HD11 HD23 ' A' ' 74' ' ' LEU . 96.5 mt -48.1 -42.0 27.81 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.261 0.624 . . . . 0.0 112.578 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -58.25 -32.22 68.15 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.584 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . 21.1 mt-10 -84.25 -6.07 59.34 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.49 151.73 26.38 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.188 -0.32 . . . . 0.0 111.136 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -172.41 -171.07 0.77 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 2.4 tp10 72.26 -174.01 0.16 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.43 1.092 . . . . 0.0 111.215 178.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.462 ' H ' ' HG3' ' A' ' 25' ' ' GLU . . . -106.26 36.81 4.16 Favored Glycine 0 CA--C 1.504 -0.611 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.594 HG21 ' HA ' ' A' ' 58' ' ' LYS . 17.6 pt -105.93 150.16 38.91 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 114.45 -0.875 . . . . 0.0 111.228 -170.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 1.062 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 62.5 Cg_exo -57.05 158.94 16.12 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.984 2.456 . . . . 0.0 112.304 175.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.6 m -115.9 121.78 43.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.929 -175.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.483 HD11 HD21 ' A' ' 112' ' ' LEU . 80.0 mt -110.17 108.75 26.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.617 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 61.0 mt -105.57 113.78 43.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.824 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.9 ptm -110.25 120.49 42.62 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.515 0.674 . . . . 0.0 109.474 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.512 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 87.3 m-85 -78.73 125.56 29.53 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.505 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.679 ' HE2' ' HB3' ' A' ' 65' ' ' ARG . 29.2 pttt -116.7 -174.26 2.54 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.755 -171.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.447 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 2.1 m -144.98 154.57 42.7 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.446 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 1.8 t70 -47.58 -51.9 19.55 Favored 'General case' 0 C--N 1.32 -0.674 0 O-C-N 124.239 0.962 . . . . 0.0 111.558 174.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.2 m -116.76 98.74 6.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.64 0.257 . . . . 0.0 111.637 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.447 ' SG ' ' HB ' ' A' ' 35' ' ' THR . 7.3 p -169.46 113.44 0.51 Allowed Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.901 171.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.568 ' O ' HG12 ' A' ' 42' ' ' VAL . 2.4 Cg_endo -80.49 -4.62 13.07 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.533 2.155 . . . . 0.0 113.605 -175.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -74.77 -21.8 59.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.834 0.35 . . . . 0.0 110.477 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 82.5 m -68.53 -43.45 76.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.817 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 39' ' ' PRO . 9.8 p -65.56 -29.31 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 120.93 0.395 . . . . 0.0 110.702 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.665 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -65.14 -48.76 72.45 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.28 0.562 . . . . 0.0 109.68 177.43 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 25.2 ttt -67.69 -30.16 69.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.867 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.563 ' HG2' ' CE2' ' A' ' 63' ' ' TYR . 76.0 mt-30 -56.22 -40.76 74.56 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.384 173.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.665 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 3.6 mtpm? -59.1 -53.98 52.21 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.174 0.511 . . . . 0.0 110.259 177.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -62.21 -41.3 98.26 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.971 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.642 HD13 HG21 ' A' ' 61' ' ' ILE . 84.3 mt -62.22 -43.04 99.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.472 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.3 m -53.61 -44.24 69.29 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.73 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -63.73 -61.7 2.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.219 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.8 t -57.08 -32.16 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.2 0.524 . . . . 0.0 111.284 -175.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.545 ' HB3' ' OD1' ' A' ' 15' ' ' ASN . 68.0 m -66.83 -30.48 70.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.789 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -83.49 -31.14 26.66 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.066 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -71.14 -15.4 62.5 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.424 0.631 . . . . 0.0 110.865 174.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.671 ' HA ' HH11 ' A' ' 55' ' ' ARG . 0.5 OUTLIER -141.86 77.62 1.59 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 174.974 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.579 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 1.3 pm0 -58.27 115.63 3.07 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -161.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.717 ' HA2' ' HB3' ' A' ' 15' ' ' ASN . . . 50.69 33.23 26.38 Favored Glycine 0 CA--C 1.52 0.35 0 CA-C-N 115.012 -0.995 . . . . 0.0 114.43 173.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.594 ' HA ' HG21 ' A' ' 27' ' ' ILE . 27.3 mmtp -109.73 14.93 23.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.571 0.701 . . . . 0.0 111.279 -176.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -159.66 111.03 2.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.199 166.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.427 HD22 HG13 ' A' ' 27' ' ' ILE . 10.8 p30 -76.48 131.38 38.99 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.093 -174.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.642 HG21 HD13 ' A' ' 48' ' ' LEU . 30.1 mm -97.87 108.49 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.445 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.749 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 1.4 t80 -95.87 110.97 23.07 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.672 ' CE1' HG23 ' A' ' 16' ' ' VAL . 36.8 m-85 -90.77 102.04 14.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.059 177.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -78.97 103.98 9.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.8 0.333 . . . . 0.0 111.424 -172.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.679 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 13.6 ptp180 -68.29 123.95 22.15 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.307 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.0 tp -79.8 8.15 7.32 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 121.808 -0.557 . . . . 0.0 109.969 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.453 ' OE1' ' HB2' ' A' ' 65' ' ' ARG . 2.4 mp0 -84.07 -28.02 27.87 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.199 -172.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -119.21 -177.52 3.37 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -170.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -36.3 20.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.121 -169.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HD2' ' H ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -57.56 -29.57 64.51 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.876 0.846 . . . . 0.0 110.758 -179.234 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.92 -11.32 58.27 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.032 -174.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.4 mm -67.85 -44.56 85.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -67.49 -47.51 69.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.54 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.414 HD23 HD11 ' A' ' 20' ' ' LEU . 2.0 tm? -60.31 -46.18 90.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.553 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.88 -43.52 98.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.488 0.185 . . . . 0.0 110.831 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -63.09 -34.19 77.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 0.0 110.805 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -60.74 -16.85 44.36 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.367 0.604 . . . . 0.0 111.622 176.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.455 ' CD2' ' HE3' ' A' ' 95' ' ' LYS . 32.4 m-85 -124.3 4.02 8.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.435 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.6 t70 54.29 33.8 19.1 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.952 0.882 . . . . 0.0 110.425 -174.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.69 84.75 7.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.004 -176.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -103.14 5.05 37.63 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.934 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.6 pt -128.68 141.21 47.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.777 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 m -127.97 143.63 48.5 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.738 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -92.54 136.14 7.86 Favored 'Cis proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.579 -1.426 . . . . 0.0 111.983 -1.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.68 128.43 54.9 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.937 0.399 . . . . 0.0 111.022 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.4 m -109.29 118.07 35.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.425 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.617 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 14.8 p -108.29 135.46 46.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.083 0.468 . . . . 0.0 110.13 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -111.0 114.62 28.07 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.551 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.523 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 4.8 mp -117.24 143.14 46.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.829 177.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.507 ' HA ' ' HB3' ' A' ' 28' ' ' PRO . 5.4 t0 -80.73 179.64 7.7 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 170.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.767 ' HE2' ' HE2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -74.4 -14.19 60.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.92 0.391 . . . . 0.0 110.56 -177.159 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -70.8 -12.34 61.49 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.713 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.64 11.65 63.65 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.13 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 11.2 m120 -79.0 113.93 17.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.693 0.283 . . . . 0.0 111.295 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.523 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 57.6 mtpt -71.43 95.47 1.36 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.205 172.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -87.58 -54.46 4.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.626 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -134.24 148.95 50.92 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.561 -172.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.406 HG12 HG23 ' A' ' 87' ' ' VAL . 30.0 m -129.54 147.1 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.599 174.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -140.16 139.02 35.65 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -104.43 122.65 45.94 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.555 0.534 . . . . 0.0 109.767 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.52 -161.78 17.89 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.988 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.428 HD21 ' OE1' ' A' ' 43' ' ' GLU . 44.0 tp -90.03 164.33 14.55 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 122.651 0.38 . . . . 0.0 111.154 -174.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.401 ' N ' ' HG ' ' A' ' 102' ' ' LEU . 58.3 mtm -149.45 172.12 15.48 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 122.937 0.495 . . . . 0.0 110.054 174.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.431 ' HA ' ' HD3' ' A' ' 104' ' ' ARG . 8.0 mmt180 -100.95 163.14 12.44 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.47 ' HA ' HD12 ' A' ' 108' ' ' ILE . 6.3 ptpp? -56.1 -40.98 74.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -62.15 -30.6 71.16 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.927 0.394 . . . . 0.0 111.525 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.54 ' O ' HG12 ' A' ' 111' ' ' ILE . 10.3 m120 -67.93 -45.74 73.47 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 176.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.605 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 50.1 mt -58.93 -48.1 87.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.586 174.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -50.13 -50.41 48.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.363 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.9 m -65.47 -40.33 93.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.318 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 107' ' ' ASN . 47.5 mm -67.1 -41.12 86.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.712 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.638 ' HB3' HG21 ' A' ' 117' ' ' VAL . 87.5 mt -59.59 -39.95 85.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.114 0.483 . . . . 0.0 109.942 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -61.21 -36.71 80.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.015 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 62.6 m -85.36 -16.72 38.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.63 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.6 tp -78.38 -81.91 0.1 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.084 0.468 . . . . 0.0 110.039 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.411 ' HA3' ' OD2' ' A' ' 90' ' ' ASP . . . 171.49 -54.95 0.18 Allowed Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 174.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.062 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 29.1 t 50.42 78.23 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.059 0 CA-C-O 121.561 0.696 . . . . 0.0 111.308 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.767 ' HE2' ' HE2' ' A' ' 91' ' ' LYS . 28.3 mtmm . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.753 -175.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.691 ' HB3' HG11 ' A' ' 16' ' ' VAL . 50.4 m . . . . . 0 C--O 1.225 -0.211 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 15' ' ' ASN . 94.9 mt -99.07 146.75 7.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.475 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 82.5 m-20 75.26 14.63 2.98 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.935 0.772 . . . . 0.0 109.985 -173.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.691 HG11 ' HB3' ' A' ' 13' ' ' SER . 2.4 m -107.88 157.28 8.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.431 -176.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 p -129.57 149.09 33.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.349 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -64.02 -56.39 15.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.184 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.724 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 3.0 t30 -157.95 177.96 10.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.382 -0.827 . . . . 0.0 108.831 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.418 ' HG ' ' CE2' ' A' ' 62' ' ' TYR . 30.7 mt -59.45 -30.77 68.74 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.08 -38.64 70.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.294 0.569 . . . . 0.0 110.659 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -87.94 -5.5 58.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.28 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.507 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -85.48 162.98 18.72 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -172.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 23' ' ' ALA . 4.6 mtmm -167.21 90.77 0.37 Allowed 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 124.78 1.232 . . . . 0.0 107.883 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.34 107.43 18.26 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -159.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -116.28 12.05 16.67 Favored Glycine 0 CA--C 1.503 -0.673 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 159.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.46 ' C ' ' HA ' ' A' ' 91' ' ' LYS . 3.0 pt -122.18 152.9 61.11 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 113.22 -1.49 . . . . 0.0 108.529 -176.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.593 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 50.3 Cg_exo -55.62 122.68 12.17 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 121.816 1.677 . . . . 0.0 111.719 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.5 m -99.0 115.8 29.77 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.944 -176.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.514 HD11 HD11 ' A' ' 112' ' ' LEU . 2.1 mp -98.42 108.21 21.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 176.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.682 ' HB ' HG23 ' A' ' 87' ' ' VAL . 62.4 mt -108.45 110.72 33.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.289 -176.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.506 ' HB3' HG23 ' A' ' 86' ' ' THR . 5.0 ppp? -117.2 142.7 46.71 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.022 176.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.661 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 82.7 m-85 -102.15 144.49 30.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.68 -174.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.878 ' HE2' ' HB3' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -138.85 135.59 34.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.024 177.698 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.4 m -81.71 162.09 23.11 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -50.52 -49.69 55.03 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.27 0.356 . . . . 0.0 111.539 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.3 m -109.32 95.79 5.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.628 0.251 . . . . 0.0 111.275 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.3 p -165.54 131.35 2.02 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 111.462 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.564 ' O ' HG12 ' A' ' 42' ' ' VAL . 64.0 Cg_endo -77.86 -19.69 12.34 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.382 2.055 . . . . 0.0 112.809 177.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.583 ' HB3' ' HG3' ' A' ' 84' ' ' PRO . 54.8 m-85 -58.9 -24.03 61.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.064 0.459 . . . . 0.0 110.82 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 45.3 t -64.12 -50.44 68.22 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.641 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 39' ' ' PRO . 10.0 p -68.34 -32.82 57.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.022 -174.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.601 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 16.2 mt-10 -65.87 -49.91 66.41 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 120.667 0.27 . . . . 0.0 110.993 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -36.96 85.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.917 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.544 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 25.8 mt-30 -60.74 -44.73 96.3 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 176.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 9.8 mtpm? -56.58 -53.68 54.8 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.064 0.459 . . . . 0.0 111.042 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 12.3 mm-40 -62.64 -43.86 97.74 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.131 -174.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.526 HD13 HG21 ' A' ' 61' ' ' ILE . 47.6 mt -59.68 -43.11 94.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.954 175.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.4 m -58.77 -41.18 86.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.05 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.417 ' CD2' ' HA ' ' A' ' 47' ' ' GLU . 24.6 m-85 -59.79 -48.72 80.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.054 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.685 HG22 ' HG3' ' A' ' 105' ' ' LYS . 3.0 t -60.48 -43.37 94.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.039 0.447 . . . . 0.0 110.539 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -62.75 -30.83 71.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.376 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -56.94 -38.04 72.36 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.163 0.506 . . . . 0.0 110.522 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -94.42 2.53 55.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.458 -172.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.554 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 9.4 ptp180 -156.76 85.49 0.97 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.918 0.866 . . . . 0.0 111.553 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.43 ' HA ' HD21 ' A' ' 15' ' ' ASN . 1.1 pm0 -76.68 128.45 34.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.082 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.32 41.51 98.15 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.667 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.554 ' HG2' ' HB2' ' A' ' 55' ' ' ARG . 13.9 mptt -108.63 -27.4 9.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.227 0.537 . . . . 0.0 110.009 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -158.56 154.58 26.87 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.082 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 15' ' ' ASN . 50.2 t30 -108.84 134.05 52.05 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.907 0.384 . . . . 0.0 110.302 -177.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.688 HD12 HG12 ' A' ' 16' ' ' VAL . 34.0 mt -106.78 108.74 25.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.757 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.724 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -96.94 119.93 36.33 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.878 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 68.6 m-85 -94.4 103.47 15.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.598 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.18 101.18 13.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.069 0.461 . . . . 0.0 110.764 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.571 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 29.0 ptt180 -91.75 131.38 37.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.011 178.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.07 9.79 1.81 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.428 0.632 . . . . 0.0 111.215 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.44 ' HB3' ' HD2' ' A' ' 65' ' ' ARG . 57.1 tt0 -78.43 -22.55 47.5 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.543 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.496 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 45.7 mt-10 -110.39 140.24 44.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.043 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.673 ' HA ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -59.06 -35.41 73.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.159 0.584 . . . . 0.0 112.516 -174.847 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.496 ' HE3' ' HB3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -58.97 -27.99 65.9 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.934 0.397 . . . . 0.0 111.22 -177.611 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.485 ' HA ' ' CB ' ' A' ' 74' ' ' LEU . 87.2 m-20 -92.37 2.68 56.51 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.189 -175.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.673 HD13 ' HA ' ' A' ' 69' ' ' GLU . 1.4 mp -71.09 -52.46 27.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.97 -46.17 89.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.811 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.485 ' CB ' ' HA ' ' A' ' 71' ' ' ASN . 0.5 OUTLIER -55.05 -44.47 74.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.567 179.409 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.661 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -55.93 -56.38 21.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.52 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -70.46 -33.12 70.92 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.577 -176.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.447 ' HE3' ' HB2' ' A' ' 77' ' ' LYS . 21.7 ttmt -67.04 -17.19 64.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.355 0.598 . . . . 0.0 110.737 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.448 ' HB2' ' HZ ' ' A' ' 33' ' ' PHE . 51.1 m-85 -118.61 23.67 11.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.391 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 73.15 10.98 5.15 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.095 166.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.09 93.56 7.04 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.33 0.586 . . . . 0.0 111.034 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -101.8 -12.54 18.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.796 175.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 23.9 pt -136.81 -179.51 2.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.641 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.48 145.1 47.83 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.685 0.279 . . . . 0.0 111.117 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.716 ' HD2' ' HA2' ' A' ' 101' ' ' GLY . 97.9 Cg_endo -93.87 120.14 2.84 Favored 'Cis proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.258 -1.559 . . . . 0.0 112.529 -1.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.428 ' O ' ' HD1' ' A' ' 33' ' ' PHE . 70.0 m -92.36 124.54 36.49 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.506 HG23 ' HB3' ' A' ' 32' ' ' MET . 10.5 m -114.57 116.41 28.74 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.213 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.705 HG12 HG12 ' A' ' 98' ' ' VAL . 13.6 m -100.69 123.09 53.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.296 0.57 . . . . 0.0 110.112 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.765 ' HB3' HD11 ' A' ' 115' ' ' LEU . 86.7 m-85 -99.47 110.3 22.79 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.992 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.671 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 5.8 mp -107.1 143.48 35.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.586 175.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.546 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 13.4 t70 -88.18 -165.45 1.32 Allowed 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.625 175.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.546 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -52.28 -35.52 50.45 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -169.311 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -107.73 18.85 20.88 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.666 -173.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.37 23.67 50.22 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.832 172.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.671 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 9.7 m120 -77.06 112.65 13.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 117.391 0.595 . . . . 0.0 110.757 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -68.19 85.38 0.25 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -84.42 -45.21 12.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.296 -173.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.458 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 90.9 t80 -140.23 129.32 23.58 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.365 -176.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.705 HG12 HG12 ' A' ' 87' ' ' VAL . 15.0 m -107.92 148.01 12.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 172.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.458 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 62.6 t60 -136.76 128.81 29.49 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -177.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -99.82 120.57 39.96 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.716 ' HA2' ' HD2' ' A' ' 84' ' ' PRO . . . 101.91 166.71 27.09 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -175.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.45 ' CD1' ' H ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -93.1 169.22 10.58 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 117.198 0.499 . . . . 0.0 110.181 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.6 ptt? -157.14 168.07 28.52 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.405 ' N ' ' HD2' ' A' ' 104' ' ' ARG . 5.5 mmm180 -91.29 174.11 7.56 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.975 -171.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.685 ' HG3' HG22 ' A' ' 51' ' ' VAL . 55.0 tttm -46.46 -55.19 7.83 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.851 0.719 . . . . 0.0 112.469 -176.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -59.27 -34.78 72.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 0.0 111.334 -175.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -69.31 -50.15 49.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.145 0.498 . . . . 0.0 109.774 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.501 ' O ' HD22 ' A' ' 112' ' ' LEU . 41.7 mt -60.5 -49.56 83.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.933 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.488 ' HA ' HD23 ' A' ' 112' ' ' LEU . 35.0 tt0 -56.31 -47.77 78.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.452 -174.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.6 m -59.91 -31.36 69.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.441 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.563 ' O ' ' HG ' ' A' ' 115' ' ' LEU . 66.6 mt -72.6 -33.8 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.065 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.593 ' HB3' HG21 ' A' ' 117' ' ' VAL . 2.7 mm? -62.53 -38.7 90.99 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.187 172.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -63.81 -27.39 69.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.646 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.6 t -85.75 -14.03 46.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.061 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.765 HD11 ' HB3' ' A' ' 88' ' ' PHE . 95.7 mt -85.17 -73.98 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.383 0.611 . . . . 0.0 109.766 176.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 173.67 -59.81 0.14 Allowed Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.332 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.593 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 39.3 t 52.22 41.84 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 122.951 1.358 . . . . 0.0 108.021 -175.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.7 pttm . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 113.901 -1.5 . . . . 0.0 112.58 -165.383 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.465 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 13.2 m . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.619 0.247 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.3 mt 69.06 -68.8 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.881 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.23 59.66 5.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.563 0.697 . . . . 0.0 110.121 174.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.465 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 1.0 OUTLIER -98.26 128.85 49.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.886 177.104 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.576 HG22 ' HG3' ' A' ' 22' ' ' GLU . 2.4 t -124.62 141.6 44.21 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-O 121.633 0.73 . . . . 0.0 112.567 -172.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -76.76 -35.49 57.69 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 113.864 -1.516 . . . . 0.0 112.38 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.757 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 66.0 t30 -172.6 -178.85 2.03 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.407 ' H ' ' CG ' ' A' ' 19' ' ' ASN . 83.5 mt -60.38 -29.66 69.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.757 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -78.57 -31.67 47.38 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.094 0.406 . . . . 0.0 110.988 -178.433 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.576 ' HG3' HG22 ' A' ' 17' ' ' VAL . 3.9 tp10 -72.42 -11.88 60.87 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.679 0.752 . . . . 0.0 109.876 170.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.485 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -95.14 171.73 8.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.435 -177.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.521 ' NZ ' ' HB3' ' A' ' 24' ' ' LYS . 4.3 mtpm? -135.01 167.32 21.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.125 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.487 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -86.44 174.81 8.74 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.267 170.124 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.02 -61.58 1.59 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.76 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -87.79 127.47 57.9 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-O 120.88 0.371 . . . . 0.0 110.047 178.081 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.923 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 50.9 Cg_exo -56.22 145.28 77.79 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.397 2.065 . . . . 0.0 111.118 176.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.5 m -119.54 129.61 54.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.18 0.514 . . . . 0.0 111.979 -172.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.615 HD11 HD21 ' A' ' 112' ' ' LEU . 79.6 mt -98.48 121.51 49.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.722 HG12 ' HB3' ' A' ' 62' ' ' TYR . 61.2 mt -118.58 119.85 62.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.146 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.431 ' O ' ' HG3' ' A' ' 32' ' ' MET . 26.5 ptm -108.0 117.48 34.24 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.983 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.492 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 87.4 m-85 -86.41 114.2 22.99 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.361 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.731 ' HG3' ' SG ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -138.71 145.15 39.96 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.741 -174.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 m -66.92 136.18 54.97 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 164.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -65.03 -39.38 93.3 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.792 -164.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 m -98.18 92.99 6.0 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.822 0.344 . . . . 0.0 111.153 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.659 ' SG ' ' HB2' ' A' ' 41' ' ' CYS . 25.7 p -160.87 142.68 9.12 Favored Pre-proline 0 CA--C 1.519 -0.236 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.351 174.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -64.92 -34.39 48.47 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.499 2.133 . . . . 0.0 112.48 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -68.66 -21.62 64.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 -177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.731 ' SG ' ' HG3' ' A' ' 34' ' ' LYS . 39.7 t -61.33 -53.43 56.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.022 175.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.23 -34.3 69.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.835 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -63.48 -50.24 70.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.403 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -71.74 -31.03 66.24 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.547 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 22.8 mt-30 -63.17 -33.59 75.79 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.543 173.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 41.6 mmtt -64.66 -46.65 81.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.548 175.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 51' ' ' VAL . 58.2 mm-40 -52.29 -54.52 30.44 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 123.572 0.545 . . . . 0.0 109.557 175.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.456 HD23 HD13 ' A' ' 108' ' ' ILE . 63.7 mt -57.37 -43.56 83.66 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.792 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.1 t -60.75 -39.94 90.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.164 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -76.36 -30.29 57.52 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.842 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.854 HG22 ' HG3' ' A' ' 105' ' ' LYS . 41.9 t -66.12 -39.54 84.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.254 0.55 . . . . 0.0 109.61 172.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.508 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 31.3 m -64.23 -31.66 72.95 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.889 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' A' ' 53' ' ' LYS . 4.2 mmmp? -74.44 -10.91 60.03 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.737 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -102.72 -8.72 20.63 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.23 0.538 . . . . 0.0 109.676 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.768 ' CZ ' ' HA ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -158.07 75.7 0.76 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.281 -178.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 52' ' ' SER . 20.1 mp0 -79.07 141.34 37.45 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.252 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.5 25.55 60.89 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.991 171.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.655 ' HB3' ' HG3' ' A' ' 55' ' ' ARG . 16.9 tptp -117.07 -21.82 8.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.352 0.596 . . . . 0.0 109.738 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.413 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 43.9 p90 -140.56 161.19 38.32 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 172.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -112.42 151.88 29.33 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 121.128 -0.229 . . . . 0.0 110.681 -174.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.3 mt -127.07 111.81 26.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.921 0.391 . . . . 0.0 111.124 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.722 ' HB3' HG12 ' A' ' 31' ' ' ILE . 2.5 t80 -103.24 119.74 39.43 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.547 ' CE1' ' HG2' ' A' ' 45' ' ' GLN . 87.1 m-85 -90.44 103.92 16.55 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.788 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -80.82 94.35 6.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.406 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.484 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -88.13 116.31 26.23 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.37 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 mp -66.36 11.58 0.08 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.871 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.421 ' H ' ' C ' ' A' ' 65' ' ' ARG . 35.0 tt0 -78.46 -32.09 48.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.757 0.789 . . . . 0.0 109.36 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -98.43 140.75 32.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.976 -172.292 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -31.48 72.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.886 -175.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HD2' ' OE2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -57.67 -19.09 24.37 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 178.787 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.579 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 52.4 m-80 -87.08 -2.51 58.68 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.729 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 84.5 mt -70.3 -56.8 9.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -64.6 -40.04 94.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.219 175.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 71' ' ' ASN . 0.4 OUTLIER -58.89 -47.18 85.88 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.033 178.204 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -62.71 -45.65 91.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.772 0.32 . . . . 0.0 111.226 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -62.93 -34.56 77.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.314 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -57.58 -31.11 65.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.018 0.437 . . . . 0.0 111.142 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -111.81 1.98 16.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.422 -176.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.3 t70 60.66 48.02 7.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.912 0.863 . . . . 0.0 110.332 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.38 116.13 28.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.364 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -107.81 -57.86 2.05 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.891 -171.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 36.6 pt -119.72 154.2 22.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.088 0.47 . . . . 0.0 111.078 -177.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.2 m -102.62 153.7 37.99 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.868 -177.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -89.66 127.91 7.64 Favored 'Cis proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.057 -1.643 . . . . 0.0 112.277 -0.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.419 HG23 ' HB2' ' A' ' 33' ' ' PHE . 9.0 t -120.81 134.3 55.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.077 0.465 . . . . 0.0 109.995 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.3 m -115.21 125.26 53.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.941 -176.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.4 HG22 HG23 ' A' ' 98' ' ' VAL . 66.3 t -105.24 127.87 59.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.046 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -107.83 114.42 28.36 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.242 0.544 . . . . 0.0 110.224 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.541 ' HB3' ' HA2' ' A' ' 93' ' ' GLY . 58.3 mt -99.16 142.29 30.83 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.69 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 6.4 t70 -71.25 -165.46 0.13 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.966 ' HD3' ' HG3' ' A' ' 118' ' ' LYS . 9.7 pttm -61.58 -31.73 71.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -170.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -96.32 1.88 52.3 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.91 -0.494 . . . . 0.0 110.838 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.541 ' HA2' ' HB3' ' A' ' 89' ' ' LEU . . . 85.93 26.53 34.27 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.061 -176.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 24.2 m120 -85.34 141.06 30.3 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 176.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.3 94.15 5.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.594 -174.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -84.23 -52.33 6.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.108 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 72.0 t80 -133.86 144.85 49.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 -178.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.4 HG23 HG22 ' A' ' 87' ' ' VAL . 3.4 p -136.47 136.95 48.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.427 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 74.8 t60 -120.18 137.02 54.42 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -174.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -112.67 112.46 23.99 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 123.568 0.542 . . . . 0.0 109.752 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.65 -177.67 16.42 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 44.7 tp -76.63 155.67 33.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.007 0.432 . . . . 0.0 111.042 -177.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.1 ptm -159.73 146.58 16.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 175.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.453 ' O ' HG13 ' A' ' 108' ' ' ILE . 35.2 mmt180 -98.8 174.31 6.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.869 0.366 . . . . 0.0 111.827 -174.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.854 ' HG3' HG22 ' A' ' 51' ' ' VAL . 63.7 tttm -46.23 -54.27 9.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.898 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.518 ' HA ' ' CD ' ' A' ' 109' ' ' GLU . 26.9 t-20 -65.74 -28.46 69.06 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.141 0.496 . . . . 0.0 111.446 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.496 ' O ' HD13 ' A' ' 111' ' ' ILE . 9.7 m120 -67.22 -38.95 86.13 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.547 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 42.0 mt -64.58 -47.08 90.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.528 174.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.56 ' OE2' ' HG2' ' A' ' 105' ' ' LYS . 68.1 mt-10 -49.71 -54.75 17.0 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.446 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.54 ' O ' ' HB3' ' A' ' 113' ' ' ASN . 25.4 m -67.41 -31.3 71.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.052 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 107' ' ' ASN . 1.4 mp -71.58 -41.69 71.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.778 178.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.622 ' HB3' ' CG2' ' A' ' 117' ' ' VAL . 56.4 mt -62.74 -33.25 74.74 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.54 ' HB3' ' O ' ' A' ' 110' ' ' THR . 23.2 t-20 -57.8 -44.41 86.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.918 178.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.8 m -85.13 -23.03 28.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.271 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.472 HD21 ' O ' ' A' ' 89' ' ' LEU . 62.6 tp -67.78 -78.49 0.06 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.425 0.631 . . . . 0.0 109.807 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.964 ' HA3' ' HD2' ' A' ' 118' ' ' LYS . . . 172.32 -53.84 0.17 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.96 171.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.923 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 21.6 t 56.4 41.0 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 123.162 1.458 . . . . 0.0 107.545 -174.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.966 ' HG3' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 112.801 -2.0 . . . . 0.0 111.907 -169.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 49' ' ' SER . 21.3 m . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 13' ' ' SER . 97.2 mt 71.19 141.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -175.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 66.79 12.35 8.81 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.298 0.57 . . . . 0.0 110.148 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 p -81.94 135.66 24.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.82 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.712 HG13 ' HG2' ' A' ' 22' ' ' GLU . 92.7 t -134.58 143.71 37.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.123 -176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.689 ' HG3' ' HB2' ' A' ' 19' ' ' ASN . 1.3 tp10 -69.3 -56.1 8.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.789 0.328 . . . . 0.0 111.199 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.814 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 2.9 t-20 -143.14 170.18 16.21 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.963 -167.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.49 -30.8 71.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.04 171.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.814 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 13.5 pt-20 -71.89 -13.85 61.77 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.335 0.588 . . . . 0.0 110.524 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.712 ' HG2' HG13 ' A' ' 17' ' ' VAL . 22.2 tt0 -110.62 0.65 17.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.703 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.74 162.26 20.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.121 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -154.6 148.93 26.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.649 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 81.94 164.95 0.14 Allowed 'General case' 0 C--N 1.333 -0.109 0 O-C-N 124.401 1.063 . . . . 0.0 112.295 167.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.99 56.89 4.34 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.812 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 26.2 pt -116.61 146.95 38.74 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.765 -0.218 . . . . 0.0 110.538 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.692 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 49.5 Cg_exo -57.71 135.56 70.06 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.838 2.359 . . . . 0.0 112.089 178.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.467 ' HA ' ' OD1' ' A' ' 60' ' ' ASN . 52.4 m -99.07 114.69 27.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.687 -177.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.569 HD13 ' HB2' ' A' ' 59' ' ' PHE . 2.0 mp -98.74 108.58 22.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.354 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.751 HG12 ' HB3' ' A' ' 62' ' ' TYR . 62.5 mt -103.56 136.81 34.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.302 -177.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.8 ptm -128.15 122.61 32.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.145 0.498 . . . . 0.0 110.279 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.78 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 96.1 m-85 -85.72 113.75 22.15 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.102 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -139.67 149.81 44.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.125 -177.297 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.469 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 9.1 p -85.14 177.46 7.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.715 -0.221 . . . . 0.0 110.5 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.451 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 15.4 t70 -60.92 -80.62 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.982 0.42 . . . . 0.0 110.759 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.5 m -82.19 98.37 8.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.005 0.431 . . . . 0.0 110.631 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 41' ' ' CYS . 24.8 p -154.77 135.9 8.95 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.64 176.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.0 -26.81 30.82 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.135 1.89 . . . . 0.0 112.267 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.532 ' HB3' ' HG3' ' A' ' 84' ' ' PRO . 69.7 m-85 -58.58 -35.07 71.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.773 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.523 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 45.9 t -63.55 -53.04 58.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.186 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.497 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 43.5 t -60.89 -44.32 97.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.121 -177.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.911 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 15.0 tp10 -57.93 -50.69 72.49 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.725 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.49 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 8.1 tpt -68.02 -35.9 79.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.417 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 87.4 mt-30 -61.27 -39.39 90.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.319 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.911 ' HE3' ' HA ' ' A' ' 43' ' ' GLU . 10.1 mtmp? -56.14 -53.36 58.01 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.461 0.648 . . . . 0.0 109.39 175.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.577 ' HG3' ' HA ' ' A' ' 104' ' ' ARG . 24.7 mm-40 -62.36 -42.32 99.31 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.028 -176.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.741 HD13 HG21 ' A' ' 61' ' ' ILE . 96.4 mt -60.22 -43.33 96.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.469 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 13' ' ' SER . 45.4 t -58.2 -43.24 87.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.344 0.593 . . . . 0.0 110.078 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -65.54 -43.28 90.45 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.807 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.7 HG13 ' HG2' ' A' ' 109' ' ' GLU . 92.9 t -65.3 -48.33 83.74 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.047 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.8 m -60.9 -31.62 71.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.803 0.335 . . . . 0.0 111.312 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.741 ' HZ3' ' HB3' ' A' ' 53' ' ' LYS . 4.4 ttpm? -64.0 -24.69 67.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.152 0.501 . . . . 0.0 110.601 175.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -109.11 2.93 21.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.561 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.564 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 10.1 tpp180 -156.36 79.23 0.96 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -176.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.25 125.91 32.09 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -172.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 53.89 30.67 45.59 Favored Glycine 0 C--N 1.33 0.212 0 CA-C-N 115.903 -0.59 . . . . 0.0 113.666 174.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.564 ' HB2' ' HG3' ' A' ' 55' ' ' ARG . 61.4 mmtt -110.93 -6.19 14.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.516 0.674 . . . . 0.0 109.228 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.569 ' HB2' HD13 ' A' ' 30' ' ' ILE . 4.6 p90 -162.49 143.34 10.1 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.385 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.467 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 20.8 p-10 -111.03 136.34 50.19 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.056 0.455 . . . . 0.0 110.82 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.741 HG21 HD13 ' A' ' 48' ' ' LEU . 4.5 mp -96.96 109.5 23.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.536 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.751 ' HB3' HG12 ' A' ' 31' ' ' ILE . 1.1 t80 -89.72 115.32 27.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.247 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -80.21 104.34 10.69 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.732 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -85.43 85.38 7.44 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.766 ' HB2' ' CD ' ' A' ' 67' ' ' GLU . 6.7 ptt180 -91.42 116.86 29.19 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.963 -170.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.478 ' HA ' HD22 ' A' ' 71' ' ' ASN . 4.1 mm? -72.04 5.82 2.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.625 -176.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.766 ' CD ' ' HB2' ' A' ' 65' ' ' ARG . 7.1 pm0 -84.58 -13.61 51.23 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.597 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 32.6 mt-10 -101.38 128.42 47.57 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.311 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -59.4 -37.39 77.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.06 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.597 ' HD2' ' HB3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -58.99 -24.59 62.86 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 122.084 0.945 . . . . 0.0 110.902 -179.132 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.498 ' N ' ' HD3' ' A' ' 70' ' ' LYS . 12.0 t30 -97.74 3.77 50.05 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.861 -172.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.3 mt -71.42 -51.02 36.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 169.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.33 -39.72 89.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.261 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.478 ' CB ' ' HA ' ' A' ' 71' ' ' ASN . 1.6 tm? -57.81 -42.57 84.56 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.913 176.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.78 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -51.68 -56.5 13.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.839 176.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -63.8 -32.54 74.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.504 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -62.31 -14.95 44.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.285 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.616 ' HB3' HG11 ' A' ' 87' ' ' VAL . 57.5 m-85 -127.78 21.54 6.42 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 70.25 15.43 7.47 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.006 0.522 . . . . 0.0 111.634 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.23 130.05 41.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.038 0.447 . . . . 0.0 110.685 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -133.63 -40.22 0.88 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.167 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.496 HD11 ' HB3' ' A' ' 100' ' ' GLN . 36.9 pt -122.28 179.85 2.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.741 0.305 . . . . 0.0 110.5 177.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.7 m -128.51 139.27 35.05 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.704 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.532 ' HG3' ' HB3' ' A' ' 40' ' ' TYR . 79.3 Cg_endo -93.36 128.15 5.03 Favored 'Cis proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.275 -1.552 . . . . 0.0 112.796 -0.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.422 ' O ' ' HD1' ' A' ' 33' ' ' PHE . 64.6 m -108.31 114.62 28.63 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 174.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.435 ' CG2' ' HB3' ' A' ' 99' ' ' HIS . 5.1 t -108.63 122.36 46.94 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.42 0.628 . . . . 0.0 110.74 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.691 HG23 ' HB ' ' A' ' 31' ' ' ILE . 14.0 m -102.62 120.94 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.226 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.744 ' HB3' HD11 ' A' ' 115' ' ' LEU . 96.6 m-85 -99.09 112.73 24.79 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.586 -177.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.0 mt -104.17 137.32 42.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.527 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 23.8 t0 -71.58 179.13 3.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.512 ' HB2' ' HE3' ' A' ' 91' ' ' LYS . 14.8 ptmt -60.88 -13.8 18.08 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.53 -41.42 15.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.796 0.332 . . . . 0.0 110.515 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.2 -17.04 5.97 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.216 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -57.58 139.71 52.83 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.499 0.666 . . . . 0.0 111.771 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -77.46 90.14 3.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.443 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -78.04 -45.99 22.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -174.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.443 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 87.3 t80 -145.85 136.56 24.3 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.894 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.658 HG12 HG12 ' A' ' 87' ' ' VAL . 16.2 m -118.07 149.75 20.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 173.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.443 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 53.4 t60 -137.12 118.18 14.36 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.496 ' HB3' HD11 ' A' ' 82' ' ' ILE . 1.4 mp0 -101.32 106.43 17.6 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.875 0.734 . . . . 0.0 109.211 176.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 131.55 -176.03 19.36 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.968 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.637 HD21 ' HG2' ' A' ' 43' ' ' GLU . 34.8 tp -92.19 161.3 14.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.753 0.311 . . . . 0.0 111.051 -175.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -171.94 162.49 6.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.577 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 1.8 mpt_? -102.13 177.61 4.84 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -174.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.485 ' HA ' HD12 ' A' ' 108' ' ' ILE . 13.7 ptmm? -49.73 -43.36 47.74 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -171.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -67.05 -32.49 73.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.108 0.48 . . . . 0.0 110.374 -175.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.598 ' O ' HG12 ' A' ' 111' ' ' ILE . 15.8 m120 -67.67 -48.1 67.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.612 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 105' ' ' LYS . 26.6 mt -58.6 -50.84 77.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.078 177.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.7 ' HG2' HG13 ' A' ' 51' ' ' VAL . 1.2 tm-20 -55.6 -48.93 74.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.318 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.2 m -59.81 -33.43 71.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.978 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.669 ' O ' ' HG ' ' A' ' 115' ' ' LEU . 48.9 mm -69.4 -41.05 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.723 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 8.8 mt -60.21 -45.17 94.1 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -61.16 -26.95 68.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.063 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.6 t -83.82 -25.3 30.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.744 HD11 ' HB3' ' A' ' 88' ' ' PHE . 57.2 mt -72.34 -60.7 2.1 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.746 0.784 . . . . 0.0 109.739 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 158.98 -50.48 0.4 Allowed Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.15 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.692 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 40.0 t 53.29 42.45 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 122.808 1.289 . . . . 0.0 109.105 -177.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.498 ' O ' ' HD2' ' A' ' 91' ' ' LYS . 35.0 mtmm . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.887 -174.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.58 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 35.3 t . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 69.4 mt 70.96 -69.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.992 175.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.854 HD22 ' HB3' ' A' ' 52' ' ' SER . 54.0 m-80 -83.17 31.91 0.44 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.912 0.387 . . . . 0.0 110.426 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.58 ' HB ' ' HB3' ' A' ' 13' ' ' SER . 8.7 p -97.23 148.66 5.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.283 -173.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' A' ' 23' ' ' ALA . 8.8 p -133.3 145.9 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.011 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -66.72 -45.1 79.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.407 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.632 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 16.1 t-20 -160.25 168.83 24.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.242 -175.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 84.9 mt -62.05 -29.41 70.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.84 0.352 . . . . 0.0 110.439 178.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -59.78 -32.22 70.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.542 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -97.21 -0.96 45.92 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.546 -177.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.508 ' HB2' HG21 ' A' ' 17' ' ' VAL . . . -107.62 171.64 7.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.371 0.605 . . . . 0.0 112.47 -170.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -129.84 155.82 45.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.897 177.831 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.5 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -103.54 177.24 4.9 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.772 0.32 . . . . 0.0 110.92 -176.262 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.595 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . 108.81 -35.53 4.9 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.81 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -105.73 152.93 40.25 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 177.009 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.79 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 63.8 Cg_exo -53.28 135.04 59.2 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.827 2.351 . . . . 0.0 112.194 177.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.408 ' HB ' HD12 ' A' ' 89' ' ' LEU . 25.8 m -106.0 112.92 26.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.425 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.44 HD13 ' HB2' ' A' ' 59' ' ' PHE . 1.7 mp -97.91 109.32 23.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 87' ' ' VAL . 59.3 mt -103.67 126.23 58.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.598 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.443 ' O ' ' HG3' ' A' ' 32' ' ' MET . 24.3 ptm -118.81 116.97 27.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.66 0.743 . . . . 0.0 110.153 173.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 87.5 m-85 -81.5 119.05 23.25 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.346 174.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.558 ' HE3' ' HB3' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -139.56 145.15 38.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.968 0.413 . . . . 0.0 111.259 -177.686 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.558 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 5.3 m -91.52 157.04 17.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.668 175.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.753 ' HB2' ' HG2' ' A' ' 67' ' ' GLU . 12.6 t70 -61.58 -66.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 111.841 -178.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.1 m -82.01 54.32 2.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.616 0.722 . . . . 0.0 111.407 -172.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.558 ' SG ' ' HB ' ' A' ' 35' ' ' THR . 37.4 m -145.24 113.67 4.83 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.514 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.52 -3.46 11.9 Favored 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 122.363 2.042 . . . . 0.0 113.37 -176.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -68.99 -17.33 63.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.667 0.27 . . . . 0.0 110.892 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.448 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 26.4 p -74.27 -55.36 6.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.482 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.589 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 12.4 p -60.64 -35.58 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.149 -175.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.58 ' HG2' HD21 ' A' ' 102' ' ' LEU . 24.0 tp10 -57.86 -51.09 71.02 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.055 0.455 . . . . 0.0 110.803 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 24.0 ttt -74.5 -29.29 61.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.303 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 28.8 mt-30 -63.86 -33.9 76.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.76 176.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 2.9 mtmm -60.22 -51.9 67.61 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.571 ' HG3' ' HA ' ' A' ' 104' ' ' ARG . 33.2 mm-40 -55.7 -46.4 77.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.804 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.433 HD13 HG21 ' A' ' 61' ' ' ILE . 89.7 mt -59.7 -39.22 83.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.003 178.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.0 t -65.58 -45.22 84.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.088 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.457 ' CB ' ' HD2' ' A' ' 105' ' ' LYS . 20.8 m-85 -58.82 -39.82 82.34 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.653 178.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 47' ' ' GLU . 84.9 t -66.97 -53.29 35.4 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.597 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.854 ' HB3' HD22 ' A' ' 15' ' ' ASN . 21.5 m -59.53 -30.85 68.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.927 0.394 . . . . 0.0 111.473 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.585 ' HB3' ' NZ ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -55.85 -29.45 59.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.896 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -113.53 -34.24 5.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.883 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.677 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 2.5 tpp180 -89.7 75.03 7.46 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.5 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 2.2 mm-40 -82.49 128.39 34.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.173 -174.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.96 42.9 82.03 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.987 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.677 ' HB2' ' HG3' ' A' ' 55' ' ' ARG . 38.7 mmtm -126.87 -12.89 5.89 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.751 -0.264 . . . . 0.0 110.895 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.44 ' HB2' HD13 ' A' ' 30' ' ' ILE . 1.2 p90 -160.43 149.86 17.47 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -112.83 129.88 56.29 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.433 HG21 HD13 ' A' ' 48' ' ' LEU . 4.7 mp -97.71 110.97 26.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.947 0.403 . . . . 0.0 110.587 -178.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.632 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 12.5 t80 -96.91 116.06 28.52 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.018 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.558 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 15.0 m-30 -77.91 103.77 8.05 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.005 176.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 33' ' ' PHE . . . -85.13 74.34 10.49 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.559 ' C ' ' H ' ' A' ' 67' ' ' GLU . 23.9 ptt180 -84.03 125.89 32.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.294 -174.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.14 12.25 0.09 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.323 0.582 . . . . 0.0 111.3 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.753 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 25.8 mt-10 -82.33 -26.08 33.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.35 -177.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.511 ' CB ' ' HD2' ' A' ' 70' ' ' LYS . 44.6 mt-10 -118.08 147.31 43.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.654 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -69.19 -18.21 63.89 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -175.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.605 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.6 OUTLIER -62.64 -32.26 73.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.576 0.703 . . . . 0.0 110.034 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.605 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 5.7 m-80 -83.58 -9.65 58.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.323 -174.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.0 mm -71.49 -42.6 72.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.16 -45.46 88.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.489 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 71' ' ' ASN . 4.4 mm? -58.11 -39.25 78.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.171 175.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.607 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -55.71 -57.23 12.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.485 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -66.17 -33.69 76.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.022 0.439 . . . . 0.0 110.601 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.439 ' HE3' ' HB2' ' A' ' 77' ' ' LYS . 19.2 ttmt -66.96 -17.44 64.92 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.261 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -122.16 11.4 10.16 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 70.59 24.82 4.32 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.595 0.559 . . . . 0.0 111.272 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.17 101.63 11.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.517 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -94.62 -43.17 8.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.888 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.7 pt -133.46 152.54 35.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.813 0.34 . . . . 0.0 110.682 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 84' ' ' PRO . 23.6 m -101.8 158.88 30.93 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.905 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.548 ' HA ' ' HB ' ' A' ' 83' ' ' VAL . 2.3 Cg_endo -83.01 125.41 10.33 Favored 'Cis proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.755 -1.352 . . . . 0.0 112.101 -0.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.523 ' HB ' ' CD1' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -97.4 112.55 24.33 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.697 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.4 m -101.44 111.7 24.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.276 0.56 . . . . 0.0 110.459 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' A' ' 31' ' ' ILE . 99.5 t -108.19 110.21 31.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.259 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.419 ' CD2' ' HD2' ' A' ' 97' ' ' TYR . 97.4 m-85 -91.79 105.68 17.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.082 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.408 HD12 ' HB ' ' A' ' 29' ' ' THR . 78.4 mt -95.62 136.05 36.51 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.432 175.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.423 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 25.7 t70 -72.61 177.37 4.76 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 172.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -53.58 -27.58 27.34 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -175.361 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.497 ' HG2' ' HG3' ' A' ' 91' ' ' LYS . 4.0 mm-40 -90.93 4.04 53.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.792 0.329 . . . . 0.0 111.166 -175.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.85 14.22 79.98 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.676 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -81.63 141.89 33.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.765 0.316 . . . . 0.0 110.507 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -79.31 82.01 5.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.839 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -78.52 -42.59 29.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.878 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.419 ' HD2' ' CD2' ' A' ' 88' ' ' PHE . 69.0 t80 -141.63 113.56 7.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.133 0.492 . . . . 0.0 111.18 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.97 128.74 65.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -137.85 143.18 40.81 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.522 ' HG2' HG23 ' A' ' 85' ' ' THR . 77.6 mt-30 -119.98 124.21 45.37 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.683 0.278 . . . . 0.0 110.447 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 142.75 -167.45 26.25 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.808 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.58 HD21 ' HG2' ' A' ' 43' ' ' GLU . 59.9 tp -106.09 121.6 44.47 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 74.0 mtp -116.06 159.72 21.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.553 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.571 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 3.3 mpt_? -111.09 170.49 8.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.703 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.457 ' HD2' ' CB ' ' A' ' 50' ' ' TYR . 23.5 tttp -46.91 -53.79 11.43 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -176.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -56.86 -39.2 73.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.008 0.432 . . . . 0.0 111.309 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.533 ' O ' HG12 ' A' ' 111' ' ' ILE . 9.2 m120 -70.6 -44.89 66.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.844 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.58 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 62.3 mt -60.26 -48.72 87.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.91 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.498 ' CD ' HH21 ' A' ' 55' ' ' ARG . 5.5 mm-40 -54.5 -47.99 72.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.594 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 113' ' ' ASN . 24.0 m -64.59 -38.33 90.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.742 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 107' ' ' ASN . 35.4 mm -65.17 -40.98 90.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.765 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 59.8 mt -62.31 -34.79 77.3 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.844 0.354 . . . . 0.0 110.136 177.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 110' ' ' THR . 90.4 m-20 -58.87 -45.24 90.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.853 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.8 m -86.49 -16.99 35.32 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.5 tp -70.7 -71.38 0.25 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.35 0.595 . . . . 0.0 110.381 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -178.39 -73.54 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.554 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.79 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 52.0 t 51.71 73.87 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 122.195 0.998 . . . . 0.0 109.82 -175.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.5 pttm . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.686 -172.656 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.625 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 72.9 m . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.462 0.173 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 69.9 mt 69.42 -74.23 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.15 0.58 . . . . 0.0 111.694 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -86.81 29.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.83 0.348 . . . . 0.0 110.929 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 3.0 p -72.94 129.02 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.504 -176.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.65 HG13 ' HB3' ' A' ' 22' ' ' GLU . 73.0 t -127.41 134.04 66.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.596 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -66.38 -55.2 16.99 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.789 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.568 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 47.2 t30 -153.22 179.58 8.61 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -177.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.33 -31.02 68.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.766 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 2.6 mp0 -59.89 -35.82 75.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.987 0.422 . . . . 0.0 110.465 176.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.65 ' HB3' HG13 ' A' ' 17' ' ' VAL . 3.7 mm-40 -82.91 -8.03 59.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.413 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.35 107.86 15.34 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 172.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.541 ' HE2' ' O ' ' A' ' 22' ' ' GLU . 17.6 mtmt -131.19 174.03 10.44 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.991 -171.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 66.59 167.61 0.22 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.301 1.0 . . . . 0.0 110.207 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.93 50.95 4.37 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.667 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.41 HG13 ' ND2' ' A' ' 60' ' ' ASN . 18.2 pt -116.45 149.39 43.64 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.727 0.299 . . . . 0.0 110.491 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.703 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 40.8 Cg_exo -60.59 168.92 6.06 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 123.217 2.611 . . . . 0.0 112.655 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.468 ' HB ' HD12 ' A' ' 89' ' ' LEU . 34.9 m -135.89 125.01 24.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.525 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.446 HD13 ' CD2' ' A' ' 59' ' ' PHE . 2.4 mp -105.63 115.04 46.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.816 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.566 ' HB ' ' HB ' ' A' ' 87' ' ' VAL . 67.6 mt -100.46 139.38 22.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.78 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.523 ' HG3' ' SD ' ' A' ' 44' ' ' MET . 2.1 tmt? -134.48 113.34 11.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.183 0.516 . . . . 0.0 109.887 171.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 91.6 m-85 -76.93 135.29 38.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.529 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.441 ' HG3' ' SG ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -142.28 153.86 44.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.289 -178.303 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -72.57 164.98 25.58 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 67' ' ' GLU . 6.6 p-10 -58.58 -45.22 89.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.681 0.276 . . . . 0.0 110.968 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -130.92 96.9 4.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.977 0.418 . . . . 0.0 111.275 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 41' ' ' CYS . 11.7 p -150.97 140.7 14.01 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.729 177.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 11.6 Cg_exo -69.94 -29.99 22.15 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.533 2.155 . . . . 0.0 112.273 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.574 ' HB3' ' HG3' ' A' ' 84' ' ' PRO . 90.2 m-85 -60.91 -26.98 67.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.095 0.474 . . . . 0.0 110.561 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . 21.5 t -60.03 -54.42 46.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.869 177.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.417 ' HA ' ' HG2' ' A' ' 45' ' ' GLN . 8.0 p -73.2 -38.13 53.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.432 -172.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.54 ' HG2' HD21 ' A' ' 102' ' ' LEU . 5.2 tp10 -61.6 -50.64 71.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.071 0.462 . . . . 0.0 110.875 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.523 ' SD ' ' HG3' ' A' ' 32' ' ' MET . 24.1 ttt -69.21 -37.25 77.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.053 0.454 . . . . 0.0 111.216 -175.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.455 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 12.9 pt20 -74.12 -31.49 62.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.354 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.912 ' HE2' ' HA ' ' A' ' 46' ' ' LYS . 8.5 mmpt? -74.26 -29.81 61.85 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.535 176.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 51' ' ' VAL . 13.4 mm-40 -62.03 -44.74 96.06 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 169.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 45' ' ' GLN . 98.1 mt -57.37 -36.99 71.92 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.313 173.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.9 t -66.19 -37.96 86.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.425 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.57 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 13.2 m-30 -65.05 -39.22 93.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.876 0.37 . . . . 0.0 110.177 175.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.582 HG22 ' HG3' ' A' ' 105' ' ' LYS . 44.1 t -65.11 -36.33 77.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.106 176.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.3 m -63.67 -31.8 73.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.824 178.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -66.84 -27.06 67.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.321 0.581 . . . . 0.0 110.738 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -100.77 2.58 41.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.584 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.541 ' HE ' HG12 ' A' ' 117' ' ' VAL . 21.1 tpt180 -161.23 76.63 0.54 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.427 0.632 . . . . 0.0 109.437 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -82.61 125.1 30.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.866 -172.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.405 ' O ' ' HD2' ' A' ' 58' ' ' LYS . . . 60.4 42.63 99.01 Favored Glycine 0 C--O 1.226 -0.346 0 CA-C-N 115.782 -0.644 . . . . 0.0 113.418 175.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HB2' ' HG3' ' A' ' 55' ' ' ARG . 11.7 mptt -125.31 0.56 7.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.902 0.351 . . . . 0.0 110.959 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.446 ' CD2' HD13 ' A' ' 30' ' ' ILE . 52.4 p90 -165.89 140.11 4.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.024 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.62 ' HB3' HG21 ' A' ' 17' ' ' VAL . 46.5 m-80 -82.66 131.22 35.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.375 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.7 mt -101.9 108.11 23.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 175.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.568 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 18.0 t80 -93.49 118.91 31.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.88 0.371 . . . . 0.0 110.067 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.455 ' CE1' ' HB2' ' A' ' 45' ' ' GLN . 11.8 m-85 -87.4 104.05 16.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.258 0.552 . . . . 0.0 110.707 178.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 33' ' ' PHE . . . -96.57 81.54 3.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.531 -175.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.485 ' C ' ' H ' ' A' ' 67' ' ' GLU . 19.7 ptt180 -95.28 130.48 42.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.814 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.2 tp -70.18 7.48 0.98 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.577 0.703 . . . . 0.0 110.546 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 36' ' ' ASP . 34.6 tt0 -83.03 -17.52 43.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.456 -175.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.417 ' HG3' ' HG3' ' A' ' 65' ' ' ARG . 36.1 mt-10 -103.79 -0.51 29.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -170.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.495 ' HA ' HG12 ' A' ' 72' ' ' ILE . 1.2 mp0 69.23 -36.62 0.34 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.557 0.535 . . . . 0.0 112.202 -177.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.491 ' HD2' ' ND2' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -61.05 -25.04 66.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.323 0.582 . . . . 0.0 110.729 175.844 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.588 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 44.5 m-80 -86.69 -0.86 57.09 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.816 178.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.495 HG12 ' HA ' ' A' ' 69' ' ' GLU . 45.2 mm -66.66 -45.18 88.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -72.21 -49.57 34.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.425 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 71' ' ' ASN . 3.8 mm? -57.18 -38.44 73.62 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.737 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.495 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -63.7 -48.4 77.27 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.055 177.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -62.42 -37.49 86.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.128 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -53.27 -35.85 60.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.481 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -113.35 13.27 19.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.842 -176.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.9 t70 63.35 29.32 15.7 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.693 0.759 . . . . 0.0 110.749 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.45 ' O ' ' HB1' ' A' ' 75' ' ' ALA . . . -87.77 104.2 16.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.362 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -127.98 -11.22 5.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.49 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.6 mt -114.95 133.4 61.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.061 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.1 m -114.05 145.81 34.36 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.681 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.574 ' HG3' ' HB3' ' A' ' 40' ' ' TYR . 6.0 Cg_endo -85.68 157.71 59.69 Favored 'Cis proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.43 -1.487 . . . . 0.0 111.811 -0.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.6 t -153.56 137.86 16.62 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 9.5 t -124.83 140.74 52.65 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.425 0.631 . . . . 0.0 110.88 -175.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 31' ' ' ILE . 72.4 t -115.87 110.43 31.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.413 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.537 ' HB3' HD22 ' A' ' 115' ' ' LEU . 97.3 m-85 -89.84 108.34 19.64 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.526 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.55 HD23 ' HA ' ' A' ' 95' ' ' LYS . 67.3 mt -97.47 130.44 44.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.815 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.84 169.62 16.4 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.877 ' HG2' ' HG3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -61.93 -23.88 66.63 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.565 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -76.53 -5.82 49.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.113 0.482 . . . . 0.0 110.022 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.65 22.46 50.22 Favored Glycine 0 N--CA 1.453 -0.185 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.599 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -107.24 148.64 28.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.55 ' HA ' HD23 ' A' ' 89' ' ' LEU . 4.6 ttpm? -77.19 117.81 19.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -97.37 -50.08 4.68 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.105 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.473 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 84.7 t80 -148.87 136.24 20.24 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.606 -175.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.489 HG12 HG22 ' A' ' 87' ' ' VAL . 27.5 m -113.94 148.29 16.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.76 172.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.473 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 36.6 t60 -142.83 141.24 31.57 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -111.16 121.76 46.14 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 145.76 170.78 14.78 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.981 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.54 HD21 ' HG2' ' A' ' 43' ' ' GLU . 43.8 tp -82.09 -61.56 1.87 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.465 0.65 . . . . 0.0 111.224 -177.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.526 ' O ' ' HD2' ' A' ' 104' ' ' ARG . 57.5 mtm 64.18 175.73 0.18 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.176 -1.374 . . . . 0.0 111.091 -175.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.526 ' HD2' ' O ' ' A' ' 103' ' ' MET . 10.7 mmm180 -122.61 178.15 5.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.921 173.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.582 ' HG3' HG22 ' A' ' 51' ' ' VAL . 47.1 tttm -45.53 -59.19 2.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -177.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -66.75 -28.85 68.74 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.399 -173.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -64.0 -47.99 78.15 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.627 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 61.5 mt -59.25 -47.5 90.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.796 174.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -50.57 -48.25 57.61 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.766 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 m -61.93 -41.76 98.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.867 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 63.1 mt -67.83 -37.67 78.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.204 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.63 ' HB3' HG21 ' A' ' 117' ' ' VAL . 87.2 mt -63.19 -35.45 80.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.374 . . . . 0.0 110.433 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -60.76 -39.8 90.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.674 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.6 m -79.46 -28.19 41.59 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.333 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.537 HD22 ' HB3' ' A' ' 88' ' ' PHE . 45.6 tp -66.25 -70.34 0.25 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.712 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 171.52 -73.54 0.1 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.605 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.703 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 11.6 t 55.61 36.52 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 122.677 1.227 . . . . 0.0 109.399 -176.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.877 ' HG3' ' HG2' ' A' ' 91' ' ' LYS . 8.2 ptmt . . . . . 0 C--N 1.319 -0.718 0 CA-C-N 113.527 -1.669 . . . . 0.0 110.02 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.596 ' HB3' HG21 ' A' ' 16' ' ' VAL . 34.4 m . . . . . 0 N--CA 1.445 -0.679 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.0 mt -93.22 -65.3 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.215 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 14.2 m-80 -81.08 59.21 3.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.02 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.699 ' HB ' ' HE2' ' A' ' 63' ' ' TYR . 16.6 m -131.98 151.4 35.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.085 0.469 . . . . 0.0 111.774 -173.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.498 HG11 ' HB2' ' A' ' 23' ' ' ALA . 4.2 p -146.31 164.24 9.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.114 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -90.94 -54.26 4.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.985 0.422 . . . . 0.0 110.999 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.796 ' HA ' ' CE2' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -130.67 162.89 28.41 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.683 -170.384 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.674 HD22 ' CE2' ' A' ' 62' ' ' TYR . 2.0 mm? -65.36 -35.17 80.15 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.598 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 1.7 pm0 -67.09 -23.52 65.86 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.346 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.452 ' HB2' ' H ' ' A' ' 19' ' ' ASN . 21.7 mm-40 -87.51 -8.65 56.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.561 172.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.498 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -121.29 172.51 7.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.562 0.696 . . . . 0.0 112.133 -170.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.763 ' NZ ' ' HA ' ' A' ' 24' ' ' LYS . 2.3 tpmp? -140.21 160.39 40.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.522 176.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -87.87 179.3 6.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.985 0.422 . . . . 0.0 110.936 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.69 -29.94 10.17 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -174.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.616 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -117.95 134.18 23.32 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 172.657 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 1.048 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 75.2 Cg_exo -52.54 136.77 57.62 Favored 'Trans proline' 0 CA--C 1.517 -0.356 0 C-N-CA 123.092 2.528 . . . . 0.0 112.424 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.562 ' HB ' HD12 ' A' ' 89' ' ' LEU . 23.6 m -108.69 119.76 40.47 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.207 0.527 . . . . 0.0 111.199 -174.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.417 HD12 ' N ' ' A' ' 30' ' ' ILE . 4.1 mp -99.32 107.17 20.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.801 HG12 ' HB3' ' A' ' 62' ' ' TYR . 50.0 mt -95.74 111.91 27.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 120.731 0.301 . . . . 0.0 110.75 -177.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 25.2 ptm -118.42 136.65 53.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.157 0.503 . . . . 0.0 109.828 175.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.557 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 37.3 m-85 -91.18 132.3 36.17 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.502 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.627 ' HE2' ' HB3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -130.9 139.53 50.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.158 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.0 m -78.09 161.38 27.45 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.494 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 15.1 t70 -68.54 103.33 1.66 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.2 m 73.51 89.44 0.09 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.92 -175.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.9 p -148.06 127.16 6.28 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.567 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.22 -33.66 5.54 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.285 1.99 . . . . 0.0 114.084 -173.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -67.47 -25.17 65.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.806 0.336 . . . . 0.0 111.165 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.578 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 97.6 m -80.06 -35.98 36.27 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.053 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 65.0 t -64.8 -34.85 72.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.82 176.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -57.01 -45.97 82.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.281 175.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.6 ttt -69.11 -31.19 69.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.737 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.578 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 83.4 mt-30 -59.84 -40.12 87.42 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 110.117 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -56.16 -53.36 57.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.608 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 51' ' ' VAL . 57.2 mm-40 -56.99 -47.23 81.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.77 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.74 HD13 HD13 ' A' ' 61' ' ' ILE . 91.3 mt -58.62 -36.9 74.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.472 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.4 t -66.59 -37.58 85.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.99 0.424 . . . . 0.0 110.13 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.425 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 30.5 m-85 -70.34 -36.44 74.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.517 177.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 47' ' ' GLU . 22.4 t -67.95 -31.82 53.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 175.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.5 m -62.97 -32.92 74.35 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.025 174.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.479 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 27.2 mmtm -73.35 -15.79 61.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.138 0.494 . . . . 0.0 110.725 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -87.51 -40.08 14.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.687 173.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.667 ' HG3' ' HG3' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -133.09 75.39 1.62 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.617 -175.236 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 5.8 tp10 -82.44 134.46 35.23 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 120.905 0.383 . . . . 0.0 111.356 -171.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.57 41.22 95.44 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.255 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.667 ' HG3' ' HG3' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -123.08 -9.1 8.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.776 0.322 . . . . 0.0 110.856 -174.093 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.55 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 10.2 p90 -156.68 -176.84 6.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.6 -177.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 29' ' ' THR . 57.2 t30 -144.83 132.99 21.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.896 178.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.74 HD13 HD13 ' A' ' 48' ' ' LEU . 71.6 mt -105.38 114.24 44.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.565 -176.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.801 ' HB3' HG12 ' A' ' 31' ' ' ILE . 4.5 t80 -84.18 115.82 22.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.699 ' HE2' ' HB ' ' A' ' 16' ' ' VAL . 76.1 m-85 -93.38 110.82 22.36 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.054 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.666 ' HB2' ' HE1' ' A' ' 62' ' ' TYR . . . -86.39 102.72 14.29 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 121.255 -0.178 . . . . 0.0 110.793 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.627 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 8.7 ptm180 -78.01 114.48 16.92 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.876 176.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.4 tp -67.92 10.95 0.17 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.061 0.458 . . . . 0.0 110.836 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 65' ' ' ARG . 3.8 tp10 -84.34 -42.35 15.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.19 0.519 . . . . 0.0 110.424 -175.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.576 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 30.5 mm-40 -93.54 173.58 7.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.08 -172.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.413 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -86.22 -31.88 21.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.856 -176.253 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HD2' ' H ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -60.15 -33.15 71.78 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.241 0.543 . . . . 0.0 110.371 178.521 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.576 ' OD1' ' HB2' ' A' ' 68' ' ' GLU . 5.0 m120 -80.19 -17.35 52.63 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.416 -178.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 69' ' ' GLU . 75.1 mt -70.88 -42.76 77.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -59.86 -48.95 79.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.626 173.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.435 ' HG ' ' OH ' ' A' ' 62' ' ' TYR . 1.2 tm? -55.77 -47.34 77.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.315 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.557 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -53.9 -52.15 61.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.854 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -73.27 -34.84 66.01 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.527 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.432 ' HB2' ' HE3' ' A' ' 77' ' ' LYS . 27.1 ttmt -63.49 -32.86 74.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.241 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -102.73 -0.53 31.47 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.669 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.1 t70 67.64 40.65 2.47 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.704 0.764 . . . . 0.0 111.095 174.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.48 102.84 4.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.946 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -107.26 -31.95 8.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.351 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.808 HD13 ' H ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -85.05 159.06 3.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.798 0.332 . . . . 0.0 110.947 -178.65 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.1 m -119.42 145.27 38.37 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.719 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -95.25 118.25 2.03 Favored 'Cis proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.637 -1.401 . . . . 0.0 112.517 -1.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.654 HG22 ' HB3' ' A' ' 100' ' ' GLN . 1.2 p -97.9 143.46 28.47 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 173.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.1 m -135.49 121.05 19.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.179 0.514 . . . . 0.0 111.151 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.686 HG12 HG12 ' A' ' 98' ' ' VAL . 20.3 m -112.6 126.65 70.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.003 176.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.562 ' HB3' HD22 ' A' ' 115' ' ' LEU . 94.8 m-85 -98.48 118.61 35.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.829 -174.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.562 HD12 ' HB ' ' A' ' 29' ' ' THR . 10.4 mt -107.57 139.61 41.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.037 -177.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.435 ' OD2' ' HG2' ' A' ' 92' ' ' GLU . 25.0 t70 -63.51 171.48 2.53 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 171.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.497 ' HD3' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -62.36 -16.45 54.64 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 122.015 -0.428 . . . . 0.0 111.84 -176.261 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.435 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 16.9 mm-40 -72.94 -23.69 60.71 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.954 0.407 . . . . 0.0 110.753 175.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.74 17.53 35.41 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -170.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -90.15 126.24 35.73 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -72.34 112.87 8.79 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.174 0.296 . . . . 0.0 110.511 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -100.67 -54.58 2.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.746 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 87.6 t80 -124.84 141.84 51.85 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.195 -175.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.686 HG12 HG12 ' A' ' 87' ' ' VAL . 30.0 m -121.65 139.64 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.553 176.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.576 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 8.2 t60 -151.17 139.86 20.72 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.654 ' HB3' HG22 ' A' ' 85' ' ' THR . 9.1 pt20 -130.04 139.52 50.99 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.014 0.435 . . . . 0.0 110.804 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.48 -172.35 18.16 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.6 tp -93.66 130.17 39.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.908 0.354 . . . . 0.0 110.162 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 71.8 mtm -127.08 165.38 19.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.192 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.466 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 37.3 mmt180 -114.34 175.51 5.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.741 178.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.567 ' O ' ' HG3' ' A' ' 109' ' ' GLU . 58.0 tttm -45.78 -59.36 2.83 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.106 0.962 . . . . 0.0 112.835 -175.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.549 ' HA ' ' OE1' ' A' ' 109' ' ' GLU . 29.0 t-20 -64.66 -28.88 69.91 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -174.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.502 ' O ' HG12 ' A' ' 111' ' ' ILE . 10.7 m120 -65.4 -45.34 84.35 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.55 HD13 HD23 ' A' ' 48' ' ' LEU . 50.3 mt -64.97 -42.52 94.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.933 176.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 105' ' ' LYS . 81.0 mt-10 -51.91 -48.96 63.94 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.887 176.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.0 m -64.39 -42.24 96.23 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.778 -177.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 107' ' ' ASN . 48.7 mm -67.37 -47.81 79.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.184 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.551 ' HB3' HG21 ' A' ' 117' ' ' VAL . 81.0 mt -65.32 -34.45 78.37 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 110.806 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -60.41 -37.99 82.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.412 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.7 m -85.15 -35.93 21.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.165 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.562 HD22 ' HB3' ' A' ' 88' ' ' PHE . 34.7 tp -57.13 -72.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.102 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -176.66 -80.75 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.767 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.048 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 22.9 t 53.04 71.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 121.662 0.744 . . . . 0.0 109.537 -175.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.2 pttt . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.373 -168.061 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.658 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . 22.7 m . . . . . 0 N--CA 1.447 -0.597 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.0 mt 69.52 -78.24 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 123.047 0.539 . . . . 0.0 111.042 -171.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -113.98 16.56 18.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.524 0.678 . . . . 0.0 109.265 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.658 ' CG2' ' HA ' ' A' ' 13' ' ' SER . 51.5 t -76.27 125.32 35.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.433 175.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.519 HG22 ' HB2' ' A' ' 22' ' ' GLU . 4.6 p -111.52 134.9 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-O 121.592 0.711 . . . . 0.0 110.374 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -61.47 -54.45 43.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.543 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.539 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -131.69 158.83 40.08 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.369 -177.009 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.65 -29.75 69.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.798 0.332 . . . . 0.0 110.585 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.5 pm0 -73.38 -23.51 60.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.405 177.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.519 ' HB2' HG22 ' A' ' 17' ' ' VAL . 29.3 mm-40 -67.01 -18.96 65.62 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.008 0.432 . . . . 0.0 110.492 173.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.515 ' HB1' HD11 ' A' ' 27' ' ' ILE . . . -91.71 113.59 25.9 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -122.38 -6.47 8.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.705 0.764 . . . . 0.0 112.165 -173.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.532 ' HB2' HD12 ' A' ' 27' ' ' ILE . 3.8 mp0 -76.05 170.94 15.31 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.383 178.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.48 55.32 4.99 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.385 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.625 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -114.65 143.41 29.93 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.792 0.33 . . . . 0.0 111.357 -173.277 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 1.003 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 60.5 Cg_exo -56.65 151.36 47.49 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.696 2.264 . . . . 0.0 111.649 170.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.0 m -112.7 111.21 21.84 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.787 -175.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.6 mm -102.99 124.76 57.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.757 HG12 ' HB3' ' A' ' 62' ' ' TYR . 54.3 mt -125.04 115.46 44.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.069 -173.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.456 ' SD ' ' NZ ' ' A' ' 34' ' ' LYS . 2.1 tmt? -112.07 124.36 52.24 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.619 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 53.8 m-85 -87.38 144.57 26.7 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.899 -175.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.936 ' HE3' ' HB3' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -149.44 171.24 16.89 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -178.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.0 t -122.69 -174.44 2.92 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.02 -62.88 1.53 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.229 0.537 . . . . 0.0 110.569 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.2 m -93.76 90.92 6.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.075 -176.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.484 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 20.1 p -158.88 121.15 1.94 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.91 0.386 . . . . 0.0 111.388 175.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 2.9 Cg_exo -75.34 -16.48 19.45 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.53 2.153 . . . . 0.0 112.429 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -64.44 -26.12 68.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.009 0.433 . . . . 0.0 110.637 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.653 ' SG ' ' HD3' ' A' ' 34' ' ' LYS . 53.4 t -67.42 -44.41 78.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.679 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.518 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 7.6 p -74.76 -30.35 24.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.779 0.323 . . . . 0.0 110.756 -176.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -69.7 -49.0 57.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.813 0.339 . . . . 0.0 110.323 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.423 ' HG3' ' OE1' ' A' ' 47' ' ' GLU . 3.5 ttt -69.43 -28.45 66.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.991 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -53.32 -45.02 68.86 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.223 171.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 81.9 mttt -58.12 -53.81 54.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.964 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.432 ' O ' HG23 ' A' ' 51' ' ' VAL . 52.7 mt-10 -57.43 -50.65 72.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.919 -178.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 48.6 mt -61.39 -42.95 99.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.638 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 13.9 t -66.81 -32.94 74.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.369 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.44 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 16.6 m-85 -66.9 -43.08 84.31 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.774 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 47' ' ' GLU . 51.0 t -60.3 -52.22 63.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-O 121.223 0.535 . . . . 0.0 110.016 176.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.8 m -59.4 -29.35 67.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.552 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.457 ' HZ3' ' HB2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -67.51 -16.91 64.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.518 -179.353 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -120.44 8.94 10.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.286 0.565 . . . . 0.0 109.791 177.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.713 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 8.0 ttm-85 -151.38 76.9 1.23 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.356 -175.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -82.32 124.77 30.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.83 -169.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.11 25.92 54.89 Favored Glycine 0 CA--C 1.518 0.249 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.333 176.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.713 ' HB2' ' HG2' ' A' ' 55' ' ' ARG . 55.7 mmtt -96.2 -5.68 39.92 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.719 0.771 . . . . 0.0 108.927 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.554 ' HB3' HG13 ' A' ' 117' ' ' VAL . 28.7 p90 -170.79 136.49 1.18 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.042 175.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -95.05 131.33 41.15 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.7 mt -89.64 107.7 18.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.096 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.757 ' HB3' HG12 ' A' ' 31' ' ' ILE . 3.8 t80 -88.43 112.62 23.14 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.936 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 50.3 m-85 -91.73 102.9 15.52 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.589 178.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.92 93.59 4.43 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.975 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.646 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 11.0 ptt180 -89.3 118.25 28.85 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.27 0.557 . . . . 0.0 111.272 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.485 HD22 HD13 ' A' ' 72' ' ' ILE . 53.4 mt -72.77 11.51 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.02 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.528 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 23.9 tt0 -66.4 -33.64 76.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.871 174.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -106.85 177.2 4.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.351 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.53 -27.0 22.88 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.1 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.572 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -57.6 -33.5 68.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.423 -176.296 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.572 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 68.6 m-80 -90.23 2.39 55.47 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.983 -174.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.485 HD13 HD22 ' A' ' 66' ' ' LEU . 49.7 mm -71.17 -54.44 17.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 172.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -65.23 -41.87 93.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.253 175.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.477 ' HB3' ' HA ' ' A' ' 71' ' ' ASN . 1.3 tm? -57.37 -42.61 82.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.101 177.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.619 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -53.17 -53.16 54.64 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.462 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -67.3 -34.3 77.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.771 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -62.76 -21.44 65.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.063 0.458 . . . . 0.0 111.588 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.508 ' CD2' HG11 ' A' ' 87' ' ' VAL . 52.3 m-85 -119.73 19.32 12.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.643 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 65.13 17.02 10.88 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.801 0.688 . . . . 0.0 111.37 168.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.458 ' O ' ' HB1' ' A' ' 75' ' ' ALA . . . -123.91 102.17 7.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.079 0.466 . . . . 0.0 111.605 -171.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -113.61 9.21 17.85 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.207 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.9 pt -125.23 171.36 14.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.875 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.57 136.99 19.39 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.229 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -87.26 150.61 38.32 Favored 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 123.65 -1.396 . . . . 0.0 112.667 -0.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 15.1 m -150.26 124.6 9.53 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 88.3 m -122.15 122.89 40.26 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.314 0.578 . . . . 0.0 110.936 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.62 HG23 ' HB ' ' A' ' 98' ' ' VAL . 11.2 p -100.16 132.32 45.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.635 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 1.02 ' HB3' HD11 ' A' ' 115' ' ' LEU . 86.2 m-85 -106.04 108.8 20.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.799 -175.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.49 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 5.5 mp -111.97 138.82 48.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.786 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -80.65 -176.75 5.94 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.601 ' HE2' ' HE2' ' A' ' 118' ' ' LYS . 0.5 OUTLIER -60.57 -22.22 63.45 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -172.494 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 -75.85 -12.54 60.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.72 0.295 . . . . 0.0 111.295 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.443 ' O ' HD23 ' A' ' 89' ' ' LEU . . . 85.42 21.06 55.51 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.784 -176.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 92.0 m-20 -92.27 125.36 36.9 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.971 -0.134 . . . . 0.0 110.703 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.49 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 54.2 mtmt -70.5 93.84 0.93 Allowed 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.453 ' HB3' ' CD2' ' A' ' 115' ' ' LEU . 87.6 t80 -83.58 -39.4 20.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.817 0.342 . . . . 0.0 110.338 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.597 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 71.2 t80 -154.04 127.07 8.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.716 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.62 ' HB ' HG23 ' A' ' 87' ' ' VAL . 7.6 p -114.3 133.42 60.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.597 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 49.5 t60 -139.31 137.76 36.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -172.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -110.41 158.18 18.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.825 0.345 . . . . 0.0 111.075 178.485 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.1 -173.85 20.15 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.028 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.6 tp -104.17 149.59 25.12 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 16.8 ptm -164.8 125.62 2.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.724 -0.216 . . . . 0.0 110.441 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -58.04 163.77 2.63 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.625 -173.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.44 ' HD2' ' HB3' ' A' ' 50' ' ' TYR . 13.6 ptmm? -50.59 -44.43 56.88 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.237 -174.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.404 ' N ' ' HG3' ' A' ' 105' ' ' LYS . 18.8 m120 -63.48 -34.24 77.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.383 0.611 . . . . 0.0 110.932 -176.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -74.11 -40.18 62.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.394 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.496 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 73.8 mt -59.32 -46.27 92.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.246 171.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -58.05 -35.56 71.51 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.004 178.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.5 m -63.92 -41.46 97.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.001 0.429 . . . . 0.0 110.434 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.9 mm -70.89 -41.91 77.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.179 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.565 ' HB3' HG21 ' A' ' 117' ' ' VAL . 85.8 mt -57.53 -41.97 81.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.446 176.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -59.53 -37.11 77.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.803 176.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.1 m -70.37 -24.89 63.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.101 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 1.02 HD11 ' HB3' ' A' ' 88' ' ' PHE . 27.1 mt -81.28 -73.62 0.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 122.095 0.95 . . . . 0.0 109.788 175.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 162.87 -63.47 0.26 Allowed Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -175.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.003 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 48.8 t 52.85 73.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.579 0.704 . . . . 0.0 111.782 172.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.601 ' HE2' ' HE2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.609 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' A' ' 49' ' ' SER . 49.0 m . . . . . 0 C--O 1.228 -0.074 0 CA-C-O 121.248 0.546 . . . . 0.0 110.45 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.7 mt -80.85 -20.63 11.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.531 0.681 . . . . 0.0 109.941 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 47.2 m-80 -94.0 25.06 3.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.606 176.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.412 HG23 ' HE2' ' A' ' 63' ' ' TYR . 7.5 p -63.87 138.96 22.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.641 -173.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.474 HG21 ' HB3' ' A' ' 60' ' ' ASN . 76.0 t -137.93 123.65 25.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.798 175.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -76.13 -55.52 5.51 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.603 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.783 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 59.0 t30 -140.18 -179.38 5.95 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.579 HD11 HD11 ' A' ' 74' ' ' LEU . 83.7 mt -50.39 -32.6 17.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.419 ' CD ' ' HB3' ' A' ' 19' ' ' ASN . 6.7 pm0 -63.41 -39.64 95.04 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.674 0.249 . . . . 0.0 111.674 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.408 ' OE1' ' HG2' ' A' ' 21' ' ' GLU . 55.7 mp0 -81.52 4.51 21.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.808 175.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.36 171.04 10.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.941 0.4 . . . . 0.0 111.957 -175.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.507 ' HE2' ' OD1' ' A' ' 60' ' ' ASN . 23.1 mtmm -148.57 173.25 13.36 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -120.51 -179.56 4.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.677 0.275 . . . . 0.0 111.378 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.09 -47.74 2.68 Favored Glycine 0 C--N 1.332 0.355 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.044 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.765 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -100.19 146.66 32.33 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 175.552 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 1.06 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 84.2 Cg_exo -51.02 158.66 3.04 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.197 2.598 . . . . 0.0 112.436 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.489 HG23 ' HB2' ' A' ' 60' ' ' ASN . 41.7 m -131.44 126.15 34.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.244 0.545 . . . . 0.0 111.43 -175.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.541 HD11 HD21 ' A' ' 112' ' ' LEU . 63.5 mt -98.76 111.52 28.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.495 176.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.614 ' HB ' ' HB ' ' A' ' 87' ' ' VAL . 6.0 mm -91.01 107.81 19.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.417 ' HA ' ' O ' ' A' ' 85' ' ' THR . 21.0 ttt -111.71 107.74 16.94 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.311 0.576 . . . . 0.0 110.647 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.681 ' CE1' ' HA ' ' A' ' 75' ' ' ALA . 87.0 m-85 -72.64 133.12 44.5 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.179 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 1.072 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 60.1 pttt -133.84 179.88 5.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.147 -176.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -137.39 -174.56 3.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.469 0.176 . . . . 0.0 110.589 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -77.33 -17.94 57.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.507 0.67 . . . . 0.0 110.548 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.4 m -143.64 101.97 3.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.873 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 2.2 p -160.13 101.68 1.41 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.986 0.422 . . . . 0.0 112.021 -176.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.8 -32.99 13.33 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.07 1.846 . . . . 0.0 112.655 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -70.51 -23.12 62.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.964 0.411 . . . . 0.0 110.749 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 79.7 m -79.15 -43.62 23.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.956 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.444 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 12.0 p -65.5 -31.03 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.484 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.749 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 8.5 tp10 -58.38 -50.04 75.08 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.347 0.594 . . . . 0.0 110.283 175.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 21.0 ttt -73.62 -29.3 62.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.86 -177.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.556 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 54.8 mt-30 -62.56 -33.75 75.58 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.692 0.282 . . . . 0.0 110.65 175.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.749 ' HE2' ' HA ' ' A' ' 43' ' ' GLU . 47.3 mtmt -65.29 -47.05 77.99 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.642 ' O ' HG23 ' A' ' 51' ' ' VAL . 62.5 mm-40 -56.04 -52.21 65.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.849 177.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.5 ' HB3' HD13 ' A' ' 61' ' ' ILE . 90.0 mt -56.9 -33.58 67.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.171 178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 8.7 t -65.83 -43.56 88.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.023 0.44 . . . . 0.0 109.854 177.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -68.03 -34.27 76.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.706 178.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.745 HG22 ' HG3' ' A' ' 105' ' ' LYS . 34.4 t -65.35 -39.54 85.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 175.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.7 m -61.77 -30.57 70.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.691 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -59.3 -43.09 92.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.049 0.452 . . . . 0.0 110.132 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -82.22 -50.5 8.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.757 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.435 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -99.11 74.06 1.95 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.281 0.562 . . . . 0.0 109.761 -175.257 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.67 119.06 25.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.255 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.55 47.09 36.27 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.23 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.454 ' HD3' ' HA ' ' A' ' 58' ' ' LYS . 36.5 mmtm -132.64 -7.43 3.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.657 0.265 . . . . 0.0 111.31 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.495 ' O ' ' HB3' ' A' ' 15' ' ' ASN . 0.9 OUTLIER -163.92 155.55 16.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.667 177.141 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.507 ' OD1' ' HE2' ' A' ' 24' ' ' LYS . 36.9 m-80 -96.39 132.36 42.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 171.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.5 HD13 ' HB3' ' A' ' 48' ' ' LEU . 71.2 mt -107.16 105.32 18.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.533 173.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.783 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 1.1 t80 -101.17 111.75 24.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.133 0.492 . . . . 0.0 110.025 -177.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.626 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 73.1 m-85 -90.77 102.58 15.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.978 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.501 ' HB1' ' HB3' ' A' ' 71' ' ' ASN . . . -85.29 97.0 9.7 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 121.184 -0.206 . . . . 0.0 110.801 -177.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 1.072 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 32.8 ptt180 -76.7 114.86 15.92 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.831 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.5 mp -63.7 11.71 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.141 0.496 . . . . 0.0 111.742 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.578 ' H ' ' C ' ' A' ' 65' ' ' ARG . 62.3 tt0 -77.26 -31.41 54.91 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.185 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -112.77 148.14 35.42 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.749 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -65.65 -20.86 66.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.914 -172.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.589 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -63.45 -33.45 75.59 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.214 0.531 . . . . 0.0 110.485 -178.078 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.589 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 4.1 m120 -85.99 -17.65 34.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.571 -173.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.3 mt -69.85 -42.85 80.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -65.08 -40.64 94.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.168 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.579 HD11 HD11 ' A' ' 20' ' ' LEU . 2.3 mm? -62.71 -38.86 92.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.896 175.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.681 ' HA ' ' CE1' ' A' ' 33' ' ' PHE . . . -54.41 -52.37 61.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.439 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -64.95 -33.39 75.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.478 -178.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 mtmm -64.96 -16.27 63.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.964 0.412 . . . . 0.0 111.176 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.672 ' HB3' HG21 ' A' ' 87' ' ' VAL . 60.6 m-85 -119.66 15.48 12.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.664 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 65.57 21.99 11.74 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.666 0.604 . . . . 0.0 110.845 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.41 163.2 14.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.954 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -158.45 -36.97 0.07 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.948 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.1 pt -117.95 -176.14 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.985 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.74 147.08 55.58 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.186 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.65 155.42 80.6 Favored 'Cis proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.648 -1.397 . . . . 0.0 111.802 -0.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.586 HG23 ' HG3' ' A' ' 100' ' ' GLN . 88.3 m -144.12 110.19 5.39 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.8 p -102.12 113.69 27.17 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.082 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.672 HG21 ' HB3' ' A' ' 78' ' ' TYR . 85.1 t -100.65 109.88 26.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.319 176.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -89.67 105.86 18.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.139 0.495 . . . . 0.0 110.492 -178.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 95' ' ' LYS . 46.8 mt -99.13 148.89 23.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.132 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.402 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 7.3 t70 -83.6 -166.01 1.27 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -59.92 -32.45 70.78 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -170.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -105.81 10.72 32.52 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.01 0.433 . . . . 0.0 110.773 -173.886 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.64 20.15 45.38 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.163 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 5.8 m-20 -68.32 116.93 9.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.012 0.406 . . . . 0.0 110.433 176.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.546 ' HA ' HD23 ' A' ' 89' ' ' LEU . 39.7 ttmt -74.1 89.09 1.95 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.601 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -89.27 -47.18 8.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.246 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.52 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 77.9 t80 -144.54 111.26 5.72 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.747 -177.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.449 HG23 HG22 ' A' ' 87' ' ' VAL . 2.2 p -103.18 134.46 44.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 172.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.52 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 17.3 t60 -138.24 126.64 23.21 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -175.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.586 ' HG3' HG23 ' A' ' 85' ' ' THR . 24.1 mp0 -96.63 140.09 31.75 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 123.611 0.569 . . . . 0.0 109.733 174.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.98 162.68 18.01 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.515 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.2 tp -73.95 141.04 45.95 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 122.522 0.329 . . . . 0.0 111.429 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 60.0 mtm -135.63 159.47 41.52 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 171.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -97.14 164.51 12.47 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.745 ' HG3' HG22 ' A' ' 51' ' ' VAL . 61.0 tttm -46.92 -52.37 14.69 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -175.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 25.7 t-20 -58.45 -32.82 69.08 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -177.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.541 ' O ' HG12 ' A' ' 111' ' ' ILE . 10.8 m120 -65.04 -46.35 81.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.441 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 41.5 mt -61.9 -43.93 98.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.836 176.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 105' ' ' LYS . 79.3 mm-40 -49.58 -47.21 49.56 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.015 176.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 m -72.11 -39.47 68.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.087 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 107' ' ' ASN . 48.5 mm -65.1 -44.54 95.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.875 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.718 ' HB3' HG21 ' A' ' 117' ' ' VAL . 82.8 mt -63.52 -38.73 92.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.068 0.461 . . . . 0.0 110.279 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -58.23 -41.15 83.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.892 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.9 m -85.13 -8.38 58.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.712 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 tp -85.01 -86.62 0.13 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.016 0.436 . . . . 0.0 109.842 176.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -179.03 -60.44 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.06 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 40.8 t 57.51 64.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 122.028 0.918 . . . . 0.0 110.756 177.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.114 -177.891 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 121.174 0.511 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.554 HG22 ' HB3' ' A' ' 52' ' ' SER . 1.1 tt -74.53 -8.42 11.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.484 -172.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -111.76 37.35 2.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.544 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.496 HG23 ' CD1' ' A' ' 63' ' ' TYR . 8.0 p -82.72 140.54 16.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.684 -176.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.409 HG21 HD21 ' A' ' 60' ' ' ASN . 3.8 p -139.6 159.92 27.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.485 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 19' ' ' ASN . 5.1 tp10 -83.53 -55.89 4.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.207 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.649 ' HA ' ' CE2' ' A' ' 62' ' ' TYR . 5.9 t-20 -142.59 169.07 18.26 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.543 -169.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.77 -32.35 73.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.355 176.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -63.34 -24.39 67.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.72 0.771 . . . . 0.0 109.943 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -97.65 10.28 40.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.645 -177.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -109.58 145.45 36.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.186 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -97.38 154.09 17.68 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 174.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.47 177.34 3.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.661 177.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . 89.53 -55.13 3.84 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.535 174.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 24.9 pt -84.51 134.83 41.78 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.913 0.387 . . . . 0.0 110.495 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 1.0 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 48.2 Cg_exo -59.14 144.49 99.36 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.783 2.322 . . . . 0.0 111.338 176.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.461 ' HB ' HD12 ' A' ' 89' ' ' LEU . 25.1 m -110.55 122.13 47.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.151 0.5 . . . . 0.0 111.185 -175.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.6 mt -104.39 108.67 25.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.745 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.682 ' HB ' HG23 ' A' ' 87' ' ' VAL . 5.4 mp -97.62 128.42 48.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.494 ' HB3' HG22 ' A' ' 86' ' ' THR . 26.2 ptm -121.45 122.74 40.43 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.472 0.653 . . . . 0.0 110.353 178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.563 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 93.7 m-85 -90.6 122.47 33.43 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.309 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.64 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 14.2 pttp -128.75 133.77 48.22 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.226 -174.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.488 ' HA ' ' HB2' ' A' ' 66' ' ' LEU . 17.8 p -75.1 178.17 5.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.561 0.22 . . . . 0.0 110.68 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.98 -58.94 6.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.053 0.454 . . . . 0.0 109.935 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.9 m -102.71 101.22 11.31 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.685 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 34' ' ' LYS . 4.0 p -136.03 104.21 9.72 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 120.996 0.426 . . . . 0.0 112.016 -177.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 38' ' ' CYS . 54.0 Cg_endo -71.62 -29.56 15.91 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.988 1.792 . . . . 0.0 111.889 176.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -63.31 -30.2 71.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.723 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.634 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 52.8 t -66.27 -51.11 60.74 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.113 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.7 t -57.11 -43.25 81.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.893 0.378 . . . . 0.0 110.912 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.605 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 7.6 tp10 -58.24 -49.03 78.55 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.932 177.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.4 ttt -72.16 -29.34 63.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.967 -177.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.634 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 99.0 mt-30 -57.89 -39.01 76.82 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 110.035 174.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.605 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 42.8 mtpt -60.03 -53.12 61.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.192 176.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.526 ' O ' HG23 ' A' ' 51' ' ' VAL . 63.6 mm-40 -58.7 -45.11 90.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.869 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.92 -33.15 73.72 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.953 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.3 t -64.95 -43.08 93.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.201 0.524 . . . . 0.0 109.682 176.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -66.47 -22.55 66.2 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.229 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.728 HG22 ' HG3' ' A' ' 105' ' ' LYS . 40.5 t -86.47 -41.97 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.005 0.431 . . . . 0.0 110.645 177.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.554 ' HB3' HG22 ' A' ' 14' ' ' ILE . 57.0 m -58.8 -30.83 67.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.341 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.413 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . 36.0 ttpt -51.59 -53.18 41.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.423 -178.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -105.9 15.99 25.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.707 0.289 . . . . 0.0 111.713 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 55' ' ' ARG . 12.8 ttm180 -138.68 75.91 1.54 Allowed 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.059 0.933 . . . . 0.0 109.633 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.709 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 1.5 tm-20 -71.39 132.0 44.18 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 113.87 -1.514 . . . . 0.0 110.07 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 41.47 46.86 4.63 Favored Glycine 0 C--N 1.333 0.408 0 O-C-N 124.016 0.822 . . . . 0.0 114.734 169.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.709 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 35.6 mmtm -120.14 -1.45 10.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.642 0.734 . . . . 0.0 109.434 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -158.46 150.61 21.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.453 -1.249 . . . . 0.0 108.723 172.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.409 HD21 HG21 ' A' ' 17' ' ' VAL . 62.4 t30 -114.27 124.75 52.79 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 178.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.4 mt -98.61 110.32 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.228 0.537 . . . . 0.0 111.564 -174.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.649 ' CE2' ' HA ' ' A' ' 19' ' ' ASN . 1.3 t80 -85.42 114.75 22.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.14 177.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.496 ' CD1' HG23 ' A' ' 16' ' ' VAL . 12.7 m-85 -89.94 103.26 15.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.223 0.535 . . . . 0.0 110.518 176.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.563 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -88.86 81.63 6.9 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.17 -179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.64 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 20.3 ptt180 -71.73 108.24 4.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.569 177.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 35' ' ' THR . 9.1 mp -65.87 10.5 0.1 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.185 0.517 . . . . 0.0 111.851 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' A' ' 65' ' ' ARG . 30.5 tt0 -64.23 -31.3 72.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.342 172.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -96.87 170.09 9.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.331 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -94.29 -11.96 29.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.339 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -67.28 -11.01 56.42 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.868 0.842 . . . . 0.0 110.826 177.217 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -89.89 -5.99 56.23 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.051 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.9 mt -69.19 -56.34 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -70.73 -38.13 73.55 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.724 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -57.42 -42.22 81.91 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.74 177.107 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.489 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -63.36 -56.57 15.31 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.722 -177.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -65.4 -32.21 73.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.633 -175.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 14.1 tmtt? -61.95 -18.58 60.84 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.971 0.415 . . . . 0.0 110.595 177.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.721 ' HB3' HG11 ' A' ' 87' ' ' VAL . 58.9 m-85 -127.4 25.48 6.11 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 66.0 15.29 10.01 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.323 0.582 . . . . 0.0 111.527 171.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.67 142.71 31.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.641 -174.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -146.16 -34.16 0.31 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.718 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.1 pt -125.59 -177.72 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.039 0.447 . . . . 0.0 111.3 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 84' ' ' PRO . 4.2 p -118.87 137.47 25.03 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.306 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 51.9 Cg_endo -96.65 126.33 2.92 Favored 'Cis proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.86 -1.308 . . . . 0.0 113.223 -0.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.2 m -100.39 116.99 33.66 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 171.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 2.3 p -115.5 115.23 26.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.999 0.428 . . . . 0.0 111.146 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.721 HG11 ' HB3' ' A' ' 78' ' ' TYR . 2.0 m -100.54 124.47 54.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.482 0.658 . . . . 0.0 110.219 176.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.572 ' HB3' HD22 ' A' ' 115' ' ' LEU . 73.3 m-85 -98.18 106.31 18.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.083 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.461 HD12 ' HB ' ' A' ' 29' ' ' THR . 44.0 mt -88.19 132.18 34.45 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 174.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.06 171.6 3.51 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 173.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 6.2 pttm -52.86 -25.23 10.96 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.447 0.699 . . . . 0.0 112.455 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.413 ' OE2' ' HG3' ' A' ' 91' ' ' LYS . 0.7 OUTLIER -83.21 -9.6 59.06 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.306 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.85 10.05 61.87 Favored Glycine 0 CA--C 1.517 0.207 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.728 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 2.5 p-10 -85.78 144.4 27.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.756 -0.261 . . . . 0.0 110.708 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.417 ' HA ' HD23 ' A' ' 89' ' ' LEU . 10.4 ttmt -81.21 92.41 6.32 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -85.48 -45.12 12.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.062 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.507 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 89.1 t80 -137.3 148.12 46.13 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.194 -176.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.701 ' HB ' HG12 ' A' ' 87' ' ' VAL . 2.2 p -134.76 135.36 53.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.649 173.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.507 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 50.4 t60 -122.42 119.5 31.2 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -109.47 105.67 15.11 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 133.22 179.95 16.8 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -174.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.477 HD21 ' HG2' ' A' ' 43' ' ' GLU . 33.2 tp -87.5 164.9 15.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.715 0.258 . . . . 0.0 110.84 -176.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.451 ' HB2' ' HB2' ' A' ' 107' ' ' ASN . 27.0 ptt? -172.01 156.36 4.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.613 173.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.405 HH12 ' CD ' ' A' ' 43' ' ' GLU . 32.4 mmt180 -91.84 170.87 9.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.754 -0.203 . . . . 0.0 110.987 -176.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.728 ' HG3' HG22 ' A' ' 51' ' ' VAL . 82.5 tttt -47.23 -49.87 22.25 Favored 'General case' 0 C--O 1.222 -0.346 0 O-C-N 123.63 0.581 . . . . 0.0 112.071 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -56.35 -35.43 67.65 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.158 0.504 . . . . 0.0 111.543 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 103' ' ' MET . 6.5 m120 -73.96 -40.02 63.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.49 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 61.7 mt -60.77 -46.03 96.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.378 172.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 105' ' ' LYS . 10.6 mm-40 -50.49 -48.41 56.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.317 176.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.4 m -63.86 -43.0 97.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.718 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 107' ' ' ASN . 42.8 mm -65.22 -42.99 95.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.816 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.703 ' HB3' HG21 ' A' ' 117' ' ' VAL . 81.6 mt -60.57 -42.23 96.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.617 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -64.25 -31.36 72.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.157 177.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.6 t -86.13 -9.7 56.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.462 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.572 HD22 ' HB3' ' A' ' 88' ' ' PHE . 45.9 tp -93.11 -73.92 0.54 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.116 0.484 . . . . 0.0 110.231 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 172.2 -61.38 0.15 Allowed Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.0 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 41.9 t 50.33 78.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.957 0.884 . . . . 0.0 111.605 178.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.796 -174.722 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.536 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 9.8 m . . . . . 0 N--CA 1.454 -0.253 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.1 mt 70.33 -69.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.911 -175.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.752 HD21 ' HA2' ' A' ' 57' ' ' GLY . 12.9 m120 -92.93 31.28 1.43 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.262 0.553 . . . . 0.0 110.487 177.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 7.7 p -74.69 133.58 31.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.202 -177.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.419 HG21 ' HB3' ' A' ' 60' ' ' ASN . 67.5 t -134.84 136.38 52.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.847 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -65.83 -53.95 33.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.928 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.673 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 35.2 t30 -164.77 174.33 10.81 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -173.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -50.48 -29.4 10.32 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.805 0.336 . . . . 0.0 111.208 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.673 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 10.2 pt-20 -55.83 -37.2 68.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.321 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -103.18 8.3 38.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.625 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.26 139.66 52.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.622 0.249 . . . . 0.0 110.347 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -128.18 154.74 45.46 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.759 -174.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 61.8 -170.36 0.16 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.064 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -110.22 43.99 1.6 Allowed Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.151 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.553 HG13 ' ND2' ' A' ' 60' ' ' ASN . 7.0 pt -100.68 147.25 33.38 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.609 -0.295 . . . . 0.0 111.058 -178.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 1.087 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 88.1 Cg_exo -50.59 160.07 1.88 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.64 2.893 . . . . 0.0 113.227 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.7 m -123.37 128.16 49.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.435 -175.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.458 HD11 HD21 ' A' ' 112' ' ' LEU . 80.0 mt -107.45 109.63 28.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.616 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 42.5 mt -105.15 110.22 30.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.263 -177.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.537 ' SD ' ' NZ ' ' A' ' 34' ' ' LYS . 5.1 ppp? -114.69 139.58 49.55 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.767 0.794 . . . . 0.0 110.058 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -103.87 150.03 24.53 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.016 -170.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.654 ' HB3' ' HZ2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -152.77 161.51 42.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.934 178.565 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.633 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -75.06 -173.8 2.07 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 175.114 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.457 ' HB2' ' OE1' ' A' ' 67' ' ' GLU . 31.6 t70 -60.27 -29.37 68.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.057 0.456 . . . . 0.0 110.725 175.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -158.46 132.49 7.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.546 176.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 12.5 p -165.8 137.35 3.1 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.772 176.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 24.2 Cg_exo -63.14 -29.85 74.61 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.693 2.262 . . . . 0.0 112.811 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -62.94 -31.12 72.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.516 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 46.9 t -71.47 -36.32 71.13 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.111 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.548 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 46.9 t -67.93 -42.0 85.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.835 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -57.96 -50.24 74.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.669 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.471 ' HB2' HD21 ' A' ' 102' ' ' LEU . 21.5 ttt -72.15 -29.0 63.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.664 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.445 ' HG2' ' OH ' ' A' ' 63' ' ' TYR . 23.0 tm0? -61.08 -42.41 98.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 177.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 31.7 mmmt -63.04 -45.45 92.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.934 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.599 ' O ' HG23 ' A' ' 51' ' ' VAL . 72.0 mm-40 -58.06 -47.88 81.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.698 176.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.56 -35.41 77.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.213 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.7 m -59.72 -43.93 93.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.079 0.466 . . . . 0.0 110.176 173.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -66.97 -41.03 87.54 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.615 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 47' ' ' GLU . 55.3 t -60.24 -44.56 95.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.571 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.664 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 m -66.24 -30.85 71.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.969 0.414 . . . . 0.0 111.282 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -77.66 -24.71 49.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.045 0.45 . . . . 0.0 110.557 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -93.39 -38.63 11.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.22 0.533 . . . . 0.0 110.199 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -114.8 79.03 1.21 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.63 120.92 19.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.567 -168.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.752 ' HA2' HD21 ' A' ' 15' ' ' ASN . . . 60.91 57.86 16.64 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.549 -0.75 . . . . 0.0 113.184 173.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.86 ' HE3' HG12 ' A' ' 117' ' ' VAL . 29.1 mmmt -132.67 -3.2 3.31 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.655 -0.32 . . . . 0.0 111.571 -176.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -166.82 153.92 9.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 111.149 -176.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.553 ' ND2' HG13 ' A' ' 27' ' ' ILE . 58.6 m-80 -95.64 129.82 42.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.99 174.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.6 mt -98.92 108.76 22.84 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 CA-C-O 120.542 0.211 . . . . 0.0 110.657 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.483 ' HB3' ' HA ' ' A' ' 31' ' ' ILE . 0.3 OUTLIER -96.28 118.28 32.51 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.338 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.607 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 31.2 m-85 -97.27 103.74 15.7 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.143 0.497 . . . . 0.0 110.368 173.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.415 ' HB1' HD22 ' A' ' 71' ' ' ASN . . . -94.27 100.62 12.64 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.231 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.501 ' C ' ' H ' ' A' ' 67' ' ' GLU . 3.4 ptp180 -84.61 117.22 23.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.273 172.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.7 mt -66.73 10.51 0.13 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.268 0.556 . . . . 0.0 112.082 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 65' ' ' ARG . 20.7 tp10 -80.4 -25.19 39.2 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.584 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -96.85 159.01 15.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.951 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -71.5 -22.91 61.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.166 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.493 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.9 OUTLIER -65.16 -25.84 67.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.415 0.626 . . . . 0.0 111.166 -174.914 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.493 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 7.8 m120 -89.94 -7.49 53.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.76 -168.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.7 mm -69.23 -50.94 48.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.78 -44.25 86.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.143 174.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -60.48 -40.98 93.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.593 -178.414 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 80' ' ' ALA . . . -68.9 -55.87 9.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.349 . . . . 0.0 111.655 -177.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -63.2 -34.23 77.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.676 -174.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.44 ' HE3' ' HB2' ' A' ' 77' ' ' LYS . 26.8 ttmt -64.61 -16.91 63.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.901 0.381 . . . . 0.0 110.912 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.579 ' CE1' HD21 ' A' ' 89' ' ' LEU . 75.7 m-85 -122.02 16.96 10.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.797 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 67.77 23.48 8.55 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.87 0.367 . . . . 0.0 111.535 174.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.451 ' HB1' HG21 ' A' ' 85' ' ' THR . . . -102.34 136.49 42.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.615 -178.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -144.33 -75.55 0.24 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.015 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.0 pt -71.15 142.05 16.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.99 0.424 . . . . 0.0 110.95 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.3 153.08 38.33 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.634 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -87.94 119.75 4.87 Favored 'Cis proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.25 -1.563 . . . . 0.0 112.411 0.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.567 ' HB ' ' HG3' ' A' ' 100' ' ' GLN . 5.1 t -110.31 142.52 41.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.249 177.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.7 m -132.39 127.86 36.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.747 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.616 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 10.8 p -108.89 128.33 64.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.25 0.548 . . . . 0.0 110.342 176.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -101.42 111.79 24.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.441 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.579 HD21 ' CE1' ' A' ' 78' ' ' TYR . 5.7 mp -107.91 146.01 32.97 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.079 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -83.2 -172.48 4.16 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 173.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.93 ' HE3' ' HE2' ' A' ' 118' ' ' LYS . 18.7 pttp -62.79 -33.04 74.36 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -172.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -93.42 18.04 10.43 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.458 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 78.54 25.34 61.07 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.819 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.561 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 81.3 m-20 -78.95 110.07 13.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.563 0.22 . . . . 0.0 110.68 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 78' ' ' TYR . 11.7 ptmm? -72.36 86.78 1.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.53 0.681 . . . . 0.0 109.696 177.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -80.42 -53.09 6.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.374 -172.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 75.8 t80 -135.76 127.6 29.33 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.768 -173.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.486 HG12 HG23 ' A' ' 87' ' ' VAL . 33.7 m -111.01 150.69 13.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 172.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.413 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 11.9 t60 -156.3 134.33 11.23 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.567 ' HG3' ' HB ' ' A' ' 85' ' ' THR . 2.3 mp0 -105.01 128.69 53.42 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 173.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 141.4 -161.3 26.94 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.458 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 44' ' ' MET . 1.1 tm? -129.87 121.3 26.42 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.671 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 3.3 mpp? -116.25 161.34 19.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.845 0.355 . . . . 0.0 110.202 178.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -93.95 167.97 11.27 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.086 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -50.3 -42.77 53.07 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -62.32 -38.76 90.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.186 0.517 . . . . 0.0 110.855 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.671 ' HB2' ' HB3' ' A' ' 103' ' ' MET . 3.5 m120 -71.05 -43.97 66.74 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.503 -176.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.62 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 48.9 mt -58.72 -50.04 80.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.872 176.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -56.51 -48.76 76.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.337 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.5 m -60.03 -38.17 81.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.067 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 107' ' ' ASN . 80.4 mt -65.35 -40.86 89.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.839 0.352 . . . . 0.0 110.231 176.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 57.4 mt -63.27 -35.83 81.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.183 177.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -64.86 -30.29 71.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.444 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.0 m -85.45 -9.85 56.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.709 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.2 tp -87.52 -88.18 0.14 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.387 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -174.5 -54.05 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.087 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 17.4 t 52.97 57.22 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 122.327 1.06 . . . . 0.0 109.871 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.93 ' HE2' ' HE3' ' A' ' 91' ' ' LYS . 19.8 pttm . . . . . 0 C--N 1.321 -0.662 0 CA-C-N 114.266 -1.333 . . . . 0.0 110.486 -173.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.57 ' CB ' HG23 ' A' ' 16' ' ' VAL . 20.3 m . . . . . 0 N--CA 1.45 -0.448 0 CA-C-O 121.099 0.476 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.476 ' N ' HD12 ' A' ' 14' ' ' ILE . 3.3 mp -85.81 -28.66 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.529 0.681 . . . . 0.0 110.1 -176.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -79.45 10.33 3.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.493 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.57 HG23 ' CB ' ' A' ' 13' ' ' SER . 1.0 OUTLIER -64.36 142.28 17.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.675 0.75 . . . . 0.0 112.842 -173.089 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.649 HG21 ' HB3' ' A' ' 60' ' ' ASN . 84.3 t -134.85 124.95 44.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.606 174.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -79.47 -30.92 42.3 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.138 0.495 . . . . 0.0 110.798 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -176.24 176.4 1.69 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -48.87 -34.24 12.23 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.5 mp0 -58.67 -33.73 70.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.642 0.258 . . . . 0.0 111.613 177.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -99.15 19.94 14.37 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.751 0.31 . . . . 0.0 111.019 -175.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.96 145.33 26.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.906 0.384 . . . . 0.0 111.143 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -116.71 114.42 24.0 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -81.41 168.57 18.2 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.284 -175.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.46 -35.0 5.32 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -172.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.5 pt -113.01 157.39 40.84 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 114.925 -0.638 . . . . 0.0 109.729 176.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.602 ' HG2' HG22 ' A' ' 117' ' ' VAL . 49.0 Cg_exo -57.76 169.71 2.39 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.868 2.379 . . . . 0.0 112.608 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.48 ' HA ' ' HB2' ' A' ' 60' ' ' ASN . 63.1 m -136.38 115.28 12.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.932 0.396 . . . . 0.0 111.063 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.438 HD12 ' HD2' ' A' ' 88' ' ' PHE . 21.4 mm -101.71 139.45 22.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.604 ' HB ' HG12 ' A' ' 87' ' ' VAL . 77.2 mt -130.6 118.11 41.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.561 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 24.9 ptm -109.23 120.54 42.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.469 0.652 . . . . 0.0 109.856 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.58 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 87.8 m-85 -90.41 117.36 29.06 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.752 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HG3' ' HB2' ' A' ' 41' ' ' CYS . 0.1 OUTLIER -150.8 149.35 29.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.364 -178.959 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.4 t -81.7 165.22 21.19 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 170.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.684 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -88.92 9.93 23.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.015 0.436 . . . . 0.0 110.871 -169.824 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.4 p -108.9 -16.69 14.1 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 65.7 m -83.03 128.53 64.95 Favored Pre-proline 0 C--N 1.33 -0.265 0 O-C-N 122.25 -0.281 . . . . 0.0 111.001 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.91 -25.76 7.29 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 121.938 1.759 . . . . 0.0 113.569 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -62.97 -19.74 64.58 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.798 0.332 . . . . 0.0 110.965 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.625 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 7.3 p -71.73 -34.4 69.53 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.35 -35.79 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.691 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -62.99 -49.53 74.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.135 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.5 ttt -65.84 -32.88 74.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.2 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 19.8 mt-30 -63.66 -33.2 75.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.934 175.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -68.42 -41.41 80.43 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.216 176.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 51' ' ' VAL . 18.9 mm-40 -55.72 -54.04 49.17 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 172.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.547 HD13 HG21 ' A' ' 61' ' ' ILE . 68.7 mt -58.24 -33.43 69.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.487 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.1 t -65.61 -40.66 92.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.788 0.328 . . . . 0.0 110.58 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.432 ' HB2' ' HE2' ' A' ' 105' ' ' LYS . 19.8 m-85 -72.69 -31.74 65.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.06 178.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.917 HG22 ' HG3' ' A' ' 105' ' ' LYS . 16.8 t -68.76 -38.66 79.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.2 t -64.06 -31.11 72.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.925 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 50' ' ' TYR . 16.1 tppt? -68.27 -42.55 79.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.378 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -93.24 -20.88 20.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.63 -176.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.3 76.23 1.71 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.521 0.677 . . . . 0.0 109.507 178.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.451 ' O ' ' HE3' ' A' ' 58' ' ' LYS . 1.2 pm0 -72.14 124.34 24.8 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.738 -173.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.34 40.13 37.39 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.614 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.451 ' HE3' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -113.49 -4.59 13.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.076 0.465 . . . . 0.0 110.059 -174.019 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -171.79 141.93 1.47 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.922 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.649 ' HB3' HG21 ' A' ' 17' ' ' VAL . 50.8 m-80 -77.27 145.78 37.28 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.613 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.547 HG21 HD13 ' A' ' 48' ' ' LEU . 21.3 mt -128.09 107.04 15.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 171.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.512 ' CD2' HG23 ' A' ' 31' ' ' ILE . 4.7 t80 -98.92 117.27 33.05 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.473 ' CE2' HG22 ' A' ' 16' ' ' VAL . 25.3 m-85 -90.99 103.59 16.29 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.58 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -81.5 78.29 8.27 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.984 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.583 ' C ' ' H ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -69.84 113.14 6.8 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.62 174.059 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.7 tp -64.57 11.43 0.05 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.342 0.591 . . . . 0.0 111.123 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.684 ' HB2' ' HB2' ' A' ' 36' ' ' ASP . 7.8 tp10 -80.62 -25.55 38.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.091 -178.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.427 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 44.2 mt-10 -105.87 -174.39 2.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.247 0.546 . . . . 0.0 112.056 -175.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -90.42 -31.44 16.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.947 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.547 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -54.31 -40.61 68.09 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.641 0.734 . . . . 0.0 111.664 -173.389 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.547 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 2.6 p30 -101.51 10.28 40.51 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.875 -172.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.2 mm -67.45 -49.61 69.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 167.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.56 -43.96 62.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.606 174.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.498 ' CB ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -62.78 -43.84 97.75 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.674 -177.018 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.02 -41.83 77.2 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 122.187 -0.321 . . . . 0.0 110.857 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -61.9 -32.96 73.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.461 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -55.91 -33.33 64.56 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.525 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -112.19 8.02 19.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.726 0.298 . . . . 0.0 110.575 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 t0 53.81 50.63 16.52 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.255 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.28 71.04 10.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.326 0.584 . . . . 0.0 110.609 177.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -82.87 -13.66 55.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.836 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 23.1 pt -113.9 155.91 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.189 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.18 148.93 66.52 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.985 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -90.77 121.48 4.4 Favored 'Cis proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.372 -1.512 . . . . 0.0 112.587 -1.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 94.5 m -100.52 117.19 34.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.3 m -110.38 125.78 53.57 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.089 0.471 . . . . 0.0 111.323 -175.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.604 HG12 ' HB ' ' A' ' 31' ' ' ILE . 10.5 p -108.04 140.81 25.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.551 175.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.948 ' HB3' HD11 ' A' ' 115' ' ' LEU . 52.4 m-85 -118.29 113.74 21.92 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.226 -174.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.454 ' CD2' ' HA ' ' A' ' 95' ' ' LYS . 32.3 mt -107.88 143.75 36.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.673 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.62 ' HB3' ' HB2' ' A' ' 94' ' ' ASN . 24.7 t0 -78.28 172.05 14.16 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -63.71 -18.64 64.22 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -87.69 -0.42 56.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 0.0 110.059 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.51 12.03 67.77 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.441 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.62 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 94.5 m-20 -70.06 117.71 11.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.597 -0.301 . . . . 0.0 111.445 -177.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.454 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -73.0 102.2 3.43 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.582 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -104.35 -72.53 0.7 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.91 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -113.0 141.49 46.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.89 -169.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.1 p -139.48 135.75 40.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 174.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -149.35 137.96 20.98 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -106.72 123.72 48.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.896 0.379 . . . . 0.0 110.611 178.215 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 148.43 179.29 24.25 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.949 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.3 tp -83.0 102.06 11.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.902 0.382 . . . . 0.0 110.352 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 79.4 mmm -94.98 154.35 17.22 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -115.36 171.17 7.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.784 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.917 ' HG3' HG22 ' A' ' 51' ' ' VAL . 38.8 ttmt -46.59 -59.34 3.07 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -175.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -61.5 -30.75 70.82 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.935 0.398 . . . . 0.0 111.67 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.529 ' O ' HD13 ' A' ' 111' ' ' ILE . 18.3 m120 -70.47 -40.5 73.63 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.613 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 41.1 mt -63.11 -51.37 72.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 173.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -50.97 -52.49 42.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.341 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.4 m -60.13 -40.93 91.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.004 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.624 ' O ' ' HG ' ' A' ' 115' ' ' LEU . 1.7 mp -69.06 -38.75 78.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.68 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 86.7 mt -58.01 -43.11 86.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.263 0.554 . . . . 0.0 109.783 176.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -56.7 -40.81 76.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.227 176.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.4 m -75.26 -28.99 60.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.452 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.948 HD11 ' HB3' ' A' ' 88' ' ' PHE . 85.1 mt -68.01 -58.32 4.71 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.481 0.657 . . . . 0.0 109.664 175.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 159.79 -71.3 0.23 Allowed Glycine 0 N--CA 1.438 -1.2 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.165 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.602 HG22 ' HG2' ' A' ' 28' ' ' PRO . 40.9 t 54.97 72.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.908 0.861 . . . . 0.0 109.557 -173.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 118' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.006 -171.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.0 m . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.667 ' HB ' ' CD ' ' A' ' 56' ' ' GLU . 4.2 mp -90.77 -14.71 8.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.999 0.904 . . . . 0.0 108.903 177.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -71.16 7.66 1.19 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.305 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.475 HG23 ' CE2' ' A' ' 63' ' ' TYR . 6.5 p -60.0 129.24 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -173.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -133.17 140.07 47.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.813 170.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.77 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 28.0 tp10 -70.53 -50.56 36.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.335 177.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.869 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 27.9 t-20 -149.13 171.05 17.06 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.275 -174.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 20' ' ' LEU . 3.8 mm? -50.05 -29.93 9.78 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.194 0.308 . . . . 0.0 111.061 171.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.869 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 12.9 pt-20 -61.31 -29.95 70.19 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.956 0.408 . . . . 0.0 110.881 175.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.77 ' HG3' ' HB3' ' A' ' 18' ' ' GLU . 13.6 mm-40 -95.24 -0.22 53.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.264 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.17 159.69 25.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.303 0.573 . . . . 0.0 112.145 -172.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.637 ' HB2' HD11 ' A' ' 27' ' ' ILE . 29.7 mtmt -115.39 161.96 17.8 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.688 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.44 166.01 10.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.888 0.375 . . . . 0.0 111.977 -177.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.13 -49.43 3.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.063 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.815 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -91.46 149.59 39.75 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.721 0.296 . . . . 0.0 110.62 178.115 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 1.053 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 52.0 Cg_exo -60.72 171.01 3.89 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 123.264 2.643 . . . . 0.0 112.891 176.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.532 HG23 ' HB2' ' A' ' 60' ' ' ASN . 26.4 m -130.74 131.4 44.72 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.921 -176.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.537 HD11 HD21 ' A' ' 112' ' ' LEU . 65.3 mt -110.0 114.13 46.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.664 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.613 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 9.5 mm -100.39 109.93 26.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 25.5 ptm -111.96 131.83 55.14 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.857 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.637 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 77.3 m-85 -97.53 120.55 38.11 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.217 -176.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.573 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -125.6 162.23 25.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.997 -174.587 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.3 t -135.89 164.92 26.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.061 0.457 . . . . 0.0 110.648 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.488 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . 24.3 t70 -75.79 -27.75 58.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.799 -178.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.1 m -81.82 -66.55 0.87 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.042 -174.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.613 ' HB3' ' HD2' ' A' ' 40' ' ' TYR . 29.9 m -68.69 122.12 83.62 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.223 -176.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -79.01 3.72 7.17 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.437 2.091 . . . . 0.0 113.332 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.613 ' HD2' ' HB3' ' A' ' 38' ' ' CYS . 96.1 m-85 -61.4 -23.94 66.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.996 0.427 . . . . 0.0 110.614 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.2 p -64.71 -52.02 59.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.245 177.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.433 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 41.7 t -60.47 -30.99 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.71 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.403 ' HA ' ' OE1' ' A' ' 43' ' ' GLU . 5.3 tp10 -68.02 -49.89 58.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.438 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.2 ttt -66.02 -30.3 70.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.863 0.363 . . . . 0.0 110.199 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -60.93 -37.27 81.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.023 176.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 43.7 mttp -64.49 -47.83 77.47 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.853 0.359 . . . . 0.0 110.046 177.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.51 ' O ' HG23 ' A' ' 51' ' ' VAL . 21.0 mm-40 -57.28 -44.27 83.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.299 177.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.5 mt -60.7 -34.1 73.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.971 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.5 m -59.87 -44.57 94.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.075 0.464 . . . . 0.0 110.29 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -70.05 -29.5 66.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.047 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 47' ' ' GLU . 50.9 t -76.22 -47.01 32.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.629 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.618 ' HB3' ' OE2' ' A' ' 56' ' ' GLU . 15.1 m -62.81 -29.17 70.52 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-O 120.881 0.372 . . . . 0.0 110.513 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -50.11 -32.96 17.17 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.184 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.405 ' CD ' ' HE ' ' A' ' 55' ' ' ARG . 1.1 tm-20 -104.32 -48.57 3.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.388 0.613 . . . . 0.0 109.365 171.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.663 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 9.4 tpp85 -91.02 66.52 5.83 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.915 -173.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.667 ' CD ' ' HB ' ' A' ' 14' ' ' ILE . 3.9 mm-40 -90.52 144.73 25.5 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.005 172.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.45 34.2 54.55 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.491 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.663 ' HB2' ' HG3' ' A' ' 55' ' ' ARG . 26.8 mmtp -113.05 -14.09 13.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.251 0.548 . . . . 0.0 109.727 -174.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.575 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 0.8 OUTLIER -165.68 -175.01 3.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.398 179.008 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.532 ' HB2' HG23 ' A' ' 29' ' ' THR . 44.1 m-80 -108.2 129.28 55.2 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.209 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.3 mm -106.64 107.54 22.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 173.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.865 ' CE2' ' HA ' ' A' ' 19' ' ' ASN . 0.7 OUTLIER -98.2 112.1 24.2 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.448 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.475 ' CE2' HG23 ' A' ' 16' ' ' VAL . 89.7 m-85 -89.8 102.75 15.45 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 173.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.613 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -79.67 91.03 5.2 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.573 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 8.0 ptp180 -68.97 104.21 2.04 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.443 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.7 mp -65.42 10.74 0.08 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.092 0.472 . . . . 0.0 110.907 176.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.543 ' H ' ' C ' ' A' ' 65' ' ' ARG . 2.0 mp0 -83.29 -29.44 28.36 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.012 177.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.487 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 22.6 mt-10 -102.48 -171.67 2.0 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-O 121.379 0.609 . . . . 0.0 112.48 -175.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -95.17 -35.35 11.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.966 -174.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.522 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -56.33 -28.17 58.13 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.408 0.623 . . . . 0.0 111.144 -176.376 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.522 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 3.6 m120 -87.69 -8.45 56.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.435 -170.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.8 mm -68.3 -57.86 7.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.46 -38.89 91.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.2 174.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.495 ' HG ' ' OH ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -58.86 -38.91 79.85 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.312 179.343 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.637 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -61.14 -48.23 82.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.062 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -65.55 -34.17 77.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.809 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -57.91 -33.8 69.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.041 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.422 ' CD1' HG11 ' A' ' 87' ' ' VAL . 72.6 m-85 -115.81 16.99 16.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.902 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 61.9 35.02 16.6 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.006 170.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.411 ' HB1' HG21 ' A' ' 85' ' ' THR . . . -91.65 146.1 24.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.696 -176.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -154.58 -35.01 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.45 174.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.0 mt -91.94 134.9 28.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.787 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 84' ' ' PRO . 16.1 m -108.34 134.74 20.1 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.568 176.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 63.5 Cg_endo -91.7 141.79 11.14 Favored 'Cis proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.321 -1.533 . . . . 0.0 112.509 -0.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.429 HG23 ' CD1' ' A' ' 33' ' ' PHE . 9.0 t -126.06 147.18 49.63 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.5 t -141.17 130.39 23.52 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.891 0.376 . . . . 0.0 110.462 -177.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.613 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 8.8 p -113.61 128.29 70.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.382 0.611 . . . . 0.0 110.198 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.552 ' HB3' HD22 ' A' ' 115' ' ' LEU . 88.8 m-85 -100.03 118.54 36.62 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.147 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.594 ' O ' ' HB3' ' A' ' 28' ' ' PRO . 7.1 mp -106.12 139.43 40.65 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.159 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -68.77 177.51 2.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 173.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.869 ' HE3' ' HE2' ' A' ' 118' ' ' LYS . 4.5 pttm -63.16 -26.19 68.7 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 122.36 0.264 . . . . 0.0 111.596 -176.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -71.13 -25.56 62.63 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.747 0.308 . . . . 0.0 110.967 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.99 22.29 10.96 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.671 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 28.7 m120 -86.81 132.09 33.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.687 0.244 . . . . 0.0 110.484 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -71.4 84.3 0.8 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.428 0.633 . . . . 0.0 109.724 173.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -73.03 -47.82 41.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.081 -174.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -145.21 116.68 8.04 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.127 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 87' ' ' VAL . 7.2 p -105.67 137.02 37.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 174.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -124.05 136.04 53.99 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -116.5 110.35 18.48 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 175.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 135.3 158.79 8.4 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -175.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.3 tp -77.9 141.78 38.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.757 0.313 . . . . 0.0 111.131 -176.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.483 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 54.7 mtm -131.63 166.89 20.43 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -102.67 175.03 5.63 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -54.85 -48.43 72.9 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.413 ' HA ' ' CD ' ' A' ' 109' ' ' GLU . 5.0 t-20 -66.51 -28.52 68.63 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.007 0.432 . . . . 0.0 110.811 -176.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.511 ' O ' HG12 ' A' ' 111' ' ' ILE . 11.2 m120 -66.16 -45.48 80.79 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 176.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.524 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 54.2 mt -61.71 -45.5 98.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.597 175.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.413 ' CD ' ' HA ' ' A' ' 106' ' ' ASN . 40.9 mt-10 -50.37 -48.29 55.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.528 176.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.3 m -65.25 -40.09 93.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.068 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 107' ' ' ASN . 49.1 mm -68.27 -43.52 84.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.516 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.537 HD21 HD11 ' A' ' 30' ' ' ILE . 98.2 mt -57.2 -43.54 82.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.18 0.514 . . . . 0.0 110.51 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -60.48 -43.2 97.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.117 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.0 m -86.53 -2.58 58.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.816 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' A' ' 88' ' ' PHE . 63.5 tp -82.85 -69.93 0.59 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.971 0.415 . . . . 0.0 111.869 -174.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.781 ' O ' ' HG2' ' A' ' 118' ' ' LYS . . . 149.32 -3.16 0.63 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.547 -172.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.053 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 39.0 t -33.86 107.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.141 0.976 . . . . 0.0 113.283 171.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.869 ' HE2' ' HE3' ' A' ' 91' ' ' LYS . 22.5 pttm . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 114.672 -1.149 . . . . 0.0 107.95 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.567 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 5.6 m . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.373 0.13 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.0 mt 64.59 -68.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 O-C-N 123.681 0.613 . . . . 0.0 111.133 -173.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -89.15 45.82 1.33 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.061 0.458 . . . . 0.0 110.641 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 2.4 p -79.71 123.12 36.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.603 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.593 HG11 ' HB2' ' A' ' 23' ' ' ALA . 41.0 t -109.65 141.93 23.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.104 -175.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -83.14 -33.64 26.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.756 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.82 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 20.1 t-20 -173.33 175.58 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.7 mt -60.58 -29.74 69.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.019 0.438 . . . . 0.0 110.447 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.82 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 12.0 pt-20 -65.13 -32.25 73.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.554 176.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -93.31 7.8 42.96 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.493 0.663 . . . . 0.0 110.122 178.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.593 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -110.24 158.58 18.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.249 -176.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -133.24 135.61 45.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.117 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.06 163.63 27.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.785 0.326 . . . . 0.0 110.269 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.58 -35.72 3.23 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.687 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -116.0 145.54 35.06 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.177 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.543 ' HD2' ' O ' ' A' ' 58' ' ' LYS . 99.4 Cg_exo -44.93 133.61 10.82 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.17 2.58 . . . . 0.0 112.757 177.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.4 m -101.4 109.25 21.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.366 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.683 HD13 ' HB2' ' A' ' 59' ' ' PHE . 2.4 mp -98.67 108.19 21.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.706 ' HB ' HG23 ' A' ' 87' ' ' VAL . 67.8 mt -104.35 112.02 36.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.069 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.421 ' SD ' ' HB3' ' A' ' 34' ' ' LYS . 4.5 ppp? -109.55 144.15 38.24 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.5 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 87.5 m-85 -104.84 130.34 52.99 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.776 -177.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.873 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 12.5 pttp -143.98 149.06 36.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.108 -172.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.568 HG22 ' H ' ' A' ' 36' ' ' ASP . 1.4 m -74.04 -174.18 1.81 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 168.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.568 ' H ' HG22 ' A' ' 35' ' ' THR . 7.0 t70 -54.12 -75.36 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.798 0.332 . . . . 0.0 110.812 175.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.1 m -110.88 127.17 55.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.861 0.363 . . . . 0.0 110.696 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 44.0 m -146.3 134.76 10.87 Favored Pre-proline 0 C--O 1.235 0.313 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.325 178.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.28 -31.19 14.67 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.116 1.877 . . . . 0.0 113.044 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -68.74 -28.7 67.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.926 0.393 . . . . 0.0 110.694 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 38' ' ' CYS . 58.8 m -74.37 -42.38 59.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.694 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.0 p -70.5 -29.58 39.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.161 0.505 . . . . 0.0 110.19 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -66.02 -46.23 78.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.898 175.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.442 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 23.8 ttt -63.16 -35.28 79.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.518 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.465 ' HG2' ' OH ' ' A' ' 63' ' ' TYR . 38.0 mt-30 -57.78 -40.63 80.28 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.192 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -58.68 -50.5 73.65 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.535 ' HG3' ' HA ' ' A' ' 104' ' ' ARG . 70.0 mm-40 -59.96 -40.26 88.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.098 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.817 HD13 HD13 ' A' ' 61' ' ' ILE . 96.7 mt -60.28 -43.66 96.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.492 177.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.9 t -62.99 -37.07 85.7 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.177 0.513 . . . . 0.0 110.15 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.617 ' HA ' ' HE3' ' A' ' 53' ' ' LYS . 23.0 m-85 -64.05 -23.94 67.52 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.567 177.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.538 HG22 ' HE3' ' A' ' 105' ' ' LYS . 46.3 t -83.15 -43.18 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.8 m -55.41 -31.86 62.2 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.16 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.617 ' HE3' ' HA ' ' A' ' 50' ' ' TYR . 10.1 mtmp? -62.27 -35.16 78.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.786 0.327 . . . . 0.0 111.103 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.579 ' OE1' ' HB2' ' A' ' 53' ' ' LYS . 1.7 mp0 -103.96 9.0 36.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.554 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -154.83 92.8 1.49 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -172.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.12 116.48 7.26 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.119 0.485 . . . . 0.0 109.698 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 59' ' ' PHE . . . 47.02 -105.75 0.12 Allowed Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.168 -173.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.543 ' O ' ' HD2' ' A' ' 28' ' ' PRO . 0.3 OUTLIER 53.58 8.33 0.13 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.826 -1.187 . . . . 0.0 112.946 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.683 ' HB2' HD13 ' A' ' 30' ' ' ILE . 9.5 p90 -163.21 114.14 1.43 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.565 0.698 . . . . 0.0 110.414 174.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.498 ' HB3' HG21 ' A' ' 17' ' ' VAL . 5.4 m-20 -84.15 116.2 22.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.796 174.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.817 HD13 HD13 ' A' ' 48' ' ' LEU . 26.7 mt -96.33 107.91 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.746 -176.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.582 ' HB3' HG12 ' A' ' 31' ' ' ILE . 4.4 t80 -91.18 117.23 29.45 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.505 ' HD2' ' HD3' ' A' ' 34' ' ' LYS . 44.1 m-85 -91.48 106.46 18.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.782 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -83.13 69.83 9.95 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.775 0.797 . . . . 0.0 109.447 178.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.873 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 26.1 ptt180 -62.52 118.45 7.58 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.965 175.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 34' ' ' LYS . 4.4 mm? -66.64 10.24 0.14 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.873 0.368 . . . . 0.0 111.618 178.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.486 ' H ' ' C ' ' A' ' 65' ' ' ARG . 17.9 mt-10 -69.05 -40.95 78.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.543 0.687 . . . . 0.0 109.974 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.598 ' HB2' ' HD2' ' A' ' 70' ' ' LYS . 27.0 mt-10 -89.83 151.99 21.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.908 -174.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -70.7 -34.21 71.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.216 0.531 . . . . 0.0 110.173 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.598 ' HD2' ' HB2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -58.15 -27.1 63.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.883 179.02 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.495 ' N ' ' HD3' ' A' ' 70' ' ' LYS . 76.8 m-20 -87.47 -3.41 59.0 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.223 -178.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.4 mm -70.72 -43.1 77.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 171.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -71.77 -41.35 68.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.217 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 74' ' ' LEU . 0.8 OUTLIER -60.85 -47.42 86.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.205 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.5 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -62.93 -48.65 77.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.833 0.349 . . . . 0.0 110.967 178.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -61.42 -34.48 75.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.657 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -57.18 -33.22 67.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.181 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.453 ' CE1' ' HD3' ' A' ' 95' ' ' LYS . 85.3 m-85 -111.66 12.53 21.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.961 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.2 t70 67.33 21.86 9.69 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.433 0.635 . . . . 0.0 111.24 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.73 93.43 4.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.898 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -112.75 -8.15 13.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.454 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.567 HD13 ' H ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -125.17 153.39 32.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.001 178.552 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.7 m -131.27 153.22 81.61 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.455 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -90.59 145.65 16.64 Favored 'Cis proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.282 -1.549 . . . . 0.0 112.662 -0.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.1 t -142.61 149.55 39.13 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.3 m -138.6 131.12 28.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.684 0.278 . . . . 0.0 111.35 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.706 HG23 ' HB ' ' A' ' 31' ' ' ILE . 5.5 m -102.4 120.87 52.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.893 173.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -96.55 118.38 32.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.221 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.499 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 6.6 mp -113.68 145.06 41.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.75 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -63.93 171.66 2.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.949 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.515 ' HG2' ' CD ' ' A' ' 118' ' ' LYS . 2.2 pptp? -52.04 -25.1 7.79 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.901 0.881 . . . . 0.0 112.756 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.444 ' HB2' ' NZ ' ' A' ' 91' ' ' LYS . 21.6 tt0 -92.1 -4.81 53.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.069 0.462 . . . . 0.0 111.036 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.98 29.07 24.12 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.827 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -110.06 134.04 52.57 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.499 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 35.1 mtmm -65.56 147.07 54.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.061 0.457 . . . . 0.0 111.202 -175.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -127.58 -46.27 1.45 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.132 173.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.499 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 81.4 t80 -147.45 134.09 19.91 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.466 -175.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.52 ' HB ' HG12 ' A' ' 87' ' ' VAL . 3.1 p -116.85 140.36 39.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 173.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.499 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 31.3 t60 -135.85 146.75 47.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -114.88 135.95 53.64 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.69 -149.04 18.34 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.12 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.3 tp -127.11 144.86 50.93 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.538 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 3.4 mpp? -131.28 165.02 24.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.354 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.535 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 32.3 mmt180 -103.22 168.21 9.32 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 173.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.58 ' HG3' ' N ' ' A' ' 106' ' ' ASN . 5.1 ptmt -54.93 -43.11 73.04 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -171.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.58 ' N ' ' HG3' ' A' ' 105' ' ' LYS . 12.9 t-20 -66.21 -32.23 73.53 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.908 0.385 . . . . 0.0 111.074 -178.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 103' ' ' MET . 9.1 m120 -66.74 -42.89 85.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.573 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 60.5 mt -62.59 -48.47 88.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.825 174.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -49.52 -51.79 34.01 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.109 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 m -63.16 -41.11 99.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.998 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 107' ' ' ASN . 42.9 mm -63.52 -40.9 90.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 91.0 mt -64.98 -37.45 87.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.594 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.74 -39.3 88.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.846 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.3 t -85.49 -10.49 56.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.471 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.5 tp -82.96 -56.25 3.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.523 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 168.83 -79.2 0.1 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.279 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.555 HG21 ' HB3' ' A' ' 112' ' ' LEU . 57.5 t 52.43 81.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.774 0.797 . . . . 0.0 111.623 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.515 ' CD ' ' HG2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.866 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.56 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . 8.4 p . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.1 mt 70.81 -74.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 123.322 0.649 . . . . 0.0 111.719 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -97.39 23.33 7.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.658 -174.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.56 ' CG2' ' HB2' ' A' ' 13' ' ' SER . 15.9 m -75.43 138.67 20.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.781 0.8 . . . . 0.0 112.732 -174.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 60' ' ' ASN . 48.6 t -121.81 124.84 72.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.558 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . 6.5 tp10 -59.42 -54.61 44.71 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.221 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.659 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 4.1 t30 -158.9 168.87 25.67 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -53.49 -29.16 34.74 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -170.199 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -66.58 -29.13 69.12 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.318 -0.239 . . . . 0.0 111.356 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.418 ' HG2' ' HB3' ' A' ' 18' ' ' GLU . 4.1 mp0 -80.43 -12.11 59.6 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.44 144.93 56.82 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.532 ' HD3' ' H ' ' A' ' 25' ' ' GLU . 5.0 tmtt? -127.9 151.69 48.77 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.356 -173.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.532 ' H ' ' HD3' ' A' ' 24' ' ' LYS . 25.6 mm-40 60.29 -164.11 0.23 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.928 175.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -119.19 47.65 1.01 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.917 -174.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.658 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -99.15 158.45 32.26 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 171.687 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -53.95 158.59 8.62 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.936 2.424 . . . . 0.0 112.504 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.5 m -127.21 128.99 46.98 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.063 0.459 . . . . 0.0 110.856 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.762 HD11 HD21 ' A' ' 112' ' ' LEU . 80.9 mt -98.23 108.18 21.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.591 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.808 ' HB ' HG23 ' A' ' 87' ' ' VAL . 22.5 mm -95.82 109.33 22.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 24.8 ptm -121.68 136.14 54.95 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.034 -0.667 . . . . 0.0 111.075 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.833 ' HZ ' ' HB2' ' A' ' 78' ' ' TYR . 47.1 m-85 -96.48 119.9 35.81 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.343 -178.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HG3' ' HB3' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -130.87 132.59 45.26 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.509 -170.021 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.696 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 7.3 m -99.96 162.87 12.72 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.96 -49.77 55.08 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.6 m -66.8 -52.55 42.69 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -171.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.727 ' SG ' HG21 ' A' ' 83' ' ' VAL . 2.7 p -70.99 125.55 92.02 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -167.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.651 ' O ' HG22 ' A' ' 42' ' ' VAL . 69.5 Cg_endo -75.79 -9.81 19.78 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.094 2.529 . . . . 0.0 112.653 175.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -59.47 -29.81 68.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.486 0.66 . . . . 0.0 109.768 174.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.647 ' HB3' ' HG3' ' A' ' 34' ' ' LYS . 75.0 m -78.93 -36.9 41.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.649 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 39' ' ' PRO . 2.8 m -68.44 -30.62 48.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.34 -177.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 1.8 mt-10 -61.97 -48.28 81.05 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.824 0.345 . . . . 0.0 110.78 173.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -37.75 78.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.637 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 77.3 mt-30 -58.3 -49.59 76.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.903 175.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 73.3 mmtt -58.04 -43.31 86.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.162 0.506 . . . . 0.0 110.062 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.588 ' O ' HG23 ' A' ' 51' ' ' VAL . 52.0 mm-40 -62.47 -46.86 86.58 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.199 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 48' ' ' LEU . 27.0 mt -59.77 -34.82 73.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.466 177.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.6 m -57.62 -45.87 84.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.209 0.528 . . . . 0.0 110.271 176.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -76.77 -30.36 56.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.754 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 47' ' ' GLU . 77.9 t -62.9 -41.76 93.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -65.13 -36.6 84.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.338 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -74.38 -15.6 60.92 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -109.82 -1.83 17.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.474 0.654 . . . . 0.0 109.977 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -145.7 75.31 1.42 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.356 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -67.12 118.41 10.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.791 -175.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.09 62.64 5.92 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.292 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -134.93 2.32 3.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.805 0.302 . . . . 0.0 111.086 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -168.65 145.07 3.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.412 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.567 ' HB3' HG21 ' A' ' 17' ' ' VAL . 47.4 m-80 -90.88 128.83 36.9 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.145 176.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.7 mt -103.68 108.0 23.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.659 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 55.0 t80 -92.36 114.98 27.68 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.051 177.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -92.35 105.07 17.34 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.135 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.562 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -88.27 75.78 8.5 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.633 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 26.2 ptt180 -68.22 113.78 6.14 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.642 177.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.15 12.0 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.104 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.569 ' H ' ' C ' ' A' ' 65' ' ' ARG . 1.4 mp0 -83.23 -20.88 33.75 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.011 -175.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -112.83 -176.8 2.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.0 0.428 . . . . 0.0 111.083 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.41 -31.45 16.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.097 -175.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.48 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -61.37 -29.53 69.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.572 0.701 . . . . 0.0 110.79 -175.667 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.48 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 3.6 m120 -81.78 -11.61 58.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.705 -174.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.5 mm -72.03 -51.33 31.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.098 0.475 . . . . 0.0 110.181 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -67.19 -37.89 84.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.103 177.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.46 -43.75 98.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.897 177.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.719 ' HA ' ' CE1' ' A' ' 33' ' ' PHE . . . -52.06 -56.01 17.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.385 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -69.3 -33.53 73.32 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.062 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -59.22 -26.57 64.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.124 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.833 ' HB2' ' HZ ' ' A' ' 33' ' ' PHE . 79.7 m-85 -119.92 21.43 11.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.735 -178.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 69.66 33.49 2.98 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 167.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.407 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . . . -71.61 152.9 42.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.002 0.429 . . . . 0.0 110.977 176.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -141.25 -81.15 0.24 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.14 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 34.4 pt -113.23 171.18 3.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.727 HG21 ' SG ' ' A' ' 38' ' ' CYS . 19.4 m -101.9 150.89 37.8 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-O 120.522 0.201 . . . . 0.0 111.34 -176.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -92.78 116.43 2.34 Favored 'Cis proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.617 -1.41 . . . . 0.0 112.654 -1.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.738 HG23 ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -96.04 135.64 37.54 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.614 HG23 ' HB3' ' A' ' 99' ' ' HIS . 6.1 t -144.74 132.12 20.77 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.125 178.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.808 HG23 ' HB ' ' A' ' 31' ' ' ILE . 3.9 m -112.34 116.77 53.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.796 175.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.681 ' HB3' HD21 ' A' ' 115' ' ' LEU . 92.5 m-85 -90.61 116.96 28.9 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.769 -177.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 27.6 mt -102.38 137.4 40.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.721 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -73.07 -171.79 0.96 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.981 ' HG2' ' HB2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -69.99 -24.76 63.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.888 -0.508 . . . . 0.0 111.73 -175.114 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.569 ' HB2' ' ND2' ' A' ' 94' ' ' ASN . 8.3 mm-40 -81.23 -6.25 58.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.397 0.617 . . . . 0.0 109.348 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.46 31.71 40.49 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.21 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.569 ' ND2' ' HB2' ' A' ' 92' ' ' GLU . 35.3 m-80 -93.26 143.19 26.5 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.912 177.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -72.28 85.82 1.09 Allowed 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.865 0.728 . . . . 0.0 109.519 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -85.43 -50.79 7.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.276 -172.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.422 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 73.3 t80 -133.64 126.79 31.6 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.675 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.619 HG12 HG12 ' A' ' 87' ' ' VAL . 3.6 m -103.69 151.53 6.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.614 ' HB3' HG23 ' A' ' 86' ' ' THR . 55.8 t60 -142.8 140.89 31.53 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.738 ' NE2' HG23 ' A' ' 85' ' ' THR . 5.7 tp-100 -127.93 138.35 52.61 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 172.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.97 173.68 29.03 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.717 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.9 tp -75.03 152.31 38.68 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.364 0.602 . . . . 0.0 111.253 -175.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.644 ' SD ' HG12 ' A' ' 108' ' ' ILE . 5.3 ptp -146.42 137.96 24.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.206 172.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.462 ' O ' HG13 ' A' ' 108' ' ' ILE . 18.1 tpp180 -85.99 171.57 11.33 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.55 ' HG3' HG22 ' A' ' 51' ' ' VAL . 47.9 tttm -45.98 -57.33 4.5 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -174.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.41 -36.36 75.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.673 0.273 . . . . 0.0 111.163 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.645 ' O ' HG12 ' A' ' 111' ' ' ILE . 5.7 m-20 -62.9 -48.91 76.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.617 178.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.644 HG12 ' SD ' ' A' ' 103' ' ' MET . 25.6 mt -59.12 -47.36 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.81 0.814 . . . . 0.0 110.281 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -62.74 -41.32 99.13 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.98 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.491 ' O ' ' HB3' ' A' ' 113' ' ' ASN . 59.5 m -64.23 -30.62 71.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.577 177.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.645 HG12 ' O ' ' A' ' 107' ' ' ASN . 50.6 mm -67.62 -36.64 76.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.513 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.762 HD21 HD11 ' A' ' 30' ' ' ILE . 25.3 mt -60.7 -38.78 86.15 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.491 ' HB3' ' O ' ' A' ' 110' ' ' THR . 17.1 t30 -59.92 -44.74 94.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.957 176.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.5 p -72.33 -30.14 64.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.736 0.303 . . . . 0.0 111.036 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.681 HD21 ' HB3' ' A' ' 88' ' ' PHE . 3.9 mp -63.2 -55.13 27.62 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.31 0.576 . . . . 0.0 109.93 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 148.2 -53.58 0.53 Allowed Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.245 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.0 t 50.42 75.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -171.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.981 ' HB2' ' HG2' ' A' ' 91' ' ' LYS . 25.4 mtpp . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.616 -162.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.582 ' HB3' HG11 ' A' ' 16' ' ' VAL . 15.5 m . . . . . 0 N--CA 1.446 -0.659 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.8 mt -96.3 137.34 24.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.462 -177.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 94.3 m-20 66.86 24.96 9.63 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.842 0.714 . . . . 0.0 110.971 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.582 HG11 ' HB3' ' A' ' 13' ' ' SER . 11.7 m -102.01 157.24 4.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.642 0.258 . . . . 0.0 110.855 -176.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.56 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 5.3 p -146.47 157.45 11.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.083 0.468 . . . . 0.0 111.488 -176.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -82.66 -55.18 4.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.617 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.704 ' HA ' ' CE2' ' A' ' 62' ' ' TYR . 18.7 t-20 -136.72 160.38 39.0 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.854 -173.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.1 mt -53.3 -35.06 59.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.38 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -65.42 -31.54 72.69 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.726 0.298 . . . . 0.0 111.008 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -79.42 -15.5 57.71 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.408 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.09 111.6 6.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 0.0 110.394 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.796 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 10.6 mmpt? -88.08 145.67 25.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.318 0.58 . . . . 0.0 111.928 -177.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 58.13 -166.12 0.16 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.677 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -105.26 72.22 0.23 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.097 -175.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.527 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -108.04 149.9 39.71 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 174.373 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.859 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 53.3 Cg_exo -54.11 141.55 68.76 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.573 2.182 . . . . 0.0 111.416 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 m -111.68 120.61 42.6 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.875 0.369 . . . . 0.0 111.169 -175.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.454 HD12 ' CD2' ' A' ' 88' ' ' PHE . 17.3 mm -106.85 122.5 60.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.674 ' HB ' ' CG2' ' A' ' 87' ' ' VAL . 69.2 mt -114.69 115.65 50.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.919 -174.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.5 tpt -109.85 116.5 31.77 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.678 177.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.644 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 85.4 m-85 -83.64 118.28 23.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.347 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.936 ' HE2' ' HB3' ' A' ' 63' ' ' TYR . 6.4 pttt -132.39 146.54 52.04 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.416 -169.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m -67.8 138.54 56.24 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 158.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 18.8 t0 -57.14 -32.63 66.56 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.076 0.465 . . . . 0.0 111.075 -168.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.1 m -124.6 92.35 3.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.428 173.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 18.2 p -138.3 142.01 33.67 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.338 177.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.48 -28.1 62.14 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.383 2.056 . . . . 0.0 112.927 -177.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -66.83 -31.09 71.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.913 0.387 . . . . 0.0 110.291 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 45' ' ' GLN . 53.0 t -71.75 -35.07 69.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.008 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 45.5 t -69.59 -46.11 76.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.558 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.467 ' HG2' HD21 ' A' ' 102' ' ' LEU . 4.4 tp10 -61.64 -49.64 75.76 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.755 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.419 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 19.8 ttt -66.58 -29.12 69.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.197 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.517 ' HB2' ' O ' ' A' ' 41' ' ' CYS . 23.0 tm0? -60.0 -41.78 92.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.016 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -62.82 -47.81 81.81 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 51' ' ' VAL . 16.2 mm-40 -57.84 -47.34 82.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.522 177.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.484 HD13 HD13 ' A' ' 61' ' ' ILE . 97.9 mt -58.67 -41.7 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.731 178.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.9 m -57.17 -41.56 79.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.638 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.539 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 21.1 m-85 -65.95 -37.04 84.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.737 178.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 47' ' ' GLU . 41.2 t -72.63 -50.68 32.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.931 -177.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.7 m -60.73 -31.54 70.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 0.0 111.121 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -57.65 -29.96 65.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.382 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -110.38 -2.04 16.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.987 -175.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.54 ' HB2' ' HG3' ' A' ' 58' ' ' LYS . 17.1 ptp180 -146.73 97.69 2.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.004 0.906 . . . . 0.0 110.768 174.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.24 133.05 35.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.953 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.06 35.95 71.84 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.462 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.54 ' HG3' ' HB2' ' A' ' 55' ' ' ARG . 41.4 mmtm -112.43 -4.05 14.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.933 0.397 . . . . 0.0 110.963 -178.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 28' ' ' PRO . 6.2 p90 -176.03 138.31 0.34 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.191 173.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.56 ' OD1' ' HB ' ' A' ' 17' ' ' VAL . 7.5 t-20 -105.6 124.04 48.91 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.554 HD12 HG12 ' A' ' 16' ' ' VAL . 40.5 mt -89.22 107.61 18.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.291 0.567 . . . . 0.0 111.207 -175.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.704 ' CE2' ' HA ' ' A' ' 19' ' ' ASN . 10.7 t80 -88.49 106.19 18.12 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.89 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.936 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 75.6 m-85 -78.93 102.29 8.2 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.347 176.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.615 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -85.85 74.48 10.18 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.24 0.543 . . . . 0.0 109.859 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.933 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 12.4 ptt85 -63.55 116.98 6.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.787 175.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.7 tp -74.24 9.57 1.59 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.033 0.444 . . . . 0.0 110.473 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.533 ' HB2' ' HB2' ' A' ' 36' ' ' ASP . 0.3 OUTLIER -82.53 -18.65 40.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.191 -175.877 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -113.21 154.51 26.61 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.187 0.518 . . . . 0.0 111.128 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.407 ' HG3' ' H ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -65.15 -32.55 74.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.207 -172.812 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -26.56 68.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.021 0.439 . . . . 0.0 111.672 -175.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.477 ' HA ' ' CB ' ' A' ' 74' ' ' LEU . 91.2 m-20 -90.51 1.11 57.01 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.48 -176.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.6 mm -70.69 -50.43 44.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 173.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -72.78 -34.08 66.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.481 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.477 ' CB ' ' HA ' ' A' ' 71' ' ' ASN . 1.1 tm? -60.18 -45.82 91.8 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.644 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -57.59 -49.99 74.57 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.994 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -64.41 -34.76 78.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.927 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -62.44 -20.06 64.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.965 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.574 ' HB3' HG11 ' A' ' 87' ' ' VAL . 77.3 m-85 -124.55 15.95 8.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.076 -177.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.8 t70 65.22 27.3 12.22 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.927 0.87 . . . . 0.0 110.826 172.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.72 104.01 15.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.425 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -107.1 -39.74 5.64 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.75 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.1 pt -107.08 171.93 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.033 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.04 145.02 53.96 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.733 174.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.02 157.26 84.09 Favored 'Cis proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.36 -1.517 . . . . 0.0 112.606 -0.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.554 ' OG1' ' HB2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -145.84 129.33 16.94 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.771 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.7 m -123.26 116.38 23.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.224 0.535 . . . . 0.0 111.45 -176.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.674 ' CG2' ' HB ' ' A' ' 31' ' ' ILE . 13.2 m -102.86 135.05 42.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.176 174.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.529 ' HB3' HD22 ' A' ' 115' ' ' LEU . 79.5 m-85 -107.15 112.79 25.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.499 -176.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.465 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 6.2 mp -111.17 145.79 38.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.727 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.545 ' OD1' ' HA3' ' A' ' 116' ' ' GLY . 10.6 t70 -80.11 -165.87 0.92 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -79.4 8.59 5.93 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -168.463 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -127.42 21.22 6.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.87 0.367 . . . . 0.0 111.187 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.28 14.32 74.11 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.95 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -85.59 125.38 33.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.063 0.459 . . . . 0.0 109.957 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.492 ' HD3' HG22 ' A' ' 98' ' ' VAL . 5.0 tmmm? -82.68 109.54 16.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.888 -177.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.406 ' HB3' ' CD1' ' A' ' 115' ' ' LEU . 92.2 t80 -97.26 -59.72 1.73 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.24 -177.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.432 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 76.8 t80 -119.7 149.21 42.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.651 0.262 . . . . 0.0 110.801 -173.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.541 HG13 HG12 ' A' ' 87' ' ' VAL . 9.6 t -130.74 139.84 50.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.432 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 6.2 t60 -147.86 133.49 18.82 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.455 ' CD ' HG22 ' A' ' 85' ' ' THR . 3.3 mm-40 -106.32 158.37 16.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.623 0.249 . . . . 0.0 110.342 -173.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.96 -153.12 20.74 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.588 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.467 HD21 ' HG2' ' A' ' 43' ' ' GLU . 57.8 tp -114.21 120.98 42.32 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.739 0.304 . . . . 0.0 110.475 -176.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 74.9 mtp -111.21 162.24 15.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.893 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -105.44 171.2 7.46 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.174 -0.21 . . . . 0.0 110.537 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.539 ' HD2' ' HB3' ' A' ' 50' ' ' TYR . 52.5 tttp -47.4 -58.83 3.71 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.726 0.641 . . . . 0.0 111.974 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 3.8 m-20 -53.73 -33.56 56.04 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.081 0.467 . . . . 0.0 111.834 -176.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.534 ' O ' HG12 ' A' ' 111' ' ' ILE . 5.7 m120 -73.72 -46.57 45.29 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.355 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.567 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 57.1 mt -58.78 -43.56 88.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.767 174.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 105' ' ' LYS . 71.6 mm-40 -48.71 -56.37 8.76 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.844 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.5 m -72.4 -37.82 68.58 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.486 -174.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 107' ' ' ASN . 38.8 mm -63.43 -41.62 93.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.839 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 86.5 mt -62.44 -39.03 92.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.92 0.391 . . . . 0.0 110.155 176.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -62.81 -37.4 86.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.745 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.5 t -76.98 -37.51 55.03 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.581 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 88' ' ' PHE . 51.8 tp -57.94 -70.93 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.614 178.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.545 ' HA3' ' OD1' ' A' ' 90' ' ' ASP . . . -175.44 -74.44 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.01 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.859 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 85.6 t 55.72 76.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.971 0.891 . . . . 0.0 109.847 -174.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 118' ' ' LYS . 20.6 pttm . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.469 -174.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.409 ' HG3' ' HG ' ' A' ' 3' ' ' LEU . 22.9 ptp . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -76.51 84.07 3.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.994 0.426 . . . . 0.0 110.862 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 3' ' ' LEU . 1.8 pp -159.97 154.45 23.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.795 175.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 66.34 -64.46 0.22 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 124.012 0.82 . . . . 0.0 111.406 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.3 -35.33 2.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.467 -0.397 . . . . 0.0 113.122 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tt -63.29 -52.81 53.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -162.69 35.5 0.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.117 0.484 . . . . 0.0 110.383 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -140.85 25.93 2.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.742 0.782 . . . . 0.0 110.104 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.3 tp -67.96 -26.93 35.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.285 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -80.35 18.3 0.92 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.054 -172.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.585 ' O ' ' HB3' ' A' ' 12' ' ' GLN . 57.7 t80 -74.84 73.25 2.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.262 0.553 . . . . 0.0 110.098 174.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.585 ' HB3' ' O ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER 156.78 -18.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.132 1.773 . . . . 0.0 106.886 178.37 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.628 ' HB3' HG11 ' A' ' 16' ' ' VAL . 33.4 m -104.16 101.14 10.89 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 113.959 -1.473 . . . . 0.0 109.718 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 15' ' ' ASN . 96.1 mt -107.02 146.09 13.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.56 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 84.4 m-20 71.21 13.94 6.68 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.602 0.564 . . . . 0.0 110.159 -174.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.628 HG11 ' HB3' ' A' ' 13' ' ' SER . 4.5 m -105.4 166.27 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.889 -174.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.707 HG21 ' HB2' ' A' ' 23' ' ' ALA . 12.4 m -141.34 147.99 21.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.427 ' H ' ' HG2' ' A' ' 18' ' ' GLU . 1.6 mm-40 -64.19 -51.09 65.43 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.264 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.863 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 14.5 t-20 -148.36 169.3 20.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.732 -176.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.631 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 56.9 mt -60.48 -27.53 67.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.912 0.387 . . . . 0.0 110.305 174.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -57.44 -33.8 68.31 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.79 174.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -91.03 -27.41 18.65 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.972 0.415 . . . . 0.0 110.871 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.707 ' HB2' HG21 ' A' ' 17' ' ' VAL . . . -71.9 156.82 38.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.596 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.494 ' HD2' ' O ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -131.89 -177.81 4.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.606 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.501 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -103.73 174.96 5.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.622 -175.561 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' A' ' 119' ' ' GLU . . . 93.69 -62.86 1.93 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.738 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -77.66 127.69 81.71 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.636 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 1.016 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 85.9 Cg_exo -48.58 143.74 15.51 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.806 2.337 . . . . 0.0 112.1 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.484 HG23 ' OD1' ' A' ' 60' ' ' ASN . 23.8 m -115.64 124.51 51.09 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.225 -171.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 30' ' ' ILE . 2.9 mp -109.22 117.62 54.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.653 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 2.3 mm -105.62 116.43 49.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.063 -175.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.48 ' O ' ' HG3' ' A' ' 32' ' ' MET . 26.5 ptm -110.77 112.3 24.07 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.707 0.765 . . . . 0.0 110.107 174.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 81.6 m-85 -83.64 128.32 34.43 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.018 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.638 ' HE2' ' CB ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -142.77 142.27 31.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.696 -175.002 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.445 ' O ' ' HE3' ' A' ' 34' ' ' LYS . 1.2 p -75.0 170.87 15.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 174.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -49.68 -74.55 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 O-C-N 123.358 0.411 . . . . 0.0 110.798 176.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -88.88 110.84 21.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.961 0.41 . . . . 0.0 110.316 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.499 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 5.9 p -152.73 121.32 3.21 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.037 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 8.0 Cg_exo -72.11 -35.97 6.33 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.523 2.149 . . . . 0.0 112.839 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -61.81 -24.37 66.83 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.591 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.628 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 49.7 t -61.95 -50.12 73.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.069 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.5 t -59.49 -44.84 93.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 5.7 tp10 -55.79 -46.79 77.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.928 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.507 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 23.4 ttt -73.85 -30.49 62.7 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.053 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.628 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 94.2 mt-30 -59.43 -48.44 81.62 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 121.458 -0.097 . . . . 0.0 110.988 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -65.54 -36.06 82.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.522 0.201 . . . . 0.0 111.196 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -59.03 -44.86 91.81 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.18 0.514 . . . . 0.0 109.812 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.806 HD13 HG21 ' A' ' 61' ' ' ILE . 97.9 mt -62.42 -35.91 80.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.056 178.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -58.89 -40.63 85.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.916 0.389 . . . . 0.0 110.228 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.472 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 20.2 m-85 -65.7 -43.31 89.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.322 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.441 HG22 ' HG3' ' A' ' 105' ' ' LYS . 48.7 t -62.1 -42.66 95.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.464 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.4 m -65.74 -31.69 72.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.13 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -61.24 -40.52 94.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.73 176.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.56 -10.37 54.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.586 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.85 84.3 1.97 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.957 0.408 . . . . 0.0 111.168 -177.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -78.98 123.51 27.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.916 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.42 73.92 0.37 Allowed Glycine 0 C--N 1.332 0.313 0 O-C-N 123.596 0.56 . . . . 0.0 113.297 173.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.922 ' HD2' HG12 ' A' ' 117' ' ' VAL . 9.6 mmtt -144.14 -36.73 0.33 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.987 0.423 . . . . 0.0 110.941 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.405 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 39.1 p90 -144.88 168.87 19.2 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.57 HD22 HG12 ' A' ' 27' ' ' ILE . 8.9 p30 -118.25 137.9 52.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.27 0.557 . . . . 0.0 110.723 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.806 HG21 HD13 ' A' ' 48' ' ' LEU . 52.6 mt -104.08 109.72 28.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.118 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.863 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 2.6 t80 -95.01 118.51 31.96 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.926 0.393 . . . . 0.0 110.559 -178.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.521 ' CE1' ' HG2' ' A' ' 45' ' ' GLN . 81.0 m-85 -83.45 103.26 12.67 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 173.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.519 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -90.8 86.15 6.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.377 0.608 . . . . 0.0 109.968 -173.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.638 ' CB ' ' HE2' ' A' ' 34' ' ' LYS . 17.8 ptt180 -77.49 129.01 35.16 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.508 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.3 tp -73.2 12.32 0.59 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.71 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.598 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 10.4 mt-10 -79.98 -13.63 59.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.574 -175.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -116.88 170.48 8.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.338 -173.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.48 -33.53 25.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.158 -176.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.621 ' HD2' ' H ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -61.95 -26.41 68.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.894 0.378 . . . . 0.0 110.702 -177.563 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.648 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 78.5 m-20 -87.79 3.77 46.89 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.909 -176.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.8 mt -72.17 -58.68 4.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 171.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.49 -38.8 84.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.137 175.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.648 ' HB2' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -56.09 -46.18 79.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.199 176.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.26 -56.45 19.86 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.686 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -67.56 -33.54 75.25 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.573 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -63.36 -24.6 67.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.983 0.42 . . . . 0.0 110.788 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.568 ' CE1' HD21 ' A' ' 89' ' ' LEU . 95.0 m-85 -122.05 22.48 10.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.884 -176.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 66.95 29.17 8.3 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.523 0.514 . . . . 0.0 111.556 166.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.402 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -87.33 113.56 23.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.885 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.532 ' ND2' HG13 ' A' ' 82' ' ' ILE . 3.8 p-10 -138.71 -2.53 1.73 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.271 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.532 HG13 ' ND2' ' A' ' 81' ' ' ASN . 50.5 mt -136.78 142.22 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 34' ' ' LYS . 99.5 t -101.15 129.3 27.39 Favored Pre-proline 0 C--N 1.319 -0.729 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.667 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 58.4 Cg_endo -95.11 135.18 5.24 Favored 'Cis proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.423 -1.49 . . . . 0.0 113.42 -0.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.594 HG23 ' HG2' ' A' ' 100' ' ' GLN . 19.9 m -87.73 107.5 18.67 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.2 m -100.94 108.03 19.66 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.653 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 6.8 p -108.2 126.16 64.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.445 0.64 . . . . 0.0 110.128 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 1.005 ' HB3' HD11 ' A' ' 115' ' ' LEU . 89.0 m-85 -99.22 119.4 37.83 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.579 -177.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.568 HD21 ' CE1' ' A' ' 78' ' ' TYR . 5.6 mp -115.31 141.73 47.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.817 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 25.1 t70 -75.15 -164.48 0.31 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.526 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 6.1 pttm -53.3 -42.86 67.05 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -168.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.492 ' OE1' ' HG2' ' A' ' 91' ' ' LYS . 0.5 OUTLIER -99.26 6.06 46.41 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.056 -0.403 . . . . 0.0 111.396 -176.268 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.562 ' HA2' ' HB3' ' A' ' 89' ' ' LEU . . . 94.66 30.2 8.7 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.759 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 90.1 m-20 -70.92 106.49 3.65 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.403 -0.469 . . . . 0.0 109.93 173.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.452 ' HG3' ' CG2' ' A' ' 87' ' ' VAL . 39.0 ttpt -64.69 100.41 0.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 176.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -98.45 -50.38 4.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.291 -176.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.511 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 91.7 t80 -137.47 122.0 18.44 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.171 -0.611 . . . . 0.0 111.8 -174.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.551 HG12 HG23 ' A' ' 87' ' ' VAL . 11.5 m -103.14 147.04 10.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 172.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.511 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 15.9 t60 -145.4 119.01 9.12 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.594 ' HG2' HG23 ' A' ' 85' ' ' THR . 39.3 mt-30 -102.93 106.22 16.73 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 143.41 160.84 8.58 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.445 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.533 HD21 ' HG2' ' A' ' 43' ' ' GLU . 45.9 tp -71.56 149.75 45.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.935 0.398 . . . . 0.0 111.243 -176.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 69.9 mtm -141.03 -170.14 2.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.19 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.491 HH12 ' CD ' ' A' ' 43' ' ' GLU . 33.2 mmt180 -131.27 165.97 22.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.378 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.472 ' HD2' ' HB3' ' A' ' 50' ' ' TYR . 55.6 tttm -44.7 -56.83 4.1 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.116 0.885 . . . . 0.0 112.299 -176.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -51.93 -47.31 64.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.345 0.593 . . . . 0.0 111.601 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.609 ' O ' HG12 ' A' ' 111' ' ' ILE . 47.0 m-20 -73.84 -40.45 63.29 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.931 -172.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.533 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 60.9 mt -60.21 -47.02 93.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.577 0.703 . . . . 0.0 109.301 174.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -62.98 -39.95 96.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.219 -175.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 57.9 m -64.42 -35.93 82.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.162 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 107' ' ' ASN . 40.8 mm -70.26 -34.95 60.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.632 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 20.9 mt -60.38 -42.89 96.79 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.714 0.769 . . . . 0.0 108.987 174.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -62.1 -30.39 70.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.901 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.9 m -76.05 -30.25 58.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.977 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 1.005 HD11 ' HB3' ' A' ' 88' ' ' PHE . 51.6 mt -70.58 -59.95 2.54 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 122.185 0.993 . . . . 0.0 109.081 174.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 145.86 -44.95 0.83 Allowed Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.371 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.016 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 19.2 t 46.58 61.35 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 122.112 0.958 . . . . 0.0 109.397 -176.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -81.83 -51.57 7.99 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.848 -169.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.541 ' HB3' ' O ' ' A' ' 26' ' ' GLY . 12.2 tp10 -72.99 171.42 12.88 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.438 173.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.444 ' HA3' ' HD3' ' A' ' 58' ' ' LYS . . . 97.3 14.8 40.4 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -170.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -79.21 62.49 3.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.729 0.776 . . . . 0.0 109.891 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -133.47 16.97 4.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.047 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 34.8 t60 -77.1 120.72 22.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.709 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -55.29 128.58 34.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.522 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -72.77 -21.82 60.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.005 0.431 . . . . 0.0 110.24 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 77.9 t60 . . . . . 0 C--O 1.24 0.575 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.165 177.77 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 mmt . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 120.622 0.249 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 1.025 ' HA ' ' HG3' ' A' ' 18' ' ' GLU . 0.8 OUTLIER -140.03 -179.6 6.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.84 -177.634 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.666 ' HG ' ' HG3' ' A' ' 4' ' ' GLU . 67.7 tp -57.0 -71.39 0.1 Allowed 'General case' 0 C--N 1.332 -0.154 0 O-C-N 123.54 0.525 . . . . 0.0 110.755 177.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.666 ' HG3' ' HG ' ' A' ' 3' ' ' LEU . 45.2 mt-10 -123.14 -11.84 7.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.439 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.53 -54.61 4.05 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.907 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.441 ' O ' ' HB3' ' A' ' 7' ' ' LYS . 31.7 pt -106.41 154.46 7.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.523 ' HG2' ' HG3' ' A' ' 8' ' ' GLN . 27.7 ttpt 72.76 -63.69 0.42 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.656 0.598 . . . . 0.0 111.711 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.523 ' HG3' ' HG2' ' A' ' 7' ' ' LYS . 28.0 mt-30 -124.05 137.4 54.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.446 0.641 . . . . 0.0 112.006 -175.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.53 HG13 ' H ' ' A' ' 11' ' ' PHE . 13.3 pt -112.67 -159.15 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.216 175.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.473 ' HB3' HG11 ' A' ' 16' ' ' VAL . 3.6 t-20 -58.1 -24.61 59.33 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.814 0.34 . . . . 0.0 110.855 178.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.53 ' H ' HG13 ' A' ' 9' ' ' ILE . 18.7 t80 72.78 -175.73 0.17 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.319 172.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 69.13 -61.2 0.44 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.739 0.816 . . . . 0.0 109.883 -173.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.506 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 14.9 m -96.82 129.37 44.27 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.416 ' O ' HG22 ' A' ' 14' ' ' ILE . 46.7 mt -86.66 2.87 4.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.792 0.806 . . . . 0.0 110.69 -174.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -117.47 16.37 14.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.623 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 12.6 p -85.01 143.59 11.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -171.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.952 ' HB ' ' HB2' ' A' ' 22' ' ' GLU . 27.5 m -128.34 152.95 37.15 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.222 169.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 1.025 ' HG3' ' HA ' ' A' ' 2' ' ' SER . 15.8 mm-40 -75.51 -35.1 60.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.349 -174.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.732 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 51.5 t30 -163.41 -176.09 4.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.692 -177.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.1 mt -61.52 -30.6 70.74 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.4 mp0 -56.87 -45.56 82.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.329 176.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.952 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . 5.4 mm-40 -76.69 -24.76 53.17 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.591 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.91 153.25 43.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.682 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.589 ' NZ ' ' HA ' ' A' ' 24' ' ' LYS . 2.4 tpmp? -145.4 156.26 43.66 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.995 -175.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -73.51 179.88 3.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.049 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 119' ' ' GLU . . . 84.85 -59.82 4.87 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -175.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.419 HG13 ' HB2' ' A' ' 60' ' ' ASN . 6.5 pt -90.32 121.9 68.02 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.525 -0.338 . . . . 0.0 110.165 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.945 ' HG3' ' H ' ' A' ' 117' ' ' VAL . 16.5 Cg_endo -57.26 138.51 86.55 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.64 2.227 . . . . 0.0 111.009 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.2 m -103.52 123.76 47.51 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.256 0.551 . . . . 0.0 111.923 -172.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.607 HD11 HD11 ' A' ' 112' ' ' LEU . 75.2 mt -98.63 113.26 32.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 173.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.759 ' HB ' HG23 ' A' ' 87' ' ' VAL . 58.4 mt -107.03 111.98 37.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.35 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.458 ' HG2' ' HD1' ' A' ' 63' ' ' TYR . 21.8 ptm -109.8 129.63 55.61 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.061 176.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.554 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 92.0 m-85 -94.33 112.78 24.59 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.605 ' HB2' ' HB3' ' A' ' 41' ' ' CYS . 55.6 pttt -117.75 138.73 51.84 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.446 -170.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.467 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 0.7 OUTLIER -71.18 149.67 46.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.969 174.43 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -70.31 -45.12 66.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.98 -177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.2 t -94.75 9.77 37.67 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.467 ' SG ' ' HB ' ' A' ' 35' ' ' THR . 76.6 m -106.72 122.19 42.6 Favored Pre-proline 0 C--N 1.327 -0.409 0 O-C-N 121.845 -0.535 . . . . 0.0 111.065 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 6.3 Cg_exo -78.01 -2.88 12.97 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.391 2.061 . . . . 0.0 113.179 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -65.57 -15.95 63.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.935 0.397 . . . . 0.0 110.796 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.605 ' HB3' ' HB2' ' A' ' 34' ' ' LYS . 24.9 p -68.84 -43.79 74.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.818 175.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.2 t -62.89 -30.63 49.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.279 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.529 ' HA ' ' NZ ' ' A' ' 46' ' ' LYS . 7.5 tp10 -58.69 -51.99 67.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.346 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.9 ttt -75.03 -37.31 61.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.54 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.498 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 16.5 mt-30 -59.2 -43.64 92.23 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.76 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.529 ' NZ ' ' HA ' ' A' ' 43' ' ' GLU . 22.7 pttm -70.13 -41.87 73.35 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.446 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.542 ' O ' HG23 ' A' ' 51' ' ' VAL . 24.1 mm-40 -51.03 -49.91 59.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.898 0.38 . . . . 0.0 110.386 172.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.435 HD13 HG21 ' A' ' 61' ' ' ILE . 71.2 mt -60.73 -37.66 82.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.515 177.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.8 m -67.59 -37.35 82.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.782 0.325 . . . . 0.0 110.712 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -65.12 -33.5 76.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.523 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 47' ' ' GLU . 21.7 t -73.2 -40.89 58.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.892 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.2 m -56.84 -30.65 64.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.142 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.524 ' HZ3' ' HB3' ' A' ' 53' ' ' LYS . 4.6 ttpm? -52.49 -36.53 55.28 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.756 176.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -109.84 -18.44 13.41 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.204 0.526 . . . . 0.0 110.756 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.58 ' HB3' ' HB2' ' A' ' 58' ' ' LYS . 11.5 mpt_? -111.96 74.55 0.87 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.367 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.73 116.48 22.7 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.84 35.14 91.58 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.467 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.58 ' HB2' ' HB3' ' A' ' 55' ' ' ARG . 12.7 mptt -101.76 -20.02 15.12 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -165.41 153.99 11.76 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.165 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.419 ' HB2' HG13 ' A' ' 27' ' ' ILE . 39.8 t-20 -103.92 138.1 40.97 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.339 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.435 HG21 HD13 ' A' ' 48' ' ' LEU . 11.0 mt -117.34 111.87 36.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.714 0.292 . . . . 0.0 110.943 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.732 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 3.3 t80 -98.84 118.41 35.52 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.498 ' CE1' ' HG2' ' A' ' 45' ' ' GLN . 21.7 m-85 -94.65 103.57 15.5 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.398 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.554 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -80.58 87.16 5.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.163 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.501 ' C ' ' H ' ' A' ' 67' ' ' GLU . 1.8 ptm180 -69.59 123.71 22.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.139 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 34' ' ' LYS . 5.4 tp -69.75 11.2 0.29 Allowed 'General case' 0 C--N 1.322 -0.613 0 O-C-N 122.025 -0.422 . . . . 0.0 110.933 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 65' ' ' ARG . 21.0 mt-10 -82.47 -19.73 38.28 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.7 -173.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.44 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 46.2 mt-10 -117.04 151.29 37.09 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -59.81 -31.03 69.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.103 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.451 ' HD2' ' OD1' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -58.95 -25.92 63.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.268 -178.691 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.451 ' OD1' ' HD2' ' A' ' 70' ' ' LYS . 10.4 m120 -91.19 -12.18 36.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.963 -176.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.5 mt -71.16 -48.63 53.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.98 -43.56 92.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.762 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -58.52 -42.88 88.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.403 178.514 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.26 -57.38 12.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.441 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -67.23 -33.25 74.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.608 0.242 . . . . 0.0 111.258 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.417 ' HB2' ' NZ ' ' A' ' 77' ' ' LYS . 3.3 ttmp? -63.01 -28.85 70.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.972 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -112.01 8.23 20.11 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 71.72 26.84 3.0 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.599 0.562 . . . . 0.0 111.877 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.75 103.67 10.75 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.175 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -117.72 -35.45 3.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.823 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 12.4 mt -112.57 130.1 66.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.49 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.8 m -102.35 140.47 21.16 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.67 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -86.82 147.7 35.56 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.34 -1.525 . . . . 0.0 112.085 -0.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.0 t -140.78 149.73 42.46 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.4 t -140.71 142.01 34.88 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.22 0.533 . . . . 0.0 110.606 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.816 HG12 HG12 ' A' ' 98' ' ' VAL . 6.2 m -115.49 127.89 72.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.79 176.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.416 ' CD1' ' HD2' ' A' ' 97' ' ' TYR . 83.0 m-85 -97.56 118.74 34.75 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.485 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 6.4 mp -108.35 141.51 40.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.79 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 46.6 t0 -80.18 -179.19 6.94 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.463 ' HZ3' ' CD ' ' A' ' 92' ' ' GLU . 7.9 pttm -49.57 -32.11 11.93 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -175.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.463 ' CD ' ' HZ3' ' A' ' 91' ' ' LYS . 32.6 mp0 -69.26 -29.0 66.81 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 122.087 -0.383 . . . . 0.0 111.338 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.33 30.37 7.01 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.972 -173.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 2.5 p-10 -105.59 132.99 51.06 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 175.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.423 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 16.6 ptmt -75.73 117.79 17.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.832 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -106.45 -54.83 2.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.989 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.419 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 73.0 t80 -109.61 135.17 51.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.105 -174.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.816 HG12 HG12 ' A' ' 87' ' ' VAL . 29.3 m -111.82 148.02 15.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.419 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 38.0 t60 -145.84 131.84 19.25 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -117.9 149.81 40.26 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 176.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.38 -124.0 8.1 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.62 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.415 ' HG ' ' N ' ' A' ' 103' ' ' MET . 27.3 tp -136.53 167.94 20.43 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 122.731 -0.276 . . . . 0.0 110.336 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.415 ' N ' ' HG ' ' A' ' 102' ' ' LEU . 20.3 ptm -168.6 147.08 4.17 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.405 ' HD3' ' HA ' ' A' ' 104' ' ' ARG . 23.3 mmt180 -89.87 168.67 11.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.18 -177.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -53.07 -41.46 64.9 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.234 -177.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -65.83 -35.37 80.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.876 0.37 . . . . 0.0 110.475 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.529 ' O ' HG12 ' A' ' 111' ' ' ILE . 11.7 m120 -64.48 -47.32 79.4 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.2 mt -59.32 -50.8 78.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.099 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -51.88 -50.14 61.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.746 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.2 m -65.16 -38.15 89.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.659 0.266 . . . . 0.0 111.094 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 107' ' ' ASN . 39.9 mm -63.61 -47.26 92.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 177.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.607 HD11 HD11 ' A' ' 30' ' ' ILE . 83.2 mt -62.66 -39.43 93.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.047 0.451 . . . . 0.0 110.055 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -54.71 -44.85 73.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.239 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.5 m -86.14 -23.87 26.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.878 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.0 tp -91.12 -64.97 1.05 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -175.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.69 ' HA2' ' HZ3' ' A' ' 118' ' ' LYS . . . -139.03 -122.82 2.04 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 119.989 -1.1 . . . . 0.0 113.816 -169.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.945 ' H ' ' HG3' ' A' ' 28' ' ' PRO . 12.7 t 58.44 35.14 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 122.152 0.977 . . . . 0.0 109.075 -173.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HZ3' ' HA2' ' A' ' 116' ' ' GLY . 37.2 mtmm -107.56 59.51 0.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.223 -174.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 1.2 tm-20 -119.7 -86.4 0.65 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' H ' ' HB3' ' A' ' 119' ' ' GLU . . . -78.66 39.49 1.97 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.738 173.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -88.33 5.43 42.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.269 0.556 . . . . 0.0 109.548 -177.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -68.06 -28.61 67.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.608 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 59.1 t60 70.17 -56.4 0.59 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.585 0.754 . . . . 0.0 112.296 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -76.52 92.35 3.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.732 0.301 . . . . 0.0 110.607 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -98.31 -6.81 30.18 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.4 p80 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 117.648 -1.167 . . . . 0.0 108.164 175.579 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.7 ttm . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 120.925 0.393 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.2 m -150.9 -51.74 0.13 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 84.8 mt -110.47 -153.95 0.53 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 170.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.542 ' OE2' ' HA ' ' A' ' 8' ' ' GLN . 5.1 mp0 -65.14 171.87 3.41 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 172.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.468 ' HA3' ' HG3' ' A' ' 18' ' ' GLU . . . -77.72 47.54 2.79 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.446 -176.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.656 ' O ' ' HB3' ' A' ' 7' ' ' LYS . 8.7 tp 170.28 -19.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 122.969 0.508 . . . . 0.0 111.01 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.656 ' HB3' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER 80.16 103.68 0.07 Allowed 'General case' 0 C--N 1.345 0.389 0 O-C-N 123.551 0.532 . . . . 0.0 109.695 -173.611 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.542 ' HA ' ' OE2' ' A' ' 4' ' ' GLU . 11.3 mm-40 65.24 89.45 0.1 Allowed 'General case' 0 C--N 1.327 -0.395 0 O-C-N 124.11 0.881 . . . . 0.0 110.955 -176.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.406 HG22 ' HG2' ' A' ' 4' ' ' GLU . 9.5 tp -90.79 -27.63 4.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.866 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 13' ' ' SER . 8.2 t-20 -165.07 174.0 10.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.444 ' C ' ' H ' ' A' ' 13' ' ' SER . 91.0 t80 -96.59 -33.82 11.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.805 0.336 . . . . 0.0 110.687 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -83.52 25.67 0.74 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.813 0.816 . . . . 0.0 108.948 174.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.806 ' HB3' HG21 ' A' ' 16' ' ' VAL . 44.8 m -145.05 96.18 2.81 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.894 -172.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.9 mt -108.41 -61.21 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.885 0.374 . . . . 0.0 111.092 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 7.2 m-20 -85.25 30.18 0.62 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.662 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.806 HG21 ' HB3' ' A' ' 13' ' ' SER . 20.4 m -91.54 155.56 3.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -166.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.55 HG11 ' HB2' ' A' ' 23' ' ' ALA . 47.1 t -136.21 143.01 37.04 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.441 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HG3' ' HA3' ' A' ' 5' ' ' GLY . 31.2 mm-40 -71.97 -45.89 59.39 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.201 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.62 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 19.1 t30 -164.02 176.12 9.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.831 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.669 HD11 HD11 ' A' ' 74' ' ' LEU . 86.2 mt -49.03 -36.7 18.63 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -174.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.545 ' OE2' ' HB3' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -77.24 -27.42 53.32 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -172.329 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -77.73 -10.65 59.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.713 0.292 . . . . 0.0 111.355 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.55 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -87.9 171.43 10.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.955 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.721 ' HZ3' ' HB3' ' A' ' 24' ' ' LYS . 4.2 mtpm? -136.08 152.89 51.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.011 0.434 . . . . 0.0 111.644 177.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.65 170.77 15.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.542 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.3 -29.02 5.83 Favored Glycine 0 CA--C 1.504 -0.619 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.598 ' HB ' ' HA ' ' A' ' 59' ' ' PHE . 22.9 pt -113.55 131.08 23.17 Favored Pre-proline 0 C--N 1.315 -0.899 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 1.051 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 54.7 Cg_exo -56.59 162.79 7.79 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 123.047 2.498 . . . . 0.0 113.111 -174.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.1 m -122.97 122.66 39.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.179 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.436 HD12 ' N ' ' A' ' 30' ' ' ILE . 2.5 mp -104.61 109.19 26.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 174.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.423 HG12 ' HB3' ' A' ' 62' ' ' TYR . 64.3 mt -105.45 113.85 43.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.468 -177.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.491 ' O ' ' HG3' ' A' ' 32' ' ' MET . 25.1 ptm -108.91 112.99 25.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.639 0.733 . . . . 0.0 110.057 178.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.744 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 90.1 m-85 -76.36 114.12 14.71 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.535 177.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.523 ' HG3' ' SG ' ' A' ' 41' ' ' CYS . 0.1 OUTLIER -138.77 148.99 44.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.133 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.0 t -97.99 -173.2 2.54 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -55.99 -51.44 67.72 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.701 0.625 . . . . 0.0 110.769 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -92.73 -162.52 0.94 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.615 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.436 ' HB3' ' HD2' ' A' ' 40' ' ' TYR . 50.7 m 74.61 106.02 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.491 0 C-N-CA 123.639 0.776 . . . . 0.0 110.993 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 2.7 Cg_exo -74.74 3.45 5.46 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.561 2.174 . . . . 0.0 113.145 -176.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.436 ' HD2' ' HB3' ' A' ' 38' ' ' CYS . 80.0 m-85 -65.3 -27.28 68.5 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.523 ' SG ' ' HG3' ' A' ' 34' ' ' LYS . 42.3 t -64.58 -55.05 22.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.646 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.531 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 12.7 p -63.42 -31.09 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.772 0.32 . . . . 0.0 110.99 -175.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -68.14 -49.49 60.67 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.214 0.53 . . . . 0.0 110.21 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.1 ttt -67.75 -29.4 68.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.174 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 51.8 mt-30 -61.21 -38.7 87.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.128 175.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.531 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 81.5 mttt -60.1 -49.34 78.05 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.382 0.611 . . . . 0.0 109.671 175.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.551 ' O ' HG23 ' A' ' 51' ' ' VAL . 9.9 mm-40 -57.06 -48.79 77.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.413 176.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.474 HD13 HG21 ' A' ' 61' ' ' ILE . 91.9 mt -60.12 -29.79 68.85 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.29 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 68.6 m -62.12 -47.46 84.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.068 0.461 . . . . 0.0 110.412 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -73.02 -33.56 65.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.28 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 47' ' ' GLU . 57.8 t -67.46 -36.73 77.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.106 0.479 . . . . 0.0 110.167 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.0 m -66.26 -30.74 71.23 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.053 175.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -74.03 -28.78 61.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.391 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -70.47 -47.26 61.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.086 174.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.651 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 1.2 ttm180 -123.43 75.18 1.3 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.808 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -69.79 118.51 12.73 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.749 -172.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.46 50.76 60.61 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.575 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.651 ' HB2' ' HG2' ' A' ' 55' ' ' ARG . 39.0 mmtm -136.03 8.59 3.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.693 0.282 . . . . 0.0 110.79 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.598 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 50.5 p90 -169.93 149.03 3.59 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.488 ' ND2' HG13 ' A' ' 27' ' ' ILE . 15.3 m-80 -88.86 135.19 33.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.484 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.474 HG21 HD13 ' A' ' 48' ' ' LEU . 60.7 mt -114.68 106.18 20.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 168.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.62 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 4.0 t80 -96.32 116.67 29.4 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -76.93 103.95 7.15 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 174.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.744 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -77.45 72.82 4.02 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.699 ' HD2' ' OE2' ' A' ' 68' ' ' GLU . 2.6 ptp180 -69.61 109.79 4.5 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 113.624 -1.625 . . . . 0.0 111.515 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.8 tp -72.24 4.67 3.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.729 -177.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.673 ' CD ' ' HB2' ' A' ' 65' ' ' ARG . 5.6 pm0 -83.04 -13.98 54.75 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.121 0.486 . . . . 0.0 110.056 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.699 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 62.1 mt-10 -106.55 144.29 33.44 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.912 175.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -21.38 62.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.034 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.519 ' HG3' ' HB3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -55.8 -23.25 28.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.221 0.534 . . . . 0.0 112.026 177.099 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.652 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 22.7 m-20 -88.1 8.96 24.31 Favored 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -177.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 77.7 mt -71.47 -50.71 38.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 168.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -68.03 -48.67 65.04 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.52 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.669 HD11 HD11 ' A' ' 20' ' ' LEU . 4.4 mm? -58.4 -41.66 85.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.373 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.458 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -56.76 -56.65 18.83 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 120.501 0.191 . . . . 0.0 111.047 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -65.32 -33.95 77.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.758 0.313 . . . . 0.0 111.042 -176.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.557 ' HZ2' ' HB2' ' A' ' 77' ' ' LYS . 4.1 ttmp? -64.2 -25.61 68.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.112 0.482 . . . . 0.0 110.88 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.688 ' HB3' HG21 ' A' ' 87' ' ' VAL . 89.2 m-85 -120.34 22.71 11.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.015 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 68.44 16.84 9.19 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.334 0.588 . . . . 0.0 111.333 169.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' A' ' 75' ' ' ALA . . . -83.94 140.51 31.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.908 -176.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -151.76 -40.2 0.11 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.65 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 22.8 pt -116.73 160.44 16.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.975 173.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.07 152.52 60.13 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.924 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -91.84 149.57 16.61 Favored 'Cis proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.038 -1.651 . . . . 0.0 112.428 -0.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.8 t -138.06 129.82 28.27 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.1 m -108.5 123.25 48.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.931 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.688 HG21 ' HB3' ' A' ' 78' ' ' TYR . 67.1 t -105.16 117.65 51.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.78 176.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -96.03 111.11 23.22 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.402 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -100.04 138.95 36.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.337 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.8 -172.67 0.53 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.616 ' NZ ' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -67.14 -26.14 66.52 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.068 -0.395 . . . . 0.0 112.056 -176.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.616 ' HG2' ' NZ ' ' A' ' 91' ' ' LYS . 38.6 mm-40 -75.05 -47.11 30.54 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.91 20.99 1.42 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.814 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 92' ' ' GLU . 43.7 m-80 -78.13 133.1 37.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -71.04 86.35 0.73 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.202 176.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -86.73 -51.59 6.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.206 -172.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -137.5 125.91 23.42 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.454 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.6 m -112.14 149.51 14.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 173.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -146.27 122.39 10.8 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.41 115.08 27.73 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 135.37 -168.72 23.69 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.3 tp -90.54 149.85 22.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.77 0.319 . . . . 0.0 110.46 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 56.1 mmm -127.09 161.6 28.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.417 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 10.1 mmm180 -113.37 168.53 9.66 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.4 ' HE2' ' HB2' ' A' ' 105' ' ' LYS . 14.3 ptmm? -57.3 -47.62 81.03 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -172.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.505 ' HA ' ' OE1' ' A' ' 109' ' ' GLU . 14.8 t-20 -64.23 -32.29 73.82 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.97 0.414 . . . . 0.0 111.2 -177.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.543 ' O ' HG12 ' A' ' 111' ' ' ILE . 9.3 m120 -65.03 -45.79 84.01 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.568 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 53.1 mt -62.94 -50.04 81.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.066 175.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.505 ' OE1' ' HA ' ' A' ' 106' ' ' ASN . 43.7 mt-10 -51.28 -49.77 60.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.755 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.5 m -66.69 -43.91 83.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.008 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 107' ' ' ASN . 40.4 mm -60.22 -43.61 93.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.497 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 57.5 mt -59.91 -39.77 86.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 0.0 111.238 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -61.21 -41.14 96.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.325 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.3 m -86.06 -17.43 35.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.912 0.387 . . . . 0.0 111.443 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.9 tp -66.84 -54.39 22.92 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.626 -173.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.681 ' O ' ' HG2' ' A' ' 118' ' ' LYS . . . 136.69 13.29 0.97 Allowed Glycine 0 N--CA 1.442 -0.967 0 C-N-CA 119.862 -1.161 . . . . 0.0 112.872 -177.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.051 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 61.9 t -43.14 100.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.152 0.501 . . . . 0.0 111.888 167.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 29.7 pttt 169.66 -178.4 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.57 141.9 37.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 118.767 0.712 . . . . 0.0 109.999 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -146.76 -4.68 0.42 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.264 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.568 ' NE2' ' HA ' ' A' ' 92' ' ' GLU . 49.6 m-70 -74.75 -19.56 60.18 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.78 0.29 . . . . 0.0 111.697 -175.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -64.01 88.0 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.365 0.602 . . . . 0.0 110.578 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.488 ' HA ' ' OXT' ' A' ' 126' ' ' HIS . 7.4 m80 -158.85 36.51 0.22 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.075 177.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -117.45 12.26 14.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.235 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -154.57 -35.84 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.628 175.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.488 ' OXT' ' HA ' ' A' ' 123' ' ' HIS . 65.4 m-70 . . . . . 0 C--O 1.245 0.822 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.395 172.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 mtt . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 21' ' ' GLU . 49.4 m -153.76 69.94 0.81 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.498 176.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.666 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 60.1 tp 64.67 79.9 0.24 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.529 -175.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -72.09 -45.85 59.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.566 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.33 20.91 65.9 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.784 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 tp -155.05 154.03 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 O-C-N 122.722 -0.281 . . . . 0.0 110.863 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 17.3 tptp 72.13 -61.39 0.5 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 171.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.678 ' HG3' HG22 ' A' ' 9' ' ' ILE . 12.8 pt20 -96.09 -9.95 29.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.524 0.678 . . . . 0.0 111.234 -175.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.791 HD11 HG22 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -176.27 128.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.695 -177.761 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -166.24 -71.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.995 0.426 . . . . 0.0 111.822 -176.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -79.95 121.4 25.41 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -170.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 171.5 -67.64 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.94 172.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.4 m -125.14 3.02 7.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.591 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.0 mt 70.96 -60.1 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.066 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.525 HD21 ' HA2' ' A' ' 57' ' ' GLY . 14.6 m120 -83.3 30.4 0.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.263 0.554 . . . . 0.0 110.749 177.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.791 HG22 HD11 ' A' ' 9' ' ' ILE . 0.6 OUTLIER -80.1 126.73 39.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.622 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.537 HG11 ' HB2' ' A' ' 23' ' ' ALA . 73.2 t -119.74 132.97 68.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.943 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -71.24 -54.69 10.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.159 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.634 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 7.0 t30 -155.08 169.56 23.83 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.11 -173.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.1 mt -46.73 -45.16 19.45 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.634 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -77.28 -17.74 58.12 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.282 0.563 . . . . 0.0 110.247 -176.811 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.666 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 66.4 mm-40 -87.82 17.88 4.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.035 171.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.537 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -122.59 160.41 25.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.301 176.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.433 ' HG3' ' HG2' ' A' ' 25' ' ' GLU . 11.8 ptmm? -173.86 -168.95 0.45 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.521 ' HB2' HD12 ' A' ' 27' ' ' ILE . 4.6 mm-40 75.55 -170.72 0.09 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.106 0.879 . . . . 0.0 110.789 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.586 ' O ' ' HE2' ' A' ' 91' ' ' LYS . . . -117.4 38.18 3.06 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.198 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.705 HG22 ' HG2' ' A' ' 119' ' ' GLU . 0.2 OUTLIER -100.81 155.56 36.19 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 110.513 -0.18 . . . . 0.0 110.513 -178.651 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.722 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 32.5 Cg_exo -60.09 144.61 99.47 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.444 2.096 . . . . 0.0 111.63 173.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.9 m -110.96 115.13 28.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.683 -176.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.2 mt -98.71 107.98 21.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.659 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 55.4 mt -99.93 111.94 31.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.147 0.498 . . . . 0.0 109.875 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.542 ' HA ' ' O ' ' A' ' 85' ' ' THR . 8.3 tpt -109.35 108.93 19.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.27 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.585 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 74.3 m-85 -80.2 152.26 29.24 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.678 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.719 ' HE2' ' HB3' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -159.98 155.74 25.94 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 175.765 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.573 ' HA ' ' HB2' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -67.72 -173.09 0.31 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 173.66 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.405 ' H ' HG22 ' A' ' 35' ' ' THR . 7.9 p-10 -51.31 -45.55 62.26 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.752 0.31 . . . . 0.0 110.748 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.6 p -137.96 -98.02 0.19 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.33 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.622 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 34.3 m 65.71 130.13 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 123.465 0.706 . . . . 0.0 111.731 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 13.9 Cg_exo -67.96 -33.61 25.65 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.085 1.857 . . . . 0.0 113.143 -177.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -64.66 -28.68 69.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.912 0.387 . . . . 0.0 110.822 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 38' ' ' CYS . 52.3 m -70.26 -36.56 74.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.987 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 45' ' ' GLN . 41.4 t -75.38 -33.21 27.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.427 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.98 -51.11 63.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.195 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.461 ' HE3' ' HB2' ' A' ' 103' ' ' MET . 25.5 ttt -68.21 -29.37 68.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.193 0.52 . . . . 0.0 109.717 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' A' ' 42' ' ' VAL . 4.6 tp60 -58.12 -38.99 77.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.575 174.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.692 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -67.81 -42.23 81.87 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.402 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 51' ' ' VAL . 7.6 mm-40 -57.9 -45.27 86.7 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.346 0.404 . . . . 0.0 110.479 173.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.544 HD23 HD13 ' A' ' 108' ' ' ILE . 96.1 mt -58.16 -44.13 87.77 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.897 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.1 m -60.21 -37.9 81.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.662 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.565 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 20.2 m-85 -74.85 -28.55 60.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.993 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 47' ' ' GLU . 68.7 t -65.47 -44.25 94.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.6 m -65.32 -31.54 72.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.369 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 50' ' ' TYR . 41.8 tttm -58.73 -39.25 80.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.809 173.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 50' ' ' TYR . 31.6 mm-40 -85.69 -17.9 34.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.843 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.589 ' NE ' ' HA ' ' A' ' 55' ' ' ARG . 3.0 tpm_? -153.0 88.93 1.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 111.569 -176.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.28 147.07 28.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.348 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.525 ' HA2' HD21 ' A' ' 15' ' ' ASN . . . 59.17 39.86 95.01 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.773 -0.648 . . . . 0.0 114.497 171.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 28' ' ' PRO . 69.5 mmtt -133.28 1.52 3.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.207 0.504 . . . . 0.0 110.791 175.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -170.46 153.69 4.39 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.436 ' HB3' HG21 ' A' ' 17' ' ' VAL . 83.1 m-20 -121.28 138.25 54.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.847 0.356 . . . . 0.0 110.428 177.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.5 mp -101.94 108.26 23.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.212 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.695 ' OH ' ' HG ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -89.55 115.23 26.8 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 177.848 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.719 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 86.9 m-85 -95.07 104.18 16.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.02 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.405 ' HB3' ' CD2' ' A' ' 33' ' ' PHE . . . -87.77 107.01 18.45 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.692 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 9.7 ptt180 -105.56 130.24 53.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.228 -177.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.573 ' HB2' ' HA ' ' A' ' 35' ' ' THR . 8.0 mp -71.85 7.73 1.45 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.152 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.685 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 44.7 mt-10 -62.14 -34.26 76.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.415 0.626 . . . . 0.0 109.485 169.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.698 ' HB2' ' HD2' ' A' ' 70' ' ' LYS . 35.6 mt-10 -104.58 172.95 6.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.53 -170.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.471 ' CD ' ' H ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -94.79 -24.35 17.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.779 -177.848 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.755 ' HD3' HD21 ' A' ' 71' ' ' ASN . 0.0 OUTLIER -54.27 -17.55 3.03 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.197 0.522 . . . . 0.0 111.862 176.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.755 HD21 ' HD3' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -80.58 -9.76 59.77 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.629 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.2 mm -61.56 -58.75 6.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.602 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -70.54 -40.87 73.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.627 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.695 ' HG ' ' OH ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -62.93 -46.5 87.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.691 -176.58 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.585 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -62.49 -49.52 75.05 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.71 0.291 . . . . 0.0 110.916 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -65.92 -33.93 76.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.06 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -61.8 -25.22 67.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.999 0.428 . . . . 0.0 110.878 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 33' ' ' PHE . 90.2 m-85 -124.48 23.05 8.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.911 -176.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 66.03 25.7 10.9 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.595 0.559 . . . . 0.0 111.442 166.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.76 97.53 8.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.851 0.358 . . . . 0.0 111.238 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -106.07 -36.09 7.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.16 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.9 pt -132.74 141.39 45.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.966 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 84' ' ' PRO . 34.7 m -102.57 157.78 33.04 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.434 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 83' ' ' VAL . 20.8 Cg_exo -67.29 150.48 83.01 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.054 -1.227 . . . . 0.0 112.401 -0.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 32' ' ' MET . 1.2 m -135.06 108.35 7.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -176.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.04 109.04 16.97 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.001 0.429 . . . . 0.0 110.822 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.659 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 12.6 p -100.78 123.97 54.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.516 0.674 . . . . 0.0 109.362 175.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.534 ' HB3' HD22 ' A' ' 115' ' ' LEU . 85.4 m-85 -99.01 110.43 23.04 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.497 -176.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.629 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 6.7 mp -102.83 129.65 49.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.734 176.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -68.35 169.83 9.94 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.774 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.586 ' HE2' ' O ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -61.76 -14.33 31.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -175.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.67 -5.39 58.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 111.26 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.81 10.8 71.86 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.604 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 2.5 p-10 -86.67 131.32 34.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.806 0.336 . . . . 0.0 110.66 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.629 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 20.5 ptmt -77.28 87.17 3.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.217 0.532 . . . . 0.0 109.859 175.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -74.79 -53.64 8.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.618 -173.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.53 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 63.4 t80 -137.54 114.46 10.65 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.866 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 87' ' ' VAL . 4.4 p -96.66 137.0 25.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 172.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.53 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 48.6 t60 -134.1 134.29 42.1 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -175.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -110.41 131.91 54.64 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 173.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 122.75 173.38 14.15 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.264 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.8 tp -82.01 141.12 33.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.824 0.345 . . . . 0.0 111.323 -175.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.461 ' HB2' ' HE3' ' A' ' 44' ' ' MET . 78.4 mmm -134.15 161.29 35.29 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.413 ' O ' HG13 ' A' ' 108' ' ' ILE . 17.5 mmm180 -106.86 171.52 7.32 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.524 ' HE2' ' HB3' ' A' ' 50' ' ' TYR . 36.5 ttmt -46.62 -60.29 2.47 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.6 0.562 . . . . 0.0 112.004 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.569 ' HA ' ' OE1' ' A' ' 109' ' ' GLU . 6.7 t-20 -67.66 -27.46 66.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.065 0.46 . . . . 0.0 111.12 -174.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.496 ' O ' HG12 ' A' ' 111' ' ' ILE . 13.1 m120 -67.4 -42.76 82.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.544 HD13 HD23 ' A' ' 48' ' ' LEU . 56.7 mt -61.7 -46.15 97.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.369 173.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.569 ' OE1' ' HA ' ' A' ' 106' ' ' ASN . 50.9 mt-10 -52.79 -48.03 67.16 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.539 176.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.1 m -61.27 -37.5 83.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.095 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 107' ' ' ASN . 49.7 mm -69.04 -43.79 81.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.328 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.535 ' HB3' ' CG2' ' A' ' 117' ' ' VAL . 72.8 mt -61.7 -39.22 90.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.907 0.384 . . . . 0.0 110.107 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -58.15 -38.05 75.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.799 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.0 m -86.22 -5.74 59.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.029 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.534 HD22 ' HB3' ' A' ' 88' ' ' PHE . 53.9 tp -93.47 -66.72 0.9 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.704 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 174.9 -72.23 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.78 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.722 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 21.4 t 55.32 29.62 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 122.493 1.14 . . . . 0.0 109.719 -177.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.433 ' O ' ' HD2' ' A' ' 91' ' ' LYS . 17.8 pttm -89.45 79.56 6.92 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.962 -175.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.705 ' HG2' HG22 ' A' ' 27' ' ' ILE . 7.6 tp10 -130.41 141.98 50.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.685 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -124.18 -50.67 0.2 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.414 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 59.88 24.87 13.94 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.936 0.494 . . . . 0.0 111.785 -176.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 72.24 -56.96 0.64 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.411 0.684 . . . . 0.0 111.839 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.444 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 52.7 t60 -120.97 -93.97 0.51 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.425 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.444 ' HB2' ' O ' ' A' ' 123' ' ' HIS . 8.2 t60 174.5 -58.42 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.024 0.44 . . . . 0.0 110.397 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -159.97 -66.12 0.07 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.769 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.7 t60 . . . . . 0 C--O 1.242 0.698 0 CA-C-O 117.607 -1.187 . . . . 0.0 108.939 177.703 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 m -62.23 -43.89 97.8 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.443 0.64 . . . . 0.0 109.646 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.526 ' HB2' HE22 ' A' ' 8' ' ' GLN . 1.4 pp -117.68 175.02 5.84 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.788 173.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.482 ' HB2' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -83.14 -82.16 0.15 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.729 0.3 . . . . 0.0 111.776 -178.491 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 110.76 21.49 6.75 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -173.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.482 HG12 ' HB2' ' A' ' 4' ' ' GLU . 37.1 pt -106.59 -29.12 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.416 -0.392 . . . . 0.0 111.122 -177.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.05 -1.53 18.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.281 0.563 . . . . 0.0 109.687 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.526 HE22 ' HB2' ' A' ' 3' ' ' LEU . 21.0 pt20 -129.61 -166.73 1.7 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.26 -177.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 16' ' ' VAL . 12.2 tt -43.2 134.24 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.681 0.753 . . . . 0.0 112.113 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -125.36 174.83 7.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.704 -176.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -87.37 0.78 54.95 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.394 -0.192 . . . . 0.0 111.479 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -47.77 -71.48 0.07 Allowed 'General case' 0 C--O 1.236 0.382 0 O-C-N 123.535 0.522 . . . . 0.0 111.762 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.551 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 6.8 m -93.97 -6.18 46.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.172 178.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 13' ' ' SER . 74.5 mt 74.0 -63.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 123.733 0.645 . . . . 0.0 110.37 -174.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.717 ' HB3' ' HA2' ' A' ' 57' ' ' GLY . 0.5 OUTLIER -87.83 32.08 0.75 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.333 0.587 . . . . 0.0 110.581 174.513 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.672 HG23 ' CE1' ' A' ' 63' ' ' TYR . 1.2 p -86.61 111.35 21.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.789 174.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.584 ' HB ' ' HB2' ' A' ' 22' ' ' GLU . 20.8 m -114.0 136.42 50.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.107 0.479 . . . . 0.0 109.933 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -65.54 -54.46 27.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.894 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.749 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 4.9 t30 -144.87 179.33 7.4 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.295 -174.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.414 HD11 HD23 ' A' ' 74' ' ' LEU . 96.5 mt -48.1 -42.0 27.81 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.261 0.624 . . . . 0.0 112.578 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -58.25 -32.22 68.15 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.584 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . 21.1 mt-10 -84.25 -6.07 59.34 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.49 151.73 26.38 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.188 -0.32 . . . . 0.0 111.136 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -172.41 -171.07 0.77 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 2.4 tp10 72.26 -174.01 0.16 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.43 1.092 . . . . 0.0 111.215 178.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.462 ' H ' ' HG3' ' A' ' 25' ' ' GLU . . . -106.26 36.81 4.16 Favored Glycine 0 CA--C 1.504 -0.611 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.594 HG21 ' HA ' ' A' ' 58' ' ' LYS . 17.6 pt -105.93 150.16 38.91 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 114.45 -0.875 . . . . 0.0 111.228 -170.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 1.062 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 62.5 Cg_exo -57.05 158.94 16.12 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.984 2.456 . . . . 0.0 112.304 175.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.6 m -115.9 121.78 43.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.929 -175.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.483 HD11 HD21 ' A' ' 112' ' ' LEU . 80.0 mt -110.17 108.75 26.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.617 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 61.0 mt -105.57 113.78 43.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.824 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.9 ptm -110.25 120.49 42.62 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.515 0.674 . . . . 0.0 109.474 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.512 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 87.3 m-85 -78.73 125.56 29.53 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.505 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.679 ' HE2' ' HB3' ' A' ' 65' ' ' ARG . 29.2 pttt -116.7 -174.26 2.54 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.755 -171.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.447 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 2.1 m -144.98 154.57 42.7 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.446 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 1.8 t70 -47.58 -51.9 19.55 Favored 'General case' 0 C--N 1.32 -0.674 0 O-C-N 124.239 0.962 . . . . 0.0 111.558 174.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.2 m -116.76 98.74 6.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.64 0.257 . . . . 0.0 111.637 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.447 ' SG ' ' HB ' ' A' ' 35' ' ' THR . 7.3 p -169.46 113.44 0.51 Allowed Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.901 171.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.568 ' O ' HG12 ' A' ' 42' ' ' VAL . 2.4 Cg_endo -80.49 -4.62 13.07 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.533 2.155 . . . . 0.0 113.605 -175.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -74.77 -21.8 59.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.834 0.35 . . . . 0.0 110.477 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 82.5 m -68.53 -43.45 76.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.817 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 39' ' ' PRO . 9.8 p -65.56 -29.31 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 120.93 0.395 . . . . 0.0 110.702 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.665 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -65.14 -48.76 72.45 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.28 0.562 . . . . 0.0 109.68 177.43 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 25.2 ttt -67.69 -30.16 69.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.867 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.563 ' HG2' ' CE2' ' A' ' 63' ' ' TYR . 76.0 mt-30 -56.22 -40.76 74.56 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.384 173.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.665 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 3.6 mtpm? -59.1 -53.98 52.21 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.174 0.511 . . . . 0.0 110.259 177.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -62.21 -41.3 98.26 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.971 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.642 HD13 HG21 ' A' ' 61' ' ' ILE . 84.3 mt -62.22 -43.04 99.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.472 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.3 m -53.61 -44.24 69.29 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.73 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -63.73 -61.7 2.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.219 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.8 t -57.08 -32.16 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.2 0.524 . . . . 0.0 111.284 -175.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.545 ' HB3' ' OD1' ' A' ' 15' ' ' ASN . 68.0 m -66.83 -30.48 70.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.789 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -83.49 -31.14 26.66 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.066 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -71.14 -15.4 62.5 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.424 0.631 . . . . 0.0 110.865 174.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.671 ' HA ' HH11 ' A' ' 55' ' ' ARG . 0.5 OUTLIER -141.86 77.62 1.59 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 174.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.579 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 1.3 pm0 -58.27 115.63 3.07 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -161.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.717 ' HA2' ' HB3' ' A' ' 15' ' ' ASN . . . 50.69 33.23 26.38 Favored Glycine 0 CA--C 1.52 0.35 0 CA-C-N 115.012 -0.995 . . . . 0.0 114.43 173.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.594 ' HA ' HG21 ' A' ' 27' ' ' ILE . 27.3 mmtp -109.73 14.93 23.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.571 0.701 . . . . 0.0 111.279 -176.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -159.66 111.03 2.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.199 166.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.427 HD22 HG13 ' A' ' 27' ' ' ILE . 10.8 p30 -76.48 131.38 38.99 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.093 -174.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.642 HG21 HD13 ' A' ' 48' ' ' LEU . 30.1 mm -97.87 108.49 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.445 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.749 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 1.4 t80 -95.87 110.97 23.07 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.672 ' CE1' HG23 ' A' ' 16' ' ' VAL . 36.8 m-85 -90.77 102.04 14.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.059 177.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -78.97 103.98 9.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.8 0.333 . . . . 0.0 111.424 -172.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.679 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 13.6 ptp180 -68.29 123.95 22.15 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.307 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.0 tp -79.8 8.15 7.32 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 121.808 -0.557 . . . . 0.0 109.969 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.453 ' OE1' ' HB2' ' A' ' 65' ' ' ARG . 2.4 mp0 -84.07 -28.02 27.87 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.199 -172.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -119.21 -177.52 3.37 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -170.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -36.3 20.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.121 -169.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HD2' ' H ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -57.56 -29.57 64.51 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.876 0.846 . . . . 0.0 110.758 -179.234 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.92 -11.32 58.27 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.032 -174.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.4 mm -67.85 -44.56 85.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -67.49 -47.51 69.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.54 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.414 HD23 HD11 ' A' ' 20' ' ' LEU . 2.0 tm? -60.31 -46.18 90.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.553 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.88 -43.52 98.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.488 0.185 . . . . 0.0 110.831 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -63.09 -34.19 77.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 0.0 110.805 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -60.74 -16.85 44.36 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.367 0.604 . . . . 0.0 111.622 176.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.455 ' CD2' ' HE3' ' A' ' 95' ' ' LYS . 32.4 m-85 -124.3 4.02 8.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.435 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.6 t70 54.29 33.8 19.1 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.952 0.882 . . . . 0.0 110.425 -174.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.69 84.75 7.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.004 -176.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -103.14 5.05 37.63 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.934 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.6 pt -128.68 141.21 47.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.777 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 m -127.97 143.63 48.5 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.738 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -92.54 136.14 7.86 Favored 'Cis proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.579 -1.426 . . . . 0.0 111.983 -1.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.68 128.43 54.9 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.937 0.399 . . . . 0.0 111.022 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.4 m -109.29 118.07 35.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.425 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.617 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 14.8 p -108.29 135.46 46.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.083 0.468 . . . . 0.0 110.13 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -111.0 114.62 28.07 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.551 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.523 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 4.8 mp -117.24 143.14 46.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.829 177.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.507 ' HA ' ' HB3' ' A' ' 28' ' ' PRO . 5.4 t0 -80.73 179.64 7.7 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 170.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.767 ' HE2' ' HE2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -74.4 -14.19 60.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.92 0.391 . . . . 0.0 110.56 -177.159 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -70.8 -12.34 61.49 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.713 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.64 11.65 63.65 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.13 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 11.2 m120 -79.0 113.93 17.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.693 0.283 . . . . 0.0 111.295 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.523 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 57.6 mtpt -71.43 95.47 1.36 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.205 172.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -87.58 -54.46 4.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.626 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -134.24 148.95 50.92 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.561 -172.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.406 HG12 HG23 ' A' ' 87' ' ' VAL . 30.0 m -129.54 147.1 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.599 174.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -140.16 139.02 35.65 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -104.43 122.65 45.94 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.555 0.534 . . . . 0.0 109.767 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.52 -161.78 17.89 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.988 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.428 HD21 ' OE1' ' A' ' 43' ' ' GLU . 44.0 tp -90.03 164.33 14.55 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 122.651 0.38 . . . . 0.0 111.154 -174.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.401 ' N ' ' HG ' ' A' ' 102' ' ' LEU . 58.3 mtm -149.45 172.12 15.48 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 122.937 0.495 . . . . 0.0 110.054 174.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.431 ' HA ' ' HD3' ' A' ' 104' ' ' ARG . 8.0 mmt180 -100.95 163.14 12.44 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.47 ' HA ' HD12 ' A' ' 108' ' ' ILE . 6.3 ptpp? -56.1 -40.98 74.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -62.15 -30.6 71.16 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.927 0.394 . . . . 0.0 111.525 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.54 ' O ' HG12 ' A' ' 111' ' ' ILE . 10.3 m120 -67.93 -45.74 73.47 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 176.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.605 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 50.1 mt -58.93 -48.1 87.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.586 174.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -50.13 -50.41 48.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.363 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.9 m -65.47 -40.33 93.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.318 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 107' ' ' ASN . 47.5 mm -67.1 -41.12 86.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.712 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.638 ' HB3' HG21 ' A' ' 117' ' ' VAL . 87.5 mt -59.59 -39.95 85.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.114 0.483 . . . . 0.0 109.942 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -61.21 -36.71 80.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.015 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 62.6 m -85.36 -16.72 38.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.63 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.6 tp -78.38 -81.91 0.1 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.084 0.468 . . . . 0.0 110.039 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.411 ' HA3' ' OD2' ' A' ' 90' ' ' ASP . . . 171.49 -54.95 0.18 Allowed Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 174.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.062 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 29.1 t 50.42 78.23 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.059 0 CA-C-O 121.561 0.696 . . . . 0.0 111.308 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.767 ' HE2' ' HE2' ' A' ' 91' ' ' LYS . 28.3 mtmm -121.01 140.08 52.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.753 -175.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.482 ' HG2' ' HD2' ' A' ' 58' ' ' LYS . 19.9 mt-10 -82.43 96.56 8.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.177 0.513 . . . . 0.0 110.554 175.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.98 -160.54 38.25 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.338 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -104.49 96.98 6.97 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 172.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -71.01 -4.82 26.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.022 -169.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -145.54 93.67 2.39 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -97.9 162.37 13.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.391 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -70.17 135.3 48.97 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 . . . . . 0 C--O 1.245 0.86 0 CA-C-O 117.963 -1.018 . . . . 0.0 108.616 173.836 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.472 ' H3 ' ' CD ' ' A' ' 4' ' ' GLU . 3.8 mpp? . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.661 0.267 . . . . 0.0 110.415 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.3 t -177.32 119.81 0.11 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 47.1 tp 57.16 78.37 0.23 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.559 0.695 . . . . 0.0 109.585 -171.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.472 ' CD ' ' H3 ' ' A' ' 1' ' ' MET . 5.3 mm-40 -76.27 100.64 5.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.355 -172.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.17 55.6 4.82 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.374 173.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.767 HG12 ' H ' ' A' ' 7' ' ' LYS . 19.2 tt -160.02 -174.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -174.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.767 ' H ' HG12 ' A' ' 6' ' ' ILE . 44.2 mmtt -69.63 27.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -175.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.722 ' HG2' HG23 ' A' ' 6' ' ' ILE . 15.6 mm100 -84.18 -4.26 58.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.566 0.698 . . . . 0.0 110.462 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.3 tt -92.97 -32.39 4.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.706 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -93.64 77.53 4.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.751 -176.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -123.43 -49.24 1.92 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.027 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 13' ' ' SER . 11.0 pt20 -81.77 154.96 25.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 162.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.691 ' HB3' HG11 ' A' ' 16' ' ' VAL . 50.4 m 67.94 88.48 0.11 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -169.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 15' ' ' ASN . 94.9 mt -99.07 146.75 7.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.475 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 82.5 m-20 75.26 14.63 2.98 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.935 0.772 . . . . 0.0 109.985 -173.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.691 HG11 ' HB3' ' A' ' 13' ' ' SER . 2.4 m -107.88 157.28 8.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.431 -176.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 p -129.57 149.09 33.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.349 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -64.02 -56.39 15.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.184 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.724 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 3.0 t30 -157.95 177.96 10.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.382 -0.827 . . . . 0.0 108.831 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.418 ' HG ' ' CE2' ' A' ' 62' ' ' TYR . 30.7 mt -59.45 -30.77 68.74 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.08 -38.64 70.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.294 0.569 . . . . 0.0 110.659 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -87.94 -5.5 58.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.28 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.507 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -85.48 162.98 18.72 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -172.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 23' ' ' ALA . 4.6 mtmm -167.21 90.77 0.37 Allowed 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 124.78 1.232 . . . . 0.0 107.883 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.34 107.43 18.26 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -159.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -116.28 12.05 16.67 Favored Glycine 0 CA--C 1.503 -0.673 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 159.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.46 ' C ' ' HA ' ' A' ' 91' ' ' LYS . 3.0 pt -122.18 152.9 61.11 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 113.22 -1.49 . . . . 0.0 108.529 -176.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.593 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 50.3 Cg_exo -55.62 122.68 12.17 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 121.816 1.677 . . . . 0.0 111.719 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.5 m -99.0 115.8 29.77 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.944 -176.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.514 HD11 HD11 ' A' ' 112' ' ' LEU . 2.1 mp -98.42 108.21 21.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 176.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.682 ' HB ' HG23 ' A' ' 87' ' ' VAL . 62.4 mt -108.45 110.72 33.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.289 -176.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.506 ' HB3' HG23 ' A' ' 86' ' ' THR . 5.0 ppp? -117.2 142.7 46.71 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.022 176.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.661 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 82.7 m-85 -102.15 144.49 30.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.68 -174.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.878 ' HE2' ' HB3' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -138.85 135.59 34.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.024 177.698 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.4 m -81.71 162.09 23.11 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -50.52 -49.69 55.03 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.27 0.356 . . . . 0.0 111.539 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.3 m -109.32 95.79 5.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.628 0.251 . . . . 0.0 111.275 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.3 p -165.54 131.35 2.02 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 111.462 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.564 ' O ' HG12 ' A' ' 42' ' ' VAL . 64.0 Cg_endo -77.86 -19.69 12.34 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.382 2.055 . . . . 0.0 112.809 177.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.583 ' HB3' ' HG3' ' A' ' 84' ' ' PRO . 54.8 m-85 -58.9 -24.03 61.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.064 0.459 . . . . 0.0 110.82 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 45.3 t -64.12 -50.44 68.22 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.641 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 39' ' ' PRO . 10.0 p -68.34 -32.82 57.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.022 -174.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.601 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 16.2 mt-10 -65.87 -49.91 66.41 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 120.667 0.27 . . . . 0.0 110.993 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -36.96 85.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.917 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.544 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 25.8 mt-30 -60.74 -44.73 96.3 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 176.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 9.8 mtpm? -56.58 -53.68 54.8 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.064 0.459 . . . . 0.0 111.042 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 12.3 mm-40 -62.64 -43.86 97.74 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.131 -174.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.526 HD13 HG21 ' A' ' 61' ' ' ILE . 47.6 mt -59.68 -43.11 94.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.954 175.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.4 m -58.77 -41.18 86.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.05 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.417 ' CD2' ' HA ' ' A' ' 47' ' ' GLU . 24.6 m-85 -59.79 -48.72 80.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.054 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.685 HG22 ' HG3' ' A' ' 105' ' ' LYS . 3.0 t -60.48 -43.37 94.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.039 0.447 . . . . 0.0 110.539 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -62.75 -30.83 71.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.376 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -56.94 -38.04 72.36 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.163 0.506 . . . . 0.0 110.522 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -94.42 2.53 55.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.458 -172.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.554 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 9.4 ptp180 -156.76 85.49 0.97 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.918 0.866 . . . . 0.0 111.553 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.43 ' HA ' HD21 ' A' ' 15' ' ' ASN . 1.1 pm0 -76.68 128.45 34.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.082 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.32 41.51 98.15 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.667 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.554 ' HG2' ' HB2' ' A' ' 55' ' ' ARG . 13.9 mptt -108.63 -27.4 9.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.227 0.537 . . . . 0.0 110.009 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -158.56 154.58 26.87 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.082 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 15' ' ' ASN . 50.2 t30 -108.84 134.05 52.05 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.907 0.384 . . . . 0.0 110.302 -177.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.688 HD12 HG12 ' A' ' 16' ' ' VAL . 34.0 mt -106.78 108.74 25.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.757 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.724 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -96.94 119.93 36.33 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.878 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 68.6 m-85 -94.4 103.47 15.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.598 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.18 101.18 13.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.069 0.461 . . . . 0.0 110.764 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.571 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 29.0 ptt180 -91.75 131.38 37.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.011 178.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.07 9.79 1.81 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.428 0.632 . . . . 0.0 111.215 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.44 ' HB3' ' HD2' ' A' ' 65' ' ' ARG . 57.1 tt0 -78.43 -22.55 47.5 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.543 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.496 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 45.7 mt-10 -110.39 140.24 44.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.043 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.673 ' HA ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -59.06 -35.41 73.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.159 0.584 . . . . 0.0 112.516 -174.847 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.496 ' HE3' ' HB3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -58.97 -27.99 65.9 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.934 0.397 . . . . 0.0 111.22 -177.611 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.485 ' HA ' ' CB ' ' A' ' 74' ' ' LEU . 87.2 m-20 -92.37 2.68 56.51 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.189 -175.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.673 HD13 ' HA ' ' A' ' 69' ' ' GLU . 1.4 mp -71.09 -52.46 27.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.97 -46.17 89.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.811 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.485 ' CB ' ' HA ' ' A' ' 71' ' ' ASN . 0.5 OUTLIER -55.05 -44.47 74.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.567 179.409 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.661 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -55.93 -56.38 21.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.52 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -70.46 -33.12 70.92 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.577 -176.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.447 ' HE3' ' HB2' ' A' ' 77' ' ' LYS . 21.7 ttmt -67.04 -17.19 64.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.355 0.598 . . . . 0.0 110.737 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.448 ' HB2' ' HZ ' ' A' ' 33' ' ' PHE . 51.1 m-85 -118.61 23.67 11.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.391 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 73.15 10.98 5.15 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.095 166.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.09 93.56 7.04 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.33 0.586 . . . . 0.0 111.034 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -101.8 -12.54 18.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.796 175.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 23.9 pt -136.81 -179.51 2.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.641 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.48 145.1 47.83 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.685 0.279 . . . . 0.0 111.117 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.716 ' HD2' ' HA2' ' A' ' 101' ' ' GLY . 97.9 Cg_endo -93.87 120.14 2.84 Favored 'Cis proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.258 -1.559 . . . . 0.0 112.529 -1.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.428 ' O ' ' HD1' ' A' ' 33' ' ' PHE . 70.0 m -92.36 124.54 36.49 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.506 HG23 ' HB3' ' A' ' 32' ' ' MET . 10.5 m -114.57 116.41 28.74 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.213 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.705 HG12 HG12 ' A' ' 98' ' ' VAL . 13.6 m -100.69 123.09 53.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.296 0.57 . . . . 0.0 110.112 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.765 ' HB3' HD11 ' A' ' 115' ' ' LEU . 86.7 m-85 -99.47 110.3 22.79 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.992 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.671 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 5.8 mp -107.1 143.48 35.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.586 175.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.546 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 13.4 t70 -88.18 -165.45 1.32 Allowed 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.625 175.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.546 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -52.28 -35.52 50.45 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -169.311 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -107.73 18.85 20.88 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.666 -173.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.37 23.67 50.22 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.832 172.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.671 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 9.7 m120 -77.06 112.65 13.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 117.391 0.595 . . . . 0.0 110.757 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -68.19 85.38 0.25 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -84.42 -45.21 12.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.296 -173.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.458 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 90.9 t80 -140.23 129.32 23.58 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.365 -176.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.705 HG12 HG12 ' A' ' 87' ' ' VAL . 15.0 m -107.92 148.01 12.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 172.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.458 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 62.6 t60 -136.76 128.81 29.49 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -177.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -99.82 120.57 39.96 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.716 ' HA2' ' HD2' ' A' ' 84' ' ' PRO . . . 101.91 166.71 27.09 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -175.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.45 ' CD1' ' H ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -93.1 169.22 10.58 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 117.198 0.499 . . . . 0.0 110.181 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.6 ptt? -157.14 168.07 28.52 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.405 ' N ' ' HD2' ' A' ' 104' ' ' ARG . 5.5 mmm180 -91.29 174.11 7.56 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.975 -171.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.685 ' HG3' HG22 ' A' ' 51' ' ' VAL . 55.0 tttm -46.46 -55.19 7.83 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.851 0.719 . . . . 0.0 112.469 -176.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -59.27 -34.78 72.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 0.0 111.334 -175.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -69.31 -50.15 49.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.145 0.498 . . . . 0.0 109.774 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.501 ' O ' HD22 ' A' ' 112' ' ' LEU . 41.7 mt -60.5 -49.56 83.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.933 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.488 ' HA ' HD23 ' A' ' 112' ' ' LEU . 35.0 tt0 -56.31 -47.77 78.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.452 -174.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.6 m -59.91 -31.36 69.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.441 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.563 ' O ' ' HG ' ' A' ' 115' ' ' LEU . 66.6 mt -72.6 -33.8 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.065 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.593 ' HB3' HG21 ' A' ' 117' ' ' VAL . 2.7 mm? -62.53 -38.7 90.99 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.187 172.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -63.81 -27.39 69.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.646 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.6 t -85.75 -14.03 46.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.061 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.765 HD11 ' HB3' ' A' ' 88' ' ' PHE . 95.7 mt -85.17 -73.98 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.383 0.611 . . . . 0.0 109.766 176.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 173.67 -59.81 0.14 Allowed Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.332 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.593 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 39.3 t 52.22 41.84 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 122.951 1.358 . . . . 0.0 108.021 -175.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -93.2 14.89 16.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 113.901 -1.5 . . . . 0.0 112.58 -165.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.528 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . 2.7 tp10 -84.57 -30.17 25.25 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.814 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.04 25.31 1.24 Allowed Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.282 -0.485 . . . . 0.0 113.588 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -149.4 22.79 0.93 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.856 0.36 . . . . 0.0 110.444 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -105.02 12.79 31.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.851 0.358 . . . . 0.0 111.215 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -76.83 92.76 3.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.051 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -57.57 132.7 53.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.726 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -126.72 -57.52 1.35 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.649 -0.691 . . . . 0.0 109.798 172.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 m -70.09 -56.4 7.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.157 0.504 . . . . 0.0 110.182 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -94.32 95.21 8.75 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.542 ' HG3' ' HA ' ' A' ' 8' ' ' GLN . 3.9 mm-40 60.76 -167.25 0.19 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.304 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.88 -44.61 94.39 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.108 172.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.458 HG13 ' N ' ' A' ' 7' ' ' LYS . 35.0 pt -135.99 -40.27 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.736 0.303 . . . . 0.0 111.696 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.458 ' N ' HG13 ' A' ' 6' ' ' ILE . 35.6 ttpt -160.11 -71.28 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.113 0.483 . . . . 0.0 109.751 -174.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.542 ' HA ' ' HG3' ' A' ' 4' ' ' GLU . 19.5 tp60 -135.47 8.24 3.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 122.203 1.001 . . . . 0.0 108.597 172.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.8 mt -124.89 158.09 32.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.541 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -71.84 -178.88 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.267 0.556 . . . . 0.0 111.524 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.535 ' O ' ' HB2' ' A' ' 12' ' ' GLN . 19.2 p90 -96.49 -148.72 0.31 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.618 -175.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.535 ' HB2' ' O ' ' A' ' 11' ' ' PHE . 16.0 mt-30 76.64 -63.76 0.37 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.634 0.774 . . . . 0.0 111.384 -176.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.465 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 13.2 m -76.13 -34.1 59.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.799 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.3 mt 69.06 -68.8 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.881 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.23 59.66 5.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.563 0.697 . . . . 0.0 110.121 174.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.465 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 1.0 OUTLIER -98.26 128.85 49.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.886 177.104 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.576 HG22 ' HG3' ' A' ' 22' ' ' GLU . 2.4 t -124.62 141.6 44.21 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-O 121.633 0.73 . . . . 0.0 112.567 -172.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -76.76 -35.49 57.69 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 113.864 -1.516 . . . . 0.0 112.38 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.757 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 66.0 t30 -172.6 -178.85 2.03 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.407 ' H ' ' CG ' ' A' ' 19' ' ' ASN . 83.5 mt -60.38 -29.66 69.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.757 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -78.57 -31.67 47.38 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.094 0.406 . . . . 0.0 110.988 -178.433 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.576 ' HG3' HG22 ' A' ' 17' ' ' VAL . 3.9 tp10 -72.42 -11.88 60.87 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.679 0.752 . . . . 0.0 109.876 170.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.485 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -95.14 171.73 8.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.435 -177.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.521 ' NZ ' ' HB3' ' A' ' 24' ' ' LYS . 4.3 mtpm? -135.01 167.32 21.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.125 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.487 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -86.44 174.81 8.74 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.267 170.124 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.02 -61.58 1.59 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.76 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -87.79 127.47 57.9 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-O 120.88 0.371 . . . . 0.0 110.047 178.081 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.923 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 50.9 Cg_exo -56.22 145.28 77.79 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.397 2.065 . . . . 0.0 111.118 176.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.5 m -119.54 129.61 54.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.18 0.514 . . . . 0.0 111.979 -172.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.615 HD11 HD21 ' A' ' 112' ' ' LEU . 79.6 mt -98.48 121.51 49.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.722 HG12 ' HB3' ' A' ' 62' ' ' TYR . 61.2 mt -118.58 119.85 62.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.146 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.431 ' O ' ' HG3' ' A' ' 32' ' ' MET . 26.5 ptm -108.0 117.48 34.24 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.983 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.492 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 87.4 m-85 -86.41 114.2 22.99 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.361 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.731 ' HG3' ' SG ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -138.71 145.15 39.96 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.741 -174.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 m -66.92 136.18 54.97 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 164.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -65.03 -39.38 93.3 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.792 -164.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 m -98.18 92.99 6.0 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.822 0.344 . . . . 0.0 111.153 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.659 ' SG ' ' HB2' ' A' ' 41' ' ' CYS . 25.7 p -160.87 142.68 9.12 Favored Pre-proline 0 CA--C 1.519 -0.236 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.351 174.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -64.92 -34.39 48.47 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.499 2.133 . . . . 0.0 112.48 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -68.66 -21.62 64.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 -177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.731 ' SG ' ' HG3' ' A' ' 34' ' ' LYS . 39.7 t -61.33 -53.43 56.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.022 175.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.23 -34.3 69.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.835 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -63.48 -50.24 70.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.403 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -71.74 -31.03 66.24 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.547 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 22.8 mt-30 -63.17 -33.59 75.79 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.543 173.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 41.6 mmtt -64.66 -46.65 81.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.548 175.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 51' ' ' VAL . 58.2 mm-40 -52.29 -54.52 30.44 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 123.572 0.545 . . . . 0.0 109.557 175.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.456 HD23 HD13 ' A' ' 108' ' ' ILE . 63.7 mt -57.37 -43.56 83.66 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.792 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.1 t -60.75 -39.94 90.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.164 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -76.36 -30.29 57.52 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.842 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.854 HG22 ' HG3' ' A' ' 105' ' ' LYS . 41.9 t -66.12 -39.54 84.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.254 0.55 . . . . 0.0 109.61 172.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.508 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 31.3 m -64.23 -31.66 72.95 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.889 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' A' ' 53' ' ' LYS . 4.2 mmmp? -74.44 -10.91 60.03 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.737 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -102.72 -8.72 20.63 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.23 0.538 . . . . 0.0 109.676 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.768 ' CZ ' ' HA ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -158.07 75.7 0.76 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.281 -178.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 52' ' ' SER . 20.1 mp0 -79.07 141.34 37.45 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.252 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.5 25.55 60.89 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.991 171.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.655 ' HB3' ' HG3' ' A' ' 55' ' ' ARG . 16.9 tptp -117.07 -21.82 8.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.352 0.596 . . . . 0.0 109.738 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.413 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 43.9 p90 -140.56 161.19 38.32 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 172.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -112.42 151.88 29.33 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 121.128 -0.229 . . . . 0.0 110.681 -174.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.3 mt -127.07 111.81 26.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.921 0.391 . . . . 0.0 111.124 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.722 ' HB3' HG12 ' A' ' 31' ' ' ILE . 2.5 t80 -103.24 119.74 39.43 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.547 ' CE1' ' HG2' ' A' ' 45' ' ' GLN . 87.1 m-85 -90.44 103.92 16.55 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.788 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -80.82 94.35 6.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.406 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.484 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -88.13 116.31 26.23 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.37 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 mp -66.36 11.58 0.08 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.871 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.421 ' H ' ' C ' ' A' ' 65' ' ' ARG . 35.0 tt0 -78.46 -32.09 48.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.757 0.789 . . . . 0.0 109.36 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -98.43 140.75 32.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.976 -172.292 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -31.48 72.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.886 -175.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HD2' ' OE2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -57.67 -19.09 24.37 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 178.787 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.579 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 52.4 m-80 -87.08 -2.51 58.68 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.729 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 84.5 mt -70.3 -56.8 9.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -64.6 -40.04 94.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.219 175.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 71' ' ' ASN . 0.4 OUTLIER -58.89 -47.18 85.88 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.033 178.204 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -62.71 -45.65 91.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.772 0.32 . . . . 0.0 111.226 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -62.93 -34.56 77.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.314 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -57.58 -31.11 65.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.018 0.437 . . . . 0.0 111.142 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -111.81 1.98 16.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.422 -176.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.3 t70 60.66 48.02 7.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.912 0.863 . . . . 0.0 110.332 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.38 116.13 28.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.364 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -107.81 -57.86 2.05 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.891 -171.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 36.6 pt -119.72 154.2 22.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.088 0.47 . . . . 0.0 111.078 -177.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.2 m -102.62 153.7 37.99 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.868 -177.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -89.66 127.91 7.64 Favored 'Cis proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.057 -1.643 . . . . 0.0 112.277 -0.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.419 HG23 ' HB2' ' A' ' 33' ' ' PHE . 9.0 t -120.81 134.3 55.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.077 0.465 . . . . 0.0 109.995 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.3 m -115.21 125.26 53.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.941 -176.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.4 HG22 HG23 ' A' ' 98' ' ' VAL . 66.3 t -105.24 127.87 59.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.046 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -107.83 114.42 28.36 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.242 0.544 . . . . 0.0 110.224 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.541 ' HB3' ' HA2' ' A' ' 93' ' ' GLY . 58.3 mt -99.16 142.29 30.83 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.69 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 6.4 t70 -71.25 -165.46 0.13 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.966 ' HD3' ' HG3' ' A' ' 118' ' ' LYS . 9.7 pttm -61.58 -31.73 71.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -170.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -96.32 1.88 52.3 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.91 -0.494 . . . . 0.0 110.838 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.541 ' HA2' ' HB3' ' A' ' 89' ' ' LEU . . . 85.93 26.53 34.27 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.061 -176.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 24.2 m120 -85.34 141.06 30.3 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 176.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.3 94.15 5.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.594 -174.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -84.23 -52.33 6.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.108 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 72.0 t80 -133.86 144.85 49.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 -178.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.4 HG23 HG22 ' A' ' 87' ' ' VAL . 3.4 p -136.47 136.95 48.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.427 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 74.8 t60 -120.18 137.02 54.42 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -174.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -112.67 112.46 23.99 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 123.568 0.542 . . . . 0.0 109.752 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.65 -177.67 16.42 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 44.7 tp -76.63 155.67 33.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.007 0.432 . . . . 0.0 111.042 -177.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.1 ptm -159.73 146.58 16.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 175.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.453 ' O ' HG13 ' A' ' 108' ' ' ILE . 35.2 mmt180 -98.8 174.31 6.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.869 0.366 . . . . 0.0 111.827 -174.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.854 ' HG3' HG22 ' A' ' 51' ' ' VAL . 63.7 tttm -46.23 -54.27 9.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.898 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.518 ' HA ' ' CD ' ' A' ' 109' ' ' GLU . 26.9 t-20 -65.74 -28.46 69.06 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.141 0.496 . . . . 0.0 111.446 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.496 ' O ' HD13 ' A' ' 111' ' ' ILE . 9.7 m120 -67.22 -38.95 86.13 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.547 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 42.0 mt -64.58 -47.08 90.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.528 174.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.56 ' OE2' ' HG2' ' A' ' 105' ' ' LYS . 68.1 mt-10 -49.71 -54.75 17.0 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.446 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.54 ' O ' ' HB3' ' A' ' 113' ' ' ASN . 25.4 m -67.41 -31.3 71.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.052 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 107' ' ' ASN . 1.4 mp -71.58 -41.69 71.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.778 178.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.622 ' HB3' ' CG2' ' A' ' 117' ' ' VAL . 56.4 mt -62.74 -33.25 74.74 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.54 ' HB3' ' O ' ' A' ' 110' ' ' THR . 23.2 t-20 -57.8 -44.41 86.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.918 178.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.8 m -85.13 -23.03 28.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.271 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.472 HD21 ' O ' ' A' ' 89' ' ' LEU . 62.6 tp -67.78 -78.49 0.06 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.425 0.631 . . . . 0.0 109.807 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.964 ' HA3' ' HD2' ' A' ' 118' ' ' LYS . . . 172.32 -53.84 0.17 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.96 171.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.923 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 21.6 t 56.4 41.0 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 123.162 1.458 . . . . 0.0 107.545 -174.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.966 ' HG3' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -77.68 -139.01 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 112.801 -2.0 . . . . 0.0 111.907 -169.35 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.499 ' H ' ' HB2' ' A' ' 118' ' ' LYS . 2.8 tm-20 81.62 146.86 0.08 Allowed 'General case' 0 N--CA 1.47 0.545 0 O-C-N 124.142 0.901 . . . . 0.0 108.915 -175.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.96 -33.16 84.8 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.464 -0.398 . . . . 0.0 113.488 -171.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.539 ' O ' ' HE2' ' A' ' 58' ' ' LYS . 67.0 m80 -78.26 82.06 4.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.219 0.533 . . . . 0.0 110.632 -177.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -138.08 -49.59 0.57 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.283 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -161.07 133.48 6.04 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -146.84 145.02 29.73 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.629 0.252 . . . . 0.0 110.342 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -121.71 -70.94 0.75 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 173.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 . . . . . 0 C--O 1.243 0.755 0 CA-C-O 118.442 -0.789 . . . . 0.0 109.789 178.293 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 mmt . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 m 67.79 98.69 0.05 Allowed 'General case' 0 N--CA 1.464 0.238 0 O-C-N 124.06 0.85 . . . . 0.0 110.526 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 pp -163.11 17.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.924 -175.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 2.0 mp0 -65.62 -20.84 66.47 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.908 0.385 . . . . 0.0 110.8 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.51 -53.26 4.72 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.399 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.3 pt -52.37 -26.31 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -174.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -135.58 19.96 3.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.266 0.555 . . . . 0.0 110.312 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -104.51 42.15 1.23 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.21 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 28.0 pt -78.36 16.64 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.553 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 69.03 97.64 0.06 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.582 0.706 . . . . 0.0 111.091 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -70.74 93.38 0.94 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.242 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -167.26 -64.34 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.62 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 49' ' ' SER . 21.3 m -68.13 -38.69 82.48 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 13' ' ' SER . 97.2 mt 71.19 141.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -175.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 66.79 12.35 8.81 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.298 0.57 . . . . 0.0 110.148 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 p -81.94 135.66 24.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.82 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.712 HG13 ' HG2' ' A' ' 22' ' ' GLU . 92.7 t -134.58 143.71 37.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.123 -176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.689 ' HG3' ' HB2' ' A' ' 19' ' ' ASN . 1.3 tp10 -69.3 -56.1 8.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.789 0.328 . . . . 0.0 111.199 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.814 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 2.9 t-20 -143.14 170.18 16.21 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.963 -167.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.49 -30.8 71.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.04 171.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.814 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 13.5 pt-20 -71.89 -13.85 61.77 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.335 0.588 . . . . 0.0 110.524 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.712 ' HG2' HG13 ' A' ' 17' ' ' VAL . 22.2 tt0 -110.62 0.65 17.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.703 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.74 162.26 20.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.121 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -154.6 148.93 26.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.649 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.415 ' OE1' ' NE2' ' A' ' 121' ' ' HIS . 3.2 tp10 81.94 164.95 0.14 Allowed 'General case' 0 C--N 1.333 -0.109 0 O-C-N 124.401 1.063 . . . . 0.0 112.295 167.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.99 56.89 4.34 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.812 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 26.2 pt -116.61 146.95 38.74 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.765 -0.218 . . . . 0.0 110.538 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.692 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 49.5 Cg_exo -57.71 135.56 70.06 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.838 2.359 . . . . 0.0 112.089 178.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.467 ' HA ' ' OD1' ' A' ' 60' ' ' ASN . 52.4 m -99.07 114.69 27.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.687 -177.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.569 HD13 ' HB2' ' A' ' 59' ' ' PHE . 2.0 mp -98.74 108.58 22.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.354 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.751 HG12 ' HB3' ' A' ' 62' ' ' TYR . 62.5 mt -103.56 136.81 34.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.302 -177.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.8 ptm -128.15 122.61 32.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.145 0.498 . . . . 0.0 110.279 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.78 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 96.1 m-85 -85.72 113.75 22.15 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.102 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -139.67 149.81 44.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.125 -177.297 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.469 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 9.1 p -85.14 177.46 7.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.715 -0.221 . . . . 0.0 110.5 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.451 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 15.4 t70 -60.92 -80.62 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.982 0.42 . . . . 0.0 110.759 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.5 m -82.19 98.37 8.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.005 0.431 . . . . 0.0 110.631 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 41' ' ' CYS . 24.8 p -154.77 135.9 8.95 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.64 176.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.0 -26.81 30.82 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.135 1.89 . . . . 0.0 112.267 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.532 ' HB3' ' HG3' ' A' ' 84' ' ' PRO . 69.7 m-85 -58.58 -35.07 71.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.773 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.523 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 45.9 t -63.55 -53.04 58.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.186 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.497 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 43.5 t -60.89 -44.32 97.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.121 -177.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.911 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 15.0 tp10 -57.93 -50.69 72.49 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.725 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.49 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 8.1 tpt -68.02 -35.9 79.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.417 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 87.4 mt-30 -61.27 -39.39 90.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.319 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.911 ' HE3' ' HA ' ' A' ' 43' ' ' GLU . 10.1 mtmp? -56.14 -53.36 58.01 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.461 0.648 . . . . 0.0 109.39 175.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.577 ' HG3' ' HA ' ' A' ' 104' ' ' ARG . 24.7 mm-40 -62.36 -42.32 99.31 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.028 -176.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.741 HD13 HG21 ' A' ' 61' ' ' ILE . 96.4 mt -60.22 -43.33 96.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.469 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 13' ' ' SER . 45.4 t -58.2 -43.24 87.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.344 0.593 . . . . 0.0 110.078 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -65.54 -43.28 90.45 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.807 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.7 HG13 ' HG2' ' A' ' 109' ' ' GLU . 92.9 t -65.3 -48.33 83.74 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.047 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.8 m -60.9 -31.62 71.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.803 0.335 . . . . 0.0 111.312 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.741 ' HZ3' ' HB3' ' A' ' 53' ' ' LYS . 4.4 ttpm? -64.0 -24.69 67.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.152 0.501 . . . . 0.0 110.601 175.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -109.11 2.93 21.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.561 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.564 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 10.1 tpp180 -156.36 79.23 0.96 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -176.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.25 125.91 32.09 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -172.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 53.89 30.67 45.59 Favored Glycine 0 C--N 1.33 0.212 0 CA-C-N 115.903 -0.59 . . . . 0.0 113.666 174.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.564 ' HB2' ' HG3' ' A' ' 55' ' ' ARG . 61.4 mmtt -110.93 -6.19 14.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.516 0.674 . . . . 0.0 109.228 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.569 ' HB2' HD13 ' A' ' 30' ' ' ILE . 4.6 p90 -162.49 143.34 10.1 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.385 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.467 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 20.8 p-10 -111.03 136.34 50.19 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.056 0.455 . . . . 0.0 110.82 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.741 HG21 HD13 ' A' ' 48' ' ' LEU . 4.5 mp -96.96 109.5 23.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.536 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.751 ' HB3' HG12 ' A' ' 31' ' ' ILE . 1.1 t80 -89.72 115.32 27.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.247 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -80.21 104.34 10.69 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.732 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -85.43 85.38 7.44 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.766 ' HB2' ' CD ' ' A' ' 67' ' ' GLU . 6.7 ptt180 -91.42 116.86 29.19 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.963 -170.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.478 ' HA ' HD22 ' A' ' 71' ' ' ASN . 4.1 mm? -72.04 5.82 2.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.625 -176.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.766 ' CD ' ' HB2' ' A' ' 65' ' ' ARG . 7.1 pm0 -84.58 -13.61 51.23 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.597 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 32.6 mt-10 -101.38 128.42 47.57 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.311 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -59.4 -37.39 77.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.06 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.597 ' HD2' ' HB3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -58.99 -24.59 62.86 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 122.084 0.945 . . . . 0.0 110.902 -179.132 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.498 ' N ' ' HD3' ' A' ' 70' ' ' LYS . 12.0 t30 -97.74 3.77 50.05 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.861 -172.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.3 mt -71.42 -51.02 36.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 169.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.33 -39.72 89.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.261 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.478 ' CB ' ' HA ' ' A' ' 71' ' ' ASN . 1.6 tm? -57.81 -42.57 84.56 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.913 176.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.78 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -51.68 -56.5 13.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.839 176.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -63.8 -32.54 74.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.504 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -62.31 -14.95 44.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.285 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.616 ' HB3' HG11 ' A' ' 87' ' ' VAL . 57.5 m-85 -127.78 21.54 6.42 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 70.25 15.43 7.47 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.006 0.522 . . . . 0.0 111.634 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.23 130.05 41.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.038 0.447 . . . . 0.0 110.685 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -133.63 -40.22 0.88 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.167 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.496 HD11 ' HB3' ' A' ' 100' ' ' GLN . 36.9 pt -122.28 179.85 2.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.741 0.305 . . . . 0.0 110.5 177.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.7 m -128.51 139.27 35.05 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.704 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.532 ' HG3' ' HB3' ' A' ' 40' ' ' TYR . 79.3 Cg_endo -93.36 128.15 5.03 Favored 'Cis proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.275 -1.552 . . . . 0.0 112.796 -0.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.422 ' O ' ' HD1' ' A' ' 33' ' ' PHE . 64.6 m -108.31 114.62 28.63 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 174.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.435 ' CG2' ' HB3' ' A' ' 99' ' ' HIS . 5.1 t -108.63 122.36 46.94 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.42 0.628 . . . . 0.0 110.74 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.691 HG23 ' HB ' ' A' ' 31' ' ' ILE . 14.0 m -102.62 120.94 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.226 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.744 ' HB3' HD11 ' A' ' 115' ' ' LEU . 96.6 m-85 -99.09 112.73 24.79 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.586 -177.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.0 mt -104.17 137.32 42.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.527 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 23.8 t0 -71.58 179.13 3.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.512 ' HB2' ' HE3' ' A' ' 91' ' ' LYS . 14.8 ptmt -60.88 -13.8 18.08 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.53 -41.42 15.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.796 0.332 . . . . 0.0 110.515 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.2 -17.04 5.97 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.216 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -57.58 139.71 52.83 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.499 0.666 . . . . 0.0 111.771 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -77.46 90.14 3.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.443 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -78.04 -45.99 22.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -174.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.443 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 87.3 t80 -145.85 136.56 24.3 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.894 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.658 HG12 HG12 ' A' ' 87' ' ' VAL . 16.2 m -118.07 149.75 20.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 173.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.443 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 53.4 t60 -137.12 118.18 14.36 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.496 ' HB3' HD11 ' A' ' 82' ' ' ILE . 1.4 mp0 -101.32 106.43 17.6 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.875 0.734 . . . . 0.0 109.211 176.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 131.55 -176.03 19.36 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.968 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.637 HD21 ' HG2' ' A' ' 43' ' ' GLU . 34.8 tp -92.19 161.3 14.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.753 0.311 . . . . 0.0 111.051 -175.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -171.94 162.49 6.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.577 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 1.8 mpt_? -102.13 177.61 4.84 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -174.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.485 ' HA ' HD12 ' A' ' 108' ' ' ILE . 13.7 ptmm? -49.73 -43.36 47.74 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -171.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -67.05 -32.49 73.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.108 0.48 . . . . 0.0 110.374 -175.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.598 ' O ' HG12 ' A' ' 111' ' ' ILE . 15.8 m120 -67.67 -48.1 67.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.612 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 105' ' ' LYS . 26.6 mt -58.6 -50.84 77.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.078 177.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.7 ' HG2' HG13 ' A' ' 51' ' ' VAL . 1.2 tm-20 -55.6 -48.93 74.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.318 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.2 m -59.81 -33.43 71.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.978 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.669 ' O ' ' HG ' ' A' ' 115' ' ' LEU . 48.9 mm -69.4 -41.05 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.723 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 8.8 mt -60.21 -45.17 94.1 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -61.16 -26.95 68.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.063 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.6 t -83.82 -25.3 30.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.744 HD11 ' HB3' ' A' ' 88' ' ' PHE . 57.2 mt -72.34 -60.7 2.1 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.746 0.784 . . . . 0.0 109.739 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 158.98 -50.48 0.4 Allowed Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.15 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.692 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 40.0 t 53.29 42.45 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 122.808 1.289 . . . . 0.0 109.105 -177.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.498 ' O ' ' HD2' ' A' ' 91' ' ' LYS . 35.0 mtmm -85.88 75.26 10.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.887 -174.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -50.69 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.809 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.0 29.05 35.44 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.776 174.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.415 ' NE2' ' OE1' ' A' ' 25' ' ' GLU . 36.0 m-70 -111.6 -34.64 6.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.39 0.595 . . . . 0.0 111.518 176.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -72.38 74.87 1.02 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.748 0.785 . . . . 0.0 111.62 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -165.54 114.7 1.02 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.796 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -116.14 151.24 36.04 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -171.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -105.01 -6.55 19.93 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 164.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 . . . . . 0 C--O 1.246 0.894 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.546 179.306 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.839 0.352 . . . . 0.0 110.4 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.3 t -153.77 103.69 2.63 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 3' ' ' LEU . 0.8 OUTLIER 65.05 87.33 0.12 Allowed 'General case' 0 CA--C 1.531 0.245 0 O-C-N 123.737 0.648 . . . . 0.0 109.619 -175.372 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 8' ' ' GLN . 4.5 mp0 -82.76 -25.47 32.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.699 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.31 -54.25 3.94 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.165 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.1 pt -138.37 -32.36 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.789 0.328 . . . . 0.0 111.597 -175.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -85.77 41.78 0.93 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.022 0.439 . . . . 0.0 111.673 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.577 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . 31.8 tt0 -119.1 15.45 13.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.829 0.823 . . . . 0.0 108.846 177.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.1 tp -101.1 95.1 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.809 -172.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -129.17 -3.05 5.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.608 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.508 ' O ' ' HB2' ' A' ' 12' ' ' GLN . 43.7 p90 -142.31 133.34 25.92 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.115 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.508 ' HB2' ' O ' ' A' ' 11' ' ' PHE . 5.4 tp-100 168.63 -61.69 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.58 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 35.3 t -106.73 7.1 30.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.268 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 69.4 mt 70.96 -69.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.992 175.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.854 HD22 ' HB3' ' A' ' 52' ' ' SER . 54.0 m-80 -83.17 31.91 0.44 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.912 0.387 . . . . 0.0 110.426 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.58 ' HB ' ' HB3' ' A' ' 13' ' ' SER . 8.7 p -97.23 148.66 5.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.283 -173.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' A' ' 23' ' ' ALA . 8.8 p -133.3 145.9 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.011 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -66.72 -45.1 79.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.407 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.632 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 16.1 t-20 -160.25 168.83 24.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.242 -175.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 84.9 mt -62.05 -29.41 70.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.84 0.352 . . . . 0.0 110.439 178.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -59.78 -32.22 70.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.542 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -97.21 -0.96 45.92 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.546 -177.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.508 ' HB2' HG21 ' A' ' 17' ' ' VAL . . . -107.62 171.64 7.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.371 0.605 . . . . 0.0 112.47 -170.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -129.84 155.82 45.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.897 177.831 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.5 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -103.54 177.24 4.9 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.772 0.32 . . . . 0.0 110.92 -176.262 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.595 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . 108.81 -35.53 4.9 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.81 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -105.73 152.93 40.25 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 177.009 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.79 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 63.8 Cg_exo -53.28 135.04 59.2 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.827 2.351 . . . . 0.0 112.194 177.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.408 ' HB ' HD12 ' A' ' 89' ' ' LEU . 25.8 m -106.0 112.92 26.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.425 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.44 HD13 ' HB2' ' A' ' 59' ' ' PHE . 1.7 mp -97.91 109.32 23.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 87' ' ' VAL . 59.3 mt -103.67 126.23 58.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.598 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.443 ' O ' ' HG3' ' A' ' 32' ' ' MET . 24.3 ptm -118.81 116.97 27.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.66 0.743 . . . . 0.0 110.153 173.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 87.5 m-85 -81.5 119.05 23.25 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.346 174.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.558 ' HE3' ' HB3' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -139.56 145.15 38.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.968 0.413 . . . . 0.0 111.259 -177.686 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.558 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 5.3 m -91.52 157.04 17.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.668 175.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.753 ' HB2' ' HG2' ' A' ' 67' ' ' GLU . 12.6 t70 -61.58 -66.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 111.841 -178.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.1 m -82.01 54.32 2.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.616 0.722 . . . . 0.0 111.407 -172.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.558 ' SG ' ' HB ' ' A' ' 35' ' ' THR . 37.4 m -145.24 113.67 4.83 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.514 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.52 -3.46 11.9 Favored 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 122.363 2.042 . . . . 0.0 113.37 -176.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -68.99 -17.33 63.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.667 0.27 . . . . 0.0 110.892 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.448 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 26.4 p -74.27 -55.36 6.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.482 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.589 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 12.4 p -60.64 -35.58 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.149 -175.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.58 ' HG2' HD21 ' A' ' 102' ' ' LEU . 24.0 tp10 -57.86 -51.09 71.02 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.055 0.455 . . . . 0.0 110.803 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 24.0 ttt -74.5 -29.29 61.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.303 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 28.8 mt-30 -63.86 -33.9 76.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.76 176.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 2.9 mtmm -60.22 -51.9 67.61 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.571 ' HG3' ' HA ' ' A' ' 104' ' ' ARG . 33.2 mm-40 -55.7 -46.4 77.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.804 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.433 HD13 HG21 ' A' ' 61' ' ' ILE . 89.7 mt -59.7 -39.22 83.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.003 178.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.0 t -65.58 -45.22 84.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.088 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.457 ' CB ' ' HD2' ' A' ' 105' ' ' LYS . 20.8 m-85 -58.82 -39.82 82.34 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.653 178.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 47' ' ' GLU . 84.9 t -66.97 -53.29 35.4 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.597 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.854 ' HB3' HD22 ' A' ' 15' ' ' ASN . 21.5 m -59.53 -30.85 68.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.927 0.394 . . . . 0.0 111.473 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.585 ' HB3' ' NZ ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -55.85 -29.45 59.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.896 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -113.53 -34.24 5.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.883 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.677 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 2.5 tpp180 -89.7 75.03 7.46 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.5 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 2.2 mm-40 -82.49 128.39 34.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.173 -174.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.96 42.9 82.03 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.987 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.677 ' HB2' ' HG3' ' A' ' 55' ' ' ARG . 38.7 mmtm -126.87 -12.89 5.89 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.751 -0.264 . . . . 0.0 110.895 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.44 ' HB2' HD13 ' A' ' 30' ' ' ILE . 1.2 p90 -160.43 149.86 17.47 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -112.83 129.88 56.29 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.433 HG21 HD13 ' A' ' 48' ' ' LEU . 4.7 mp -97.71 110.97 26.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.947 0.403 . . . . 0.0 110.587 -178.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.632 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 12.5 t80 -96.91 116.06 28.52 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.018 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.558 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 15.0 m-30 -77.91 103.77 8.05 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.005 176.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 33' ' ' PHE . . . -85.13 74.34 10.49 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.559 ' C ' ' H ' ' A' ' 67' ' ' GLU . 23.9 ptt180 -84.03 125.89 32.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.294 -174.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.14 12.25 0.09 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.323 0.582 . . . . 0.0 111.3 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.753 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 25.8 mt-10 -82.33 -26.08 33.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.35 -177.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.511 ' CB ' ' HD2' ' A' ' 70' ' ' LYS . 44.6 mt-10 -118.08 147.31 43.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.654 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -69.19 -18.21 63.89 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -175.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.605 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.6 OUTLIER -62.64 -32.26 73.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.576 0.703 . . . . 0.0 110.034 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.605 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 5.7 m-80 -83.58 -9.65 58.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.323 -174.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.0 mm -71.49 -42.6 72.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.16 -45.46 88.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.489 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 71' ' ' ASN . 4.4 mm? -58.11 -39.25 78.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.171 175.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.607 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -55.71 -57.23 12.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.485 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -66.17 -33.69 76.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.022 0.439 . . . . 0.0 110.601 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.439 ' HE3' ' HB2' ' A' ' 77' ' ' LYS . 19.2 ttmt -66.96 -17.44 64.92 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.261 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -122.16 11.4 10.16 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 70.59 24.82 4.32 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.595 0.559 . . . . 0.0 111.272 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.17 101.63 11.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.517 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -94.62 -43.17 8.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.888 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.7 pt -133.46 152.54 35.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.813 0.34 . . . . 0.0 110.682 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 84' ' ' PRO . 23.6 m -101.8 158.88 30.93 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.905 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.548 ' HA ' ' HB ' ' A' ' 83' ' ' VAL . 2.3 Cg_endo -83.01 125.41 10.33 Favored 'Cis proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.755 -1.352 . . . . 0.0 112.101 -0.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.523 ' HB ' ' CD1' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -97.4 112.55 24.33 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.697 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.4 m -101.44 111.7 24.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.276 0.56 . . . . 0.0 110.459 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' A' ' 31' ' ' ILE . 99.5 t -108.19 110.21 31.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.259 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.419 ' CD2' ' HD2' ' A' ' 97' ' ' TYR . 97.4 m-85 -91.79 105.68 17.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.082 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.408 HD12 ' HB ' ' A' ' 29' ' ' THR . 78.4 mt -95.62 136.05 36.51 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.432 175.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.423 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 25.7 t70 -72.61 177.37 4.76 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 172.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.641 ' HE2' ' N ' ' A' ' 120' ' ' GLY . 0.0 OUTLIER -53.58 -27.58 27.34 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -175.361 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.497 ' HG2' ' HG3' ' A' ' 91' ' ' LYS . 4.0 mm-40 -90.93 4.04 53.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.792 0.329 . . . . 0.0 111.166 -175.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.85 14.22 79.98 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.676 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -81.63 141.89 33.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.765 0.316 . . . . 0.0 110.507 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -79.31 82.01 5.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.839 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -78.52 -42.59 29.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.878 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.419 ' HD2' ' CD2' ' A' ' 88' ' ' PHE . 69.0 t80 -141.63 113.56 7.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.133 0.492 . . . . 0.0 111.18 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.97 128.74 65.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -137.85 143.18 40.81 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.522 ' HG2' HG23 ' A' ' 85' ' ' THR . 77.6 mt-30 -119.98 124.21 45.37 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.683 0.278 . . . . 0.0 110.447 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 142.75 -167.45 26.25 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.808 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.58 HD21 ' HG2' ' A' ' 43' ' ' GLU . 59.9 tp -106.09 121.6 44.47 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 74.0 mtp -116.06 159.72 21.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.553 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.571 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 3.3 mpt_? -111.09 170.49 8.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.703 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.457 ' HD2' ' CB ' ' A' ' 50' ' ' TYR . 23.5 tttp -46.91 -53.79 11.43 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -176.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -56.86 -39.2 73.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.008 0.432 . . . . 0.0 111.309 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.533 ' O ' HG12 ' A' ' 111' ' ' ILE . 9.2 m120 -70.6 -44.89 66.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.844 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.58 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 62.3 mt -60.26 -48.72 87.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.91 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.498 ' CD ' HH21 ' A' ' 55' ' ' ARG . 5.5 mm-40 -54.5 -47.99 72.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.594 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 113' ' ' ASN . 24.0 m -64.59 -38.33 90.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.742 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 107' ' ' ASN . 35.4 mm -65.17 -40.98 90.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.765 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 59.8 mt -62.31 -34.79 77.3 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.844 0.354 . . . . 0.0 110.136 177.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 110' ' ' THR . 90.4 m-20 -58.87 -45.24 90.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.853 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.8 m -86.49 -16.99 35.32 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.5 tp -70.7 -71.38 0.25 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.35 0.595 . . . . 0.0 110.381 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -178.39 -73.54 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.554 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.79 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 52.0 t 51.71 73.87 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 122.195 0.998 . . . . 0.0 109.82 -175.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -158.97 167.23 29.9 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.686 -172.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 0.3 OUTLIER -141.43 88.39 2.14 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 173.387 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.641 ' N ' ' HE2' ' A' ' 91' ' ' LYS . . . -66.14 100.72 0.54 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 168.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -53.81 105.95 0.16 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -167.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -74.41 -169.43 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.247 172.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -68.0 85.93 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.589 0.709 . . . . 0.0 111.349 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -114.41 15.98 17.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.122 174.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -100.95 144.54 29.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.427 -175.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 70.8 m80 . . . . . 0 C--O 1.243 0.762 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 171.517 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.0 m -68.03 105.24 1.97 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.971 0.415 . . . . 0.0 110.59 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.64 -13.54 20.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.273 0.558 . . . . 0.0 110.604 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.721 ' HG3' ' H ' ' A' ' 5' ' ' GLY . 5.6 pt-20 -106.46 -74.53 0.65 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.758 -174.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.721 ' H ' ' HG3' ' A' ' 4' ' ' GLU . . . 75.64 -52.79 2.79 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.264 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.712 HG13 ' HG3' ' A' ' 7' ' ' LYS . 29.0 pt -122.33 -162.99 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.712 ' HG3' HG13 ' A' ' 6' ' ' ILE . 85.3 mttt 72.53 -69.96 0.17 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.027 0.531 . . . . 0.0 111.014 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -79.8 -34.52 39.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.892 0.854 . . . . 0.0 110.275 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.65 HG23 HG22 ' A' ' 16' ' ' VAL . 26.7 mt -88.55 100.61 10.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.314 174.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 179.64 -37.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -176.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -141.68 -158.58 0.88 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.031 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 75.3 -50.99 0.65 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.569 0.747 . . . . 0.0 111.739 176.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.625 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 72.9 m -107.55 -5.01 17.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.462 0.173 . . . . 0.0 111.263 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 69.9 mt 69.42 -74.23 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.15 0.58 . . . . 0.0 111.694 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -86.81 29.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.83 0.348 . . . . 0.0 110.929 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.65 HG22 HG23 ' A' ' 9' ' ' ILE . 3.0 p -72.94 129.02 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.504 -176.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.65 HG13 ' HB3' ' A' ' 22' ' ' GLU . 73.0 t -127.41 134.04 66.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.596 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.509 ' OE1' ' HA2' ' A' ' 5' ' ' GLY . 11.9 tp10 -66.38 -55.2 16.99 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.789 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.568 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 47.2 t30 -153.22 179.58 8.61 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -177.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.33 -31.02 68.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.766 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 2.6 mp0 -59.89 -35.82 75.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.987 0.422 . . . . 0.0 110.465 176.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.65 ' HB3' HG13 ' A' ' 17' ' ' VAL . 3.7 mm-40 -82.91 -8.03 59.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.413 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.35 107.86 15.34 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 172.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.541 ' HE2' ' O ' ' A' ' 22' ' ' GLU . 17.6 mtmt -131.19 174.03 10.44 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.991 -171.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.54 ' OE1' ' HA ' ' A' ' 121' ' ' HIS . 7.4 tp10 66.59 167.61 0.22 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.301 1.0 . . . . 0.0 110.207 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 120' ' ' GLY . . . -81.93 50.95 4.37 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.667 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.41 HG13 ' ND2' ' A' ' 60' ' ' ASN . 18.2 pt -116.45 149.39 43.64 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.727 0.299 . . . . 0.0 110.491 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.703 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 40.8 Cg_exo -60.59 168.92 6.06 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 123.217 2.611 . . . . 0.0 112.655 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.468 ' HB ' HD12 ' A' ' 89' ' ' LEU . 34.9 m -135.89 125.01 24.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.525 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.446 HD13 ' CD2' ' A' ' 59' ' ' PHE . 2.4 mp -105.63 115.04 46.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.816 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.566 ' HB ' ' HB ' ' A' ' 87' ' ' VAL . 67.6 mt -100.46 139.38 22.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.78 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.523 ' HG3' ' SD ' ' A' ' 44' ' ' MET . 2.1 tmt? -134.48 113.34 11.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.183 0.516 . . . . 0.0 109.887 171.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 91.6 m-85 -76.93 135.29 38.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.529 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.441 ' HG3' ' SG ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -142.28 153.86 44.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.289 -178.303 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -72.57 164.98 25.58 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 67' ' ' GLU . 6.6 p-10 -58.58 -45.22 89.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.681 0.276 . . . . 0.0 110.968 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -130.92 96.9 4.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.977 0.418 . . . . 0.0 111.275 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 41' ' ' CYS . 11.7 p -150.97 140.7 14.01 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.729 177.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 11.6 Cg_exo -69.94 -29.99 22.15 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.533 2.155 . . . . 0.0 112.273 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.574 ' HB3' ' HG3' ' A' ' 84' ' ' PRO . 90.2 m-85 -60.91 -26.98 67.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.095 0.474 . . . . 0.0 110.561 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . 21.5 t -60.03 -54.42 46.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.869 177.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.417 ' HA ' ' HG2' ' A' ' 45' ' ' GLN . 8.0 p -73.2 -38.13 53.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.432 -172.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.54 ' HG2' HD21 ' A' ' 102' ' ' LEU . 5.2 tp10 -61.6 -50.64 71.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.071 0.462 . . . . 0.0 110.875 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.523 ' SD ' ' HG3' ' A' ' 32' ' ' MET . 24.1 ttt -69.21 -37.25 77.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.053 0.454 . . . . 0.0 111.216 -175.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.455 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 12.9 pt20 -74.12 -31.49 62.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.354 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.912 ' HE2' ' HA ' ' A' ' 46' ' ' LYS . 8.5 mmpt? -74.26 -29.81 61.85 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.535 176.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 51' ' ' VAL . 13.4 mm-40 -62.03 -44.74 96.06 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 169.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 45' ' ' GLN . 98.1 mt -57.37 -36.99 71.92 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.313 173.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.9 t -66.19 -37.96 86.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.425 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.57 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 13.2 m-30 -65.05 -39.22 93.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.876 0.37 . . . . 0.0 110.177 175.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.582 HG22 ' HG3' ' A' ' 105' ' ' LYS . 44.1 t -65.11 -36.33 77.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.106 176.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.3 m -63.67 -31.8 73.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.824 178.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -66.84 -27.06 67.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.321 0.581 . . . . 0.0 110.738 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -100.77 2.58 41.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.584 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.541 ' HE ' HG12 ' A' ' 117' ' ' VAL . 21.1 tpt180 -161.23 76.63 0.54 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.427 0.632 . . . . 0.0 109.437 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -82.61 125.1 30.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.866 -172.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.405 ' O ' ' HD2' ' A' ' 58' ' ' LYS . . . 60.4 42.63 99.01 Favored Glycine 0 C--O 1.226 -0.346 0 CA-C-N 115.782 -0.644 . . . . 0.0 113.418 175.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HB2' ' HG3' ' A' ' 55' ' ' ARG . 11.7 mptt -125.31 0.56 7.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.902 0.351 . . . . 0.0 110.959 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.446 ' CD2' HD13 ' A' ' 30' ' ' ILE . 52.4 p90 -165.89 140.11 4.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.024 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.62 ' HB3' HG21 ' A' ' 17' ' ' VAL . 46.5 m-80 -82.66 131.22 35.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.375 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.7 mt -101.9 108.11 23.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 175.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.568 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 18.0 t80 -93.49 118.91 31.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.88 0.371 . . . . 0.0 110.067 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.455 ' CE1' ' HB2' ' A' ' 45' ' ' GLN . 11.8 m-85 -87.4 104.05 16.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.258 0.552 . . . . 0.0 110.707 178.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 33' ' ' PHE . . . -96.57 81.54 3.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.531 -175.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.57 HH22 ' CD ' ' A' ' 4' ' ' GLU . 19.7 ptt180 -95.28 130.48 42.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.814 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.2 tp -70.18 7.48 0.98 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.577 0.703 . . . . 0.0 110.546 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 36' ' ' ASP . 34.6 tt0 -83.03 -17.52 43.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.456 -175.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.417 ' HG3' ' HG3' ' A' ' 65' ' ' ARG . 36.1 mt-10 -103.79 -0.51 29.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -170.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.495 ' HA ' HG12 ' A' ' 72' ' ' ILE . 1.2 mp0 69.23 -36.62 0.34 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.557 0.535 . . . . 0.0 112.202 -177.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.491 ' HD2' ' ND2' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -61.05 -25.04 66.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.323 0.582 . . . . 0.0 110.729 175.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.588 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 44.5 m-80 -86.69 -0.86 57.09 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.816 178.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.495 HG12 ' HA ' ' A' ' 69' ' ' GLU . 45.2 mm -66.66 -45.18 88.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -72.21 -49.57 34.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.425 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 71' ' ' ASN . 3.8 mm? -57.18 -38.44 73.62 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.737 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.495 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -63.7 -48.4 77.27 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.055 177.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -62.42 -37.49 86.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.128 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -53.27 -35.85 60.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.481 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -113.35 13.27 19.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.842 -176.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.9 t70 63.35 29.32 15.7 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.693 0.759 . . . . 0.0 110.749 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.45 ' O ' ' HB1' ' A' ' 75' ' ' ALA . . . -87.77 104.2 16.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.362 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -127.98 -11.22 5.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.49 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.6 mt -114.95 133.4 61.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.061 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.1 m -114.05 145.81 34.36 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.681 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.574 ' HG3' ' HB3' ' A' ' 40' ' ' TYR . 6.0 Cg_endo -85.68 157.71 59.69 Favored 'Cis proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.43 -1.487 . . . . 0.0 111.811 -0.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.6 t -153.56 137.86 16.62 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 9.5 t -124.83 140.74 52.65 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.425 0.631 . . . . 0.0 110.88 -175.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 31' ' ' ILE . 72.4 t -115.87 110.43 31.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.413 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.537 ' HB3' HD22 ' A' ' 115' ' ' LEU . 97.3 m-85 -89.84 108.34 19.64 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.526 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.55 HD23 ' HA ' ' A' ' 95' ' ' LYS . 67.3 mt -97.47 130.44 44.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.815 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.84 169.62 16.4 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.877 ' HG2' ' HG3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -61.93 -23.88 66.63 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.565 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -76.53 -5.82 49.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.113 0.482 . . . . 0.0 110.022 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.65 22.46 50.22 Favored Glycine 0 N--CA 1.453 -0.185 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.599 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -107.24 148.64 28.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.55 ' HA ' HD23 ' A' ' 89' ' ' LEU . 4.6 ttpm? -77.19 117.81 19.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -97.37 -50.08 4.68 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.105 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.473 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 84.7 t80 -148.87 136.24 20.24 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.606 -175.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.489 HG12 HG22 ' A' ' 87' ' ' VAL . 27.5 m -113.94 148.29 16.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.76 172.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.473 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 36.6 t60 -142.83 141.24 31.57 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -111.16 121.76 46.14 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 145.76 170.78 14.78 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.981 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.54 HD21 ' HG2' ' A' ' 43' ' ' GLU . 43.8 tp -82.09 -61.56 1.87 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.465 0.65 . . . . 0.0 111.224 -177.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.526 ' O ' ' HD2' ' A' ' 104' ' ' ARG . 57.5 mtm 64.18 175.73 0.18 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.176 -1.374 . . . . 0.0 111.091 -175.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.526 ' HD2' ' O ' ' A' ' 103' ' ' MET . 10.7 mmm180 -122.61 178.15 5.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.921 173.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.582 ' HG3' HG22 ' A' ' 51' ' ' VAL . 47.1 tttm -45.53 -59.19 2.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -177.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -66.75 -28.85 68.74 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.399 -173.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -64.0 -47.99 78.15 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.627 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 61.5 mt -59.25 -47.5 90.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.796 174.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -50.57 -48.25 57.61 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.766 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 m -61.93 -41.76 98.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.867 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 63.1 mt -67.83 -37.67 78.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.204 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.63 ' HB3' HG21 ' A' ' 117' ' ' VAL . 87.2 mt -63.19 -35.45 80.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.374 . . . . 0.0 110.433 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -60.76 -39.8 90.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.674 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.6 m -79.46 -28.19 41.59 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.333 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.537 HD22 ' HB3' ' A' ' 88' ' ' PHE . 45.6 tp -66.25 -70.34 0.25 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.712 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 171.52 -73.54 0.1 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.605 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.703 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 11.6 t 55.61 36.52 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 122.677 1.227 . . . . 0.0 109.399 -176.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.877 ' HG3' ' HG2' ' A' ' 91' ' ' LYS . 8.2 ptmt -101.56 128.0 48.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.527 -1.669 . . . . 0.0 110.02 -177.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -92.81 110.4 21.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.863 -175.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.572 ' O ' ' HA3' ' A' ' 26' ' ' GLY . . . -117.82 93.02 0.56 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.618 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.54 ' HA ' ' OE1' ' A' ' 25' ' ' GLU . 97.6 m-70 -59.96 124.7 21.02 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.04 0.448 . . . . 0.0 110.953 -177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -82.7 81.11 8.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.938 -173.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 13.2 p80 178.66 170.58 0.83 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.204 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.502 ' HB2' ' H ' ' A' ' 126' ' ' HIS . 6.6 m80 -99.42 -151.59 0.39 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -64.2 -22.6 67.0 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 163.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.502 ' H ' ' HB2' ' A' ' 124' ' ' HIS . 48.9 t-80 . . . . . 0 C--O 1.243 0.755 0 CA-C-N 113.77 -1.559 . . . . 0.0 107.732 168.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 23.1 mmt . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.508 ' OG ' ' HB3' ' A' ' 22' ' ' GLU . 75.5 m -72.41 78.43 1.03 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.671 0.748 . . . . 0.0 112.733 -173.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 3' ' ' LEU . 1.4 tm? -113.36 99.48 7.81 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 166.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.478 ' HB2' ' HG2' ' A' ' 8' ' ' GLN . 15.2 pt-20 -65.54 -38.18 88.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.323 -168.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.82 -60.19 4.41 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.018 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.9 tp -106.97 146.61 13.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.437 ' HA ' ' OE1' ' A' ' 4' ' ' GLU . 12.8 tptp -68.22 99.87 0.96 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.995 0.426 . . . . 0.0 110.751 -176.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.478 ' HG2' ' HB2' ' A' ' 4' ' ' GLU . 4.6 pt20 -124.51 -4.35 7.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.554 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.439 HG12 ' OE1' ' A' ' 4' ' ' GLU . 25.1 pt -113.58 149.76 15.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.858 173.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -106.05 -172.66 2.13 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.064 0.459 . . . . 0.0 111.626 -172.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.511 ' O ' ' HB3' ' A' ' 12' ' ' GLN . 32.1 p90 -88.41 -165.63 1.38 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.393 173.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.511 ' HB3' ' O ' ' A' ' 11' ' ' PHE . 30.6 tt0 72.94 -63.73 0.42 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -175.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.596 ' HB3' HG21 ' A' ' 16' ' ' VAL . 34.4 m -80.44 90.68 5.65 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.421 173.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.0 mt -93.22 -65.3 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.215 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 14.2 m-80 -81.08 59.21 3.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.02 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.699 ' HB ' ' HE2' ' A' ' 63' ' ' TYR . 16.6 m -131.98 151.4 35.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.085 0.469 . . . . 0.0 111.774 -173.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.498 HG11 ' HB2' ' A' ' 23' ' ' ALA . 4.2 p -146.31 164.24 9.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.114 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -90.94 -54.26 4.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.985 0.422 . . . . 0.0 110.999 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.796 ' HA ' ' CE2' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -130.67 162.89 28.41 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.683 -170.384 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.674 HD22 ' CE2' ' A' ' 62' ' ' TYR . 2.0 mm? -65.36 -35.17 80.15 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.598 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 1.7 pm0 -67.09 -23.52 65.86 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.346 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.508 ' HB3' ' OG ' ' A' ' 2' ' ' SER . 21.7 mm-40 -87.51 -8.65 56.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.561 172.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.498 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -121.29 172.51 7.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.562 0.696 . . . . 0.0 112.133 -170.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.763 ' NZ ' ' HA ' ' A' ' 24' ' ' LYS . 2.3 tpmp? -140.21 160.39 40.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.522 176.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -87.87 179.3 6.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.985 0.422 . . . . 0.0 110.936 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.69 -29.94 10.17 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -174.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.616 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -117.95 134.18 23.32 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 172.657 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 1.048 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 75.2 Cg_exo -52.54 136.77 57.62 Favored 'Trans proline' 0 CA--C 1.517 -0.356 0 C-N-CA 123.092 2.528 . . . . 0.0 112.424 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.562 ' HB ' HD12 ' A' ' 89' ' ' LEU . 23.6 m -108.69 119.76 40.47 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.207 0.527 . . . . 0.0 111.199 -174.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.417 HD12 ' N ' ' A' ' 30' ' ' ILE . 4.1 mp -99.32 107.17 20.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.801 HG12 ' HB3' ' A' ' 62' ' ' TYR . 50.0 mt -95.74 111.91 27.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 120.731 0.301 . . . . 0.0 110.75 -177.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 25.2 ptm -118.42 136.65 53.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.157 0.503 . . . . 0.0 109.828 175.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.557 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 37.3 m-85 -91.18 132.3 36.17 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.502 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.627 ' HE2' ' HB3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -130.9 139.53 50.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.158 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.0 m -78.09 161.38 27.45 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.494 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 15.1 t70 -68.54 103.33 1.66 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.2 m 73.51 89.44 0.09 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.92 -175.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.9 p -148.06 127.16 6.28 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.567 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.22 -33.66 5.54 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.285 1.99 . . . . 0.0 114.084 -173.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -67.47 -25.17 65.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.806 0.336 . . . . 0.0 111.165 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.578 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 97.6 m -80.06 -35.98 36.27 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.053 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 65.0 t -64.8 -34.85 72.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.82 176.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -57.01 -45.97 82.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.281 175.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.6 ttt -69.11 -31.19 69.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.737 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.578 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 83.4 mt-30 -59.84 -40.12 87.42 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 110.117 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -56.16 -53.36 57.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.608 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 51' ' ' VAL . 57.2 mm-40 -56.99 -47.23 81.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.77 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.74 HD13 HD13 ' A' ' 61' ' ' ILE . 91.3 mt -58.62 -36.9 74.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.472 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.4 t -66.59 -37.58 85.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.99 0.424 . . . . 0.0 110.13 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.425 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 30.5 m-85 -70.34 -36.44 74.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.517 177.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 47' ' ' GLU . 22.4 t -67.95 -31.82 53.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 175.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.5 m -62.97 -32.92 74.35 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.025 174.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.479 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 27.2 mmtm -73.35 -15.79 61.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.138 0.494 . . . . 0.0 110.725 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -87.51 -40.08 14.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.687 173.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.667 ' HG3' ' HG3' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -133.09 75.39 1.62 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.617 -175.236 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 5.8 tp10 -82.44 134.46 35.23 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 120.905 0.383 . . . . 0.0 111.356 -171.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.57 41.22 95.44 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.255 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.667 ' HG3' ' HG3' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -123.08 -9.1 8.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.776 0.322 . . . . 0.0 110.856 -174.093 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.55 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 10.2 p90 -156.68 -176.84 6.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.6 -177.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 29' ' ' THR . 57.2 t30 -144.83 132.99 21.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.896 178.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.74 HD13 HD13 ' A' ' 48' ' ' LEU . 71.6 mt -105.38 114.24 44.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.565 -176.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.801 ' HB3' HG12 ' A' ' 31' ' ' ILE . 4.5 t80 -84.18 115.82 22.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.699 ' HE2' ' HB ' ' A' ' 16' ' ' VAL . 76.1 m-85 -93.38 110.82 22.36 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.054 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.666 ' HB2' ' HE1' ' A' ' 62' ' ' TYR . . . -86.39 102.72 14.29 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 121.255 -0.178 . . . . 0.0 110.793 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.627 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 8.7 ptm180 -78.01 114.48 16.92 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.876 176.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.4 tp -67.92 10.95 0.17 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.061 0.458 . . . . 0.0 110.836 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 65' ' ' ARG . 3.8 tp10 -84.34 -42.35 15.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.19 0.519 . . . . 0.0 110.424 -175.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.576 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 30.5 mm-40 -93.54 173.58 7.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.08 -172.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.413 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -86.22 -31.88 21.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.856 -176.253 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HD2' ' H ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -60.15 -33.15 71.78 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.241 0.543 . . . . 0.0 110.371 178.521 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.576 ' OD1' ' HB2' ' A' ' 68' ' ' GLU . 5.0 m120 -80.19 -17.35 52.63 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.416 -178.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 69' ' ' GLU . 75.1 mt -70.88 -42.76 77.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -59.86 -48.95 79.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.626 173.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.435 ' HG ' ' OH ' ' A' ' 62' ' ' TYR . 1.2 tm? -55.77 -47.34 77.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.315 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.557 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -53.9 -52.15 61.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.854 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -73.27 -34.84 66.01 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.527 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.432 ' HB2' ' HE3' ' A' ' 77' ' ' LYS . 27.1 ttmt -63.49 -32.86 74.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.241 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -102.73 -0.53 31.47 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.669 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.1 t70 67.64 40.65 2.47 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.704 0.764 . . . . 0.0 111.095 174.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.48 102.84 4.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.946 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -107.26 -31.95 8.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.351 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.808 HD13 ' H ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -85.05 159.06 3.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.798 0.332 . . . . 0.0 110.947 -178.65 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.1 m -119.42 145.27 38.37 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.719 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -95.25 118.25 2.03 Favored 'Cis proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.637 -1.401 . . . . 0.0 112.517 -1.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.654 HG22 ' HB3' ' A' ' 100' ' ' GLN . 1.2 p -97.9 143.46 28.47 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 173.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.1 m -135.49 121.05 19.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.179 0.514 . . . . 0.0 111.151 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.686 HG12 HG12 ' A' ' 98' ' ' VAL . 20.3 m -112.6 126.65 70.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.003 176.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.562 ' HB3' HD22 ' A' ' 115' ' ' LEU . 94.8 m-85 -98.48 118.61 35.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.829 -174.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.562 HD12 ' HB ' ' A' ' 29' ' ' THR . 10.4 mt -107.57 139.61 41.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.037 -177.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.435 ' OD2' ' HG2' ' A' ' 92' ' ' GLU . 25.0 t70 -63.51 171.48 2.53 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 171.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.585 ' HG3' ' HG2' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -62.36 -16.45 54.64 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 122.015 -0.428 . . . . 0.0 111.84 -176.261 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.435 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 16.9 mm-40 -72.94 -23.69 60.71 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.954 0.407 . . . . 0.0 110.753 175.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.74 17.53 35.41 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -170.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -90.15 126.24 35.73 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -72.34 112.87 8.79 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.174 0.296 . . . . 0.0 110.511 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -100.67 -54.58 2.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.746 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 87.6 t80 -124.84 141.84 51.85 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.195 -175.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.686 HG12 HG12 ' A' ' 87' ' ' VAL . 30.0 m -121.65 139.64 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.553 176.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.576 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 8.2 t60 -151.17 139.86 20.72 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.654 ' HB3' HG22 ' A' ' 85' ' ' THR . 9.1 pt20 -130.04 139.52 50.99 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.014 0.435 . . . . 0.0 110.804 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.48 -172.35 18.16 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.6 tp -93.66 130.17 39.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.908 0.354 . . . . 0.0 110.162 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 71.8 mtm -127.08 165.38 19.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.192 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.466 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 37.3 mmt180 -114.34 175.51 5.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.741 178.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.567 ' O ' ' HG3' ' A' ' 109' ' ' GLU . 58.0 tttm -45.78 -59.36 2.83 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.106 0.962 . . . . 0.0 112.835 -175.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.549 ' HA ' ' OE1' ' A' ' 109' ' ' GLU . 29.0 t-20 -64.66 -28.88 69.91 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -174.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.502 ' O ' HG12 ' A' ' 111' ' ' ILE . 10.7 m120 -65.4 -45.34 84.35 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.55 HD13 HD23 ' A' ' 48' ' ' LEU . 50.3 mt -64.97 -42.52 94.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.933 176.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 105' ' ' LYS . 81.0 mt-10 -51.91 -48.96 63.94 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.887 176.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.0 m -64.39 -42.24 96.23 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.778 -177.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 107' ' ' ASN . 48.7 mm -67.37 -47.81 79.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.184 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.551 ' HB3' HG21 ' A' ' 117' ' ' VAL . 81.0 mt -65.32 -34.45 78.37 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 110.806 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -60.41 -37.99 82.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.412 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.7 m -85.15 -35.93 21.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.165 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.562 HD22 ' HB3' ' A' ' 88' ' ' PHE . 34.7 tp -57.13 -72.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.102 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -176.66 -80.75 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.767 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.048 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 22.9 t 53.04 71.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 121.662 0.744 . . . . 0.0 109.537 -175.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -165.36 146.7 7.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.373 -168.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.585 ' HG2' ' HG3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -174.44 168.13 3.89 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 166.59 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.82 -8.45 49.83 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.866 -176.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -80.05 78.6 6.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.17 0.51 . . . . 0.0 109.881 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -136.99 128.89 29.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.767 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -77.99 88.49 4.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.615 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 36.4 m80 61.31 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 O-C-N 123.762 0.664 . . . . 0.0 110.593 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -161.5 16.54 0.1 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 . . . . . 0 C--O 1.25 1.104 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.174 -176.144 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.4 ttp . . . . . 0 N--CA 1.478 0.954 0 CA-C-O 120.989 0.423 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 m -75.14 -30.72 60.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.369 -174.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 3' ' ' LEU . 3.4 mm? -116.33 136.78 52.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.85 0.357 . . . . 0.0 111.124 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.634 ' OE1' ' HB2' ' A' ' 7' ' ' LYS . 65.5 mt-10 -118.51 -172.72 2.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.997 177.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -119.32 15.13 10.85 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 172.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.402 HG13 ' H ' ' A' ' 7' ' ' LYS . 10.8 pt -135.74 -55.26 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.634 ' HB2' ' OE1' ' A' ' 4' ' ' GLU . 9.4 mtmp? -110.41 -62.5 1.51 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.201 -0.312 . . . . 0.0 111.105 -174.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.447 ' HB2' ' HG3' ' A' ' 4' ' ' GLU . 28.7 mt-30 -74.74 77.1 2.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.241 0.543 . . . . 0.0 111.825 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.445 HD12 ' HB3' ' A' ' 13' ' ' SER . 3.0 pt -135.49 -36.97 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.246 171.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.8 m120 66.9 -139.91 0.14 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.072 171.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -58.21 155.9 10.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.07 -0.513 . . . . 0.0 112.149 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 70.85 -2.93 2.13 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.098 -175.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.658 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . 22.7 m -140.8 -86.99 0.18 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.0 mt 69.52 -78.24 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 123.047 0.539 . . . . 0.0 111.042 -171.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -113.98 16.56 18.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.524 0.678 . . . . 0.0 109.265 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.658 ' CG2' ' HA ' ' A' ' 13' ' ' SER . 51.5 t -76.27 125.32 35.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.433 175.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.519 HG22 ' HB2' ' A' ' 22' ' ' GLU . 4.6 p -111.52 134.9 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-O 121.592 0.711 . . . . 0.0 110.374 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -61.47 -54.45 43.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.543 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.539 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -131.69 158.83 40.08 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.369 -177.009 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.65 -29.75 69.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.798 0.332 . . . . 0.0 110.585 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.5 pm0 -73.38 -23.51 60.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.405 177.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.519 ' HB2' HG22 ' A' ' 17' ' ' VAL . 29.3 mm-40 -67.01 -18.96 65.62 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.008 0.432 . . . . 0.0 110.492 173.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.515 ' HB1' HD11 ' A' ' 27' ' ' ILE . . . -91.71 113.59 25.9 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -122.38 -6.47 8.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.705 0.764 . . . . 0.0 112.165 -173.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.532 ' HB2' HD12 ' A' ' 27' ' ' ILE . 3.8 mp0 -76.05 170.94 15.31 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.383 178.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.48 55.32 4.99 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.385 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.625 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -114.65 143.41 29.93 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.792 0.33 . . . . 0.0 111.357 -173.277 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 1.003 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 60.5 Cg_exo -56.65 151.36 47.49 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.696 2.264 . . . . 0.0 111.649 170.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.0 m -112.7 111.21 21.84 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.787 -175.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.6 mm -102.99 124.76 57.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.757 HG12 ' HB3' ' A' ' 62' ' ' TYR . 54.3 mt -125.04 115.46 44.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.069 -173.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.456 ' SD ' ' NZ ' ' A' ' 34' ' ' LYS . 2.1 tmt? -112.07 124.36 52.24 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.619 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 53.8 m-85 -87.38 144.57 26.7 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.899 -175.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.936 ' HE3' ' HB3' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -149.44 171.24 16.89 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -178.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.0 t -122.69 -174.44 2.92 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.02 -62.88 1.53 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.229 0.537 . . . . 0.0 110.569 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.2 m -93.76 90.92 6.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.075 -176.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.484 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 20.1 p -158.88 121.15 1.94 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.91 0.386 . . . . 0.0 111.388 175.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 2.9 Cg_exo -75.34 -16.48 19.45 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.53 2.153 . . . . 0.0 112.429 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -64.44 -26.12 68.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.009 0.433 . . . . 0.0 110.637 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.653 ' SG ' ' HD3' ' A' ' 34' ' ' LYS . 53.4 t -67.42 -44.41 78.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.679 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.518 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 7.6 p -74.76 -30.35 24.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.779 0.323 . . . . 0.0 110.756 -176.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -69.7 -49.0 57.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.813 0.339 . . . . 0.0 110.323 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.423 ' HG3' ' OE1' ' A' ' 47' ' ' GLU . 3.5 ttt -69.43 -28.45 66.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.991 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -53.32 -45.02 68.86 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.223 171.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 81.9 mttt -58.12 -53.81 54.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.964 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.432 ' O ' HG23 ' A' ' 51' ' ' VAL . 52.7 mt-10 -57.43 -50.65 72.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.919 -178.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 48.6 mt -61.39 -42.95 99.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.638 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 13.9 t -66.81 -32.94 74.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.369 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.44 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 16.6 m-85 -66.9 -43.08 84.31 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.774 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 47' ' ' GLU . 51.0 t -60.3 -52.22 63.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-O 121.223 0.535 . . . . 0.0 110.016 176.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.8 m -59.4 -29.35 67.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.552 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.457 ' HZ3' ' HB2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -67.51 -16.91 64.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.518 -179.353 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -120.44 8.94 10.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.286 0.565 . . . . 0.0 109.791 177.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.713 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 8.0 ttm-85 -151.38 76.9 1.23 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.356 -175.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -82.32 124.77 30.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.83 -169.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.11 25.92 54.89 Favored Glycine 0 CA--C 1.518 0.249 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.333 176.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.713 ' HB2' ' HG2' ' A' ' 55' ' ' ARG . 55.7 mmtt -96.2 -5.68 39.92 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.719 0.771 . . . . 0.0 108.927 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.554 ' HB3' HG13 ' A' ' 117' ' ' VAL . 28.7 p90 -170.79 136.49 1.18 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.042 175.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -95.05 131.33 41.15 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.7 mt -89.64 107.7 18.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.096 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.757 ' HB3' HG12 ' A' ' 31' ' ' ILE . 3.8 t80 -88.43 112.62 23.14 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.936 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 50.3 m-85 -91.73 102.9 15.52 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.589 178.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.92 93.59 4.43 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.975 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.646 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 11.0 ptt180 -89.3 118.25 28.85 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.27 0.557 . . . . 0.0 111.272 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.485 HD22 HD13 ' A' ' 72' ' ' ILE . 53.4 mt -72.77 11.51 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.02 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.528 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 23.9 tt0 -66.4 -33.64 76.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.871 174.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -106.85 177.2 4.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.351 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.53 -27.0 22.88 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.1 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.572 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -57.6 -33.5 68.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.423 -176.296 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.572 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 68.6 m-80 -90.23 2.39 55.47 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.983 -174.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.485 HD13 HD22 ' A' ' 66' ' ' LEU . 49.7 mm -71.17 -54.44 17.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 172.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -65.23 -41.87 93.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.253 175.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.477 ' HB3' ' HA ' ' A' ' 71' ' ' ASN . 1.3 tm? -57.37 -42.61 82.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.101 177.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.619 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -53.17 -53.16 54.64 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.462 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -67.3 -34.3 77.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.771 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -62.76 -21.44 65.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.063 0.458 . . . . 0.0 111.588 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.508 ' CD2' HG11 ' A' ' 87' ' ' VAL . 52.3 m-85 -119.73 19.32 12.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.643 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 65.13 17.02 10.88 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.801 0.688 . . . . 0.0 111.37 168.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.458 ' O ' ' HB1' ' A' ' 75' ' ' ALA . . . -123.91 102.17 7.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.079 0.466 . . . . 0.0 111.605 -171.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -113.61 9.21 17.85 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.207 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.9 pt -125.23 171.36 14.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.875 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.57 136.99 19.39 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.229 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -87.26 150.61 38.32 Favored 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 123.65 -1.396 . . . . 0.0 112.667 -0.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 15.1 m -150.26 124.6 9.53 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 88.3 m -122.15 122.89 40.26 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.314 0.578 . . . . 0.0 110.936 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.62 HG23 ' HB ' ' A' ' 98' ' ' VAL . 11.2 p -100.16 132.32 45.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.635 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 1.02 ' HB3' HD11 ' A' ' 115' ' ' LEU . 86.2 m-85 -106.04 108.8 20.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.799 -175.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.49 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 5.5 mp -111.97 138.82 48.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.786 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -80.65 -176.75 5.94 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.601 ' HE2' ' HE2' ' A' ' 118' ' ' LYS . 0.5 OUTLIER -60.57 -22.22 63.45 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -172.494 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 -75.85 -12.54 60.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.72 0.295 . . . . 0.0 111.295 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.443 ' O ' HD23 ' A' ' 89' ' ' LEU . . . 85.42 21.06 55.51 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.784 -176.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 92.0 m-20 -92.27 125.36 36.9 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.971 -0.134 . . . . 0.0 110.703 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.49 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 54.2 mtmt -70.5 93.84 0.93 Allowed 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.453 ' HB3' ' CD2' ' A' ' 115' ' ' LEU . 87.6 t80 -83.58 -39.4 20.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.817 0.342 . . . . 0.0 110.338 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.597 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 71.2 t80 -154.04 127.07 8.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.716 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.62 ' HB ' HG23 ' A' ' 87' ' ' VAL . 7.6 p -114.3 133.42 60.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.597 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 49.5 t60 -139.31 137.76 36.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -172.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -110.41 158.18 18.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.825 0.345 . . . . 0.0 111.075 178.485 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.1 -173.85 20.15 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.028 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.6 tp -104.17 149.59 25.12 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 16.8 ptm -164.8 125.62 2.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.724 -0.216 . . . . 0.0 110.441 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -58.04 163.77 2.63 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.625 -173.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.44 ' HD2' ' HB3' ' A' ' 50' ' ' TYR . 13.6 ptmm? -50.59 -44.43 56.88 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.237 -174.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.404 ' N ' ' HG3' ' A' ' 105' ' ' LYS . 18.8 m120 -63.48 -34.24 77.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.383 0.611 . . . . 0.0 110.932 -176.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -74.11 -40.18 62.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.394 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.496 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 73.8 mt -59.32 -46.27 92.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.246 171.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -58.05 -35.56 71.51 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.004 178.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.5 m -63.92 -41.46 97.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.001 0.429 . . . . 0.0 110.434 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.9 mm -70.89 -41.91 77.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.179 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.565 ' HB3' HG21 ' A' ' 117' ' ' VAL . 85.8 mt -57.53 -41.97 81.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.446 176.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -59.53 -37.11 77.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.803 176.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.1 m -70.37 -24.89 63.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.101 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 1.02 HD11 ' HB3' ' A' ' 88' ' ' PHE . 27.1 mt -81.28 -73.62 0.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 122.095 0.95 . . . . 0.0 109.788 175.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 162.87 -63.47 0.26 Allowed Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -175.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.003 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 48.8 t 52.85 73.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.579 0.704 . . . . 0.0 111.782 172.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.601 ' HE2' ' HE2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -173.93 154.18 2.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.609 -178.487 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.95 -45.84 6.77 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -123.56 179.16 16.22 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.462 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -78.34 81.8 4.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.998 0.399 . . . . 0.0 110.711 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.0 t60 39.5 85.34 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 O-C-N 124.467 1.105 . . . . 0.0 112.893 169.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -119.1 85.78 2.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.598 0.713 . . . . 0.0 112.293 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -150.9 13.36 0.7 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.374 -1.284 . . . . 0.0 108.599 172.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -110.44 150.43 28.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.171 -176.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 . . . . . 0 C--O 1.245 0.821 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.022 -179.341 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 m 57.8 45.63 18.33 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.713 0.633 . . . . 0.0 112.133 173.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 pp -106.46 165.5 11.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.796 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -80.65 -90.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.501 ' H ' ' HB2' ' A' ' 10' ' ' ASN . . . 84.31 -10.81 60.2 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.575 ' O ' ' HB3' ' A' ' 7' ' ' LYS . 19.5 pt -154.05 152.21 10.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.575 ' HB3' ' O ' ' A' ' 6' ' ' ILE . 29.5 tttm 72.6 -46.21 0.64 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.653 0.596 . . . . 0.0 109.926 -174.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -135.99 138.81 42.64 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 170.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 9.6 tp -67.42 134.66 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.253 0.549 . . . . 0.0 111.599 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.501 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 0.6 OUTLIER -141.48 161.11 38.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.001 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.6 p90 57.92 -17.74 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.577 1.551 . . . . 0.0 114.889 174.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 13' ' ' SER . 16.2 mm100 -78.84 95.67 5.45 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 171.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' A' ' 49' ' ' SER . 49.0 m 78.57 134.45 0.06 Allowed 'General case' 0 C--O 1.228 -0.074 0 O-C-N 124.506 1.129 . . . . 0.0 110.45 -172.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.7 mt -80.85 -20.63 11.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.531 0.681 . . . . 0.0 109.941 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 47.2 m-80 -94.0 25.06 3.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.606 176.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.412 HG23 ' HE2' ' A' ' 63' ' ' TYR . 7.5 p -63.87 138.96 22.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.641 -173.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.474 HG21 ' HB3' ' A' ' 60' ' ' ASN . 76.0 t -137.93 123.65 25.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.798 175.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -76.13 -55.52 5.51 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.603 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.783 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 59.0 t30 -140.18 -179.38 5.95 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.579 HD11 HD11 ' A' ' 74' ' ' LEU . 83.7 mt -50.39 -32.6 17.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.419 ' CD ' ' HB3' ' A' ' 19' ' ' ASN . 6.7 pm0 -63.41 -39.64 95.04 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.674 0.249 . . . . 0.0 111.674 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.408 ' OE1' ' HG2' ' A' ' 21' ' ' GLU . 55.7 mp0 -81.52 4.51 21.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.808 175.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.36 171.04 10.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.941 0.4 . . . . 0.0 111.957 -175.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.507 ' HE2' ' OD1' ' A' ' 60' ' ' ASN . 23.1 mtmm -148.57 173.25 13.36 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -120.51 -179.56 4.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.677 0.275 . . . . 0.0 111.378 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.09 -47.74 2.68 Favored Glycine 0 C--N 1.332 0.355 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.044 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.765 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -100.19 146.66 32.33 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 175.552 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 1.06 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 84.2 Cg_exo -51.02 158.66 3.04 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.197 2.598 . . . . 0.0 112.436 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.489 HG23 ' HB2' ' A' ' 60' ' ' ASN . 41.7 m -131.44 126.15 34.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.244 0.545 . . . . 0.0 111.43 -175.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.541 HD11 HD21 ' A' ' 112' ' ' LEU . 63.5 mt -98.76 111.52 28.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.495 176.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.614 ' HB ' ' HB ' ' A' ' 87' ' ' VAL . 6.0 mm -91.01 107.81 19.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.417 ' HA ' ' O ' ' A' ' 85' ' ' THR . 21.0 ttt -111.71 107.74 16.94 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.311 0.576 . . . . 0.0 110.647 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.681 ' CE1' ' HA ' ' A' ' 75' ' ' ALA . 87.0 m-85 -72.64 133.12 44.5 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.179 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 1.072 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 60.1 pttt -133.84 179.88 5.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.147 -176.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -137.39 -174.56 3.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.469 0.176 . . . . 0.0 110.589 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -77.33 -17.94 57.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.507 0.67 . . . . 0.0 110.548 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.4 m -143.64 101.97 3.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.873 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 2.2 p -160.13 101.68 1.41 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.986 0.422 . . . . 0.0 112.021 -176.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.8 -32.99 13.33 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.07 1.846 . . . . 0.0 112.655 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -70.51 -23.12 62.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.964 0.411 . . . . 0.0 110.749 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 79.7 m -79.15 -43.62 23.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.956 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.444 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 12.0 p -65.5 -31.03 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.484 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.749 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 8.5 tp10 -58.38 -50.04 75.08 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.347 0.594 . . . . 0.0 110.283 175.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 21.0 ttt -73.62 -29.3 62.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.86 -177.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.556 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 54.8 mt-30 -62.56 -33.75 75.58 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.692 0.282 . . . . 0.0 110.65 175.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.749 ' HE2' ' HA ' ' A' ' 43' ' ' GLU . 47.3 mtmt -65.29 -47.05 77.99 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.642 ' O ' HG23 ' A' ' 51' ' ' VAL . 62.5 mm-40 -56.04 -52.21 65.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.849 177.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.5 ' HB3' HD13 ' A' ' 61' ' ' ILE . 90.0 mt -56.9 -33.58 67.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.171 178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 8.7 t -65.83 -43.56 88.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.023 0.44 . . . . 0.0 109.854 177.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -68.03 -34.27 76.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.706 178.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.745 HG22 ' HG3' ' A' ' 105' ' ' LYS . 34.4 t -65.35 -39.54 85.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 175.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.7 m -61.77 -30.57 70.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.691 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -59.3 -43.09 92.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.049 0.452 . . . . 0.0 110.132 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -82.22 -50.5 8.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.757 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.435 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -99.11 74.06 1.95 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.281 0.562 . . . . 0.0 109.761 -175.257 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.67 119.06 25.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.255 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.55 47.09 36.27 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.23 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.454 ' HD3' ' HA ' ' A' ' 58' ' ' LYS . 36.5 mmtm -132.64 -7.43 3.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.657 0.265 . . . . 0.0 111.31 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.495 ' O ' ' HB3' ' A' ' 15' ' ' ASN . 0.9 OUTLIER -163.92 155.55 16.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.667 177.141 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.507 ' OD1' ' HE2' ' A' ' 24' ' ' LYS . 36.9 m-80 -96.39 132.36 42.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 171.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.5 HD13 ' HB3' ' A' ' 48' ' ' LEU . 71.2 mt -107.16 105.32 18.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.533 173.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.783 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 1.1 t80 -101.17 111.75 24.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.133 0.492 . . . . 0.0 110.025 -177.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.626 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 73.1 m-85 -90.77 102.58 15.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.978 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.501 ' HB1' ' HB3' ' A' ' 71' ' ' ASN . . . -85.29 97.0 9.7 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 121.184 -0.206 . . . . 0.0 110.801 -177.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 1.072 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 32.8 ptt180 -76.7 114.86 15.92 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.831 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.5 mp -63.7 11.71 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.141 0.496 . . . . 0.0 111.742 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.578 ' H ' ' C ' ' A' ' 65' ' ' ARG . 62.3 tt0 -77.26 -31.41 54.91 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.185 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -112.77 148.14 35.42 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.749 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -65.65 -20.86 66.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.914 -172.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.589 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -63.45 -33.45 75.59 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.214 0.531 . . . . 0.0 110.485 -178.078 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.589 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 4.1 m120 -85.99 -17.65 34.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.571 -173.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.3 mt -69.85 -42.85 80.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -65.08 -40.64 94.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.168 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.579 HD11 HD11 ' A' ' 20' ' ' LEU . 2.3 mm? -62.71 -38.86 92.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.896 175.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.681 ' HA ' ' CE1' ' A' ' 33' ' ' PHE . . . -54.41 -52.37 61.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.439 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -64.95 -33.39 75.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.478 -178.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 mtmm -64.96 -16.27 63.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.964 0.412 . . . . 0.0 111.176 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.672 ' HB3' HG21 ' A' ' 87' ' ' VAL . 60.6 m-85 -119.66 15.48 12.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.664 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 65.57 21.99 11.74 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.666 0.604 . . . . 0.0 110.845 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.41 163.2 14.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.954 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -158.45 -36.97 0.07 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.948 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.1 pt -117.95 -176.14 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.985 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.74 147.08 55.58 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.186 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.65 155.42 80.6 Favored 'Cis proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.648 -1.397 . . . . 0.0 111.802 -0.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.586 HG23 ' HG3' ' A' ' 100' ' ' GLN . 88.3 m -144.12 110.19 5.39 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.8 p -102.12 113.69 27.17 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.082 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.672 HG21 ' HB3' ' A' ' 78' ' ' TYR . 85.1 t -100.65 109.88 26.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.319 176.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -89.67 105.86 18.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.139 0.495 . . . . 0.0 110.492 -178.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 95' ' ' LYS . 46.8 mt -99.13 148.89 23.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.132 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.402 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 7.3 t70 -83.6 -166.01 1.27 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -59.92 -32.45 70.78 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -170.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -105.81 10.72 32.52 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.01 0.433 . . . . 0.0 110.773 -173.886 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.64 20.15 45.38 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.163 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 5.8 m-20 -68.32 116.93 9.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.012 0.406 . . . . 0.0 110.433 176.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.546 ' HA ' HD23 ' A' ' 89' ' ' LEU . 39.7 ttmt -74.1 89.09 1.95 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.601 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -89.27 -47.18 8.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.246 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.52 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 77.9 t80 -144.54 111.26 5.72 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.747 -177.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.449 HG23 HG22 ' A' ' 87' ' ' VAL . 2.2 p -103.18 134.46 44.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 172.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.52 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 17.3 t60 -138.24 126.64 23.21 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -175.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.586 ' HG3' HG23 ' A' ' 85' ' ' THR . 24.1 mp0 -96.63 140.09 31.75 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 123.611 0.569 . . . . 0.0 109.733 174.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.98 162.68 18.01 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.515 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.2 tp -73.95 141.04 45.95 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 122.522 0.329 . . . . 0.0 111.429 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 60.0 mtm -135.63 159.47 41.52 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 171.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -97.14 164.51 12.47 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.745 ' HG3' HG22 ' A' ' 51' ' ' VAL . 61.0 tttm -46.92 -52.37 14.69 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -175.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 25.7 t-20 -58.45 -32.82 69.08 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -177.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.541 ' O ' HG12 ' A' ' 111' ' ' ILE . 10.8 m120 -65.04 -46.35 81.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.441 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 41.5 mt -61.9 -43.93 98.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.836 176.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 105' ' ' LYS . 79.3 mm-40 -49.58 -47.21 49.56 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.015 176.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 m -72.11 -39.47 68.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.087 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 107' ' ' ASN . 48.5 mm -65.1 -44.54 95.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.875 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.718 ' HB3' HG21 ' A' ' 117' ' ' VAL . 82.8 mt -63.52 -38.73 92.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.068 0.461 . . . . 0.0 110.279 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -58.23 -41.15 83.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.892 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.9 m -85.13 -8.38 58.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.712 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 tp -85.01 -86.62 0.13 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.016 0.436 . . . . 0.0 109.842 176.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -179.03 -60.44 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.06 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 40.8 t 57.51 64.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 122.028 0.918 . . . . 0.0 110.756 177.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 119' ' ' GLU . 7.5 ptmt -164.14 162.02 22.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.114 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.411 ' O ' ' HE3' ' A' ' 118' ' ' LYS . 4.1 tm-20 -93.36 145.85 24.17 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 173.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.601 ' O ' ' HB2' ' A' ' 121' ' ' HIS . . . -50.75 -70.01 0.96 Allowed Glycine 0 C--N 1.331 0.301 0 O-C-N 123.372 0.42 . . . . 0.0 112.983 -174.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.601 ' HB2' ' O ' ' A' ' 120' ' ' GLY . 19.2 t-80 163.54 76.37 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.805 0.842 . . . . 0.0 109.24 175.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -57.27 138.33 54.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.092 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 42.9 t60 71.79 90.99 0.09 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.636 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 64.84 104.42 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.451 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -67.98 -42.05 81.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.048 0.451 . . . . 0.0 110.2 178.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 . . . . . 0 C--O 1.245 0.851 0 CA-C-O 118.373 -0.823 . . . . 0.0 109.179 178.423 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.483 1.219 0 CA-C-O 120.545 0.212 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.1 m -104.76 108.14 19.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.839 0.352 . . . . 0.0 110.812 -176.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 3' ' ' LEU . 2.2 mp -111.77 -29.96 7.49 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 8' ' ' GLN . 10.6 mp0 -90.34 33.55 0.89 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.887 -176.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 81.44 -72.41 2.76 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.39 -174.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.575 HG13 ' HG2' ' A' ' 7' ' ' LYS . 8.4 tp -176.42 128.09 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.703 0.287 . . . . 0.0 110.58 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.823 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 10.6 mmpt? 63.76 16.88 10.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.704 176.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.484 ' HA ' ' HB2' ' A' ' 4' ' ' GLU . 79.5 mt-30 56.11 95.55 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.72 0.637 . . . . 0.0 111.969 -177.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 tt -115.37 103.8 15.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.202 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 40.5 t30 71.37 118.08 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.509 0.671 . . . . 0.0 112.534 172.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -100.0 -10.36 21.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.637 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -72.37 -47.26 50.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.948 0.404 . . . . 0.0 110.72 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.7 m -92.91 108.29 19.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.174 0.511 . . . . 0.0 109.71 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.554 HG22 ' HB3' ' A' ' 52' ' ' SER . 1.1 tt -74.53 -8.42 11.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.484 -172.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -111.76 37.35 2.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.544 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.496 HG23 ' CD1' ' A' ' 63' ' ' TYR . 8.0 p -82.72 140.54 16.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.684 -176.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.409 HG21 HD21 ' A' ' 60' ' ' ASN . 3.8 p -139.6 159.92 27.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.485 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 19' ' ' ASN . 5.1 tp10 -83.53 -55.89 4.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.207 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.649 ' HA ' ' CE2' ' A' ' 62' ' ' TYR . 5.9 t-20 -142.59 169.07 18.26 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.543 -169.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.77 -32.35 73.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.355 176.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -63.34 -24.39 67.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.72 0.771 . . . . 0.0 109.943 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -97.65 10.28 40.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.645 -177.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -109.58 145.45 36.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.186 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -97.38 154.09 17.68 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 174.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.47 177.34 3.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.661 177.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . 89.53 -55.13 3.84 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.535 174.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 24.9 pt -84.51 134.83 41.78 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.913 0.387 . . . . 0.0 110.495 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 1.0 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 48.2 Cg_exo -59.14 144.49 99.36 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.783 2.322 . . . . 0.0 111.338 176.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.461 ' HB ' HD12 ' A' ' 89' ' ' LEU . 25.1 m -110.55 122.13 47.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.151 0.5 . . . . 0.0 111.185 -175.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.6 mt -104.39 108.67 25.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.745 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.682 ' HB ' HG23 ' A' ' 87' ' ' VAL . 5.4 mp -97.62 128.42 48.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.494 ' HB3' HG22 ' A' ' 86' ' ' THR . 26.2 ptm -121.45 122.74 40.43 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.472 0.653 . . . . 0.0 110.353 178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.563 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 93.7 m-85 -90.6 122.47 33.43 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.309 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.64 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 14.2 pttp -128.75 133.77 48.22 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.226 -174.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.488 ' HA ' ' HB2' ' A' ' 66' ' ' LEU . 17.8 p -75.1 178.17 5.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.561 0.22 . . . . 0.0 110.68 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.98 -58.94 6.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.053 0.454 . . . . 0.0 109.935 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.9 m -102.71 101.22 11.31 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.685 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 34' ' ' LYS . 4.0 p -136.03 104.21 9.72 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 120.996 0.426 . . . . 0.0 112.016 -177.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 38' ' ' CYS . 54.0 Cg_endo -71.62 -29.56 15.91 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.988 1.792 . . . . 0.0 111.889 176.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -63.31 -30.2 71.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.723 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.634 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 52.8 t -66.27 -51.11 60.74 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.113 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.7 t -57.11 -43.25 81.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.893 0.378 . . . . 0.0 110.912 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.605 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 7.6 tp10 -58.24 -49.03 78.55 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.932 177.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.4 ttt -72.16 -29.34 63.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.967 -177.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.634 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 99.0 mt-30 -57.89 -39.01 76.82 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 110.035 174.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.605 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 42.8 mtpt -60.03 -53.12 61.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.192 176.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.526 ' O ' HG23 ' A' ' 51' ' ' VAL . 63.6 mm-40 -58.7 -45.11 90.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.869 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.92 -33.15 73.72 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.953 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.3 t -64.95 -43.08 93.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.201 0.524 . . . . 0.0 109.682 176.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -66.47 -22.55 66.2 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.229 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.728 HG22 ' HG3' ' A' ' 105' ' ' LYS . 40.5 t -86.47 -41.97 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.005 0.431 . . . . 0.0 110.645 177.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.554 ' HB3' HG22 ' A' ' 14' ' ' ILE . 57.0 m -58.8 -30.83 67.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.341 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . 36.0 ttpt -51.59 -53.18 41.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.423 -178.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -105.9 15.99 25.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.707 0.289 . . . . 0.0 111.713 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 55' ' ' ARG . 12.8 ttm180 -138.68 75.91 1.54 Allowed 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.059 0.933 . . . . 0.0 109.633 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.709 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 1.5 tm-20 -71.39 132.0 44.18 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 113.87 -1.514 . . . . 0.0 110.07 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 41.47 46.86 4.63 Favored Glycine 0 C--N 1.333 0.408 0 O-C-N 124.016 0.822 . . . . 0.0 114.734 169.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.709 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 35.6 mmtm -120.14 -1.45 10.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.642 0.734 . . . . 0.0 109.434 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -158.46 150.61 21.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.453 -1.249 . . . . 0.0 108.723 172.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.409 HD21 HG21 ' A' ' 17' ' ' VAL . 62.4 t30 -114.27 124.75 52.79 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 178.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.4 mt -98.61 110.32 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.228 0.537 . . . . 0.0 111.564 -174.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.649 ' CE2' ' HA ' ' A' ' 19' ' ' ASN . 1.3 t80 -85.42 114.75 22.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.14 177.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.496 ' CD1' HG23 ' A' ' 16' ' ' VAL . 12.7 m-85 -89.94 103.26 15.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.223 0.535 . . . . 0.0 110.518 176.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.563 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -88.86 81.63 6.9 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.17 -179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.64 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 20.3 ptt180 -71.73 108.24 4.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.569 177.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 35' ' ' THR . 9.1 mp -65.87 10.5 0.1 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.185 0.517 . . . . 0.0 111.851 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' A' ' 65' ' ' ARG . 30.5 tt0 -64.23 -31.3 72.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.342 172.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -96.87 170.09 9.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.331 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -94.29 -11.96 29.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.339 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -67.28 -11.01 56.42 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.868 0.842 . . . . 0.0 110.826 177.217 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -89.89 -5.99 56.23 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.051 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.9 mt -69.19 -56.34 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -70.73 -38.13 73.55 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.724 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -57.42 -42.22 81.91 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.74 177.107 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.489 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -63.36 -56.57 15.31 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.722 -177.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -65.4 -32.21 73.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.633 -175.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 14.1 tmtt? -61.95 -18.58 60.84 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.971 0.415 . . . . 0.0 110.595 177.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.721 ' HB3' HG11 ' A' ' 87' ' ' VAL . 58.9 m-85 -127.4 25.48 6.11 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 66.0 15.29 10.01 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.323 0.582 . . . . 0.0 111.527 171.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.67 142.71 31.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.641 -174.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -146.16 -34.16 0.31 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.718 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.1 pt -125.59 -177.72 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.039 0.447 . . . . 0.0 111.3 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 84' ' ' PRO . 4.2 p -118.87 137.47 25.03 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.306 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 51.9 Cg_endo -96.65 126.33 2.92 Favored 'Cis proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.86 -1.308 . . . . 0.0 113.223 -0.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.2 m -100.39 116.99 33.66 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 171.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 2.3 p -115.5 115.23 26.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.999 0.428 . . . . 0.0 111.146 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.721 HG11 ' HB3' ' A' ' 78' ' ' TYR . 2.0 m -100.54 124.47 54.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.482 0.658 . . . . 0.0 110.219 176.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.572 ' HB3' HD22 ' A' ' 115' ' ' LEU . 73.3 m-85 -98.18 106.31 18.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.083 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.461 HD12 ' HB ' ' A' ' 29' ' ' THR . 44.0 mt -88.19 132.18 34.45 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 174.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.06 171.6 3.51 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 173.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 6.2 pttm -52.86 -25.23 10.96 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.447 0.699 . . . . 0.0 112.455 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.413 ' OE2' ' HG3' ' A' ' 91' ' ' LYS . 0.7 OUTLIER -83.21 -9.6 59.06 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.306 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.85 10.05 61.87 Favored Glycine 0 CA--C 1.517 0.207 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.728 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 2.5 p-10 -85.78 144.4 27.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.756 -0.261 . . . . 0.0 110.708 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.417 ' HA ' HD23 ' A' ' 89' ' ' LEU . 10.4 ttmt -81.21 92.41 6.32 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -85.48 -45.12 12.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.062 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.507 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 89.1 t80 -137.3 148.12 46.13 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.194 -176.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.701 ' HB ' HG12 ' A' ' 87' ' ' VAL . 2.2 p -134.76 135.36 53.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.649 173.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.507 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 50.4 t60 -122.42 119.5 31.2 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -109.47 105.67 15.11 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 133.22 179.95 16.8 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -174.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.477 HD21 ' HG2' ' A' ' 43' ' ' GLU . 33.2 tp -87.5 164.9 15.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.715 0.258 . . . . 0.0 110.84 -176.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.451 ' HB2' ' HB2' ' A' ' 107' ' ' ASN . 27.0 ptt? -172.01 156.36 4.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.613 173.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.405 HH12 ' CD ' ' A' ' 43' ' ' GLU . 32.4 mmt180 -91.84 170.87 9.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.754 -0.203 . . . . 0.0 110.987 -176.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.728 ' HG3' HG22 ' A' ' 51' ' ' VAL . 82.5 tttt -47.23 -49.87 22.25 Favored 'General case' 0 C--O 1.222 -0.346 0 O-C-N 123.63 0.581 . . . . 0.0 112.071 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -56.35 -35.43 67.65 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.158 0.504 . . . . 0.0 111.543 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 103' ' ' MET . 6.5 m120 -73.96 -40.02 63.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.49 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 61.7 mt -60.77 -46.03 96.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.378 172.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 105' ' ' LYS . 10.6 mm-40 -50.49 -48.41 56.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.317 176.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.4 m -63.86 -43.0 97.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.718 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 107' ' ' ASN . 42.8 mm -65.22 -42.99 95.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.816 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.703 ' HB3' HG21 ' A' ' 117' ' ' VAL . 81.6 mt -60.57 -42.23 96.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.617 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -64.25 -31.36 72.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.157 177.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.6 t -86.13 -9.7 56.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.462 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.572 HD22 ' HB3' ' A' ' 88' ' ' PHE . 45.9 tp -93.11 -73.92 0.54 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.116 0.484 . . . . 0.0 110.231 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 172.2 -61.38 0.15 Allowed Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.0 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 41.9 t 50.33 78.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.957 0.884 . . . . 0.0 111.605 178.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -148.13 178.45 8.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.796 -174.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.8 90.65 1.64 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 167.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -140.51 36.28 1.8 Allowed Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 119.982 -1.104 . . . . 0.0 113.361 -171.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -71.44 -51.04 26.02 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -86.42 79.45 8.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.404 172.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -114.88 125.61 53.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.296 -172.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 67.38 158.59 0.14 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.941 0.776 . . . . 0.0 111.03 176.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -101.4 -21.18 14.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.905 -0.497 . . . . 0.0 110.56 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.8 p80 . . . . . 0 C--O 1.244 0.814 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.905 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.1 mmm . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.1 p -65.48 -49.66 68.24 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.646 0.26 . . . . 0.0 111.0 -176.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 pp -91.44 165.58 13.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.833 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -73.1 132.65 43.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.844 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -121.63 32.67 4.56 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.327 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 tp -138.36 84.85 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.757 0.789 . . . . 0.0 112.179 -177.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.462 ' NZ ' ' HB3' ' A' ' 7' ' ' LYS . 2.7 ttpm? 66.37 2.27 2.36 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.374 168.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 29.8 mm-40 65.45 107.67 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.061 0.458 . . . . 0.0 109.869 -171.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.433 HD11 HG21 ' A' ' 16' ' ' VAL . 10.8 tp -157.03 16.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.254 0.55 . . . . 0.0 110.966 -175.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -50.61 -41.82 55.21 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.446 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -148.09 97.64 2.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.221 0.534 . . . . 0.0 110.533 -177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -127.57 -53.4 1.35 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.715 173.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.536 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 9.8 m -121.69 16.87 11.14 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.955 176.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.1 mt 70.33 -69.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.911 -175.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.752 HD21 ' HA2' ' A' ' 57' ' ' GLY . 12.9 m120 -92.93 31.28 1.43 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.262 0.553 . . . . 0.0 110.487 177.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 7.7 p -74.69 133.58 31.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.202 -177.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.419 HG21 ' HB3' ' A' ' 60' ' ' ASN . 67.5 t -134.84 136.38 52.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.847 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -65.83 -53.95 33.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.928 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.673 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 35.2 t30 -164.77 174.33 10.81 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -173.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -50.48 -29.4 10.32 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.805 0.336 . . . . 0.0 111.208 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.673 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 10.2 pt-20 -55.83 -37.2 68.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.321 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -103.18 8.3 38.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.625 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.26 139.66 52.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.622 0.249 . . . . 0.0 110.347 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -128.18 154.74 45.46 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.759 -174.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 61.8 -170.36 0.16 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.064 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -110.22 43.99 1.6 Allowed Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.151 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.553 HG13 ' ND2' ' A' ' 60' ' ' ASN . 7.0 pt -100.68 147.25 33.38 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.609 -0.295 . . . . 0.0 111.058 -178.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 1.087 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 88.1 Cg_exo -50.59 160.07 1.88 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.64 2.893 . . . . 0.0 113.227 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.7 m -123.37 128.16 49.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.435 -175.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.458 HD11 HD21 ' A' ' 112' ' ' LEU . 80.0 mt -107.45 109.63 28.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.616 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 42.5 mt -105.15 110.22 30.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.263 -177.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.537 ' SD ' ' NZ ' ' A' ' 34' ' ' LYS . 5.1 ppp? -114.69 139.58 49.55 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.767 0.794 . . . . 0.0 110.058 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -103.87 150.03 24.53 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.016 -170.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.654 ' HB3' ' HZ2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -152.77 161.51 42.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.934 178.565 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.633 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -75.06 -173.8 2.07 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 175.114 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.457 ' HB2' ' OE1' ' A' ' 67' ' ' GLU . 31.6 t70 -60.27 -29.37 68.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.057 0.456 . . . . 0.0 110.725 175.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -158.46 132.49 7.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.546 176.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 12.5 p -165.8 137.35 3.1 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.772 176.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 24.2 Cg_exo -63.14 -29.85 74.61 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.693 2.262 . . . . 0.0 112.811 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -62.94 -31.12 72.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.516 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 46.9 t -71.47 -36.32 71.13 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.111 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.548 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 46.9 t -67.93 -42.0 85.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.835 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -57.96 -50.24 74.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.669 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.471 ' HB2' HD21 ' A' ' 102' ' ' LEU . 21.5 ttt -72.15 -29.0 63.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.664 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.445 ' HG2' ' OH ' ' A' ' 63' ' ' TYR . 23.0 tm0? -61.08 -42.41 98.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 177.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 31.7 mmmt -63.04 -45.45 92.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.934 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.599 ' O ' HG23 ' A' ' 51' ' ' VAL . 72.0 mm-40 -58.06 -47.88 81.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.698 176.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.56 -35.41 77.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.213 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.7 m -59.72 -43.93 93.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.079 0.466 . . . . 0.0 110.176 173.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -66.97 -41.03 87.54 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.615 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 47' ' ' GLU . 55.3 t -60.24 -44.56 95.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.571 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.664 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 m -66.24 -30.85 71.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.969 0.414 . . . . 0.0 111.282 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -77.66 -24.71 49.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.045 0.45 . . . . 0.0 110.557 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -93.39 -38.63 11.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.22 0.533 . . . . 0.0 110.199 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -114.8 79.03 1.21 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.63 120.92 19.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.567 -168.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.752 ' HA2' HD21 ' A' ' 15' ' ' ASN . . . 60.91 57.86 16.64 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.549 -0.75 . . . . 0.0 113.184 173.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.86 ' HE3' HG12 ' A' ' 117' ' ' VAL . 29.1 mmmt -132.67 -3.2 3.31 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.655 -0.32 . . . . 0.0 111.571 -176.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -166.82 153.92 9.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 111.149 -176.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.553 ' ND2' HG13 ' A' ' 27' ' ' ILE . 58.6 m-80 -95.64 129.82 42.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.99 174.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.6 mt -98.92 108.76 22.84 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 CA-C-O 120.542 0.211 . . . . 0.0 110.657 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.483 ' HB3' ' HA ' ' A' ' 31' ' ' ILE . 0.3 OUTLIER -96.28 118.28 32.51 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.338 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.607 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 31.2 m-85 -97.27 103.74 15.7 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.143 0.497 . . . . 0.0 110.368 173.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.415 ' HB1' HD22 ' A' ' 71' ' ' ASN . . . -94.27 100.62 12.64 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.231 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.501 ' C ' ' H ' ' A' ' 67' ' ' GLU . 3.4 ptp180 -84.61 117.22 23.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.273 172.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.7 mt -66.73 10.51 0.13 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.268 0.556 . . . . 0.0 112.082 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 65' ' ' ARG . 20.7 tp10 -80.4 -25.19 39.2 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.584 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -96.85 159.01 15.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.951 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -71.5 -22.91 61.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.166 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.493 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.9 OUTLIER -65.16 -25.84 67.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.415 0.626 . . . . 0.0 111.166 -174.914 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.493 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 7.8 m120 -89.94 -7.49 53.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.76 -168.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.7 mm -69.23 -50.94 48.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.78 -44.25 86.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.143 174.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -60.48 -40.98 93.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.593 -178.414 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 80' ' ' ALA . . . -68.9 -55.87 9.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.349 . . . . 0.0 111.655 -177.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -63.2 -34.23 77.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.676 -174.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.44 ' HE3' ' HB2' ' A' ' 77' ' ' LYS . 26.8 ttmt -64.61 -16.91 63.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.901 0.381 . . . . 0.0 110.912 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.579 ' CE1' HD21 ' A' ' 89' ' ' LEU . 75.7 m-85 -122.02 16.96 10.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.797 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 67.77 23.48 8.55 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.87 0.367 . . . . 0.0 111.535 174.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.451 ' HB1' HG21 ' A' ' 85' ' ' THR . . . -102.34 136.49 42.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.615 -178.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -144.33 -75.55 0.24 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.015 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.0 pt -71.15 142.05 16.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.99 0.424 . . . . 0.0 110.95 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.3 153.08 38.33 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.634 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -87.94 119.75 4.87 Favored 'Cis proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.25 -1.563 . . . . 0.0 112.411 0.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.567 ' HB ' ' HG3' ' A' ' 100' ' ' GLN . 5.1 t -110.31 142.52 41.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.249 177.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.7 m -132.39 127.86 36.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.747 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.616 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 10.8 p -108.89 128.33 64.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.25 0.548 . . . . 0.0 110.342 176.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -101.42 111.79 24.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.441 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.579 HD21 ' CE1' ' A' ' 78' ' ' TYR . 5.7 mp -107.91 146.01 32.97 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.079 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -83.2 -172.48 4.16 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 173.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.93 ' HE3' ' HE2' ' A' ' 118' ' ' LYS . 18.7 pttp -62.79 -33.04 74.36 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -172.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -93.42 18.04 10.43 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.458 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 78.54 25.34 61.07 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.819 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.561 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 81.3 m-20 -78.95 110.07 13.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.563 0.22 . . . . 0.0 110.68 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 78' ' ' TYR . 11.7 ptmm? -72.36 86.78 1.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.53 0.681 . . . . 0.0 109.696 177.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -80.42 -53.09 6.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.374 -172.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 75.8 t80 -135.76 127.6 29.33 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.768 -173.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.486 HG12 HG23 ' A' ' 87' ' ' VAL . 33.7 m -111.01 150.69 13.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 172.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.413 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 11.9 t60 -156.3 134.33 11.23 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.567 ' HG3' ' HB ' ' A' ' 85' ' ' THR . 2.3 mp0 -105.01 128.69 53.42 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 173.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 141.4 -161.3 26.94 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.458 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 44' ' ' MET . 1.1 tm? -129.87 121.3 26.42 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.671 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 3.3 mpp? -116.25 161.34 19.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.845 0.355 . . . . 0.0 110.202 178.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -93.95 167.97 11.27 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.086 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -50.3 -42.77 53.07 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -62.32 -38.76 90.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.186 0.517 . . . . 0.0 110.855 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.671 ' HB2' ' HB3' ' A' ' 103' ' ' MET . 3.5 m120 -71.05 -43.97 66.74 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.503 -176.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.62 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 48.9 mt -58.72 -50.04 80.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.872 176.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -56.51 -48.76 76.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.337 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.5 m -60.03 -38.17 81.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.067 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 107' ' ' ASN . 80.4 mt -65.35 -40.86 89.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.839 0.352 . . . . 0.0 110.231 176.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 57.4 mt -63.27 -35.83 81.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.183 177.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -64.86 -30.29 71.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.444 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.0 m -85.45 -9.85 56.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.709 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.2 tp -87.52 -88.18 0.14 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.387 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -174.5 -54.05 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.087 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 17.4 t 52.97 57.22 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 122.327 1.06 . . . . 0.0 109.871 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.93 ' HE2' ' HE3' ' A' ' 91' ' ' LYS . 19.8 pttm -123.14 146.85 47.41 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.266 -1.333 . . . . 0.0 110.486 -173.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -98.62 -33.46 10.95 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 172.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 178.93 -113.53 0.41 Allowed Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.623 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -150.63 -175.32 5.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 63.3 t60 66.97 24.16 9.66 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.05 173.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -71.4 -33.59 69.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 171.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -71.49 123.12 21.7 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 170.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -79.28 -60.82 2.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.784 0.325 . . . . 0.0 111.013 -172.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.43 -0.795 . . . . 0.0 109.779 178.342 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 121.0 0.429 . . . . 0.0 110.102 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.4 m -146.27 99.78 3.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.97 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 52.8 tp -124.33 128.36 48.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.399 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.86 87.06 7.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.485 0.66 . . . . 0.0 110.712 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.93 -21.12 78.98 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.954 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 24.6 pt -142.89 172.16 8.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 120.672 0.272 . . . . 0.0 111.125 -177.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? 71.46 -53.29 0.68 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.738 1.215 . . . . 0.0 112.071 177.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -82.09 87.61 6.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.25 0.548 . . . . 0.0 110.272 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.481 HG21 HG11 ' A' ' 16' ' ' VAL . 38.1 pt -83.28 -8.39 11.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.493 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.6 t30 71.37 -80.36 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.085 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.426 ' O ' ' HB3' ' A' ' 12' ' ' GLN . 42.0 t80 -175.07 -166.46 0.23 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -170.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.426 ' HB3' ' O ' ' A' ' 11' ' ' PHE . 10.0 tt0 80.97 -45.7 0.23 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.801 0.84 . . . . 0.0 111.529 172.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.57 ' CB ' HG23 ' A' ' 16' ' ' VAL . 20.3 m -119.86 104.94 10.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.099 0.476 . . . . 0.0 110.302 177.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.476 ' N ' HD12 ' A' ' 14' ' ' ILE . 3.3 mp -85.81 -28.66 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.529 0.681 . . . . 0.0 110.1 -176.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -79.45 10.33 3.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.493 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.57 HG23 ' CB ' ' A' ' 13' ' ' SER . 1.0 OUTLIER -64.36 142.28 17.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.675 0.75 . . . . 0.0 112.842 -173.089 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.649 HG21 ' HB3' ' A' ' 60' ' ' ASN . 84.3 t -134.85 124.95 44.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.606 174.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -79.47 -30.92 42.3 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.138 0.495 . . . . 0.0 110.798 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -176.24 176.4 1.69 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -48.87 -34.24 12.23 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.5 mp0 -58.67 -33.73 70.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.642 0.258 . . . . 0.0 111.613 177.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -99.15 19.94 14.37 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.751 0.31 . . . . 0.0 111.019 -175.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.96 145.33 26.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.906 0.384 . . . . 0.0 111.143 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -116.71 114.42 24.0 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -81.41 168.57 18.2 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.284 -175.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.46 -35.0 5.32 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -172.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.5 pt -113.01 157.39 40.84 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 114.925 -0.638 . . . . 0.0 109.729 176.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.602 ' HG2' HG22 ' A' ' 117' ' ' VAL . 49.0 Cg_exo -57.76 169.71 2.39 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.868 2.379 . . . . 0.0 112.608 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.48 ' HA ' ' HB2' ' A' ' 60' ' ' ASN . 63.1 m -136.38 115.28 12.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.932 0.396 . . . . 0.0 111.063 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.438 HD12 ' HD2' ' A' ' 88' ' ' PHE . 21.4 mm -101.71 139.45 22.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.604 ' HB ' HG12 ' A' ' 87' ' ' VAL . 77.2 mt -130.6 118.11 41.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.561 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 24.9 ptm -109.23 120.54 42.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.469 0.652 . . . . 0.0 109.856 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.58 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 87.8 m-85 -90.41 117.36 29.06 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.752 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HG3' ' HB2' ' A' ' 41' ' ' CYS . 0.1 OUTLIER -150.8 149.35 29.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.364 -178.959 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.4 t -81.7 165.22 21.19 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 170.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.684 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -88.92 9.93 23.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.015 0.436 . . . . 0.0 110.871 -169.824 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.4 p -108.9 -16.69 14.1 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 65.7 m -83.03 128.53 64.95 Favored Pre-proline 0 C--N 1.33 -0.265 0 O-C-N 122.25 -0.281 . . . . 0.0 111.001 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.91 -25.76 7.29 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 121.938 1.759 . . . . 0.0 113.569 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -62.97 -19.74 64.58 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.798 0.332 . . . . 0.0 110.965 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.625 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 7.3 p -71.73 -34.4 69.53 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.35 -35.79 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.691 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -62.99 -49.53 74.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.135 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.5 ttt -65.84 -32.88 74.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.2 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 19.8 mt-30 -63.66 -33.2 75.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.934 175.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -68.42 -41.41 80.43 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.216 176.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 51' ' ' VAL . 18.9 mm-40 -55.72 -54.04 49.17 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 172.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.547 HD13 HG21 ' A' ' 61' ' ' ILE . 68.7 mt -58.24 -33.43 69.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.487 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.1 t -65.61 -40.66 92.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.788 0.328 . . . . 0.0 110.58 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.432 ' HB2' ' HE2' ' A' ' 105' ' ' LYS . 19.8 m-85 -72.69 -31.74 65.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.06 178.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.917 HG22 ' HG3' ' A' ' 105' ' ' LYS . 16.8 t -68.76 -38.66 79.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.2 t -64.06 -31.11 72.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.925 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 50' ' ' TYR . 16.1 tppt? -68.27 -42.55 79.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.378 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -93.24 -20.88 20.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.63 -176.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.3 76.23 1.71 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.521 0.677 . . . . 0.0 109.507 178.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.451 ' O ' ' HE3' ' A' ' 58' ' ' LYS . 1.2 pm0 -72.14 124.34 24.8 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.738 -173.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.34 40.13 37.39 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.614 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.451 ' HE3' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -113.49 -4.59 13.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.076 0.465 . . . . 0.0 110.059 -174.019 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -171.79 141.93 1.47 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.922 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.649 ' HB3' HG21 ' A' ' 17' ' ' VAL . 50.8 m-80 -77.27 145.78 37.28 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.613 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.547 HG21 HD13 ' A' ' 48' ' ' LEU . 21.3 mt -128.09 107.04 15.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 171.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.512 ' CD2' HG23 ' A' ' 31' ' ' ILE . 4.7 t80 -98.92 117.27 33.05 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.473 ' CE2' HG22 ' A' ' 16' ' ' VAL . 25.3 m-85 -90.99 103.59 16.29 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.58 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -81.5 78.29 8.27 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.984 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.583 ' C ' ' H ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -69.84 113.14 6.8 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.62 174.059 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.7 tp -64.57 11.43 0.05 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.342 0.591 . . . . 0.0 111.123 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.684 ' HB2' ' HB2' ' A' ' 36' ' ' ASP . 7.8 tp10 -80.62 -25.55 38.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.091 -178.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.427 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 44.2 mt-10 -105.87 -174.39 2.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.247 0.546 . . . . 0.0 112.056 -175.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -90.42 -31.44 16.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.947 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.547 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -54.31 -40.61 68.09 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.641 0.734 . . . . 0.0 111.664 -173.389 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.547 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 2.6 p30 -101.51 10.28 40.51 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.875 -172.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.2 mm -67.45 -49.61 69.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 167.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.56 -43.96 62.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.606 174.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.498 ' CB ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -62.78 -43.84 97.75 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.674 -177.018 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.02 -41.83 77.2 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 122.187 -0.321 . . . . 0.0 110.857 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -61.9 -32.96 73.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.461 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -55.91 -33.33 64.56 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.525 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -112.19 8.02 19.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.726 0.298 . . . . 0.0 110.575 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 t0 53.81 50.63 16.52 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.255 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.28 71.04 10.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.326 0.584 . . . . 0.0 110.609 177.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -82.87 -13.66 55.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.836 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 23.1 pt -113.9 155.91 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.189 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.18 148.93 66.52 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.985 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -90.77 121.48 4.4 Favored 'Cis proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.372 -1.512 . . . . 0.0 112.587 -1.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 94.5 m -100.52 117.19 34.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.3 m -110.38 125.78 53.57 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.089 0.471 . . . . 0.0 111.323 -175.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.604 HG12 ' HB ' ' A' ' 31' ' ' ILE . 10.5 p -108.04 140.81 25.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.551 175.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.948 ' HB3' HD11 ' A' ' 115' ' ' LEU . 52.4 m-85 -118.29 113.74 21.92 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.226 -174.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.454 ' CD2' ' HA ' ' A' ' 95' ' ' LYS . 32.3 mt -107.88 143.75 36.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.673 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.62 ' HB3' ' HB2' ' A' ' 94' ' ' ASN . 24.7 t0 -78.28 172.05 14.16 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.676 ' HE2' ' HA ' ' A' ' 119' ' ' GLU . 17.4 pttp -63.71 -18.64 64.22 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -174.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -87.69 -0.42 56.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 0.0 110.059 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.51 12.03 67.77 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.441 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.62 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 94.5 m-20 -70.06 117.71 11.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.597 -0.301 . . . . 0.0 111.445 -177.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.454 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -73.0 102.2 3.43 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.582 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -104.35 -72.53 0.7 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.91 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -113.0 141.49 46.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.89 -169.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.1 p -139.48 135.75 40.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 174.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -149.35 137.96 20.98 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -106.72 123.72 48.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.896 0.379 . . . . 0.0 110.611 178.215 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 148.43 179.29 24.25 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.949 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.3 tp -83.0 102.06 11.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.902 0.382 . . . . 0.0 110.352 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 79.4 mmm -94.98 154.35 17.22 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -115.36 171.17 7.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.784 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.917 ' HG3' HG22 ' A' ' 51' ' ' VAL . 38.8 ttmt -46.59 -59.34 3.07 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -175.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -61.5 -30.75 70.82 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.935 0.398 . . . . 0.0 111.67 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.529 ' O ' HD13 ' A' ' 111' ' ' ILE . 18.3 m120 -70.47 -40.5 73.63 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.613 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 41.1 mt -63.11 -51.37 72.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 173.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -50.97 -52.49 42.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.341 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.4 m -60.13 -40.93 91.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.004 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.624 ' O ' ' HG ' ' A' ' 115' ' ' LEU . 1.7 mp -69.06 -38.75 78.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.68 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 86.7 mt -58.01 -43.11 86.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.263 0.554 . . . . 0.0 109.783 176.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -56.7 -40.81 76.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.227 176.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.4 m -75.26 -28.99 60.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.452 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.948 HD11 ' HB3' ' A' ' 88' ' ' PHE . 85.1 mt -68.01 -58.32 4.71 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.481 0.657 . . . . 0.0 109.664 175.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 159.79 -71.3 0.23 Allowed Glycine 0 N--CA 1.438 -1.2 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.165 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.602 HG22 ' HG2' ' A' ' 28' ' ' PRO . 40.9 t 54.97 72.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.908 0.861 . . . . 0.0 109.557 -173.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 118' ' ' LYS . 0.6 OUTLIER -138.95 -172.79 3.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.006 -171.352 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.676 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -175.3 138.47 0.42 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 164.396 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -84.06 -22.49 54.84 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.9 -172.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -79.25 78.61 5.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.273 0.559 . . . . 0.0 111.975 -174.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -94.7 -18.0 21.7 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 170.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.3 m170 -152.63 158.84 42.99 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.271 -1.331 . . . . 0.0 107.528 172.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -101.71 61.26 0.89 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.711 0.767 . . . . 0.0 111.473 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -112.36 13.64 20.32 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 163.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 . . . . . 0 C--O 1.256 1.417 0 CA-C-N 113.208 -1.814 . . . . 0.0 107.143 -179.362 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.627 0.251 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.6 m -151.9 20.13 0.69 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.429 0.633 . . . . 0.0 110.017 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -161.42 83.7 0.62 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -102.79 3.18 36.51 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.834 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.91 -68.29 0.35 Allowed Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.159 -175.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.0 pt -154.79 -48.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 121.044 0.45 . . . . 0.0 110.648 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -111.0 122.24 47.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.711 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -77.11 85.82 3.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.233 0.54 . . . . 0.0 110.681 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.6 pt -116.12 -42.93 3.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.29 176.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -168.41 177.72 5.2 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -145.45 74.54 1.4 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.313 0.578 . . . . 0.0 109.76 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.688 ' HG2' ' HB3' ' A' ' 45' ' ' GLN . 21.8 mp0 -128.6 -68.78 0.74 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.737 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.0 m -100.28 138.12 37.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.888 174.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.667 ' HB ' ' CD ' ' A' ' 56' ' ' GLU . 4.2 mp -90.77 -14.71 8.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.999 0.904 . . . . 0.0 108.903 177.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -71.16 7.66 1.19 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.305 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.475 HG23 ' CE2' ' A' ' 63' ' ' TYR . 6.5 p -60.0 129.24 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -173.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -133.17 140.07 47.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.813 170.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.77 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 28.0 tp10 -70.53 -50.56 36.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.335 177.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.869 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 27.9 t-20 -149.13 171.05 17.06 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.275 -174.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 20' ' ' LEU . 3.8 mm? -50.05 -29.93 9.78 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.194 0.308 . . . . 0.0 111.061 171.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.869 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 12.9 pt-20 -61.31 -29.95 70.19 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.956 0.408 . . . . 0.0 110.881 175.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.77 ' HG3' ' HB3' ' A' ' 18' ' ' GLU . 13.6 mm-40 -95.24 -0.22 53.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.264 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.17 159.69 25.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.303 0.573 . . . . 0.0 112.145 -172.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.637 ' HB2' HD11 ' A' ' 27' ' ' ILE . 29.7 mtmt -115.39 161.96 17.8 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.688 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.44 166.01 10.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.888 0.375 . . . . 0.0 111.977 -177.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.13 -49.43 3.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.063 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.815 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -91.46 149.59 39.75 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.721 0.296 . . . . 0.0 110.62 178.115 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 1.053 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 52.0 Cg_exo -60.72 171.01 3.89 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 123.264 2.643 . . . . 0.0 112.891 176.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.532 HG23 ' HB2' ' A' ' 60' ' ' ASN . 26.4 m -130.74 131.4 44.72 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.921 -176.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.537 HD11 HD21 ' A' ' 112' ' ' LEU . 65.3 mt -110.0 114.13 46.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.664 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.613 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 9.5 mm -100.39 109.93 26.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 25.5 ptm -111.96 131.83 55.14 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.857 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.637 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 77.3 m-85 -97.53 120.55 38.11 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.217 -176.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.573 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -125.6 162.23 25.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.997 -174.587 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.3 t -135.89 164.92 26.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.061 0.457 . . . . 0.0 110.648 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.488 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . 24.3 t70 -75.79 -27.75 58.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.799 -178.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.1 m -81.82 -66.55 0.87 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.042 -174.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.613 ' HB3' ' HD2' ' A' ' 40' ' ' TYR . 29.9 m -68.69 122.12 83.62 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.223 -176.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -79.01 3.72 7.17 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.437 2.091 . . . . 0.0 113.332 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.613 ' HD2' ' HB3' ' A' ' 38' ' ' CYS . 96.1 m-85 -61.4 -23.94 66.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.996 0.427 . . . . 0.0 110.614 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.2 p -64.71 -52.02 59.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.245 177.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.433 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 41.7 t -60.47 -30.99 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.71 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.403 ' HA ' ' OE1' ' A' ' 43' ' ' GLU . 5.3 tp10 -68.02 -49.89 58.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.438 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.2 ttt -66.02 -30.3 70.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.863 0.363 . . . . 0.0 110.199 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.688 ' HB3' ' HG2' ' A' ' 12' ' ' GLN . 74.2 mt-30 -60.93 -37.27 81.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.023 176.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 43.7 mttp -64.49 -47.83 77.47 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.853 0.359 . . . . 0.0 110.046 177.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.51 ' O ' HG23 ' A' ' 51' ' ' VAL . 21.0 mm-40 -57.28 -44.27 83.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.299 177.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.5 mt -60.7 -34.1 73.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.971 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.5 m -59.87 -44.57 94.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.075 0.464 . . . . 0.0 110.29 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -70.05 -29.5 66.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.047 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 47' ' ' GLU . 50.9 t -76.22 -47.01 32.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.629 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.618 ' HB3' ' OE2' ' A' ' 56' ' ' GLU . 15.1 m -62.81 -29.17 70.52 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-O 120.881 0.372 . . . . 0.0 110.513 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -50.11 -32.96 17.17 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.184 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.405 ' CD ' ' HE ' ' A' ' 55' ' ' ARG . 1.1 tm-20 -104.32 -48.57 3.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.388 0.613 . . . . 0.0 109.365 171.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.663 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 9.4 tpp85 -91.02 66.52 5.83 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.915 -173.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.667 ' CD ' ' HB ' ' A' ' 14' ' ' ILE . 3.9 mm-40 -90.52 144.73 25.5 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.005 172.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.45 34.2 54.55 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.491 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.663 ' HB2' ' HG3' ' A' ' 55' ' ' ARG . 26.8 mmtp -113.05 -14.09 13.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.251 0.548 . . . . 0.0 109.727 -174.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.575 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 0.8 OUTLIER -165.68 -175.01 3.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.398 179.008 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.532 ' HB2' HG23 ' A' ' 29' ' ' THR . 44.1 m-80 -108.2 129.28 55.2 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.209 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.3 mm -106.64 107.54 22.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 173.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.865 ' CE2' ' HA ' ' A' ' 19' ' ' ASN . 0.7 OUTLIER -98.2 112.1 24.2 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.448 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.475 ' CE2' HG23 ' A' ' 16' ' ' VAL . 89.7 m-85 -89.8 102.75 15.45 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 173.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.613 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -79.67 91.03 5.2 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.573 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 8.0 ptp180 -68.97 104.21 2.04 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.443 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.7 mp -65.42 10.74 0.08 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.092 0.472 . . . . 0.0 110.907 176.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.543 ' H ' ' C ' ' A' ' 65' ' ' ARG . 2.0 mp0 -83.29 -29.44 28.36 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.012 177.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.487 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 22.6 mt-10 -102.48 -171.67 2.0 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-O 121.379 0.609 . . . . 0.0 112.48 -175.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -95.17 -35.35 11.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.966 -174.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.522 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -56.33 -28.17 58.13 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.408 0.623 . . . . 0.0 111.144 -176.376 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.522 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 3.6 m120 -87.69 -8.45 56.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.435 -170.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.8 mm -68.3 -57.86 7.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.46 -38.89 91.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.2 174.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.495 ' HG ' ' OH ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -58.86 -38.91 79.85 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.312 179.343 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.637 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -61.14 -48.23 82.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.062 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -65.55 -34.17 77.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.809 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -57.91 -33.8 69.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.041 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.422 ' CD1' HG11 ' A' ' 87' ' ' VAL . 72.6 m-85 -115.81 16.99 16.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.902 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 61.9 35.02 16.6 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.006 170.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.411 ' HB1' HG21 ' A' ' 85' ' ' THR . . . -91.65 146.1 24.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.696 -176.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -154.58 -35.01 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.45 174.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.0 mt -91.94 134.9 28.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.787 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 84' ' ' PRO . 16.1 m -108.34 134.74 20.1 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.568 176.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 63.5 Cg_endo -91.7 141.79 11.14 Favored 'Cis proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.321 -1.533 . . . . 0.0 112.509 -0.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.429 HG23 ' CD1' ' A' ' 33' ' ' PHE . 9.0 t -126.06 147.18 49.63 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.5 t -141.17 130.39 23.52 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.891 0.376 . . . . 0.0 110.462 -177.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.613 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 8.8 p -113.61 128.29 70.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.382 0.611 . . . . 0.0 110.198 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.552 ' HB3' HD22 ' A' ' 115' ' ' LEU . 88.8 m-85 -100.03 118.54 36.62 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.147 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.594 ' O ' ' HB3' ' A' ' 28' ' ' PRO . 7.1 mp -106.12 139.43 40.65 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.159 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -68.77 177.51 2.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 173.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.869 ' HE3' ' HE2' ' A' ' 118' ' ' LYS . 4.5 pttm -63.16 -26.19 68.7 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 122.36 0.264 . . . . 0.0 111.596 -176.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -71.13 -25.56 62.63 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.747 0.308 . . . . 0.0 110.967 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.99 22.29 10.96 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.671 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 28.7 m120 -86.81 132.09 33.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.687 0.244 . . . . 0.0 110.484 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -71.4 84.3 0.8 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.428 0.633 . . . . 0.0 109.724 173.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -73.03 -47.82 41.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.081 -174.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -145.21 116.68 8.04 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.127 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 87' ' ' VAL . 7.2 p -105.67 137.02 37.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 174.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -124.05 136.04 53.99 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -116.5 110.35 18.48 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 175.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 135.3 158.79 8.4 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -175.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.3 tp -77.9 141.78 38.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.757 0.313 . . . . 0.0 111.131 -176.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.483 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 54.7 mtm -131.63 166.89 20.43 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -102.67 175.03 5.63 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -54.85 -48.43 72.9 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.413 ' HA ' ' CD ' ' A' ' 109' ' ' GLU . 5.0 t-20 -66.51 -28.52 68.63 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.007 0.432 . . . . 0.0 110.811 -176.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.511 ' O ' HG12 ' A' ' 111' ' ' ILE . 11.2 m120 -66.16 -45.48 80.79 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 176.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.524 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 54.2 mt -61.71 -45.5 98.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.597 175.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.413 ' CD ' ' HA ' ' A' ' 106' ' ' ASN . 40.9 mt-10 -50.37 -48.29 55.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.528 176.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.3 m -65.25 -40.09 93.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.068 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 107' ' ' ASN . 49.1 mm -68.27 -43.52 84.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.516 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.537 HD21 HD11 ' A' ' 30' ' ' ILE . 98.2 mt -57.2 -43.54 82.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.18 0.514 . . . . 0.0 110.51 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -60.48 -43.2 97.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.117 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.0 m -86.53 -2.58 58.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.816 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' A' ' 88' ' ' PHE . 63.5 tp -82.85 -69.93 0.59 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.971 0.415 . . . . 0.0 111.869 -174.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.781 ' O ' ' HG2' ' A' ' 118' ' ' LYS . . . 149.32 -3.16 0.63 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.547 -172.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.053 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 39.0 t -33.86 107.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.141 0.976 . . . . 0.0 113.283 171.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.869 ' HE2' ' HE3' ' A' ' 91' ' ' LYS . 22.5 pttm 176.4 -172.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.672 -1.149 . . . . 0.0 107.95 177.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.26 158.03 24.0 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 174.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.85 74.41 1.99 Allowed Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.335 -172.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -124.2 -3.21 8.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.702 0.287 . . . . 0.0 111.1 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -113.42 109.66 19.05 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -131.33 -47.94 0.99 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -84.26 157.29 21.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.547 0.689 . . . . 0.0 112.565 -168.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -149.14 135.66 19.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.146 175.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.1 p80 . . . . . 0 C--N 1.322 -0.601 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.711 177.688 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 tpt . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.714 0.292 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.5 m 72.85 -58.1 0.61 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.25 0.62 . . . . 0.0 111.351 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.57 HD13 ' H ' ' A' ' 5' ' ' GLY . 0.8 OUTLIER -90.11 85.92 6.42 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.517 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.865 ' HG3' ' HG2' ' A' ' 8' ' ' GLN . 2.1 mm-40 -93.22 21.98 5.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.474 -174.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.57 ' H ' HD13 ' A' ' 3' ' ' LEU . . . 79.82 -71.46 2.72 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.845 -177.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.1 pt -146.91 -50.54 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.381 . . . . 0.0 111.065 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -138.25 144.71 40.67 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.865 ' HG2' ' HG3' ' A' ' 4' ' ' GLU . 36.8 mt-30 -78.12 99.47 6.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.908 0.385 . . . . 0.0 110.52 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.5 tp -158.2 154.93 4.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.29 142.43 47.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.209 0.528 . . . . 0.0 111.86 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.513 ' HD1' ' H ' ' A' ' 11' ' ' PHE . 2.9 p90 -88.57 4.0 48.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.232 -177.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -60.47 -33.72 72.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.77 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.567 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 5.6 m -93.94 -18.44 21.92 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.106 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.0 mt 64.59 -68.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 O-C-N 123.681 0.613 . . . . 0.0 111.133 -173.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -89.15 45.82 1.33 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.061 0.458 . . . . 0.0 110.641 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 2.4 p -79.71 123.12 36.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.603 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.593 HG11 ' HB2' ' A' ' 23' ' ' ALA . 41.0 t -109.65 141.93 23.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.104 -175.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -83.14 -33.64 26.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.756 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.82 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 20.1 t-20 -173.33 175.58 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.7 mt -60.58 -29.74 69.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.019 0.438 . . . . 0.0 110.447 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.82 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 12.0 pt-20 -65.13 -32.25 73.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.554 176.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -93.31 7.8 42.96 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.493 0.663 . . . . 0.0 110.122 178.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.593 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -110.24 158.58 18.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.249 -176.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -133.24 135.61 45.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.117 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.06 163.63 27.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.785 0.326 . . . . 0.0 110.269 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.58 -35.72 3.23 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.687 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -116.0 145.54 35.06 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.177 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.543 ' HD2' ' O ' ' A' ' 58' ' ' LYS . 99.4 Cg_exo -44.93 133.61 10.82 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.17 2.58 . . . . 0.0 112.757 177.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.4 m -101.4 109.25 21.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.366 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.683 HD13 ' HB2' ' A' ' 59' ' ' PHE . 2.4 mp -98.67 108.19 21.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.706 ' HB ' HG23 ' A' ' 87' ' ' VAL . 67.8 mt -104.35 112.02 36.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.069 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.421 ' SD ' ' HB3' ' A' ' 34' ' ' LYS . 4.5 ppp? -109.55 144.15 38.24 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.5 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 87.5 m-85 -104.84 130.34 52.99 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.776 -177.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.873 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 12.5 pttp -143.98 149.06 36.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.108 -172.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.568 HG22 ' H ' ' A' ' 36' ' ' ASP . 1.4 m -74.04 -174.18 1.81 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 168.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.568 ' H ' HG22 ' A' ' 35' ' ' THR . 7.0 t70 -54.12 -75.36 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.798 0.332 . . . . 0.0 110.812 175.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.1 m -110.88 127.17 55.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.861 0.363 . . . . 0.0 110.696 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 44.0 m -146.3 134.76 10.87 Favored Pre-proline 0 C--O 1.235 0.313 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.325 178.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.28 -31.19 14.67 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.116 1.877 . . . . 0.0 113.044 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -68.74 -28.7 67.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.926 0.393 . . . . 0.0 110.694 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 38' ' ' CYS . 58.8 m -74.37 -42.38 59.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.694 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.0 p -70.5 -29.58 39.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.161 0.505 . . . . 0.0 110.19 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -66.02 -46.23 78.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.898 175.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.442 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 23.8 ttt -63.16 -35.28 79.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.518 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.465 ' HG2' ' OH ' ' A' ' 63' ' ' TYR . 37.7 mt-30 -57.78 -40.63 80.28 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.192 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -58.68 -50.5 73.65 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.535 ' HG3' ' HA ' ' A' ' 104' ' ' ARG . 70.0 mm-40 -59.96 -40.26 88.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.098 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.817 HD13 HD13 ' A' ' 61' ' ' ILE . 96.7 mt -60.28 -43.66 96.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.492 177.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.9 t -62.99 -37.07 85.7 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.177 0.513 . . . . 0.0 110.15 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.617 ' HA ' ' HE3' ' A' ' 53' ' ' LYS . 23.0 m-85 -64.05 -23.94 67.52 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.567 177.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.538 HG22 ' HE3' ' A' ' 105' ' ' LYS . 46.3 t -83.15 -43.18 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.8 m -55.41 -31.86 62.2 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.16 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.617 ' HE3' ' HA ' ' A' ' 50' ' ' TYR . 10.1 mtmp? -62.27 -35.16 78.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.786 0.327 . . . . 0.0 111.103 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.579 ' OE1' ' HB2' ' A' ' 53' ' ' LYS . 1.7 mp0 -103.96 9.0 36.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.554 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -154.83 92.8 1.49 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -172.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.12 116.48 7.26 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.119 0.485 . . . . 0.0 109.698 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 59' ' ' PHE . . . 47.02 -105.75 0.12 Allowed Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.168 -173.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.543 ' O ' ' HD2' ' A' ' 28' ' ' PRO . 0.3 OUTLIER 53.58 8.33 0.13 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.826 -1.187 . . . . 0.0 112.946 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.683 ' HB2' HD13 ' A' ' 30' ' ' ILE . 9.5 p90 -163.21 114.14 1.43 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.565 0.698 . . . . 0.0 110.414 174.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.498 ' HB3' HG21 ' A' ' 17' ' ' VAL . 5.4 m-20 -84.15 116.2 22.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.796 174.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.817 HD13 HD13 ' A' ' 48' ' ' LEU . 26.7 mt -96.33 107.91 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.746 -176.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.582 ' HB3' HG12 ' A' ' 31' ' ' ILE . 4.4 t80 -91.18 117.23 29.45 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.505 ' HD2' ' HD3' ' A' ' 34' ' ' LYS . 44.1 m-85 -91.48 106.46 18.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.782 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -83.13 69.83 9.95 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.775 0.797 . . . . 0.0 109.447 178.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.873 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 26.1 ptt180 -62.52 118.45 7.58 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.965 175.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 34' ' ' LYS . 4.4 mm? -66.64 10.24 0.14 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.873 0.368 . . . . 0.0 111.618 178.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.486 ' H ' ' C ' ' A' ' 65' ' ' ARG . 17.9 mt-10 -69.05 -40.95 78.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.543 0.687 . . . . 0.0 109.974 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.598 ' HB2' ' HD2' ' A' ' 70' ' ' LYS . 27.0 mt-10 -89.83 151.99 21.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.908 -174.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -70.7 -34.21 71.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.216 0.531 . . . . 0.0 110.173 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.598 ' HD2' ' HB2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -58.15 -27.1 63.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.883 179.02 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.495 ' N ' ' HD3' ' A' ' 70' ' ' LYS . 76.8 m-20 -87.47 -3.41 59.0 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.223 -178.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.4 mm -70.72 -43.1 77.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 171.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -71.77 -41.35 68.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.217 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 74' ' ' LEU . 0.8 OUTLIER -60.85 -47.42 86.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.205 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.5 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -62.93 -48.65 77.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.833 0.349 . . . . 0.0 110.967 178.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -61.42 -34.48 75.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.657 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -57.18 -33.22 67.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.181 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.453 ' CE1' ' HD3' ' A' ' 95' ' ' LYS . 85.3 m-85 -111.66 12.53 21.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.961 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.2 t70 67.33 21.86 9.69 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.433 0.635 . . . . 0.0 111.24 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.73 93.43 4.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.898 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -112.75 -8.15 13.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.454 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.567 HD13 ' H ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -125.17 153.39 32.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.001 178.552 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.7 m -131.27 153.22 81.61 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.455 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -90.59 145.65 16.64 Favored 'Cis proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.282 -1.549 . . . . 0.0 112.662 -0.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.1 t -142.61 149.55 39.13 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.3 m -138.6 131.12 28.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.684 0.278 . . . . 0.0 111.35 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.706 HG23 ' HB ' ' A' ' 31' ' ' ILE . 5.5 m -102.4 120.87 52.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.893 173.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -96.55 118.38 32.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.221 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.499 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 6.6 mp -113.68 145.06 41.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.75 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -63.93 171.66 2.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.949 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.515 ' HG2' ' CD ' ' A' ' 118' ' ' LYS . 2.2 pptp? -52.04 -25.1 7.79 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.901 0.881 . . . . 0.0 112.756 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.444 ' HB2' ' NZ ' ' A' ' 91' ' ' LYS . 21.6 tt0 -92.1 -4.81 53.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.069 0.462 . . . . 0.0 111.036 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.98 29.07 24.12 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.827 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -110.06 134.04 52.57 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.499 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 35.1 mtmm -65.56 147.07 54.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.061 0.457 . . . . 0.0 111.202 -175.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -127.58 -46.27 1.45 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.132 173.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.499 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 81.4 t80 -147.45 134.09 19.91 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.466 -175.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.52 ' HB ' HG12 ' A' ' 87' ' ' VAL . 3.1 p -116.85 140.36 39.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 173.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.499 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 31.3 t60 -135.85 146.75 47.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -114.88 135.95 53.64 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.69 -149.04 18.34 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.12 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.3 tp -127.11 144.86 50.93 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.538 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 3.4 mpp? -131.28 165.02 24.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.354 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.535 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 32.3 mmt180 -103.22 168.21 9.32 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 173.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.58 ' HG3' ' N ' ' A' ' 106' ' ' ASN . 5.1 ptmt -54.93 -43.11 73.04 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -171.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.58 ' N ' ' HG3' ' A' ' 105' ' ' LYS . 12.9 t-20 -66.21 -32.23 73.53 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.908 0.385 . . . . 0.0 111.074 -178.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 103' ' ' MET . 9.1 m120 -66.74 -42.89 85.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.573 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 60.5 mt -62.59 -48.47 88.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.825 174.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -49.52 -51.79 34.01 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.109 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 m -63.16 -41.11 99.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.998 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 107' ' ' ASN . 42.9 mm -63.52 -40.9 90.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 91.0 mt -64.98 -37.45 87.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.594 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.74 -39.3 88.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.846 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.3 t -85.49 -10.49 56.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.471 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.5 tp -82.96 -56.25 3.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.523 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 168.83 -79.2 0.1 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.279 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.555 HG21 ' HB3' ' A' ' 112' ' ' LEU . 57.5 t 52.43 81.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.774 0.797 . . . . 0.0 111.623 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.515 ' CD ' ' HG2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -165.83 -165.36 0.81 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.866 -179.228 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.448 ' HB2' ' CE ' ' A' ' 118' ' ' LYS . 7.8 tp10 80.38 153.15 0.12 Allowed 'General case' 0 C--O 1.234 0.277 0 O-C-N 124.432 1.083 . . . . 0.0 111.576 174.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.41 ' H ' ' H ' ' A' ' 121' ' ' HIS . . . 177.41 -2.83 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.826 -178.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.41 ' H ' ' H ' ' A' ' 120' ' ' GLY . 17.6 p80 -89.47 92.07 8.97 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 117.736 0.768 . . . . 0.0 110.619 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -59.36 -34.77 72.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.287 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -127.48 139.52 52.75 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.086 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -98.4 -33.02 11.21 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -86.6 150.91 23.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.949 176.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 . . . . . 0 C--O 1.246 0.918 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.094 173.586 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtm . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.8 p -116.12 103.8 10.91 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.14 -48.72 1.33 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.628 0.728 . . . . 0.0 110.118 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.594 ' CD ' ' H ' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -94.85 -74.89 0.53 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.966 -172.789 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.594 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 116.26 -2.04 20.69 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 -175.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 34.6 pt -126.62 -3.31 4.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.071 0.462 . . . . 0.0 110.854 -177.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -111.9 7.76 20.13 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -76.54 29.86 0.12 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.927 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.514 HG12 ' HB3' ' A' ' 13' ' ' SER . 13.9 tt -82.0 50.92 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 122.526 1.155 . . . . 0.0 109.317 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -70.83 -30.24 66.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.131 -176.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.61 ' HD2' ' HG3' ' A' ' 12' ' ' GLN . 30.3 p90 -120.07 168.44 11.18 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.22 -178.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.61 ' HG3' ' HD2' ' A' ' 11' ' ' PHE . 88.1 mt-30 62.46 23.78 14.12 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.875 0.735 . . . . 0.0 110.119 -175.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.56 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . 8.4 p -122.8 -92.15 0.54 Allowed 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -169.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.1 mt 70.81 -74.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 123.322 0.649 . . . . 0.0 111.719 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -97.39 23.33 7.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.658 -174.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.56 ' CG2' ' HB2' ' A' ' 13' ' ' SER . 15.9 m -75.43 138.67 20.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.781 0.8 . . . . 0.0 112.732 -174.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 60' ' ' ASN . 48.6 t -121.81 124.84 72.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.558 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . 6.5 tp10 -59.42 -54.61 44.71 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.221 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.659 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 4.1 t30 -158.9 168.87 25.67 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -53.49 -29.16 34.74 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -170.199 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -66.58 -29.13 69.12 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.318 -0.239 . . . . 0.0 111.356 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.418 ' HG2' ' HB3' ' A' ' 18' ' ' GLU . 4.1 mp0 -80.43 -12.11 59.6 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.44 144.93 56.82 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.532 ' HD3' ' H ' ' A' ' 25' ' ' GLU . 5.0 tmtt? -127.9 151.69 48.77 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.356 -173.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.532 ' H ' ' HD3' ' A' ' 24' ' ' LYS . 25.6 mm-40 60.29 -164.11 0.23 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.928 175.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -119.19 47.65 1.01 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.917 -174.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.658 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -99.15 158.45 32.26 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 171.687 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -53.95 158.59 8.62 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.936 2.424 . . . . 0.0 112.504 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.5 m -127.21 128.99 46.98 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.063 0.459 . . . . 0.0 110.856 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.762 HD11 HD21 ' A' ' 112' ' ' LEU . 80.9 mt -98.23 108.18 21.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.591 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.808 ' HB ' HG23 ' A' ' 87' ' ' VAL . 22.5 mm -95.82 109.33 22.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 24.8 ptm -121.68 136.14 54.95 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.034 -0.667 . . . . 0.0 111.075 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.833 ' HZ ' ' HB2' ' A' ' 78' ' ' TYR . 47.1 m-85 -96.48 119.9 35.81 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.343 -178.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HG3' ' HB3' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -130.87 132.59 45.26 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.509 -170.021 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.696 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 7.3 m -99.96 162.87 12.72 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.96 -49.77 55.08 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.6 m -66.8 -52.55 42.69 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -171.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.727 ' SG ' HG21 ' A' ' 83' ' ' VAL . 2.7 p -70.99 125.55 92.02 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -167.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.651 ' O ' HG22 ' A' ' 42' ' ' VAL . 69.5 Cg_endo -75.79 -9.81 19.78 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.094 2.529 . . . . 0.0 112.653 175.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -59.47 -29.81 68.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.486 0.66 . . . . 0.0 109.768 174.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.647 ' HB3' ' HG3' ' A' ' 34' ' ' LYS . 75.0 m -78.93 -36.9 41.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.649 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 39' ' ' PRO . 2.8 m -68.44 -30.62 48.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.34 -177.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 1.8 mt-10 -61.97 -48.28 81.05 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.824 0.345 . . . . 0.0 110.78 173.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -37.75 78.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.637 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 77.3 mt-30 -58.3 -49.59 76.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.903 175.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 73.3 mmtt -58.04 -43.31 86.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.162 0.506 . . . . 0.0 110.062 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.588 ' O ' HG23 ' A' ' 51' ' ' VAL . 52.0 mm-40 -62.47 -46.86 86.58 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.199 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 48' ' ' LEU . 27.0 mt -59.77 -34.82 73.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.466 177.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.6 m -57.62 -45.87 84.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.209 0.528 . . . . 0.0 110.271 176.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -76.77 -30.36 56.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.754 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 47' ' ' GLU . 77.9 t -62.9 -41.76 93.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -65.13 -36.6 84.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.338 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -74.38 -15.6 60.92 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -109.82 -1.83 17.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.474 0.654 . . . . 0.0 109.977 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -145.7 75.31 1.42 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.356 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -67.12 118.41 10.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.791 -175.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.09 62.64 5.92 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.292 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -134.93 2.32 3.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.805 0.302 . . . . 0.0 111.086 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -168.65 145.07 3.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.412 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.567 ' HB3' HG21 ' A' ' 17' ' ' VAL . 47.4 m-80 -90.88 128.83 36.9 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.145 176.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.7 mt -103.68 108.0 23.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.659 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 55.0 t80 -92.36 114.98 27.68 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.051 177.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -92.35 105.07 17.34 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.135 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.562 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -88.27 75.78 8.5 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.633 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 26.2 ptt180 -68.22 113.78 6.14 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.642 177.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.15 12.0 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.104 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.569 ' H ' ' C ' ' A' ' 65' ' ' ARG . 1.4 mp0 -83.23 -20.88 33.75 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.011 -175.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -112.83 -176.8 2.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.0 0.428 . . . . 0.0 111.083 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.41 -31.45 16.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.097 -175.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.48 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -61.37 -29.53 69.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.572 0.701 . . . . 0.0 110.79 -175.667 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.48 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 3.6 m120 -81.78 -11.61 58.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.705 -174.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.5 mm -72.03 -51.33 31.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.098 0.475 . . . . 0.0 110.181 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -67.19 -37.89 84.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.103 177.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.46 -43.75 98.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.897 177.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.719 ' HA ' ' CE1' ' A' ' 33' ' ' PHE . . . -52.06 -56.01 17.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.385 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -69.3 -33.53 73.32 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.062 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -59.22 -26.57 64.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.124 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.833 ' HB2' ' HZ ' ' A' ' 33' ' ' PHE . 79.7 m-85 -119.92 21.43 11.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.735 -178.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 69.66 33.49 2.98 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 167.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.407 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . . . -71.61 152.9 42.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.002 0.429 . . . . 0.0 110.977 176.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -141.25 -81.15 0.24 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.14 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 34.4 pt -113.23 171.18 3.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.727 HG21 ' SG ' ' A' ' 38' ' ' CYS . 19.4 m -101.9 150.89 37.8 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-O 120.522 0.201 . . . . 0.0 111.34 -176.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -92.78 116.43 2.34 Favored 'Cis proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.617 -1.41 . . . . 0.0 112.654 -1.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.738 HG23 ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -96.04 135.64 37.54 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.614 HG23 ' HB3' ' A' ' 99' ' ' HIS . 6.1 t -144.74 132.12 20.77 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.125 178.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.808 HG23 ' HB ' ' A' ' 31' ' ' ILE . 3.9 m -112.34 116.77 53.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.796 175.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.681 ' HB3' HD21 ' A' ' 115' ' ' LEU . 92.5 m-85 -90.61 116.96 28.9 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.769 -177.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 27.6 mt -102.38 137.4 40.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.721 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -73.07 -171.79 0.96 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.981 ' HG2' ' HB2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -69.99 -24.76 63.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.888 -0.508 . . . . 0.0 111.73 -175.114 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.569 ' HB2' ' ND2' ' A' ' 94' ' ' ASN . 8.3 mm-40 -81.23 -6.25 58.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.397 0.617 . . . . 0.0 109.348 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.46 31.71 40.49 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.21 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.569 ' ND2' ' HB2' ' A' ' 92' ' ' GLU . 35.3 m-80 -93.26 143.19 26.5 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.912 177.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -72.28 85.82 1.09 Allowed 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.865 0.728 . . . . 0.0 109.519 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -85.43 -50.79 7.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.276 -172.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.422 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 73.3 t80 -133.64 126.79 31.6 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.675 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.619 HG12 HG12 ' A' ' 87' ' ' VAL . 3.6 m -103.69 151.53 6.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.614 ' HB3' HG23 ' A' ' 86' ' ' THR . 55.8 t60 -142.8 140.89 31.53 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.738 ' NE2' HG23 ' A' ' 85' ' ' THR . 5.7 tp-100 -127.93 138.35 52.61 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 172.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.97 173.68 29.03 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.717 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.9 tp -75.03 152.31 38.68 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.364 0.602 . . . . 0.0 111.253 -175.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.644 ' SD ' HG12 ' A' ' 108' ' ' ILE . 5.3 ptp -146.42 137.96 24.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.206 172.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.462 ' O ' HG13 ' A' ' 108' ' ' ILE . 18.1 tpp180 -85.99 171.57 11.33 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.55 ' HG3' HG22 ' A' ' 51' ' ' VAL . 47.9 tttm -45.98 -57.33 4.5 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -174.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.41 -36.36 75.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.673 0.273 . . . . 0.0 111.163 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.645 ' O ' HG12 ' A' ' 111' ' ' ILE . 5.7 m-20 -62.9 -48.91 76.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.617 178.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.644 HG12 ' SD ' ' A' ' 103' ' ' MET . 25.6 mt -59.12 -47.36 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.81 0.814 . . . . 0.0 110.281 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -62.74 -41.32 99.13 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.98 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.491 ' O ' ' HB3' ' A' ' 113' ' ' ASN . 59.5 m -64.23 -30.62 71.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.577 177.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.645 HG12 ' O ' ' A' ' 107' ' ' ASN . 50.6 mm -67.62 -36.64 76.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.513 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.762 HD21 HD11 ' A' ' 30' ' ' ILE . 25.3 mt -60.7 -38.78 86.15 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.491 ' HB3' ' O ' ' A' ' 110' ' ' THR . 17.1 t30 -59.92 -44.74 94.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.957 176.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.5 p -72.33 -30.14 64.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.736 0.303 . . . . 0.0 111.036 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.681 HD21 ' HB3' ' A' ' 88' ' ' PHE . 3.9 mp -63.2 -55.13 27.62 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.31 0.576 . . . . 0.0 109.93 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 148.2 -53.58 0.53 Allowed Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.245 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.0 t 50.42 75.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -171.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.981 ' HB2' ' HG2' ' A' ' 91' ' ' LYS . 25.4 mtpp -104.59 26.03 9.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.616 -162.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -112.96 128.02 56.38 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.622 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.58 55.92 3.83 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.918 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -92.96 83.61 4.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.352 0.596 . . . . 0.0 110.043 173.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -119.29 41.36 3.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.393 -176.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -55.71 130.69 44.25 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.196 0.522 . . . . 0.0 111.141 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -149.78 138.33 20.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.374 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -64.08 128.17 34.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.781 0.324 . . . . 0.0 110.753 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 . . . . . 0 C--O 1.246 0.887 0 CA-C-O 118.284 -0.865 . . . . 0.0 109.491 174.775 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptm . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.1 t -109.17 149.76 28.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 3' ' ' LEU . 1.8 tm? -129.63 101.28 5.84 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.704 ' HG3' ' HE3' ' A' ' 7' ' ' LYS . 0.4 OUTLIER -130.25 150.62 51.41 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.646 177.572 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.712 ' HA3' ' HB3' ' A' ' 18' ' ' GLU . . . -133.89 -28.97 0.48 Allowed Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.594 176.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.415 HG23 ' HB3' ' A' ' 22' ' ' GLU . 32.3 pt -68.98 -21.83 25.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.108 0.48 . . . . 0.0 110.976 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.704 ' HE3' ' HG3' ' A' ' 4' ' ' GLU . 27.5 ttpp -92.32 -11.54 34.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.387 0.613 . . . . 0.0 109.999 177.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -104.68 22.04 15.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.628 -174.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.506 HG13 ' H ' ' A' ' 11' ' ' PHE . 39.4 pt -76.51 -25.93 16.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.869 -177.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.7 t30 67.52 6.26 4.84 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.09 0.556 . . . . 0.0 111.635 176.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.506 ' H ' HG13 ' A' ' 9' ' ' ILE . 22.4 m-85 66.86 177.16 0.23 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.465 -177.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 68.81 -50.6 0.58 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.041 -171.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.582 ' HB3' HG11 ' A' ' 16' ' ' VAL . 15.5 m -67.81 92.62 0.36 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.285 168.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.8 mt -96.3 137.34 24.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.462 -177.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 94.3 m-20 66.86 24.96 9.63 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.842 0.714 . . . . 0.0 110.971 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.582 HG11 ' HB3' ' A' ' 13' ' ' SER . 11.7 m -102.01 157.24 4.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.642 0.258 . . . . 0.0 110.855 -176.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.56 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 5.3 p -146.47 157.45 11.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.083 0.468 . . . . 0.0 111.488 -176.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.712 ' HB3' ' HA3' ' A' ' 5' ' ' GLY . 9.7 tp10 -82.66 -55.18 4.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.617 174.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.704 ' HA ' ' CE2' ' A' ' 62' ' ' TYR . 18.7 t-20 -136.72 160.38 39.0 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.854 -173.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.1 mt -53.3 -35.06 59.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.38 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -65.42 -31.54 72.69 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.726 0.298 . . . . 0.0 111.008 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.415 ' HB3' HG23 ' A' ' 6' ' ' ILE . 31.5 mm-40 -79.42 -15.5 57.71 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.408 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.09 111.6 6.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 0.0 110.394 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.796 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 10.6 mmpt? -88.08 145.67 25.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.318 0.58 . . . . 0.0 111.928 -177.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 58.13 -166.12 0.16 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.677 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -105.26 72.22 0.23 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.097 -175.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.527 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -108.04 149.9 39.71 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 174.373 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.859 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 53.3 Cg_exo -54.11 141.55 68.76 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.573 2.182 . . . . 0.0 111.416 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 m -111.68 120.61 42.6 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.875 0.369 . . . . 0.0 111.169 -175.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.454 HD12 ' CD2' ' A' ' 88' ' ' PHE . 17.3 mm -106.85 122.5 60.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.674 ' HB ' ' CG2' ' A' ' 87' ' ' VAL . 69.2 mt -114.69 115.65 50.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.919 -174.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.5 tpt -109.85 116.5 31.77 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.678 177.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.644 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 85.4 m-85 -83.64 118.28 23.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.347 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.936 ' HE2' ' HB3' ' A' ' 63' ' ' TYR . 6.4 pttt -132.39 146.54 52.04 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.416 -169.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m -67.8 138.54 56.24 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 158.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 18.8 t0 -57.14 -32.63 66.56 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.076 0.465 . . . . 0.0 111.075 -168.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.1 m -124.6 92.35 3.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.428 173.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 18.2 p -138.3 142.01 33.67 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.338 177.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.48 -28.1 62.14 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.383 2.056 . . . . 0.0 112.927 -177.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -66.83 -31.09 71.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.913 0.387 . . . . 0.0 110.291 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 45' ' ' GLN . 53.0 t -71.75 -35.07 69.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.008 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 45.5 t -69.59 -46.11 76.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.558 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.467 ' HG2' HD21 ' A' ' 102' ' ' LEU . 4.4 tp10 -61.64 -49.64 75.76 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.755 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.419 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 19.8 ttt -66.58 -29.12 69.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.197 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.517 ' HB2' ' O ' ' A' ' 41' ' ' CYS . 23.0 tm0? -60.0 -41.78 92.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.016 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -62.82 -47.81 81.81 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 51' ' ' VAL . 16.2 mm-40 -57.84 -47.34 82.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.522 177.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.484 HD13 HD13 ' A' ' 61' ' ' ILE . 97.9 mt -58.67 -41.7 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.731 178.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.9 m -57.17 -41.56 79.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.638 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.539 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 21.1 m-85 -65.95 -37.04 84.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.737 178.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 47' ' ' GLU . 41.2 t -72.63 -50.68 32.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.931 -177.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.7 m -60.73 -31.54 70.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 0.0 111.121 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -57.65 -29.96 65.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.382 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -110.38 -2.04 16.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.987 -175.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.54 ' HB2' ' HG3' ' A' ' 58' ' ' LYS . 17.1 ptp180 -146.73 97.69 2.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.004 0.906 . . . . 0.0 110.768 174.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.24 133.05 35.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.953 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.06 35.95 71.84 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.462 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.54 ' HG3' ' HB2' ' A' ' 55' ' ' ARG . 41.4 mmtm -112.43 -4.05 14.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.933 0.397 . . . . 0.0 110.963 -178.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 28' ' ' PRO . 6.2 p90 -176.03 138.31 0.34 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.191 173.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.56 ' OD1' ' HB ' ' A' ' 17' ' ' VAL . 7.5 t-20 -105.6 124.04 48.91 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.554 HD12 HG12 ' A' ' 16' ' ' VAL . 40.5 mt -89.22 107.61 18.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.291 0.567 . . . . 0.0 111.207 -175.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.704 ' CE2' ' HA ' ' A' ' 19' ' ' ASN . 10.7 t80 -88.49 106.19 18.12 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.89 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.936 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 75.6 m-85 -78.93 102.29 8.2 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.347 176.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.615 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -85.85 74.48 10.18 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.24 0.543 . . . . 0.0 109.859 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.933 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 12.4 ptt85 -63.55 116.98 6.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.787 175.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.7 tp -74.24 9.57 1.59 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.033 0.444 . . . . 0.0 110.473 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.533 ' HB2' ' HB2' ' A' ' 36' ' ' ASP . 0.3 OUTLIER -82.53 -18.65 40.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.191 -175.877 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -113.21 154.51 26.61 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.187 0.518 . . . . 0.0 111.128 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.407 ' HG3' ' H ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -65.15 -32.55 74.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.207 -172.812 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -26.56 68.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.021 0.439 . . . . 0.0 111.672 -175.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.477 ' HA ' ' CB ' ' A' ' 74' ' ' LEU . 91.2 m-20 -90.51 1.11 57.01 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.48 -176.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.6 mm -70.69 -50.43 44.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 173.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -72.78 -34.08 66.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.481 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.477 ' CB ' ' HA ' ' A' ' 71' ' ' ASN . 1.1 tm? -60.18 -45.82 91.8 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.644 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -57.59 -49.99 74.57 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.994 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -64.41 -34.76 78.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.927 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -62.44 -20.06 64.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.965 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.574 ' HB3' HG11 ' A' ' 87' ' ' VAL . 77.3 m-85 -124.55 15.95 8.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.076 -177.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.8 t70 65.22 27.3 12.22 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.927 0.87 . . . . 0.0 110.826 172.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.72 104.01 15.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.425 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -107.1 -39.74 5.64 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.75 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.1 pt -107.08 171.93 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.033 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.04 145.02 53.96 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.733 174.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.02 157.26 84.09 Favored 'Cis proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.36 -1.517 . . . . 0.0 112.606 -0.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.554 ' OG1' ' HB2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -145.84 129.33 16.94 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.771 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.7 m -123.26 116.38 23.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.224 0.535 . . . . 0.0 111.45 -176.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.674 ' CG2' ' HB ' ' A' ' 31' ' ' ILE . 13.2 m -102.86 135.05 42.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.176 174.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.529 ' HB3' HD22 ' A' ' 115' ' ' LEU . 79.5 m-85 -107.15 112.79 25.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.499 -176.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.465 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 6.2 mp -111.17 145.79 38.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.727 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.545 ' OD1' ' HA3' ' A' ' 116' ' ' GLY . 10.6 t70 -80.11 -165.87 0.92 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -79.4 8.59 5.93 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -168.463 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -127.42 21.22 6.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.87 0.367 . . . . 0.0 111.187 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.28 14.32 74.11 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.95 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -85.59 125.38 33.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.063 0.459 . . . . 0.0 109.957 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.492 ' HD3' HG22 ' A' ' 98' ' ' VAL . 5.0 tmmm? -82.68 109.54 16.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.888 -177.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.406 ' HB3' ' CD1' ' A' ' 115' ' ' LEU . 92.2 t80 -97.26 -59.72 1.73 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.24 -177.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.432 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 76.8 t80 -119.7 149.21 42.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.651 0.262 . . . . 0.0 110.801 -173.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.541 HG13 HG12 ' A' ' 87' ' ' VAL . 9.6 t -130.74 139.84 50.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.432 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 6.2 t60 -147.86 133.49 18.82 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.455 ' CD ' HG22 ' A' ' 85' ' ' THR . 3.3 mm-40 -106.32 158.37 16.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.623 0.249 . . . . 0.0 110.342 -173.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.96 -153.12 20.74 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.588 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.467 HD21 ' HG2' ' A' ' 43' ' ' GLU . 57.8 tp -114.21 120.98 42.32 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.739 0.304 . . . . 0.0 110.475 -176.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 74.9 mtp -111.21 162.24 15.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.893 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -105.44 171.2 7.46 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.174 -0.21 . . . . 0.0 110.537 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.539 ' HD2' ' HB3' ' A' ' 50' ' ' TYR . 52.5 tttp -47.4 -58.83 3.71 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.726 0.641 . . . . 0.0 111.974 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 3.8 m-20 -53.73 -33.56 56.04 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.081 0.467 . . . . 0.0 111.834 -176.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.534 ' O ' HG12 ' A' ' 111' ' ' ILE . 5.7 m120 -73.72 -46.57 45.29 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.355 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.567 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 57.1 mt -58.78 -43.56 88.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.767 174.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 105' ' ' LYS . 71.6 mm-40 -48.71 -56.37 8.76 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.844 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.5 m -72.4 -37.82 68.58 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.486 -174.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 107' ' ' ASN . 38.8 mm -63.43 -41.62 93.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.839 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 86.5 mt -62.44 -39.03 92.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.92 0.391 . . . . 0.0 110.155 176.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -62.81 -37.4 86.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.745 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.5 t -76.98 -37.51 55.03 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.581 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 88' ' ' PHE . 51.8 tp -57.94 -70.93 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.614 178.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.545 ' HA3' ' OD1' ' A' ' 90' ' ' ASP . . . -175.44 -74.44 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.01 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.859 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 85.6 t 55.72 76.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.971 0.891 . . . . 0.0 109.847 -174.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 118' ' ' LYS . 20.6 pttm -159.34 103.18 1.6 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.469 -174.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -71.25 -40.34 71.07 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.54 8.28 77.51 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.73 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -81.5 93.78 6.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.109 0.48 . . . . 0.0 110.273 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -126.05 108.29 11.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.474 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -83.7 120.96 26.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.127 0.489 . . . . 0.0 110.568 -177.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -90.41 -22.98 21.18 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -76.09 170.6 15.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.367 173.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.08 -174.364 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.628 ' HB3' HG11 ' A' ' 16' ' ' VAL . 33.4 m . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 121.237 0.541 . . . . 0.0 109.718 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 15' ' ' ASN . 96.1 mt -107.02 146.09 13.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.56 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 84.4 m-20 71.21 13.94 6.68 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.602 0.564 . . . . 0.0 110.159 -174.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.628 HG11 ' HB3' ' A' ' 13' ' ' SER . 4.5 m -105.4 166.27 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.889 -174.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.707 HG21 ' HB2' ' A' ' 23' ' ' ALA . 12.4 m -141.34 147.99 21.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.427 ' H ' ' HG2' ' A' ' 18' ' ' GLU . 1.6 mm-40 -64.19 -51.09 65.43 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.264 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.863 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 14.5 t-20 -148.36 169.3 20.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.732 -176.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.631 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 56.9 mt -60.48 -27.53 67.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.912 0.387 . . . . 0.0 110.305 174.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -57.44 -33.8 68.31 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.79 174.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -91.03 -27.41 18.65 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.972 0.415 . . . . 0.0 110.871 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.707 ' HB2' HG21 ' A' ' 17' ' ' VAL . . . -71.9 156.82 38.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.596 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.494 ' HD2' ' O ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -131.89 -177.81 4.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.606 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.501 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -103.73 174.96 5.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.622 -175.561 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.69 -62.86 1.93 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.738 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -77.66 127.69 81.71 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 1.016 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 85.9 Cg_exo -48.58 143.74 15.51 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.806 2.337 . . . . 0.0 112.1 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.484 HG23 ' OD1' ' A' ' 60' ' ' ASN . 23.8 m -115.64 124.51 51.09 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.225 -171.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 30' ' ' ILE . 2.9 mp -109.22 117.62 54.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.653 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 2.3 mm -105.62 116.43 49.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.063 -175.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.48 ' O ' ' HG3' ' A' ' 32' ' ' MET . 26.5 ptm -110.77 112.3 24.07 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.707 0.765 . . . . 0.0 110.107 174.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 81.6 m-85 -83.64 128.32 34.43 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.018 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.638 ' HE2' ' CB ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -142.77 142.27 31.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.696 -175.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.445 ' O ' ' HE3' ' A' ' 34' ' ' LYS . 1.2 p -75.0 170.87 15.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 174.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -49.68 -74.55 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 O-C-N 123.358 0.411 . . . . 0.0 110.798 176.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -88.88 110.84 21.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.961 0.41 . . . . 0.0 110.316 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.499 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 5.9 p -152.73 121.32 3.21 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.037 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 8.0 Cg_exo -72.11 -35.97 6.33 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.523 2.149 . . . . 0.0 112.839 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -61.81 -24.37 66.83 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.591 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.628 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 49.7 t -61.95 -50.12 73.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.069 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.5 t -59.49 -44.84 93.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 5.7 tp10 -55.79 -46.79 77.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.928 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.507 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 23.4 ttt -73.85 -30.49 62.7 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.053 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.628 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 27.8 mt-30 -59.43 -48.44 81.62 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 121.458 -0.097 . . . . 0.0 110.988 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -65.54 -36.06 82.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.522 0.201 . . . . 0.0 111.196 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -59.03 -44.86 91.81 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.18 0.514 . . . . 0.0 109.812 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.806 HD13 HG21 ' A' ' 61' ' ' ILE . 97.9 mt -62.42 -35.91 80.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.056 178.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -58.89 -40.63 85.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.916 0.389 . . . . 0.0 110.228 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.472 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 20.2 m-85 -65.7 -43.31 89.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.322 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.441 HG22 ' HG3' ' A' ' 105' ' ' LYS . 48.7 t -62.1 -42.66 95.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.464 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.4 m -65.74 -31.69 72.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.13 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -61.24 -40.52 94.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.73 176.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.56 -10.37 54.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.586 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.85 84.3 1.97 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.957 0.408 . . . . 0.0 111.168 -177.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -78.98 123.51 27.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.916 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.42 73.92 0.37 Allowed Glycine 0 C--N 1.332 0.313 0 O-C-N 123.596 0.56 . . . . 0.0 113.297 173.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.922 ' HD2' HG12 ' A' ' 117' ' ' VAL . 9.6 mmtt -144.14 -36.73 0.33 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.987 0.423 . . . . 0.0 110.941 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.405 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 39.1 p90 -144.88 168.87 19.2 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.57 HD22 HG12 ' A' ' 27' ' ' ILE . 8.9 p30 -118.25 137.9 52.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.27 0.557 . . . . 0.0 110.723 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.806 HG21 HD13 ' A' ' 48' ' ' LEU . 52.6 mt -104.08 109.72 28.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.118 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.863 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 2.6 t80 -95.01 118.51 31.96 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.926 0.393 . . . . 0.0 110.559 -178.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.521 ' CE1' ' HG2' ' A' ' 45' ' ' GLN . 81.0 m-85 -83.45 103.26 12.67 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 173.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.519 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -90.8 86.15 6.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.377 0.608 . . . . 0.0 109.968 -173.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.638 ' CB ' ' HE2' ' A' ' 34' ' ' LYS . 17.8 ptt180 -77.49 129.01 35.16 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.508 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.3 tp -73.2 12.32 0.59 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.71 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.598 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 10.4 mt-10 -79.98 -13.63 59.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.574 -175.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -116.88 170.48 8.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.338 -173.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.48 -33.53 25.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.158 -176.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.621 ' HD2' ' H ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -61.95 -26.41 68.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.894 0.378 . . . . 0.0 110.702 -177.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.648 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 78.5 m-20 -87.79 3.77 46.89 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.909 -176.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.8 mt -72.17 -58.68 4.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 171.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.49 -38.8 84.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.137 175.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.648 ' HB2' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -56.09 -46.18 79.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.199 176.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.26 -56.45 19.86 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.686 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -67.56 -33.54 75.25 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.573 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -63.36 -24.6 67.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.983 0.42 . . . . 0.0 110.788 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.568 ' CE1' HD21 ' A' ' 89' ' ' LEU . 95.0 m-85 -122.05 22.48 10.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.884 -176.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 66.95 29.17 8.3 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.523 0.514 . . . . 0.0 111.556 166.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.402 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -87.33 113.56 23.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.885 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.532 ' ND2' HG13 ' A' ' 82' ' ' ILE . 3.8 p-10 -138.71 -2.53 1.73 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.271 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.532 HG13 ' ND2' ' A' ' 81' ' ' ASN . 50.5 mt -136.78 142.22 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 34' ' ' LYS . 99.5 t -101.15 129.3 27.39 Favored Pre-proline 0 C--N 1.319 -0.729 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.667 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 58.4 Cg_endo -95.11 135.18 5.24 Favored 'Cis proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.423 -1.49 . . . . 0.0 113.42 -0.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.594 HG23 ' HG2' ' A' ' 100' ' ' GLN . 19.9 m -87.73 107.5 18.67 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.2 m -100.94 108.03 19.66 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.653 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 6.8 p -108.2 126.16 64.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.445 0.64 . . . . 0.0 110.128 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 1.005 ' HB3' HD11 ' A' ' 115' ' ' LEU . 89.0 m-85 -99.22 119.4 37.83 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.579 -177.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.568 HD21 ' CE1' ' A' ' 78' ' ' TYR . 5.6 mp -115.31 141.73 47.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.817 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 25.1 t70 -75.15 -164.48 0.31 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.526 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 6.1 pttm -53.3 -42.86 67.05 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -168.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.492 ' OE1' ' HG2' ' A' ' 91' ' ' LYS . 0.5 OUTLIER -99.26 6.06 46.41 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.056 -0.403 . . . . 0.0 111.396 -176.268 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.562 ' HA2' ' HB3' ' A' ' 89' ' ' LEU . . . 94.66 30.2 8.7 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.759 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 10.0 m120 -70.92 106.49 3.65 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.403 -0.469 . . . . 0.0 109.93 173.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.452 ' HG3' ' CG2' ' A' ' 87' ' ' VAL . 39.0 ttpt -64.69 100.41 0.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 176.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -98.45 -50.38 4.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.291 -176.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.511 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 91.7 t80 -137.47 122.0 18.44 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.171 -0.611 . . . . 0.0 111.8 -174.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.551 HG12 HG23 ' A' ' 87' ' ' VAL . 11.5 m -103.14 147.04 10.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 172.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.511 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 15.9 t60 -145.4 119.01 9.12 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.594 ' HG2' HG23 ' A' ' 85' ' ' THR . 39.3 mt-30 -102.93 106.22 16.73 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 143.41 160.84 8.58 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.445 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.533 HD21 ' HG2' ' A' ' 43' ' ' GLU . 45.9 tp -71.56 149.75 45.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.935 0.398 . . . . 0.0 111.243 -176.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 69.9 mtm -141.03 -170.14 2.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.19 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.491 HH12 ' CD ' ' A' ' 43' ' ' GLU . 33.2 mmt180 -131.27 165.97 22.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.378 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.472 ' HD2' ' HB3' ' A' ' 50' ' ' TYR . 55.6 tttm -44.7 -56.83 4.1 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.116 0.885 . . . . 0.0 112.299 -176.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -51.93 -47.31 64.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.345 0.593 . . . . 0.0 111.601 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.609 ' O ' HG12 ' A' ' 111' ' ' ILE . 47.0 m-20 -73.84 -40.45 63.29 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.931 -172.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.533 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 60.9 mt -60.21 -47.02 93.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.577 0.703 . . . . 0.0 109.301 174.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -62.98 -39.95 96.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.219 -175.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 57.9 m -64.42 -35.93 82.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.162 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 107' ' ' ASN . 40.8 mm -70.26 -34.95 60.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.632 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 20.9 mt -60.38 -42.89 96.79 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.714 0.769 . . . . 0.0 108.987 174.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -62.1 -30.39 70.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.901 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.9 m -76.05 -30.25 58.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.977 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 1.005 HD11 ' HB3' ' A' ' 88' ' ' PHE . 51.6 mt -70.58 -59.95 2.54 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 122.185 0.993 . . . . 0.0 109.081 174.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 145.86 -44.95 0.83 Allowed Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.371 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.016 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 19.2 t 46.58 61.35 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 122.112 0.958 . . . . 0.0 109.397 -176.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 mttm . . . . . 0 CA--C 1.512 -0.5 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.848 -169.309 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.506 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 14.9 m . . . . . 0 N--CA 1.444 -0.753 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.416 ' O ' HG22 ' A' ' 14' ' ' ILE . 46.7 mt -86.66 2.87 4.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.792 0.806 . . . . 0.0 110.69 -174.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -117.47 16.37 14.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.623 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 12.6 p -85.01 143.59 11.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -171.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.952 ' HB ' ' HB2' ' A' ' 22' ' ' GLU . 27.5 m -128.34 152.95 37.15 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.222 169.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -75.51 -35.1 60.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.349 -174.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.732 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 51.5 t30 -163.41 -176.09 4.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.692 -177.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.1 mt -61.52 -30.6 70.74 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.4 mp0 -56.87 -45.56 82.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.329 176.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.952 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . 5.4 mm-40 -76.69 -24.76 53.17 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.591 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.91 153.25 43.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.682 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.589 ' NZ ' ' HA ' ' A' ' 24' ' ' LYS . 2.4 tpmp? -145.4 156.26 43.66 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.995 -175.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -73.51 179.88 3.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.049 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.85 -59.82 4.87 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -175.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.419 HG13 ' HB2' ' A' ' 60' ' ' ASN . 6.5 pt -90.32 121.9 68.02 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.525 -0.338 . . . . 0.0 110.165 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.945 ' HG3' ' H ' ' A' ' 117' ' ' VAL . 16.5 Cg_endo -57.26 138.51 86.55 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.64 2.227 . . . . 0.0 111.009 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.2 m -103.52 123.76 47.51 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.256 0.551 . . . . 0.0 111.923 -172.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.607 HD11 HD11 ' A' ' 112' ' ' LEU . 75.2 mt -98.63 113.26 32.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 173.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.759 ' HB ' HG23 ' A' ' 87' ' ' VAL . 58.4 mt -107.03 111.98 37.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.35 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.458 ' HG2' ' HD1' ' A' ' 63' ' ' TYR . 21.8 ptm -109.8 129.63 55.61 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.061 176.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.554 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 92.0 m-85 -94.33 112.78 24.59 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.605 ' HB2' ' HB3' ' A' ' 41' ' ' CYS . 55.6 pttt -117.75 138.73 51.84 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.446 -170.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.467 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 0.7 OUTLIER -71.18 149.67 46.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.969 174.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -70.31 -45.12 66.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.98 -177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.2 t -94.75 9.77 37.67 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.467 ' SG ' ' HB ' ' A' ' 35' ' ' THR . 76.6 m -106.72 122.19 42.6 Favored Pre-proline 0 C--N 1.327 -0.409 0 O-C-N 121.845 -0.535 . . . . 0.0 111.065 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 6.3 Cg_exo -78.01 -2.88 12.97 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.391 2.061 . . . . 0.0 113.179 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -65.57 -15.95 63.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.935 0.397 . . . . 0.0 110.796 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.605 ' HB3' ' HB2' ' A' ' 34' ' ' LYS . 24.9 p -68.84 -43.79 74.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.818 175.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.2 t -62.89 -30.63 49.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.279 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.529 ' HA ' ' NZ ' ' A' ' 46' ' ' LYS . 7.5 tp10 -58.69 -51.99 67.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.346 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.9 ttt -75.03 -37.31 61.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.54 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.498 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 16.5 mt-30 -59.2 -43.64 92.23 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.76 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.529 ' NZ ' ' HA ' ' A' ' 43' ' ' GLU . 22.7 pttm -70.13 -41.87 73.35 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.446 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.542 ' O ' HG23 ' A' ' 51' ' ' VAL . 24.1 mm-40 -51.03 -49.91 59.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.898 0.38 . . . . 0.0 110.386 172.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.435 HD13 HG21 ' A' ' 61' ' ' ILE . 71.2 mt -60.73 -37.66 82.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.515 177.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.8 m -67.59 -37.35 82.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.782 0.325 . . . . 0.0 110.712 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -65.12 -33.5 76.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.523 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 47' ' ' GLU . 21.7 t -73.2 -40.89 58.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.892 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.2 m -56.84 -30.65 64.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.142 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.524 ' HZ3' ' HB3' ' A' ' 53' ' ' LYS . 4.6 ttpm? -52.49 -36.53 55.28 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.756 176.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -109.84 -18.44 13.41 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.204 0.526 . . . . 0.0 110.756 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.58 ' HB3' ' HB2' ' A' ' 58' ' ' LYS . 11.5 mpt_? -111.96 74.55 0.87 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.367 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.73 116.48 22.7 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.84 35.14 91.58 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.467 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.58 ' HB2' ' HB3' ' A' ' 55' ' ' ARG . 12.7 mptt -101.76 -20.02 15.12 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -165.41 153.99 11.76 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.165 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.419 ' HB2' HG13 ' A' ' 27' ' ' ILE . 39.8 t-20 -103.92 138.1 40.97 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.339 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.435 HG21 HD13 ' A' ' 48' ' ' LEU . 11.0 mt -117.34 111.87 36.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.714 0.292 . . . . 0.0 110.943 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.732 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 3.3 t80 -98.84 118.41 35.52 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.498 ' CE1' ' HG2' ' A' ' 45' ' ' GLN . 21.7 m-85 -94.65 103.57 15.5 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.398 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.554 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -80.58 87.16 5.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.163 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.501 ' C ' ' H ' ' A' ' 67' ' ' GLU . 1.8 ptm180 -69.59 123.71 22.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.139 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 34' ' ' LYS . 5.4 tp -69.75 11.2 0.29 Allowed 'General case' 0 C--N 1.322 -0.613 0 O-C-N 122.025 -0.422 . . . . 0.0 110.933 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 65' ' ' ARG . 21.0 mt-10 -82.47 -19.73 38.28 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.7 -173.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.44 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 46.2 mt-10 -117.04 151.29 37.09 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -59.81 -31.03 69.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.103 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.451 ' HD2' ' OD1' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -58.95 -25.92 63.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.268 -178.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.451 ' OD1' ' HD2' ' A' ' 70' ' ' LYS . 10.4 m120 -91.19 -12.18 36.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.963 -176.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.5 mt -71.16 -48.63 53.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.98 -43.56 92.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.762 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -58.52 -42.88 88.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.403 178.514 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.26 -57.38 12.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.441 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -67.23 -33.25 74.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.608 0.242 . . . . 0.0 111.258 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.417 ' HB2' ' NZ ' ' A' ' 77' ' ' LYS . 3.3 ttmp? -63.01 -28.85 70.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.972 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -112.01 8.23 20.11 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 71.72 26.84 3.0 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.599 0.562 . . . . 0.0 111.877 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.75 103.67 10.75 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.175 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -117.72 -35.45 3.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.823 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 12.4 mt -112.57 130.1 66.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.49 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.8 m -102.35 140.47 21.16 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.67 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -86.82 147.7 35.56 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.34 -1.525 . . . . 0.0 112.085 -0.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.0 t -140.78 149.73 42.46 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.4 t -140.71 142.01 34.88 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.22 0.533 . . . . 0.0 110.606 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.816 HG12 HG12 ' A' ' 98' ' ' VAL . 6.2 m -115.49 127.89 72.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.79 176.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.416 ' CD1' ' HD2' ' A' ' 97' ' ' TYR . 83.0 m-85 -97.56 118.74 34.75 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.485 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 6.4 mp -108.35 141.51 40.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.79 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 46.6 t0 -80.18 -179.19 6.94 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.463 ' HZ3' ' CD ' ' A' ' 92' ' ' GLU . 7.9 pttm -49.57 -32.11 11.93 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -175.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.524 ' HB2' HD22 ' A' ' 94' ' ' ASN . 32.6 mp0 -69.26 -29.0 66.81 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 122.087 -0.383 . . . . 0.0 111.338 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.33 30.37 7.01 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.972 -173.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.524 HD22 ' HB2' ' A' ' 92' ' ' GLU . 9.9 p30 -105.59 132.99 51.06 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 175.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.423 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 16.6 ptmt -75.73 117.79 17.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.832 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -106.45 -54.83 2.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.989 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.419 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 73.0 t80 -109.61 135.17 51.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.105 -174.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.816 HG12 HG12 ' A' ' 87' ' ' VAL . 29.3 m -111.82 148.02 15.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.419 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 38.0 t60 -145.84 131.84 19.25 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -117.9 149.81 40.26 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 176.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.38 -124.0 8.1 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.62 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.415 ' HG ' ' N ' ' A' ' 103' ' ' MET . 27.3 tp -136.53 167.94 20.43 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 122.731 -0.276 . . . . 0.0 110.336 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.415 ' N ' ' HG ' ' A' ' 102' ' ' LEU . 20.3 ptm -168.6 147.08 4.17 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.405 ' HD3' ' HA ' ' A' ' 104' ' ' ARG . 23.3 mmt180 -89.87 168.67 11.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.18 -177.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -53.07 -41.46 64.9 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.234 -177.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -65.83 -35.37 80.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.876 0.37 . . . . 0.0 110.475 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.529 ' O ' HG12 ' A' ' 111' ' ' ILE . 11.7 m120 -64.48 -47.32 79.4 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.2 mt -59.32 -50.8 78.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.099 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -51.88 -50.14 61.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.746 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.2 m -65.16 -38.15 89.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.659 0.266 . . . . 0.0 111.094 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 107' ' ' ASN . 39.9 mm -63.61 -47.26 92.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 177.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.607 HD11 HD11 ' A' ' 30' ' ' ILE . 83.2 mt -62.66 -39.43 93.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.047 0.451 . . . . 0.0 110.055 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -54.71 -44.85 73.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.239 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.5 m -86.14 -23.87 26.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.878 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.0 tp -91.12 -64.97 1.05 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -175.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.69 ' HA2' ' HZ3' ' A' ' 118' ' ' LYS . . . -139.03 -122.82 2.04 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 119.989 -1.1 . . . . 0.0 113.816 -169.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.945 ' H ' ' HG3' ' A' ' 28' ' ' PRO . 12.7 t 58.44 35.14 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 122.152 0.977 . . . . 0.0 109.075 -173.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HZ3' ' HA2' ' A' ' 116' ' ' GLY . 37.2 mtmm . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.223 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.806 ' HB3' HG21 ' A' ' 16' ' ' VAL . 44.8 m . . . . . 0 N--CA 1.441 -0.919 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.9 mt -108.41 -61.21 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.885 0.374 . . . . 0.0 111.092 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 7.2 m-20 -85.25 30.18 0.62 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.662 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.806 HG21 ' HB3' ' A' ' 13' ' ' SER . 20.4 m -91.54 155.56 3.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -166.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.55 HG11 ' HB2' ' A' ' 23' ' ' ALA . 47.1 t -136.21 143.01 37.04 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.441 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -71.97 -45.89 59.39 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.201 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.62 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 19.1 t30 -164.02 176.12 9.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.831 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.669 HD11 HD11 ' A' ' 74' ' ' LEU . 86.2 mt -49.03 -36.7 18.63 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -174.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.545 ' OE2' ' HB3' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -77.24 -27.42 53.32 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -172.329 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -77.73 -10.65 59.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.713 0.292 . . . . 0.0 111.355 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.55 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -87.9 171.43 10.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.955 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.721 ' HZ3' ' HB3' ' A' ' 24' ' ' LYS . 4.2 mtpm? -136.08 152.89 51.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.011 0.434 . . . . 0.0 111.644 177.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.65 170.77 15.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.542 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.3 -29.02 5.83 Favored Glycine 0 CA--C 1.504 -0.619 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.598 ' HB ' ' HA ' ' A' ' 59' ' ' PHE . 22.9 pt -113.55 131.08 23.17 Favored Pre-proline 0 C--N 1.315 -0.899 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 1.051 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 54.7 Cg_exo -56.59 162.79 7.79 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 123.047 2.498 . . . . 0.0 113.111 -174.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.1 m -122.97 122.66 39.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.179 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.436 HD12 ' N ' ' A' ' 30' ' ' ILE . 2.5 mp -104.61 109.19 26.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 174.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.423 HG12 ' HB3' ' A' ' 62' ' ' TYR . 64.3 mt -105.45 113.85 43.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.468 -177.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.491 ' O ' ' HG3' ' A' ' 32' ' ' MET . 25.1 ptm -108.91 112.99 25.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.639 0.733 . . . . 0.0 110.057 178.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.744 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 90.1 m-85 -76.36 114.12 14.71 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.535 177.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.523 ' HG3' ' SG ' ' A' ' 41' ' ' CYS . 0.1 OUTLIER -138.77 148.99 44.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.133 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.0 t -97.99 -173.2 2.54 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -55.99 -51.44 67.72 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.701 0.625 . . . . 0.0 110.769 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -92.73 -162.52 0.94 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.615 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.436 ' HB3' ' HD2' ' A' ' 40' ' ' TYR . 50.7 m 74.61 106.02 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.491 0 C-N-CA 123.639 0.776 . . . . 0.0 110.993 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 2.7 Cg_exo -74.74 3.45 5.46 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.561 2.174 . . . . 0.0 113.145 -176.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.436 ' HD2' ' HB3' ' A' ' 38' ' ' CYS . 80.0 m-85 -65.3 -27.28 68.5 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.523 ' SG ' ' HG3' ' A' ' 34' ' ' LYS . 42.3 t -64.58 -55.05 22.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.646 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.531 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 12.7 p -63.42 -31.09 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.772 0.32 . . . . 0.0 110.99 -175.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -68.14 -49.49 60.67 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.214 0.53 . . . . 0.0 110.21 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.1 ttt -67.75 -29.4 68.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.174 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 51.8 mt-30 -61.21 -38.7 87.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.128 175.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.531 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 81.5 mttt -60.1 -49.34 78.05 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.382 0.611 . . . . 0.0 109.671 175.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.551 ' O ' HG23 ' A' ' 51' ' ' VAL . 9.9 mm-40 -57.06 -48.79 77.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.413 176.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.474 HD13 HG21 ' A' ' 61' ' ' ILE . 91.9 mt -60.12 -29.79 68.85 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.29 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 68.6 m -62.12 -47.46 84.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.068 0.461 . . . . 0.0 110.412 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -73.02 -33.56 65.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.28 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 47' ' ' GLU . 57.8 t -67.46 -36.73 77.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.106 0.479 . . . . 0.0 110.167 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.0 m -66.26 -30.74 71.23 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.053 175.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -74.03 -28.78 61.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.391 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -70.47 -47.26 61.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.086 174.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.651 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 1.2 ttm180 -123.43 75.18 1.3 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.808 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -69.79 118.51 12.73 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.749 -172.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.46 50.76 60.61 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.575 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.651 ' HB2' ' HG2' ' A' ' 55' ' ' ARG . 39.0 mmtm -136.03 8.59 3.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.693 0.282 . . . . 0.0 110.79 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.598 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 50.5 p90 -169.93 149.03 3.59 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.488 ' ND2' HG13 ' A' ' 27' ' ' ILE . 15.3 m-80 -88.86 135.19 33.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.484 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.474 HG21 HD13 ' A' ' 48' ' ' LEU . 60.7 mt -114.68 106.18 20.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 168.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.62 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 4.0 t80 -96.32 116.67 29.4 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -76.93 103.95 7.15 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 174.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.744 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -77.45 72.82 4.02 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.699 ' HD2' ' OE2' ' A' ' 68' ' ' GLU . 2.6 ptp180 -69.61 109.79 4.5 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 113.624 -1.625 . . . . 0.0 111.515 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.8 tp -72.24 4.67 3.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.729 -177.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.673 ' CD ' ' HB2' ' A' ' 65' ' ' ARG . 5.6 pm0 -83.04 -13.98 54.75 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.121 0.486 . . . . 0.0 110.056 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.699 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 62.1 mt-10 -106.55 144.29 33.44 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.912 175.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -21.38 62.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.034 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.519 ' HG3' ' HB3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -55.8 -23.25 28.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.221 0.534 . . . . 0.0 112.026 177.099 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.652 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 22.7 m-20 -88.1 8.96 24.31 Favored 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -177.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 77.7 mt -71.47 -50.71 38.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 168.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -68.03 -48.67 65.04 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.52 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.669 HD11 HD11 ' A' ' 20' ' ' LEU . 4.4 mm? -58.4 -41.66 85.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.373 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.458 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -56.76 -56.65 18.83 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 120.501 0.191 . . . . 0.0 111.047 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -65.32 -33.95 77.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.758 0.313 . . . . 0.0 111.042 -176.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.557 ' HZ2' ' HB2' ' A' ' 77' ' ' LYS . 4.1 ttmp? -64.2 -25.61 68.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.112 0.482 . . . . 0.0 110.88 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.688 ' HB3' HG21 ' A' ' 87' ' ' VAL . 89.2 m-85 -120.34 22.71 11.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.015 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 68.44 16.84 9.19 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.334 0.588 . . . . 0.0 111.333 169.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' A' ' 75' ' ' ALA . . . -83.94 140.51 31.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.908 -176.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -151.76 -40.2 0.11 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.65 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 22.8 pt -116.73 160.44 16.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.975 173.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.07 152.52 60.13 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.924 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -91.84 149.57 16.61 Favored 'Cis proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.038 -1.651 . . . . 0.0 112.428 -0.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.8 t -138.06 129.82 28.27 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.1 m -108.5 123.25 48.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.931 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.688 HG21 ' HB3' ' A' ' 78' ' ' TYR . 67.1 t -105.16 117.65 51.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.78 176.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -96.03 111.11 23.22 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.402 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -100.04 138.95 36.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.337 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.8 -172.67 0.53 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.616 ' NZ ' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -67.14 -26.14 66.52 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.068 -0.395 . . . . 0.0 112.056 -176.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.616 ' HG2' ' NZ ' ' A' ' 91' ' ' LYS . 38.6 mm-40 -75.05 -47.11 30.54 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.91 20.99 1.42 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.814 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 92' ' ' GLU . 43.7 m-80 -78.13 133.1 37.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -71.04 86.35 0.73 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.202 176.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -86.73 -51.59 6.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.206 -172.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -137.5 125.91 23.42 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.454 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.6 m -112.14 149.51 14.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 173.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -146.27 122.39 10.8 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.41 115.08 27.73 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 135.37 -168.72 23.69 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.3 tp -90.54 149.85 22.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.77 0.319 . . . . 0.0 110.46 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 56.1 mmm -127.09 161.6 28.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.417 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 10.1 mmm180 -113.37 168.53 9.66 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.4 ' HE2' ' HB2' ' A' ' 105' ' ' LYS . 14.3 ptmm? -57.3 -47.62 81.03 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -172.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.505 ' HA ' ' OE1' ' A' ' 109' ' ' GLU . 14.8 t-20 -64.23 -32.29 73.82 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.97 0.414 . . . . 0.0 111.2 -177.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.543 ' O ' HG12 ' A' ' 111' ' ' ILE . 9.3 m120 -65.03 -45.79 84.01 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.568 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 53.1 mt -62.94 -50.04 81.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.066 175.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.505 ' OE1' ' HA ' ' A' ' 106' ' ' ASN . 43.7 mt-10 -51.28 -49.77 60.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.755 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.5 m -66.69 -43.91 83.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.008 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 107' ' ' ASN . 40.4 mm -60.22 -43.61 93.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.497 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 57.5 mt -59.91 -39.77 86.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 0.0 111.238 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -61.21 -41.14 96.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.325 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.3 m -86.06 -17.43 35.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.912 0.387 . . . . 0.0 111.443 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.9 tp -66.84 -54.39 22.92 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.626 -173.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.681 ' O ' ' HG2' ' A' ' 118' ' ' LYS . . . 136.69 13.29 0.97 Allowed Glycine 0 N--CA 1.442 -0.967 0 C-N-CA 119.862 -1.161 . . . . 0.0 112.872 -177.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.051 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 61.9 t -43.14 100.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.152 0.501 . . . . 0.0 111.888 167.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 29.7 pttt . . . . . 0 C--O 1.221 -0.438 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 120.574 0.226 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.0 mt 70.96 -60.1 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.066 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.525 HD21 ' HA2' ' A' ' 57' ' ' GLY . 14.6 m120 -83.3 30.4 0.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.263 0.554 . . . . 0.0 110.749 177.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.583 HG23 ' CE2' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -80.1 126.73 39.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.622 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.537 HG11 ' HB2' ' A' ' 23' ' ' ALA . 73.2 t -119.74 132.97 68.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.943 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -71.24 -54.69 10.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.159 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.634 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 7.0 t30 -155.08 169.56 23.83 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.11 -173.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.1 mt -46.73 -45.16 19.45 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.634 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -77.28 -17.74 58.12 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.282 0.563 . . . . 0.0 110.247 -176.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -87.82 17.88 4.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.035 171.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.537 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -122.59 160.41 25.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.301 176.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.433 ' HG3' ' HG2' ' A' ' 25' ' ' GLU . 11.8 ptmm? -173.86 -168.95 0.45 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.521 ' HB2' HD12 ' A' ' 27' ' ' ILE . 4.6 mm-40 75.55 -170.72 0.09 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.106 0.879 . . . . 0.0 110.789 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.586 ' O ' ' HE2' ' A' ' 91' ' ' LYS . . . -117.4 38.18 3.06 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.198 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.666 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -100.81 155.56 36.19 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 110.513 -0.18 . . . . 0.0 110.513 -178.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.722 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 32.5 Cg_exo -60.09 144.61 99.47 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.444 2.096 . . . . 0.0 111.63 173.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.9 m -110.96 115.13 28.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.683 -176.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.2 mt -98.71 107.98 21.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.659 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 55.4 mt -99.93 111.94 31.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.147 0.498 . . . . 0.0 109.875 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.542 ' HA ' ' O ' ' A' ' 85' ' ' THR . 8.3 tpt -109.35 108.93 19.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.27 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.585 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 74.3 m-85 -80.2 152.26 29.24 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.678 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.719 ' HE2' ' HB3' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -159.98 155.74 25.94 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 175.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.573 ' HA ' ' HB2' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -67.72 -173.09 0.31 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 173.66 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.405 ' H ' HG22 ' A' ' 35' ' ' THR . 7.9 p-10 -51.31 -45.55 62.26 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.752 0.31 . . . . 0.0 110.748 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.6 p -137.96 -98.02 0.19 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.33 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.622 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 34.3 m 65.71 130.13 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 123.465 0.706 . . . . 0.0 111.731 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 13.9 Cg_exo -67.96 -33.61 25.65 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.085 1.857 . . . . 0.0 113.143 -177.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -64.66 -28.68 69.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.912 0.387 . . . . 0.0 110.822 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 38' ' ' CYS . 52.3 m -70.26 -36.56 74.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.987 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 45' ' ' GLN . 41.4 t -75.38 -33.21 27.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.427 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.98 -51.11 63.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.195 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.461 ' HE3' ' HB2' ' A' ' 103' ' ' MET . 25.5 ttt -68.21 -29.37 68.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.193 0.52 . . . . 0.0 109.717 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' A' ' 42' ' ' VAL . 4.6 tp60 -58.12 -38.99 77.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.575 174.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.692 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -67.81 -42.23 81.87 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.402 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 51' ' ' VAL . 7.6 mm-40 -57.9 -45.27 86.7 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.346 0.404 . . . . 0.0 110.479 173.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.544 HD23 HD13 ' A' ' 108' ' ' ILE . 96.1 mt -58.16 -44.13 87.77 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.897 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.1 m -60.21 -37.9 81.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.662 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.565 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 20.2 m-85 -74.85 -28.55 60.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.993 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 47' ' ' GLU . 68.7 t -65.47 -44.25 94.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.6 m -65.32 -31.54 72.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.369 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 50' ' ' TYR . 41.8 tttm -58.73 -39.25 80.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.809 173.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 50' ' ' TYR . 31.6 mm-40 -85.69 -17.9 34.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.843 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.589 ' NE ' ' HA ' ' A' ' 55' ' ' ARG . 3.0 tpm_? -153.0 88.93 1.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 111.569 -176.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.28 147.07 28.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.348 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.525 ' HA2' HD21 ' A' ' 15' ' ' ASN . . . 59.17 39.86 95.01 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.773 -0.648 . . . . 0.0 114.497 171.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 28' ' ' PRO . 69.5 mmtt -133.28 1.52 3.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.207 0.504 . . . . 0.0 110.791 175.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -170.46 153.69 4.39 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.436 ' HB3' HG21 ' A' ' 17' ' ' VAL . 83.1 m-20 -121.28 138.25 54.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.847 0.356 . . . . 0.0 110.428 177.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.5 mp -101.94 108.26 23.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.212 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.695 ' OH ' ' HG ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -89.55 115.23 26.8 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 177.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.719 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 86.9 m-85 -95.07 104.18 16.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.02 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.65 ' C ' HD21 ' A' ' 71' ' ' ASN . . . -87.77 107.01 18.45 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.692 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 9.7 ptt180 -105.56 130.24 53.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.228 -177.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.769 HD12 HD22 ' A' ' 71' ' ' ASN . 8.0 mp -71.85 7.73 1.45 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.152 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.685 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 44.7 mt-10 -62.14 -34.26 76.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.415 0.626 . . . . 0.0 109.485 169.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.698 ' HB2' ' HD2' ' A' ' 70' ' ' LYS . 35.6 mt-10 -104.58 172.95 6.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.53 -170.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.471 ' CD ' ' H ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -94.79 -24.35 17.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.779 -177.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.698 ' HD2' ' HB2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -54.27 -17.55 3.03 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.197 0.522 . . . . 0.0 111.862 176.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.769 HD22 HD12 ' A' ' 66' ' ' LEU . 5.7 m-20 -80.58 -9.76 59.77 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.2 mm -61.56 -58.75 6.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.602 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -70.54 -40.87 73.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.627 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.695 ' HG ' ' OH ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -62.93 -46.5 87.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.691 -176.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.585 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -62.49 -49.52 75.05 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.71 0.291 . . . . 0.0 110.916 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -65.92 -33.93 76.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.06 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -61.8 -25.22 67.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.999 0.428 . . . . 0.0 110.878 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 33' ' ' PHE . 90.2 m-85 -124.48 23.05 8.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.911 -176.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 66.03 25.7 10.9 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.595 0.559 . . . . 0.0 111.442 166.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.76 97.53 8.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.851 0.358 . . . . 0.0 111.238 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -106.07 -36.09 7.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.16 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.9 pt -132.74 141.39 45.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.966 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 84' ' ' PRO . 34.7 m -102.57 157.78 33.04 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.434 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 83' ' ' VAL . 20.8 Cg_exo -67.29 150.48 83.01 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.054 -1.227 . . . . 0.0 112.401 -0.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 32' ' ' MET . 1.2 m -135.06 108.35 7.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -176.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.04 109.04 16.97 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.001 0.429 . . . . 0.0 110.822 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.659 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 12.6 p -100.78 123.97 54.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.516 0.674 . . . . 0.0 109.362 175.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.534 ' HB3' HD22 ' A' ' 115' ' ' LEU . 85.4 m-85 -99.01 110.43 23.04 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.497 -176.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.629 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 6.7 mp -102.83 129.65 49.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.734 176.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -68.35 169.83 9.94 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.774 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.586 ' HE2' ' O ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -61.76 -14.33 31.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -175.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.67 -5.39 58.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 111.26 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.81 10.8 71.86 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.604 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 8.6 p30 -86.67 131.32 34.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.806 0.336 . . . . 0.0 110.66 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.629 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 20.5 ptmt -77.28 87.17 3.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.217 0.532 . . . . 0.0 109.859 175.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -74.79 -53.64 8.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.618 -173.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.53 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 63.4 t80 -137.54 114.46 10.65 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.866 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 87' ' ' VAL . 4.4 p -96.66 137.0 25.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 172.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.53 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 48.6 t60 -134.1 134.29 42.1 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -175.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.41 131.91 54.64 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 173.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 122.75 173.38 14.15 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.264 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.8 tp -82.01 141.12 33.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.824 0.345 . . . . 0.0 111.323 -175.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.461 ' HB2' ' HE3' ' A' ' 44' ' ' MET . 78.4 mmm -134.15 161.29 35.29 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.413 ' O ' HG13 ' A' ' 108' ' ' ILE . 17.5 mmm180 -106.86 171.52 7.32 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.524 ' HE2' ' HB3' ' A' ' 50' ' ' TYR . 36.5 ttmt -46.62 -60.29 2.47 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.6 0.562 . . . . 0.0 112.004 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.569 ' HA ' ' OE1' ' A' ' 109' ' ' GLU . 6.7 t-20 -67.66 -27.46 66.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.065 0.46 . . . . 0.0 111.12 -174.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.496 ' O ' HG12 ' A' ' 111' ' ' ILE . 13.1 m120 -67.4 -42.76 82.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.544 HD13 HD23 ' A' ' 48' ' ' LEU . 56.7 mt -61.7 -46.15 97.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.369 173.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.569 ' OE1' ' HA ' ' A' ' 106' ' ' ASN . 50.9 mt-10 -52.79 -48.03 67.16 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.539 176.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.1 m -61.27 -37.5 83.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.095 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 107' ' ' ASN . 49.7 mm -69.04 -43.79 81.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.328 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.535 ' HB3' ' CG2' ' A' ' 117' ' ' VAL . 72.8 mt -61.7 -39.22 90.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.907 0.384 . . . . 0.0 110.107 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -58.15 -38.05 75.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.799 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.0 m -86.22 -5.74 59.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.029 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.534 HD22 ' HB3' ' A' ' 88' ' ' PHE . 53.9 tp -93.47 -66.72 0.9 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.704 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 174.9 -72.23 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.78 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.722 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 21.4 t 55.32 29.62 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 122.493 1.14 . . . . 0.0 109.719 -177.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.433 ' O ' ' HD2' ' A' ' 91' ' ' LYS . 17.8 pttm . . . . . 0 N--CA 1.447 -0.575 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.962 -175.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.551 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 6.8 m . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 13' ' ' SER . 74.5 mt 74.0 -63.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 123.733 0.645 . . . . 0.0 110.37 -174.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.717 ' HB3' ' HA2' ' A' ' 57' ' ' GLY . 0.5 OUTLIER -87.83 32.08 0.75 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.333 0.587 . . . . 0.0 110.581 174.513 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.672 HG23 ' CE1' ' A' ' 63' ' ' TYR . 1.2 p -86.61 111.35 21.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.789 174.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.584 ' HB ' ' HB2' ' A' ' 22' ' ' GLU . 20.8 m -114.0 136.42 50.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.107 0.479 . . . . 0.0 109.933 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -65.54 -54.46 27.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.894 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.749 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 4.9 t30 -144.87 179.33 7.4 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.295 -174.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.414 HD11 HD23 ' A' ' 74' ' ' LEU . 96.5 mt -48.1 -42.0 27.81 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.261 0.624 . . . . 0.0 112.578 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -58.25 -32.22 68.15 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.584 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . 21.1 mt-10 -84.25 -6.07 59.34 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.49 151.73 26.38 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.188 -0.32 . . . . 0.0 111.136 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -172.41 -171.07 0.77 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 2.4 tp10 72.26 -174.01 0.16 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.43 1.092 . . . . 0.0 111.215 178.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.462 ' H ' ' HG3' ' A' ' 25' ' ' GLU . . . -106.26 36.81 4.16 Favored Glycine 0 CA--C 1.504 -0.611 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.594 HG21 ' HA ' ' A' ' 58' ' ' LYS . 17.6 pt -105.93 150.16 38.91 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 114.45 -0.875 . . . . 0.0 111.228 -170.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 1.062 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 62.5 Cg_exo -57.05 158.94 16.12 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.984 2.456 . . . . 0.0 112.304 175.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.6 m -115.9 121.78 43.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.929 -175.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.483 HD11 HD21 ' A' ' 112' ' ' LEU . 80.0 mt -110.17 108.75 26.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.617 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 61.0 mt -105.57 113.78 43.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.824 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.9 ptm -110.25 120.49 42.62 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.515 0.674 . . . . 0.0 109.474 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.512 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 87.3 m-85 -78.73 125.56 29.53 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.505 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.679 ' HE2' ' HB3' ' A' ' 65' ' ' ARG . 29.2 pttt -116.7 -174.26 2.54 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.755 -171.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.447 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 2.1 m -144.98 154.57 42.7 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.446 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 1.8 t70 -47.58 -51.9 19.55 Favored 'General case' 0 C--N 1.32 -0.674 0 O-C-N 124.239 0.962 . . . . 0.0 111.558 174.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.2 m -116.76 98.74 6.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.64 0.257 . . . . 0.0 111.637 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.447 ' SG ' ' HB ' ' A' ' 35' ' ' THR . 7.3 p -169.46 113.44 0.51 Allowed Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.901 171.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.568 ' O ' HG12 ' A' ' 42' ' ' VAL . 2.4 Cg_endo -80.49 -4.62 13.07 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.533 2.155 . . . . 0.0 113.605 -175.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -74.77 -21.8 59.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.834 0.35 . . . . 0.0 110.477 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 82.5 m -68.53 -43.45 76.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.817 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 39' ' ' PRO . 9.8 p -65.56 -29.31 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 120.93 0.395 . . . . 0.0 110.702 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.665 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -65.14 -48.76 72.45 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.28 0.562 . . . . 0.0 109.68 177.43 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 25.2 ttt -67.69 -30.16 69.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.867 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.563 ' HG2' ' CE2' ' A' ' 63' ' ' TYR . 27.0 mt-30 -56.22 -40.76 74.56 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.384 173.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.665 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 3.6 mtpm? -59.1 -53.98 52.21 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.174 0.511 . . . . 0.0 110.259 177.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -62.21 -41.3 98.26 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.971 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.642 HD13 HG21 ' A' ' 61' ' ' ILE . 84.3 mt -62.22 -43.04 99.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.472 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.3 m -53.61 -44.24 69.29 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.73 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -63.73 -61.7 2.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.219 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.8 t -57.08 -32.16 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.2 0.524 . . . . 0.0 111.284 -175.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.545 ' HB3' ' OD1' ' A' ' 15' ' ' ASN . 68.0 m -66.83 -30.48 70.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.789 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -83.49 -31.14 26.66 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.066 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -71.14 -15.4 62.5 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.424 0.631 . . . . 0.0 110.865 174.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.671 ' HA ' HH11 ' A' ' 55' ' ' ARG . 0.5 OUTLIER -141.86 77.62 1.59 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 174.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.579 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 1.3 pm0 -58.27 115.63 3.07 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -161.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.717 ' HA2' ' HB3' ' A' ' 15' ' ' ASN . . . 50.69 33.23 26.38 Favored Glycine 0 CA--C 1.52 0.35 0 CA-C-N 115.012 -0.995 . . . . 0.0 114.43 173.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.594 ' HA ' HG21 ' A' ' 27' ' ' ILE . 27.3 mmtp -109.73 14.93 23.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.571 0.701 . . . . 0.0 111.279 -176.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -159.66 111.03 2.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.199 166.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.427 HD22 HG13 ' A' ' 27' ' ' ILE . 10.8 p30 -76.48 131.38 38.99 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.093 -174.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.642 HG21 HD13 ' A' ' 48' ' ' LEU . 30.1 mm -97.87 108.49 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.445 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.749 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 1.4 t80 -95.87 110.97 23.07 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.672 ' CE1' HG23 ' A' ' 16' ' ' VAL . 36.8 m-85 -90.77 102.04 14.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.059 177.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -78.97 103.98 9.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.8 0.333 . . . . 0.0 111.424 -172.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.679 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 13.6 ptp180 -68.29 123.95 22.15 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.307 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.0 tp -79.8 8.15 7.32 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 121.808 -0.557 . . . . 0.0 109.969 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.453 ' OE1' ' HB2' ' A' ' 65' ' ' ARG . 2.4 mp0 -84.07 -28.02 27.87 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.199 -172.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -119.21 -177.52 3.37 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -170.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -36.3 20.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.121 -169.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HD2' ' H ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -57.56 -29.57 64.51 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.876 0.846 . . . . 0.0 110.758 -179.234 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.92 -11.32 58.27 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.032 -174.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.4 mm -67.85 -44.56 85.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -67.49 -47.51 69.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.54 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.414 HD23 HD11 ' A' ' 20' ' ' LEU . 2.0 tm? -60.31 -46.18 90.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.553 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.88 -43.52 98.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.488 0.185 . . . . 0.0 110.831 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -63.09 -34.19 77.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 0.0 110.805 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -60.74 -16.85 44.36 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.367 0.604 . . . . 0.0 111.622 176.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.455 ' CD2' ' HE3' ' A' ' 95' ' ' LYS . 32.4 m-85 -124.3 4.02 8.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.435 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.6 t70 54.29 33.8 19.1 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.952 0.882 . . . . 0.0 110.425 -174.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.69 84.75 7.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.004 -176.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -103.14 5.05 37.63 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.934 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.6 pt -128.68 141.21 47.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.777 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 m -127.97 143.63 48.5 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.738 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -92.54 136.14 7.86 Favored 'Cis proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.579 -1.426 . . . . 0.0 111.983 -1.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.68 128.43 54.9 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.937 0.399 . . . . 0.0 111.022 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.4 m -109.29 118.07 35.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.425 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.617 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 14.8 p -108.29 135.46 46.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.083 0.468 . . . . 0.0 110.13 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -111.0 114.62 28.07 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.551 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.523 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 4.8 mp -117.24 143.14 46.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.829 177.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.507 ' HA ' ' HB3' ' A' ' 28' ' ' PRO . 5.4 t0 -80.73 179.64 7.7 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 170.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.767 ' HE2' ' HE2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -74.4 -14.19 60.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.92 0.391 . . . . 0.0 110.56 -177.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -70.8 -12.34 61.49 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.713 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.64 11.65 63.65 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.13 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 34.6 m-80 -79.0 113.93 17.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.693 0.283 . . . . 0.0 111.295 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.523 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 57.6 mtpt -71.43 95.47 1.36 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.205 172.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -87.58 -54.46 4.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.626 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -134.24 148.95 50.92 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.561 -172.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.406 HG12 HG23 ' A' ' 87' ' ' VAL . 30.0 m -129.54 147.1 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.599 174.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -140.16 139.02 35.65 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -104.43 122.65 45.94 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.555 0.534 . . . . 0.0 109.767 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.52 -161.78 17.89 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.988 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.428 HD21 ' OE1' ' A' ' 43' ' ' GLU . 44.0 tp -90.03 164.33 14.55 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 122.651 0.38 . . . . 0.0 111.154 -174.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.401 ' N ' ' HG ' ' A' ' 102' ' ' LEU . 58.3 mtm -149.45 172.12 15.48 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 122.937 0.495 . . . . 0.0 110.054 174.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.431 ' HA ' ' HD3' ' A' ' 104' ' ' ARG . 8.0 mmt180 -100.95 163.14 12.44 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.47 ' HA ' HD12 ' A' ' 108' ' ' ILE . 6.3 ptpp? -56.1 -40.98 74.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -62.15 -30.6 71.16 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.927 0.394 . . . . 0.0 111.525 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.54 ' O ' HG12 ' A' ' 111' ' ' ILE . 10.3 m120 -67.93 -45.74 73.47 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 176.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.605 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 50.1 mt -58.93 -48.1 87.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.586 174.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -50.13 -50.41 48.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.363 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.9 m -65.47 -40.33 93.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.318 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 107' ' ' ASN . 47.5 mm -67.1 -41.12 86.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.712 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.638 ' HB3' HG21 ' A' ' 117' ' ' VAL . 87.5 mt -59.59 -39.95 85.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.114 0.483 . . . . 0.0 109.942 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -61.21 -36.71 80.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.015 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 62.6 m -85.36 -16.72 38.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.63 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.6 tp -78.38 -81.91 0.1 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.084 0.468 . . . . 0.0 110.039 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.411 ' HA3' ' OD2' ' A' ' 90' ' ' ASP . . . 171.49 -54.95 0.18 Allowed Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 174.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.062 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 29.1 t 50.42 78.23 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.059 0 CA-C-O 121.561 0.696 . . . . 0.0 111.308 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.767 ' HE2' ' HE2' ' A' ' 91' ' ' LYS . 28.3 mtmm . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.753 -175.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.691 ' HB3' HG11 ' A' ' 16' ' ' VAL . 50.4 m . . . . . 0 C--O 1.225 -0.211 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 15' ' ' ASN . 94.9 mt -99.07 146.75 7.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.475 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 82.5 m-20 75.26 14.63 2.98 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.935 0.772 . . . . 0.0 109.985 -173.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.691 HG11 ' HB3' ' A' ' 13' ' ' SER . 2.4 m -107.88 157.28 8.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.431 -176.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 p -129.57 149.09 33.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.349 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -64.02 -56.39 15.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.184 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.724 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 3.0 t30 -157.95 177.96 10.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.382 -0.827 . . . . 0.0 108.831 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.418 ' HG ' ' CE2' ' A' ' 62' ' ' TYR . 30.7 mt -59.45 -30.77 68.74 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.08 -38.64 70.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.294 0.569 . . . . 0.0 110.659 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -87.94 -5.5 58.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.28 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.507 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -85.48 162.98 18.72 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -172.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 23' ' ' ALA . 4.6 mtmm -167.21 90.77 0.37 Allowed 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 124.78 1.232 . . . . 0.0 107.883 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.34 107.43 18.26 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -159.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -116.28 12.05 16.67 Favored Glycine 0 CA--C 1.503 -0.673 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 159.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.46 ' C ' ' HA ' ' A' ' 91' ' ' LYS . 3.0 pt -122.18 152.9 61.11 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 113.22 -1.49 . . . . 0.0 108.529 -176.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.593 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 50.3 Cg_exo -55.62 122.68 12.17 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 121.816 1.677 . . . . 0.0 111.719 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.5 m -99.0 115.8 29.77 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.944 -176.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.514 HD11 HD11 ' A' ' 112' ' ' LEU . 2.1 mp -98.42 108.21 21.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 176.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.682 ' HB ' HG23 ' A' ' 87' ' ' VAL . 62.4 mt -108.45 110.72 33.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.289 -176.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.506 ' HB3' HG23 ' A' ' 86' ' ' THR . 5.0 ppp? -117.2 142.7 46.71 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.022 176.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.661 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 82.7 m-85 -102.15 144.49 30.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.68 -174.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.878 ' HE2' ' HB3' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -138.85 135.59 34.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.024 177.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.4 m -81.71 162.09 23.11 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -50.52 -49.69 55.03 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.27 0.356 . . . . 0.0 111.539 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.3 m -109.32 95.79 5.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.628 0.251 . . . . 0.0 111.275 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.3 p -165.54 131.35 2.02 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 111.462 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.564 ' O ' HG12 ' A' ' 42' ' ' VAL . 64.0 Cg_endo -77.86 -19.69 12.34 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.382 2.055 . . . . 0.0 112.809 177.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.583 ' HB3' ' HG3' ' A' ' 84' ' ' PRO . 54.8 m-85 -58.9 -24.03 61.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.064 0.459 . . . . 0.0 110.82 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 45.3 t -64.12 -50.44 68.22 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.641 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 39' ' ' PRO . 10.0 p -68.34 -32.82 57.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.022 -174.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.601 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 16.2 mt-10 -65.87 -49.91 66.41 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 120.667 0.27 . . . . 0.0 110.993 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -36.96 85.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.917 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.544 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 25.8 mt-30 -60.74 -44.73 96.3 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 176.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 9.8 mtpm? -56.58 -53.68 54.8 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.064 0.459 . . . . 0.0 111.042 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 12.3 mm-40 -62.64 -43.86 97.74 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.131 -174.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.526 HD13 HG21 ' A' ' 61' ' ' ILE . 47.6 mt -59.68 -43.11 94.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.954 175.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.4 m -58.77 -41.18 86.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.05 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.417 ' CD2' ' HA ' ' A' ' 47' ' ' GLU . 24.6 m-85 -59.79 -48.72 80.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.054 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.685 HG22 ' HG3' ' A' ' 105' ' ' LYS . 3.0 t -60.48 -43.37 94.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.039 0.447 . . . . 0.0 110.539 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -62.75 -30.83 71.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.376 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -56.94 -38.04 72.36 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.163 0.506 . . . . 0.0 110.522 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -94.42 2.53 55.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.458 -172.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.554 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 9.4 ptp180 -156.76 85.49 0.97 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.918 0.866 . . . . 0.0 111.553 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.43 ' HA ' HD21 ' A' ' 15' ' ' ASN . 1.1 pm0 -76.68 128.45 34.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.082 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.32 41.51 98.15 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.667 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.554 ' HG2' ' HB2' ' A' ' 55' ' ' ARG . 13.9 mptt -108.63 -27.4 9.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.227 0.537 . . . . 0.0 110.009 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -158.56 154.58 26.87 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.082 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 15' ' ' ASN . 50.2 t30 -108.84 134.05 52.05 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.907 0.384 . . . . 0.0 110.302 -177.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.688 HD12 HG12 ' A' ' 16' ' ' VAL . 34.0 mt -106.78 108.74 25.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.757 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.724 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -96.94 119.93 36.33 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.878 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 68.6 m-85 -94.4 103.47 15.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.598 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.18 101.18 13.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.069 0.461 . . . . 0.0 110.764 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.571 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 29.0 ptt180 -91.75 131.38 37.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.011 178.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.07 9.79 1.81 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.428 0.632 . . . . 0.0 111.215 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.44 ' HB3' ' HD2' ' A' ' 65' ' ' ARG . 57.1 tt0 -78.43 -22.55 47.5 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.543 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.496 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 45.7 mt-10 -110.39 140.24 44.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.043 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.673 ' HA ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -59.06 -35.41 73.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.159 0.584 . . . . 0.0 112.516 -174.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.496 ' HE3' ' HB3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -58.97 -27.99 65.9 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.934 0.397 . . . . 0.0 111.22 -177.611 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.485 ' HA ' ' CB ' ' A' ' 74' ' ' LEU . 87.2 m-20 -92.37 2.68 56.51 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.189 -175.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.673 HD13 ' HA ' ' A' ' 69' ' ' GLU . 1.4 mp -71.09 -52.46 27.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.97 -46.17 89.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.811 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.485 ' CB ' ' HA ' ' A' ' 71' ' ' ASN . 0.5 OUTLIER -55.05 -44.47 74.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.567 179.409 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.661 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -55.93 -56.38 21.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.52 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -70.46 -33.12 70.92 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.577 -176.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.447 ' HE3' ' HB2' ' A' ' 77' ' ' LYS . 21.7 ttmt -67.04 -17.19 64.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.355 0.598 . . . . 0.0 110.737 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.448 ' HB2' ' HZ ' ' A' ' 33' ' ' PHE . 51.1 m-85 -118.61 23.67 11.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.391 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 73.15 10.98 5.15 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.095 166.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.09 93.56 7.04 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.33 0.586 . . . . 0.0 111.034 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -101.8 -12.54 18.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.796 175.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 23.9 pt -136.81 -179.51 2.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.641 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.48 145.1 47.83 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.685 0.279 . . . . 0.0 111.117 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.716 ' HD2' ' HA2' ' A' ' 101' ' ' GLY . 97.9 Cg_endo -93.87 120.14 2.84 Favored 'Cis proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.258 -1.559 . . . . 0.0 112.529 -1.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.428 ' O ' ' HD1' ' A' ' 33' ' ' PHE . 70.0 m -92.36 124.54 36.49 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.506 HG23 ' HB3' ' A' ' 32' ' ' MET . 10.5 m -114.57 116.41 28.74 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.213 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.705 HG12 HG12 ' A' ' 98' ' ' VAL . 13.6 m -100.69 123.09 53.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.296 0.57 . . . . 0.0 110.112 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.765 ' HB3' HD11 ' A' ' 115' ' ' LEU . 86.7 m-85 -99.47 110.3 22.79 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.992 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.671 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 5.8 mp -107.1 143.48 35.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.586 175.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.546 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 13.4 t70 -88.18 -165.45 1.32 Allowed 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.625 175.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.546 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -52.28 -35.52 50.45 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -169.311 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -107.73 18.85 20.88 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.666 -173.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.37 23.67 50.22 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.832 172.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.671 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 32.0 m-80 -77.06 112.65 13.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 117.391 0.595 . . . . 0.0 110.757 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -68.19 85.38 0.25 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -84.42 -45.21 12.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.296 -173.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.458 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 90.9 t80 -140.23 129.32 23.58 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.365 -176.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.705 HG12 HG12 ' A' ' 87' ' ' VAL . 15.0 m -107.92 148.01 12.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 172.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.458 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 62.6 t60 -136.76 128.81 29.49 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -177.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -99.82 120.57 39.96 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.716 ' HA2' ' HD2' ' A' ' 84' ' ' PRO . . . 101.91 166.71 27.09 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -175.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.45 ' CD1' ' H ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -93.1 169.22 10.58 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 117.198 0.499 . . . . 0.0 110.181 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.6 ptt? -157.14 168.07 28.52 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.405 ' N ' ' HD2' ' A' ' 104' ' ' ARG . 5.5 mmm180 -91.29 174.11 7.56 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.975 -171.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.685 ' HG3' HG22 ' A' ' 51' ' ' VAL . 55.0 tttm -46.46 -55.19 7.83 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.851 0.719 . . . . 0.0 112.469 -176.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -59.27 -34.78 72.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 0.0 111.334 -175.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -69.31 -50.15 49.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.145 0.498 . . . . 0.0 109.774 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.501 ' O ' HD22 ' A' ' 112' ' ' LEU . 41.7 mt -60.5 -49.56 83.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.933 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.488 ' HA ' HD23 ' A' ' 112' ' ' LEU . 35.0 tt0 -56.31 -47.77 78.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.452 -174.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.6 m -59.91 -31.36 69.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.441 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.563 ' O ' ' HG ' ' A' ' 115' ' ' LEU . 66.6 mt -72.6 -33.8 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.065 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.593 ' HB3' HG21 ' A' ' 117' ' ' VAL . 2.7 mm? -62.53 -38.7 90.99 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.187 172.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -63.81 -27.39 69.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.646 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.6 t -85.75 -14.03 46.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.061 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.765 HD11 ' HB3' ' A' ' 88' ' ' PHE . 95.7 mt -85.17 -73.98 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.383 0.611 . . . . 0.0 109.766 176.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 173.67 -59.81 0.14 Allowed Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.332 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.593 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 39.3 t 52.22 41.84 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 122.951 1.358 . . . . 0.0 108.021 -175.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.7 pttm . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 113.901 -1.5 . . . . 0.0 112.58 -165.383 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.465 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 13.2 m . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.619 0.247 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.3 mt 69.06 -68.8 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.881 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.23 59.66 5.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.563 0.697 . . . . 0.0 110.121 174.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.465 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 1.0 OUTLIER -98.26 128.85 49.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.886 177.104 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.576 HG22 ' HG3' ' A' ' 22' ' ' GLU . 2.4 t -124.62 141.6 44.21 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-O 121.633 0.73 . . . . 0.0 112.567 -172.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -76.76 -35.49 57.69 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 113.864 -1.516 . . . . 0.0 112.38 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.757 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 66.0 t30 -172.6 -178.85 2.03 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.407 ' H ' ' CG ' ' A' ' 19' ' ' ASN . 83.5 mt -60.38 -29.66 69.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.757 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -78.57 -31.67 47.38 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.094 0.406 . . . . 0.0 110.988 -178.433 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.576 ' HG3' HG22 ' A' ' 17' ' ' VAL . 3.9 tp10 -72.42 -11.88 60.87 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.679 0.752 . . . . 0.0 109.876 170.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.485 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -95.14 171.73 8.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.435 -177.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.521 ' NZ ' ' HB3' ' A' ' 24' ' ' LYS . 4.3 mtpm? -135.01 167.32 21.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.125 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.487 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -86.44 174.81 8.74 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.267 170.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.02 -61.58 1.59 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.76 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -87.79 127.47 57.9 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-O 120.88 0.371 . . . . 0.0 110.047 178.081 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.923 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 50.9 Cg_exo -56.22 145.28 77.79 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.397 2.065 . . . . 0.0 111.118 176.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.5 m -119.54 129.61 54.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.18 0.514 . . . . 0.0 111.979 -172.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.615 HD11 HD21 ' A' ' 112' ' ' LEU . 79.6 mt -98.48 121.51 49.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.722 HG12 ' HB3' ' A' ' 62' ' ' TYR . 61.2 mt -118.58 119.85 62.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.146 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.431 ' O ' ' HG3' ' A' ' 32' ' ' MET . 26.5 ptm -108.0 117.48 34.24 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.983 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.492 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 87.4 m-85 -86.41 114.2 22.99 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.361 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.731 ' HG3' ' SG ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -138.71 145.15 39.96 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.741 -174.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 m -66.92 136.18 54.97 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 164.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -65.03 -39.38 93.3 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.792 -164.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 m -98.18 92.99 6.0 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.822 0.344 . . . . 0.0 111.153 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.659 ' SG ' ' HB2' ' A' ' 41' ' ' CYS . 25.7 p -160.87 142.68 9.12 Favored Pre-proline 0 CA--C 1.519 -0.236 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.351 174.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -64.92 -34.39 48.47 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.499 2.133 . . . . 0.0 112.48 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -68.66 -21.62 64.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 -177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.731 ' SG ' ' HG3' ' A' ' 34' ' ' LYS . 39.7 t -61.33 -53.43 56.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.022 175.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.23 -34.3 69.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.835 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -63.48 -50.24 70.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.403 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -71.74 -31.03 66.24 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.547 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 22.8 mt-30 -63.17 -33.59 75.79 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.543 173.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 41.6 mmtt -64.66 -46.65 81.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.548 175.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 51' ' ' VAL . 58.2 mm-40 -52.29 -54.52 30.44 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 123.572 0.545 . . . . 0.0 109.557 175.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.456 HD23 HD13 ' A' ' 108' ' ' ILE . 63.7 mt -57.37 -43.56 83.66 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.792 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.1 t -60.75 -39.94 90.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.164 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -76.36 -30.29 57.52 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.842 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.854 HG22 ' HG3' ' A' ' 105' ' ' LYS . 41.9 t -66.12 -39.54 84.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.254 0.55 . . . . 0.0 109.61 172.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.508 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 31.3 m -64.23 -31.66 72.95 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.889 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' A' ' 53' ' ' LYS . 4.2 mmmp? -74.44 -10.91 60.03 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.737 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -102.72 -8.72 20.63 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.23 0.538 . . . . 0.0 109.676 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.768 ' CZ ' ' HA ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -158.07 75.7 0.76 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.281 -178.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 52' ' ' SER . 20.1 mp0 -79.07 141.34 37.45 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.252 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.5 25.55 60.89 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.991 171.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.655 ' HB3' ' HG3' ' A' ' 55' ' ' ARG . 16.9 tptp -117.07 -21.82 8.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.352 0.596 . . . . 0.0 109.738 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.413 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 43.9 p90 -140.56 161.19 38.32 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 172.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -112.42 151.88 29.33 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 121.128 -0.229 . . . . 0.0 110.681 -174.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.3 mt -127.07 111.81 26.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.921 0.391 . . . . 0.0 111.124 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.722 ' HB3' HG12 ' A' ' 31' ' ' ILE . 2.5 t80 -103.24 119.74 39.43 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.547 ' CE1' ' HG2' ' A' ' 45' ' ' GLN . 87.1 m-85 -90.44 103.92 16.55 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.788 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -80.82 94.35 6.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.406 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.484 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -88.13 116.31 26.23 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.37 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 mp -66.36 11.58 0.08 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.871 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.421 ' H ' ' C ' ' A' ' 65' ' ' ARG . 35.0 tt0 -78.46 -32.09 48.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.757 0.789 . . . . 0.0 109.36 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -98.43 140.75 32.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.976 -172.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -31.48 72.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.886 -175.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HD2' ' OE2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -57.67 -19.09 24.37 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 178.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.579 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 52.4 m-80 -87.08 -2.51 58.68 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.729 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 84.5 mt -70.3 -56.8 9.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -64.6 -40.04 94.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.219 175.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 71' ' ' ASN . 0.4 OUTLIER -58.89 -47.18 85.88 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.033 178.204 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -62.71 -45.65 91.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.772 0.32 . . . . 0.0 111.226 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -62.93 -34.56 77.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.314 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -57.58 -31.11 65.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.018 0.437 . . . . 0.0 111.142 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -111.81 1.98 16.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.422 -176.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.3 t70 60.66 48.02 7.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.912 0.863 . . . . 0.0 110.332 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.38 116.13 28.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.364 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -107.81 -57.86 2.05 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.891 -171.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 36.6 pt -119.72 154.2 22.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.088 0.47 . . . . 0.0 111.078 -177.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.2 m -102.62 153.7 37.99 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.868 -177.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -89.66 127.91 7.64 Favored 'Cis proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.057 -1.643 . . . . 0.0 112.277 -0.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.419 HG23 ' HB2' ' A' ' 33' ' ' PHE . 9.0 t -120.81 134.3 55.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.077 0.465 . . . . 0.0 109.995 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.3 m -115.21 125.26 53.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.941 -176.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.4 HG22 HG23 ' A' ' 98' ' ' VAL . 66.3 t -105.24 127.87 59.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.046 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -107.83 114.42 28.36 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.242 0.544 . . . . 0.0 110.224 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.541 ' HB3' ' HA2' ' A' ' 93' ' ' GLY . 58.3 mt -99.16 142.29 30.83 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.69 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 6.4 t70 -71.25 -165.46 0.13 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.966 ' HD3' ' HG3' ' A' ' 118' ' ' LYS . 9.7 pttm -61.58 -31.73 71.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -170.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.463 ' HB2' ' ND2' ' A' ' 94' ' ' ASN . 4.8 mp0 -96.32 1.88 52.3 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.91 -0.494 . . . . 0.0 110.838 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.541 ' HA2' ' HB3' ' A' ' 89' ' ' LEU . . . 85.93 26.53 34.27 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.061 -176.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 92' ' ' GLU . 63.4 m-80 -85.34 141.06 30.3 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 176.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.3 94.15 5.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.594 -174.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -84.23 -52.33 6.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.108 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 72.0 t80 -133.86 144.85 49.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 -178.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.4 HG23 HG22 ' A' ' 87' ' ' VAL . 3.4 p -136.47 136.95 48.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.427 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 74.8 t60 -120.18 137.02 54.42 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -174.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -112.67 112.46 23.99 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 123.568 0.542 . . . . 0.0 109.752 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.65 -177.67 16.42 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 44.7 tp -76.63 155.67 33.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.007 0.432 . . . . 0.0 111.042 -177.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.1 ptm -159.73 146.58 16.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 175.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.453 ' O ' HG13 ' A' ' 108' ' ' ILE . 35.2 mmt180 -98.8 174.31 6.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.869 0.366 . . . . 0.0 111.827 -174.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.854 ' HG3' HG22 ' A' ' 51' ' ' VAL . 63.7 tttm -46.23 -54.27 9.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.898 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.518 ' HA ' ' CD ' ' A' ' 109' ' ' GLU . 26.9 t-20 -65.74 -28.46 69.06 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.141 0.496 . . . . 0.0 111.446 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.496 ' O ' HD13 ' A' ' 111' ' ' ILE . 9.7 m120 -67.22 -38.95 86.13 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.547 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 42.0 mt -64.58 -47.08 90.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.528 174.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.56 ' OE2' ' HG2' ' A' ' 105' ' ' LYS . 68.1 mt-10 -49.71 -54.75 17.0 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.446 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.54 ' O ' ' HB3' ' A' ' 113' ' ' ASN . 25.4 m -67.41 -31.3 71.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.052 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 107' ' ' ASN . 1.4 mp -71.58 -41.69 71.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.778 178.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.622 ' HB3' ' CG2' ' A' ' 117' ' ' VAL . 56.4 mt -62.74 -33.25 74.74 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.54 ' HB3' ' O ' ' A' ' 110' ' ' THR . 23.2 t-20 -57.8 -44.41 86.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.918 178.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.8 m -85.13 -23.03 28.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.271 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.472 HD21 ' O ' ' A' ' 89' ' ' LEU . 62.6 tp -67.78 -78.49 0.06 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.425 0.631 . . . . 0.0 109.807 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.964 ' HA3' ' HD2' ' A' ' 118' ' ' LYS . . . 172.32 -53.84 0.17 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.96 171.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.923 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 21.6 t 56.4 41.0 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 123.162 1.458 . . . . 0.0 107.545 -174.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.966 ' HG3' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 112.801 -2.0 . . . . 0.0 111.907 -169.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 49' ' ' SER . 21.3 m . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 13' ' ' SER . 97.2 mt 71.19 141.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -175.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 66.79 12.35 8.81 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.298 0.57 . . . . 0.0 110.148 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 p -81.94 135.66 24.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.82 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.712 HG13 ' HG2' ' A' ' 22' ' ' GLU . 92.7 t -134.58 143.71 37.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.123 -176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.689 ' HG3' ' HB2' ' A' ' 19' ' ' ASN . 1.3 tp10 -69.3 -56.1 8.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.789 0.328 . . . . 0.0 111.199 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.814 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 2.9 t-20 -143.14 170.18 16.21 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.963 -167.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.49 -30.8 71.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.04 171.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.814 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 13.5 pt-20 -71.89 -13.85 61.77 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.335 0.588 . . . . 0.0 110.524 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.712 ' HG2' HG13 ' A' ' 17' ' ' VAL . 22.2 tt0 -110.62 0.65 17.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.703 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.74 162.26 20.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.121 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -154.6 148.93 26.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.649 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 81.94 164.95 0.14 Allowed 'General case' 0 C--N 1.333 -0.109 0 O-C-N 124.401 1.063 . . . . 0.0 112.295 167.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.99 56.89 4.34 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.812 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 26.2 pt -116.61 146.95 38.74 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.765 -0.218 . . . . 0.0 110.538 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.692 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 49.5 Cg_exo -57.71 135.56 70.06 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.838 2.359 . . . . 0.0 112.089 178.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.467 ' HA ' ' OD1' ' A' ' 60' ' ' ASN . 52.4 m -99.07 114.69 27.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.687 -177.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.569 HD13 ' HB2' ' A' ' 59' ' ' PHE . 2.0 mp -98.74 108.58 22.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.354 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.751 HG12 ' HB3' ' A' ' 62' ' ' TYR . 62.5 mt -103.56 136.81 34.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.302 -177.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.8 ptm -128.15 122.61 32.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.145 0.498 . . . . 0.0 110.279 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.78 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 96.1 m-85 -85.72 113.75 22.15 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.102 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -139.67 149.81 44.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.125 -177.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.469 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 9.1 p -85.14 177.46 7.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.715 -0.221 . . . . 0.0 110.5 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.451 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 15.4 t70 -60.92 -80.62 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.982 0.42 . . . . 0.0 110.759 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.5 m -82.19 98.37 8.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.005 0.431 . . . . 0.0 110.631 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 41' ' ' CYS . 24.8 p -154.77 135.9 8.95 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.64 176.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.0 -26.81 30.82 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.135 1.89 . . . . 0.0 112.267 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.532 ' HB3' ' HG3' ' A' ' 84' ' ' PRO . 69.7 m-85 -58.58 -35.07 71.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.773 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.523 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 45.9 t -63.55 -53.04 58.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.186 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.497 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 43.5 t -60.89 -44.32 97.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.121 -177.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.911 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 15.0 tp10 -57.93 -50.69 72.49 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.725 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.49 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 8.1 tpt -68.02 -35.9 79.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.417 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 25.9 mt-30 -61.27 -39.39 90.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.319 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.911 ' HE3' ' HA ' ' A' ' 43' ' ' GLU . 10.1 mtmp? -56.14 -53.36 58.01 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.461 0.648 . . . . 0.0 109.39 175.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.577 ' HG3' ' HA ' ' A' ' 104' ' ' ARG . 24.7 mm-40 -62.36 -42.32 99.31 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.028 -176.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.741 HD13 HG21 ' A' ' 61' ' ' ILE . 96.4 mt -60.22 -43.33 96.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.469 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 13' ' ' SER . 45.4 t -58.2 -43.24 87.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.344 0.593 . . . . 0.0 110.078 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -65.54 -43.28 90.45 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.807 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.7 HG13 ' HG2' ' A' ' 109' ' ' GLU . 92.9 t -65.3 -48.33 83.74 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.047 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.8 m -60.9 -31.62 71.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.803 0.335 . . . . 0.0 111.312 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.741 ' HZ3' ' HB3' ' A' ' 53' ' ' LYS . 4.4 ttpm? -64.0 -24.69 67.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.152 0.501 . . . . 0.0 110.601 175.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -109.11 2.93 21.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.561 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.564 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 10.1 tpp180 -156.36 79.23 0.96 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -176.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.25 125.91 32.09 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -172.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 53.89 30.67 45.59 Favored Glycine 0 C--N 1.33 0.212 0 CA-C-N 115.903 -0.59 . . . . 0.0 113.666 174.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.564 ' HB2' ' HG3' ' A' ' 55' ' ' ARG . 61.4 mmtt -110.93 -6.19 14.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.516 0.674 . . . . 0.0 109.228 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.569 ' HB2' HD13 ' A' ' 30' ' ' ILE . 4.6 p90 -162.49 143.34 10.1 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.385 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.467 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 20.8 p-10 -111.03 136.34 50.19 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.056 0.455 . . . . 0.0 110.82 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.741 HG21 HD13 ' A' ' 48' ' ' LEU . 4.5 mp -96.96 109.5 23.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.536 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.751 ' HB3' HG12 ' A' ' 31' ' ' ILE . 1.1 t80 -89.72 115.32 27.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.247 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -80.21 104.34 10.69 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.732 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -85.43 85.38 7.44 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.766 ' HB2' ' CD ' ' A' ' 67' ' ' GLU . 6.7 ptt180 -91.42 116.86 29.19 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.963 -170.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.478 ' HA ' HD22 ' A' ' 71' ' ' ASN . 4.1 mm? -72.04 5.82 2.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.625 -176.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.766 ' CD ' ' HB2' ' A' ' 65' ' ' ARG . 7.1 pm0 -84.58 -13.61 51.23 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.597 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 32.6 mt-10 -101.38 128.42 47.57 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.311 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -59.4 -37.39 77.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.06 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.597 ' HD2' ' HB3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -58.99 -24.59 62.86 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 122.084 0.945 . . . . 0.0 110.902 -179.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.498 ' N ' ' HD3' ' A' ' 70' ' ' LYS . 12.0 t30 -97.74 3.77 50.05 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.861 -172.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.3 mt -71.42 -51.02 36.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 169.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.33 -39.72 89.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.261 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.478 ' CB ' ' HA ' ' A' ' 71' ' ' ASN . 1.6 tm? -57.81 -42.57 84.56 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.913 176.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.78 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -51.68 -56.5 13.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.839 176.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -63.8 -32.54 74.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.504 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -62.31 -14.95 44.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.285 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.616 ' HB3' HG11 ' A' ' 87' ' ' VAL . 57.5 m-85 -127.78 21.54 6.42 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 70.25 15.43 7.47 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.006 0.522 . . . . 0.0 111.634 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.23 130.05 41.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.038 0.447 . . . . 0.0 110.685 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -133.63 -40.22 0.88 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.167 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.496 HD11 ' HB3' ' A' ' 100' ' ' GLN . 36.9 pt -122.28 179.85 2.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.741 0.305 . . . . 0.0 110.5 177.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.7 m -128.51 139.27 35.05 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.704 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.532 ' HG3' ' HB3' ' A' ' 40' ' ' TYR . 79.3 Cg_endo -93.36 128.15 5.03 Favored 'Cis proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.275 -1.552 . . . . 0.0 112.796 -0.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.422 ' O ' ' HD1' ' A' ' 33' ' ' PHE . 64.6 m -108.31 114.62 28.63 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 174.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.435 ' CG2' ' HB3' ' A' ' 99' ' ' HIS . 5.1 t -108.63 122.36 46.94 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.42 0.628 . . . . 0.0 110.74 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.691 HG23 ' HB ' ' A' ' 31' ' ' ILE . 14.0 m -102.62 120.94 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.226 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.744 ' HB3' HD11 ' A' ' 115' ' ' LEU . 96.6 m-85 -99.09 112.73 24.79 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.586 -177.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.0 mt -104.17 137.32 42.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.527 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 23.8 t0 -71.58 179.13 3.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.512 ' HB2' ' HE3' ' A' ' 91' ' ' LYS . 14.8 ptmt -60.88 -13.8 18.08 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.53 -41.42 15.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.796 0.332 . . . . 0.0 110.515 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.2 -17.04 5.97 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.216 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -57.58 139.71 52.83 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.499 0.666 . . . . 0.0 111.771 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -77.46 90.14 3.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.443 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -78.04 -45.99 22.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -174.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.443 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 87.3 t80 -145.85 136.56 24.3 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.894 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.658 HG12 HG12 ' A' ' 87' ' ' VAL . 16.2 m -118.07 149.75 20.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 173.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.443 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 53.4 t60 -137.12 118.18 14.36 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.496 ' HB3' HD11 ' A' ' 82' ' ' ILE . 1.4 mp0 -101.32 106.43 17.6 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.875 0.734 . . . . 0.0 109.211 176.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 131.55 -176.03 19.36 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.968 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.637 HD21 ' HG2' ' A' ' 43' ' ' GLU . 34.8 tp -92.19 161.3 14.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.753 0.311 . . . . 0.0 111.051 -175.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -171.94 162.49 6.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.577 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 1.8 mpt_? -102.13 177.61 4.84 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -174.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.485 ' HA ' HD12 ' A' ' 108' ' ' ILE . 13.7 ptmm? -49.73 -43.36 47.74 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -171.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -67.05 -32.49 73.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.108 0.48 . . . . 0.0 110.374 -175.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.598 ' O ' HG12 ' A' ' 111' ' ' ILE . 15.8 m120 -67.67 -48.1 67.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.612 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 105' ' ' LYS . 26.6 mt -58.6 -50.84 77.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.078 177.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.7 ' HG2' HG13 ' A' ' 51' ' ' VAL . 1.2 tm-20 -55.6 -48.93 74.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.318 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.2 m -59.81 -33.43 71.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.978 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.669 ' O ' ' HG ' ' A' ' 115' ' ' LEU . 48.9 mm -69.4 -41.05 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.723 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 8.8 mt -60.21 -45.17 94.1 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -61.16 -26.95 68.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.063 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.6 t -83.82 -25.3 30.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.744 HD11 ' HB3' ' A' ' 88' ' ' PHE . 57.2 mt -72.34 -60.7 2.1 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.746 0.784 . . . . 0.0 109.739 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 158.98 -50.48 0.4 Allowed Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.15 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.692 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 40.0 t 53.29 42.45 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 122.808 1.289 . . . . 0.0 109.105 -177.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.498 ' O ' ' HD2' ' A' ' 91' ' ' LYS . 35.0 mtmm . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.887 -174.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.58 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 35.3 t . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 69.4 mt 70.96 -69.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.992 175.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.854 HD22 ' HB3' ' A' ' 52' ' ' SER . 54.0 m-80 -83.17 31.91 0.44 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.912 0.387 . . . . 0.0 110.426 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.58 ' HB ' ' HB3' ' A' ' 13' ' ' SER . 8.7 p -97.23 148.66 5.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.283 -173.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' A' ' 23' ' ' ALA . 8.8 p -133.3 145.9 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.011 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -66.72 -45.1 79.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.407 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.632 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 16.1 t-20 -160.25 168.83 24.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.242 -175.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 84.9 mt -62.05 -29.41 70.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.84 0.352 . . . . 0.0 110.439 178.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -59.78 -32.22 70.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.542 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -97.21 -0.96 45.92 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.546 -177.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.508 ' HB2' HG21 ' A' ' 17' ' ' VAL . . . -107.62 171.64 7.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.371 0.605 . . . . 0.0 112.47 -170.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -129.84 155.82 45.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.897 177.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.5 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -103.54 177.24 4.9 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.772 0.32 . . . . 0.0 110.92 -176.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.595 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . 108.81 -35.53 4.9 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.81 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -105.73 152.93 40.25 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 177.009 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.79 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 63.8 Cg_exo -53.28 135.04 59.2 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.827 2.351 . . . . 0.0 112.194 177.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.408 ' HB ' HD12 ' A' ' 89' ' ' LEU . 25.8 m -106.0 112.92 26.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.425 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.44 HD13 ' HB2' ' A' ' 59' ' ' PHE . 1.7 mp -97.91 109.32 23.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 87' ' ' VAL . 59.3 mt -103.67 126.23 58.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.598 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.443 ' O ' ' HG3' ' A' ' 32' ' ' MET . 24.3 ptm -118.81 116.97 27.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.66 0.743 . . . . 0.0 110.153 173.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 87.5 m-85 -81.5 119.05 23.25 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.346 174.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.558 ' HE3' ' HB3' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -139.56 145.15 38.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.968 0.413 . . . . 0.0 111.259 -177.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.558 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 5.3 m -91.52 157.04 17.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.668 175.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.753 ' HB2' ' HG2' ' A' ' 67' ' ' GLU . 12.6 t70 -61.58 -66.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 111.841 -178.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.1 m -82.01 54.32 2.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.616 0.722 . . . . 0.0 111.407 -172.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.558 ' SG ' ' HB ' ' A' ' 35' ' ' THR . 37.4 m -145.24 113.67 4.83 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.514 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.52 -3.46 11.9 Favored 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 122.363 2.042 . . . . 0.0 113.37 -176.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -68.99 -17.33 63.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.667 0.27 . . . . 0.0 110.892 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.448 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 26.4 p -74.27 -55.36 6.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.482 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.589 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 12.4 p -60.64 -35.58 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.149 -175.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.58 ' HG2' HD21 ' A' ' 102' ' ' LEU . 24.0 tp10 -57.86 -51.09 71.02 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.055 0.455 . . . . 0.0 110.803 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 24.0 ttt -74.5 -29.29 61.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.303 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 28.8 mt-30 -63.86 -33.9 76.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.76 176.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 2.9 mtmm -60.22 -51.9 67.61 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.571 ' HG3' ' HA ' ' A' ' 104' ' ' ARG . 33.2 mm-40 -55.7 -46.4 77.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.804 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.433 HD13 HG21 ' A' ' 61' ' ' ILE . 89.7 mt -59.7 -39.22 83.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.003 178.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.0 t -65.58 -45.22 84.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.088 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.457 ' CB ' ' HD2' ' A' ' 105' ' ' LYS . 20.8 m-85 -58.82 -39.82 82.34 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.653 178.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 47' ' ' GLU . 84.9 t -66.97 -53.29 35.4 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.597 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.854 ' HB3' HD22 ' A' ' 15' ' ' ASN . 21.5 m -59.53 -30.85 68.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.927 0.394 . . . . 0.0 111.473 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.585 ' HB3' ' NZ ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -55.85 -29.45 59.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.896 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -113.53 -34.24 5.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.883 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.677 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 2.5 tpp180 -89.7 75.03 7.46 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.5 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 2.2 mm-40 -82.49 128.39 34.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.173 -174.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.96 42.9 82.03 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.987 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.677 ' HB2' ' HG3' ' A' ' 55' ' ' ARG . 38.7 mmtm -126.87 -12.89 5.89 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.751 -0.264 . . . . 0.0 110.895 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.44 ' HB2' HD13 ' A' ' 30' ' ' ILE . 1.2 p90 -160.43 149.86 17.47 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -112.83 129.88 56.29 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.433 HG21 HD13 ' A' ' 48' ' ' LEU . 4.7 mp -97.71 110.97 26.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.947 0.403 . . . . 0.0 110.587 -178.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.632 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 12.5 t80 -96.91 116.06 28.52 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.018 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.558 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 15.0 m-30 -77.91 103.77 8.05 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.005 176.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 33' ' ' PHE . . . -85.13 74.34 10.49 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.559 ' C ' ' H ' ' A' ' 67' ' ' GLU . 23.9 ptt180 -84.03 125.89 32.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.294 -174.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.14 12.25 0.09 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.323 0.582 . . . . 0.0 111.3 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.753 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 25.8 mt-10 -82.33 -26.08 33.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.35 -177.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.511 ' CB ' ' HD2' ' A' ' 70' ' ' LYS . 44.6 mt-10 -118.08 147.31 43.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.654 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -69.19 -18.21 63.89 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -175.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.605 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.6 OUTLIER -62.64 -32.26 73.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.576 0.703 . . . . 0.0 110.034 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.605 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 5.6 m120 -83.58 -9.65 58.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.323 -174.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.0 mm -71.49 -42.6 72.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.16 -45.46 88.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.489 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 71' ' ' ASN . 4.4 mm? -58.11 -39.25 78.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.171 175.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.607 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -55.71 -57.23 12.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.485 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -66.17 -33.69 76.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.022 0.439 . . . . 0.0 110.601 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.439 ' HE3' ' HB2' ' A' ' 77' ' ' LYS . 19.2 ttmt -66.96 -17.44 64.92 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.261 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -122.16 11.4 10.16 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 70.59 24.82 4.32 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.595 0.559 . . . . 0.0 111.272 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.17 101.63 11.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.517 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -94.62 -43.17 8.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.888 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.7 pt -133.46 152.54 35.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.813 0.34 . . . . 0.0 110.682 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 84' ' ' PRO . 23.6 m -101.8 158.88 30.93 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.905 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.548 ' HA ' ' HB ' ' A' ' 83' ' ' VAL . 2.3 Cg_endo -83.01 125.41 10.33 Favored 'Cis proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.755 -1.352 . . . . 0.0 112.101 -0.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.523 ' HB ' ' CD1' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -97.4 112.55 24.33 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.4 m -101.44 111.7 24.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.276 0.56 . . . . 0.0 110.459 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' A' ' 31' ' ' ILE . 99.5 t -108.19 110.21 31.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.259 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.419 ' CD2' ' HD2' ' A' ' 97' ' ' TYR . 97.4 m-85 -91.79 105.68 17.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.082 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.408 HD12 ' HB ' ' A' ' 29' ' ' THR . 78.4 mt -95.62 136.05 36.51 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.432 175.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.511 ' HB3' ' ND2' ' A' ' 94' ' ' ASN . 25.7 t70 -72.61 177.37 4.76 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 172.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -53.58 -27.58 27.34 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -175.361 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.497 ' HG2' ' HG3' ' A' ' 91' ' ' LYS . 4.0 mm-40 -90.93 4.04 53.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.792 0.329 . . . . 0.0 111.166 -175.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.85 14.22 79.98 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.676 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.511 ' ND2' ' HB3' ' A' ' 90' ' ' ASP . 9.8 p30 -81.63 141.89 33.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.765 0.316 . . . . 0.0 110.507 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -79.31 82.01 5.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.839 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -78.52 -42.59 29.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.878 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.419 ' HD2' ' CD2' ' A' ' 88' ' ' PHE . 69.0 t80 -141.63 113.56 7.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.133 0.492 . . . . 0.0 111.18 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.97 128.74 65.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -137.85 143.18 40.81 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.522 ' HG2' HG23 ' A' ' 85' ' ' THR . 27.1 mt-30 -119.98 124.21 45.37 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.683 0.278 . . . . 0.0 110.447 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 142.75 -167.45 26.25 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.808 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.58 HD21 ' HG2' ' A' ' 43' ' ' GLU . 59.9 tp -106.09 121.6 44.47 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 74.0 mtp -116.06 159.72 21.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.553 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.571 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 3.3 mpt_? -111.09 170.49 8.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.703 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.457 ' HD2' ' CB ' ' A' ' 50' ' ' TYR . 23.5 tttp -46.91 -53.79 11.43 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -176.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -56.86 -39.2 73.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.008 0.432 . . . . 0.0 111.309 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.533 ' O ' HG12 ' A' ' 111' ' ' ILE . 9.2 m120 -70.6 -44.89 66.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.844 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.58 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 62.3 mt -60.26 -48.72 87.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.91 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.498 ' CD ' HH21 ' A' ' 55' ' ' ARG . 5.5 mm-40 -54.5 -47.99 72.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.594 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 113' ' ' ASN . 24.0 m -64.59 -38.33 90.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.742 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 107' ' ' ASN . 35.4 mm -65.17 -40.98 90.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.765 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 59.8 mt -62.31 -34.79 77.3 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.844 0.354 . . . . 0.0 110.136 177.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 110' ' ' THR . 9.6 m120 -58.87 -45.24 90.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.853 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.8 m -86.49 -16.99 35.32 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.5 tp -70.7 -71.38 0.25 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.35 0.595 . . . . 0.0 110.381 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -178.39 -73.54 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.554 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.79 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 52.0 t 51.71 73.87 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 122.195 0.998 . . . . 0.0 109.82 -175.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.5 pttm . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.686 -172.656 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.625 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 72.9 m . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.462 0.173 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 69.9 mt 69.42 -74.23 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.15 0.58 . . . . 0.0 111.694 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -86.81 29.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.83 0.348 . . . . 0.0 110.929 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 3.0 p -72.94 129.02 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.504 -176.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.65 HG13 ' HB3' ' A' ' 22' ' ' GLU . 73.0 t -127.41 134.04 66.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.596 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -66.38 -55.2 16.99 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.789 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.568 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 47.2 t30 -153.22 179.58 8.61 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -177.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.33 -31.02 68.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.766 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 2.6 mp0 -59.89 -35.82 75.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.987 0.422 . . . . 0.0 110.465 176.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.65 ' HB3' HG13 ' A' ' 17' ' ' VAL . 3.7 mm-40 -82.91 -8.03 59.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.413 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.35 107.86 15.34 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 172.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.541 ' HE2' ' O ' ' A' ' 22' ' ' GLU . 17.6 mtmt -131.19 174.03 10.44 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.991 -171.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 66.59 167.61 0.22 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.301 1.0 . . . . 0.0 110.207 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.93 50.95 4.37 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.667 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.41 HG13 ' ND2' ' A' ' 60' ' ' ASN . 18.2 pt -116.45 149.39 43.64 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.727 0.299 . . . . 0.0 110.491 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.703 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 40.8 Cg_exo -60.59 168.92 6.06 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 123.217 2.611 . . . . 0.0 112.655 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.468 ' HB ' HD12 ' A' ' 89' ' ' LEU . 34.9 m -135.89 125.01 24.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.525 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.446 HD13 ' CD2' ' A' ' 59' ' ' PHE . 2.4 mp -105.63 115.04 46.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.816 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.566 ' HB ' ' HB ' ' A' ' 87' ' ' VAL . 67.6 mt -100.46 139.38 22.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.78 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.523 ' HG3' ' SD ' ' A' ' 44' ' ' MET . 2.1 tmt? -134.48 113.34 11.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.183 0.516 . . . . 0.0 109.887 171.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 91.6 m-85 -76.93 135.29 38.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.529 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.441 ' HG3' ' SG ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -142.28 153.86 44.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.289 -178.303 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -72.57 164.98 25.58 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 67' ' ' GLU . 6.6 p-10 -58.58 -45.22 89.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.681 0.276 . . . . 0.0 110.968 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -130.92 96.9 4.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.977 0.418 . . . . 0.0 111.275 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 41' ' ' CYS . 11.7 p -150.97 140.7 14.01 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.729 177.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 11.6 Cg_exo -69.94 -29.99 22.15 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.533 2.155 . . . . 0.0 112.273 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.574 ' HB3' ' HG3' ' A' ' 84' ' ' PRO . 90.2 m-85 -60.91 -26.98 67.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.095 0.474 . . . . 0.0 110.561 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . 21.5 t -60.03 -54.42 46.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.869 177.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.417 ' HA ' ' HG2' ' A' ' 45' ' ' GLN . 8.0 p -73.2 -38.13 53.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.432 -172.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.54 ' HG2' HD21 ' A' ' 102' ' ' LEU . 5.2 tp10 -61.6 -50.64 71.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.071 0.462 . . . . 0.0 110.875 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.523 ' SD ' ' HG3' ' A' ' 32' ' ' MET . 24.1 ttt -69.21 -37.25 77.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.053 0.454 . . . . 0.0 111.216 -175.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.455 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 12.9 pt20 -74.12 -31.49 62.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.354 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.912 ' HE2' ' HA ' ' A' ' 46' ' ' LYS . 8.5 mmpt? -74.26 -29.81 61.85 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.535 176.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 51' ' ' VAL . 13.4 mm-40 -62.03 -44.74 96.06 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 169.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 45' ' ' GLN . 98.1 mt -57.37 -36.99 71.92 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.313 173.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.9 t -66.19 -37.96 86.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.425 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.57 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 13.2 m-30 -65.05 -39.22 93.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.876 0.37 . . . . 0.0 110.177 175.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.582 HG22 ' HG3' ' A' ' 105' ' ' LYS . 44.1 t -65.11 -36.33 77.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.106 176.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.3 m -63.67 -31.8 73.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.824 178.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -66.84 -27.06 67.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.321 0.581 . . . . 0.0 110.738 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -100.77 2.58 41.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.584 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.541 ' HE ' HG12 ' A' ' 117' ' ' VAL . 21.1 tpt180 -161.23 76.63 0.54 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.427 0.632 . . . . 0.0 109.437 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -82.61 125.1 30.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.866 -172.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.405 ' O ' ' HD2' ' A' ' 58' ' ' LYS . . . 60.4 42.63 99.01 Favored Glycine 0 C--O 1.226 -0.346 0 CA-C-N 115.782 -0.644 . . . . 0.0 113.418 175.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HB2' ' HG3' ' A' ' 55' ' ' ARG . 11.7 mptt -125.31 0.56 7.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.902 0.351 . . . . 0.0 110.959 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.446 ' CD2' HD13 ' A' ' 30' ' ' ILE . 52.4 p90 -165.89 140.11 4.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.024 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.62 ' HB3' HG21 ' A' ' 17' ' ' VAL . 46.5 m-80 -82.66 131.22 35.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.375 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.7 mt -101.9 108.11 23.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 175.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.568 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 18.0 t80 -93.49 118.91 31.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.88 0.371 . . . . 0.0 110.067 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.455 ' CE1' ' HB2' ' A' ' 45' ' ' GLN . 11.8 m-85 -87.4 104.05 16.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.258 0.552 . . . . 0.0 110.707 178.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 33' ' ' PHE . . . -96.57 81.54 3.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.531 -175.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.485 ' C ' ' H ' ' A' ' 67' ' ' GLU . 19.7 ptt180 -95.28 130.48 42.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.814 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.2 tp -70.18 7.48 0.98 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.577 0.703 . . . . 0.0 110.546 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 36' ' ' ASP . 34.6 tt0 -83.03 -17.52 43.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.456 -175.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.417 ' HG3' ' HG3' ' A' ' 65' ' ' ARG . 36.1 mt-10 -103.79 -0.51 29.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -170.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.495 ' HA ' HG12 ' A' ' 72' ' ' ILE . 1.2 mp0 69.23 -36.62 0.34 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.557 0.535 . . . . 0.0 112.202 -177.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.491 ' HD2' ' ND2' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -61.05 -25.04 66.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.323 0.582 . . . . 0.0 110.729 175.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.588 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 44.5 m-80 -86.69 -0.86 57.09 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.816 178.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.495 HG12 ' HA ' ' A' ' 69' ' ' GLU . 45.2 mm -66.66 -45.18 88.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -72.21 -49.57 34.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.425 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 71' ' ' ASN . 3.8 mm? -57.18 -38.44 73.62 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.737 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.495 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -63.7 -48.4 77.27 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.055 177.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -62.42 -37.49 86.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.128 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -53.27 -35.85 60.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.481 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -113.35 13.27 19.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.842 -176.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.9 t70 63.35 29.32 15.7 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.693 0.759 . . . . 0.0 110.749 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.45 ' O ' ' HB1' ' A' ' 75' ' ' ALA . . . -87.77 104.2 16.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.362 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -127.98 -11.22 5.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.49 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.6 mt -114.95 133.4 61.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.061 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.1 m -114.05 145.81 34.36 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.681 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.574 ' HG3' ' HB3' ' A' ' 40' ' ' TYR . 6.0 Cg_endo -85.68 157.71 59.69 Favored 'Cis proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.43 -1.487 . . . . 0.0 111.811 -0.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.6 t -153.56 137.86 16.62 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 9.5 t -124.83 140.74 52.65 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.425 0.631 . . . . 0.0 110.88 -175.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 31' ' ' ILE . 72.4 t -115.87 110.43 31.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.413 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.537 ' HB3' HD22 ' A' ' 115' ' ' LEU . 97.3 m-85 -89.84 108.34 19.64 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.526 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.55 HD23 ' HA ' ' A' ' 95' ' ' LYS . 67.3 mt -97.47 130.44 44.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.815 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.84 169.62 16.4 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.877 ' HG2' ' HG3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -61.93 -23.88 66.63 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.661 ' HB3' HD22 ' A' ' 94' ' ' ASN . 1.1 tp10 -76.53 -5.82 49.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.113 0.482 . . . . 0.0 110.022 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.65 22.46 50.22 Favored Glycine 0 N--CA 1.453 -0.185 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.599 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.661 HD22 ' HB3' ' A' ' 92' ' ' GLU . 9.0 p30 -107.24 148.64 28.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.55 ' HA ' HD23 ' A' ' 89' ' ' LEU . 4.6 ttpm? -77.19 117.81 19.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -97.37 -50.08 4.68 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.105 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.473 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 84.7 t80 -148.87 136.24 20.24 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.606 -175.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.489 HG12 HG22 ' A' ' 87' ' ' VAL . 27.5 m -113.94 148.29 16.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.76 172.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.473 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 36.6 t60 -142.83 141.24 31.57 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -111.16 121.76 46.14 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 145.76 170.78 14.78 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.981 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.54 HD21 ' HG2' ' A' ' 43' ' ' GLU . 43.8 tp -82.09 -61.56 1.87 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.465 0.65 . . . . 0.0 111.224 -177.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.526 ' O ' ' HD2' ' A' ' 104' ' ' ARG . 57.5 mtm 64.18 175.73 0.18 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.176 -1.374 . . . . 0.0 111.091 -175.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.526 ' HD2' ' O ' ' A' ' 103' ' ' MET . 10.7 mmm180 -122.61 178.15 5.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.921 173.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.582 ' HG3' HG22 ' A' ' 51' ' ' VAL . 47.1 tttm -45.53 -59.19 2.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -177.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -66.75 -28.85 68.74 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.399 -173.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -64.0 -47.99 78.15 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.627 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 61.5 mt -59.25 -47.5 90.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.796 174.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -50.57 -48.25 57.61 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.766 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 m -61.93 -41.76 98.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.867 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 63.1 mt -67.83 -37.67 78.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.204 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.63 ' HB3' HG21 ' A' ' 117' ' ' VAL . 87.2 mt -63.19 -35.45 80.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.374 . . . . 0.0 110.433 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.76 -39.8 90.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.674 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.6 m -79.46 -28.19 41.59 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.333 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.537 HD22 ' HB3' ' A' ' 88' ' ' PHE . 45.6 tp -66.25 -70.34 0.25 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.712 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 171.52 -73.54 0.1 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.605 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.703 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 11.6 t 55.61 36.52 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 122.677 1.227 . . . . 0.0 109.399 -176.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.877 ' HG3' ' HG2' ' A' ' 91' ' ' LYS . 8.2 ptmt . . . . . 0 C--N 1.319 -0.718 0 CA-C-N 113.527 -1.669 . . . . 0.0 110.02 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.596 ' HB3' HG21 ' A' ' 16' ' ' VAL . 34.4 m . . . . . 0 N--CA 1.445 -0.679 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.0 mt -93.22 -65.3 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.215 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 14.2 m-80 -81.08 59.21 3.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.02 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.699 ' HB ' ' HE2' ' A' ' 63' ' ' TYR . 16.6 m -131.98 151.4 35.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.085 0.469 . . . . 0.0 111.774 -173.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.498 HG11 ' HB2' ' A' ' 23' ' ' ALA . 4.2 p -146.31 164.24 9.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.114 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -90.94 -54.26 4.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.985 0.422 . . . . 0.0 110.999 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.796 ' HA ' ' CE2' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -130.67 162.89 28.41 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.683 -170.384 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.674 HD22 ' CE2' ' A' ' 62' ' ' TYR . 2.0 mm? -65.36 -35.17 80.15 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.598 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 1.7 pm0 -67.09 -23.52 65.86 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.346 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.452 ' HB2' ' H ' ' A' ' 19' ' ' ASN . 21.7 mm-40 -87.51 -8.65 56.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.561 172.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.498 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -121.29 172.51 7.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.562 0.696 . . . . 0.0 112.133 -170.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.763 ' NZ ' ' HA ' ' A' ' 24' ' ' LYS . 2.3 tpmp? -140.21 160.39 40.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.522 176.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -87.87 179.3 6.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.985 0.422 . . . . 0.0 110.936 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.69 -29.94 10.17 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -174.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.616 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -117.95 134.18 23.32 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 172.657 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 1.048 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 75.2 Cg_exo -52.54 136.77 57.62 Favored 'Trans proline' 0 CA--C 1.517 -0.356 0 C-N-CA 123.092 2.528 . . . . 0.0 112.424 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.562 ' HB ' HD12 ' A' ' 89' ' ' LEU . 23.6 m -108.69 119.76 40.47 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.207 0.527 . . . . 0.0 111.199 -174.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.417 HD12 ' N ' ' A' ' 30' ' ' ILE . 4.1 mp -99.32 107.17 20.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.801 HG12 ' HB3' ' A' ' 62' ' ' TYR . 50.0 mt -95.74 111.91 27.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 120.731 0.301 . . . . 0.0 110.75 -177.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 25.2 ptm -118.42 136.65 53.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.157 0.503 . . . . 0.0 109.828 175.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.557 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 37.3 m-85 -91.18 132.3 36.17 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.502 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.627 ' HE2' ' HB3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -130.9 139.53 50.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.158 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.0 m -78.09 161.38 27.45 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.494 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 15.1 t70 -68.54 103.33 1.66 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.2 m 73.51 89.44 0.09 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.92 -175.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.9 p -148.06 127.16 6.28 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.567 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.22 -33.66 5.54 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.285 1.99 . . . . 0.0 114.084 -173.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -67.47 -25.17 65.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.806 0.336 . . . . 0.0 111.165 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.578 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 97.6 m -80.06 -35.98 36.27 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.053 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 65.0 t -64.8 -34.85 72.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.82 176.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -57.01 -45.97 82.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.281 175.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.6 ttt -69.11 -31.19 69.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.737 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.578 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 20.5 mt-30 -59.84 -40.12 87.42 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 110.117 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -56.16 -53.36 57.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.608 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 51' ' ' VAL . 57.2 mm-40 -56.99 -47.23 81.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.77 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.74 HD13 HD13 ' A' ' 61' ' ' ILE . 91.3 mt -58.62 -36.9 74.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.472 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.4 t -66.59 -37.58 85.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.99 0.424 . . . . 0.0 110.13 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.425 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 30.5 m-85 -70.34 -36.44 74.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.517 177.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 47' ' ' GLU . 22.4 t -67.95 -31.82 53.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 175.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.5 m -62.97 -32.92 74.35 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.025 174.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.479 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 27.2 mmtm -73.35 -15.79 61.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.138 0.494 . . . . 0.0 110.725 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -87.51 -40.08 14.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.687 173.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.667 ' HG3' ' HG3' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -133.09 75.39 1.62 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.617 -175.236 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 5.8 tp10 -82.44 134.46 35.23 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 120.905 0.383 . . . . 0.0 111.356 -171.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.57 41.22 95.44 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.255 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.667 ' HG3' ' HG3' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -123.08 -9.1 8.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.776 0.322 . . . . 0.0 110.856 -174.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.55 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 10.2 p90 -156.68 -176.84 6.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.6 -177.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 29' ' ' THR . 57.2 t30 -144.83 132.99 21.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.896 178.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.74 HD13 HD13 ' A' ' 48' ' ' LEU . 71.6 mt -105.38 114.24 44.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.565 -176.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.801 ' HB3' HG12 ' A' ' 31' ' ' ILE . 4.5 t80 -84.18 115.82 22.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.699 ' HE2' ' HB ' ' A' ' 16' ' ' VAL . 76.1 m-85 -93.38 110.82 22.36 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.054 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.666 ' HB2' ' HE1' ' A' ' 62' ' ' TYR . . . -86.39 102.72 14.29 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 121.255 -0.178 . . . . 0.0 110.793 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.627 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 8.7 ptm180 -78.01 114.48 16.92 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.876 176.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.4 tp -67.92 10.95 0.17 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.061 0.458 . . . . 0.0 110.836 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 65' ' ' ARG . 3.8 tp10 -84.34 -42.35 15.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.19 0.519 . . . . 0.0 110.424 -175.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.576 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 30.5 mm-40 -93.54 173.58 7.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.08 -172.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.413 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -86.22 -31.88 21.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.856 -176.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HD2' ' H ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -60.15 -33.15 71.78 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.241 0.543 . . . . 0.0 110.371 178.521 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.576 ' OD1' ' HB2' ' A' ' 68' ' ' GLU . 5.0 m120 -80.19 -17.35 52.63 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.416 -178.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 69' ' ' GLU . 75.1 mt -70.88 -42.76 77.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -59.86 -48.95 79.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.626 173.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.435 ' HG ' ' OH ' ' A' ' 62' ' ' TYR . 1.2 tm? -55.77 -47.34 77.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.315 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.557 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -53.9 -52.15 61.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.854 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -73.27 -34.84 66.01 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.527 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.432 ' HB2' ' HE3' ' A' ' 77' ' ' LYS . 27.1 ttmt -63.49 -32.86 74.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.241 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -102.73 -0.53 31.47 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.669 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.1 t70 67.64 40.65 2.47 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.704 0.764 . . . . 0.0 111.095 174.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.48 102.84 4.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.946 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -107.26 -31.95 8.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.351 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.808 HD13 ' H ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -85.05 159.06 3.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.798 0.332 . . . . 0.0 110.947 -178.65 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.1 m -119.42 145.27 38.37 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.719 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -95.25 118.25 2.03 Favored 'Cis proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.637 -1.401 . . . . 0.0 112.517 -1.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.654 HG22 ' HB3' ' A' ' 100' ' ' GLN . 1.2 p -97.9 143.46 28.47 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 173.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.1 m -135.49 121.05 19.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.179 0.514 . . . . 0.0 111.151 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.686 HG12 HG12 ' A' ' 98' ' ' VAL . 20.3 m -112.6 126.65 70.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.003 176.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.562 ' HB3' HD22 ' A' ' 115' ' ' LEU . 94.8 m-85 -98.48 118.61 35.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.829 -174.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.562 HD12 ' HB ' ' A' ' 29' ' ' THR . 10.4 mt -107.57 139.61 41.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.037 -177.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.435 ' OD2' ' HG2' ' A' ' 92' ' ' GLU . 25.0 t70 -63.51 171.48 2.53 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 171.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.497 ' HD3' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -62.36 -16.45 54.64 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 122.015 -0.428 . . . . 0.0 111.84 -176.261 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.435 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 16.9 mm-40 -72.94 -23.69 60.71 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.954 0.407 . . . . 0.0 110.753 175.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.74 17.53 35.41 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -170.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.443 HD22 ' N ' ' A' ' 94' ' ' ASN . 0.9 OUTLIER -90.15 126.24 35.73 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -179.575 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -72.34 112.87 8.79 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.174 0.296 . . . . 0.0 110.511 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -100.67 -54.58 2.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.746 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 87.6 t80 -124.84 141.84 51.85 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.195 -175.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.686 HG12 HG12 ' A' ' 87' ' ' VAL . 30.0 m -121.65 139.64 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.553 176.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.576 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 8.2 t60 -151.17 139.86 20.72 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.654 ' HB3' HG22 ' A' ' 85' ' ' THR . 9.1 pt20 -130.04 139.52 50.99 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.014 0.435 . . . . 0.0 110.804 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.48 -172.35 18.16 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.6 tp -93.66 130.17 39.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.908 0.354 . . . . 0.0 110.162 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 71.8 mtm -127.08 165.38 19.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.192 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.466 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 37.3 mmt180 -114.34 175.51 5.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.741 178.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.567 ' O ' ' HG3' ' A' ' 109' ' ' GLU . 58.0 tttm -45.78 -59.36 2.83 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.106 0.962 . . . . 0.0 112.835 -175.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.549 ' HA ' ' OE1' ' A' ' 109' ' ' GLU . 29.0 t-20 -64.66 -28.88 69.91 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -174.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.502 ' O ' HG12 ' A' ' 111' ' ' ILE . 10.7 m120 -65.4 -45.34 84.35 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.55 HD13 HD23 ' A' ' 48' ' ' LEU . 50.3 mt -64.97 -42.52 94.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.933 176.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 105' ' ' LYS . 81.0 mt-10 -51.91 -48.96 63.94 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.887 176.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.0 m -64.39 -42.24 96.23 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.778 -177.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 107' ' ' ASN . 48.7 mm -67.37 -47.81 79.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.184 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.551 ' HB3' HG21 ' A' ' 117' ' ' VAL . 81.0 mt -65.32 -34.45 78.37 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 110.806 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -60.41 -37.99 82.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.412 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.7 m -85.15 -35.93 21.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.165 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.562 HD22 ' HB3' ' A' ' 88' ' ' PHE . 34.7 tp -57.13 -72.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.102 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -176.66 -80.75 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.767 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.048 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 22.9 t 53.04 71.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 121.662 0.744 . . . . 0.0 109.537 -175.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.2 pttt . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.373 -168.061 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.658 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . 22.7 m . . . . . 0 N--CA 1.447 -0.597 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.0 mt 69.52 -78.24 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 123.047 0.539 . . . . 0.0 111.042 -171.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -113.98 16.56 18.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.524 0.678 . . . . 0.0 109.265 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.658 ' CG2' ' HA ' ' A' ' 13' ' ' SER . 51.5 t -76.27 125.32 35.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.433 175.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.519 HG22 ' HB2' ' A' ' 22' ' ' GLU . 4.6 p -111.52 134.9 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-O 121.592 0.711 . . . . 0.0 110.374 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -61.47 -54.45 43.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.543 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.539 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -131.69 158.83 40.08 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.369 -177.009 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.65 -29.75 69.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.798 0.332 . . . . 0.0 110.585 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.5 pm0 -73.38 -23.51 60.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.405 177.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.519 ' HB2' HG22 ' A' ' 17' ' ' VAL . 29.3 mm-40 -67.01 -18.96 65.62 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.008 0.432 . . . . 0.0 110.492 173.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.515 ' HB1' HD11 ' A' ' 27' ' ' ILE . . . -91.71 113.59 25.9 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -122.38 -6.47 8.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.705 0.764 . . . . 0.0 112.165 -173.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.532 ' HB2' HD12 ' A' ' 27' ' ' ILE . 3.8 mp0 -76.05 170.94 15.31 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.383 178.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.48 55.32 4.99 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.385 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.625 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -114.65 143.41 29.93 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.792 0.33 . . . . 0.0 111.357 -173.277 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 1.003 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 60.5 Cg_exo -56.65 151.36 47.49 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.696 2.264 . . . . 0.0 111.649 170.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.0 m -112.7 111.21 21.84 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.787 -175.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.6 mm -102.99 124.76 57.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.757 HG12 ' HB3' ' A' ' 62' ' ' TYR . 54.3 mt -125.04 115.46 44.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.069 -173.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.456 ' SD ' ' NZ ' ' A' ' 34' ' ' LYS . 2.1 tmt? -112.07 124.36 52.24 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.619 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 53.8 m-85 -87.38 144.57 26.7 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.899 -175.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.936 ' HE3' ' HB3' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -149.44 171.24 16.89 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -178.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.0 t -122.69 -174.44 2.92 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.02 -62.88 1.53 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.229 0.537 . . . . 0.0 110.569 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.2 m -93.76 90.92 6.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.075 -176.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.484 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 20.1 p -158.88 121.15 1.94 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.91 0.386 . . . . 0.0 111.388 175.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 2.9 Cg_exo -75.34 -16.48 19.45 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.53 2.153 . . . . 0.0 112.429 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -64.44 -26.12 68.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.009 0.433 . . . . 0.0 110.637 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.653 ' SG ' ' HD3' ' A' ' 34' ' ' LYS . 53.4 t -67.42 -44.41 78.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.679 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.518 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 7.6 p -74.76 -30.35 24.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.779 0.323 . . . . 0.0 110.756 -176.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -69.7 -49.0 57.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.813 0.339 . . . . 0.0 110.323 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.423 ' HG3' ' OE1' ' A' ' 47' ' ' GLU . 3.5 ttt -69.43 -28.45 66.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.991 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -53.32 -45.02 68.86 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.223 171.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 81.9 mttt -58.12 -53.81 54.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.964 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.432 ' O ' HG23 ' A' ' 51' ' ' VAL . 52.7 mt-10 -57.43 -50.65 72.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.919 -178.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 48.6 mt -61.39 -42.95 99.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.638 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 13.9 t -66.81 -32.94 74.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.369 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.44 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 16.6 m-85 -66.9 -43.08 84.31 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.774 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 47' ' ' GLU . 51.0 t -60.3 -52.22 63.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-O 121.223 0.535 . . . . 0.0 110.016 176.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.8 m -59.4 -29.35 67.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.552 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.457 ' HZ3' ' HB2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -67.51 -16.91 64.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.518 -179.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -120.44 8.94 10.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.286 0.565 . . . . 0.0 109.791 177.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.713 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 8.0 ttm-85 -151.38 76.9 1.23 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.356 -175.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -82.32 124.77 30.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.83 -169.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.11 25.92 54.89 Favored Glycine 0 CA--C 1.518 0.249 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.333 176.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.713 ' HB2' ' HG2' ' A' ' 55' ' ' ARG . 55.7 mmtt -96.2 -5.68 39.92 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.719 0.771 . . . . 0.0 108.927 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.554 ' HB3' HG13 ' A' ' 117' ' ' VAL . 28.7 p90 -170.79 136.49 1.18 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.042 175.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -95.05 131.33 41.15 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.7 mt -89.64 107.7 18.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.096 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.757 ' HB3' HG12 ' A' ' 31' ' ' ILE . 3.8 t80 -88.43 112.62 23.14 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.936 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 50.3 m-85 -91.73 102.9 15.52 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.589 178.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.92 93.59 4.43 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.975 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.646 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 11.0 ptt180 -89.3 118.25 28.85 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.27 0.557 . . . . 0.0 111.272 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.485 HD22 HD13 ' A' ' 72' ' ' ILE . 53.4 mt -72.77 11.51 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.02 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.528 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 23.9 tt0 -66.4 -33.64 76.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.871 174.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -106.85 177.2 4.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.351 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.53 -27.0 22.88 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.1 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.572 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -57.6 -33.5 68.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.423 -176.296 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.572 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 68.6 m-80 -90.23 2.39 55.47 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.983 -174.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.485 HD13 HD22 ' A' ' 66' ' ' LEU . 49.7 mm -71.17 -54.44 17.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 172.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -65.23 -41.87 93.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.253 175.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.477 ' HB3' ' HA ' ' A' ' 71' ' ' ASN . 1.3 tm? -57.37 -42.61 82.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.101 177.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.619 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -53.17 -53.16 54.64 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.462 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -67.3 -34.3 77.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.771 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -62.76 -21.44 65.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.063 0.458 . . . . 0.0 111.588 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.508 ' CD2' HG11 ' A' ' 87' ' ' VAL . 52.3 m-85 -119.73 19.32 12.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.643 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 65.13 17.02 10.88 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.801 0.688 . . . . 0.0 111.37 168.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.458 ' O ' ' HB1' ' A' ' 75' ' ' ALA . . . -123.91 102.17 7.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.079 0.466 . . . . 0.0 111.605 -171.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -113.61 9.21 17.85 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.207 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.9 pt -125.23 171.36 14.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.875 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.57 136.99 19.39 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.229 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -87.26 150.61 38.32 Favored 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 123.65 -1.396 . . . . 0.0 112.667 -0.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 15.1 m -150.26 124.6 9.53 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 88.3 m -122.15 122.89 40.26 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.314 0.578 . . . . 0.0 110.936 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.62 HG23 ' HB ' ' A' ' 98' ' ' VAL . 11.2 p -100.16 132.32 45.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.635 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 1.02 ' HB3' HD11 ' A' ' 115' ' ' LEU . 86.2 m-85 -106.04 108.8 20.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.799 -175.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.49 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 5.5 mp -111.97 138.82 48.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.786 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -80.65 -176.75 5.94 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.601 ' HE2' ' HE2' ' A' ' 118' ' ' LYS . 0.5 OUTLIER -60.57 -22.22 63.45 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -172.494 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 -75.85 -12.54 60.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.72 0.295 . . . . 0.0 111.295 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.443 ' O ' HD23 ' A' ' 89' ' ' LEU . . . 85.42 21.06 55.51 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.784 -176.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 92.0 m-20 -92.27 125.36 36.9 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.971 -0.134 . . . . 0.0 110.703 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.49 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 54.2 mtmt -70.5 93.84 0.93 Allowed 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.453 ' HB3' ' CD2' ' A' ' 115' ' ' LEU . 87.6 t80 -83.58 -39.4 20.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.817 0.342 . . . . 0.0 110.338 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.597 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 71.2 t80 -154.04 127.07 8.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.716 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.62 ' HB ' HG23 ' A' ' 87' ' ' VAL . 7.6 p -114.3 133.42 60.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.597 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 49.5 t60 -139.31 137.76 36.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -172.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -110.41 158.18 18.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.825 0.345 . . . . 0.0 111.075 178.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.1 -173.85 20.15 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.028 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.6 tp -104.17 149.59 25.12 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 16.8 ptm -164.8 125.62 2.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.724 -0.216 . . . . 0.0 110.441 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -58.04 163.77 2.63 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.625 -173.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.44 ' HD2' ' HB3' ' A' ' 50' ' ' TYR . 13.6 ptmm? -50.59 -44.43 56.88 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.237 -174.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.404 ' N ' ' HG3' ' A' ' 105' ' ' LYS . 18.8 m120 -63.48 -34.24 77.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.383 0.611 . . . . 0.0 110.932 -176.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -74.11 -40.18 62.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.394 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.496 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 73.8 mt -59.32 -46.27 92.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.246 171.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -58.05 -35.56 71.51 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.004 178.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.5 m -63.92 -41.46 97.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.001 0.429 . . . . 0.0 110.434 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.9 mm -70.89 -41.91 77.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.179 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.565 ' HB3' HG21 ' A' ' 117' ' ' VAL . 85.8 mt -57.53 -41.97 81.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.446 176.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -59.53 -37.11 77.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.803 176.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.1 m -70.37 -24.89 63.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.101 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 1.02 HD11 ' HB3' ' A' ' 88' ' ' PHE . 27.1 mt -81.28 -73.62 0.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 122.095 0.95 . . . . 0.0 109.788 175.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 162.87 -63.47 0.26 Allowed Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -175.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.003 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 48.8 t 52.85 73.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.579 0.704 . . . . 0.0 111.782 172.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.601 ' HE2' ' HE2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.609 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' A' ' 49' ' ' SER . 49.0 m . . . . . 0 C--O 1.228 -0.074 0 CA-C-O 121.248 0.546 . . . . 0.0 110.45 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.7 mt -80.85 -20.63 11.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.531 0.681 . . . . 0.0 109.941 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 47.2 m-80 -94.0 25.06 3.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.606 176.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.412 HG23 ' HE2' ' A' ' 63' ' ' TYR . 7.5 p -63.87 138.96 22.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.641 -173.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.474 HG21 ' HB3' ' A' ' 60' ' ' ASN . 76.0 t -137.93 123.65 25.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.798 175.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -76.13 -55.52 5.51 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.603 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.783 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 59.0 t30 -140.18 -179.38 5.95 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.579 HD11 HD11 ' A' ' 74' ' ' LEU . 83.7 mt -50.39 -32.6 17.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.419 ' CD ' ' HB3' ' A' ' 19' ' ' ASN . 6.7 pm0 -63.41 -39.64 95.04 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.674 0.249 . . . . 0.0 111.674 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.408 ' OE1' ' HG2' ' A' ' 21' ' ' GLU . 55.7 mp0 -81.52 4.51 21.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.808 175.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.36 171.04 10.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.941 0.4 . . . . 0.0 111.957 -175.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.507 ' HE2' ' OD1' ' A' ' 60' ' ' ASN . 23.1 mtmm -148.57 173.25 13.36 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -120.51 -179.56 4.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.677 0.275 . . . . 0.0 111.378 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.09 -47.74 2.68 Favored Glycine 0 C--N 1.332 0.355 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.044 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.765 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -100.19 146.66 32.33 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 175.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 1.06 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 84.2 Cg_exo -51.02 158.66 3.04 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.197 2.598 . . . . 0.0 112.436 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.489 HG23 ' HB2' ' A' ' 60' ' ' ASN . 41.7 m -131.44 126.15 34.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.244 0.545 . . . . 0.0 111.43 -175.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.541 HD11 HD21 ' A' ' 112' ' ' LEU . 63.5 mt -98.76 111.52 28.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.495 176.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.614 ' HB ' ' HB ' ' A' ' 87' ' ' VAL . 6.0 mm -91.01 107.81 19.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.417 ' HA ' ' O ' ' A' ' 85' ' ' THR . 21.0 ttt -111.71 107.74 16.94 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.311 0.576 . . . . 0.0 110.647 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.681 ' CE1' ' HA ' ' A' ' 75' ' ' ALA . 87.0 m-85 -72.64 133.12 44.5 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.179 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 1.072 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 60.1 pttt -133.84 179.88 5.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.147 -176.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -137.39 -174.56 3.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.469 0.176 . . . . 0.0 110.589 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -77.33 -17.94 57.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.507 0.67 . . . . 0.0 110.548 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.4 m -143.64 101.97 3.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.873 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 2.2 p -160.13 101.68 1.41 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.986 0.422 . . . . 0.0 112.021 -176.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.8 -32.99 13.33 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.07 1.846 . . . . 0.0 112.655 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -70.51 -23.12 62.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.964 0.411 . . . . 0.0 110.749 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 79.7 m -79.15 -43.62 23.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.956 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.513 ' HA ' HE21 ' A' ' 45' ' ' GLN . 12.0 p -65.5 -31.03 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.484 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.749 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 8.5 tp10 -58.38 -50.04 75.08 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.347 0.594 . . . . 0.0 110.283 175.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 21.0 ttt -73.62 -29.3 62.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.86 -177.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.556 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 49.1 mt-30 -62.56 -33.75 75.58 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.692 0.282 . . . . 0.0 110.65 175.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.749 ' HE2' ' HA ' ' A' ' 43' ' ' GLU . 47.3 mtmt -65.29 -47.05 77.99 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.642 ' O ' HG23 ' A' ' 51' ' ' VAL . 62.5 mm-40 -56.04 -52.21 65.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.849 177.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.5 ' HB3' HD13 ' A' ' 61' ' ' ILE . 90.0 mt -56.9 -33.58 67.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.171 178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 8.7 t -65.83 -43.56 88.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.023 0.44 . . . . 0.0 109.854 177.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -68.03 -34.27 76.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.706 178.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.745 HG22 ' HG3' ' A' ' 105' ' ' LYS . 34.4 t -65.35 -39.54 85.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 175.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.7 m -61.77 -30.57 70.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.691 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -59.3 -43.09 92.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.049 0.452 . . . . 0.0 110.132 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -82.22 -50.5 8.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.757 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.435 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -99.11 74.06 1.95 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.281 0.562 . . . . 0.0 109.761 -175.257 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.67 119.06 25.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.255 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.55 47.09 36.27 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.23 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.454 ' HD3' ' HA ' ' A' ' 58' ' ' LYS . 36.5 mmtm -132.64 -7.43 3.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.657 0.265 . . . . 0.0 111.31 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.495 ' O ' ' HB3' ' A' ' 15' ' ' ASN . 0.9 OUTLIER -163.92 155.55 16.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.667 177.141 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.507 ' OD1' ' HE2' ' A' ' 24' ' ' LYS . 36.9 m-80 -96.39 132.36 42.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 171.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.5 HD13 ' HB3' ' A' ' 48' ' ' LEU . 71.2 mt -107.16 105.32 18.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.533 173.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.783 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 1.1 t80 -101.17 111.75 24.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.133 0.492 . . . . 0.0 110.025 -177.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.626 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 73.1 m-85 -90.77 102.58 15.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.978 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.501 ' HB1' ' HB3' ' A' ' 71' ' ' ASN . . . -85.29 97.0 9.7 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 121.184 -0.206 . . . . 0.0 110.801 -177.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 1.072 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 32.8 ptt180 -76.7 114.86 15.92 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.831 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.5 mp -63.7 11.71 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.141 0.496 . . . . 0.0 111.742 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.578 ' H ' ' C ' ' A' ' 65' ' ' ARG . 62.3 tt0 -77.26 -31.41 54.91 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.185 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -112.77 148.14 35.42 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.749 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -65.65 -20.86 66.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.914 -172.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.589 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -63.45 -33.45 75.59 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.214 0.531 . . . . 0.0 110.485 -178.078 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.589 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 4.1 m120 -85.99 -17.65 34.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.571 -173.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.3 mt -69.85 -42.85 80.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -65.08 -40.64 94.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.168 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.579 HD11 HD11 ' A' ' 20' ' ' LEU . 2.3 mm? -62.71 -38.86 92.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.896 175.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.681 ' HA ' ' CE1' ' A' ' 33' ' ' PHE . . . -54.41 -52.37 61.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.439 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -64.95 -33.39 75.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.478 -178.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 mtmm -64.96 -16.27 63.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.964 0.412 . . . . 0.0 111.176 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.672 ' HB3' HG21 ' A' ' 87' ' ' VAL . 60.6 m-85 -119.66 15.48 12.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.664 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 65.57 21.99 11.74 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.666 0.604 . . . . 0.0 110.845 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.41 163.2 14.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.954 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -158.45 -36.97 0.07 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.948 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.1 pt -117.95 -176.14 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.985 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.74 147.08 55.58 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.186 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.65 155.42 80.6 Favored 'Cis proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.648 -1.397 . . . . 0.0 111.802 -0.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.586 HG23 ' HG3' ' A' ' 100' ' ' GLN . 88.3 m -144.12 110.19 5.39 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.8 p -102.12 113.69 27.17 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.082 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.672 HG21 ' HB3' ' A' ' 78' ' ' TYR . 85.1 t -100.65 109.88 26.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.319 176.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -89.67 105.86 18.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.139 0.495 . . . . 0.0 110.492 -178.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 95' ' ' LYS . 46.8 mt -99.13 148.89 23.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.132 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.402 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 7.3 t70 -83.6 -166.01 1.27 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -59.92 -32.45 70.78 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -170.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -105.81 10.72 32.52 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.01 0.433 . . . . 0.0 110.773 -173.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.64 20.15 45.38 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.163 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -68.32 116.93 9.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.012 0.406 . . . . 0.0 110.433 176.258 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.546 ' HA ' HD23 ' A' ' 89' ' ' LEU . 39.7 ttmt -74.1 89.09 1.95 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.601 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -89.27 -47.18 8.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.246 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.52 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 77.9 t80 -144.54 111.26 5.72 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.747 -177.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.449 HG23 HG22 ' A' ' 87' ' ' VAL . 2.2 p -103.18 134.46 44.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 172.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.52 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 17.3 t60 -138.24 126.64 23.21 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -175.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.586 ' HG3' HG23 ' A' ' 85' ' ' THR . 24.1 mp0 -96.63 140.09 31.75 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 123.611 0.569 . . . . 0.0 109.733 174.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.98 162.68 18.01 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.515 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.2 tp -73.95 141.04 45.95 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 122.522 0.329 . . . . 0.0 111.429 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 60.0 mtm -135.63 159.47 41.52 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 171.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -97.14 164.51 12.47 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.745 ' HG3' HG22 ' A' ' 51' ' ' VAL . 61.0 tttm -46.92 -52.37 14.69 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -175.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 25.7 t-20 -58.45 -32.82 69.08 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -177.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.541 ' O ' HG12 ' A' ' 111' ' ' ILE . 10.8 m120 -65.04 -46.35 81.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.441 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 41.5 mt -61.9 -43.93 98.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.836 176.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 105' ' ' LYS . 79.3 mm-40 -49.58 -47.21 49.56 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.015 176.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 m -72.11 -39.47 68.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.087 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 107' ' ' ASN . 48.5 mm -65.1 -44.54 95.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.875 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.718 ' HB3' HG21 ' A' ' 117' ' ' VAL . 82.8 mt -63.52 -38.73 92.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.068 0.461 . . . . 0.0 110.279 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -58.23 -41.15 83.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.892 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.9 m -85.13 -8.38 58.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.712 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 tp -85.01 -86.62 0.13 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.016 0.436 . . . . 0.0 109.842 176.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -179.03 -60.44 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.06 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 40.8 t 57.51 64.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 122.028 0.918 . . . . 0.0 110.756 177.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.114 -177.891 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 121.174 0.511 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.554 HG22 ' HB3' ' A' ' 52' ' ' SER . 1.1 tt -74.53 -8.42 11.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.484 -172.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -111.76 37.35 2.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.544 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.496 HG23 ' CD1' ' A' ' 63' ' ' TYR . 8.0 p -82.72 140.54 16.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.684 -176.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.409 HG21 HD21 ' A' ' 60' ' ' ASN . 3.8 p -139.6 159.92 27.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.485 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 19' ' ' ASN . 5.1 tp10 -83.53 -55.89 4.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.207 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.649 ' HA ' ' CE2' ' A' ' 62' ' ' TYR . 5.9 t-20 -142.59 169.07 18.26 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.543 -169.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.77 -32.35 73.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.355 176.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -63.34 -24.39 67.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.72 0.771 . . . . 0.0 109.943 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -97.65 10.28 40.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.645 -177.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -109.58 145.45 36.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.186 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -97.38 154.09 17.68 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 174.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.47 177.34 3.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.661 177.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . 89.53 -55.13 3.84 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.535 174.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 24.9 pt -84.51 134.83 41.78 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.913 0.387 . . . . 0.0 110.495 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 1.0 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 48.2 Cg_exo -59.14 144.49 99.36 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.783 2.322 . . . . 0.0 111.338 176.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.461 ' HB ' HD12 ' A' ' 89' ' ' LEU . 25.1 m -110.55 122.13 47.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.151 0.5 . . . . 0.0 111.185 -175.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.6 mt -104.39 108.67 25.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.745 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.682 ' HB ' HG23 ' A' ' 87' ' ' VAL . 5.4 mp -97.62 128.42 48.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.494 ' HB3' HG22 ' A' ' 86' ' ' THR . 26.2 ptm -121.45 122.74 40.43 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.472 0.653 . . . . 0.0 110.353 178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.563 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 93.7 m-85 -90.6 122.47 33.43 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.309 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.64 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 14.2 pttp -128.75 133.77 48.22 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.226 -174.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.488 ' HA ' ' HB2' ' A' ' 66' ' ' LEU . 17.8 p -75.1 178.17 5.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.561 0.22 . . . . 0.0 110.68 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.98 -58.94 6.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.053 0.454 . . . . 0.0 109.935 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.9 m -102.71 101.22 11.31 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.685 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 34' ' ' LYS . 4.0 p -136.03 104.21 9.72 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 120.996 0.426 . . . . 0.0 112.016 -177.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 38' ' ' CYS . 54.0 Cg_endo -71.62 -29.56 15.91 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.988 1.792 . . . . 0.0 111.889 176.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -63.31 -30.2 71.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.723 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.634 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 52.8 t -66.27 -51.11 60.74 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.113 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.403 ' HA ' ' NE2' ' A' ' 45' ' ' GLN . 42.7 t -57.11 -43.25 81.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.893 0.378 . . . . 0.0 110.912 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.605 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 7.6 tp10 -58.24 -49.03 78.55 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.932 177.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.4 ttt -72.16 -29.34 63.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.967 -177.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.634 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 27.4 mt-30 -57.89 -39.01 76.82 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 110.035 174.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.605 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 42.8 mtpt -60.03 -53.12 61.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.192 176.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.526 ' O ' HG23 ' A' ' 51' ' ' VAL . 63.6 mm-40 -58.7 -45.11 90.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.869 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.92 -33.15 73.72 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.953 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.3 t -64.95 -43.08 93.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.201 0.524 . . . . 0.0 109.682 176.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -66.47 -22.55 66.2 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.229 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.728 HG22 ' HG3' ' A' ' 105' ' ' LYS . 40.5 t -86.47 -41.97 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.005 0.431 . . . . 0.0 110.645 177.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.554 ' HB3' HG22 ' A' ' 14' ' ' ILE . 57.0 m -58.8 -30.83 67.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.341 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.413 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . 36.0 ttpt -51.59 -53.18 41.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.423 -178.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -105.9 15.99 25.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.707 0.289 . . . . 0.0 111.713 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 55' ' ' ARG . 12.8 ttm180 -138.68 75.91 1.54 Allowed 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.059 0.933 . . . . 0.0 109.633 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.709 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 1.5 tm-20 -71.39 132.0 44.18 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 113.87 -1.514 . . . . 0.0 110.07 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 41.47 46.86 4.63 Favored Glycine 0 C--N 1.333 0.408 0 O-C-N 124.016 0.822 . . . . 0.0 114.734 169.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.709 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 35.6 mmtm -120.14 -1.45 10.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.642 0.734 . . . . 0.0 109.434 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -158.46 150.61 21.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.453 -1.249 . . . . 0.0 108.723 172.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.409 HD21 HG21 ' A' ' 17' ' ' VAL . 62.4 t30 -114.27 124.75 52.79 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 178.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.4 mt -98.61 110.32 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.228 0.537 . . . . 0.0 111.564 -174.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.649 ' CE2' ' HA ' ' A' ' 19' ' ' ASN . 1.3 t80 -85.42 114.75 22.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.14 177.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.496 ' CD1' HG23 ' A' ' 16' ' ' VAL . 12.7 m-85 -89.94 103.26 15.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.223 0.535 . . . . 0.0 110.518 176.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.563 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -88.86 81.63 6.9 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.17 -179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.64 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 20.3 ptt180 -71.73 108.24 4.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.569 177.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 35' ' ' THR . 9.1 mp -65.87 10.5 0.1 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.185 0.517 . . . . 0.0 111.851 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' A' ' 65' ' ' ARG . 30.5 tt0 -64.23 -31.3 72.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.342 172.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -96.87 170.09 9.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.331 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -94.29 -11.96 29.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.339 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -67.28 -11.01 56.42 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.868 0.842 . . . . 0.0 110.826 177.217 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -89.89 -5.99 56.23 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.051 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.9 mt -69.19 -56.34 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -70.73 -38.13 73.55 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.724 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -57.42 -42.22 81.91 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.74 177.107 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.489 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -63.36 -56.57 15.31 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.722 -177.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -65.4 -32.21 73.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.633 -175.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 14.1 tmtt? -61.95 -18.58 60.84 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.971 0.415 . . . . 0.0 110.595 177.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.721 ' HB3' HG11 ' A' ' 87' ' ' VAL . 58.9 m-85 -127.4 25.48 6.11 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 66.0 15.29 10.01 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.323 0.582 . . . . 0.0 111.527 171.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.67 142.71 31.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.641 -174.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -146.16 -34.16 0.31 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.718 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.1 pt -125.59 -177.72 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.039 0.447 . . . . 0.0 111.3 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 84' ' ' PRO . 4.2 p -118.87 137.47 25.03 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.306 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 51.9 Cg_endo -96.65 126.33 2.92 Favored 'Cis proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.86 -1.308 . . . . 0.0 113.223 -0.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.2 m -100.39 116.99 33.66 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 171.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 2.3 p -115.5 115.23 26.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.999 0.428 . . . . 0.0 111.146 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.721 HG11 ' HB3' ' A' ' 78' ' ' TYR . 2.0 m -100.54 124.47 54.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.482 0.658 . . . . 0.0 110.219 176.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.572 ' HB3' HD22 ' A' ' 115' ' ' LEU . 73.3 m-85 -98.18 106.31 18.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.083 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.461 HD12 ' HB ' ' A' ' 29' ' ' THR . 44.0 mt -88.19 132.18 34.45 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 174.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.06 171.6 3.51 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 173.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 6.2 pttm -52.86 -25.23 10.96 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.447 0.699 . . . . 0.0 112.455 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.413 ' OE2' ' HG3' ' A' ' 91' ' ' LYS . 0.7 OUTLIER -83.21 -9.6 59.06 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.306 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.85 10.05 61.87 Favored Glycine 0 CA--C 1.517 0.207 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.728 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 7.9 p30 -85.78 144.4 27.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.756 -0.261 . . . . 0.0 110.708 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.417 ' HA ' HD23 ' A' ' 89' ' ' LEU . 10.4 ttmt -81.21 92.41 6.32 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -85.48 -45.12 12.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.062 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.507 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 89.1 t80 -137.3 148.12 46.13 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.194 -176.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.701 ' HB ' HG12 ' A' ' 87' ' ' VAL . 2.2 p -134.76 135.36 53.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.649 173.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.507 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 50.4 t60 -122.42 119.5 31.2 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -109.47 105.67 15.11 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 133.22 179.95 16.8 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -174.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.477 HD21 ' HG2' ' A' ' 43' ' ' GLU . 33.2 tp -87.5 164.9 15.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.715 0.258 . . . . 0.0 110.84 -176.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.451 ' HB2' ' HB2' ' A' ' 107' ' ' ASN . 27.0 ptt? -172.01 156.36 4.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.613 173.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.405 HH12 ' CD ' ' A' ' 43' ' ' GLU . 32.4 mmt180 -91.84 170.87 9.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.754 -0.203 . . . . 0.0 110.987 -176.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.728 ' HG3' HG22 ' A' ' 51' ' ' VAL . 82.5 tttt -47.23 -49.87 22.25 Favored 'General case' 0 C--O 1.222 -0.346 0 O-C-N 123.63 0.581 . . . . 0.0 112.071 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -56.35 -35.43 67.65 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.158 0.504 . . . . 0.0 111.543 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 103' ' ' MET . 6.5 m120 -73.96 -40.02 63.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.49 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 61.7 mt -60.77 -46.03 96.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.378 172.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 105' ' ' LYS . 10.6 mm-40 -50.49 -48.41 56.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.317 176.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.4 m -63.86 -43.0 97.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.718 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 107' ' ' ASN . 42.8 mm -65.22 -42.99 95.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.816 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.703 ' HB3' HG21 ' A' ' 117' ' ' VAL . 81.6 mt -60.57 -42.23 96.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.617 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -64.25 -31.36 72.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.157 177.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.6 t -86.13 -9.7 56.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.462 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.572 HD22 ' HB3' ' A' ' 88' ' ' PHE . 45.9 tp -93.11 -73.92 0.54 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.116 0.484 . . . . 0.0 110.231 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 172.2 -61.38 0.15 Allowed Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.0 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 41.9 t 50.33 78.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.957 0.884 . . . . 0.0 111.605 178.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.796 -174.722 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.536 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 9.8 m . . . . . 0 N--CA 1.454 -0.253 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.1 mt 70.33 -69.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.911 -175.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.752 HD21 ' HA2' ' A' ' 57' ' ' GLY . 12.9 m120 -92.93 31.28 1.43 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.262 0.553 . . . . 0.0 110.487 177.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 7.7 p -74.69 133.58 31.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.202 -177.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.419 HG21 ' HB3' ' A' ' 60' ' ' ASN . 67.5 t -134.84 136.38 52.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.847 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -65.83 -53.95 33.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.928 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.673 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 35.2 t30 -164.77 174.33 10.81 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -173.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -50.48 -29.4 10.32 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.805 0.336 . . . . 0.0 111.208 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.673 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 10.2 pt-20 -55.83 -37.2 68.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.321 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -103.18 8.3 38.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.625 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.26 139.66 52.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.622 0.249 . . . . 0.0 110.347 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -128.18 154.74 45.46 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.759 -174.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 61.8 -170.36 0.16 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.064 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -110.22 43.99 1.6 Allowed Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.151 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.553 HG13 ' ND2' ' A' ' 60' ' ' ASN . 7.0 pt -100.68 147.25 33.38 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.609 -0.295 . . . . 0.0 111.058 -178.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 1.087 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 88.1 Cg_exo -50.59 160.07 1.88 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.64 2.893 . . . . 0.0 113.227 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.7 m -123.37 128.16 49.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.435 -175.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.458 HD11 HD21 ' A' ' 112' ' ' LEU . 80.0 mt -107.45 109.63 28.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.616 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 42.5 mt -105.15 110.22 30.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.263 -177.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.537 ' SD ' ' NZ ' ' A' ' 34' ' ' LYS . 5.1 ppp? -114.69 139.58 49.55 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.767 0.794 . . . . 0.0 110.058 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -103.87 150.03 24.53 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.016 -170.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.654 ' HB3' ' HZ2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -152.77 161.51 42.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.934 178.565 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.633 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -75.06 -173.8 2.07 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 175.114 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.457 ' HB2' ' OE1' ' A' ' 67' ' ' GLU . 31.6 t70 -60.27 -29.37 68.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.057 0.456 . . . . 0.0 110.725 175.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -158.46 132.49 7.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.546 176.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 12.5 p -165.8 137.35 3.1 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.772 176.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 24.2 Cg_exo -63.14 -29.85 74.61 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.693 2.262 . . . . 0.0 112.811 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -62.94 -31.12 72.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.516 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 46.9 t -71.47 -36.32 71.13 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.111 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.548 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 46.9 t -67.93 -42.0 85.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.835 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -57.96 -50.24 74.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.669 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.471 ' HB2' HD21 ' A' ' 102' ' ' LEU . 21.5 ttt -72.15 -29.0 63.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.664 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.445 ' HG2' ' OH ' ' A' ' 63' ' ' TYR . 23.0 tm0? -61.08 -42.41 98.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 177.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 31.7 mmmt -63.04 -45.45 92.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.934 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.599 ' O ' HG23 ' A' ' 51' ' ' VAL . 72.0 mm-40 -58.06 -47.88 81.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.698 176.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.56 -35.41 77.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.213 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.7 m -59.72 -43.93 93.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.079 0.466 . . . . 0.0 110.176 173.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -66.97 -41.03 87.54 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.615 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 47' ' ' GLU . 55.3 t -60.24 -44.56 95.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.571 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.664 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 m -66.24 -30.85 71.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.969 0.414 . . . . 0.0 111.282 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -77.66 -24.71 49.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.045 0.45 . . . . 0.0 110.557 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -93.39 -38.63 11.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.22 0.533 . . . . 0.0 110.199 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -114.8 79.03 1.21 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.63 120.92 19.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.567 -168.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.752 ' HA2' HD21 ' A' ' 15' ' ' ASN . . . 60.91 57.86 16.64 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.549 -0.75 . . . . 0.0 113.184 173.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.86 ' HE3' HG12 ' A' ' 117' ' ' VAL . 29.1 mmmt -132.67 -3.2 3.31 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.655 -0.32 . . . . 0.0 111.571 -176.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -166.82 153.92 9.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 111.149 -176.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.553 ' ND2' HG13 ' A' ' 27' ' ' ILE . 58.6 m-80 -95.64 129.82 42.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.99 174.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.6 mt -98.92 108.76 22.84 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 CA-C-O 120.542 0.211 . . . . 0.0 110.657 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.483 ' HB3' ' HA ' ' A' ' 31' ' ' ILE . 0.3 OUTLIER -96.28 118.28 32.51 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.338 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.607 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 31.2 m-85 -97.27 103.74 15.7 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.143 0.497 . . . . 0.0 110.368 173.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.415 ' HB1' HD22 ' A' ' 71' ' ' ASN . . . -94.27 100.62 12.64 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.231 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.501 ' C ' ' H ' ' A' ' 67' ' ' GLU . 3.4 ptp180 -84.61 117.22 23.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.273 172.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.7 mt -66.73 10.51 0.13 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.268 0.556 . . . . 0.0 112.082 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 65' ' ' ARG . 20.7 tp10 -80.4 -25.19 39.2 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.584 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -96.85 159.01 15.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.951 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -71.5 -22.91 61.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.166 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.493 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.9 OUTLIER -65.16 -25.84 67.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.415 0.626 . . . . 0.0 111.166 -174.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.493 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 7.8 m120 -89.94 -7.49 53.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.76 -168.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.7 mm -69.23 -50.94 48.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.78 -44.25 86.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.143 174.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -60.48 -40.98 93.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.593 -178.414 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 80' ' ' ALA . . . -68.9 -55.87 9.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.349 . . . . 0.0 111.655 -177.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -63.2 -34.23 77.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.676 -174.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.44 ' HE3' ' HB2' ' A' ' 77' ' ' LYS . 26.8 ttmt -64.61 -16.91 63.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.901 0.381 . . . . 0.0 110.912 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.579 ' CE1' HD21 ' A' ' 89' ' ' LEU . 75.7 m-85 -122.02 16.96 10.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.797 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 67.77 23.48 8.55 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.87 0.367 . . . . 0.0 111.535 174.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.451 ' HB1' HG21 ' A' ' 85' ' ' THR . . . -102.34 136.49 42.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.615 -178.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -144.33 -75.55 0.24 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.015 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.0 pt -71.15 142.05 16.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.99 0.424 . . . . 0.0 110.95 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.3 153.08 38.33 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.634 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -87.94 119.75 4.87 Favored 'Cis proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.25 -1.563 . . . . 0.0 112.411 0.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.567 ' HB ' ' HG3' ' A' ' 100' ' ' GLN . 5.1 t -110.31 142.52 41.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.249 177.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.7 m -132.39 127.86 36.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.747 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.616 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 10.8 p -108.89 128.33 64.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.25 0.548 . . . . 0.0 110.342 176.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -101.42 111.79 24.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.441 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.579 HD21 ' CE1' ' A' ' 78' ' ' TYR . 5.7 mp -107.91 146.01 32.97 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.079 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -83.2 -172.48 4.16 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 173.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.93 ' HE3' ' HE2' ' A' ' 118' ' ' LYS . 18.7 pttp -62.79 -33.04 74.36 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -172.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -93.42 18.04 10.43 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.458 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 78.54 25.34 61.07 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.819 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.561 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 81.3 m-20 -78.95 110.07 13.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.563 0.22 . . . . 0.0 110.68 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 78' ' ' TYR . 11.7 ptmm? -72.36 86.78 1.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.53 0.681 . . . . 0.0 109.696 177.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -80.42 -53.09 6.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.374 -172.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 75.8 t80 -135.76 127.6 29.33 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.768 -173.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.486 HG12 HG23 ' A' ' 87' ' ' VAL . 33.7 m -111.01 150.69 13.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 172.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.413 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 11.9 t60 -156.3 134.33 11.23 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.567 ' HG3' ' HB ' ' A' ' 85' ' ' THR . 2.3 mp0 -105.01 128.69 53.42 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 173.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 141.4 -161.3 26.94 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.458 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 44' ' ' MET . 1.1 tm? -129.87 121.3 26.42 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.671 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 3.3 mpp? -116.25 161.34 19.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.845 0.355 . . . . 0.0 110.202 178.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -93.95 167.97 11.27 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.086 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -50.3 -42.77 53.07 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -62.32 -38.76 90.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.186 0.517 . . . . 0.0 110.855 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.671 ' HB2' ' HB3' ' A' ' 103' ' ' MET . 3.5 m120 -71.05 -43.97 66.74 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.503 -176.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.62 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 48.9 mt -58.72 -50.04 80.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.872 176.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -56.51 -48.76 76.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.337 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.5 m -60.03 -38.17 81.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.067 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 107' ' ' ASN . 80.4 mt -65.35 -40.86 89.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.839 0.352 . . . . 0.0 110.231 176.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 57.4 mt -63.27 -35.83 81.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.183 177.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.86 -30.29 71.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.444 177.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.0 m -85.45 -9.85 56.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.709 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.2 tp -87.52 -88.18 0.14 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.387 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -174.5 -54.05 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.087 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 17.4 t 52.97 57.22 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 122.327 1.06 . . . . 0.0 109.871 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.93 ' HE2' ' HE3' ' A' ' 91' ' ' LYS . 19.8 pttm . . . . . 0 C--N 1.321 -0.662 0 CA-C-N 114.266 -1.333 . . . . 0.0 110.486 -173.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.57 ' CB ' HG23 ' A' ' 16' ' ' VAL . 20.3 m . . . . . 0 N--CA 1.45 -0.448 0 CA-C-O 121.099 0.476 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.476 ' N ' HD12 ' A' ' 14' ' ' ILE . 3.3 mp -85.81 -28.66 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.529 0.681 . . . . 0.0 110.1 -176.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -79.45 10.33 3.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.493 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.57 HG23 ' CB ' ' A' ' 13' ' ' SER . 1.0 OUTLIER -64.36 142.28 17.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.675 0.75 . . . . 0.0 112.842 -173.089 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.649 HG21 ' HB3' ' A' ' 60' ' ' ASN . 84.3 t -134.85 124.95 44.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.606 174.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -79.47 -30.92 42.3 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.138 0.495 . . . . 0.0 110.798 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -176.24 176.4 1.69 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -48.87 -34.24 12.23 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.5 mp0 -58.67 -33.73 70.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.642 0.258 . . . . 0.0 111.613 177.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -99.15 19.94 14.37 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.751 0.31 . . . . 0.0 111.019 -175.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.96 145.33 26.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.906 0.384 . . . . 0.0 111.143 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -116.71 114.42 24.0 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -81.41 168.57 18.2 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.284 -175.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.46 -35.0 5.32 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -172.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.5 pt -113.01 157.39 40.84 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 114.925 -0.638 . . . . 0.0 109.729 176.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.602 ' HG2' HG22 ' A' ' 117' ' ' VAL . 49.0 Cg_exo -57.76 169.71 2.39 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.868 2.379 . . . . 0.0 112.608 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.48 ' HA ' ' HB2' ' A' ' 60' ' ' ASN . 63.1 m -136.38 115.28 12.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.932 0.396 . . . . 0.0 111.063 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.438 HD12 ' HD2' ' A' ' 88' ' ' PHE . 21.4 mm -101.71 139.45 22.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.604 ' HB ' HG12 ' A' ' 87' ' ' VAL . 77.2 mt -130.6 118.11 41.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.561 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 24.9 ptm -109.23 120.54 42.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.469 0.652 . . . . 0.0 109.856 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.58 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 87.8 m-85 -90.41 117.36 29.06 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.752 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HG3' ' HB2' ' A' ' 41' ' ' CYS . 0.1 OUTLIER -150.8 149.35 29.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.364 -178.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.4 t -81.7 165.22 21.19 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 170.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.684 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -88.92 9.93 23.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.015 0.436 . . . . 0.0 110.871 -169.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.4 p -108.9 -16.69 14.1 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 65.7 m -83.03 128.53 64.95 Favored Pre-proline 0 C--N 1.33 -0.265 0 O-C-N 122.25 -0.281 . . . . 0.0 111.001 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.91 -25.76 7.29 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 121.938 1.759 . . . . 0.0 113.569 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -62.97 -19.74 64.58 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.798 0.332 . . . . 0.0 110.965 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.625 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 7.3 p -71.73 -34.4 69.53 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.35 -35.79 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.691 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -62.99 -49.53 74.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.135 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.5 ttt -65.84 -32.88 74.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.2 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 19.8 mt-30 -63.66 -33.2 75.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.934 175.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -68.42 -41.41 80.43 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.216 176.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 51' ' ' VAL . 18.9 mm-40 -55.72 -54.04 49.17 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 172.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.547 HD13 HG21 ' A' ' 61' ' ' ILE . 68.7 mt -58.24 -33.43 69.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.487 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.1 t -65.61 -40.66 92.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.788 0.328 . . . . 0.0 110.58 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.432 ' HB2' ' HE2' ' A' ' 105' ' ' LYS . 19.8 m-85 -72.69 -31.74 65.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.06 178.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.917 HG22 ' HG3' ' A' ' 105' ' ' LYS . 16.8 t -68.76 -38.66 79.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.2 t -64.06 -31.11 72.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.925 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 50' ' ' TYR . 16.1 tppt? -68.27 -42.55 79.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.378 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -93.24 -20.88 20.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.63 -176.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.3 76.23 1.71 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.521 0.677 . . . . 0.0 109.507 178.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.451 ' O ' ' HE3' ' A' ' 58' ' ' LYS . 1.2 pm0 -72.14 124.34 24.8 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.738 -173.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.34 40.13 37.39 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.614 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.451 ' HE3' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -113.49 -4.59 13.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.076 0.465 . . . . 0.0 110.059 -174.019 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -171.79 141.93 1.47 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.922 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.649 ' HB3' HG21 ' A' ' 17' ' ' VAL . 50.8 m-80 -77.27 145.78 37.28 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.613 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.547 HG21 HD13 ' A' ' 48' ' ' LEU . 21.3 mt -128.09 107.04 15.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 171.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.512 ' CD2' HG23 ' A' ' 31' ' ' ILE . 4.7 t80 -98.92 117.27 33.05 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.473 ' CE2' HG22 ' A' ' 16' ' ' VAL . 25.3 m-85 -90.99 103.59 16.29 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.58 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -81.5 78.29 8.27 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.984 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.583 ' C ' ' H ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -69.84 113.14 6.8 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.62 174.059 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.7 tp -64.57 11.43 0.05 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.342 0.591 . . . . 0.0 111.123 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.684 ' HB2' ' HB2' ' A' ' 36' ' ' ASP . 7.8 tp10 -80.62 -25.55 38.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.091 -178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.427 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 44.2 mt-10 -105.87 -174.39 2.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.247 0.546 . . . . 0.0 112.056 -175.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -90.42 -31.44 16.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.947 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.547 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -54.31 -40.61 68.09 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.641 0.734 . . . . 0.0 111.664 -173.389 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.547 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 2.6 p30 -101.51 10.28 40.51 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.875 -172.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.2 mm -67.45 -49.61 69.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 167.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.56 -43.96 62.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.606 174.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.498 ' CB ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -62.78 -43.84 97.75 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.674 -177.018 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.02 -41.83 77.2 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 122.187 -0.321 . . . . 0.0 110.857 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -61.9 -32.96 73.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.461 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -55.91 -33.33 64.56 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.525 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -112.19 8.02 19.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.726 0.298 . . . . 0.0 110.575 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 t0 53.81 50.63 16.52 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.255 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.28 71.04 10.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.326 0.584 . . . . 0.0 110.609 177.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -82.87 -13.66 55.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.836 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 23.1 pt -113.9 155.91 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.189 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.18 148.93 66.52 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.985 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -90.77 121.48 4.4 Favored 'Cis proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.372 -1.512 . . . . 0.0 112.587 -1.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 94.5 m -100.52 117.19 34.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.3 m -110.38 125.78 53.57 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.089 0.471 . . . . 0.0 111.323 -175.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.604 HG12 ' HB ' ' A' ' 31' ' ' ILE . 10.5 p -108.04 140.81 25.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.551 175.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.948 ' HB3' HD11 ' A' ' 115' ' ' LEU . 52.4 m-85 -118.29 113.74 21.92 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.226 -174.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.454 ' CD2' ' HA ' ' A' ' 95' ' ' LYS . 32.3 mt -107.88 143.75 36.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.673 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.62 ' HB3' ' HB2' ' A' ' 94' ' ' ASN . 24.7 t0 -78.28 172.05 14.16 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -63.71 -18.64 64.22 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -87.69 -0.42 56.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 0.0 110.059 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.51 12.03 67.77 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.441 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.62 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 94.5 m-20 -70.06 117.71 11.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.597 -0.301 . . . . 0.0 111.445 -177.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.454 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -73.0 102.2 3.43 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.582 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -104.35 -72.53 0.7 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.91 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -113.0 141.49 46.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.89 -169.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.1 p -139.48 135.75 40.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 174.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -149.35 137.96 20.98 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -106.72 123.72 48.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.896 0.379 . . . . 0.0 110.611 178.215 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 148.43 179.29 24.25 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.949 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.3 tp -83.0 102.06 11.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.902 0.382 . . . . 0.0 110.352 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 79.4 mmm -94.98 154.35 17.22 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.467 ' HB2' HD22 ' A' ' 107' ' ' ASN . 8.8 mmm180 -115.36 171.17 7.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.784 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.917 ' HG3' HG22 ' A' ' 51' ' ' VAL . 38.8 ttmt -46.59 -59.34 3.07 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -175.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -61.5 -30.75 70.82 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.935 0.398 . . . . 0.0 111.67 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.529 ' O ' HD13 ' A' ' 111' ' ' ILE . 40.3 m-80 -70.47 -40.5 73.63 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.613 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 41.1 mt -63.11 -51.37 72.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 173.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -50.97 -52.49 42.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.341 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.4 m -60.13 -40.93 91.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.004 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.624 ' O ' ' HG ' ' A' ' 115' ' ' LEU . 1.7 mp -69.06 -38.75 78.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.68 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 86.7 mt -58.01 -43.11 86.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.263 0.554 . . . . 0.0 109.783 176.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -56.7 -40.81 76.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.227 176.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.4 m -75.26 -28.99 60.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.452 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.948 HD11 ' HB3' ' A' ' 88' ' ' PHE . 85.1 mt -68.01 -58.32 4.71 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.481 0.657 . . . . 0.0 109.664 175.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 159.79 -71.3 0.23 Allowed Glycine 0 N--CA 1.438 -1.2 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.165 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.602 HG22 ' HG2' ' A' ' 28' ' ' PRO . 40.9 t 54.97 72.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.908 0.861 . . . . 0.0 109.557 -173.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 118' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.006 -171.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.0 m . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.667 ' HB ' ' CD ' ' A' ' 56' ' ' GLU . 4.2 mp -90.77 -14.71 8.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.999 0.904 . . . . 0.0 108.903 177.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -71.16 7.66 1.19 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.305 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.475 HG23 ' CE2' ' A' ' 63' ' ' TYR . 6.5 p -60.0 129.24 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -173.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -133.17 140.07 47.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.813 170.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.77 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 28.0 tp10 -70.53 -50.56 36.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.335 177.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.869 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 27.9 t-20 -149.13 171.05 17.06 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.275 -174.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 20' ' ' LEU . 3.8 mm? -50.05 -29.93 9.78 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.194 0.308 . . . . 0.0 111.061 171.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.869 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 12.9 pt-20 -61.31 -29.95 70.19 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.956 0.408 . . . . 0.0 110.881 175.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.77 ' HG3' ' HB3' ' A' ' 18' ' ' GLU . 13.6 mm-40 -95.24 -0.22 53.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.264 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.17 159.69 25.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.303 0.573 . . . . 0.0 112.145 -172.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.637 ' HB2' HD11 ' A' ' 27' ' ' ILE . 29.7 mtmt -115.39 161.96 17.8 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.688 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.44 166.01 10.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.888 0.375 . . . . 0.0 111.977 -177.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.13 -49.43 3.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.063 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.815 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -91.46 149.59 39.75 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.721 0.296 . . . . 0.0 110.62 178.115 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 1.053 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 52.0 Cg_exo -60.72 171.01 3.89 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 123.264 2.643 . . . . 0.0 112.891 176.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.532 HG23 ' HB2' ' A' ' 60' ' ' ASN . 26.4 m -130.74 131.4 44.72 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.921 -176.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.537 HD11 HD21 ' A' ' 112' ' ' LEU . 65.3 mt -110.0 114.13 46.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.664 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.613 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 9.5 mm -100.39 109.93 26.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 25.5 ptm -111.96 131.83 55.14 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.857 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.637 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 77.3 m-85 -97.53 120.55 38.11 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.217 -176.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.573 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -125.6 162.23 25.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.997 -174.587 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.3 t -135.89 164.92 26.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.061 0.457 . . . . 0.0 110.648 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.488 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . 24.3 t70 -75.79 -27.75 58.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.799 -178.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.1 m -81.82 -66.55 0.87 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.042 -174.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.613 ' HB3' ' HD2' ' A' ' 40' ' ' TYR . 29.9 m -68.69 122.12 83.62 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.223 -176.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -79.01 3.72 7.17 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.437 2.091 . . . . 0.0 113.332 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.613 ' HD2' ' HB3' ' A' ' 38' ' ' CYS . 96.1 m-85 -61.4 -23.94 66.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.996 0.427 . . . . 0.0 110.614 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.2 p -64.71 -52.02 59.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.245 177.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.433 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 41.7 t -60.47 -30.99 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.71 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.403 ' HA ' ' OE1' ' A' ' 43' ' ' GLU . 5.3 tp10 -68.02 -49.89 58.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.438 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.2 ttt -66.02 -30.3 70.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.863 0.363 . . . . 0.0 110.199 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -60.93 -37.27 81.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.023 176.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 43.7 mttp -64.49 -47.83 77.47 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.853 0.359 . . . . 0.0 110.046 177.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.51 ' O ' HG23 ' A' ' 51' ' ' VAL . 21.0 mm-40 -57.28 -44.27 83.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.299 177.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.5 mt -60.7 -34.1 73.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.971 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.5 m -59.87 -44.57 94.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.075 0.464 . . . . 0.0 110.29 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -70.05 -29.5 66.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.047 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 47' ' ' GLU . 50.9 t -76.22 -47.01 32.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.629 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.618 ' HB3' ' OE2' ' A' ' 56' ' ' GLU . 15.1 m -62.81 -29.17 70.52 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-O 120.881 0.372 . . . . 0.0 110.513 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -50.11 -32.96 17.17 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.184 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.405 ' CD ' ' HE ' ' A' ' 55' ' ' ARG . 1.1 tm-20 -104.32 -48.57 3.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.388 0.613 . . . . 0.0 109.365 171.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.663 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 9.4 tpp85 -91.02 66.52 5.83 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.915 -173.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.667 ' CD ' ' HB ' ' A' ' 14' ' ' ILE . 3.9 mm-40 -90.52 144.73 25.5 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.005 172.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.45 34.2 54.55 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.491 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.663 ' HB2' ' HG3' ' A' ' 55' ' ' ARG . 26.8 mmtp -113.05 -14.09 13.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.251 0.548 . . . . 0.0 109.727 -174.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.575 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 0.8 OUTLIER -165.68 -175.01 3.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.398 179.008 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.532 ' HB2' HG23 ' A' ' 29' ' ' THR . 44.1 m-80 -108.2 129.28 55.2 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.209 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.3 mm -106.64 107.54 22.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 173.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.865 ' CE2' ' HA ' ' A' ' 19' ' ' ASN . 0.7 OUTLIER -98.2 112.1 24.2 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.448 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.475 ' CE2' HG23 ' A' ' 16' ' ' VAL . 89.7 m-85 -89.8 102.75 15.45 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 173.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.613 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -79.67 91.03 5.2 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.573 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 8.0 ptp180 -68.97 104.21 2.04 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.443 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.7 mp -65.42 10.74 0.08 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.092 0.472 . . . . 0.0 110.907 176.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.543 ' H ' ' C ' ' A' ' 65' ' ' ARG . 2.0 mp0 -83.29 -29.44 28.36 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.012 177.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.487 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 22.6 mt-10 -102.48 -171.67 2.0 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-O 121.379 0.609 . . . . 0.0 112.48 -175.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -95.17 -35.35 11.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.966 -174.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.522 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -56.33 -28.17 58.13 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.408 0.623 . . . . 0.0 111.144 -176.376 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.522 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 3.6 m120 -87.69 -8.45 56.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.435 -170.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.8 mm -68.3 -57.86 7.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.46 -38.89 91.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.2 174.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.495 ' HG ' ' OH ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -58.86 -38.91 79.85 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.312 179.343 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.637 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -61.14 -48.23 82.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.062 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -65.55 -34.17 77.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.809 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -57.91 -33.8 69.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.041 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.422 ' CD1' HG11 ' A' ' 87' ' ' VAL . 72.6 m-85 -115.81 16.99 16.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.902 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 61.9 35.02 16.6 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.006 170.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.411 ' HB1' HG21 ' A' ' 85' ' ' THR . . . -91.65 146.1 24.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.696 -176.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -154.58 -35.01 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.45 174.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.0 mt -91.94 134.9 28.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.787 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 84' ' ' PRO . 16.1 m -108.34 134.74 20.1 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.568 176.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 63.5 Cg_endo -91.7 141.79 11.14 Favored 'Cis proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.321 -1.533 . . . . 0.0 112.509 -0.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.429 HG23 ' CD1' ' A' ' 33' ' ' PHE . 9.0 t -126.06 147.18 49.63 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.5 t -141.17 130.39 23.52 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.891 0.376 . . . . 0.0 110.462 -177.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.613 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 8.8 p -113.61 128.29 70.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.382 0.611 . . . . 0.0 110.198 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.552 ' HB3' HD22 ' A' ' 115' ' ' LEU . 88.8 m-85 -100.03 118.54 36.62 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.147 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.594 ' O ' ' HB3' ' A' ' 28' ' ' PRO . 7.1 mp -106.12 139.43 40.65 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.159 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -68.77 177.51 2.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 173.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.869 ' HE3' ' HE2' ' A' ' 118' ' ' LYS . 4.5 pttm -63.16 -26.19 68.7 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 122.36 0.264 . . . . 0.0 111.596 -176.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -71.13 -25.56 62.63 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.747 0.308 . . . . 0.0 110.967 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.99 22.29 10.96 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.671 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 59.3 m-80 -86.81 132.09 33.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.687 0.244 . . . . 0.0 110.484 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -71.4 84.3 0.8 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.428 0.633 . . . . 0.0 109.724 173.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -73.03 -47.82 41.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.081 -174.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -145.21 116.68 8.04 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.127 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 87' ' ' VAL . 7.2 p -105.67 137.02 37.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 174.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -124.05 136.04 53.99 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -116.5 110.35 18.48 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 175.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 135.3 158.79 8.4 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -175.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.3 tp -77.9 141.78 38.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.757 0.313 . . . . 0.0 111.131 -176.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.483 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 54.7 mtm -131.63 166.89 20.43 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -102.67 175.03 5.63 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -54.85 -48.43 72.9 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.413 ' HA ' ' CD ' ' A' ' 109' ' ' GLU . 5.0 t-20 -66.51 -28.52 68.63 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.007 0.432 . . . . 0.0 110.811 -176.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.511 ' O ' HG12 ' A' ' 111' ' ' ILE . 11.2 m120 -66.16 -45.48 80.79 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 176.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.524 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 54.2 mt -61.71 -45.5 98.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.597 175.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.413 ' CD ' ' HA ' ' A' ' 106' ' ' ASN . 40.9 mt-10 -50.37 -48.29 55.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.528 176.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.3 m -65.25 -40.09 93.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.068 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 107' ' ' ASN . 49.1 mm -68.27 -43.52 84.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.516 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.537 HD21 HD11 ' A' ' 30' ' ' ILE . 98.2 mt -57.2 -43.54 82.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.18 0.514 . . . . 0.0 110.51 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -60.48 -43.2 97.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.117 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.0 m -86.53 -2.58 58.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.816 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' A' ' 88' ' ' PHE . 63.5 tp -82.85 -69.93 0.59 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.971 0.415 . . . . 0.0 111.869 -174.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.781 ' O ' ' HG2' ' A' ' 118' ' ' LYS . . . 149.32 -3.16 0.63 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.547 -172.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.053 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 39.0 t -33.86 107.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.141 0.976 . . . . 0.0 113.283 171.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.869 ' HE2' ' HE3' ' A' ' 91' ' ' LYS . 22.5 pttm . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 114.672 -1.149 . . . . 0.0 107.95 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.567 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 5.6 m . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.373 0.13 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.0 mt 64.59 -68.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 O-C-N 123.681 0.613 . . . . 0.0 111.133 -173.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -89.15 45.82 1.33 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.061 0.458 . . . . 0.0 110.641 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 2.4 p -79.71 123.12 36.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.603 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.593 HG11 ' HB2' ' A' ' 23' ' ' ALA . 41.0 t -109.65 141.93 23.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.104 -175.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -83.14 -33.64 26.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.756 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.82 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 20.1 t-20 -173.33 175.58 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.7 mt -60.58 -29.74 69.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.019 0.438 . . . . 0.0 110.447 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.82 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 12.0 pt-20 -65.13 -32.25 73.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.554 176.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -93.31 7.8 42.96 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.493 0.663 . . . . 0.0 110.122 178.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.593 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -110.24 158.58 18.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.249 -176.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -133.24 135.61 45.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.117 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.06 163.63 27.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.785 0.326 . . . . 0.0 110.269 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.58 -35.72 3.23 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.687 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -116.0 145.54 35.06 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.177 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.543 ' HD2' ' O ' ' A' ' 58' ' ' LYS . 99.4 Cg_exo -44.93 133.61 10.82 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.17 2.58 . . . . 0.0 112.757 177.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.4 m -101.4 109.25 21.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.366 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.683 HD13 ' HB2' ' A' ' 59' ' ' PHE . 2.4 mp -98.67 108.19 21.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.706 ' HB ' HG23 ' A' ' 87' ' ' VAL . 67.8 mt -104.35 112.02 36.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.069 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.421 ' SD ' ' HB3' ' A' ' 34' ' ' LYS . 4.5 ppp? -109.55 144.15 38.24 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.5 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 87.5 m-85 -104.84 130.34 52.99 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.776 -177.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.873 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 12.5 pttp -143.98 149.06 36.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.108 -172.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.568 HG22 ' H ' ' A' ' 36' ' ' ASP . 1.4 m -74.04 -174.18 1.81 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 168.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.568 ' H ' HG22 ' A' ' 35' ' ' THR . 7.0 t70 -54.12 -75.36 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.798 0.332 . . . . 0.0 110.812 175.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.1 m -110.88 127.17 55.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.861 0.363 . . . . 0.0 110.696 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 44.0 m -146.3 134.76 10.87 Favored Pre-proline 0 C--O 1.235 0.313 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.325 178.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.28 -31.19 14.67 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.116 1.877 . . . . 0.0 113.044 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -68.74 -28.7 67.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.926 0.393 . . . . 0.0 110.694 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 38' ' ' CYS . 58.8 m -74.37 -42.38 59.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.694 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.0 p -70.5 -29.58 39.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.161 0.505 . . . . 0.0 110.19 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -66.02 -46.23 78.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.898 175.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.442 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 23.8 ttt -63.16 -35.28 79.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.518 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.465 ' HG2' ' OH ' ' A' ' 63' ' ' TYR . 37.7 mt-30 -57.78 -40.63 80.28 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.192 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -58.68 -50.5 73.65 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.535 ' HG3' ' HA ' ' A' ' 104' ' ' ARG . 70.0 mm-40 -59.96 -40.26 88.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.098 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.817 HD13 HD13 ' A' ' 61' ' ' ILE . 96.7 mt -60.28 -43.66 96.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.492 177.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.9 t -62.99 -37.07 85.7 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.177 0.513 . . . . 0.0 110.15 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.617 ' HA ' ' HE3' ' A' ' 53' ' ' LYS . 23.0 m-85 -64.05 -23.94 67.52 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.567 177.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.538 HG22 ' HE3' ' A' ' 105' ' ' LYS . 46.3 t -83.15 -43.18 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.8 m -55.41 -31.86 62.2 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.16 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.617 ' HE3' ' HA ' ' A' ' 50' ' ' TYR . 10.1 mtmp? -62.27 -35.16 78.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.786 0.327 . . . . 0.0 111.103 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.579 ' OE1' ' HB2' ' A' ' 53' ' ' LYS . 1.7 mp0 -103.96 9.0 36.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.554 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -154.83 92.8 1.49 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -172.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.12 116.48 7.26 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.119 0.485 . . . . 0.0 109.698 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 59' ' ' PHE . . . 47.02 -105.75 0.12 Allowed Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.168 -173.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.543 ' O ' ' HD2' ' A' ' 28' ' ' PRO . 0.3 OUTLIER 53.58 8.33 0.13 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.826 -1.187 . . . . 0.0 112.946 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.683 ' HB2' HD13 ' A' ' 30' ' ' ILE . 9.5 p90 -163.21 114.14 1.43 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.565 0.698 . . . . 0.0 110.414 174.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.498 ' HB3' HG21 ' A' ' 17' ' ' VAL . 5.4 m-20 -84.15 116.2 22.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.796 174.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.817 HD13 HD13 ' A' ' 48' ' ' LEU . 26.7 mt -96.33 107.91 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.746 -176.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.582 ' HB3' HG12 ' A' ' 31' ' ' ILE . 4.4 t80 -91.18 117.23 29.45 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.505 ' HD2' ' HD3' ' A' ' 34' ' ' LYS . 44.1 m-85 -91.48 106.46 18.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.782 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -83.13 69.83 9.95 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.775 0.797 . . . . 0.0 109.447 178.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.873 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 26.1 ptt180 -62.52 118.45 7.58 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.965 175.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 34' ' ' LYS . 4.4 mm? -66.64 10.24 0.14 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.873 0.368 . . . . 0.0 111.618 178.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.486 ' H ' ' C ' ' A' ' 65' ' ' ARG . 17.9 mt-10 -69.05 -40.95 78.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.543 0.687 . . . . 0.0 109.974 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.598 ' HB2' ' HD2' ' A' ' 70' ' ' LYS . 27.0 mt-10 -89.83 151.99 21.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.908 -174.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -70.7 -34.21 71.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.216 0.531 . . . . 0.0 110.173 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.598 ' HD2' ' HB2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -58.15 -27.1 63.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.883 179.02 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.495 ' N ' ' HD3' ' A' ' 70' ' ' LYS . 76.8 m-20 -87.47 -3.41 59.0 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.223 -178.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.4 mm -70.72 -43.1 77.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 171.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -71.77 -41.35 68.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.217 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 74' ' ' LEU . 0.8 OUTLIER -60.85 -47.42 86.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.205 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.5 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -62.93 -48.65 77.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.833 0.349 . . . . 0.0 110.967 178.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -61.42 -34.48 75.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.657 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -57.18 -33.22 67.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.181 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.453 ' CE1' ' HD3' ' A' ' 95' ' ' LYS . 85.3 m-85 -111.66 12.53 21.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.961 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.2 t70 67.33 21.86 9.69 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.433 0.635 . . . . 0.0 111.24 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.73 93.43 4.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.898 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -112.75 -8.15 13.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.454 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.567 HD13 ' H ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -125.17 153.39 32.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.001 178.552 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.7 m -131.27 153.22 81.61 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.455 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -90.59 145.65 16.64 Favored 'Cis proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.282 -1.549 . . . . 0.0 112.662 -0.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.1 t -142.61 149.55 39.13 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.3 m -138.6 131.12 28.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.684 0.278 . . . . 0.0 111.35 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.706 HG23 ' HB ' ' A' ' 31' ' ' ILE . 5.5 m -102.4 120.87 52.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.893 173.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -96.55 118.38 32.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.221 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.499 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 6.6 mp -113.68 145.06 41.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.75 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -63.93 171.66 2.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.949 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.515 ' HG2' ' CD ' ' A' ' 118' ' ' LYS . 2.2 pptp? -52.04 -25.1 7.79 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.901 0.881 . . . . 0.0 112.756 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.509 ' HB3' ' ND2' ' A' ' 94' ' ' ASN . 21.6 tt0 -92.1 -4.81 53.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.069 0.462 . . . . 0.0 111.036 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.98 29.07 24.12 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.827 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.509 ' ND2' ' HB3' ' A' ' 92' ' ' GLU . 6.4 p30 -110.06 134.04 52.57 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.499 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 35.1 mtmm -65.56 147.07 54.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.061 0.457 . . . . 0.0 111.202 -175.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -127.58 -46.27 1.45 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.132 173.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.499 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 81.4 t80 -147.45 134.09 19.91 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.466 -175.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.52 ' HB ' HG12 ' A' ' 87' ' ' VAL . 3.1 p -116.85 140.36 39.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 173.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.499 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 31.3 t60 -135.85 146.75 47.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -114.88 135.95 53.64 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.69 -149.04 18.34 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.12 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.3 tp -127.11 144.86 50.93 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.538 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 3.4 mpp? -131.28 165.02 24.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.354 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.535 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 32.3 mmt180 -103.22 168.21 9.32 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 173.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.58 ' HG3' ' N ' ' A' ' 106' ' ' ASN . 5.1 ptmt -54.93 -43.11 73.04 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -171.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.58 ' N ' ' HG3' ' A' ' 105' ' ' LYS . 12.9 t-20 -66.21 -32.23 73.53 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.908 0.385 . . . . 0.0 111.074 -178.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 103' ' ' MET . 9.1 m120 -66.74 -42.89 85.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.573 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 60.5 mt -62.59 -48.47 88.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.825 174.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -49.52 -51.79 34.01 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.109 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 m -63.16 -41.11 99.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.998 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 107' ' ' ASN . 42.9 mm -63.52 -40.9 90.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 91.0 mt -64.98 -37.45 87.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.594 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -60.74 -39.3 88.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.846 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.3 t -85.49 -10.49 56.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.471 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.5 tp -82.96 -56.25 3.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.523 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 168.83 -79.2 0.1 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.279 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.555 HG21 ' HB3' ' A' ' 112' ' ' LEU . 57.5 t 52.43 81.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.774 0.797 . . . . 0.0 111.623 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.515 ' CD ' ' HG2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.866 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.56 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . 8.4 p . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.1 mt 70.81 -74.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 123.322 0.649 . . . . 0.0 111.719 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -97.39 23.33 7.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.658 -174.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.56 ' CG2' ' HB2' ' A' ' 13' ' ' SER . 15.9 m -75.43 138.67 20.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.781 0.8 . . . . 0.0 112.732 -174.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 60' ' ' ASN . 48.6 t -121.81 124.84 72.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.558 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . 6.5 tp10 -59.42 -54.61 44.71 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.221 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.659 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 4.1 t30 -158.9 168.87 25.67 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -53.49 -29.16 34.74 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -170.199 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -66.58 -29.13 69.12 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.318 -0.239 . . . . 0.0 111.356 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.418 ' HG2' ' HB3' ' A' ' 18' ' ' GLU . 4.1 mp0 -80.43 -12.11 59.6 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.44 144.93 56.82 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.532 ' HD3' ' H ' ' A' ' 25' ' ' GLU . 5.0 tmtt? -127.9 151.69 48.77 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.356 -173.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.532 ' H ' ' HD3' ' A' ' 24' ' ' LYS . 25.6 mm-40 60.29 -164.11 0.23 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.928 175.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -119.19 47.65 1.01 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.917 -174.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.658 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -99.15 158.45 32.26 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 171.687 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -53.95 158.59 8.62 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.936 2.424 . . . . 0.0 112.504 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.5 m -127.21 128.99 46.98 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.063 0.459 . . . . 0.0 110.856 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.762 HD11 HD21 ' A' ' 112' ' ' LEU . 80.9 mt -98.23 108.18 21.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.591 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.808 ' HB ' HG23 ' A' ' 87' ' ' VAL . 22.5 mm -95.82 109.33 22.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 24.8 ptm -121.68 136.14 54.95 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.034 -0.667 . . . . 0.0 111.075 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.833 ' HZ ' ' HB2' ' A' ' 78' ' ' TYR . 47.1 m-85 -96.48 119.9 35.81 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.343 -178.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HG3' ' HB3' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -130.87 132.59 45.26 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.509 -170.021 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.696 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 7.3 m -99.96 162.87 12.72 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.96 -49.77 55.08 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.6 m -66.8 -52.55 42.69 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -171.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.727 ' SG ' HG21 ' A' ' 83' ' ' VAL . 2.7 p -70.99 125.55 92.02 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -167.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.651 ' O ' HG22 ' A' ' 42' ' ' VAL . 69.5 Cg_endo -75.79 -9.81 19.78 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.094 2.529 . . . . 0.0 112.653 175.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -59.47 -29.81 68.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.486 0.66 . . . . 0.0 109.768 174.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.647 ' HB3' ' HG3' ' A' ' 34' ' ' LYS . 75.0 m -78.93 -36.9 41.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.649 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 39' ' ' PRO . 2.8 m -68.44 -30.62 48.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.34 -177.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 1.8 mt-10 -61.97 -48.28 81.05 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.824 0.345 . . . . 0.0 110.78 173.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -37.75 78.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.637 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 27.6 mt-30 -58.3 -49.59 76.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.903 175.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 73.3 mmtt -58.04 -43.31 86.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.162 0.506 . . . . 0.0 110.062 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.588 ' O ' HG23 ' A' ' 51' ' ' VAL . 52.0 mm-40 -62.47 -46.86 86.58 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.199 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 48' ' ' LEU . 27.0 mt -59.77 -34.82 73.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.466 177.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.6 m -57.62 -45.87 84.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.209 0.528 . . . . 0.0 110.271 176.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -76.77 -30.36 56.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.754 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 47' ' ' GLU . 77.9 t -62.9 -41.76 93.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -65.13 -36.6 84.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.338 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -74.38 -15.6 60.92 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -109.82 -1.83 17.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.474 0.654 . . . . 0.0 109.977 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -145.7 75.31 1.42 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.356 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -67.12 118.41 10.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.791 -175.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.09 62.64 5.92 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.292 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -134.93 2.32 3.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.805 0.302 . . . . 0.0 111.086 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -168.65 145.07 3.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.412 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.567 ' HB3' HG21 ' A' ' 17' ' ' VAL . 47.4 m-80 -90.88 128.83 36.9 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.145 176.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.7 mt -103.68 108.0 23.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.659 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 55.0 t80 -92.36 114.98 27.68 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.051 177.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -92.35 105.07 17.34 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.135 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.562 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -88.27 75.78 8.5 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.633 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 26.2 ptt180 -68.22 113.78 6.14 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.642 177.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.15 12.0 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.104 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.569 ' H ' ' C ' ' A' ' 65' ' ' ARG . 1.4 mp0 -83.23 -20.88 33.75 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.011 -175.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -112.83 -176.8 2.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.0 0.428 . . . . 0.0 111.083 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.41 -31.45 16.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.097 -175.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.48 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -61.37 -29.53 69.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.572 0.701 . . . . 0.0 110.79 -175.667 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.48 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 3.6 m120 -81.78 -11.61 58.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.705 -174.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.5 mm -72.03 -51.33 31.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.098 0.475 . . . . 0.0 110.181 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -67.19 -37.89 84.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.103 177.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.46 -43.75 98.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.897 177.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.719 ' HA ' ' CE1' ' A' ' 33' ' ' PHE . . . -52.06 -56.01 17.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.385 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -69.3 -33.53 73.32 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.062 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -59.22 -26.57 64.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.124 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.833 ' HB2' ' HZ ' ' A' ' 33' ' ' PHE . 79.7 m-85 -119.92 21.43 11.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.735 -178.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 69.66 33.49 2.98 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 167.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.407 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . . . -71.61 152.9 42.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.002 0.429 . . . . 0.0 110.977 176.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -141.25 -81.15 0.24 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.14 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 34.4 pt -113.23 171.18 3.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.727 HG21 ' SG ' ' A' ' 38' ' ' CYS . 19.4 m -101.9 150.89 37.8 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-O 120.522 0.201 . . . . 0.0 111.34 -176.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -92.78 116.43 2.34 Favored 'Cis proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.617 -1.41 . . . . 0.0 112.654 -1.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.738 HG23 ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -96.04 135.64 37.54 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.614 HG23 ' HB3' ' A' ' 99' ' ' HIS . 6.1 t -144.74 132.12 20.77 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.125 178.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.808 HG23 ' HB ' ' A' ' 31' ' ' ILE . 3.9 m -112.34 116.77 53.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.796 175.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.681 ' HB3' HD21 ' A' ' 115' ' ' LEU . 92.5 m-85 -90.61 116.96 28.9 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.769 -177.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 27.6 mt -102.38 137.4 40.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.721 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -73.07 -171.79 0.96 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.981 ' HG2' ' HB2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -69.99 -24.76 63.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.888 -0.508 . . . . 0.0 111.73 -175.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.569 ' HB2' ' ND2' ' A' ' 94' ' ' ASN . 8.3 mm-40 -81.23 -6.25 58.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.397 0.617 . . . . 0.0 109.348 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.46 31.71 40.49 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.21 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.569 ' ND2' ' HB2' ' A' ' 92' ' ' GLU . 35.3 m-80 -93.26 143.19 26.5 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.912 177.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -72.28 85.82 1.09 Allowed 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.865 0.728 . . . . 0.0 109.519 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -85.43 -50.79 7.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.276 -172.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.422 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 73.3 t80 -133.64 126.79 31.6 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.675 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.619 HG12 HG12 ' A' ' 87' ' ' VAL . 3.6 m -103.69 151.53 6.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.614 ' HB3' HG23 ' A' ' 86' ' ' THR . 55.8 t60 -142.8 140.89 31.53 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.738 ' NE2' HG23 ' A' ' 85' ' ' THR . 5.7 tp-100 -127.93 138.35 52.61 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 172.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.97 173.68 29.03 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.717 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.9 tp -75.03 152.31 38.68 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.364 0.602 . . . . 0.0 111.253 -175.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.644 ' SD ' HG12 ' A' ' 108' ' ' ILE . 5.3 ptp -146.42 137.96 24.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.206 172.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.462 ' O ' HG13 ' A' ' 108' ' ' ILE . 18.1 tpp180 -85.99 171.57 11.33 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.55 ' HG3' HG22 ' A' ' 51' ' ' VAL . 47.9 tttm -45.98 -57.33 4.5 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -174.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.41 -36.36 75.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.673 0.273 . . . . 0.0 111.163 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.645 ' O ' HG12 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -62.9 -48.91 76.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.617 178.093 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.644 HG12 ' SD ' ' A' ' 103' ' ' MET . 25.6 mt -59.12 -47.36 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.81 0.814 . . . . 0.0 110.281 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -62.74 -41.32 99.13 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.98 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.491 ' O ' ' HB3' ' A' ' 113' ' ' ASN . 59.5 m -64.23 -30.62 71.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.577 177.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.645 HG12 ' O ' ' A' ' 107' ' ' ASN . 50.6 mm -67.62 -36.64 76.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.513 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.762 HD21 HD11 ' A' ' 30' ' ' ILE . 25.3 mt -60.7 -38.78 86.15 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.491 ' HB3' ' O ' ' A' ' 110' ' ' THR . 17.1 t30 -59.92 -44.74 94.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.957 176.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.5 p -72.33 -30.14 64.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.736 0.303 . . . . 0.0 111.036 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.681 HD21 ' HB3' ' A' ' 88' ' ' PHE . 3.9 mp -63.2 -55.13 27.62 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.31 0.576 . . . . 0.0 109.93 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 148.2 -53.58 0.53 Allowed Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.245 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.0 t 50.42 75.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -171.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.981 ' HB2' ' HG2' ' A' ' 91' ' ' LYS . 25.4 mtpp . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.616 -162.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.582 ' HB3' HG11 ' A' ' 16' ' ' VAL . 15.5 m . . . . . 0 N--CA 1.446 -0.659 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.8 mt -96.3 137.34 24.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.462 -177.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 94.3 m-20 66.86 24.96 9.63 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.842 0.714 . . . . 0.0 110.971 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.582 HG11 ' HB3' ' A' ' 13' ' ' SER . 11.7 m -102.01 157.24 4.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.642 0.258 . . . . 0.0 110.855 -176.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.56 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 5.3 p -146.47 157.45 11.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.083 0.468 . . . . 0.0 111.488 -176.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -82.66 -55.18 4.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.617 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.704 ' HA ' ' CE2' ' A' ' 62' ' ' TYR . 18.7 t-20 -136.72 160.38 39.0 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.854 -173.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.1 mt -53.3 -35.06 59.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.38 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -65.42 -31.54 72.69 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.726 0.298 . . . . 0.0 111.008 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -79.42 -15.5 57.71 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.408 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.09 111.6 6.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 0.0 110.394 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.796 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 10.6 mmpt? -88.08 145.67 25.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.318 0.58 . . . . 0.0 111.928 -177.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 58.13 -166.12 0.16 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.677 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -105.26 72.22 0.23 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.097 -175.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.527 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -108.04 149.9 39.71 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 174.373 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.859 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 53.3 Cg_exo -54.11 141.55 68.76 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.573 2.182 . . . . 0.0 111.416 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 m -111.68 120.61 42.6 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.875 0.369 . . . . 0.0 111.169 -175.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.454 HD12 ' CD2' ' A' ' 88' ' ' PHE . 17.3 mm -106.85 122.5 60.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.674 ' HB ' ' CG2' ' A' ' 87' ' ' VAL . 69.2 mt -114.69 115.65 50.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.919 -174.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.5 tpt -109.85 116.5 31.77 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.678 177.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.644 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 85.4 m-85 -83.64 118.28 23.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.347 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.936 ' HE2' ' HB3' ' A' ' 63' ' ' TYR . 6.4 pttt -132.39 146.54 52.04 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.416 -169.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m -67.8 138.54 56.24 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 158.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 18.8 t0 -57.14 -32.63 66.56 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.076 0.465 . . . . 0.0 111.075 -168.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.1 m -124.6 92.35 3.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.428 173.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 18.2 p -138.3 142.01 33.67 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.338 177.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.48 -28.1 62.14 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.383 2.056 . . . . 0.0 112.927 -177.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -66.83 -31.09 71.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.913 0.387 . . . . 0.0 110.291 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 45' ' ' GLN . 53.0 t -71.75 -35.07 69.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.008 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 45.5 t -69.59 -46.11 76.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.558 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.467 ' HG2' HD21 ' A' ' 102' ' ' LEU . 4.4 tp10 -61.64 -49.64 75.76 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.755 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.419 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 19.8 ttt -66.58 -29.12 69.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.197 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.517 ' HB2' ' O ' ' A' ' 41' ' ' CYS . 23.0 tm0? -60.0 -41.78 92.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.016 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -62.82 -47.81 81.81 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 51' ' ' VAL . 16.2 mm-40 -57.84 -47.34 82.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.522 177.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.484 HD13 HD13 ' A' ' 61' ' ' ILE . 97.9 mt -58.67 -41.7 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.731 178.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.9 m -57.17 -41.56 79.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.638 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.539 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 21.1 m-85 -65.95 -37.04 84.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.737 178.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 47' ' ' GLU . 41.2 t -72.63 -50.68 32.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.931 -177.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.7 m -60.73 -31.54 70.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 0.0 111.121 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -57.65 -29.96 65.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.382 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -110.38 -2.04 16.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.987 -175.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.54 ' HB2' ' HG3' ' A' ' 58' ' ' LYS . 17.1 ptp180 -146.73 97.69 2.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.004 0.906 . . . . 0.0 110.768 174.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.24 133.05 35.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.953 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.06 35.95 71.84 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.462 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.54 ' HG3' ' HB2' ' A' ' 55' ' ' ARG . 41.4 mmtm -112.43 -4.05 14.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.933 0.397 . . . . 0.0 110.963 -178.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 28' ' ' PRO . 6.2 p90 -176.03 138.31 0.34 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.191 173.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.56 ' OD1' ' HB ' ' A' ' 17' ' ' VAL . 7.5 t-20 -105.6 124.04 48.91 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.554 HD12 HG12 ' A' ' 16' ' ' VAL . 40.5 mt -89.22 107.61 18.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.291 0.567 . . . . 0.0 111.207 -175.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.704 ' CE2' ' HA ' ' A' ' 19' ' ' ASN . 10.7 t80 -88.49 106.19 18.12 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.89 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.936 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 75.6 m-85 -78.93 102.29 8.2 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.347 176.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.615 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -85.85 74.48 10.18 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.24 0.543 . . . . 0.0 109.859 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.933 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 12.4 ptt85 -63.55 116.98 6.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.787 175.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.7 tp -74.24 9.57 1.59 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.033 0.444 . . . . 0.0 110.473 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.533 ' HB2' ' HB2' ' A' ' 36' ' ' ASP . 0.3 OUTLIER -82.53 -18.65 40.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.191 -175.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -113.21 154.51 26.61 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.187 0.518 . . . . 0.0 111.128 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.407 ' HG3' ' H ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -65.15 -32.55 74.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.207 -172.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -26.56 68.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.021 0.439 . . . . 0.0 111.672 -175.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.477 ' HA ' ' CB ' ' A' ' 74' ' ' LEU . 91.2 m-20 -90.51 1.11 57.01 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.48 -176.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.6 mm -70.69 -50.43 44.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 173.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -72.78 -34.08 66.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.481 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.477 ' CB ' ' HA ' ' A' ' 71' ' ' ASN . 1.1 tm? -60.18 -45.82 91.8 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.644 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -57.59 -49.99 74.57 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.994 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -64.41 -34.76 78.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.927 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -62.44 -20.06 64.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.965 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.574 ' HB3' HG11 ' A' ' 87' ' ' VAL . 77.3 m-85 -124.55 15.95 8.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.076 -177.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.8 t70 65.22 27.3 12.22 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.927 0.87 . . . . 0.0 110.826 172.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.72 104.01 15.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.425 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.527 HD22 HG23 ' A' ' 82' ' ' ILE . 4.2 t30 -107.1 -39.74 5.64 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.75 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.527 HG23 HD22 ' A' ' 81' ' ' ASN . 30.1 pt -107.08 171.93 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.033 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.04 145.02 53.96 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.733 174.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.02 157.26 84.09 Favored 'Cis proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.36 -1.517 . . . . 0.0 112.606 -0.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.554 ' OG1' ' HB2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -145.84 129.33 16.94 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.771 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.7 m -123.26 116.38 23.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.224 0.535 . . . . 0.0 111.45 -176.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.674 ' CG2' ' HB ' ' A' ' 31' ' ' ILE . 13.2 m -102.86 135.05 42.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.176 174.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.529 ' HB3' HD22 ' A' ' 115' ' ' LEU . 79.5 m-85 -107.15 112.79 25.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.499 -176.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.465 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 6.2 mp -111.17 145.79 38.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.727 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.545 ' OD1' ' HA3' ' A' ' 116' ' ' GLY . 10.6 t70 -80.11 -165.87 0.92 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -79.4 8.59 5.93 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -168.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.401 ' HB2' HD22 ' A' ' 94' ' ' ASN . 34.7 mt-10 -127.42 21.22 6.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.87 0.367 . . . . 0.0 111.187 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.28 14.32 74.11 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.95 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.401 HD22 ' HB2' ' A' ' 92' ' ' GLU . 7.1 p30 -85.59 125.38 33.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.063 0.459 . . . . 0.0 109.957 176.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.492 ' HD3' HG22 ' A' ' 98' ' ' VAL . 5.0 tmmm? -82.68 109.54 16.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.888 -177.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.406 ' HB3' ' CD1' ' A' ' 115' ' ' LEU . 92.2 t80 -97.26 -59.72 1.73 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.24 -177.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.432 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 76.8 t80 -119.7 149.21 42.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.651 0.262 . . . . 0.0 110.801 -173.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.541 HG13 HG12 ' A' ' 87' ' ' VAL . 9.6 t -130.74 139.84 50.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.432 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 6.2 t60 -147.86 133.49 18.82 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.455 ' CD ' HG22 ' A' ' 85' ' ' THR . 3.3 mm-40 -106.32 158.37 16.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.623 0.249 . . . . 0.0 110.342 -173.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.96 -153.12 20.74 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.588 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.467 HD21 ' HG2' ' A' ' 43' ' ' GLU . 57.8 tp -114.21 120.98 42.32 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.739 0.304 . . . . 0.0 110.475 -176.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 74.9 mtp -111.21 162.24 15.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.893 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -105.44 171.2 7.46 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.174 -0.21 . . . . 0.0 110.537 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.539 ' HD2' ' HB3' ' A' ' 50' ' ' TYR . 52.5 tttp -47.4 -58.83 3.71 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.726 0.641 . . . . 0.0 111.974 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 3.8 m-20 -53.73 -33.56 56.04 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.081 0.467 . . . . 0.0 111.834 -176.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.534 ' O ' HG12 ' A' ' 111' ' ' ILE . 5.7 m120 -73.72 -46.57 45.29 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.355 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.567 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 57.1 mt -58.78 -43.56 88.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.767 174.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 105' ' ' LYS . 71.6 mm-40 -48.71 -56.37 8.76 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.844 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.5 m -72.4 -37.82 68.58 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.486 -174.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 107' ' ' ASN . 38.8 mm -63.43 -41.62 93.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.839 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 86.5 mt -62.44 -39.03 92.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.92 0.391 . . . . 0.0 110.155 176.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -62.81 -37.4 86.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.745 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.5 t -76.98 -37.51 55.03 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.581 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 88' ' ' PHE . 51.8 tp -57.94 -70.93 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.614 178.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.545 ' HA3' ' OD1' ' A' ' 90' ' ' ASP . . . -175.44 -74.44 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.01 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.859 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 85.6 t 55.72 76.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.971 0.891 . . . . 0.0 109.847 -174.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 118' ' ' LYS . 20.6 pttm . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.469 -174.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.409 ' HG3' ' HG ' ' A' ' 3' ' ' LEU . 22.9 ptp . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -76.51 84.07 3.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.994 0.426 . . . . 0.0 110.862 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 3' ' ' LEU . 1.8 pp -159.97 154.45 23.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.795 175.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.478 ' HG3' ' NE2' ' A' ' 8' ' ' GLN . 7.7 mm-40 66.34 -64.46 0.22 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 124.012 0.82 . . . . 0.0 111.406 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.3 -35.33 2.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.467 -0.397 . . . . 0.0 113.122 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tt -63.29 -52.81 53.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -162.69 35.5 0.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.117 0.484 . . . . 0.0 110.383 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.478 ' NE2' ' HG3' ' A' ' 4' ' ' GLU . 7.5 tt0 -140.85 25.93 2.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.742 0.782 . . . . 0.0 110.104 -177.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.3 tp -67.96 -26.93 35.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.285 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -80.35 18.3 0.92 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.054 -172.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.585 ' O ' ' HB3' ' A' ' 12' ' ' GLN . 57.7 t80 -74.84 73.25 2.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.262 0.553 . . . . 0.0 110.098 174.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.585 ' HB3' ' O ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER 156.78 -18.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.132 1.773 . . . . 0.0 106.886 178.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.628 ' HB3' HG11 ' A' ' 16' ' ' VAL . 33.4 m -104.16 101.14 10.89 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 113.959 -1.473 . . . . 0.0 109.718 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 15' ' ' ASN . 96.1 mt -107.02 146.09 13.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.56 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 84.4 m-20 71.21 13.94 6.68 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.602 0.564 . . . . 0.0 110.159 -174.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.628 HG11 ' HB3' ' A' ' 13' ' ' SER . 4.5 m -105.4 166.27 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.889 -174.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.707 HG21 ' HB2' ' A' ' 23' ' ' ALA . 12.4 m -141.34 147.99 21.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.427 ' H ' ' HG2' ' A' ' 18' ' ' GLU . 1.6 mm-40 -64.19 -51.09 65.43 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.264 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.863 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 14.5 t-20 -148.36 169.3 20.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.732 -176.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.631 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 56.9 mt -60.48 -27.53 67.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.912 0.387 . . . . 0.0 110.305 174.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -57.44 -33.8 68.31 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.79 174.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -91.03 -27.41 18.65 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.972 0.415 . . . . 0.0 110.871 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.707 ' HB2' HG21 ' A' ' 17' ' ' VAL . . . -71.9 156.82 38.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.596 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.494 ' HD2' ' O ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -131.89 -177.81 4.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.606 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.501 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -103.73 174.96 5.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.622 -175.561 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' A' ' 119' ' ' GLU . . . 93.69 -62.86 1.93 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.738 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -77.66 127.69 81.71 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 1.016 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 85.9 Cg_exo -48.58 143.74 15.51 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.806 2.337 . . . . 0.0 112.1 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.484 HG23 ' OD1' ' A' ' 60' ' ' ASN . 23.8 m -115.64 124.51 51.09 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.225 -171.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 30' ' ' ILE . 2.9 mp -109.22 117.62 54.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.653 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 2.3 mm -105.62 116.43 49.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.063 -175.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.48 ' O ' ' HG3' ' A' ' 32' ' ' MET . 26.5 ptm -110.77 112.3 24.07 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.707 0.765 . . . . 0.0 110.107 174.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 81.6 m-85 -83.64 128.32 34.43 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.018 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.638 ' HE2' ' CB ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -142.77 142.27 31.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.696 -175.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.445 ' O ' ' HE3' ' A' ' 34' ' ' LYS . 1.2 p -75.0 170.87 15.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 174.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -49.68 -74.55 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 O-C-N 123.358 0.411 . . . . 0.0 110.798 176.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -88.88 110.84 21.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.961 0.41 . . . . 0.0 110.316 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.499 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 5.9 p -152.73 121.32 3.21 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.037 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 8.0 Cg_exo -72.11 -35.97 6.33 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.523 2.149 . . . . 0.0 112.839 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -61.81 -24.37 66.83 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.591 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.628 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 49.7 t -61.95 -50.12 73.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.069 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.5 t -59.49 -44.84 93.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 5.7 tp10 -55.79 -46.79 77.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.928 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.507 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 23.4 ttt -73.85 -30.49 62.7 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.053 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.628 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 27.8 mt-30 -59.43 -48.44 81.62 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 121.458 -0.097 . . . . 0.0 110.988 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -65.54 -36.06 82.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.522 0.201 . . . . 0.0 111.196 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -59.03 -44.86 91.81 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.18 0.514 . . . . 0.0 109.812 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.806 HD13 HG21 ' A' ' 61' ' ' ILE . 97.9 mt -62.42 -35.91 80.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.056 178.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -58.89 -40.63 85.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.916 0.389 . . . . 0.0 110.228 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.472 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 20.2 m-85 -65.7 -43.31 89.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.322 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.441 HG22 ' HG3' ' A' ' 105' ' ' LYS . 48.7 t -62.1 -42.66 95.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.464 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.4 m -65.74 -31.69 72.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.13 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -61.24 -40.52 94.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.73 176.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.56 -10.37 54.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.586 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.85 84.3 1.97 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.957 0.408 . . . . 0.0 111.168 -177.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -78.98 123.51 27.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.916 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.42 73.92 0.37 Allowed Glycine 0 C--N 1.332 0.313 0 O-C-N 123.596 0.56 . . . . 0.0 113.297 173.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.922 ' HD2' HG12 ' A' ' 117' ' ' VAL . 9.6 mmtt -144.14 -36.73 0.33 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.987 0.423 . . . . 0.0 110.941 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.405 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 39.1 p90 -144.88 168.87 19.2 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.57 HD22 HG12 ' A' ' 27' ' ' ILE . 8.9 p30 -118.25 137.9 52.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.27 0.557 . . . . 0.0 110.723 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.806 HG21 HD13 ' A' ' 48' ' ' LEU . 52.6 mt -104.08 109.72 28.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.118 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.863 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 2.6 t80 -95.01 118.51 31.96 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.926 0.393 . . . . 0.0 110.559 -178.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.521 ' CE1' ' HG2' ' A' ' 45' ' ' GLN . 81.0 m-85 -83.45 103.26 12.67 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 173.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.519 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -90.8 86.15 6.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.377 0.608 . . . . 0.0 109.968 -173.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.638 ' CB ' ' HE2' ' A' ' 34' ' ' LYS . 17.8 ptt180 -77.49 129.01 35.16 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.508 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.3 tp -73.2 12.32 0.59 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.71 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.598 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 10.4 mt-10 -79.98 -13.63 59.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.574 -175.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -116.88 170.48 8.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.338 -173.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.48 -33.53 25.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.158 -176.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.621 ' HD2' ' H ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -61.95 -26.41 68.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.894 0.378 . . . . 0.0 110.702 -177.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.648 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 78.5 m-20 -87.79 3.77 46.89 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.909 -176.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.8 mt -72.17 -58.68 4.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 171.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.49 -38.8 84.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.137 175.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.648 ' HB2' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -56.09 -46.18 79.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.199 176.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.26 -56.45 19.86 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.686 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -67.56 -33.54 75.25 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.573 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -63.36 -24.6 67.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.983 0.42 . . . . 0.0 110.788 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.568 ' CE1' HD21 ' A' ' 89' ' ' LEU . 95.0 m-85 -122.05 22.48 10.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.884 -176.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 66.95 29.17 8.3 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.523 0.514 . . . . 0.0 111.556 166.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.402 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -87.33 113.56 23.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.885 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.532 ' ND2' HG13 ' A' ' 82' ' ' ILE . 3.8 p-10 -138.71 -2.53 1.73 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.271 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.532 HG13 ' ND2' ' A' ' 81' ' ' ASN . 50.5 mt -136.78 142.22 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 34' ' ' LYS . 99.5 t -101.15 129.3 27.39 Favored Pre-proline 0 C--N 1.319 -0.729 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.667 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 58.4 Cg_endo -95.11 135.18 5.24 Favored 'Cis proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.423 -1.49 . . . . 0.0 113.42 -0.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.594 HG23 ' HG2' ' A' ' 100' ' ' GLN . 19.9 m -87.73 107.5 18.67 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.2 m -100.94 108.03 19.66 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.653 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 6.8 p -108.2 126.16 64.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.445 0.64 . . . . 0.0 110.128 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 1.005 ' HB3' HD11 ' A' ' 115' ' ' LEU . 89.0 m-85 -99.22 119.4 37.83 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.579 -177.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.568 HD21 ' CE1' ' A' ' 78' ' ' TYR . 5.6 mp -115.31 141.73 47.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.817 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 25.1 t70 -75.15 -164.48 0.31 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.526 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 6.1 pttm -53.3 -42.86 67.05 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -168.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.492 ' OE1' ' HG2' ' A' ' 91' ' ' LYS . 0.5 OUTLIER -99.26 6.06 46.41 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.056 -0.403 . . . . 0.0 111.396 -176.268 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.562 ' HA2' ' HB3' ' A' ' 89' ' ' LEU . . . 94.66 30.2 8.7 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.759 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 10.0 m120 -70.92 106.49 3.65 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.403 -0.469 . . . . 0.0 109.93 173.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.452 ' HG3' ' CG2' ' A' ' 87' ' ' VAL . 39.0 ttpt -64.69 100.41 0.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 176.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -98.45 -50.38 4.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.291 -176.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.511 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 91.7 t80 -137.47 122.0 18.44 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.171 -0.611 . . . . 0.0 111.8 -174.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.551 HG12 HG23 ' A' ' 87' ' ' VAL . 11.5 m -103.14 147.04 10.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 172.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.511 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 15.9 t60 -145.4 119.01 9.12 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.594 ' HG2' HG23 ' A' ' 85' ' ' THR . 39.3 mt-30 -102.93 106.22 16.73 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 143.41 160.84 8.58 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.445 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.533 HD21 ' HG2' ' A' ' 43' ' ' GLU . 45.9 tp -71.56 149.75 45.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.935 0.398 . . . . 0.0 111.243 -176.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 69.9 mtm -141.03 -170.14 2.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.19 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.491 HH12 ' CD ' ' A' ' 43' ' ' GLU . 33.2 mmt180 -131.27 165.97 22.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.378 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.472 ' HD2' ' HB3' ' A' ' 50' ' ' TYR . 55.6 tttm -44.7 -56.83 4.1 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.116 0.885 . . . . 0.0 112.299 -176.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -51.93 -47.31 64.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.345 0.593 . . . . 0.0 111.601 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.609 ' O ' HG12 ' A' ' 111' ' ' ILE . 47.0 m-20 -73.84 -40.45 63.29 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.931 -172.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.533 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 60.9 mt -60.21 -47.02 93.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.577 0.703 . . . . 0.0 109.301 174.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -62.98 -39.95 96.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.219 -175.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 57.9 m -64.42 -35.93 82.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.162 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 107' ' ' ASN . 40.8 mm -70.26 -34.95 60.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.632 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 20.9 mt -60.38 -42.89 96.79 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.714 0.769 . . . . 0.0 108.987 174.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -62.1 -30.39 70.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.901 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.9 m -76.05 -30.25 58.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.977 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 1.005 HD11 ' HB3' ' A' ' 88' ' ' PHE . 51.6 mt -70.58 -59.95 2.54 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 122.185 0.993 . . . . 0.0 109.081 174.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 145.86 -44.95 0.83 Allowed Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.371 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.016 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 19.2 t 46.58 61.35 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 122.112 0.958 . . . . 0.0 109.397 -176.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -81.83 -51.57 7.99 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.848 -169.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.541 ' HB3' ' O ' ' A' ' 26' ' ' GLY . 12.2 tp10 -72.99 171.42 12.88 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.438 173.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.444 ' HA3' ' HD3' ' A' ' 58' ' ' LYS . . . 97.3 14.8 40.4 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -170.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -79.21 62.49 3.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.729 0.776 . . . . 0.0 109.891 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -133.47 16.97 4.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.047 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 34.8 t60 -77.1 120.72 22.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.709 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -55.29 128.58 34.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.522 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -72.77 -21.82 60.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.005 0.431 . . . . 0.0 110.24 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 77.9 t60 . . . . . 0 C--O 1.24 0.575 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.165 177.77 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 mmt . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 120.622 0.249 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 1.025 ' HA ' ' HG3' ' A' ' 18' ' ' GLU . 0.8 OUTLIER -140.03 -179.6 6.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.84 -177.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.666 ' HG ' ' HG3' ' A' ' 4' ' ' GLU . 67.7 tp -57.0 -71.39 0.1 Allowed 'General case' 0 C--N 1.332 -0.154 0 O-C-N 123.54 0.525 . . . . 0.0 110.755 177.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.666 ' HG3' ' HG ' ' A' ' 3' ' ' LEU . 45.2 mt-10 -123.14 -11.84 7.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.439 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.53 -54.61 4.05 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.907 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.441 ' O ' ' HB3' ' A' ' 7' ' ' LYS . 31.7 pt -106.41 154.46 7.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.523 ' HG2' ' HG3' ' A' ' 8' ' ' GLN . 27.7 ttpt 72.76 -63.69 0.42 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.656 0.598 . . . . 0.0 111.711 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.523 ' HG3' ' HG2' ' A' ' 7' ' ' LYS . 28.0 mt-30 -124.05 137.4 54.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.446 0.641 . . . . 0.0 112.006 -175.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.53 HG13 ' H ' ' A' ' 11' ' ' PHE . 13.3 pt -112.67 -159.15 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.216 175.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.473 ' HB3' HG11 ' A' ' 16' ' ' VAL . 3.6 t-20 -58.1 -24.61 59.33 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.814 0.34 . . . . 0.0 110.855 178.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.53 ' H ' HG13 ' A' ' 9' ' ' ILE . 18.7 t80 72.78 -175.73 0.17 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.319 172.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 69.13 -61.2 0.44 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.739 0.816 . . . . 0.0 109.883 -173.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.506 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 14.9 m -96.82 129.37 44.27 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.416 ' O ' HG22 ' A' ' 14' ' ' ILE . 46.7 mt -86.66 2.87 4.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.792 0.806 . . . . 0.0 110.69 -174.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -117.47 16.37 14.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.623 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 12.6 p -85.01 143.59 11.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -171.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.952 ' HB ' ' HB2' ' A' ' 22' ' ' GLU . 27.5 m -128.34 152.95 37.15 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.222 169.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 1.025 ' HG3' ' HA ' ' A' ' 2' ' ' SER . 15.8 mm-40 -75.51 -35.1 60.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.349 -174.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.732 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 51.5 t30 -163.41 -176.09 4.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.692 -177.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.1 mt -61.52 -30.6 70.74 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.4 mp0 -56.87 -45.56 82.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.329 176.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.952 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . 5.4 mm-40 -76.69 -24.76 53.17 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.591 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.91 153.25 43.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.682 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.589 ' NZ ' ' HA ' ' A' ' 24' ' ' LYS . 2.4 tpmp? -145.4 156.26 43.66 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.995 -175.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -73.51 179.88 3.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.049 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 119' ' ' GLU . . . 84.85 -59.82 4.87 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -175.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.419 HG13 ' HB2' ' A' ' 60' ' ' ASN . 6.5 pt -90.32 121.9 68.02 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.525 -0.338 . . . . 0.0 110.165 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.945 ' HG3' ' H ' ' A' ' 117' ' ' VAL . 16.5 Cg_endo -57.26 138.51 86.55 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.64 2.227 . . . . 0.0 111.009 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.2 m -103.52 123.76 47.51 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.256 0.551 . . . . 0.0 111.923 -172.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.607 HD11 HD11 ' A' ' 112' ' ' LEU . 75.2 mt -98.63 113.26 32.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 173.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.759 ' HB ' HG23 ' A' ' 87' ' ' VAL . 58.4 mt -107.03 111.98 37.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.35 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.458 ' HG2' ' HD1' ' A' ' 63' ' ' TYR . 21.8 ptm -109.8 129.63 55.61 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.061 176.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.554 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 92.0 m-85 -94.33 112.78 24.59 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.605 ' HB2' ' HB3' ' A' ' 41' ' ' CYS . 55.6 pttt -117.75 138.73 51.84 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.446 -170.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.467 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 0.7 OUTLIER -71.18 149.67 46.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.969 174.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -70.31 -45.12 66.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.98 -177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.2 t -94.75 9.77 37.67 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.467 ' SG ' ' HB ' ' A' ' 35' ' ' THR . 76.6 m -106.72 122.19 42.6 Favored Pre-proline 0 C--N 1.327 -0.409 0 O-C-N 121.845 -0.535 . . . . 0.0 111.065 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 6.3 Cg_exo -78.01 -2.88 12.97 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.391 2.061 . . . . 0.0 113.179 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -65.57 -15.95 63.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.935 0.397 . . . . 0.0 110.796 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.605 ' HB3' ' HB2' ' A' ' 34' ' ' LYS . 24.9 p -68.84 -43.79 74.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.818 175.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.2 t -62.89 -30.63 49.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.279 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.529 ' HA ' ' NZ ' ' A' ' 46' ' ' LYS . 7.5 tp10 -58.69 -51.99 67.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.346 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.9 ttt -75.03 -37.31 61.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.54 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.498 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 16.5 mt-30 -59.2 -43.64 92.23 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.76 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.529 ' NZ ' ' HA ' ' A' ' 43' ' ' GLU . 22.7 pttm -70.13 -41.87 73.35 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.446 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.542 ' O ' HG23 ' A' ' 51' ' ' VAL . 24.1 mm-40 -51.03 -49.91 59.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.898 0.38 . . . . 0.0 110.386 172.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.435 HD13 HG21 ' A' ' 61' ' ' ILE . 71.2 mt -60.73 -37.66 82.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.515 177.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.8 m -67.59 -37.35 82.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.782 0.325 . . . . 0.0 110.712 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -65.12 -33.5 76.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.523 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 47' ' ' GLU . 21.7 t -73.2 -40.89 58.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.892 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.2 m -56.84 -30.65 64.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.142 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.524 ' HZ3' ' HB3' ' A' ' 53' ' ' LYS . 4.6 ttpm? -52.49 -36.53 55.28 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.756 176.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -109.84 -18.44 13.41 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.204 0.526 . . . . 0.0 110.756 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.58 ' HB3' ' HB2' ' A' ' 58' ' ' LYS . 11.5 mpt_? -111.96 74.55 0.87 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.367 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.73 116.48 22.7 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.84 35.14 91.58 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.467 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.58 ' HB2' ' HB3' ' A' ' 55' ' ' ARG . 12.7 mptt -101.76 -20.02 15.12 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -165.41 153.99 11.76 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.165 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.419 ' HB2' HG13 ' A' ' 27' ' ' ILE . 39.8 t-20 -103.92 138.1 40.97 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.339 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.435 HG21 HD13 ' A' ' 48' ' ' LEU . 11.0 mt -117.34 111.87 36.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.714 0.292 . . . . 0.0 110.943 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.732 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 3.3 t80 -98.84 118.41 35.52 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.498 ' CE1' ' HG2' ' A' ' 45' ' ' GLN . 21.7 m-85 -94.65 103.57 15.5 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.398 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.554 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -80.58 87.16 5.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.163 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.501 ' C ' ' H ' ' A' ' 67' ' ' GLU . 1.8 ptm180 -69.59 123.71 22.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.139 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 34' ' ' LYS . 5.4 tp -69.75 11.2 0.29 Allowed 'General case' 0 C--N 1.322 -0.613 0 O-C-N 122.025 -0.422 . . . . 0.0 110.933 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 65' ' ' ARG . 21.0 mt-10 -82.47 -19.73 38.28 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.7 -173.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.44 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 46.2 mt-10 -117.04 151.29 37.09 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -59.81 -31.03 69.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.103 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.451 ' HD2' ' OD1' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -58.95 -25.92 63.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.268 -178.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.451 ' OD1' ' HD2' ' A' ' 70' ' ' LYS . 10.4 m120 -91.19 -12.18 36.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.963 -176.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.5 mt -71.16 -48.63 53.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.98 -43.56 92.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.762 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -58.52 -42.88 88.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.403 178.514 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.26 -57.38 12.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.441 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -67.23 -33.25 74.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.608 0.242 . . . . 0.0 111.258 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.417 ' HB2' ' NZ ' ' A' ' 77' ' ' LYS . 3.3 ttmp? -63.01 -28.85 70.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.972 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -112.01 8.23 20.11 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 71.72 26.84 3.0 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.599 0.562 . . . . 0.0 111.877 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.75 103.67 10.75 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.175 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -117.72 -35.45 3.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.823 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 12.4 mt -112.57 130.1 66.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.49 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.8 m -102.35 140.47 21.16 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.67 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -86.82 147.7 35.56 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.34 -1.525 . . . . 0.0 112.085 -0.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.0 t -140.78 149.73 42.46 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.4 t -140.71 142.01 34.88 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.22 0.533 . . . . 0.0 110.606 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.816 HG12 HG12 ' A' ' 98' ' ' VAL . 6.2 m -115.49 127.89 72.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.79 176.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.416 ' CD1' ' HD2' ' A' ' 97' ' ' TYR . 83.0 m-85 -97.56 118.74 34.75 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.485 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 6.4 mp -108.35 141.51 40.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.79 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 46.6 t0 -80.18 -179.19 6.94 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.463 ' HZ3' ' CD ' ' A' ' 92' ' ' GLU . 7.9 pttm -49.57 -32.11 11.93 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -175.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.524 ' HB2' HD22 ' A' ' 94' ' ' ASN . 32.6 mp0 -69.26 -29.0 66.81 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 122.087 -0.383 . . . . 0.0 111.338 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.33 30.37 7.01 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.972 -173.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.524 HD22 ' HB2' ' A' ' 92' ' ' GLU . 9.9 p30 -105.59 132.99 51.06 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 175.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.423 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 16.6 ptmt -75.73 117.79 17.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.832 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -106.45 -54.83 2.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.989 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.419 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 73.0 t80 -109.61 135.17 51.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.105 -174.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.816 HG12 HG12 ' A' ' 87' ' ' VAL . 29.3 m -111.82 148.02 15.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.419 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 38.0 t60 -145.84 131.84 19.25 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -117.9 149.81 40.26 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 176.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.38 -124.0 8.1 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.62 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.415 ' HG ' ' N ' ' A' ' 103' ' ' MET . 27.3 tp -136.53 167.94 20.43 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 122.731 -0.276 . . . . 0.0 110.336 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.415 ' N ' ' HG ' ' A' ' 102' ' ' LEU . 20.3 ptm -168.6 147.08 4.17 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.405 ' HD3' ' HA ' ' A' ' 104' ' ' ARG . 23.3 mmt180 -89.87 168.67 11.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.18 -177.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -53.07 -41.46 64.9 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.234 -177.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -65.83 -35.37 80.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.876 0.37 . . . . 0.0 110.475 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.529 ' O ' HG12 ' A' ' 111' ' ' ILE . 11.7 m120 -64.48 -47.32 79.4 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.2 mt -59.32 -50.8 78.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.099 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -51.88 -50.14 61.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.746 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.2 m -65.16 -38.15 89.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.659 0.266 . . . . 0.0 111.094 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 107' ' ' ASN . 39.9 mm -63.61 -47.26 92.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 177.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.607 HD11 HD11 ' A' ' 30' ' ' ILE . 83.2 mt -62.66 -39.43 93.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.047 0.451 . . . . 0.0 110.055 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -54.71 -44.85 73.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.239 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.5 m -86.14 -23.87 26.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.878 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.0 tp -91.12 -64.97 1.05 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -175.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.69 ' HA2' ' HZ3' ' A' ' 118' ' ' LYS . . . -139.03 -122.82 2.04 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 119.989 -1.1 . . . . 0.0 113.816 -169.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.945 ' H ' ' HG3' ' A' ' 28' ' ' PRO . 12.7 t 58.44 35.14 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 122.152 0.977 . . . . 0.0 109.075 -173.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HZ3' ' HA2' ' A' ' 116' ' ' GLY . 37.2 mtmm -107.56 59.51 0.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.223 -174.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 1.2 tm-20 -119.7 -86.4 0.65 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' H ' ' HB3' ' A' ' 119' ' ' GLU . . . -78.66 39.49 1.97 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.738 173.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -88.33 5.43 42.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.269 0.556 . . . . 0.0 109.548 -177.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -68.06 -28.61 67.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.608 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 59.1 t60 70.17 -56.4 0.59 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.585 0.754 . . . . 0.0 112.296 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -76.52 92.35 3.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.732 0.301 . . . . 0.0 110.607 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -98.31 -6.81 30.18 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.4 p80 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 117.648 -1.167 . . . . 0.0 108.164 175.579 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.7 ttm . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 120.925 0.393 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.2 m -150.9 -51.74 0.13 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 84.8 mt -110.47 -153.95 0.53 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 170.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.542 ' OE2' ' HA ' ' A' ' 8' ' ' GLN . 5.1 mp0 -65.14 171.87 3.41 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 172.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.468 ' HA3' ' HG3' ' A' ' 18' ' ' GLU . . . -77.72 47.54 2.79 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.446 -176.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.656 ' O ' ' HB3' ' A' ' 7' ' ' LYS . 8.7 tp 170.28 -19.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 122.969 0.508 . . . . 0.0 111.01 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.656 ' HB3' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER 80.16 103.68 0.07 Allowed 'General case' 0 C--N 1.345 0.389 0 O-C-N 123.551 0.532 . . . . 0.0 109.695 -173.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.944 ' HA ' HE21 ' A' ' 8' ' ' GLN . 0.0 OUTLIER 65.24 89.45 0.1 Allowed 'General case' 0 C--N 1.327 -0.395 0 O-C-N 124.11 0.881 . . . . 0.0 110.955 -176.498 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.406 HG22 ' HG2' ' A' ' 4' ' ' GLU . 9.5 tp -90.79 -27.63 4.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.866 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 13' ' ' SER . 8.2 t-20 -165.07 174.0 10.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.444 ' C ' ' H ' ' A' ' 13' ' ' SER . 91.0 t80 -96.59 -33.82 11.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.805 0.336 . . . . 0.0 110.687 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.584 HE22 HG23 ' A' ' 42' ' ' VAL . 24.4 mt-30 -83.52 25.67 0.74 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.813 0.816 . . . . 0.0 108.948 174.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.806 ' HB3' HG21 ' A' ' 16' ' ' VAL . 44.8 m -145.05 96.18 2.81 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.894 -172.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.9 mt -108.41 -61.21 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.885 0.374 . . . . 0.0 111.092 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 7.2 m-20 -85.25 30.18 0.62 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.662 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.806 HG21 ' HB3' ' A' ' 13' ' ' SER . 20.4 m -91.54 155.56 3.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -166.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.55 HG11 ' HB2' ' A' ' 23' ' ' ALA . 47.1 t -136.21 143.01 37.04 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.441 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HG3' ' HA3' ' A' ' 5' ' ' GLY . 31.2 mm-40 -71.97 -45.89 59.39 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.201 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.62 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 19.1 t30 -164.02 176.12 9.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.831 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.669 HD11 HD11 ' A' ' 74' ' ' LEU . 86.2 mt -49.03 -36.7 18.63 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -174.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.545 ' OE2' ' HB3' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -77.24 -27.42 53.32 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -172.329 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -77.73 -10.65 59.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.713 0.292 . . . . 0.0 111.355 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.55 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -87.9 171.43 10.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.955 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.721 ' HZ3' ' HB3' ' A' ' 24' ' ' LYS . 4.2 mtpm? -136.08 152.89 51.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.011 0.434 . . . . 0.0 111.644 177.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.65 170.77 15.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.542 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.3 -29.02 5.83 Favored Glycine 0 CA--C 1.504 -0.619 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.598 ' HB ' ' HA ' ' A' ' 59' ' ' PHE . 22.9 pt -113.55 131.08 23.17 Favored Pre-proline 0 C--N 1.315 -0.899 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 1.051 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 54.7 Cg_exo -56.59 162.79 7.79 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 123.047 2.498 . . . . 0.0 113.111 -174.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.1 m -122.97 122.66 39.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.179 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.436 HD12 ' N ' ' A' ' 30' ' ' ILE . 2.5 mp -104.61 109.19 26.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 174.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.423 HG12 ' HB3' ' A' ' 62' ' ' TYR . 64.3 mt -105.45 113.85 43.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.468 -177.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.491 ' O ' ' HG3' ' A' ' 32' ' ' MET . 25.1 ptm -108.91 112.99 25.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.639 0.733 . . . . 0.0 110.057 178.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.744 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 90.1 m-85 -76.36 114.12 14.71 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.535 177.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.523 ' HG3' ' SG ' ' A' ' 41' ' ' CYS . 0.1 OUTLIER -138.77 148.99 44.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.133 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.0 t -97.99 -173.2 2.54 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -55.99 -51.44 67.72 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.701 0.625 . . . . 0.0 110.769 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -92.73 -162.52 0.94 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.615 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.436 ' HB3' ' HD2' ' A' ' 40' ' ' TYR . 50.7 m 74.61 106.02 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.491 0 C-N-CA 123.639 0.776 . . . . 0.0 110.993 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 2.7 Cg_exo -74.74 3.45 5.46 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.561 2.174 . . . . 0.0 113.145 -176.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.436 ' HD2' ' HB3' ' A' ' 38' ' ' CYS . 80.0 m-85 -65.3 -27.28 68.5 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.523 ' SG ' ' HG3' ' A' ' 34' ' ' LYS . 42.3 t -64.58 -55.05 22.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.646 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.584 HG23 HE22 ' A' ' 12' ' ' GLN . 12.7 p -63.42 -31.09 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.772 0.32 . . . . 0.0 110.99 -175.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -68.14 -49.49 60.67 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.214 0.53 . . . . 0.0 110.21 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.1 ttt -67.75 -29.4 68.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.174 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 51.8 mt-30 -61.21 -38.7 87.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.128 175.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.531 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 81.5 mttt -60.1 -49.34 78.05 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.382 0.611 . . . . 0.0 109.671 175.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.551 ' O ' HG23 ' A' ' 51' ' ' VAL . 9.9 mm-40 -57.06 -48.79 77.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.413 176.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.474 HD13 HG21 ' A' ' 61' ' ' ILE . 91.9 mt -60.12 -29.79 68.85 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.29 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 68.6 m -62.12 -47.46 84.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.068 0.461 . . . . 0.0 110.412 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -73.02 -33.56 65.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.28 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 47' ' ' GLU . 57.8 t -67.46 -36.73 77.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.106 0.479 . . . . 0.0 110.167 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.0 m -66.26 -30.74 71.23 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.053 175.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -74.03 -28.78 61.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.391 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -70.47 -47.26 61.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.086 174.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.651 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 1.2 ttm180 -123.43 75.18 1.3 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.808 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -69.79 118.51 12.73 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.749 -172.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.46 50.76 60.61 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.575 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.651 ' HB2' ' HG2' ' A' ' 55' ' ' ARG . 39.0 mmtm -136.03 8.59 3.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.693 0.282 . . . . 0.0 110.79 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.598 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 50.5 p90 -169.93 149.03 3.59 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.488 ' ND2' HG13 ' A' ' 27' ' ' ILE . 15.3 m-80 -88.86 135.19 33.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.484 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.474 HG21 HD13 ' A' ' 48' ' ' LEU . 60.7 mt -114.68 106.18 20.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 168.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.62 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 4.0 t80 -96.32 116.67 29.4 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -76.93 103.95 7.15 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 174.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.744 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -77.45 72.82 4.02 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.699 ' HD2' ' OE2' ' A' ' 68' ' ' GLU . 2.6 ptp180 -69.61 109.79 4.5 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 113.624 -1.625 . . . . 0.0 111.515 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.8 tp -72.24 4.67 3.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.729 -177.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.673 ' CD ' ' HB2' ' A' ' 65' ' ' ARG . 5.6 pm0 -83.04 -13.98 54.75 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.121 0.486 . . . . 0.0 110.056 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.699 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 62.1 mt-10 -106.55 144.29 33.44 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.912 175.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -21.38 62.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.034 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.519 ' HG3' ' HB3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -55.8 -23.25 28.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.221 0.534 . . . . 0.0 112.026 177.099 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.652 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 22.7 m-20 -88.1 8.96 24.31 Favored 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -177.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 77.7 mt -71.47 -50.71 38.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 168.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -68.03 -48.67 65.04 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.52 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.669 HD11 HD11 ' A' ' 20' ' ' LEU . 4.4 mm? -58.4 -41.66 85.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.373 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.458 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -56.76 -56.65 18.83 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 120.501 0.191 . . . . 0.0 111.047 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -65.32 -33.95 77.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.758 0.313 . . . . 0.0 111.042 -176.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.557 ' HZ2' ' HB2' ' A' ' 77' ' ' LYS . 4.1 ttmp? -64.2 -25.61 68.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.112 0.482 . . . . 0.0 110.88 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.688 ' HB3' HG21 ' A' ' 87' ' ' VAL . 89.2 m-85 -120.34 22.71 11.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.015 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 68.44 16.84 9.19 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.334 0.588 . . . . 0.0 111.333 169.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' A' ' 75' ' ' ALA . . . -83.94 140.51 31.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.908 -176.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -151.76 -40.2 0.11 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.65 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 22.8 pt -116.73 160.44 16.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.975 173.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.07 152.52 60.13 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.924 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -91.84 149.57 16.61 Favored 'Cis proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.038 -1.651 . . . . 0.0 112.428 -0.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.8 t -138.06 129.82 28.27 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.1 m -108.5 123.25 48.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.931 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.688 HG21 ' HB3' ' A' ' 78' ' ' TYR . 67.1 t -105.16 117.65 51.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.78 176.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -96.03 111.11 23.22 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.402 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -100.04 138.95 36.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.337 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.8 -172.67 0.53 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.616 ' NZ ' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -67.14 -26.14 66.52 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.068 -0.395 . . . . 0.0 112.056 -176.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.616 ' HG2' ' NZ ' ' A' ' 91' ' ' LYS . 38.6 mm-40 -75.05 -47.11 30.54 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.91 20.99 1.42 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.814 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 92' ' ' GLU . 43.7 m-80 -78.13 133.1 37.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -71.04 86.35 0.73 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.202 176.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -86.73 -51.59 6.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.206 -172.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -137.5 125.91 23.42 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.454 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.6 m -112.14 149.51 14.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 173.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -146.27 122.39 10.8 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.41 115.08 27.73 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 135.37 -168.72 23.69 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.3 tp -90.54 149.85 22.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.77 0.319 . . . . 0.0 110.46 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 56.1 mmm -127.09 161.6 28.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.417 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 10.1 mmm180 -113.37 168.53 9.66 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.4 ' HE2' ' HB2' ' A' ' 105' ' ' LYS . 14.3 ptmm? -57.3 -47.62 81.03 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -172.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.505 ' HA ' ' OE1' ' A' ' 109' ' ' GLU . 14.8 t-20 -64.23 -32.29 73.82 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.97 0.414 . . . . 0.0 111.2 -177.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.543 ' O ' HG12 ' A' ' 111' ' ' ILE . 9.3 m120 -65.03 -45.79 84.01 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.568 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 53.1 mt -62.94 -50.04 81.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.066 175.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.505 ' OE1' ' HA ' ' A' ' 106' ' ' ASN . 43.7 mt-10 -51.28 -49.77 60.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.755 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.5 m -66.69 -43.91 83.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.008 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 107' ' ' ASN . 40.4 mm -60.22 -43.61 93.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.497 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 57.5 mt -59.91 -39.77 86.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 0.0 111.238 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -61.21 -41.14 96.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.325 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.3 m -86.06 -17.43 35.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.912 0.387 . . . . 0.0 111.443 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.9 tp -66.84 -54.39 22.92 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.626 -173.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.681 ' O ' ' HG2' ' A' ' 118' ' ' LYS . . . 136.69 13.29 0.97 Allowed Glycine 0 N--CA 1.442 -0.967 0 C-N-CA 119.862 -1.161 . . . . 0.0 112.872 -177.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.051 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 61.9 t -43.14 100.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.152 0.501 . . . . 0.0 111.888 167.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 29.7 pttt 169.66 -178.4 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.57 141.9 37.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 118.767 0.712 . . . . 0.0 109.999 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -146.76 -4.68 0.42 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.264 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.568 ' NE2' ' HA ' ' A' ' 92' ' ' GLU . 49.6 m-70 -74.75 -19.56 60.18 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.78 0.29 . . . . 0.0 111.697 -175.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -64.01 88.0 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.365 0.602 . . . . 0.0 110.578 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.488 ' HA ' ' OXT' ' A' ' 126' ' ' HIS . 7.4 m80 -158.85 36.51 0.22 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.075 177.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -117.45 12.26 14.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.235 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -154.57 -35.84 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.628 175.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.488 ' OXT' ' HA ' ' A' ' 123' ' ' HIS . 65.4 m-70 . . . . . 0 C--O 1.245 0.822 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.395 172.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 mtt . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 21' ' ' GLU . 49.4 m -153.76 69.94 0.81 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.498 176.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.666 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 60.1 tp 64.67 79.9 0.24 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.529 -175.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -72.09 -45.85 59.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.566 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.33 20.91 65.9 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.784 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 tp -155.05 154.03 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 O-C-N 122.722 -0.281 . . . . 0.0 110.863 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 17.3 tptp 72.13 -61.39 0.5 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 171.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.678 ' HG3' HG22 ' A' ' 9' ' ' ILE . 12.8 pt20 -96.09 -9.95 29.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.524 0.678 . . . . 0.0 111.234 -175.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.791 HD11 HG22 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -176.27 128.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.695 -177.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -166.24 -71.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.995 0.426 . . . . 0.0 111.822 -176.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -79.95 121.4 25.41 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -170.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 171.5 -67.64 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.94 172.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.4 m -125.14 3.02 7.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.591 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.0 mt 70.96 -60.1 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.066 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.525 HD21 ' HA2' ' A' ' 57' ' ' GLY . 14.6 m120 -83.3 30.4 0.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.263 0.554 . . . . 0.0 110.749 177.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.791 HG22 HD11 ' A' ' 9' ' ' ILE . 0.6 OUTLIER -80.1 126.73 39.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.622 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.537 HG11 ' HB2' ' A' ' 23' ' ' ALA . 73.2 t -119.74 132.97 68.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.943 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -71.24 -54.69 10.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.159 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.634 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 7.0 t30 -155.08 169.56 23.83 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.11 -173.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.1 mt -46.73 -45.16 19.45 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.634 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -77.28 -17.74 58.12 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.282 0.563 . . . . 0.0 110.247 -176.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.666 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 66.4 mm-40 -87.82 17.88 4.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.035 171.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.537 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -122.59 160.41 25.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.301 176.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.433 ' HG3' ' HG2' ' A' ' 25' ' ' GLU . 11.8 ptmm? -173.86 -168.95 0.45 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.521 ' HB2' HD12 ' A' ' 27' ' ' ILE . 4.6 mm-40 75.55 -170.72 0.09 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.106 0.879 . . . . 0.0 110.789 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.586 ' O ' ' HE2' ' A' ' 91' ' ' LYS . . . -117.4 38.18 3.06 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.198 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.705 HG22 ' HG2' ' A' ' 119' ' ' GLU . 0.2 OUTLIER -100.81 155.56 36.19 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 110.513 -0.18 . . . . 0.0 110.513 -178.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.722 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 32.5 Cg_exo -60.09 144.61 99.47 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.444 2.096 . . . . 0.0 111.63 173.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.9 m -110.96 115.13 28.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.683 -176.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.2 mt -98.71 107.98 21.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.659 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 55.4 mt -99.93 111.94 31.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.147 0.498 . . . . 0.0 109.875 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.542 ' HA ' ' O ' ' A' ' 85' ' ' THR . 8.3 tpt -109.35 108.93 19.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.27 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.585 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 74.3 m-85 -80.2 152.26 29.24 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.678 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.719 ' HE2' ' HB3' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -159.98 155.74 25.94 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 175.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.573 ' HA ' ' HB2' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -67.72 -173.09 0.31 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 173.66 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.405 ' H ' HG22 ' A' ' 35' ' ' THR . 7.9 p-10 -51.31 -45.55 62.26 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.752 0.31 . . . . 0.0 110.748 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.6 p -137.96 -98.02 0.19 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.33 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.622 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 34.3 m 65.71 130.13 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 123.465 0.706 . . . . 0.0 111.731 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 13.9 Cg_exo -67.96 -33.61 25.65 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.085 1.857 . . . . 0.0 113.143 -177.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -64.66 -28.68 69.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.912 0.387 . . . . 0.0 110.822 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 38' ' ' CYS . 52.3 m -70.26 -36.56 74.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.987 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 45' ' ' GLN . 41.4 t -75.38 -33.21 27.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.427 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.98 -51.11 63.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.195 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.461 ' HE3' ' HB2' ' A' ' 103' ' ' MET . 25.5 ttt -68.21 -29.37 68.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.193 0.52 . . . . 0.0 109.717 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' A' ' 42' ' ' VAL . 4.6 tp60 -58.12 -38.99 77.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.575 174.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.692 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -67.81 -42.23 81.87 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.402 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 51' ' ' VAL . 7.6 mm-40 -57.9 -45.27 86.7 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.346 0.404 . . . . 0.0 110.479 173.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.544 HD23 HD13 ' A' ' 108' ' ' ILE . 96.1 mt -58.16 -44.13 87.77 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.897 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.1 m -60.21 -37.9 81.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.662 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.565 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 20.2 m-85 -74.85 -28.55 60.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.993 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 47' ' ' GLU . 68.7 t -65.47 -44.25 94.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.6 m -65.32 -31.54 72.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.369 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 50' ' ' TYR . 41.8 tttm -58.73 -39.25 80.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.809 173.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 50' ' ' TYR . 31.6 mm-40 -85.69 -17.9 34.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.843 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.589 ' NE ' ' HA ' ' A' ' 55' ' ' ARG . 3.0 tpm_? -153.0 88.93 1.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 111.569 -176.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.28 147.07 28.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.348 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.525 ' HA2' HD21 ' A' ' 15' ' ' ASN . . . 59.17 39.86 95.01 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.773 -0.648 . . . . 0.0 114.497 171.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 28' ' ' PRO . 69.5 mmtt -133.28 1.52 3.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.207 0.504 . . . . 0.0 110.791 175.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -170.46 153.69 4.39 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.436 ' HB3' HG21 ' A' ' 17' ' ' VAL . 83.1 m-20 -121.28 138.25 54.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.847 0.356 . . . . 0.0 110.428 177.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.5 mp -101.94 108.26 23.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.212 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.695 ' OH ' ' HG ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -89.55 115.23 26.8 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 177.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.719 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 86.9 m-85 -95.07 104.18 16.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.02 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.65 ' C ' HD21 ' A' ' 71' ' ' ASN . . . -87.77 107.01 18.45 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.692 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 9.7 ptt180 -105.56 130.24 53.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.228 -177.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.769 HD12 HD22 ' A' ' 71' ' ' ASN . 8.0 mp -71.85 7.73 1.45 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.152 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.685 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 44.7 mt-10 -62.14 -34.26 76.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.415 0.626 . . . . 0.0 109.485 169.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.698 ' HB2' ' HD2' ' A' ' 70' ' ' LYS . 35.6 mt-10 -104.58 172.95 6.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.53 -170.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.471 ' CD ' ' H ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -94.79 -24.35 17.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.779 -177.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.698 ' HD2' ' HB2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -54.27 -17.55 3.03 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.197 0.522 . . . . 0.0 111.862 176.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.769 HD22 HD12 ' A' ' 66' ' ' LEU . 5.7 m-20 -80.58 -9.76 59.77 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.2 mm -61.56 -58.75 6.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.602 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -70.54 -40.87 73.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.627 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.695 ' HG ' ' OH ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -62.93 -46.5 87.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.691 -176.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.585 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -62.49 -49.52 75.05 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.71 0.291 . . . . 0.0 110.916 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -65.92 -33.93 76.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.06 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -61.8 -25.22 67.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.999 0.428 . . . . 0.0 110.878 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 33' ' ' PHE . 90.2 m-85 -124.48 23.05 8.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.911 -176.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 66.03 25.7 10.9 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.595 0.559 . . . . 0.0 111.442 166.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.76 97.53 8.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.851 0.358 . . . . 0.0 111.238 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -106.07 -36.09 7.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.16 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.9 pt -132.74 141.39 45.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.966 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 84' ' ' PRO . 34.7 m -102.57 157.78 33.04 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.434 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 83' ' ' VAL . 20.8 Cg_exo -67.29 150.48 83.01 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.054 -1.227 . . . . 0.0 112.401 -0.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 32' ' ' MET . 1.2 m -135.06 108.35 7.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -176.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.04 109.04 16.97 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.001 0.429 . . . . 0.0 110.822 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.659 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 12.6 p -100.78 123.97 54.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.516 0.674 . . . . 0.0 109.362 175.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.534 ' HB3' HD22 ' A' ' 115' ' ' LEU . 85.4 m-85 -99.01 110.43 23.04 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.497 -176.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.629 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 6.7 mp -102.83 129.65 49.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.734 176.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -68.35 169.83 9.94 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.774 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.586 ' HE2' ' O ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -61.76 -14.33 31.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -175.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.67 -5.39 58.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 111.26 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.81 10.8 71.86 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.604 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 8.6 p30 -86.67 131.32 34.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.806 0.336 . . . . 0.0 110.66 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.629 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 20.5 ptmt -77.28 87.17 3.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.217 0.532 . . . . 0.0 109.859 175.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -74.79 -53.64 8.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.618 -173.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.53 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 63.4 t80 -137.54 114.46 10.65 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.866 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 87' ' ' VAL . 4.4 p -96.66 137.0 25.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 172.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.53 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 48.6 t60 -134.1 134.29 42.1 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -175.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.41 131.91 54.64 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 173.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 122.75 173.38 14.15 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.264 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.8 tp -82.01 141.12 33.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.824 0.345 . . . . 0.0 111.323 -175.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.461 ' HB2' ' HE3' ' A' ' 44' ' ' MET . 78.4 mmm -134.15 161.29 35.29 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.413 ' O ' HG13 ' A' ' 108' ' ' ILE . 17.5 mmm180 -106.86 171.52 7.32 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.524 ' HE2' ' HB3' ' A' ' 50' ' ' TYR . 36.5 ttmt -46.62 -60.29 2.47 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.6 0.562 . . . . 0.0 112.004 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.569 ' HA ' ' OE1' ' A' ' 109' ' ' GLU . 6.7 t-20 -67.66 -27.46 66.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.065 0.46 . . . . 0.0 111.12 -174.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.496 ' O ' HG12 ' A' ' 111' ' ' ILE . 13.1 m120 -67.4 -42.76 82.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.544 HD13 HD23 ' A' ' 48' ' ' LEU . 56.7 mt -61.7 -46.15 97.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.369 173.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.569 ' OE1' ' HA ' ' A' ' 106' ' ' ASN . 50.9 mt-10 -52.79 -48.03 67.16 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.539 176.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.1 m -61.27 -37.5 83.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.095 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 107' ' ' ASN . 49.7 mm -69.04 -43.79 81.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.328 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.535 ' HB3' ' CG2' ' A' ' 117' ' ' VAL . 72.8 mt -61.7 -39.22 90.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.907 0.384 . . . . 0.0 110.107 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -58.15 -38.05 75.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.799 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.0 m -86.22 -5.74 59.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.029 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.534 HD22 ' HB3' ' A' ' 88' ' ' PHE . 53.9 tp -93.47 -66.72 0.9 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.704 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 174.9 -72.23 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.78 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.722 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 21.4 t 55.32 29.62 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 122.493 1.14 . . . . 0.0 109.719 -177.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.433 ' O ' ' HD2' ' A' ' 91' ' ' LYS . 17.8 pttm -89.45 79.56 6.92 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.962 -175.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.705 ' HG2' HG22 ' A' ' 27' ' ' ILE . 7.6 tp10 -130.41 141.98 50.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.685 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -124.18 -50.67 0.2 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.414 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 59.88 24.87 13.94 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.936 0.494 . . . . 0.0 111.785 -176.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 72.24 -56.96 0.64 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.411 0.684 . . . . 0.0 111.839 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.444 ' O ' ' HB2' ' A' ' 124' ' ' HIS . 52.7 t60 -120.97 -93.97 0.51 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.425 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.444 ' HB2' ' O ' ' A' ' 123' ' ' HIS . 8.2 t60 174.5 -58.42 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.024 0.44 . . . . 0.0 110.397 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -159.97 -66.12 0.07 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.769 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.7 t60 . . . . . 0 C--O 1.242 0.698 0 CA-C-O 117.607 -1.187 . . . . 0.0 108.939 177.703 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 m -62.23 -43.89 97.8 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.443 0.64 . . . . 0.0 109.646 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.526 ' HB2' HE22 ' A' ' 8' ' ' GLN . 1.4 pp -117.68 175.02 5.84 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.788 173.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.482 ' HB2' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -83.14 -82.16 0.15 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.729 0.3 . . . . 0.0 111.776 -178.491 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 110.76 21.49 6.75 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -173.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.482 HG12 ' HB2' ' A' ' 4' ' ' GLU . 37.1 pt -106.59 -29.12 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.416 -0.392 . . . . 0.0 111.122 -177.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.05 -1.53 18.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.281 0.563 . . . . 0.0 109.687 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.526 HE22 ' HB2' ' A' ' 3' ' ' LEU . 21.0 pt20 -129.61 -166.73 1.7 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.26 -177.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 16' ' ' VAL . 12.2 tt -43.2 134.24 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.681 0.753 . . . . 0.0 112.113 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -125.36 174.83 7.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.704 -176.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -87.37 0.78 54.95 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.394 -0.192 . . . . 0.0 111.479 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -47.77 -71.48 0.07 Allowed 'General case' 0 C--O 1.236 0.382 0 O-C-N 123.535 0.522 . . . . 0.0 111.762 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.551 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 6.8 m -93.97 -6.18 46.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.172 178.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 13' ' ' SER . 74.5 mt 74.0 -63.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 123.733 0.645 . . . . 0.0 110.37 -174.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.717 ' HB3' ' HA2' ' A' ' 57' ' ' GLY . 0.5 OUTLIER -87.83 32.08 0.75 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.333 0.587 . . . . 0.0 110.581 174.513 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.672 HG23 ' CE1' ' A' ' 63' ' ' TYR . 1.2 p -86.61 111.35 21.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.789 174.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.584 ' HB ' ' HB2' ' A' ' 22' ' ' GLU . 20.8 m -114.0 136.42 50.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.107 0.479 . . . . 0.0 109.933 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -65.54 -54.46 27.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.894 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.749 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 4.9 t30 -144.87 179.33 7.4 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.295 -174.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.414 HD11 HD23 ' A' ' 74' ' ' LEU . 96.5 mt -48.1 -42.0 27.81 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.261 0.624 . . . . 0.0 112.578 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -58.25 -32.22 68.15 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.584 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . 21.1 mt-10 -84.25 -6.07 59.34 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.49 151.73 26.38 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.188 -0.32 . . . . 0.0 111.136 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -172.41 -171.07 0.77 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 2.4 tp10 72.26 -174.01 0.16 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.43 1.092 . . . . 0.0 111.215 178.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.462 ' H ' ' HG3' ' A' ' 25' ' ' GLU . . . -106.26 36.81 4.16 Favored Glycine 0 CA--C 1.504 -0.611 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.594 HG21 ' HA ' ' A' ' 58' ' ' LYS . 17.6 pt -105.93 150.16 38.91 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 114.45 -0.875 . . . . 0.0 111.228 -170.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 1.062 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 62.5 Cg_exo -57.05 158.94 16.12 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.984 2.456 . . . . 0.0 112.304 175.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.6 m -115.9 121.78 43.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.929 -175.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.483 HD11 HD21 ' A' ' 112' ' ' LEU . 80.0 mt -110.17 108.75 26.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.617 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 61.0 mt -105.57 113.78 43.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.824 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.9 ptm -110.25 120.49 42.62 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.515 0.674 . . . . 0.0 109.474 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.512 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 87.3 m-85 -78.73 125.56 29.53 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.505 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.679 ' HE2' ' HB3' ' A' ' 65' ' ' ARG . 29.2 pttt -116.7 -174.26 2.54 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.755 -171.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.447 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 2.1 m -144.98 154.57 42.7 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.446 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 1.8 t70 -47.58 -51.9 19.55 Favored 'General case' 0 C--N 1.32 -0.674 0 O-C-N 124.239 0.962 . . . . 0.0 111.558 174.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.2 m -116.76 98.74 6.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.64 0.257 . . . . 0.0 111.637 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.447 ' SG ' ' HB ' ' A' ' 35' ' ' THR . 7.3 p -169.46 113.44 0.51 Allowed Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.901 171.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.568 ' O ' HG12 ' A' ' 42' ' ' VAL . 2.4 Cg_endo -80.49 -4.62 13.07 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.533 2.155 . . . . 0.0 113.605 -175.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -74.77 -21.8 59.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.834 0.35 . . . . 0.0 110.477 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 82.5 m -68.53 -43.45 76.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.817 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 39' ' ' PRO . 9.8 p -65.56 -29.31 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 120.93 0.395 . . . . 0.0 110.702 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.665 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -65.14 -48.76 72.45 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.28 0.562 . . . . 0.0 109.68 177.43 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 25.2 ttt -67.69 -30.16 69.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.867 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.563 ' HG2' ' CE2' ' A' ' 63' ' ' TYR . 27.0 mt-30 -56.22 -40.76 74.56 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.384 173.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.665 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 3.6 mtpm? -59.1 -53.98 52.21 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.174 0.511 . . . . 0.0 110.259 177.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -62.21 -41.3 98.26 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.971 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.642 HD13 HG21 ' A' ' 61' ' ' ILE . 84.3 mt -62.22 -43.04 99.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.472 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.3 m -53.61 -44.24 69.29 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.73 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -63.73 -61.7 2.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.219 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.8 t -57.08 -32.16 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.2 0.524 . . . . 0.0 111.284 -175.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.545 ' HB3' ' OD1' ' A' ' 15' ' ' ASN . 68.0 m -66.83 -30.48 70.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.789 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -83.49 -31.14 26.66 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.066 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -71.14 -15.4 62.5 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.424 0.631 . . . . 0.0 110.865 174.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.671 ' HA ' HH11 ' A' ' 55' ' ' ARG . 0.5 OUTLIER -141.86 77.62 1.59 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 174.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.579 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 1.3 pm0 -58.27 115.63 3.07 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -161.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.717 ' HA2' ' HB3' ' A' ' 15' ' ' ASN . . . 50.69 33.23 26.38 Favored Glycine 0 CA--C 1.52 0.35 0 CA-C-N 115.012 -0.995 . . . . 0.0 114.43 173.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.594 ' HA ' HG21 ' A' ' 27' ' ' ILE . 27.3 mmtp -109.73 14.93 23.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.571 0.701 . . . . 0.0 111.279 -176.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -159.66 111.03 2.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.199 166.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.427 HD22 HG13 ' A' ' 27' ' ' ILE . 10.8 p30 -76.48 131.38 38.99 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.093 -174.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.642 HG21 HD13 ' A' ' 48' ' ' LEU . 30.1 mm -97.87 108.49 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.445 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.749 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 1.4 t80 -95.87 110.97 23.07 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.672 ' CE1' HG23 ' A' ' 16' ' ' VAL . 36.8 m-85 -90.77 102.04 14.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.059 177.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -78.97 103.98 9.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.8 0.333 . . . . 0.0 111.424 -172.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.679 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 13.6 ptp180 -68.29 123.95 22.15 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.307 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.0 tp -79.8 8.15 7.32 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 121.808 -0.557 . . . . 0.0 109.969 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.453 ' OE1' ' HB2' ' A' ' 65' ' ' ARG . 2.4 mp0 -84.07 -28.02 27.87 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.199 -172.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -119.21 -177.52 3.37 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -170.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -36.3 20.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.121 -169.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HD2' ' H ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -57.56 -29.57 64.51 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.876 0.846 . . . . 0.0 110.758 -179.234 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.92 -11.32 58.27 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.032 -174.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.4 mm -67.85 -44.56 85.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -67.49 -47.51 69.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.54 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.414 HD23 HD11 ' A' ' 20' ' ' LEU . 2.0 tm? -60.31 -46.18 90.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.553 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.88 -43.52 98.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.488 0.185 . . . . 0.0 110.831 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -63.09 -34.19 77.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 0.0 110.805 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -60.74 -16.85 44.36 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.367 0.604 . . . . 0.0 111.622 176.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.455 ' CD2' ' HE3' ' A' ' 95' ' ' LYS . 32.4 m-85 -124.3 4.02 8.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.435 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.6 t70 54.29 33.8 19.1 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.952 0.882 . . . . 0.0 110.425 -174.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.69 84.75 7.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.004 -176.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -103.14 5.05 37.63 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.934 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.6 pt -128.68 141.21 47.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.777 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 m -127.97 143.63 48.5 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.738 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -92.54 136.14 7.86 Favored 'Cis proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.579 -1.426 . . . . 0.0 111.983 -1.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.68 128.43 54.9 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.937 0.399 . . . . 0.0 111.022 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.4 m -109.29 118.07 35.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.425 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.617 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 14.8 p -108.29 135.46 46.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.083 0.468 . . . . 0.0 110.13 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -111.0 114.62 28.07 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.551 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.523 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 4.8 mp -117.24 143.14 46.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.829 177.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.507 ' HA ' ' HB3' ' A' ' 28' ' ' PRO . 5.4 t0 -80.73 179.64 7.7 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 170.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.767 ' HE2' ' HE2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -74.4 -14.19 60.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.92 0.391 . . . . 0.0 110.56 -177.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -70.8 -12.34 61.49 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.713 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.64 11.65 63.65 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.13 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 34.6 m-80 -79.0 113.93 17.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.693 0.283 . . . . 0.0 111.295 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.523 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 57.6 mtpt -71.43 95.47 1.36 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.205 172.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -87.58 -54.46 4.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.626 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -134.24 148.95 50.92 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.561 -172.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.406 HG12 HG23 ' A' ' 87' ' ' VAL . 30.0 m -129.54 147.1 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.599 174.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -140.16 139.02 35.65 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -104.43 122.65 45.94 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.555 0.534 . . . . 0.0 109.767 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.52 -161.78 17.89 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.988 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.428 HD21 ' OE1' ' A' ' 43' ' ' GLU . 44.0 tp -90.03 164.33 14.55 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 122.651 0.38 . . . . 0.0 111.154 -174.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.401 ' N ' ' HG ' ' A' ' 102' ' ' LEU . 58.3 mtm -149.45 172.12 15.48 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 122.937 0.495 . . . . 0.0 110.054 174.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.431 ' HA ' ' HD3' ' A' ' 104' ' ' ARG . 8.0 mmt180 -100.95 163.14 12.44 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.47 ' HA ' HD12 ' A' ' 108' ' ' ILE . 6.3 ptpp? -56.1 -40.98 74.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -62.15 -30.6 71.16 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.927 0.394 . . . . 0.0 111.525 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.54 ' O ' HG12 ' A' ' 111' ' ' ILE . 10.3 m120 -67.93 -45.74 73.47 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 176.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.605 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 50.1 mt -58.93 -48.1 87.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.586 174.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -50.13 -50.41 48.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.363 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.9 m -65.47 -40.33 93.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.318 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 107' ' ' ASN . 47.5 mm -67.1 -41.12 86.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.712 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.638 ' HB3' HG21 ' A' ' 117' ' ' VAL . 87.5 mt -59.59 -39.95 85.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.114 0.483 . . . . 0.0 109.942 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -61.21 -36.71 80.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.015 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 62.6 m -85.36 -16.72 38.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.63 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.6 tp -78.38 -81.91 0.1 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.084 0.468 . . . . 0.0 110.039 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.411 ' HA3' ' OD2' ' A' ' 90' ' ' ASP . . . 171.49 -54.95 0.18 Allowed Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 174.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.062 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 29.1 t 50.42 78.23 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.059 0 CA-C-O 121.561 0.696 . . . . 0.0 111.308 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.767 ' HE2' ' HE2' ' A' ' 91' ' ' LYS . 28.3 mtmm -121.01 140.08 52.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.753 -175.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.482 ' HG2' ' HD2' ' A' ' 58' ' ' LYS . 19.9 mt-10 -82.43 96.56 8.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.177 0.513 . . . . 0.0 110.554 175.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.98 -160.54 38.25 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.338 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -104.49 96.98 6.97 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 172.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -71.01 -4.82 26.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.022 -169.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -145.54 93.67 2.39 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -97.9 162.37 13.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.391 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -70.17 135.3 48.97 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 . . . . . 0 C--O 1.245 0.86 0 CA-C-O 117.963 -1.018 . . . . 0.0 108.616 173.836 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.472 ' H3 ' ' CD ' ' A' ' 4' ' ' GLU . 3.8 mpp? . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.661 0.267 . . . . 0.0 110.415 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.3 t -177.32 119.81 0.11 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 47.1 tp 57.16 78.37 0.23 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.559 0.695 . . . . 0.0 109.585 -171.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.472 ' CD ' ' H3 ' ' A' ' 1' ' ' MET . 5.3 mm-40 -76.27 100.64 5.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.355 -172.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.17 55.6 4.82 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.374 173.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.767 HG12 ' H ' ' A' ' 7' ' ' LYS . 19.2 tt -160.02 -174.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -174.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.767 ' H ' HG12 ' A' ' 6' ' ' ILE . 44.2 mmtt -69.63 27.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -175.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.722 ' HG2' HG23 ' A' ' 6' ' ' ILE . 15.6 mm100 -84.18 -4.26 58.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.566 0.698 . . . . 0.0 110.462 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.3 tt -92.97 -32.39 4.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.706 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -93.64 77.53 4.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.751 -176.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -123.43 -49.24 1.92 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.027 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 13' ' ' SER . 11.0 pt20 -81.77 154.96 25.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 162.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.691 ' HB3' HG11 ' A' ' 16' ' ' VAL . 50.4 m 67.94 88.48 0.11 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -169.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 15' ' ' ASN . 94.9 mt -99.07 146.75 7.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.475 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 82.5 m-20 75.26 14.63 2.98 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.935 0.772 . . . . 0.0 109.985 -173.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.691 HG11 ' HB3' ' A' ' 13' ' ' SER . 2.4 m -107.88 157.28 8.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.431 -176.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 p -129.57 149.09 33.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.349 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -64.02 -56.39 15.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.184 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.724 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 3.0 t30 -157.95 177.96 10.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.382 -0.827 . . . . 0.0 108.831 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.418 ' HG ' ' CE2' ' A' ' 62' ' ' TYR . 30.7 mt -59.45 -30.77 68.74 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.08 -38.64 70.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.294 0.569 . . . . 0.0 110.659 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -87.94 -5.5 58.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.28 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.507 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -85.48 162.98 18.72 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -172.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 23' ' ' ALA . 4.6 mtmm -167.21 90.77 0.37 Allowed 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 124.78 1.232 . . . . 0.0 107.883 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.34 107.43 18.26 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -159.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -116.28 12.05 16.67 Favored Glycine 0 CA--C 1.503 -0.673 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 159.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.46 ' C ' ' HA ' ' A' ' 91' ' ' LYS . 3.0 pt -122.18 152.9 61.11 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 113.22 -1.49 . . . . 0.0 108.529 -176.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.593 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 50.3 Cg_exo -55.62 122.68 12.17 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 121.816 1.677 . . . . 0.0 111.719 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.5 m -99.0 115.8 29.77 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.944 -176.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.514 HD11 HD11 ' A' ' 112' ' ' LEU . 2.1 mp -98.42 108.21 21.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 176.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.682 ' HB ' HG23 ' A' ' 87' ' ' VAL . 62.4 mt -108.45 110.72 33.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.289 -176.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.506 ' HB3' HG23 ' A' ' 86' ' ' THR . 5.0 ppp? -117.2 142.7 46.71 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.022 176.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.661 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 82.7 m-85 -102.15 144.49 30.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.68 -174.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.878 ' HE2' ' HB3' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -138.85 135.59 34.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.024 177.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.4 m -81.71 162.09 23.11 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -50.52 -49.69 55.03 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.27 0.356 . . . . 0.0 111.539 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.3 m -109.32 95.79 5.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.628 0.251 . . . . 0.0 111.275 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.3 p -165.54 131.35 2.02 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 111.462 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.564 ' O ' HG12 ' A' ' 42' ' ' VAL . 64.0 Cg_endo -77.86 -19.69 12.34 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.382 2.055 . . . . 0.0 112.809 177.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.583 ' HB3' ' HG3' ' A' ' 84' ' ' PRO . 54.8 m-85 -58.9 -24.03 61.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.064 0.459 . . . . 0.0 110.82 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 45.3 t -64.12 -50.44 68.22 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.641 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 39' ' ' PRO . 10.0 p -68.34 -32.82 57.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.022 -174.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.601 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 16.2 mt-10 -65.87 -49.91 66.41 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 120.667 0.27 . . . . 0.0 110.993 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -36.96 85.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.917 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.544 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 25.8 mt-30 -60.74 -44.73 96.3 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 176.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 9.8 mtpm? -56.58 -53.68 54.8 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.064 0.459 . . . . 0.0 111.042 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 12.3 mm-40 -62.64 -43.86 97.74 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.131 -174.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.526 HD13 HG21 ' A' ' 61' ' ' ILE . 47.6 mt -59.68 -43.11 94.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.954 175.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.4 m -58.77 -41.18 86.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.05 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.417 ' CD2' ' HA ' ' A' ' 47' ' ' GLU . 24.6 m-85 -59.79 -48.72 80.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.054 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.685 HG22 ' HG3' ' A' ' 105' ' ' LYS . 3.0 t -60.48 -43.37 94.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.039 0.447 . . . . 0.0 110.539 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -62.75 -30.83 71.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.376 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -56.94 -38.04 72.36 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.163 0.506 . . . . 0.0 110.522 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -94.42 2.53 55.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.458 -172.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.554 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 9.4 ptp180 -156.76 85.49 0.97 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.918 0.866 . . . . 0.0 111.553 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.43 ' HA ' HD21 ' A' ' 15' ' ' ASN . 1.1 pm0 -76.68 128.45 34.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.082 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.32 41.51 98.15 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.667 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.554 ' HG2' ' HB2' ' A' ' 55' ' ' ARG . 13.9 mptt -108.63 -27.4 9.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.227 0.537 . . . . 0.0 110.009 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -158.56 154.58 26.87 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.082 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 15' ' ' ASN . 50.2 t30 -108.84 134.05 52.05 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.907 0.384 . . . . 0.0 110.302 -177.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.688 HD12 HG12 ' A' ' 16' ' ' VAL . 34.0 mt -106.78 108.74 25.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.757 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.724 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -96.94 119.93 36.33 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.878 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 68.6 m-85 -94.4 103.47 15.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.598 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.18 101.18 13.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.069 0.461 . . . . 0.0 110.764 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.571 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 29.0 ptt180 -91.75 131.38 37.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.011 178.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.07 9.79 1.81 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.428 0.632 . . . . 0.0 111.215 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.44 ' HB3' ' HD2' ' A' ' 65' ' ' ARG . 57.1 tt0 -78.43 -22.55 47.5 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.543 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.496 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 45.7 mt-10 -110.39 140.24 44.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.043 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.673 ' HA ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -59.06 -35.41 73.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.159 0.584 . . . . 0.0 112.516 -174.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.496 ' HE3' ' HB3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -58.97 -27.99 65.9 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.934 0.397 . . . . 0.0 111.22 -177.611 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.485 ' HA ' ' CB ' ' A' ' 74' ' ' LEU . 87.2 m-20 -92.37 2.68 56.51 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.189 -175.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.673 HD13 ' HA ' ' A' ' 69' ' ' GLU . 1.4 mp -71.09 -52.46 27.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -62.97 -46.17 89.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.811 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.485 ' CB ' ' HA ' ' A' ' 71' ' ' ASN . 0.5 OUTLIER -55.05 -44.47 74.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.567 179.409 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.661 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -55.93 -56.38 21.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.52 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -70.46 -33.12 70.92 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.577 -176.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.447 ' HE3' ' HB2' ' A' ' 77' ' ' LYS . 21.7 ttmt -67.04 -17.19 64.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.355 0.598 . . . . 0.0 110.737 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.448 ' HB2' ' HZ ' ' A' ' 33' ' ' PHE . 51.1 m-85 -118.61 23.67 11.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.391 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 73.15 10.98 5.15 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.095 166.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.09 93.56 7.04 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.33 0.586 . . . . 0.0 111.034 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -101.8 -12.54 18.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.796 175.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 23.9 pt -136.81 -179.51 2.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.641 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.48 145.1 47.83 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.685 0.279 . . . . 0.0 111.117 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.716 ' HD2' ' HA2' ' A' ' 101' ' ' GLY . 97.9 Cg_endo -93.87 120.14 2.84 Favored 'Cis proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.258 -1.559 . . . . 0.0 112.529 -1.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.428 ' O ' ' HD1' ' A' ' 33' ' ' PHE . 70.0 m -92.36 124.54 36.49 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.506 HG23 ' HB3' ' A' ' 32' ' ' MET . 10.5 m -114.57 116.41 28.74 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.213 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.705 HG12 HG12 ' A' ' 98' ' ' VAL . 13.6 m -100.69 123.09 53.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.296 0.57 . . . . 0.0 110.112 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.765 ' HB3' HD11 ' A' ' 115' ' ' LEU . 86.7 m-85 -99.47 110.3 22.79 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.992 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.671 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 5.8 mp -107.1 143.48 35.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.586 175.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.546 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 13.4 t70 -88.18 -165.45 1.32 Allowed 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.625 175.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.546 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -52.28 -35.52 50.45 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -169.311 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -107.73 18.85 20.88 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.666 -173.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.37 23.67 50.22 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.832 172.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.671 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 32.0 m-80 -77.06 112.65 13.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 117.391 0.595 . . . . 0.0 110.757 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -68.19 85.38 0.25 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -84.42 -45.21 12.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.296 -173.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.458 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 90.9 t80 -140.23 129.32 23.58 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.365 -176.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.705 HG12 HG12 ' A' ' 87' ' ' VAL . 15.0 m -107.92 148.01 12.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 172.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.458 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 62.6 t60 -136.76 128.81 29.49 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -177.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -99.82 120.57 39.96 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.716 ' HA2' ' HD2' ' A' ' 84' ' ' PRO . . . 101.91 166.71 27.09 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -175.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.45 ' CD1' ' H ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -93.1 169.22 10.58 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 117.198 0.499 . . . . 0.0 110.181 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.6 ptt? -157.14 168.07 28.52 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.405 ' N ' ' HD2' ' A' ' 104' ' ' ARG . 5.5 mmm180 -91.29 174.11 7.56 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.975 -171.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.685 ' HG3' HG22 ' A' ' 51' ' ' VAL . 55.0 tttm -46.46 -55.19 7.83 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.851 0.719 . . . . 0.0 112.469 -176.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -59.27 -34.78 72.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 0.0 111.334 -175.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -69.31 -50.15 49.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.145 0.498 . . . . 0.0 109.774 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.501 ' O ' HD22 ' A' ' 112' ' ' LEU . 41.7 mt -60.5 -49.56 83.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.933 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.488 ' HA ' HD23 ' A' ' 112' ' ' LEU . 35.0 tt0 -56.31 -47.77 78.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.452 -174.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.6 m -59.91 -31.36 69.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.441 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.563 ' O ' ' HG ' ' A' ' 115' ' ' LEU . 66.6 mt -72.6 -33.8 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.065 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.593 ' HB3' HG21 ' A' ' 117' ' ' VAL . 2.7 mm? -62.53 -38.7 90.99 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.187 172.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -63.81 -27.39 69.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.646 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.6 t -85.75 -14.03 46.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.061 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.765 HD11 ' HB3' ' A' ' 88' ' ' PHE . 95.7 mt -85.17 -73.98 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.383 0.611 . . . . 0.0 109.766 176.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 173.67 -59.81 0.14 Allowed Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.332 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.593 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 39.3 t 52.22 41.84 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 122.951 1.358 . . . . 0.0 108.021 -175.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -93.2 14.89 16.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 113.901 -1.5 . . . . 0.0 112.58 -165.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.528 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . 2.7 tp10 -84.57 -30.17 25.25 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.814 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.04 25.31 1.24 Allowed Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.282 -0.485 . . . . 0.0 113.588 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -149.4 22.79 0.93 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.856 0.36 . . . . 0.0 110.444 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -105.02 12.79 31.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.851 0.358 . . . . 0.0 111.215 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -76.83 92.76 3.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.051 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -57.57 132.7 53.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.726 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -126.72 -57.52 1.35 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.649 -0.691 . . . . 0.0 109.798 172.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 m -70.09 -56.4 7.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.157 0.504 . . . . 0.0 110.182 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -94.32 95.21 8.75 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.542 ' HG3' ' HA ' ' A' ' 8' ' ' GLN . 3.9 mm-40 60.76 -167.25 0.19 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.304 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.88 -44.61 94.39 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.108 172.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.458 HG13 ' N ' ' A' ' 7' ' ' LYS . 35.0 pt -135.99 -40.27 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.736 0.303 . . . . 0.0 111.696 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.458 ' N ' HG13 ' A' ' 6' ' ' ILE . 35.6 ttpt -160.11 -71.28 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.113 0.483 . . . . 0.0 109.751 -174.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.542 ' HA ' ' HG3' ' A' ' 4' ' ' GLU . 19.5 tp60 -135.47 8.24 3.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 122.203 1.001 . . . . 0.0 108.597 172.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.8 mt -124.89 158.09 32.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.541 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -71.84 -178.88 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.267 0.556 . . . . 0.0 111.524 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.535 ' O ' ' HB2' ' A' ' 12' ' ' GLN . 19.2 p90 -96.49 -148.72 0.31 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.618 -175.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.535 ' HB2' ' O ' ' A' ' 11' ' ' PHE . 16.0 mt-30 76.64 -63.76 0.37 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.634 0.774 . . . . 0.0 111.384 -176.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.465 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 13.2 m -76.13 -34.1 59.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.799 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.3 mt 69.06 -68.8 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.881 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.23 59.66 5.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.563 0.697 . . . . 0.0 110.121 174.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.465 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 1.0 OUTLIER -98.26 128.85 49.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.886 177.104 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.576 HG22 ' HG3' ' A' ' 22' ' ' GLU . 2.4 t -124.62 141.6 44.21 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-O 121.633 0.73 . . . . 0.0 112.567 -172.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -76.76 -35.49 57.69 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 113.864 -1.516 . . . . 0.0 112.38 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.757 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 66.0 t30 -172.6 -178.85 2.03 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.407 ' H ' ' CG ' ' A' ' 19' ' ' ASN . 83.5 mt -60.38 -29.66 69.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.757 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -78.57 -31.67 47.38 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.094 0.406 . . . . 0.0 110.988 -178.433 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.576 ' HG3' HG22 ' A' ' 17' ' ' VAL . 3.9 tp10 -72.42 -11.88 60.87 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.679 0.752 . . . . 0.0 109.876 170.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.485 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -95.14 171.73 8.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.435 -177.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.521 ' NZ ' ' HB3' ' A' ' 24' ' ' LYS . 4.3 mtpm? -135.01 167.32 21.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.125 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.487 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -86.44 174.81 8.74 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.267 170.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.02 -61.58 1.59 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.76 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -87.79 127.47 57.9 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-O 120.88 0.371 . . . . 0.0 110.047 178.081 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.923 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 50.9 Cg_exo -56.22 145.28 77.79 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.397 2.065 . . . . 0.0 111.118 176.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.5 m -119.54 129.61 54.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.18 0.514 . . . . 0.0 111.979 -172.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.615 HD11 HD21 ' A' ' 112' ' ' LEU . 79.6 mt -98.48 121.51 49.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.722 HG12 ' HB3' ' A' ' 62' ' ' TYR . 61.2 mt -118.58 119.85 62.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.146 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.431 ' O ' ' HG3' ' A' ' 32' ' ' MET . 26.5 ptm -108.0 117.48 34.24 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.983 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.492 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 87.4 m-85 -86.41 114.2 22.99 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.361 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.731 ' HG3' ' SG ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -138.71 145.15 39.96 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.741 -174.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 m -66.92 136.18 54.97 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 164.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -65.03 -39.38 93.3 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.792 -164.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 m -98.18 92.99 6.0 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.822 0.344 . . . . 0.0 111.153 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.659 ' SG ' ' HB2' ' A' ' 41' ' ' CYS . 25.7 p -160.87 142.68 9.12 Favored Pre-proline 0 CA--C 1.519 -0.236 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.351 174.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -64.92 -34.39 48.47 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.499 2.133 . . . . 0.0 112.48 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -68.66 -21.62 64.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 -177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.731 ' SG ' ' HG3' ' A' ' 34' ' ' LYS . 39.7 t -61.33 -53.43 56.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.022 175.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.23 -34.3 69.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.835 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -63.48 -50.24 70.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.403 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -71.74 -31.03 66.24 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.547 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 22.8 mt-30 -63.17 -33.59 75.79 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.543 173.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 41.6 mmtt -64.66 -46.65 81.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.548 175.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 51' ' ' VAL . 58.2 mm-40 -52.29 -54.52 30.44 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 123.572 0.545 . . . . 0.0 109.557 175.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.456 HD23 HD13 ' A' ' 108' ' ' ILE . 63.7 mt -57.37 -43.56 83.66 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.792 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.1 t -60.75 -39.94 90.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.164 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -76.36 -30.29 57.52 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.842 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.854 HG22 ' HG3' ' A' ' 105' ' ' LYS . 41.9 t -66.12 -39.54 84.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.254 0.55 . . . . 0.0 109.61 172.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.508 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 31.3 m -64.23 -31.66 72.95 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.889 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' A' ' 53' ' ' LYS . 4.2 mmmp? -74.44 -10.91 60.03 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.737 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -102.72 -8.72 20.63 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.23 0.538 . . . . 0.0 109.676 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.768 ' CZ ' ' HA ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -158.07 75.7 0.76 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.281 -178.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 52' ' ' SER . 20.1 mp0 -79.07 141.34 37.45 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.252 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.5 25.55 60.89 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.991 171.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.655 ' HB3' ' HG3' ' A' ' 55' ' ' ARG . 16.9 tptp -117.07 -21.82 8.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.352 0.596 . . . . 0.0 109.738 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.413 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 43.9 p90 -140.56 161.19 38.32 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 172.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -112.42 151.88 29.33 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 121.128 -0.229 . . . . 0.0 110.681 -174.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.3 mt -127.07 111.81 26.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.921 0.391 . . . . 0.0 111.124 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.722 ' HB3' HG12 ' A' ' 31' ' ' ILE . 2.5 t80 -103.24 119.74 39.43 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.547 ' CE1' ' HG2' ' A' ' 45' ' ' GLN . 87.1 m-85 -90.44 103.92 16.55 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.788 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -80.82 94.35 6.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.406 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.484 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -88.13 116.31 26.23 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.37 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 mp -66.36 11.58 0.08 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.871 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.421 ' H ' ' C ' ' A' ' 65' ' ' ARG . 35.0 tt0 -78.46 -32.09 48.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.757 0.789 . . . . 0.0 109.36 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -98.43 140.75 32.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.976 -172.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -31.48 72.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.886 -175.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HD2' ' OE2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -57.67 -19.09 24.37 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 178.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.579 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 52.4 m-80 -87.08 -2.51 58.68 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.729 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 84.5 mt -70.3 -56.8 9.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -64.6 -40.04 94.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.219 175.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 71' ' ' ASN . 0.4 OUTLIER -58.89 -47.18 85.88 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.033 178.204 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -62.71 -45.65 91.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.772 0.32 . . . . 0.0 111.226 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -62.93 -34.56 77.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.314 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -57.58 -31.11 65.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.018 0.437 . . . . 0.0 111.142 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -111.81 1.98 16.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.422 -176.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.3 t70 60.66 48.02 7.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.912 0.863 . . . . 0.0 110.332 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.38 116.13 28.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.364 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -107.81 -57.86 2.05 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.891 -171.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 36.6 pt -119.72 154.2 22.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.088 0.47 . . . . 0.0 111.078 -177.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.2 m -102.62 153.7 37.99 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.868 -177.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -89.66 127.91 7.64 Favored 'Cis proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.057 -1.643 . . . . 0.0 112.277 -0.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.419 HG23 ' HB2' ' A' ' 33' ' ' PHE . 9.0 t -120.81 134.3 55.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.077 0.465 . . . . 0.0 109.995 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.3 m -115.21 125.26 53.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.941 -176.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.4 HG22 HG23 ' A' ' 98' ' ' VAL . 66.3 t -105.24 127.87 59.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.046 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -107.83 114.42 28.36 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.242 0.544 . . . . 0.0 110.224 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.541 ' HB3' ' HA2' ' A' ' 93' ' ' GLY . 58.3 mt -99.16 142.29 30.83 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.69 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 28' ' ' PRO . 6.4 t70 -71.25 -165.46 0.13 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.966 ' HD3' ' HG3' ' A' ' 118' ' ' LYS . 9.7 pttm -61.58 -31.73 71.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -170.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.463 ' HB2' ' ND2' ' A' ' 94' ' ' ASN . 4.8 mp0 -96.32 1.88 52.3 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.91 -0.494 . . . . 0.0 110.838 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.541 ' HA2' ' HB3' ' A' ' 89' ' ' LEU . . . 85.93 26.53 34.27 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.061 -176.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 92' ' ' GLU . 63.4 m-80 -85.34 141.06 30.3 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 176.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.3 94.15 5.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.594 -174.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -84.23 -52.33 6.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.108 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 72.0 t80 -133.86 144.85 49.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 -178.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.4 HG23 HG22 ' A' ' 87' ' ' VAL . 3.4 p -136.47 136.95 48.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.427 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 74.8 t60 -120.18 137.02 54.42 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -174.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -112.67 112.46 23.99 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 123.568 0.542 . . . . 0.0 109.752 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.65 -177.67 16.42 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 44.7 tp -76.63 155.67 33.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.007 0.432 . . . . 0.0 111.042 -177.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.1 ptm -159.73 146.58 16.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 175.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.453 ' O ' HG13 ' A' ' 108' ' ' ILE . 35.2 mmt180 -98.8 174.31 6.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.869 0.366 . . . . 0.0 111.827 -174.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.854 ' HG3' HG22 ' A' ' 51' ' ' VAL . 63.7 tttm -46.23 -54.27 9.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.898 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.518 ' HA ' ' CD ' ' A' ' 109' ' ' GLU . 26.9 t-20 -65.74 -28.46 69.06 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.141 0.496 . . . . 0.0 111.446 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.496 ' O ' HD13 ' A' ' 111' ' ' ILE . 9.7 m120 -67.22 -38.95 86.13 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.547 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 42.0 mt -64.58 -47.08 90.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.528 174.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.56 ' OE2' ' HG2' ' A' ' 105' ' ' LYS . 68.1 mt-10 -49.71 -54.75 17.0 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.446 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.54 ' O ' ' HB3' ' A' ' 113' ' ' ASN . 25.4 m -67.41 -31.3 71.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.052 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 107' ' ' ASN . 1.4 mp -71.58 -41.69 71.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.778 178.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.622 ' HB3' ' CG2' ' A' ' 117' ' ' VAL . 56.4 mt -62.74 -33.25 74.74 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.54 ' HB3' ' O ' ' A' ' 110' ' ' THR . 23.2 t-20 -57.8 -44.41 86.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.918 178.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.8 m -85.13 -23.03 28.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.271 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.472 HD21 ' O ' ' A' ' 89' ' ' LEU . 62.6 tp -67.78 -78.49 0.06 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.425 0.631 . . . . 0.0 109.807 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.964 ' HA3' ' HD2' ' A' ' 118' ' ' LYS . . . 172.32 -53.84 0.17 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.96 171.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.923 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 21.6 t 56.4 41.0 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 123.162 1.458 . . . . 0.0 107.545 -174.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.966 ' HG3' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -77.68 -139.01 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 112.801 -2.0 . . . . 0.0 111.907 -169.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.499 ' H ' ' HB2' ' A' ' 118' ' ' LYS . 2.8 tm-20 81.62 146.86 0.08 Allowed 'General case' 0 N--CA 1.47 0.545 0 O-C-N 124.142 0.901 . . . . 0.0 108.915 -175.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.96 -33.16 84.8 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.464 -0.398 . . . . 0.0 113.488 -171.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.539 ' O ' ' HE2' ' A' ' 58' ' ' LYS . 58.9 m-70 -78.26 82.06 4.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.219 0.533 . . . . 0.0 110.632 -177.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -138.08 -49.59 0.57 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.283 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -161.07 133.48 6.04 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -146.84 145.02 29.73 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.629 0.252 . . . . 0.0 110.342 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -121.71 -70.94 0.75 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 173.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 . . . . . 0 C--O 1.243 0.755 0 CA-C-O 118.442 -0.789 . . . . 0.0 109.789 178.293 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 mmt . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 m 67.79 98.69 0.05 Allowed 'General case' 0 N--CA 1.464 0.238 0 O-C-N 124.06 0.85 . . . . 0.0 110.526 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 pp -163.11 17.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.924 -175.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 2.0 mp0 -65.62 -20.84 66.47 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.908 0.385 . . . . 0.0 110.8 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.51 -53.26 4.72 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.399 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.3 pt -52.37 -26.31 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -174.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -135.58 19.96 3.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.266 0.555 . . . . 0.0 110.312 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -104.51 42.15 1.23 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.21 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 28.0 pt -78.36 16.64 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.553 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.5 m120 69.03 97.64 0.06 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.582 0.706 . . . . 0.0 111.091 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -70.74 93.38 0.94 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.242 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -167.26 -64.34 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.62 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 49' ' ' SER . 21.3 m -68.13 -38.69 82.48 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 13' ' ' SER . 97.2 mt 71.19 141.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -175.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 66.79 12.35 8.81 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.298 0.57 . . . . 0.0 110.148 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 p -81.94 135.66 24.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.82 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.712 HG13 ' HG2' ' A' ' 22' ' ' GLU . 92.7 t -134.58 143.71 37.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.123 -176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.689 ' HG3' ' HB2' ' A' ' 19' ' ' ASN . 1.3 tp10 -69.3 -56.1 8.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.789 0.328 . . . . 0.0 111.199 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.814 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 2.9 t-20 -143.14 170.18 16.21 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.963 -167.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.49 -30.8 71.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.04 171.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.814 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 13.5 pt-20 -71.89 -13.85 61.77 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.335 0.588 . . . . 0.0 110.524 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.712 ' HG2' HG13 ' A' ' 17' ' ' VAL . 22.2 tt0 -110.62 0.65 17.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.703 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.74 162.26 20.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.121 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -154.6 148.93 26.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.649 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.415 ' OE1' ' NE2' ' A' ' 121' ' ' HIS . 3.2 tp10 81.94 164.95 0.14 Allowed 'General case' 0 C--N 1.333 -0.109 0 O-C-N 124.401 1.063 . . . . 0.0 112.295 167.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.99 56.89 4.34 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.812 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 26.2 pt -116.61 146.95 38.74 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.765 -0.218 . . . . 0.0 110.538 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.692 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 49.5 Cg_exo -57.71 135.56 70.06 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.838 2.359 . . . . 0.0 112.089 178.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.467 ' HA ' ' OD1' ' A' ' 60' ' ' ASN . 52.4 m -99.07 114.69 27.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.687 -177.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.569 HD13 ' HB2' ' A' ' 59' ' ' PHE . 2.0 mp -98.74 108.58 22.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.354 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.751 HG12 ' HB3' ' A' ' 62' ' ' TYR . 62.5 mt -103.56 136.81 34.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.302 -177.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.8 ptm -128.15 122.61 32.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.145 0.498 . . . . 0.0 110.279 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.78 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 96.1 m-85 -85.72 113.75 22.15 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.102 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -139.67 149.81 44.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.125 -177.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.469 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 9.1 p -85.14 177.46 7.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.715 -0.221 . . . . 0.0 110.5 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.451 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 15.4 t70 -60.92 -80.62 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.982 0.42 . . . . 0.0 110.759 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.5 m -82.19 98.37 8.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.005 0.431 . . . . 0.0 110.631 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 41' ' ' CYS . 24.8 p -154.77 135.9 8.95 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.64 176.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.0 -26.81 30.82 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.135 1.89 . . . . 0.0 112.267 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.532 ' HB3' ' HG3' ' A' ' 84' ' ' PRO . 69.7 m-85 -58.58 -35.07 71.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.773 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.523 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 45.9 t -63.55 -53.04 58.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.186 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.497 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 43.5 t -60.89 -44.32 97.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.121 -177.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.911 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 15.0 tp10 -57.93 -50.69 72.49 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.725 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.49 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 8.1 tpt -68.02 -35.9 79.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.417 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 25.9 mt-30 -61.27 -39.39 90.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.319 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.911 ' HE3' ' HA ' ' A' ' 43' ' ' GLU . 10.1 mtmp? -56.14 -53.36 58.01 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.461 0.648 . . . . 0.0 109.39 175.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.577 ' HG3' ' HA ' ' A' ' 104' ' ' ARG . 24.7 mm-40 -62.36 -42.32 99.31 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.028 -176.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.741 HD13 HG21 ' A' ' 61' ' ' ILE . 96.4 mt -60.22 -43.33 96.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.469 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 13' ' ' SER . 45.4 t -58.2 -43.24 87.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.344 0.593 . . . . 0.0 110.078 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -65.54 -43.28 90.45 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.807 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.7 HG13 ' HG2' ' A' ' 109' ' ' GLU . 92.9 t -65.3 -48.33 83.74 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.047 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.8 m -60.9 -31.62 71.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.803 0.335 . . . . 0.0 111.312 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.741 ' HZ3' ' HB3' ' A' ' 53' ' ' LYS . 4.4 ttpm? -64.0 -24.69 67.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.152 0.501 . . . . 0.0 110.601 175.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -109.11 2.93 21.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.561 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.564 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 10.1 tpp180 -156.36 79.23 0.96 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -176.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.25 125.91 32.09 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -172.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 53.89 30.67 45.59 Favored Glycine 0 C--N 1.33 0.212 0 CA-C-N 115.903 -0.59 . . . . 0.0 113.666 174.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.564 ' HB2' ' HG3' ' A' ' 55' ' ' ARG . 61.4 mmtt -110.93 -6.19 14.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.516 0.674 . . . . 0.0 109.228 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.569 ' HB2' HD13 ' A' ' 30' ' ' ILE . 4.6 p90 -162.49 143.34 10.1 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.385 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.467 ' OD1' ' HA ' ' A' ' 29' ' ' THR . 20.8 p-10 -111.03 136.34 50.19 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.056 0.455 . . . . 0.0 110.82 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.741 HG21 HD13 ' A' ' 48' ' ' LEU . 4.5 mp -96.96 109.5 23.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.536 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.751 ' HB3' HG12 ' A' ' 31' ' ' ILE . 1.1 t80 -89.72 115.32 27.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.247 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -80.21 104.34 10.69 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.732 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -85.43 85.38 7.44 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.766 ' HB2' ' CD ' ' A' ' 67' ' ' GLU . 6.7 ptt180 -91.42 116.86 29.19 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.963 -170.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.478 ' HA ' HD22 ' A' ' 71' ' ' ASN . 4.1 mm? -72.04 5.82 2.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.625 -176.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.766 ' CD ' ' HB2' ' A' ' 65' ' ' ARG . 7.1 pm0 -84.58 -13.61 51.23 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.597 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 32.6 mt-10 -101.38 128.42 47.57 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.311 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -59.4 -37.39 77.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.06 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.597 ' HD2' ' HB3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -58.99 -24.59 62.86 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 122.084 0.945 . . . . 0.0 110.902 -179.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.498 ' N ' ' HD3' ' A' ' 70' ' ' LYS . 12.0 t30 -97.74 3.77 50.05 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.861 -172.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.3 mt -71.42 -51.02 36.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 169.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.33 -39.72 89.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.261 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.478 ' CB ' ' HA ' ' A' ' 71' ' ' ASN . 1.6 tm? -57.81 -42.57 84.56 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.913 176.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.78 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -51.68 -56.5 13.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.839 176.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -63.8 -32.54 74.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.504 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -62.31 -14.95 44.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.285 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.616 ' HB3' HG11 ' A' ' 87' ' ' VAL . 57.5 m-85 -127.78 21.54 6.42 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 70.25 15.43 7.47 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.006 0.522 . . . . 0.0 111.634 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.23 130.05 41.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.038 0.447 . . . . 0.0 110.685 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -133.63 -40.22 0.88 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.167 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.496 HD11 ' HB3' ' A' ' 100' ' ' GLN . 36.9 pt -122.28 179.85 2.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.741 0.305 . . . . 0.0 110.5 177.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.7 m -128.51 139.27 35.05 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.704 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.532 ' HG3' ' HB3' ' A' ' 40' ' ' TYR . 79.3 Cg_endo -93.36 128.15 5.03 Favored 'Cis proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.275 -1.552 . . . . 0.0 112.796 -0.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.422 ' O ' ' HD1' ' A' ' 33' ' ' PHE . 64.6 m -108.31 114.62 28.63 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 174.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.435 ' CG2' ' HB3' ' A' ' 99' ' ' HIS . 5.1 t -108.63 122.36 46.94 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.42 0.628 . . . . 0.0 110.74 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.691 HG23 ' HB ' ' A' ' 31' ' ' ILE . 14.0 m -102.62 120.94 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.226 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.744 ' HB3' HD11 ' A' ' 115' ' ' LEU . 96.6 m-85 -99.09 112.73 24.79 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.586 -177.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.0 mt -104.17 137.32 42.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.527 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 91' ' ' LYS . 23.8 t0 -71.58 179.13 3.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.512 ' HB2' ' HE3' ' A' ' 91' ' ' LYS . 14.8 ptmt -60.88 -13.8 18.08 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.53 -41.42 15.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.796 0.332 . . . . 0.0 110.515 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.2 -17.04 5.97 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.216 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -57.58 139.71 52.83 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.499 0.666 . . . . 0.0 111.771 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -77.46 90.14 3.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.443 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -78.04 -45.99 22.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -174.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.443 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 87.3 t80 -145.85 136.56 24.3 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.894 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.658 HG12 HG12 ' A' ' 87' ' ' VAL . 16.2 m -118.07 149.75 20.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 173.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.443 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 53.4 t60 -137.12 118.18 14.36 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.496 ' HB3' HD11 ' A' ' 82' ' ' ILE . 1.4 mp0 -101.32 106.43 17.6 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.875 0.734 . . . . 0.0 109.211 176.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 131.55 -176.03 19.36 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.968 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.637 HD21 ' HG2' ' A' ' 43' ' ' GLU . 34.8 tp -92.19 161.3 14.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.753 0.311 . . . . 0.0 111.051 -175.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -171.94 162.49 6.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.577 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 1.8 mpt_? -102.13 177.61 4.84 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -174.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.485 ' HA ' HD12 ' A' ' 108' ' ' ILE . 13.7 ptmm? -49.73 -43.36 47.74 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -171.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -67.05 -32.49 73.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.108 0.48 . . . . 0.0 110.374 -175.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.598 ' O ' HG12 ' A' ' 111' ' ' ILE . 15.8 m120 -67.67 -48.1 67.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.612 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 105' ' ' LYS . 26.6 mt -58.6 -50.84 77.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.078 177.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.7 ' HG2' HG13 ' A' ' 51' ' ' VAL . 1.2 tm-20 -55.6 -48.93 74.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.318 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.2 m -59.81 -33.43 71.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.978 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.669 ' O ' ' HG ' ' A' ' 115' ' ' LEU . 48.9 mm -69.4 -41.05 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.723 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 8.8 mt -60.21 -45.17 94.1 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -61.16 -26.95 68.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.063 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.6 t -83.82 -25.3 30.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.744 HD11 ' HB3' ' A' ' 88' ' ' PHE . 57.2 mt -72.34 -60.7 2.1 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.746 0.784 . . . . 0.0 109.739 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 158.98 -50.48 0.4 Allowed Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.15 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.692 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 40.0 t 53.29 42.45 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 122.808 1.289 . . . . 0.0 109.105 -177.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.498 ' O ' ' HD2' ' A' ' 91' ' ' LYS . 35.0 mtmm -85.88 75.26 10.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.887 -174.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -50.69 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.809 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.0 29.05 35.44 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.776 174.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.415 ' NE2' ' OE1' ' A' ' 25' ' ' GLU . 36.0 m-70 -111.6 -34.64 6.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.39 0.595 . . . . 0.0 111.518 176.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -72.38 74.87 1.02 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.748 0.785 . . . . 0.0 111.62 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -165.54 114.7 1.02 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.796 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -116.14 151.24 36.04 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -171.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -105.01 -6.55 19.93 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 164.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 . . . . . 0 C--O 1.246 0.894 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.546 179.306 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.839 0.352 . . . . 0.0 110.4 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.3 t -153.77 103.69 2.63 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 3' ' ' LEU . 0.8 OUTLIER 65.05 87.33 0.12 Allowed 'General case' 0 CA--C 1.531 0.245 0 O-C-N 123.737 0.648 . . . . 0.0 109.619 -175.372 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 8' ' ' GLN . 4.5 mp0 -82.76 -25.47 32.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.699 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.31 -54.25 3.94 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.165 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.1 pt -138.37 -32.36 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.789 0.328 . . . . 0.0 111.597 -175.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -85.77 41.78 0.93 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.022 0.439 . . . . 0.0 111.673 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.577 ' HB2' ' HB2' ' A' ' 4' ' ' GLU . 31.8 tt0 -119.1 15.45 13.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.829 0.823 . . . . 0.0 108.846 177.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.1 tp -101.1 95.1 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.809 -172.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -129.17 -3.05 5.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.608 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.508 ' O ' ' HB2' ' A' ' 12' ' ' GLN . 43.7 p90 -142.31 133.34 25.92 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.115 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.508 ' HB2' ' O ' ' A' ' 11' ' ' PHE . 5.4 tp-100 168.63 -61.69 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.58 ' HB3' ' HB ' ' A' ' 16' ' ' VAL . 35.3 t -106.73 7.1 30.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.268 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 69.4 mt 70.96 -69.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.992 175.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.854 HD22 ' HB3' ' A' ' 52' ' ' SER . 54.0 m-80 -83.17 31.91 0.44 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.912 0.387 . . . . 0.0 110.426 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.58 ' HB ' ' HB3' ' A' ' 13' ' ' SER . 8.7 p -97.23 148.66 5.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.283 -173.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' A' ' 23' ' ' ALA . 8.8 p -133.3 145.9 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.011 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -66.72 -45.1 79.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.407 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.632 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 16.1 t-20 -160.25 168.83 24.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.242 -175.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 84.9 mt -62.05 -29.41 70.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.84 0.352 . . . . 0.0 110.439 178.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -59.78 -32.22 70.4 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.542 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -97.21 -0.96 45.92 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.546 -177.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.508 ' HB2' HG21 ' A' ' 17' ' ' VAL . . . -107.62 171.64 7.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.371 0.605 . . . . 0.0 112.47 -170.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -129.84 155.82 45.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.897 177.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.5 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -103.54 177.24 4.9 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.772 0.32 . . . . 0.0 110.92 -176.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.595 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . 108.81 -35.53 4.9 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.81 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -105.73 152.93 40.25 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 177.009 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.79 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 63.8 Cg_exo -53.28 135.04 59.2 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.827 2.351 . . . . 0.0 112.194 177.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.408 ' HB ' HD12 ' A' ' 89' ' ' LEU . 25.8 m -106.0 112.92 26.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.425 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.44 HD13 ' HB2' ' A' ' 59' ' ' PHE . 1.7 mp -97.91 109.32 23.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 87' ' ' VAL . 59.3 mt -103.67 126.23 58.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.598 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.443 ' O ' ' HG3' ' A' ' 32' ' ' MET . 24.3 ptm -118.81 116.97 27.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.66 0.743 . . . . 0.0 110.153 173.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 87.5 m-85 -81.5 119.05 23.25 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.346 174.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.558 ' HE3' ' HB3' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -139.56 145.15 38.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.968 0.413 . . . . 0.0 111.259 -177.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.558 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 5.3 m -91.52 157.04 17.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.668 175.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.753 ' HB2' ' HG2' ' A' ' 67' ' ' GLU . 12.6 t70 -61.58 -66.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 111.841 -178.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.1 m -82.01 54.32 2.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.616 0.722 . . . . 0.0 111.407 -172.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.558 ' SG ' ' HB ' ' A' ' 35' ' ' THR . 37.4 m -145.24 113.67 4.83 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.514 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.52 -3.46 11.9 Favored 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 122.363 2.042 . . . . 0.0 113.37 -176.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -68.99 -17.33 63.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.667 0.27 . . . . 0.0 110.892 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.448 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 26.4 p -74.27 -55.36 6.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.482 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.589 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 12.4 p -60.64 -35.58 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.149 -175.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.58 ' HG2' HD21 ' A' ' 102' ' ' LEU . 24.0 tp10 -57.86 -51.09 71.02 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.055 0.455 . . . . 0.0 110.803 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 24.0 ttt -74.5 -29.29 61.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.303 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 28.8 mt-30 -63.86 -33.9 76.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.76 176.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 2.9 mtmm -60.22 -51.9 67.61 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.571 ' HG3' ' HA ' ' A' ' 104' ' ' ARG . 33.2 mm-40 -55.7 -46.4 77.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.804 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.433 HD13 HG21 ' A' ' 61' ' ' ILE . 89.7 mt -59.7 -39.22 83.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.003 178.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.0 t -65.58 -45.22 84.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.088 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.457 ' CB ' ' HD2' ' A' ' 105' ' ' LYS . 20.8 m-85 -58.82 -39.82 82.34 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.653 178.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 47' ' ' GLU . 84.9 t -66.97 -53.29 35.4 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.597 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.854 ' HB3' HD22 ' A' ' 15' ' ' ASN . 21.5 m -59.53 -30.85 68.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.927 0.394 . . . . 0.0 111.473 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.585 ' HB3' ' NZ ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -55.85 -29.45 59.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.896 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -113.53 -34.24 5.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.883 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.677 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 2.5 tpp180 -89.7 75.03 7.46 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.5 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 2.2 mm-40 -82.49 128.39 34.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.173 -174.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.96 42.9 82.03 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.987 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.677 ' HB2' ' HG3' ' A' ' 55' ' ' ARG . 38.7 mmtm -126.87 -12.89 5.89 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 122.751 -0.264 . . . . 0.0 110.895 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.44 ' HB2' HD13 ' A' ' 30' ' ' ILE . 1.2 p90 -160.43 149.86 17.47 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -112.83 129.88 56.29 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.433 HG21 HD13 ' A' ' 48' ' ' LEU . 4.7 mp -97.71 110.97 26.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.947 0.403 . . . . 0.0 110.587 -178.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.632 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 12.5 t80 -96.91 116.06 28.52 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.018 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.558 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 15.0 m-30 -77.91 103.77 8.05 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.005 176.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 33' ' ' PHE . . . -85.13 74.34 10.49 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.559 ' C ' ' H ' ' A' ' 67' ' ' GLU . 23.9 ptt180 -84.03 125.89 32.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.294 -174.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.14 12.25 0.09 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.323 0.582 . . . . 0.0 111.3 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.753 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 25.8 mt-10 -82.33 -26.08 33.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.35 -177.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.511 ' CB ' ' HD2' ' A' ' 70' ' ' LYS . 44.6 mt-10 -118.08 147.31 43.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.654 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -69.19 -18.21 63.89 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -175.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.605 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.6 OUTLIER -62.64 -32.26 73.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.576 0.703 . . . . 0.0 110.034 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.605 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 5.6 m120 -83.58 -9.65 58.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.323 -174.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.0 mm -71.49 -42.6 72.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.16 -45.46 88.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.489 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 71' ' ' ASN . 4.4 mm? -58.11 -39.25 78.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.171 175.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.607 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -55.71 -57.23 12.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.485 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -66.17 -33.69 76.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.022 0.439 . . . . 0.0 110.601 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.439 ' HE3' ' HB2' ' A' ' 77' ' ' LYS . 19.2 ttmt -66.96 -17.44 64.92 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.261 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -122.16 11.4 10.16 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 70.59 24.82 4.32 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.595 0.559 . . . . 0.0 111.272 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.17 101.63 11.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.517 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -94.62 -43.17 8.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.888 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.7 pt -133.46 152.54 35.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.813 0.34 . . . . 0.0 110.682 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 84' ' ' PRO . 23.6 m -101.8 158.88 30.93 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.905 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.548 ' HA ' ' HB ' ' A' ' 83' ' ' VAL . 2.3 Cg_endo -83.01 125.41 10.33 Favored 'Cis proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.755 -1.352 . . . . 0.0 112.101 -0.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.523 ' HB ' ' CD1' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -97.4 112.55 24.33 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.4 m -101.44 111.7 24.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.276 0.56 . . . . 0.0 110.459 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' A' ' 31' ' ' ILE . 99.5 t -108.19 110.21 31.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.259 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.419 ' CD2' ' HD2' ' A' ' 97' ' ' TYR . 97.4 m-85 -91.79 105.68 17.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.082 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.408 HD12 ' HB ' ' A' ' 29' ' ' THR . 78.4 mt -95.62 136.05 36.51 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.432 175.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.511 ' HB3' ' ND2' ' A' ' 94' ' ' ASN . 25.7 t70 -72.61 177.37 4.76 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 172.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.641 ' HE2' ' N ' ' A' ' 120' ' ' GLY . 0.0 OUTLIER -53.58 -27.58 27.34 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -175.361 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.497 ' HG2' ' HG3' ' A' ' 91' ' ' LYS . 4.0 mm-40 -90.93 4.04 53.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.792 0.329 . . . . 0.0 111.166 -175.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.85 14.22 79.98 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.676 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.511 ' ND2' ' HB3' ' A' ' 90' ' ' ASP . 9.8 p30 -81.63 141.89 33.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.765 0.316 . . . . 0.0 110.507 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -79.31 82.01 5.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.839 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -78.52 -42.59 29.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.878 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.419 ' HD2' ' CD2' ' A' ' 88' ' ' PHE . 69.0 t80 -141.63 113.56 7.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.133 0.492 . . . . 0.0 111.18 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.97 128.74 65.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -137.85 143.18 40.81 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.522 ' HG2' HG23 ' A' ' 85' ' ' THR . 27.1 mt-30 -119.98 124.21 45.37 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.683 0.278 . . . . 0.0 110.447 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 142.75 -167.45 26.25 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.808 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.58 HD21 ' HG2' ' A' ' 43' ' ' GLU . 59.9 tp -106.09 121.6 44.47 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 74.0 mtp -116.06 159.72 21.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.553 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.571 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 3.3 mpt_? -111.09 170.49 8.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.703 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.457 ' HD2' ' CB ' ' A' ' 50' ' ' TYR . 23.5 tttp -46.91 -53.79 11.43 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -176.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -56.86 -39.2 73.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.008 0.432 . . . . 0.0 111.309 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.533 ' O ' HG12 ' A' ' 111' ' ' ILE . 9.2 m120 -70.6 -44.89 66.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.844 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.58 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 62.3 mt -60.26 -48.72 87.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.91 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.498 ' CD ' HH21 ' A' ' 55' ' ' ARG . 5.5 mm-40 -54.5 -47.99 72.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.594 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 113' ' ' ASN . 24.0 m -64.59 -38.33 90.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.742 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 107' ' ' ASN . 35.4 mm -65.17 -40.98 90.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.765 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 59.8 mt -62.31 -34.79 77.3 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.844 0.354 . . . . 0.0 110.136 177.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 110' ' ' THR . 9.6 m120 -58.87 -45.24 90.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.853 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.8 m -86.49 -16.99 35.32 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.5 tp -70.7 -71.38 0.25 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.35 0.595 . . . . 0.0 110.381 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -178.39 -73.54 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.554 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.79 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 52.0 t 51.71 73.87 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 122.195 0.998 . . . . 0.0 109.82 -175.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -158.97 167.23 29.9 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.686 -172.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 0.3 OUTLIER -141.43 88.39 2.14 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 173.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.641 ' N ' ' HE2' ' A' ' 91' ' ' LYS . . . -66.14 100.72 0.54 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 168.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -53.81 105.95 0.16 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -167.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -74.41 -169.43 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.247 172.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -68.0 85.93 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.589 0.709 . . . . 0.0 111.349 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -114.41 15.98 17.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.122 174.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -100.95 144.54 29.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.427 -175.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 70.8 m80 . . . . . 0 C--O 1.243 0.762 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 171.517 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.0 m -68.03 105.24 1.97 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.971 0.415 . . . . 0.0 110.59 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.64 -13.54 20.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.273 0.558 . . . . 0.0 110.604 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.721 ' HG3' ' H ' ' A' ' 5' ' ' GLY . 5.6 pt-20 -106.46 -74.53 0.65 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.758 -174.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.721 ' H ' ' HG3' ' A' ' 4' ' ' GLU . . . 75.64 -52.79 2.79 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.264 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.712 HG13 ' HG3' ' A' ' 7' ' ' LYS . 29.0 pt -122.33 -162.99 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.712 ' HG3' HG13 ' A' ' 6' ' ' ILE . 85.3 mttt 72.53 -69.96 0.17 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.027 0.531 . . . . 0.0 111.014 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -79.8 -34.52 39.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.892 0.854 . . . . 0.0 110.275 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.65 HG23 HG22 ' A' ' 16' ' ' VAL . 26.7 mt -88.55 100.61 10.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.314 174.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 179.64 -37.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -176.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -141.68 -158.58 0.88 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.031 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 75.3 -50.99 0.65 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.569 0.747 . . . . 0.0 111.739 176.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.625 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 72.9 m -107.55 -5.01 17.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.462 0.173 . . . . 0.0 111.263 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 69.9 mt 69.42 -74.23 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.15 0.58 . . . . 0.0 111.694 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -86.81 29.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.83 0.348 . . . . 0.0 110.929 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.65 HG22 HG23 ' A' ' 9' ' ' ILE . 3.0 p -72.94 129.02 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.504 -176.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.65 HG13 ' HB3' ' A' ' 22' ' ' GLU . 73.0 t -127.41 134.04 66.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.596 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.509 ' OE1' ' HA2' ' A' ' 5' ' ' GLY . 11.9 tp10 -66.38 -55.2 16.99 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.789 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.568 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 47.2 t30 -153.22 179.58 8.61 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -177.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.33 -31.02 68.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.766 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 2.6 mp0 -59.89 -35.82 75.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.987 0.422 . . . . 0.0 110.465 176.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.65 ' HB3' HG13 ' A' ' 17' ' ' VAL . 3.7 mm-40 -82.91 -8.03 59.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.413 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.35 107.86 15.34 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 172.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.541 ' HE2' ' O ' ' A' ' 22' ' ' GLU . 17.6 mtmt -131.19 174.03 10.44 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.991 -171.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.54 ' OE1' ' HA ' ' A' ' 121' ' ' HIS . 7.4 tp10 66.59 167.61 0.22 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.301 1.0 . . . . 0.0 110.207 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 120' ' ' GLY . . . -81.93 50.95 4.37 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.667 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.41 HG13 ' ND2' ' A' ' 60' ' ' ASN . 18.2 pt -116.45 149.39 43.64 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.727 0.299 . . . . 0.0 110.491 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.703 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 40.8 Cg_exo -60.59 168.92 6.06 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 123.217 2.611 . . . . 0.0 112.655 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.468 ' HB ' HD12 ' A' ' 89' ' ' LEU . 34.9 m -135.89 125.01 24.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.525 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.446 HD13 ' CD2' ' A' ' 59' ' ' PHE . 2.4 mp -105.63 115.04 46.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.816 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.566 ' HB ' ' HB ' ' A' ' 87' ' ' VAL . 67.6 mt -100.46 139.38 22.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.78 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.523 ' HG3' ' SD ' ' A' ' 44' ' ' MET . 2.1 tmt? -134.48 113.34 11.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.183 0.516 . . . . 0.0 109.887 171.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 91.6 m-85 -76.93 135.29 38.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.529 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.441 ' HG3' ' SG ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -142.28 153.86 44.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.289 -178.303 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -72.57 164.98 25.58 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 67' ' ' GLU . 6.6 p-10 -58.58 -45.22 89.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.681 0.276 . . . . 0.0 110.968 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -130.92 96.9 4.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.977 0.418 . . . . 0.0 111.275 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 41' ' ' CYS . 11.7 p -150.97 140.7 14.01 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.729 177.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 11.6 Cg_exo -69.94 -29.99 22.15 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.533 2.155 . . . . 0.0 112.273 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.574 ' HB3' ' HG3' ' A' ' 84' ' ' PRO . 90.2 m-85 -60.91 -26.98 67.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.095 0.474 . . . . 0.0 110.561 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . 21.5 t -60.03 -54.42 46.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.869 177.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.417 ' HA ' ' HG2' ' A' ' 45' ' ' GLN . 8.0 p -73.2 -38.13 53.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.432 -172.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.54 ' HG2' HD21 ' A' ' 102' ' ' LEU . 5.2 tp10 -61.6 -50.64 71.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.071 0.462 . . . . 0.0 110.875 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.523 ' SD ' ' HG3' ' A' ' 32' ' ' MET . 24.1 ttt -69.21 -37.25 77.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.053 0.454 . . . . 0.0 111.216 -175.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.455 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 12.9 pt20 -74.12 -31.49 62.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.354 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.912 ' HE2' ' HA ' ' A' ' 46' ' ' LYS . 8.5 mmpt? -74.26 -29.81 61.85 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.535 176.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 51' ' ' VAL . 13.4 mm-40 -62.03 -44.74 96.06 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 169.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 45' ' ' GLN . 98.1 mt -57.37 -36.99 71.92 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.313 173.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.9 t -66.19 -37.96 86.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.425 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.57 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 13.2 m-30 -65.05 -39.22 93.0 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.876 0.37 . . . . 0.0 110.177 175.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.582 HG22 ' HG3' ' A' ' 105' ' ' LYS . 44.1 t -65.11 -36.33 77.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.106 176.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.3 m -63.67 -31.8 73.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.824 178.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -66.84 -27.06 67.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.321 0.581 . . . . 0.0 110.738 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -100.77 2.58 41.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.584 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.541 ' HE ' HG12 ' A' ' 117' ' ' VAL . 21.1 tpt180 -161.23 76.63 0.54 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.427 0.632 . . . . 0.0 109.437 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -82.61 125.1 30.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.866 -172.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.405 ' O ' ' HD2' ' A' ' 58' ' ' LYS . . . 60.4 42.63 99.01 Favored Glycine 0 C--O 1.226 -0.346 0 CA-C-N 115.782 -0.644 . . . . 0.0 113.418 175.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HB2' ' HG3' ' A' ' 55' ' ' ARG . 11.7 mptt -125.31 0.56 7.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.902 0.351 . . . . 0.0 110.959 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.446 ' CD2' HD13 ' A' ' 30' ' ' ILE . 52.4 p90 -165.89 140.11 4.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.024 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.62 ' HB3' HG21 ' A' ' 17' ' ' VAL . 46.5 m-80 -82.66 131.22 35.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.375 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.7 mt -101.9 108.11 23.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 175.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.568 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 18.0 t80 -93.49 118.91 31.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.88 0.371 . . . . 0.0 110.067 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.455 ' CE1' ' HB2' ' A' ' 45' ' ' GLN . 11.8 m-85 -87.4 104.05 16.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.258 0.552 . . . . 0.0 110.707 178.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 33' ' ' PHE . . . -96.57 81.54 3.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.531 -175.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.57 HH22 ' CD ' ' A' ' 4' ' ' GLU . 19.7 ptt180 -95.28 130.48 42.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.814 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.2 tp -70.18 7.48 0.98 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.577 0.703 . . . . 0.0 110.546 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 36' ' ' ASP . 34.6 tt0 -83.03 -17.52 43.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.456 -175.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.417 ' HG3' ' HG3' ' A' ' 65' ' ' ARG . 36.1 mt-10 -103.79 -0.51 29.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -170.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.495 ' HA ' HG12 ' A' ' 72' ' ' ILE . 1.2 mp0 69.23 -36.62 0.34 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.557 0.535 . . . . 0.0 112.202 -177.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.491 ' HD2' ' ND2' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -61.05 -25.04 66.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.323 0.582 . . . . 0.0 110.729 175.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.588 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . 44.5 m-80 -86.69 -0.86 57.09 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.816 178.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.495 HG12 ' HA ' ' A' ' 69' ' ' GLU . 45.2 mm -66.66 -45.18 88.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -72.21 -49.57 34.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.425 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 71' ' ' ASN . 3.8 mm? -57.18 -38.44 73.62 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.737 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.495 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -63.7 -48.4 77.27 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.055 177.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -62.42 -37.49 86.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.128 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -53.27 -35.85 60.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.481 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -113.35 13.27 19.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.842 -176.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.9 t70 63.35 29.32 15.7 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.693 0.759 . . . . 0.0 110.749 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.45 ' O ' ' HB1' ' A' ' 75' ' ' ALA . . . -87.77 104.2 16.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.362 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -127.98 -11.22 5.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.49 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.6 mt -114.95 133.4 61.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.061 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.1 m -114.05 145.81 34.36 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.681 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.574 ' HG3' ' HB3' ' A' ' 40' ' ' TYR . 6.0 Cg_endo -85.68 157.71 59.69 Favored 'Cis proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.43 -1.487 . . . . 0.0 111.811 -0.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.6 t -153.56 137.86 16.62 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 9.5 t -124.83 140.74 52.65 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.425 0.631 . . . . 0.0 110.88 -175.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 31' ' ' ILE . 72.4 t -115.87 110.43 31.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.413 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.537 ' HB3' HD22 ' A' ' 115' ' ' LEU . 97.3 m-85 -89.84 108.34 19.64 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.526 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.55 HD23 ' HA ' ' A' ' 95' ' ' LYS . 67.3 mt -97.47 130.44 44.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.815 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.84 169.62 16.4 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.877 ' HG2' ' HG3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -61.93 -23.88 66.63 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.661 ' HB3' HD22 ' A' ' 94' ' ' ASN . 1.1 tp10 -76.53 -5.82 49.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.113 0.482 . . . . 0.0 110.022 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.65 22.46 50.22 Favored Glycine 0 N--CA 1.453 -0.185 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.599 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.661 HD22 ' HB3' ' A' ' 92' ' ' GLU . 9.0 p30 -107.24 148.64 28.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.55 ' HA ' HD23 ' A' ' 89' ' ' LEU . 4.6 ttpm? -77.19 117.81 19.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -97.37 -50.08 4.68 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.105 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.473 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 84.7 t80 -148.87 136.24 20.24 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.606 -175.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.489 HG12 HG22 ' A' ' 87' ' ' VAL . 27.5 m -113.94 148.29 16.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.76 172.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.473 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 36.6 t60 -142.83 141.24 31.57 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -111.16 121.76 46.14 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 145.76 170.78 14.78 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.981 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.54 HD21 ' HG2' ' A' ' 43' ' ' GLU . 43.8 tp -82.09 -61.56 1.87 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.465 0.65 . . . . 0.0 111.224 -177.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.526 ' O ' ' HD2' ' A' ' 104' ' ' ARG . 57.5 mtm 64.18 175.73 0.18 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.176 -1.374 . . . . 0.0 111.091 -175.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.526 ' HD2' ' O ' ' A' ' 103' ' ' MET . 10.7 mmm180 -122.61 178.15 5.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.921 173.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.582 ' HG3' HG22 ' A' ' 51' ' ' VAL . 47.1 tttm -45.53 -59.19 2.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -177.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -66.75 -28.85 68.74 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.399 -173.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -64.0 -47.99 78.15 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.627 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 61.5 mt -59.25 -47.5 90.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.796 174.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -50.57 -48.25 57.61 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.766 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 m -61.93 -41.76 98.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.867 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 63.1 mt -67.83 -37.67 78.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.204 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.63 ' HB3' HG21 ' A' ' 117' ' ' VAL . 87.2 mt -63.19 -35.45 80.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.374 . . . . 0.0 110.433 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.76 -39.8 90.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.674 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.6 m -79.46 -28.19 41.59 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.333 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.537 HD22 ' HB3' ' A' ' 88' ' ' PHE . 45.6 tp -66.25 -70.34 0.25 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.712 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 171.52 -73.54 0.1 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.605 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.703 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 11.6 t 55.61 36.52 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 122.677 1.227 . . . . 0.0 109.399 -176.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.877 ' HG3' ' HG2' ' A' ' 91' ' ' LYS . 8.2 ptmt -101.56 128.0 48.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.527 -1.669 . . . . 0.0 110.02 -177.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -92.81 110.4 21.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.863 -175.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.572 ' O ' ' HA3' ' A' ' 26' ' ' GLY . . . -117.82 93.02 0.56 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.618 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.54 ' HA ' ' OE1' ' A' ' 25' ' ' GLU . 97.6 m-70 -59.96 124.7 21.02 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.04 0.448 . . . . 0.0 110.953 -177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -82.7 81.11 8.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.938 -173.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 13.2 p80 178.66 170.58 0.83 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.204 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.502 ' HB2' ' H ' ' A' ' 126' ' ' HIS . 6.6 m80 -99.42 -151.59 0.39 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -64.2 -22.6 67.0 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 163.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.502 ' H ' ' HB2' ' A' ' 124' ' ' HIS . 48.9 t-80 . . . . . 0 C--O 1.243 0.755 0 CA-C-N 113.77 -1.559 . . . . 0.0 107.732 168.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 23.1 mmt . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.508 ' OG ' ' HB3' ' A' ' 22' ' ' GLU . 75.5 m -72.41 78.43 1.03 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.671 0.748 . . . . 0.0 112.733 -173.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 3' ' ' LEU . 1.4 tm? -113.36 99.48 7.81 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 166.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.478 ' HB2' ' HG2' ' A' ' 8' ' ' GLN . 15.2 pt-20 -65.54 -38.18 88.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.323 -168.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.82 -60.19 4.41 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.018 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.9 tp -106.97 146.61 13.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.437 ' HA ' ' OE1' ' A' ' 4' ' ' GLU . 12.8 tptp -68.22 99.87 0.96 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.995 0.426 . . . . 0.0 110.751 -176.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.478 ' HG2' ' HB2' ' A' ' 4' ' ' GLU . 17.9 pt20 -124.51 -4.35 7.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.554 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.439 HG12 ' OE1' ' A' ' 4' ' ' GLU . 25.1 pt -113.58 149.76 15.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.858 173.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -106.05 -172.66 2.13 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.064 0.459 . . . . 0.0 111.626 -172.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.511 ' O ' ' HB3' ' A' ' 12' ' ' GLN . 32.1 p90 -88.41 -165.63 1.38 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.393 173.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.511 ' HB3' ' O ' ' A' ' 11' ' ' PHE . 30.6 tt0 72.94 -63.73 0.42 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -175.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.596 ' HB3' HG21 ' A' ' 16' ' ' VAL . 34.4 m -80.44 90.68 5.65 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.421 173.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.0 mt -93.22 -65.3 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.215 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 14.2 m-80 -81.08 59.21 3.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.02 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.699 ' HB ' ' HE2' ' A' ' 63' ' ' TYR . 16.6 m -131.98 151.4 35.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.085 0.469 . . . . 0.0 111.774 -173.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.498 HG11 ' HB2' ' A' ' 23' ' ' ALA . 4.2 p -146.31 164.24 9.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.114 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -90.94 -54.26 4.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.985 0.422 . . . . 0.0 110.999 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.796 ' HA ' ' CE2' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -130.67 162.89 28.41 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.683 -170.384 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.674 HD22 ' CE2' ' A' ' 62' ' ' TYR . 2.0 mm? -65.36 -35.17 80.15 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.598 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 1.7 pm0 -67.09 -23.52 65.86 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.346 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.508 ' HB3' ' OG ' ' A' ' 2' ' ' SER . 21.7 mm-40 -87.51 -8.65 56.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.561 172.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.498 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -121.29 172.51 7.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.562 0.696 . . . . 0.0 112.133 -170.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.763 ' NZ ' ' HA ' ' A' ' 24' ' ' LYS . 2.3 tpmp? -140.21 160.39 40.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.522 176.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -87.87 179.3 6.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.985 0.422 . . . . 0.0 110.936 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.69 -29.94 10.17 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -174.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.616 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -117.95 134.18 23.32 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 172.657 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 1.048 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 75.2 Cg_exo -52.54 136.77 57.62 Favored 'Trans proline' 0 CA--C 1.517 -0.356 0 C-N-CA 123.092 2.528 . . . . 0.0 112.424 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.562 ' HB ' HD12 ' A' ' 89' ' ' LEU . 23.6 m -108.69 119.76 40.47 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.207 0.527 . . . . 0.0 111.199 -174.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.417 HD12 ' N ' ' A' ' 30' ' ' ILE . 4.1 mp -99.32 107.17 20.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.801 HG12 ' HB3' ' A' ' 62' ' ' TYR . 50.0 mt -95.74 111.91 27.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 120.731 0.301 . . . . 0.0 110.75 -177.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 25.2 ptm -118.42 136.65 53.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.157 0.503 . . . . 0.0 109.828 175.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.557 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 37.3 m-85 -91.18 132.3 36.17 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.502 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.627 ' HE2' ' HB3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -130.9 139.53 50.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.158 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.0 m -78.09 161.38 27.45 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.494 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 15.1 t70 -68.54 103.33 1.66 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.2 m 73.51 89.44 0.09 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.92 -175.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.9 p -148.06 127.16 6.28 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.567 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.22 -33.66 5.54 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.285 1.99 . . . . 0.0 114.084 -173.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -67.47 -25.17 65.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.806 0.336 . . . . 0.0 111.165 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.578 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 97.6 m -80.06 -35.98 36.27 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.053 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 65.0 t -64.8 -34.85 72.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.82 176.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -57.01 -45.97 82.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.281 175.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.6 ttt -69.11 -31.19 69.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.737 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.578 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 20.5 mt-30 -59.84 -40.12 87.42 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 110.117 176.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -56.16 -53.36 57.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.608 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 51' ' ' VAL . 57.2 mm-40 -56.99 -47.23 81.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.77 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.74 HD13 HD13 ' A' ' 61' ' ' ILE . 91.3 mt -58.62 -36.9 74.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.472 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.4 t -66.59 -37.58 85.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.99 0.424 . . . . 0.0 110.13 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.425 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 30.5 m-85 -70.34 -36.44 74.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.517 177.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 47' ' ' GLU . 22.4 t -67.95 -31.82 53.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 175.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.5 m -62.97 -32.92 74.35 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.025 174.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.479 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 27.2 mmtm -73.35 -15.79 61.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.138 0.494 . . . . 0.0 110.725 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -87.51 -40.08 14.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.687 173.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.667 ' HG3' ' HG3' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -133.09 75.39 1.62 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.617 -175.236 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 5.8 tp10 -82.44 134.46 35.23 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 120.905 0.383 . . . . 0.0 111.356 -171.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.57 41.22 95.44 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.255 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.667 ' HG3' ' HG3' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -123.08 -9.1 8.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.776 0.322 . . . . 0.0 110.856 -174.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.55 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 10.2 p90 -156.68 -176.84 6.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.6 -177.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 29' ' ' THR . 57.2 t30 -144.83 132.99 21.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.896 178.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.74 HD13 HD13 ' A' ' 48' ' ' LEU . 71.6 mt -105.38 114.24 44.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.565 -176.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.801 ' HB3' HG12 ' A' ' 31' ' ' ILE . 4.5 t80 -84.18 115.82 22.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.699 ' HE2' ' HB ' ' A' ' 16' ' ' VAL . 76.1 m-85 -93.38 110.82 22.36 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.054 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.666 ' HB2' ' HE1' ' A' ' 62' ' ' TYR . . . -86.39 102.72 14.29 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 121.255 -0.178 . . . . 0.0 110.793 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.627 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 8.7 ptm180 -78.01 114.48 16.92 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.876 176.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.4 tp -67.92 10.95 0.17 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.061 0.458 . . . . 0.0 110.836 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 65' ' ' ARG . 3.8 tp10 -84.34 -42.35 15.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.19 0.519 . . . . 0.0 110.424 -175.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.576 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 30.5 mm-40 -93.54 173.58 7.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.08 -172.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.413 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -86.22 -31.88 21.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.856 -176.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HD2' ' H ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -60.15 -33.15 71.78 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.241 0.543 . . . . 0.0 110.371 178.521 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.576 ' OD1' ' HB2' ' A' ' 68' ' ' GLU . 5.0 m120 -80.19 -17.35 52.63 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.416 -178.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 69' ' ' GLU . 75.1 mt -70.88 -42.76 77.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -59.86 -48.95 79.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.626 173.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.435 ' HG ' ' OH ' ' A' ' 62' ' ' TYR . 1.2 tm? -55.77 -47.34 77.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.315 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.557 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -53.9 -52.15 61.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.854 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -73.27 -34.84 66.01 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.527 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.432 ' HB2' ' HE3' ' A' ' 77' ' ' LYS . 27.1 ttmt -63.49 -32.86 74.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.241 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -102.73 -0.53 31.47 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.669 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.1 t70 67.64 40.65 2.47 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.704 0.764 . . . . 0.0 111.095 174.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.48 102.84 4.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.946 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -107.26 -31.95 8.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.351 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.808 HD13 ' H ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -85.05 159.06 3.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.798 0.332 . . . . 0.0 110.947 -178.65 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.1 m -119.42 145.27 38.37 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.719 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -95.25 118.25 2.03 Favored 'Cis proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.637 -1.401 . . . . 0.0 112.517 -1.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.654 HG22 ' HB3' ' A' ' 100' ' ' GLN . 1.2 p -97.9 143.46 28.47 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 173.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.1 m -135.49 121.05 19.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.179 0.514 . . . . 0.0 111.151 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.686 HG12 HG12 ' A' ' 98' ' ' VAL . 20.3 m -112.6 126.65 70.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.003 176.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.562 ' HB3' HD22 ' A' ' 115' ' ' LEU . 94.8 m-85 -98.48 118.61 35.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.829 -174.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.562 HD12 ' HB ' ' A' ' 29' ' ' THR . 10.4 mt -107.57 139.61 41.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.037 -177.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.435 ' OD2' ' HG2' ' A' ' 92' ' ' GLU . 25.0 t70 -63.51 171.48 2.53 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 171.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.585 ' HG3' ' HG2' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -62.36 -16.45 54.64 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 122.015 -0.428 . . . . 0.0 111.84 -176.261 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.435 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 16.9 mm-40 -72.94 -23.69 60.71 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.954 0.407 . . . . 0.0 110.753 175.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.74 17.53 35.41 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -170.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.443 HD22 ' N ' ' A' ' 94' ' ' ASN . 0.9 OUTLIER -90.15 126.24 35.73 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -179.575 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -72.34 112.87 8.79 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.174 0.296 . . . . 0.0 110.511 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -100.67 -54.58 2.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.746 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 87.6 t80 -124.84 141.84 51.85 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.195 -175.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.686 HG12 HG12 ' A' ' 87' ' ' VAL . 30.0 m -121.65 139.64 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.553 176.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.576 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 8.2 t60 -151.17 139.86 20.72 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.654 ' HB3' HG22 ' A' ' 85' ' ' THR . 9.1 pt20 -130.04 139.52 50.99 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.014 0.435 . . . . 0.0 110.804 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.48 -172.35 18.16 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.6 tp -93.66 130.17 39.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.908 0.354 . . . . 0.0 110.162 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 71.8 mtm -127.08 165.38 19.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.192 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.466 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 37.3 mmt180 -114.34 175.51 5.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.741 178.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.567 ' O ' ' HG3' ' A' ' 109' ' ' GLU . 58.0 tttm -45.78 -59.36 2.83 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.106 0.962 . . . . 0.0 112.835 -175.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.549 ' HA ' ' OE1' ' A' ' 109' ' ' GLU . 29.0 t-20 -64.66 -28.88 69.91 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -174.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.502 ' O ' HG12 ' A' ' 111' ' ' ILE . 10.7 m120 -65.4 -45.34 84.35 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.55 HD13 HD23 ' A' ' 48' ' ' LEU . 50.3 mt -64.97 -42.52 94.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.933 176.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 105' ' ' LYS . 81.0 mt-10 -51.91 -48.96 63.94 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.887 176.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.0 m -64.39 -42.24 96.23 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.778 -177.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 107' ' ' ASN . 48.7 mm -67.37 -47.81 79.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.184 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.551 ' HB3' HG21 ' A' ' 117' ' ' VAL . 81.0 mt -65.32 -34.45 78.37 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 110.806 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -60.41 -37.99 82.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.412 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.7 m -85.15 -35.93 21.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.165 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.562 HD22 ' HB3' ' A' ' 88' ' ' PHE . 34.7 tp -57.13 -72.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.102 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -176.66 -80.75 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.767 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.048 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 22.9 t 53.04 71.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 121.662 0.744 . . . . 0.0 109.537 -175.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -165.36 146.7 7.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.373 -168.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.585 ' HG2' ' HG3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -174.44 168.13 3.89 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 166.59 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.82 -8.45 49.83 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.866 -176.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -80.05 78.6 6.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.17 0.51 . . . . 0.0 109.881 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -136.99 128.89 29.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.767 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -77.99 88.49 4.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.615 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 36.4 m80 61.31 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 O-C-N 123.762 0.664 . . . . 0.0 110.593 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -161.5 16.54 0.1 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 . . . . . 0 C--O 1.25 1.104 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.174 -176.144 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.4 ttp . . . . . 0 N--CA 1.478 0.954 0 CA-C-O 120.989 0.423 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 m -75.14 -30.72 60.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.369 -174.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 3' ' ' LEU . 3.4 mm? -116.33 136.78 52.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.85 0.357 . . . . 0.0 111.124 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.634 ' OE1' ' HB2' ' A' ' 7' ' ' LYS . 65.5 mt-10 -118.51 -172.72 2.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.997 177.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -119.32 15.13 10.85 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 172.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.402 HG13 ' H ' ' A' ' 7' ' ' LYS . 10.8 pt -135.74 -55.26 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.634 ' HB2' ' OE1' ' A' ' 4' ' ' GLU . 9.4 mtmp? -110.41 -62.5 1.51 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.201 -0.312 . . . . 0.0 111.105 -174.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.447 ' HB2' ' HG3' ' A' ' 4' ' ' GLU . 28.7 mt-30 -74.74 77.1 2.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.241 0.543 . . . . 0.0 111.825 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.445 HD12 ' HB3' ' A' ' 13' ' ' SER . 3.0 pt -135.49 -36.97 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.246 171.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.8 m120 66.9 -139.91 0.14 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.072 171.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -58.21 155.9 10.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.07 -0.513 . . . . 0.0 112.149 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 70.85 -2.93 2.13 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.098 -175.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.658 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . 22.7 m -140.8 -86.99 0.18 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.0 mt 69.52 -78.24 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 123.047 0.539 . . . . 0.0 111.042 -171.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -113.98 16.56 18.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.524 0.678 . . . . 0.0 109.265 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.658 ' CG2' ' HA ' ' A' ' 13' ' ' SER . 51.5 t -76.27 125.32 35.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.433 175.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.519 HG22 ' HB2' ' A' ' 22' ' ' GLU . 4.6 p -111.52 134.9 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-O 121.592 0.711 . . . . 0.0 110.374 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -61.47 -54.45 43.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.543 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.539 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -131.69 158.83 40.08 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.369 -177.009 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.65 -29.75 69.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.798 0.332 . . . . 0.0 110.585 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.5 pm0 -73.38 -23.51 60.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.405 177.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.519 ' HB2' HG22 ' A' ' 17' ' ' VAL . 29.3 mm-40 -67.01 -18.96 65.62 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.008 0.432 . . . . 0.0 110.492 173.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.515 ' HB1' HD11 ' A' ' 27' ' ' ILE . . . -91.71 113.59 25.9 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -122.38 -6.47 8.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.705 0.764 . . . . 0.0 112.165 -173.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.532 ' HB2' HD12 ' A' ' 27' ' ' ILE . 3.8 mp0 -76.05 170.94 15.31 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.383 178.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.48 55.32 4.99 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.385 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.625 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -114.65 143.41 29.93 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.792 0.33 . . . . 0.0 111.357 -173.277 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 1.003 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 60.5 Cg_exo -56.65 151.36 47.49 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.696 2.264 . . . . 0.0 111.649 170.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.0 m -112.7 111.21 21.84 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.787 -175.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.6 mm -102.99 124.76 57.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.757 HG12 ' HB3' ' A' ' 62' ' ' TYR . 54.3 mt -125.04 115.46 44.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.069 -173.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.456 ' SD ' ' NZ ' ' A' ' 34' ' ' LYS . 2.1 tmt? -112.07 124.36 52.24 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.619 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 53.8 m-85 -87.38 144.57 26.7 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.899 -175.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.936 ' HE3' ' HB3' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -149.44 171.24 16.89 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -178.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.0 t -122.69 -174.44 2.92 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.02 -62.88 1.53 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.229 0.537 . . . . 0.0 110.569 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.2 m -93.76 90.92 6.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.075 -176.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.484 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 20.1 p -158.88 121.15 1.94 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.91 0.386 . . . . 0.0 111.388 175.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 2.9 Cg_exo -75.34 -16.48 19.45 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.53 2.153 . . . . 0.0 112.429 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -64.44 -26.12 68.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.009 0.433 . . . . 0.0 110.637 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.653 ' SG ' ' HD3' ' A' ' 34' ' ' LYS . 53.4 t -67.42 -44.41 78.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.679 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.518 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 7.6 p -74.76 -30.35 24.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.779 0.323 . . . . 0.0 110.756 -176.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -69.7 -49.0 57.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.813 0.339 . . . . 0.0 110.323 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.423 ' HG3' ' OE1' ' A' ' 47' ' ' GLU . 3.5 ttt -69.43 -28.45 66.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.991 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -53.32 -45.02 68.86 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.223 171.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 81.9 mttt -58.12 -53.81 54.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.964 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.432 ' O ' HG23 ' A' ' 51' ' ' VAL . 52.7 mt-10 -57.43 -50.65 72.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.919 -178.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 48.6 mt -61.39 -42.95 99.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.638 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 13.9 t -66.81 -32.94 74.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.369 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.44 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 16.6 m-85 -66.9 -43.08 84.31 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.774 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 47' ' ' GLU . 51.0 t -60.3 -52.22 63.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-O 121.223 0.535 . . . . 0.0 110.016 176.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.8 m -59.4 -29.35 67.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.552 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.457 ' HZ3' ' HB2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -67.51 -16.91 64.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.518 -179.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -120.44 8.94 10.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.286 0.565 . . . . 0.0 109.791 177.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.713 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 8.0 ttm-85 -151.38 76.9 1.23 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.356 -175.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.418 ' OE2' ' HE1' ' A' ' 124' ' ' HIS . 1.7 pm0 -82.32 124.77 30.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.83 -169.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.11 25.92 54.89 Favored Glycine 0 CA--C 1.518 0.249 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.333 176.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.713 ' HB2' ' HG2' ' A' ' 55' ' ' ARG . 55.7 mmtt -96.2 -5.68 39.92 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.719 0.771 . . . . 0.0 108.927 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.554 ' HB3' HG13 ' A' ' 117' ' ' VAL . 28.7 p90 -170.79 136.49 1.18 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.042 175.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -95.05 131.33 41.15 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.7 mt -89.64 107.7 18.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.096 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.757 ' HB3' HG12 ' A' ' 31' ' ' ILE . 3.8 t80 -88.43 112.62 23.14 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.936 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 50.3 m-85 -91.73 102.9 15.52 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.589 178.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.92 93.59 4.43 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.975 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.646 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 11.0 ptt180 -89.3 118.25 28.85 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.27 0.557 . . . . 0.0 111.272 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.485 HD22 HD13 ' A' ' 72' ' ' ILE . 53.4 mt -72.77 11.51 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.02 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.528 ' OE1' ' HD2' ' A' ' 65' ' ' ARG . 23.9 tt0 -66.4 -33.64 76.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.871 174.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -106.85 177.2 4.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.351 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.53 -27.0 22.88 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.1 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.572 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -57.6 -33.5 68.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.423 -176.296 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.572 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 68.6 m-80 -90.23 2.39 55.47 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.983 -174.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.485 HD13 HD22 ' A' ' 66' ' ' LEU . 49.7 mm -71.17 -54.44 17.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 172.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -65.23 -41.87 93.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.253 175.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.477 ' HB3' ' HA ' ' A' ' 71' ' ' ASN . 1.3 tm? -57.37 -42.61 82.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.101 177.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.619 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -53.17 -53.16 54.64 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.462 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -67.3 -34.3 77.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.771 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -62.76 -21.44 65.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.063 0.458 . . . . 0.0 111.588 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.508 ' CD2' HG11 ' A' ' 87' ' ' VAL . 52.3 m-85 -119.73 19.32 12.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.643 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 65.13 17.02 10.88 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.801 0.688 . . . . 0.0 111.37 168.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.458 ' O ' ' HB1' ' A' ' 75' ' ' ALA . . . -123.91 102.17 7.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.079 0.466 . . . . 0.0 111.605 -171.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -113.61 9.21 17.85 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.207 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.9 pt -125.23 171.36 14.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.875 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.57 136.99 19.39 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.229 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -87.26 150.61 38.32 Favored 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 123.65 -1.396 . . . . 0.0 112.667 -0.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 15.1 m -150.26 124.6 9.53 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 88.3 m -122.15 122.89 40.26 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.314 0.578 . . . . 0.0 110.936 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.62 HG23 ' HB ' ' A' ' 98' ' ' VAL . 11.2 p -100.16 132.32 45.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.635 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 1.02 ' HB3' HD11 ' A' ' 115' ' ' LEU . 86.2 m-85 -106.04 108.8 20.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.799 -175.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.49 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 5.5 mp -111.97 138.82 48.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.786 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -80.65 -176.75 5.94 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.601 ' HE2' ' HE2' ' A' ' 118' ' ' LYS . 0.5 OUTLIER -60.57 -22.22 63.45 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -172.494 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 -75.85 -12.54 60.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.72 0.295 . . . . 0.0 111.295 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.443 ' O ' HD23 ' A' ' 89' ' ' LEU . . . 85.42 21.06 55.51 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.784 -176.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 92.0 m-20 -92.27 125.36 36.9 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.971 -0.134 . . . . 0.0 110.703 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.49 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 54.2 mtmt -70.5 93.84 0.93 Allowed 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.453 ' HB3' ' CD2' ' A' ' 115' ' ' LEU . 87.6 t80 -83.58 -39.4 20.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.817 0.342 . . . . 0.0 110.338 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.597 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 71.2 t80 -154.04 127.07 8.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.716 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.62 ' HB ' HG23 ' A' ' 87' ' ' VAL . 7.6 p -114.3 133.42 60.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.597 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 49.5 t60 -139.31 137.76 36.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -172.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -110.41 158.18 18.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.825 0.345 . . . . 0.0 111.075 178.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.1 -173.85 20.15 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.028 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.6 tp -104.17 149.59 25.12 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 16.8 ptm -164.8 125.62 2.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.724 -0.216 . . . . 0.0 110.441 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -58.04 163.77 2.63 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.625 -173.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.44 ' HD2' ' HB3' ' A' ' 50' ' ' TYR . 13.6 ptmm? -50.59 -44.43 56.88 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.237 -174.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.404 ' N ' ' HG3' ' A' ' 105' ' ' LYS . 18.8 m120 -63.48 -34.24 77.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.383 0.611 . . . . 0.0 110.932 -176.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -74.11 -40.18 62.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.394 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.496 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 73.8 mt -59.32 -46.27 92.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.246 171.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -58.05 -35.56 71.51 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.004 178.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.5 m -63.92 -41.46 97.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.001 0.429 . . . . 0.0 110.434 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.9 mm -70.89 -41.91 77.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.179 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.565 ' HB3' HG21 ' A' ' 117' ' ' VAL . 85.8 mt -57.53 -41.97 81.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.446 176.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -59.53 -37.11 77.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.803 176.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.1 m -70.37 -24.89 63.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.101 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 1.02 HD11 ' HB3' ' A' ' 88' ' ' PHE . 27.1 mt -81.28 -73.62 0.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 122.095 0.95 . . . . 0.0 109.788 175.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 162.87 -63.47 0.26 Allowed Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -175.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.003 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 48.8 t 52.85 73.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.579 0.704 . . . . 0.0 111.782 172.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.601 ' HE2' ' HE2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -173.93 154.18 2.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.609 -178.487 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.95 -45.84 6.77 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -123.56 179.16 16.22 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.462 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -78.34 81.8 4.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.998 0.399 . . . . 0.0 110.711 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.0 t60 39.5 85.34 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 O-C-N 124.467 1.105 . . . . 0.0 112.893 169.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -119.1 85.78 2.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.598 0.713 . . . . 0.0 112.293 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.418 ' HE1' ' OE2' ' A' ' 56' ' ' GLU . 8.5 m170 -150.9 13.36 0.7 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.374 -1.284 . . . . 0.0 108.599 172.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -110.44 150.43 28.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.171 -176.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 . . . . . 0 C--O 1.245 0.821 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.022 -179.341 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 m 57.8 45.63 18.33 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.713 0.633 . . . . 0.0 112.133 173.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 pp -106.46 165.5 11.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.796 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -80.65 -90.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.501 ' H ' ' HB2' ' A' ' 10' ' ' ASN . . . 84.31 -10.81 60.2 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.575 ' O ' ' HB3' ' A' ' 7' ' ' LYS . 19.5 pt -154.05 152.21 10.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.575 ' HB3' ' O ' ' A' ' 6' ' ' ILE . 29.5 tttm 72.6 -46.21 0.64 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.653 0.596 . . . . 0.0 109.926 -174.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -135.99 138.81 42.64 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 170.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 9.6 tp -67.42 134.66 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.253 0.549 . . . . 0.0 111.599 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.501 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 0.6 OUTLIER -141.48 161.11 38.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.001 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.6 p90 57.92 -17.74 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.577 1.551 . . . . 0.0 114.889 174.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 13' ' ' SER . 16.2 mm100 -78.84 95.67 5.45 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 171.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' A' ' 49' ' ' SER . 49.0 m 78.57 134.45 0.06 Allowed 'General case' 0 C--O 1.228 -0.074 0 O-C-N 124.506 1.129 . . . . 0.0 110.45 -172.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.7 mt -80.85 -20.63 11.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.531 0.681 . . . . 0.0 109.941 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 47.2 m-80 -94.0 25.06 3.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.606 176.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.412 HG23 ' HE2' ' A' ' 63' ' ' TYR . 7.5 p -63.87 138.96 22.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.641 -173.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.474 HG21 ' HB3' ' A' ' 60' ' ' ASN . 76.0 t -137.93 123.65 25.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.798 175.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -76.13 -55.52 5.51 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.603 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.783 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 59.0 t30 -140.18 -179.38 5.95 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.579 HD11 HD11 ' A' ' 74' ' ' LEU . 83.7 mt -50.39 -32.6 17.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.419 ' CD ' ' HB3' ' A' ' 19' ' ' ASN . 6.7 pm0 -63.41 -39.64 95.04 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.674 0.249 . . . . 0.0 111.674 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.408 ' OE1' ' HG2' ' A' ' 21' ' ' GLU . 55.7 mp0 -81.52 4.51 21.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.808 175.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.36 171.04 10.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.941 0.4 . . . . 0.0 111.957 -175.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.507 ' HE2' ' OD1' ' A' ' 60' ' ' ASN . 23.1 mtmm -148.57 173.25 13.36 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -120.51 -179.56 4.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.677 0.275 . . . . 0.0 111.378 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.09 -47.74 2.68 Favored Glycine 0 C--N 1.332 0.355 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.044 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.765 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -100.19 146.66 32.33 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 175.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 1.06 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 84.2 Cg_exo -51.02 158.66 3.04 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.197 2.598 . . . . 0.0 112.436 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.489 HG23 ' HB2' ' A' ' 60' ' ' ASN . 41.7 m -131.44 126.15 34.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.244 0.545 . . . . 0.0 111.43 -175.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.541 HD11 HD21 ' A' ' 112' ' ' LEU . 63.5 mt -98.76 111.52 28.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.495 176.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.614 ' HB ' ' HB ' ' A' ' 87' ' ' VAL . 6.0 mm -91.01 107.81 19.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.417 ' HA ' ' O ' ' A' ' 85' ' ' THR . 21.0 ttt -111.71 107.74 16.94 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.311 0.576 . . . . 0.0 110.647 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.681 ' CE1' ' HA ' ' A' ' 75' ' ' ALA . 87.0 m-85 -72.64 133.12 44.5 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.179 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 1.072 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 60.1 pttt -133.84 179.88 5.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.147 -176.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -137.39 -174.56 3.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.469 0.176 . . . . 0.0 110.589 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -77.33 -17.94 57.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.507 0.67 . . . . 0.0 110.548 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.4 m -143.64 101.97 3.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.873 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 2.2 p -160.13 101.68 1.41 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.986 0.422 . . . . 0.0 112.021 -176.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.8 -32.99 13.33 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.07 1.846 . . . . 0.0 112.655 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -70.51 -23.12 62.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.964 0.411 . . . . 0.0 110.749 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 79.7 m -79.15 -43.62 23.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.956 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.513 ' HA ' HE21 ' A' ' 45' ' ' GLN . 12.0 p -65.5 -31.03 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.484 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.749 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 8.5 tp10 -58.38 -50.04 75.08 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.347 0.594 . . . . 0.0 110.283 175.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 21.0 ttt -73.62 -29.3 62.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.86 -177.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.556 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 49.1 mt-30 -62.56 -33.75 75.58 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.692 0.282 . . . . 0.0 110.65 175.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.749 ' HE2' ' HA ' ' A' ' 43' ' ' GLU . 47.3 mtmt -65.29 -47.05 77.99 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.642 ' O ' HG23 ' A' ' 51' ' ' VAL . 62.5 mm-40 -56.04 -52.21 65.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.849 177.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.5 ' HB3' HD13 ' A' ' 61' ' ' ILE . 90.0 mt -56.9 -33.58 67.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.171 178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 8.7 t -65.83 -43.56 88.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.023 0.44 . . . . 0.0 109.854 177.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -68.03 -34.27 76.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.706 178.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.745 HG22 ' HG3' ' A' ' 105' ' ' LYS . 34.4 t -65.35 -39.54 85.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 175.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.7 m -61.77 -30.57 70.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.691 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -59.3 -43.09 92.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.049 0.452 . . . . 0.0 110.132 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -82.22 -50.5 8.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.757 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.435 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -99.11 74.06 1.95 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.281 0.562 . . . . 0.0 109.761 -175.257 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.67 119.06 25.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.255 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.55 47.09 36.27 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.23 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.454 ' HD3' ' HA ' ' A' ' 58' ' ' LYS . 36.5 mmtm -132.64 -7.43 3.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.657 0.265 . . . . 0.0 111.31 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.495 ' O ' ' HB3' ' A' ' 15' ' ' ASN . 0.9 OUTLIER -163.92 155.55 16.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.667 177.141 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.507 ' OD1' ' HE2' ' A' ' 24' ' ' LYS . 36.9 m-80 -96.39 132.36 42.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 171.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.5 HD13 ' HB3' ' A' ' 48' ' ' LEU . 71.2 mt -107.16 105.32 18.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.533 173.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.783 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 1.1 t80 -101.17 111.75 24.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.133 0.492 . . . . 0.0 110.025 -177.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.626 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 73.1 m-85 -90.77 102.58 15.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.978 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.501 ' HB1' ' HB3' ' A' ' 71' ' ' ASN . . . -85.29 97.0 9.7 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 121.184 -0.206 . . . . 0.0 110.801 -177.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 1.072 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 32.8 ptt180 -76.7 114.86 15.92 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.831 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.5 mp -63.7 11.71 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.141 0.496 . . . . 0.0 111.742 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.578 ' H ' ' C ' ' A' ' 65' ' ' ARG . 62.3 tt0 -77.26 -31.41 54.91 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.185 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -112.77 148.14 35.42 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.749 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -65.65 -20.86 66.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.914 -172.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.589 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -63.45 -33.45 75.59 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.214 0.531 . . . . 0.0 110.485 -178.078 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.589 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 4.1 m120 -85.99 -17.65 34.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.571 -173.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.3 mt -69.85 -42.85 80.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -65.08 -40.64 94.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.168 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.579 HD11 HD11 ' A' ' 20' ' ' LEU . 2.3 mm? -62.71 -38.86 92.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.896 175.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.681 ' HA ' ' CE1' ' A' ' 33' ' ' PHE . . . -54.41 -52.37 61.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.439 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -64.95 -33.39 75.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.478 -178.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 mtmm -64.96 -16.27 63.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.964 0.412 . . . . 0.0 111.176 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.672 ' HB3' HG21 ' A' ' 87' ' ' VAL . 60.6 m-85 -119.66 15.48 12.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.664 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 65.57 21.99 11.74 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.666 0.604 . . . . 0.0 110.845 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.41 163.2 14.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.954 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -158.45 -36.97 0.07 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.948 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.1 pt -117.95 -176.14 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.985 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.74 147.08 55.58 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.186 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.65 155.42 80.6 Favored 'Cis proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.648 -1.397 . . . . 0.0 111.802 -0.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.586 HG23 ' HG3' ' A' ' 100' ' ' GLN . 88.3 m -144.12 110.19 5.39 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.8 p -102.12 113.69 27.17 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.082 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.672 HG21 ' HB3' ' A' ' 78' ' ' TYR . 85.1 t -100.65 109.88 26.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.319 176.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -89.67 105.86 18.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.139 0.495 . . . . 0.0 110.492 -178.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 95' ' ' LYS . 46.8 mt -99.13 148.89 23.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.132 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.402 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 7.3 t70 -83.6 -166.01 1.27 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -59.92 -32.45 70.78 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -170.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -105.81 10.72 32.52 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.01 0.433 . . . . 0.0 110.773 -173.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.64 20.15 45.38 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.163 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -68.32 116.93 9.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.012 0.406 . . . . 0.0 110.433 176.258 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.546 ' HA ' HD23 ' A' ' 89' ' ' LEU . 39.7 ttmt -74.1 89.09 1.95 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.601 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -89.27 -47.18 8.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.246 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.52 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 77.9 t80 -144.54 111.26 5.72 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.747 -177.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.449 HG23 HG22 ' A' ' 87' ' ' VAL . 2.2 p -103.18 134.46 44.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 172.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.52 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 17.3 t60 -138.24 126.64 23.21 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -175.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.586 ' HG3' HG23 ' A' ' 85' ' ' THR . 24.1 mp0 -96.63 140.09 31.75 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 123.611 0.569 . . . . 0.0 109.733 174.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.98 162.68 18.01 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.515 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.2 tp -73.95 141.04 45.95 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 122.522 0.329 . . . . 0.0 111.429 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 60.0 mtm -135.63 159.47 41.52 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 171.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -97.14 164.51 12.47 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.745 ' HG3' HG22 ' A' ' 51' ' ' VAL . 61.0 tttm -46.92 -52.37 14.69 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -175.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 25.7 t-20 -58.45 -32.82 69.08 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -177.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.541 ' O ' HG12 ' A' ' 111' ' ' ILE . 10.8 m120 -65.04 -46.35 81.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.441 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 41.5 mt -61.9 -43.93 98.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.836 176.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 105' ' ' LYS . 79.3 mm-40 -49.58 -47.21 49.56 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.015 176.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 m -72.11 -39.47 68.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.087 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 107' ' ' ASN . 48.5 mm -65.1 -44.54 95.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.875 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.718 ' HB3' HG21 ' A' ' 117' ' ' VAL . 82.8 mt -63.52 -38.73 92.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.068 0.461 . . . . 0.0 110.279 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -58.23 -41.15 83.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.892 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.9 m -85.13 -8.38 58.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.712 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 tp -85.01 -86.62 0.13 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.016 0.436 . . . . 0.0 109.842 176.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -179.03 -60.44 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.06 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 40.8 t 57.51 64.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 122.028 0.918 . . . . 0.0 110.756 177.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 119' ' ' GLU . 7.5 ptmt -164.14 162.02 22.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.114 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.411 ' O ' ' HE3' ' A' ' 118' ' ' LYS . 4.1 tm-20 -93.36 145.85 24.17 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 173.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.601 ' O ' ' HB2' ' A' ' 121' ' ' HIS . . . -50.75 -70.01 0.96 Allowed Glycine 0 C--N 1.331 0.301 0 O-C-N 123.372 0.42 . . . . 0.0 112.983 -174.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.601 ' HB2' ' O ' ' A' ' 120' ' ' GLY . 19.2 t-80 163.54 76.37 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.805 0.842 . . . . 0.0 109.24 175.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -57.27 138.33 54.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.092 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 42.9 t60 71.79 90.99 0.09 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.636 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 64.84 104.42 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.451 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -67.98 -42.05 81.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.048 0.451 . . . . 0.0 110.2 178.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 . . . . . 0 C--O 1.245 0.851 0 CA-C-O 118.373 -0.823 . . . . 0.0 109.179 178.423 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.483 1.219 0 CA-C-O 120.545 0.212 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.1 m -104.76 108.14 19.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.839 0.352 . . . . 0.0 110.812 -176.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 3' ' ' LEU . 2.2 mp -111.77 -29.96 7.49 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 8' ' ' GLN . 10.6 mp0 -90.34 33.55 0.89 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.887 -176.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 81.44 -72.41 2.76 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.39 -174.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.575 HG13 ' HG2' ' A' ' 7' ' ' LYS . 8.4 tp -176.42 128.09 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.703 0.287 . . . . 0.0 110.58 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.823 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 10.6 mmpt? 63.76 16.88 10.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.704 176.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.484 ' HA ' ' HB2' ' A' ' 4' ' ' GLU . 79.5 mt-30 56.11 95.55 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.72 0.637 . . . . 0.0 111.969 -177.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 tt -115.37 103.8 15.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.202 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 40.5 t30 71.37 118.08 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.509 0.671 . . . . 0.0 112.534 172.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -100.0 -10.36 21.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.637 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -72.37 -47.26 50.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.948 0.404 . . . . 0.0 110.72 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.7 m -92.91 108.29 19.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.174 0.511 . . . . 0.0 109.71 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.554 HG22 ' HB3' ' A' ' 52' ' ' SER . 1.1 tt -74.53 -8.42 11.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.484 -172.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -111.76 37.35 2.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.544 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.496 HG23 ' CD1' ' A' ' 63' ' ' TYR . 8.0 p -82.72 140.54 16.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.684 -176.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.409 HG21 HD21 ' A' ' 60' ' ' ASN . 3.8 p -139.6 159.92 27.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.485 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 19' ' ' ASN . 5.1 tp10 -83.53 -55.89 4.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.207 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.649 ' HA ' ' CE2' ' A' ' 62' ' ' TYR . 5.9 t-20 -142.59 169.07 18.26 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.543 -169.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.77 -32.35 73.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.355 176.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -63.34 -24.39 67.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.72 0.771 . . . . 0.0 109.943 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -97.65 10.28 40.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.645 -177.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -109.58 145.45 36.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.186 -177.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -97.38 154.09 17.68 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 174.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.47 177.34 3.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.661 177.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . 89.53 -55.13 3.84 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.535 174.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 24.9 pt -84.51 134.83 41.78 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.913 0.387 . . . . 0.0 110.495 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 1.0 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 48.2 Cg_exo -59.14 144.49 99.36 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.783 2.322 . . . . 0.0 111.338 176.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.461 ' HB ' HD12 ' A' ' 89' ' ' LEU . 25.1 m -110.55 122.13 47.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.151 0.5 . . . . 0.0 111.185 -175.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.6 mt -104.39 108.67 25.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.745 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.682 ' HB ' HG23 ' A' ' 87' ' ' VAL . 5.4 mp -97.62 128.42 48.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.494 ' HB3' HG22 ' A' ' 86' ' ' THR . 26.2 ptm -121.45 122.74 40.43 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.472 0.653 . . . . 0.0 110.353 178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.563 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 93.7 m-85 -90.6 122.47 33.43 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.309 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.64 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 14.2 pttp -128.75 133.77 48.22 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.226 -174.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.488 ' HA ' ' HB2' ' A' ' 66' ' ' LEU . 17.8 p -75.1 178.17 5.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.561 0.22 . . . . 0.0 110.68 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.98 -58.94 6.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.053 0.454 . . . . 0.0 109.935 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.9 m -102.71 101.22 11.31 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.685 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 34' ' ' LYS . 4.0 p -136.03 104.21 9.72 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 120.996 0.426 . . . . 0.0 112.016 -177.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 38' ' ' CYS . 54.0 Cg_endo -71.62 -29.56 15.91 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.988 1.792 . . . . 0.0 111.889 176.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -63.31 -30.2 71.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.723 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.634 ' O ' ' HG3' ' A' ' 45' ' ' GLN . 52.8 t -66.27 -51.11 60.74 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.113 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.403 ' HA ' ' NE2' ' A' ' 45' ' ' GLN . 42.7 t -57.11 -43.25 81.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.893 0.378 . . . . 0.0 110.912 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.605 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 7.6 tp10 -58.24 -49.03 78.55 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.932 177.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.4 ttt -72.16 -29.34 63.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.967 -177.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.634 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 27.4 mt-30 -57.89 -39.01 76.82 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 110.035 174.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.605 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 42.8 mtpt -60.03 -53.12 61.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.192 176.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.526 ' O ' HG23 ' A' ' 51' ' ' VAL . 63.6 mm-40 -58.7 -45.11 90.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.869 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.92 -33.15 73.72 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.953 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.3 t -64.95 -43.08 93.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.201 0.524 . . . . 0.0 109.682 176.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -66.47 -22.55 66.2 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.229 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.728 HG22 ' HG3' ' A' ' 105' ' ' LYS . 40.5 t -86.47 -41.97 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.005 0.431 . . . . 0.0 110.645 177.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.554 ' HB3' HG22 ' A' ' 14' ' ' ILE . 57.0 m -58.8 -30.83 67.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.341 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . 36.0 ttpt -51.59 -53.18 41.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.423 -178.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -105.9 15.99 25.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.707 0.289 . . . . 0.0 111.713 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 55' ' ' ARG . 12.8 ttm180 -138.68 75.91 1.54 Allowed 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.059 0.933 . . . . 0.0 109.633 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.709 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 1.5 tm-20 -71.39 132.0 44.18 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 113.87 -1.514 . . . . 0.0 110.07 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 41.47 46.86 4.63 Favored Glycine 0 C--N 1.333 0.408 0 O-C-N 124.016 0.822 . . . . 0.0 114.734 169.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.709 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 35.6 mmtm -120.14 -1.45 10.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.642 0.734 . . . . 0.0 109.434 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -158.46 150.61 21.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.453 -1.249 . . . . 0.0 108.723 172.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.409 HD21 HG21 ' A' ' 17' ' ' VAL . 62.4 t30 -114.27 124.75 52.79 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 178.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.4 mt -98.61 110.32 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.228 0.537 . . . . 0.0 111.564 -174.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.649 ' CE2' ' HA ' ' A' ' 19' ' ' ASN . 1.3 t80 -85.42 114.75 22.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.14 177.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.496 ' CD1' HG23 ' A' ' 16' ' ' VAL . 12.7 m-85 -89.94 103.26 15.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.223 0.535 . . . . 0.0 110.518 176.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.563 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -88.86 81.63 6.9 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.17 -179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.64 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 20.3 ptt180 -71.73 108.24 4.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.569 177.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 35' ' ' THR . 9.1 mp -65.87 10.5 0.1 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.185 0.517 . . . . 0.0 111.851 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' A' ' 65' ' ' ARG . 30.5 tt0 -64.23 -31.3 72.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.342 172.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -96.87 170.09 9.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.331 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -94.29 -11.96 29.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.339 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -67.28 -11.01 56.42 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.868 0.842 . . . . 0.0 110.826 177.217 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -89.89 -5.99 56.23 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.051 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.9 mt -69.19 -56.34 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -70.73 -38.13 73.55 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.724 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -57.42 -42.22 81.91 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.74 177.107 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.489 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -63.36 -56.57 15.31 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.722 -177.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -65.4 -32.21 73.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.633 -175.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 77' ' ' LYS . 14.1 tmtt? -61.95 -18.58 60.84 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.971 0.415 . . . . 0.0 110.595 177.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.721 ' HB3' HG11 ' A' ' 87' ' ' VAL . 58.9 m-85 -127.4 25.48 6.11 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 66.0 15.29 10.01 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.323 0.582 . . . . 0.0 111.527 171.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.67 142.71 31.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.641 -174.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -146.16 -34.16 0.31 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.718 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.1 pt -125.59 -177.72 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.039 0.447 . . . . 0.0 111.3 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 84' ' ' PRO . 4.2 p -118.87 137.47 25.03 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.306 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 51.9 Cg_endo -96.65 126.33 2.92 Favored 'Cis proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.86 -1.308 . . . . 0.0 113.223 -0.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.2 m -100.39 116.99 33.66 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 171.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 2.3 p -115.5 115.23 26.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.999 0.428 . . . . 0.0 111.146 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.721 HG11 ' HB3' ' A' ' 78' ' ' TYR . 2.0 m -100.54 124.47 54.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.482 0.658 . . . . 0.0 110.219 176.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.572 ' HB3' HD22 ' A' ' 115' ' ' LEU . 73.3 m-85 -98.18 106.31 18.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.083 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.461 HD12 ' HB ' ' A' ' 29' ' ' THR . 44.0 mt -88.19 132.18 34.45 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 174.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.06 171.6 3.51 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 173.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 6.2 pttm -52.86 -25.23 10.96 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.447 0.699 . . . . 0.0 112.455 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.413 ' OE2' ' HG3' ' A' ' 91' ' ' LYS . 0.7 OUTLIER -83.21 -9.6 59.06 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.306 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.85 10.05 61.87 Favored Glycine 0 CA--C 1.517 0.207 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.728 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 7.9 p30 -85.78 144.4 27.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.756 -0.261 . . . . 0.0 110.708 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.417 ' HA ' HD23 ' A' ' 89' ' ' LEU . 10.4 ttmt -81.21 92.41 6.32 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -85.48 -45.12 12.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.062 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.507 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 89.1 t80 -137.3 148.12 46.13 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.194 -176.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.701 ' HB ' HG12 ' A' ' 87' ' ' VAL . 2.2 p -134.76 135.36 53.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.649 173.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.507 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 50.4 t60 -122.42 119.5 31.2 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -109.47 105.67 15.11 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 133.22 179.95 16.8 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -174.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.477 HD21 ' HG2' ' A' ' 43' ' ' GLU . 33.2 tp -87.5 164.9 15.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.715 0.258 . . . . 0.0 110.84 -176.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.451 ' HB2' ' HB2' ' A' ' 107' ' ' ASN . 27.0 ptt? -172.01 156.36 4.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.613 173.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.405 HH12 ' CD ' ' A' ' 43' ' ' GLU . 32.4 mmt180 -91.84 170.87 9.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.754 -0.203 . . . . 0.0 110.987 -176.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.728 ' HG3' HG22 ' A' ' 51' ' ' VAL . 82.5 tttt -47.23 -49.87 22.25 Favored 'General case' 0 C--O 1.222 -0.346 0 O-C-N 123.63 0.581 . . . . 0.0 112.071 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -56.35 -35.43 67.65 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.158 0.504 . . . . 0.0 111.543 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 103' ' ' MET . 6.5 m120 -73.96 -40.02 63.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.49 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 61.7 mt -60.77 -46.03 96.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.378 172.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 105' ' ' LYS . 10.6 mm-40 -50.49 -48.41 56.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.317 176.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.4 m -63.86 -43.0 97.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.718 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 107' ' ' ASN . 42.8 mm -65.22 -42.99 95.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.816 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.703 ' HB3' HG21 ' A' ' 117' ' ' VAL . 81.6 mt -60.57 -42.23 96.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.617 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -64.25 -31.36 72.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.157 177.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.6 t -86.13 -9.7 56.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.462 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.572 HD22 ' HB3' ' A' ' 88' ' ' PHE . 45.9 tp -93.11 -73.92 0.54 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.116 0.484 . . . . 0.0 110.231 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 172.2 -61.38 0.15 Allowed Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.0 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 41.9 t 50.33 78.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.957 0.884 . . . . 0.0 111.605 178.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -148.13 178.45 8.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.796 -174.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.8 90.65 1.64 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 167.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -140.51 36.28 1.8 Allowed Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 119.982 -1.104 . . . . 0.0 113.361 -171.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -71.44 -51.04 26.02 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -86.42 79.45 8.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.404 172.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -114.88 125.61 53.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.296 -172.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 67.38 158.59 0.14 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.941 0.776 . . . . 0.0 111.03 176.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -101.4 -21.18 14.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.905 -0.497 . . . . 0.0 110.56 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.8 p80 . . . . . 0 C--O 1.244 0.814 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.905 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.1 mmm . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.1 p -65.48 -49.66 68.24 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.646 0.26 . . . . 0.0 111.0 -176.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 pp -91.44 165.58 13.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.833 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -73.1 132.65 43.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.844 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -121.63 32.67 4.56 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.327 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 tp -138.36 84.85 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.757 0.789 . . . . 0.0 112.179 -177.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.462 ' NZ ' ' HB3' ' A' ' 7' ' ' LYS . 2.7 ttpm? 66.37 2.27 2.36 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.374 168.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 29.8 mm-40 65.45 107.67 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.061 0.458 . . . . 0.0 109.869 -171.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.433 HD11 HG21 ' A' ' 16' ' ' VAL . 10.8 tp -157.03 16.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.254 0.55 . . . . 0.0 110.966 -175.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -50.61 -41.82 55.21 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.446 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -148.09 97.64 2.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.221 0.534 . . . . 0.0 110.533 -177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -127.57 -53.4 1.35 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.715 173.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.536 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 9.8 m -121.69 16.87 11.14 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.955 176.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.1 mt 70.33 -69.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.911 -175.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.752 HD21 ' HA2' ' A' ' 57' ' ' GLY . 12.9 m120 -92.93 31.28 1.43 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.262 0.553 . . . . 0.0 110.487 177.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 7.7 p -74.69 133.58 31.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.202 -177.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.419 HG21 ' HB3' ' A' ' 60' ' ' ASN . 67.5 t -134.84 136.38 52.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.847 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -65.83 -53.95 33.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.928 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.673 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 35.2 t30 -164.77 174.33 10.81 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -173.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -50.48 -29.4 10.32 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.805 0.336 . . . . 0.0 111.208 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.673 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 10.2 pt-20 -55.83 -37.2 68.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.321 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -103.18 8.3 38.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.625 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.26 139.66 52.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.622 0.249 . . . . 0.0 110.347 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -128.18 154.74 45.46 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.759 -174.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 61.8 -170.36 0.16 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.064 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -110.22 43.99 1.6 Allowed Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.151 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.553 HG13 ' ND2' ' A' ' 60' ' ' ASN . 7.0 pt -100.68 147.25 33.38 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.609 -0.295 . . . . 0.0 111.058 -178.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 1.087 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 88.1 Cg_exo -50.59 160.07 1.88 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.64 2.893 . . . . 0.0 113.227 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.7 m -123.37 128.16 49.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.435 -175.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.458 HD11 HD21 ' A' ' 112' ' ' LEU . 80.0 mt -107.45 109.63 28.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.616 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 42.5 mt -105.15 110.22 30.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.263 -177.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.537 ' SD ' ' NZ ' ' A' ' 34' ' ' LYS . 5.1 ppp? -114.69 139.58 49.55 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.767 0.794 . . . . 0.0 110.058 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -103.87 150.03 24.53 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.016 -170.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.654 ' HB3' ' HZ2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -152.77 161.51 42.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.934 178.565 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.633 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -75.06 -173.8 2.07 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 175.114 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.457 ' HB2' ' OE1' ' A' ' 67' ' ' GLU . 31.6 t70 -60.27 -29.37 68.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.057 0.456 . . . . 0.0 110.725 175.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -158.46 132.49 7.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.546 176.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 12.5 p -165.8 137.35 3.1 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.772 176.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 24.2 Cg_exo -63.14 -29.85 74.61 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.693 2.262 . . . . 0.0 112.811 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -62.94 -31.12 72.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.516 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 46.9 t -71.47 -36.32 71.13 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.111 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.548 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 46.9 t -67.93 -42.0 85.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.835 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -57.96 -50.24 74.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.669 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.471 ' HB2' HD21 ' A' ' 102' ' ' LEU . 21.5 ttt -72.15 -29.0 63.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.664 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.445 ' HG2' ' OH ' ' A' ' 63' ' ' TYR . 23.0 tm0? -61.08 -42.41 98.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 177.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 31.7 mmmt -63.04 -45.45 92.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.934 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.599 ' O ' HG23 ' A' ' 51' ' ' VAL . 72.0 mm-40 -58.06 -47.88 81.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.698 176.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.56 -35.41 77.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.213 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.7 m -59.72 -43.93 93.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.079 0.466 . . . . 0.0 110.176 173.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -66.97 -41.03 87.54 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.615 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 47' ' ' GLU . 55.3 t -60.24 -44.56 95.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.571 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.664 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 m -66.24 -30.85 71.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.969 0.414 . . . . 0.0 111.282 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -77.66 -24.71 49.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.045 0.45 . . . . 0.0 110.557 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -93.39 -38.63 11.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.22 0.533 . . . . 0.0 110.199 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -114.8 79.03 1.21 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.63 120.92 19.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.567 -168.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.752 ' HA2' HD21 ' A' ' 15' ' ' ASN . . . 60.91 57.86 16.64 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.549 -0.75 . . . . 0.0 113.184 173.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.86 ' HE3' HG12 ' A' ' 117' ' ' VAL . 29.1 mmmt -132.67 -3.2 3.31 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.655 -0.32 . . . . 0.0 111.571 -176.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -166.82 153.92 9.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 111.149 -176.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.553 ' ND2' HG13 ' A' ' 27' ' ' ILE . 58.6 m-80 -95.64 129.82 42.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.99 174.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.6 mt -98.92 108.76 22.84 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 CA-C-O 120.542 0.211 . . . . 0.0 110.657 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.483 ' HB3' ' HA ' ' A' ' 31' ' ' ILE . 0.3 OUTLIER -96.28 118.28 32.51 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.338 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.607 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 31.2 m-85 -97.27 103.74 15.7 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.143 0.497 . . . . 0.0 110.368 173.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.415 ' HB1' HD22 ' A' ' 71' ' ' ASN . . . -94.27 100.62 12.64 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.231 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.501 ' C ' ' H ' ' A' ' 67' ' ' GLU . 3.4 ptp180 -84.61 117.22 23.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.273 172.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.7 mt -66.73 10.51 0.13 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.268 0.556 . . . . 0.0 112.082 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 65' ' ' ARG . 20.7 tp10 -80.4 -25.19 39.2 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.584 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -96.85 159.01 15.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.951 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -71.5 -22.91 61.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.166 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.493 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.9 OUTLIER -65.16 -25.84 67.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.415 0.626 . . . . 0.0 111.166 -174.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.493 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 7.8 m120 -89.94 -7.49 53.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.76 -168.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.7 mm -69.23 -50.94 48.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.78 -44.25 86.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.143 174.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -60.48 -40.98 93.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.593 -178.414 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 80' ' ' ALA . . . -68.9 -55.87 9.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.349 . . . . 0.0 111.655 -177.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -63.2 -34.23 77.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.676 -174.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.44 ' HE3' ' HB2' ' A' ' 77' ' ' LYS . 26.8 ttmt -64.61 -16.91 63.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.901 0.381 . . . . 0.0 110.912 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.579 ' CE1' HD21 ' A' ' 89' ' ' LEU . 75.7 m-85 -122.02 16.96 10.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.797 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 67.77 23.48 8.55 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.87 0.367 . . . . 0.0 111.535 174.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.451 ' HB1' HG21 ' A' ' 85' ' ' THR . . . -102.34 136.49 42.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.615 -178.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -144.33 -75.55 0.24 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.015 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.0 pt -71.15 142.05 16.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.99 0.424 . . . . 0.0 110.95 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.3 153.08 38.33 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.634 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -87.94 119.75 4.87 Favored 'Cis proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.25 -1.563 . . . . 0.0 112.411 0.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.567 ' HB ' ' HG3' ' A' ' 100' ' ' GLN . 5.1 t -110.31 142.52 41.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.249 177.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.7 m -132.39 127.86 36.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.747 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.616 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 10.8 p -108.89 128.33 64.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.25 0.548 . . . . 0.0 110.342 176.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -101.42 111.79 24.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.441 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.579 HD21 ' CE1' ' A' ' 78' ' ' TYR . 5.7 mp -107.91 146.01 32.97 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.079 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -83.2 -172.48 4.16 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 173.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.93 ' HE3' ' HE2' ' A' ' 118' ' ' LYS . 18.7 pttp -62.79 -33.04 74.36 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -172.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -93.42 18.04 10.43 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.458 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 78.54 25.34 61.07 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.819 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.561 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 81.3 m-20 -78.95 110.07 13.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.563 0.22 . . . . 0.0 110.68 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 78' ' ' TYR . 11.7 ptmm? -72.36 86.78 1.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.53 0.681 . . . . 0.0 109.696 177.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -80.42 -53.09 6.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.374 -172.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 75.8 t80 -135.76 127.6 29.33 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.768 -173.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.486 HG12 HG23 ' A' ' 87' ' ' VAL . 33.7 m -111.01 150.69 13.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 172.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.413 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 11.9 t60 -156.3 134.33 11.23 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.567 ' HG3' ' HB ' ' A' ' 85' ' ' THR . 2.3 mp0 -105.01 128.69 53.42 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 173.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 141.4 -161.3 26.94 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.458 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 44' ' ' MET . 1.1 tm? -129.87 121.3 26.42 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.671 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 3.3 mpp? -116.25 161.34 19.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.845 0.355 . . . . 0.0 110.202 178.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -93.95 167.97 11.27 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.086 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -50.3 -42.77 53.07 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -62.32 -38.76 90.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.186 0.517 . . . . 0.0 110.855 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.671 ' HB2' ' HB3' ' A' ' 103' ' ' MET . 3.5 m120 -71.05 -43.97 66.74 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.503 -176.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.62 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 48.9 mt -58.72 -50.04 80.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.872 176.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -56.51 -48.76 76.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.337 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.5 m -60.03 -38.17 81.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.067 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 107' ' ' ASN . 80.4 mt -65.35 -40.86 89.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.839 0.352 . . . . 0.0 110.231 176.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 57.4 mt -63.27 -35.83 81.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.183 177.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.86 -30.29 71.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.444 177.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.0 m -85.45 -9.85 56.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.709 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.2 tp -87.52 -88.18 0.14 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.387 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -174.5 -54.05 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.087 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 17.4 t 52.97 57.22 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 122.327 1.06 . . . . 0.0 109.871 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.93 ' HE2' ' HE3' ' A' ' 91' ' ' LYS . 19.8 pttm -123.14 146.85 47.41 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.266 -1.333 . . . . 0.0 110.486 -173.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -98.62 -33.46 10.95 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 172.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 178.93 -113.53 0.41 Allowed Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.623 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -150.63 -175.32 5.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 63.3 t60 66.97 24.16 9.66 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.05 173.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -71.4 -33.59 69.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 171.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -71.49 123.12 21.7 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 170.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -79.28 -60.82 2.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.784 0.325 . . . . 0.0 111.013 -172.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.43 -0.795 . . . . 0.0 109.779 178.342 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 121.0 0.429 . . . . 0.0 110.102 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.4 m -146.27 99.78 3.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.97 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 52.8 tp -124.33 128.36 48.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.399 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.86 87.06 7.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.485 0.66 . . . . 0.0 110.712 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.93 -21.12 78.98 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.954 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 24.6 pt -142.89 172.16 8.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 120.672 0.272 . . . . 0.0 111.125 -177.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? 71.46 -53.29 0.68 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.738 1.215 . . . . 0.0 112.071 177.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -82.09 87.61 6.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.25 0.548 . . . . 0.0 110.272 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.481 HG21 HG11 ' A' ' 16' ' ' VAL . 38.1 pt -83.28 -8.39 11.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.493 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.6 t30 71.37 -80.36 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.085 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.426 ' O ' ' HB3' ' A' ' 12' ' ' GLN . 42.0 t80 -175.07 -166.46 0.23 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -170.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.426 ' HB3' ' O ' ' A' ' 11' ' ' PHE . 10.0 tt0 80.97 -45.7 0.23 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.801 0.84 . . . . 0.0 111.529 172.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.57 ' CB ' HG23 ' A' ' 16' ' ' VAL . 20.3 m -119.86 104.94 10.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.099 0.476 . . . . 0.0 110.302 177.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.476 ' N ' HD12 ' A' ' 14' ' ' ILE . 3.3 mp -85.81 -28.66 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.529 0.681 . . . . 0.0 110.1 -176.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -79.45 10.33 3.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.493 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.57 HG23 ' CB ' ' A' ' 13' ' ' SER . 1.0 OUTLIER -64.36 142.28 17.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.675 0.75 . . . . 0.0 112.842 -173.089 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.649 HG21 ' HB3' ' A' ' 60' ' ' ASN . 84.3 t -134.85 124.95 44.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.606 174.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -79.47 -30.92 42.3 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.138 0.495 . . . . 0.0 110.798 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -176.24 176.4 1.69 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -48.87 -34.24 12.23 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.5 mp0 -58.67 -33.73 70.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.642 0.258 . . . . 0.0 111.613 177.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -99.15 19.94 14.37 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.751 0.31 . . . . 0.0 111.019 -175.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.96 145.33 26.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.906 0.384 . . . . 0.0 111.143 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -116.71 114.42 24.0 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -81.41 168.57 18.2 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.284 -175.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.46 -35.0 5.32 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -172.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.5 pt -113.01 157.39 40.84 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 114.925 -0.638 . . . . 0.0 109.729 176.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.602 ' HG2' HG22 ' A' ' 117' ' ' VAL . 49.0 Cg_exo -57.76 169.71 2.39 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.868 2.379 . . . . 0.0 112.608 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.48 ' HA ' ' HB2' ' A' ' 60' ' ' ASN . 63.1 m -136.38 115.28 12.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.932 0.396 . . . . 0.0 111.063 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.438 HD12 ' HD2' ' A' ' 88' ' ' PHE . 21.4 mm -101.71 139.45 22.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.604 ' HB ' HG12 ' A' ' 87' ' ' VAL . 77.2 mt -130.6 118.11 41.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.561 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 24.9 ptm -109.23 120.54 42.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.469 0.652 . . . . 0.0 109.856 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.58 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 87.8 m-85 -90.41 117.36 29.06 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.752 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HG3' ' HB2' ' A' ' 41' ' ' CYS . 0.1 OUTLIER -150.8 149.35 29.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.364 -178.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.4 t -81.7 165.22 21.19 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 170.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.684 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -88.92 9.93 23.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.015 0.436 . . . . 0.0 110.871 -169.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.4 p -108.9 -16.69 14.1 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 65.7 m -83.03 128.53 64.95 Favored Pre-proline 0 C--N 1.33 -0.265 0 O-C-N 122.25 -0.281 . . . . 0.0 111.001 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.91 -25.76 7.29 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 121.938 1.759 . . . . 0.0 113.569 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -62.97 -19.74 64.58 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.798 0.332 . . . . 0.0 110.965 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.625 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 7.3 p -71.73 -34.4 69.53 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.35 -35.79 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.691 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -62.99 -49.53 74.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.135 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.5 ttt -65.84 -32.88 74.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.2 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 19.8 mt-30 -63.66 -33.2 75.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.934 175.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -68.42 -41.41 80.43 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.216 176.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 51' ' ' VAL . 18.9 mm-40 -55.72 -54.04 49.17 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 172.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.547 HD13 HG21 ' A' ' 61' ' ' ILE . 68.7 mt -58.24 -33.43 69.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.487 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.1 t -65.61 -40.66 92.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.788 0.328 . . . . 0.0 110.58 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.432 ' HB2' ' HE2' ' A' ' 105' ' ' LYS . 19.8 m-85 -72.69 -31.74 65.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.06 178.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.917 HG22 ' HG3' ' A' ' 105' ' ' LYS . 16.8 t -68.76 -38.66 79.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.2 t -64.06 -31.11 72.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.925 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 50' ' ' TYR . 16.1 tppt? -68.27 -42.55 79.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.378 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -93.24 -20.88 20.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.63 -176.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.3 76.23 1.71 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.521 0.677 . . . . 0.0 109.507 178.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.451 ' O ' ' HE3' ' A' ' 58' ' ' LYS . 1.2 pm0 -72.14 124.34 24.8 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.738 -173.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.34 40.13 37.39 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.614 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.451 ' HE3' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -113.49 -4.59 13.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.076 0.465 . . . . 0.0 110.059 -174.019 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -171.79 141.93 1.47 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.922 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.649 ' HB3' HG21 ' A' ' 17' ' ' VAL . 50.8 m-80 -77.27 145.78 37.28 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.613 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.547 HG21 HD13 ' A' ' 48' ' ' LEU . 21.3 mt -128.09 107.04 15.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 171.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.512 ' CD2' HG23 ' A' ' 31' ' ' ILE . 4.7 t80 -98.92 117.27 33.05 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.473 ' CE2' HG22 ' A' ' 16' ' ' VAL . 25.3 m-85 -90.99 103.59 16.29 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.58 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -81.5 78.29 8.27 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.984 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.583 ' C ' ' H ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -69.84 113.14 6.8 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.62 174.059 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.7 tp -64.57 11.43 0.05 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.342 0.591 . . . . 0.0 111.123 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.684 ' HB2' ' HB2' ' A' ' 36' ' ' ASP . 7.8 tp10 -80.62 -25.55 38.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.091 -178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.427 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 44.2 mt-10 -105.87 -174.39 2.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.247 0.546 . . . . 0.0 112.056 -175.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -90.42 -31.44 16.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.947 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.547 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -54.31 -40.61 68.09 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.641 0.734 . . . . 0.0 111.664 -173.389 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.547 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 2.6 p30 -101.51 10.28 40.51 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.875 -172.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.2 mm -67.45 -49.61 69.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 167.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.56 -43.96 62.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.606 174.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.498 ' CB ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -62.78 -43.84 97.75 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.674 -177.018 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.02 -41.83 77.2 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 122.187 -0.321 . . . . 0.0 110.857 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -61.9 -32.96 73.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.461 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -55.91 -33.33 64.56 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.525 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -112.19 8.02 19.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.726 0.298 . . . . 0.0 110.575 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 t0 53.81 50.63 16.52 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.255 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.28 71.04 10.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.326 0.584 . . . . 0.0 110.609 177.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -82.87 -13.66 55.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.836 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 23.1 pt -113.9 155.91 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.189 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.18 148.93 66.52 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.985 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -90.77 121.48 4.4 Favored 'Cis proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.372 -1.512 . . . . 0.0 112.587 -1.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 94.5 m -100.52 117.19 34.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.3 m -110.38 125.78 53.57 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.089 0.471 . . . . 0.0 111.323 -175.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.604 HG12 ' HB ' ' A' ' 31' ' ' ILE . 10.5 p -108.04 140.81 25.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.551 175.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.948 ' HB3' HD11 ' A' ' 115' ' ' LEU . 52.4 m-85 -118.29 113.74 21.92 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.226 -174.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.454 ' CD2' ' HA ' ' A' ' 95' ' ' LYS . 32.3 mt -107.88 143.75 36.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.673 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.62 ' HB3' ' HB2' ' A' ' 94' ' ' ASN . 24.7 t0 -78.28 172.05 14.16 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.676 ' HE2' ' HA ' ' A' ' 119' ' ' GLU . 17.4 pttp -63.71 -18.64 64.22 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -174.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -87.69 -0.42 56.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 0.0 110.059 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.51 12.03 67.77 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.441 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.62 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 94.5 m-20 -70.06 117.71 11.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.597 -0.301 . . . . 0.0 111.445 -177.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.454 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -73.0 102.2 3.43 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.582 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -104.35 -72.53 0.7 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.91 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -113.0 141.49 46.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.89 -169.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.1 p -139.48 135.75 40.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 174.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -149.35 137.96 20.98 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -106.72 123.72 48.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.896 0.379 . . . . 0.0 110.611 178.215 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 148.43 179.29 24.25 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.949 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.3 tp -83.0 102.06 11.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.902 0.382 . . . . 0.0 110.352 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 79.4 mmm -94.98 154.35 17.22 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.467 ' HB2' HD22 ' A' ' 107' ' ' ASN . 8.8 mmm180 -115.36 171.17 7.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.784 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.917 ' HG3' HG22 ' A' ' 51' ' ' VAL . 38.8 ttmt -46.59 -59.34 3.07 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -175.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -61.5 -30.75 70.82 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.935 0.398 . . . . 0.0 111.67 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.529 ' O ' HD13 ' A' ' 111' ' ' ILE . 40.3 m-80 -70.47 -40.5 73.63 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.613 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 41.1 mt -63.11 -51.37 72.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 173.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -50.97 -52.49 42.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.341 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.4 m -60.13 -40.93 91.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.004 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.624 ' O ' ' HG ' ' A' ' 115' ' ' LEU . 1.7 mp -69.06 -38.75 78.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.68 178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 86.7 mt -58.01 -43.11 86.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.263 0.554 . . . . 0.0 109.783 176.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -56.7 -40.81 76.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.227 176.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.4 m -75.26 -28.99 60.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.452 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.948 HD11 ' HB3' ' A' ' 88' ' ' PHE . 85.1 mt -68.01 -58.32 4.71 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.481 0.657 . . . . 0.0 109.664 175.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 159.79 -71.3 0.23 Allowed Glycine 0 N--CA 1.438 -1.2 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.165 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.602 HG22 ' HG2' ' A' ' 28' ' ' PRO . 40.9 t 54.97 72.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.908 0.861 . . . . 0.0 109.557 -173.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 118' ' ' LYS . 0.6 OUTLIER -138.95 -172.79 3.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.006 -171.352 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.676 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -175.3 138.47 0.42 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 164.396 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -84.06 -22.49 54.84 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.9 -172.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -79.25 78.61 5.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.273 0.559 . . . . 0.0 111.975 -174.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -94.7 -18.0 21.7 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 170.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.3 m170 -152.63 158.84 42.99 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.271 -1.331 . . . . 0.0 107.528 172.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -101.71 61.26 0.89 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.711 0.767 . . . . 0.0 111.473 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -112.36 13.64 20.32 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 163.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 . . . . . 0 C--O 1.256 1.417 0 CA-C-N 113.208 -1.814 . . . . 0.0 107.143 -179.362 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.627 0.251 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.6 m -151.9 20.13 0.69 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.429 0.633 . . . . 0.0 110.017 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -161.42 83.7 0.62 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -102.79 3.18 36.51 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.834 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.91 -68.29 0.35 Allowed Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.159 -175.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.0 pt -154.79 -48.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 121.044 0.45 . . . . 0.0 110.648 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -111.0 122.24 47.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.711 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -77.11 85.82 3.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.233 0.54 . . . . 0.0 110.681 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.6 pt -116.12 -42.93 3.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.29 176.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -168.41 177.72 5.2 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -145.45 74.54 1.4 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.313 0.578 . . . . 0.0 109.76 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.688 ' HG2' ' HB3' ' A' ' 45' ' ' GLN . 21.8 mp0 -128.6 -68.78 0.74 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.737 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.0 m -100.28 138.12 37.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.888 174.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.667 ' HB ' ' CD ' ' A' ' 56' ' ' GLU . 4.2 mp -90.77 -14.71 8.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.999 0.904 . . . . 0.0 108.903 177.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -71.16 7.66 1.19 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.305 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.475 HG23 ' CE2' ' A' ' 63' ' ' TYR . 6.5 p -60.0 129.24 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -173.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -133.17 140.07 47.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.813 170.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.77 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 28.0 tp10 -70.53 -50.56 36.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.335 177.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.869 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 27.9 t-20 -149.13 171.05 17.06 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.275 -174.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 20' ' ' LEU . 3.8 mm? -50.05 -29.93 9.78 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.194 0.308 . . . . 0.0 111.061 171.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.869 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 12.9 pt-20 -61.31 -29.95 70.19 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.956 0.408 . . . . 0.0 110.881 175.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.77 ' HG3' ' HB3' ' A' ' 18' ' ' GLU . 13.6 mm-40 -95.24 -0.22 53.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.264 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.17 159.69 25.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.303 0.573 . . . . 0.0 112.145 -172.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.637 ' HB2' HD11 ' A' ' 27' ' ' ILE . 29.7 mtmt -115.39 161.96 17.8 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.688 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.44 166.01 10.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.888 0.375 . . . . 0.0 111.977 -177.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.13 -49.43 3.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.063 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.815 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -91.46 149.59 39.75 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.721 0.296 . . . . 0.0 110.62 178.115 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 1.053 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 52.0 Cg_exo -60.72 171.01 3.89 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 123.264 2.643 . . . . 0.0 112.891 176.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.532 HG23 ' HB2' ' A' ' 60' ' ' ASN . 26.4 m -130.74 131.4 44.72 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.921 -176.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.537 HD11 HD21 ' A' ' 112' ' ' LEU . 65.3 mt -110.0 114.13 46.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.664 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.613 ' HB ' ' CG1' ' A' ' 87' ' ' VAL . 9.5 mm -100.39 109.93 26.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 25.5 ptm -111.96 131.83 55.14 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.857 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.637 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 77.3 m-85 -97.53 120.55 38.11 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.217 -176.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.573 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -125.6 162.23 25.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.997 -174.587 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.3 t -135.89 164.92 26.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.061 0.457 . . . . 0.0 110.648 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.488 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . 24.3 t70 -75.79 -27.75 58.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.799 -178.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.1 m -81.82 -66.55 0.87 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.042 -174.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.613 ' HB3' ' HD2' ' A' ' 40' ' ' TYR . 29.9 m -68.69 122.12 83.62 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.223 -176.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -79.01 3.72 7.17 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.437 2.091 . . . . 0.0 113.332 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.613 ' HD2' ' HB3' ' A' ' 38' ' ' CYS . 96.1 m-85 -61.4 -23.94 66.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.996 0.427 . . . . 0.0 110.614 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.2 p -64.71 -52.02 59.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.245 177.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.433 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 41.7 t -60.47 -30.99 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.71 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.403 ' HA ' ' OE1' ' A' ' 43' ' ' GLU . 5.3 tp10 -68.02 -49.89 58.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.438 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.2 ttt -66.02 -30.3 70.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.863 0.363 . . . . 0.0 110.199 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.688 ' HB3' ' HG2' ' A' ' 12' ' ' GLN . 28.2 mt-30 -60.93 -37.27 81.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.023 176.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 43.7 mttp -64.49 -47.83 77.47 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.853 0.359 . . . . 0.0 110.046 177.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.51 ' O ' HG23 ' A' ' 51' ' ' VAL . 21.0 mm-40 -57.28 -44.27 83.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.299 177.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.5 mt -60.7 -34.1 73.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.971 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.5 m -59.87 -44.57 94.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.075 0.464 . . . . 0.0 110.29 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -70.05 -29.5 66.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.047 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 47' ' ' GLU . 50.9 t -76.22 -47.01 32.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.629 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.618 ' HB3' ' OE2' ' A' ' 56' ' ' GLU . 15.1 m -62.81 -29.17 70.52 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-O 120.881 0.372 . . . . 0.0 110.513 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -50.11 -32.96 17.17 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.184 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.405 ' CD ' ' HE ' ' A' ' 55' ' ' ARG . 1.1 tm-20 -104.32 -48.57 3.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.388 0.613 . . . . 0.0 109.365 171.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.663 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 9.4 tpp85 -91.02 66.52 5.83 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.915 -173.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.667 ' CD ' ' HB ' ' A' ' 14' ' ' ILE . 3.9 mm-40 -90.52 144.73 25.5 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.005 172.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.45 34.2 54.55 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.491 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.663 ' HB2' ' HG3' ' A' ' 55' ' ' ARG . 26.8 mmtp -113.05 -14.09 13.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.251 0.548 . . . . 0.0 109.727 -174.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.575 ' HA ' ' HB ' ' A' ' 27' ' ' ILE . 0.8 OUTLIER -165.68 -175.01 3.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.398 179.008 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.532 ' HB2' HG23 ' A' ' 29' ' ' THR . 44.1 m-80 -108.2 129.28 55.2 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.209 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.3 mm -106.64 107.54 22.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 173.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.865 ' CE2' ' HA ' ' A' ' 19' ' ' ASN . 0.7 OUTLIER -98.2 112.1 24.2 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.448 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.475 ' CE2' HG23 ' A' ' 16' ' ' VAL . 89.7 m-85 -89.8 102.75 15.45 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 173.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.613 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -79.67 91.03 5.2 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.573 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 8.0 ptp180 -68.97 104.21 2.04 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.443 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.7 mp -65.42 10.74 0.08 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.092 0.472 . . . . 0.0 110.907 176.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.543 ' H ' ' C ' ' A' ' 65' ' ' ARG . 2.0 mp0 -83.29 -29.44 28.36 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.012 177.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.487 ' OE2' ' HD2' ' A' ' 65' ' ' ARG . 22.6 mt-10 -102.48 -171.67 2.0 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-O 121.379 0.609 . . . . 0.0 112.48 -175.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -95.17 -35.35 11.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.966 -174.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.522 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -56.33 -28.17 58.13 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.408 0.623 . . . . 0.0 111.144 -176.376 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.522 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 3.6 m120 -87.69 -8.45 56.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.435 -170.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.8 mm -68.3 -57.86 7.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.46 -38.89 91.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.2 174.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.495 ' HG ' ' OH ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -58.86 -38.91 79.85 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.312 179.343 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.637 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -61.14 -48.23 82.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.062 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -65.55 -34.17 77.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.809 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -57.91 -33.8 69.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.041 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.422 ' CD1' HG11 ' A' ' 87' ' ' VAL . 72.6 m-85 -115.81 16.99 16.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.902 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 61.9 35.02 16.6 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.006 170.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.411 ' HB1' HG21 ' A' ' 85' ' ' THR . . . -91.65 146.1 24.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.696 -176.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -154.58 -35.01 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.45 174.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.0 mt -91.94 134.9 28.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.787 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 84' ' ' PRO . 16.1 m -108.34 134.74 20.1 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.568 176.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 63.5 Cg_endo -91.7 141.79 11.14 Favored 'Cis proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.321 -1.533 . . . . 0.0 112.509 -0.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.429 HG23 ' CD1' ' A' ' 33' ' ' PHE . 9.0 t -126.06 147.18 49.63 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.5 t -141.17 130.39 23.52 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.891 0.376 . . . . 0.0 110.462 -177.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.613 ' CG1' ' HB ' ' A' ' 31' ' ' ILE . 8.8 p -113.61 128.29 70.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.382 0.611 . . . . 0.0 110.198 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.552 ' HB3' HD22 ' A' ' 115' ' ' LEU . 88.8 m-85 -100.03 118.54 36.62 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.147 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.594 ' O ' ' HB3' ' A' ' 28' ' ' PRO . 7.1 mp -106.12 139.43 40.65 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.159 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -68.77 177.51 2.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 173.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.869 ' HE3' ' HE2' ' A' ' 118' ' ' LYS . 4.5 pttm -63.16 -26.19 68.7 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 122.36 0.264 . . . . 0.0 111.596 -176.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -71.13 -25.56 62.63 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.747 0.308 . . . . 0.0 110.967 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.99 22.29 10.96 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.671 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 59.3 m-80 -86.81 132.09 33.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.687 0.244 . . . . 0.0 110.484 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -71.4 84.3 0.8 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.428 0.633 . . . . 0.0 109.724 173.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -73.03 -47.82 41.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.081 -174.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -145.21 116.68 8.04 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.127 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 87' ' ' VAL . 7.2 p -105.67 137.02 37.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 174.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -124.05 136.04 53.99 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -116.5 110.35 18.48 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 175.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 135.3 158.79 8.4 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -175.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.3 tp -77.9 141.78 38.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.757 0.313 . . . . 0.0 111.131 -176.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.483 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 54.7 mtm -131.63 166.89 20.43 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -102.67 175.03 5.63 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -54.85 -48.43 72.9 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.413 ' HA ' ' CD ' ' A' ' 109' ' ' GLU . 5.0 t-20 -66.51 -28.52 68.63 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.007 0.432 . . . . 0.0 110.811 -176.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.511 ' O ' HG12 ' A' ' 111' ' ' ILE . 11.2 m120 -66.16 -45.48 80.79 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 176.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.524 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 54.2 mt -61.71 -45.5 98.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.597 175.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.413 ' CD ' ' HA ' ' A' ' 106' ' ' ASN . 40.9 mt-10 -50.37 -48.29 55.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.528 176.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.3 m -65.25 -40.09 93.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.068 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 107' ' ' ASN . 49.1 mm -68.27 -43.52 84.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.516 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.537 HD21 HD11 ' A' ' 30' ' ' ILE . 98.2 mt -57.2 -43.54 82.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.18 0.514 . . . . 0.0 110.51 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -60.48 -43.2 97.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.117 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.0 m -86.53 -2.58 58.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.816 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' A' ' 88' ' ' PHE . 63.5 tp -82.85 -69.93 0.59 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.971 0.415 . . . . 0.0 111.869 -174.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.781 ' O ' ' HG2' ' A' ' 118' ' ' LYS . . . 149.32 -3.16 0.63 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.547 -172.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.053 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 39.0 t -33.86 107.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.141 0.976 . . . . 0.0 113.283 171.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.869 ' HE2' ' HE3' ' A' ' 91' ' ' LYS . 22.5 pttm 176.4 -172.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.672 -1.149 . . . . 0.0 107.95 177.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.26 158.03 24.0 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 174.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.85 74.41 1.99 Allowed Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.335 -172.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -124.2 -3.21 8.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.702 0.287 . . . . 0.0 111.1 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -113.42 109.66 19.05 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -131.33 -47.94 0.99 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -84.26 157.29 21.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.547 0.689 . . . . 0.0 112.565 -168.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -149.14 135.66 19.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.146 175.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.1 p80 . . . . . 0 C--N 1.322 -0.601 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.711 177.688 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 tpt . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.714 0.292 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.5 m 72.85 -58.1 0.61 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.25 0.62 . . . . 0.0 111.351 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.57 HD13 ' H ' ' A' ' 5' ' ' GLY . 0.8 OUTLIER -90.11 85.92 6.42 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.865 ' HG3' ' HG2' ' A' ' 8' ' ' GLN . 2.1 mm-40 -93.22 21.98 5.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.474 -174.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.57 ' H ' HD13 ' A' ' 3' ' ' LEU . . . 79.82 -71.46 2.72 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.845 -177.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.1 pt -146.91 -50.54 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.381 . . . . 0.0 111.065 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -138.25 144.71 40.67 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.865 ' HG2' ' HG3' ' A' ' 4' ' ' GLU . 36.8 mt-30 -78.12 99.47 6.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.908 0.385 . . . . 0.0 110.52 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.5 tp -158.2 154.93 4.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.29 142.43 47.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.209 0.528 . . . . 0.0 111.86 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.513 ' HD1' ' H ' ' A' ' 11' ' ' PHE . 2.9 p90 -88.57 4.0 48.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.232 -177.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -60.47 -33.72 72.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.77 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.567 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . 5.6 m -93.94 -18.44 21.92 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.106 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.0 mt 64.59 -68.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 O-C-N 123.681 0.613 . . . . 0.0 111.133 -173.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -89.15 45.82 1.33 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.061 0.458 . . . . 0.0 110.641 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 2.4 p -79.71 123.12 36.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.603 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.593 HG11 ' HB2' ' A' ' 23' ' ' ALA . 41.0 t -109.65 141.93 23.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.104 -175.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -83.14 -33.64 26.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.756 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.82 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 20.1 t-20 -173.33 175.58 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.7 mt -60.58 -29.74 69.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.019 0.438 . . . . 0.0 110.447 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.82 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 12.0 pt-20 -65.13 -32.25 73.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.554 176.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -93.31 7.8 42.96 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.493 0.663 . . . . 0.0 110.122 178.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.593 ' HB2' HG11 ' A' ' 17' ' ' VAL . . . -110.24 158.58 18.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.249 -176.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -133.24 135.61 45.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.117 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.06 163.63 27.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.785 0.326 . . . . 0.0 110.269 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.58 -35.72 3.23 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.687 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -116.0 145.54 35.06 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.177 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.543 ' HD2' ' O ' ' A' ' 58' ' ' LYS . 99.4 Cg_exo -44.93 133.61 10.82 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.17 2.58 . . . . 0.0 112.757 177.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.4 m -101.4 109.25 21.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.366 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.683 HD13 ' HB2' ' A' ' 59' ' ' PHE . 2.4 mp -98.67 108.19 21.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.706 ' HB ' HG23 ' A' ' 87' ' ' VAL . 67.8 mt -104.35 112.02 36.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.069 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.421 ' SD ' ' HB3' ' A' ' 34' ' ' LYS . 4.5 ppp? -109.55 144.15 38.24 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.5 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 87.5 m-85 -104.84 130.34 52.99 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.776 -177.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.873 ' HE3' ' HB3' ' A' ' 65' ' ' ARG . 12.5 pttp -143.98 149.06 36.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.108 -172.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.568 HG22 ' H ' ' A' ' 36' ' ' ASP . 1.4 m -74.04 -174.18 1.81 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 168.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.568 ' H ' HG22 ' A' ' 35' ' ' THR . 7.0 t70 -54.12 -75.36 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.798 0.332 . . . . 0.0 110.812 175.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.1 m -110.88 127.17 55.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.861 0.363 . . . . 0.0 110.696 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 44.0 m -146.3 134.76 10.87 Favored Pre-proline 0 C--O 1.235 0.313 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.325 178.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.28 -31.19 14.67 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.116 1.877 . . . . 0.0 113.044 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -68.74 -28.7 67.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.926 0.393 . . . . 0.0 110.694 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 38' ' ' CYS . 58.8 m -74.37 -42.38 59.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.694 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.0 p -70.5 -29.58 39.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.161 0.505 . . . . 0.0 110.19 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -66.02 -46.23 78.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.898 175.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.442 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 23.8 ttt -63.16 -35.28 79.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.518 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.465 ' HG2' ' OH ' ' A' ' 63' ' ' TYR . 37.7 mt-30 -57.78 -40.63 80.28 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.192 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -58.68 -50.5 73.65 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.535 ' HG3' ' HA ' ' A' ' 104' ' ' ARG . 70.0 mm-40 -59.96 -40.26 88.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.098 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.817 HD13 HD13 ' A' ' 61' ' ' ILE . 96.7 mt -60.28 -43.66 96.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.492 177.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.9 t -62.99 -37.07 85.7 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.177 0.513 . . . . 0.0 110.15 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.617 ' HA ' ' HE3' ' A' ' 53' ' ' LYS . 23.0 m-85 -64.05 -23.94 67.52 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.567 177.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.538 HG22 ' HE3' ' A' ' 105' ' ' LYS . 46.3 t -83.15 -43.18 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.8 m -55.41 -31.86 62.2 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.16 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.617 ' HE3' ' HA ' ' A' ' 50' ' ' TYR . 10.1 mtmp? -62.27 -35.16 78.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.786 0.327 . . . . 0.0 111.103 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.579 ' OE1' ' HB2' ' A' ' 53' ' ' LYS . 1.7 mp0 -103.96 9.0 36.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.554 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -154.83 92.8 1.49 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -172.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.12 116.48 7.26 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.119 0.485 . . . . 0.0 109.698 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 59' ' ' PHE . . . 47.02 -105.75 0.12 Allowed Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.168 -173.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.543 ' O ' ' HD2' ' A' ' 28' ' ' PRO . 0.3 OUTLIER 53.58 8.33 0.13 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.826 -1.187 . . . . 0.0 112.946 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.683 ' HB2' HD13 ' A' ' 30' ' ' ILE . 9.5 p90 -163.21 114.14 1.43 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.565 0.698 . . . . 0.0 110.414 174.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.498 ' HB3' HG21 ' A' ' 17' ' ' VAL . 5.4 m-20 -84.15 116.2 22.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.796 174.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.817 HD13 HD13 ' A' ' 48' ' ' LEU . 26.7 mt -96.33 107.91 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.746 -176.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.582 ' HB3' HG12 ' A' ' 31' ' ' ILE . 4.4 t80 -91.18 117.23 29.45 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.505 ' HD2' ' HD3' ' A' ' 34' ' ' LYS . 44.1 m-85 -91.48 106.46 18.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.782 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -83.13 69.83 9.95 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.775 0.797 . . . . 0.0 109.447 178.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.873 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 26.1 ptt180 -62.52 118.45 7.58 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.965 175.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 34' ' ' LYS . 4.4 mm? -66.64 10.24 0.14 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.873 0.368 . . . . 0.0 111.618 178.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.486 ' H ' ' C ' ' A' ' 65' ' ' ARG . 17.9 mt-10 -69.05 -40.95 78.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.543 0.687 . . . . 0.0 109.974 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.598 ' HB2' ' HD2' ' A' ' 70' ' ' LYS . 27.0 mt-10 -89.83 151.99 21.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.908 -174.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -70.7 -34.21 71.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.216 0.531 . . . . 0.0 110.173 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.598 ' HD2' ' HB2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -58.15 -27.1 63.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.883 179.02 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.495 ' N ' ' HD3' ' A' ' 70' ' ' LYS . 76.8 m-20 -87.47 -3.41 59.0 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.223 -178.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.4 mm -70.72 -43.1 77.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 171.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -71.77 -41.35 68.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.217 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 74' ' ' LEU . 0.8 OUTLIER -60.85 -47.42 86.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.205 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.5 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -62.93 -48.65 77.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.833 0.349 . . . . 0.0 110.967 178.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -61.42 -34.48 75.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.657 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -57.18 -33.22 67.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.181 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.453 ' CE1' ' HD3' ' A' ' 95' ' ' LYS . 85.3 m-85 -111.66 12.53 21.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.961 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.2 t70 67.33 21.86 9.69 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.433 0.635 . . . . 0.0 111.24 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.73 93.43 4.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.898 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -112.75 -8.15 13.77 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.454 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.567 HD13 ' H ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -125.17 153.39 32.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.001 178.552 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.7 m -131.27 153.22 81.61 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.455 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -90.59 145.65 16.64 Favored 'Cis proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.282 -1.549 . . . . 0.0 112.662 -0.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.1 t -142.61 149.55 39.13 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.3 m -138.6 131.12 28.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.684 0.278 . . . . 0.0 111.35 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.706 HG23 ' HB ' ' A' ' 31' ' ' ILE . 5.5 m -102.4 120.87 52.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.893 173.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -96.55 118.38 32.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.221 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.499 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 6.6 mp -113.68 145.06 41.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.75 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -63.93 171.66 2.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.949 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.515 ' HG2' ' CD ' ' A' ' 118' ' ' LYS . 2.2 pptp? -52.04 -25.1 7.79 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.901 0.881 . . . . 0.0 112.756 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.509 ' HB3' ' ND2' ' A' ' 94' ' ' ASN . 21.6 tt0 -92.1 -4.81 53.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.069 0.462 . . . . 0.0 111.036 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.98 29.07 24.12 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.827 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.509 ' ND2' ' HB3' ' A' ' 92' ' ' GLU . 6.4 p30 -110.06 134.04 52.57 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.499 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 35.1 mtmm -65.56 147.07 54.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.061 0.457 . . . . 0.0 111.202 -175.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -127.58 -46.27 1.45 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.132 173.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.499 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 81.4 t80 -147.45 134.09 19.91 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.466 -175.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.52 ' HB ' HG12 ' A' ' 87' ' ' VAL . 3.1 p -116.85 140.36 39.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 173.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.499 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 31.3 t60 -135.85 146.75 47.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -114.88 135.95 53.64 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.69 -149.04 18.34 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.12 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.3 tp -127.11 144.86 50.93 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.538 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 3.4 mpp? -131.28 165.02 24.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.354 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.535 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 32.3 mmt180 -103.22 168.21 9.32 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 173.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.58 ' HG3' ' N ' ' A' ' 106' ' ' ASN . 5.1 ptmt -54.93 -43.11 73.04 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -171.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.58 ' N ' ' HG3' ' A' ' 105' ' ' LYS . 12.9 t-20 -66.21 -32.23 73.53 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.908 0.385 . . . . 0.0 111.074 -178.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 103' ' ' MET . 9.1 m120 -66.74 -42.89 85.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.573 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 60.5 mt -62.59 -48.47 88.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.825 174.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -49.52 -51.79 34.01 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.109 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 m -63.16 -41.11 99.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.998 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 107' ' ' ASN . 42.9 mm -63.52 -40.9 90.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 91.0 mt -64.98 -37.45 87.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.594 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -60.74 -39.3 88.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.846 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.3 t -85.49 -10.49 56.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.471 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.5 tp -82.96 -56.25 3.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.523 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 168.83 -79.2 0.1 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.279 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.555 HG21 ' HB3' ' A' ' 112' ' ' LEU . 57.5 t 52.43 81.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.774 0.797 . . . . 0.0 111.623 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.515 ' CD ' ' HG2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -165.83 -165.36 0.81 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.866 -179.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.448 ' HB2' ' CE ' ' A' ' 118' ' ' LYS . 7.8 tp10 80.38 153.15 0.12 Allowed 'General case' 0 C--O 1.234 0.277 0 O-C-N 124.432 1.083 . . . . 0.0 111.576 174.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.41 ' H ' ' H ' ' A' ' 121' ' ' HIS . . . 177.41 -2.83 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.826 -178.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.41 ' H ' ' H ' ' A' ' 120' ' ' GLY . 17.6 p80 -89.47 92.07 8.97 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 117.736 0.768 . . . . 0.0 110.619 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -59.36 -34.77 72.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.287 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -127.48 139.52 52.75 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.086 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -98.4 -33.02 11.21 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -86.6 150.91 23.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.949 176.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 . . . . . 0 C--O 1.246 0.918 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.094 173.586 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtm . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.8 p -116.12 103.8 10.91 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.14 -48.72 1.33 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.628 0.728 . . . . 0.0 110.118 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.594 ' CD ' ' H ' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -94.85 -74.89 0.53 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.966 -172.789 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.594 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 116.26 -2.04 20.69 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 -175.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 34.6 pt -126.62 -3.31 4.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.071 0.462 . . . . 0.0 110.854 -177.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -111.9 7.76 20.13 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -76.54 29.86 0.12 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.927 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.514 HG12 ' HB3' ' A' ' 13' ' ' SER . 13.9 tt -82.0 50.92 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 122.526 1.155 . . . . 0.0 109.317 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -70.83 -30.24 66.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.131 -176.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.61 ' HD2' ' HG3' ' A' ' 12' ' ' GLN . 30.3 p90 -120.07 168.44 11.18 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.22 -178.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.61 ' HG3' ' HD2' ' A' ' 11' ' ' PHE . 88.1 mt-30 62.46 23.78 14.12 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.875 0.735 . . . . 0.0 110.119 -175.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.56 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . 8.4 p -122.8 -92.15 0.54 Allowed 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -169.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.1 mt 70.81 -74.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 123.322 0.649 . . . . 0.0 111.719 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -97.39 23.33 7.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.658 -174.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.56 ' CG2' ' HB2' ' A' ' 13' ' ' SER . 15.9 m -75.43 138.67 20.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.781 0.8 . . . . 0.0 112.732 -174.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 60' ' ' ASN . 48.6 t -121.81 124.84 72.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.558 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . 6.5 tp10 -59.42 -54.61 44.71 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.221 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.659 ' HA ' ' CE1' ' A' ' 62' ' ' TYR . 4.1 t30 -158.9 168.87 25.67 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -53.49 -29.16 34.74 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -170.199 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -66.58 -29.13 69.12 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.318 -0.239 . . . . 0.0 111.356 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.418 ' HG2' ' HB3' ' A' ' 18' ' ' GLU . 4.1 mp0 -80.43 -12.11 59.6 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.44 144.93 56.82 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.532 ' HD3' ' H ' ' A' ' 25' ' ' GLU . 5.0 tmtt? -127.9 151.69 48.77 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.356 -173.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.532 ' H ' ' HD3' ' A' ' 24' ' ' LYS . 25.6 mm-40 60.29 -164.11 0.23 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.928 175.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -119.19 47.65 1.01 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.917 -174.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.658 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -99.15 158.45 32.26 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 171.687 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -53.95 158.59 8.62 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.936 2.424 . . . . 0.0 112.504 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.5 m -127.21 128.99 46.98 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.063 0.459 . . . . 0.0 110.856 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.762 HD11 HD21 ' A' ' 112' ' ' LEU . 80.9 mt -98.23 108.18 21.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.591 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.808 ' HB ' HG23 ' A' ' 87' ' ' VAL . 22.5 mm -95.82 109.33 22.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 24.8 ptm -121.68 136.14 54.95 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.034 -0.667 . . . . 0.0 111.075 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.833 ' HZ ' ' HB2' ' A' ' 78' ' ' TYR . 47.1 m-85 -96.48 119.9 35.81 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.343 -178.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HG3' ' HB3' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -130.87 132.59 45.26 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.509 -170.021 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.696 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 7.3 m -99.96 162.87 12.72 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.96 -49.77 55.08 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.6 m -66.8 -52.55 42.69 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -171.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.727 ' SG ' HG21 ' A' ' 83' ' ' VAL . 2.7 p -70.99 125.55 92.02 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -167.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.651 ' O ' HG22 ' A' ' 42' ' ' VAL . 69.5 Cg_endo -75.79 -9.81 19.78 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.094 2.529 . . . . 0.0 112.653 175.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -59.47 -29.81 68.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.486 0.66 . . . . 0.0 109.768 174.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.647 ' HB3' ' HG3' ' A' ' 34' ' ' LYS . 75.0 m -78.93 -36.9 41.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.649 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 39' ' ' PRO . 2.8 m -68.44 -30.62 48.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.34 -177.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 1.8 mt-10 -61.97 -48.28 81.05 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.824 0.345 . . . . 0.0 110.78 173.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -37.75 78.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.637 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 27.6 mt-30 -58.3 -49.59 76.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.903 175.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 73.3 mmtt -58.04 -43.31 86.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.162 0.506 . . . . 0.0 110.062 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.588 ' O ' HG23 ' A' ' 51' ' ' VAL . 52.0 mm-40 -62.47 -46.86 86.58 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.199 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 48' ' ' LEU . 27.0 mt -59.77 -34.82 73.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.466 177.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.6 m -57.62 -45.87 84.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.209 0.528 . . . . 0.0 110.271 176.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -76.77 -30.36 56.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.754 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 47' ' ' GLU . 77.9 t -62.9 -41.76 93.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -65.13 -36.6 84.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.338 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -74.38 -15.6 60.92 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -109.82 -1.83 17.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.474 0.654 . . . . 0.0 109.977 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -145.7 75.31 1.42 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.356 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -67.12 118.41 10.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.791 -175.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.09 62.64 5.92 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.292 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -134.93 2.32 3.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.805 0.302 . . . . 0.0 111.086 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -168.65 145.07 3.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.412 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.567 ' HB3' HG21 ' A' ' 17' ' ' VAL . 47.4 m-80 -90.88 128.83 36.9 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.145 176.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.7 mt -103.68 108.0 23.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.659 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 55.0 t80 -92.36 114.98 27.68 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.051 177.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -92.35 105.07 17.34 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.135 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.562 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -88.27 75.78 8.5 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.633 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 26.2 ptt180 -68.22 113.78 6.14 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.642 177.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.15 12.0 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.104 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.569 ' H ' ' C ' ' A' ' 65' ' ' ARG . 1.4 mp0 -83.23 -20.88 33.75 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.011 -175.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -112.83 -176.8 2.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.0 0.428 . . . . 0.0 111.083 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.41 -31.45 16.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.097 -175.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.48 ' HG2' ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -61.37 -29.53 69.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.572 0.701 . . . . 0.0 110.79 -175.667 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.48 ' N ' ' HG2' ' A' ' 70' ' ' LYS . 3.6 m120 -81.78 -11.61 58.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.705 -174.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.5 mm -72.03 -51.33 31.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.098 0.475 . . . . 0.0 110.181 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -67.19 -37.89 84.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.103 177.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.46 -43.75 98.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.897 177.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.719 ' HA ' ' CE1' ' A' ' 33' ' ' PHE . . . -52.06 -56.01 17.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.385 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -69.3 -33.53 73.32 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.062 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -59.22 -26.57 64.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.124 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.833 ' HB2' ' HZ ' ' A' ' 33' ' ' PHE . 79.7 m-85 -119.92 21.43 11.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.735 -178.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 69.66 33.49 2.98 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 167.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.407 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . . . -71.61 152.9 42.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.002 0.429 . . . . 0.0 110.977 176.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -141.25 -81.15 0.24 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.14 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 34.4 pt -113.23 171.18 3.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.727 HG21 ' SG ' ' A' ' 38' ' ' CYS . 19.4 m -101.9 150.89 37.8 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-O 120.522 0.201 . . . . 0.0 111.34 -176.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -92.78 116.43 2.34 Favored 'Cis proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.617 -1.41 . . . . 0.0 112.654 -1.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.738 HG23 ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -96.04 135.64 37.54 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.614 HG23 ' HB3' ' A' ' 99' ' ' HIS . 6.1 t -144.74 132.12 20.77 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.125 178.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.808 HG23 ' HB ' ' A' ' 31' ' ' ILE . 3.9 m -112.34 116.77 53.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.796 175.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.681 ' HB3' HD21 ' A' ' 115' ' ' LEU . 92.5 m-85 -90.61 116.96 28.9 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.769 -177.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 27.6 mt -102.38 137.4 40.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.721 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -73.07 -171.79 0.96 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.981 ' HG2' ' HB2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -69.99 -24.76 63.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.888 -0.508 . . . . 0.0 111.73 -175.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.569 ' HB2' ' ND2' ' A' ' 94' ' ' ASN . 8.3 mm-40 -81.23 -6.25 58.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.397 0.617 . . . . 0.0 109.348 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.46 31.71 40.49 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.21 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.569 ' ND2' ' HB2' ' A' ' 92' ' ' GLU . 35.3 m-80 -93.26 143.19 26.5 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.912 177.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -72.28 85.82 1.09 Allowed 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.865 0.728 . . . . 0.0 109.519 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -85.43 -50.79 7.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.276 -172.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.422 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 73.3 t80 -133.64 126.79 31.6 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.675 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.619 HG12 HG12 ' A' ' 87' ' ' VAL . 3.6 m -103.69 151.53 6.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.614 ' HB3' HG23 ' A' ' 86' ' ' THR . 55.8 t60 -142.8 140.89 31.53 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.738 ' NE2' HG23 ' A' ' 85' ' ' THR . 5.7 tp-100 -127.93 138.35 52.61 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 172.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.97 173.68 29.03 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.717 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.9 tp -75.03 152.31 38.68 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.364 0.602 . . . . 0.0 111.253 -175.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.644 ' SD ' HG12 ' A' ' 108' ' ' ILE . 5.3 ptp -146.42 137.96 24.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.206 172.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.462 ' O ' HG13 ' A' ' 108' ' ' ILE . 18.1 tpp180 -85.99 171.57 11.33 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.55 ' HG3' HG22 ' A' ' 51' ' ' VAL . 47.9 tttm -45.98 -57.33 4.5 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -174.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.41 -36.36 75.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.673 0.273 . . . . 0.0 111.163 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.645 ' O ' HG12 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -62.9 -48.91 76.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.617 178.093 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.644 HG12 ' SD ' ' A' ' 103' ' ' MET . 25.6 mt -59.12 -47.36 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.81 0.814 . . . . 0.0 110.281 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -62.74 -41.32 99.13 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.98 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.491 ' O ' ' HB3' ' A' ' 113' ' ' ASN . 59.5 m -64.23 -30.62 71.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.577 177.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.645 HG12 ' O ' ' A' ' 107' ' ' ASN . 50.6 mm -67.62 -36.64 76.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.513 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.762 HD21 HD11 ' A' ' 30' ' ' ILE . 25.3 mt -60.7 -38.78 86.15 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.491 ' HB3' ' O ' ' A' ' 110' ' ' THR . 17.1 t30 -59.92 -44.74 94.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.957 176.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.5 p -72.33 -30.14 64.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.736 0.303 . . . . 0.0 111.036 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.681 HD21 ' HB3' ' A' ' 88' ' ' PHE . 3.9 mp -63.2 -55.13 27.62 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.31 0.576 . . . . 0.0 109.93 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 148.2 -53.58 0.53 Allowed Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.245 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.0 t 50.42 75.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -171.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.981 ' HB2' ' HG2' ' A' ' 91' ' ' LYS . 25.4 mtpp -104.59 26.03 9.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.616 -162.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -112.96 128.02 56.38 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.622 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.58 55.92 3.83 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.918 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -92.96 83.61 4.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.352 0.596 . . . . 0.0 110.043 173.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -119.29 41.36 3.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.393 -176.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -55.71 130.69 44.25 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.196 0.522 . . . . 0.0 111.141 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -149.78 138.33 20.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.374 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -64.08 128.17 34.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.781 0.324 . . . . 0.0 110.753 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 . . . . . 0 C--O 1.246 0.887 0 CA-C-O 118.284 -0.865 . . . . 0.0 109.491 174.775 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptm . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.1 t -109.17 149.76 28.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 3' ' ' LEU . 1.8 tm? -129.63 101.28 5.84 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.704 ' HG3' ' HE3' ' A' ' 7' ' ' LYS . 0.4 OUTLIER -130.25 150.62 51.41 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.646 177.572 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.712 ' HA3' ' HB3' ' A' ' 18' ' ' GLU . . . -133.89 -28.97 0.48 Allowed Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.594 176.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.415 HG23 ' HB3' ' A' ' 22' ' ' GLU . 32.3 pt -68.98 -21.83 25.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.108 0.48 . . . . 0.0 110.976 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.704 ' HE3' ' HG3' ' A' ' 4' ' ' GLU . 27.5 ttpp -92.32 -11.54 34.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.387 0.613 . . . . 0.0 109.999 177.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -104.68 22.04 15.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.628 -174.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.506 HG13 ' H ' ' A' ' 11' ' ' PHE . 39.4 pt -76.51 -25.93 16.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.869 -177.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.7 t30 67.52 6.26 4.84 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.09 0.556 . . . . 0.0 111.635 176.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.506 ' H ' HG13 ' A' ' 9' ' ' ILE . 22.4 m-85 66.86 177.16 0.23 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.465 -177.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 68.81 -50.6 0.58 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.041 -171.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.582 ' HB3' HG11 ' A' ' 16' ' ' VAL . 15.5 m -67.81 92.62 0.36 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.285 168.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.8 mt -96.3 137.34 24.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.462 -177.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 59' ' ' PHE . 94.3 m-20 66.86 24.96 9.63 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.842 0.714 . . . . 0.0 110.971 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.582 HG11 ' HB3' ' A' ' 13' ' ' SER . 11.7 m -102.01 157.24 4.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.642 0.258 . . . . 0.0 110.855 -176.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.56 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 5.3 p -146.47 157.45 11.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.083 0.468 . . . . 0.0 111.488 -176.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.712 ' HB3' ' HA3' ' A' ' 5' ' ' GLY . 9.7 tp10 -82.66 -55.18 4.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.617 174.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.704 ' HA ' ' CE2' ' A' ' 62' ' ' TYR . 18.7 t-20 -136.72 160.38 39.0 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.854 -173.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.1 mt -53.3 -35.06 59.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.38 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -65.42 -31.54 72.69 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.726 0.298 . . . . 0.0 111.008 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.415 ' HB3' HG23 ' A' ' 6' ' ' ILE . 31.5 mm-40 -79.42 -15.5 57.71 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.408 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.09 111.6 6.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 0.0 110.394 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.796 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 10.6 mmpt? -88.08 145.67 25.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.318 0.58 . . . . 0.0 111.928 -177.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 58.13 -166.12 0.16 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.677 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -105.26 72.22 0.23 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.097 -175.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.527 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -108.04 149.9 39.71 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 174.373 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.859 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 53.3 Cg_exo -54.11 141.55 68.76 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.573 2.182 . . . . 0.0 111.416 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 m -111.68 120.61 42.6 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.875 0.369 . . . . 0.0 111.169 -175.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.454 HD12 ' CD2' ' A' ' 88' ' ' PHE . 17.3 mm -106.85 122.5 60.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.674 ' HB ' ' CG2' ' A' ' 87' ' ' VAL . 69.2 mt -114.69 115.65 50.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.919 -174.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.5 tpt -109.85 116.5 31.77 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.678 177.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.644 ' CE2' ' HA ' ' A' ' 75' ' ' ALA . 85.4 m-85 -83.64 118.28 23.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.347 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.936 ' HE2' ' HB3' ' A' ' 63' ' ' TYR . 6.4 pttt -132.39 146.54 52.04 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.416 -169.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m -67.8 138.54 56.24 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 158.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 18.8 t0 -57.14 -32.63 66.56 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.076 0.465 . . . . 0.0 111.075 -168.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.1 m -124.6 92.35 3.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.428 173.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 18.2 p -138.3 142.01 33.67 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.338 177.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.48 -28.1 62.14 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.383 2.056 . . . . 0.0 112.927 -177.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -66.83 -31.09 71.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.913 0.387 . . . . 0.0 110.291 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 45' ' ' GLN . 53.0 t -71.75 -35.07 69.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.008 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 45.5 t -69.59 -46.11 76.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.558 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.467 ' HG2' HD21 ' A' ' 102' ' ' LEU . 4.4 tp10 -61.64 -49.64 75.76 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.755 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.419 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 19.8 ttt -66.58 -29.12 69.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.197 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.517 ' HB2' ' O ' ' A' ' 41' ' ' CYS . 23.0 tm0? -60.0 -41.78 92.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.016 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -62.82 -47.81 81.81 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 51' ' ' VAL . 16.2 mm-40 -57.84 -47.34 82.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.522 177.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.484 HD13 HD13 ' A' ' 61' ' ' ILE . 97.9 mt -58.67 -41.7 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.731 178.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.9 m -57.17 -41.56 79.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.638 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.539 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 21.1 m-85 -65.95 -37.04 84.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.737 178.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 47' ' ' GLU . 41.2 t -72.63 -50.68 32.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.931 -177.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.7 m -60.73 -31.54 70.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 0.0 111.121 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -57.65 -29.96 65.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.382 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -110.38 -2.04 16.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.987 -175.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.54 ' HB2' ' HG3' ' A' ' 58' ' ' LYS . 17.1 ptp180 -146.73 97.69 2.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.004 0.906 . . . . 0.0 110.768 174.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.24 133.05 35.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.953 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.06 35.95 71.84 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.462 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.54 ' HG3' ' HB2' ' A' ' 55' ' ' ARG . 41.4 mmtm -112.43 -4.05 14.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.933 0.397 . . . . 0.0 110.963 -178.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 28' ' ' PRO . 6.2 p90 -176.03 138.31 0.34 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.191 173.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.56 ' OD1' ' HB ' ' A' ' 17' ' ' VAL . 7.5 t-20 -105.6 124.04 48.91 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.554 HD12 HG12 ' A' ' 16' ' ' VAL . 40.5 mt -89.22 107.61 18.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.291 0.567 . . . . 0.0 111.207 -175.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.704 ' CE2' ' HA ' ' A' ' 19' ' ' ASN . 10.7 t80 -88.49 106.19 18.12 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.89 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.936 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 75.6 m-85 -78.93 102.29 8.2 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.347 176.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.615 ' HB3' ' HA ' ' A' ' 33' ' ' PHE . . . -85.85 74.48 10.18 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.24 0.543 . . . . 0.0 109.859 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.933 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 12.4 ptt85 -63.55 116.98 6.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.787 175.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.7 tp -74.24 9.57 1.59 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.033 0.444 . . . . 0.0 110.473 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.533 ' HB2' ' HB2' ' A' ' 36' ' ' ASP . 0.3 OUTLIER -82.53 -18.65 40.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.191 -175.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -113.21 154.51 26.61 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.187 0.518 . . . . 0.0 111.128 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.407 ' HG3' ' H ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -65.15 -32.55 74.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.207 -172.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -26.56 68.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.021 0.439 . . . . 0.0 111.672 -175.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.477 ' HA ' ' CB ' ' A' ' 74' ' ' LEU . 91.2 m-20 -90.51 1.11 57.01 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.48 -176.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.6 mm -70.69 -50.43 44.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 173.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -72.78 -34.08 66.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.481 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.477 ' CB ' ' HA ' ' A' ' 71' ' ' ASN . 1.1 tm? -60.18 -45.82 91.8 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.644 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . . . -57.59 -49.99 74.57 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.994 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -64.41 -34.76 78.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.927 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -62.44 -20.06 64.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.965 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.574 ' HB3' HG11 ' A' ' 87' ' ' VAL . 77.3 m-85 -124.55 15.95 8.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.076 -177.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.8 t70 65.22 27.3 12.22 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.927 0.87 . . . . 0.0 110.826 172.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.72 104.01 15.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.425 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.527 HD22 HG23 ' A' ' 82' ' ' ILE . 4.2 t30 -107.1 -39.74 5.64 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.75 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.527 HG23 HD22 ' A' ' 81' ' ' ASN . 30.1 pt -107.08 171.93 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.033 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.04 145.02 53.96 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.733 174.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.02 157.26 84.09 Favored 'Cis proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.36 -1.517 . . . . 0.0 112.606 -0.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.554 ' OG1' ' HB2' ' A' ' 33' ' ' PHE . 0.9 OUTLIER -145.84 129.33 16.94 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.771 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.7 m -123.26 116.38 23.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.224 0.535 . . . . 0.0 111.45 -176.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.674 ' CG2' ' HB ' ' A' ' 31' ' ' ILE . 13.2 m -102.86 135.05 42.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.176 174.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.529 ' HB3' HD22 ' A' ' 115' ' ' LEU . 79.5 m-85 -107.15 112.79 25.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.499 -176.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.465 ' HG ' ' HA ' ' A' ' 95' ' ' LYS . 6.2 mp -111.17 145.79 38.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.727 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.545 ' OD1' ' HA3' ' A' ' 116' ' ' GLY . 10.6 t70 -80.11 -165.87 0.92 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -79.4 8.59 5.93 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -168.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.401 ' HB2' HD22 ' A' ' 94' ' ' ASN . 34.7 mt-10 -127.42 21.22 6.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.87 0.367 . . . . 0.0 111.187 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.28 14.32 74.11 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.95 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.401 HD22 ' HB2' ' A' ' 92' ' ' GLU . 7.1 p30 -85.59 125.38 33.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.063 0.459 . . . . 0.0 109.957 176.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.492 ' HD3' HG22 ' A' ' 98' ' ' VAL . 5.0 tmmm? -82.68 109.54 16.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.888 -177.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.406 ' HB3' ' CD1' ' A' ' 115' ' ' LEU . 92.2 t80 -97.26 -59.72 1.73 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.24 -177.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.432 ' CE2' ' HB2' ' A' ' 99' ' ' HIS . 76.8 t80 -119.7 149.21 42.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.651 0.262 . . . . 0.0 110.801 -173.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.541 HG13 HG12 ' A' ' 87' ' ' VAL . 9.6 t -130.74 139.84 50.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.432 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 6.2 t60 -147.86 133.49 18.82 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.455 ' CD ' HG22 ' A' ' 85' ' ' THR . 3.3 mm-40 -106.32 158.37 16.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.623 0.249 . . . . 0.0 110.342 -173.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.96 -153.12 20.74 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.588 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.467 HD21 ' HG2' ' A' ' 43' ' ' GLU . 57.8 tp -114.21 120.98 42.32 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.739 0.304 . . . . 0.0 110.475 -176.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 74.9 mtp -111.21 162.24 15.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.893 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -105.44 171.2 7.46 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.174 -0.21 . . . . 0.0 110.537 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.539 ' HD2' ' HB3' ' A' ' 50' ' ' TYR . 52.5 tttp -47.4 -58.83 3.71 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.726 0.641 . . . . 0.0 111.974 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 3.8 m-20 -53.73 -33.56 56.04 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.081 0.467 . . . . 0.0 111.834 -176.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.534 ' O ' HG12 ' A' ' 111' ' ' ILE . 5.7 m120 -73.72 -46.57 45.29 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.355 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.567 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 57.1 mt -58.78 -43.56 88.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.767 174.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 105' ' ' LYS . 71.6 mm-40 -48.71 -56.37 8.76 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.844 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.5 m -72.4 -37.82 68.58 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.486 -174.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 107' ' ' ASN . 38.8 mm -63.43 -41.62 93.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.839 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 86.5 mt -62.44 -39.03 92.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.92 0.391 . . . . 0.0 110.155 176.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -62.81 -37.4 86.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.745 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.5 t -76.98 -37.51 55.03 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.581 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 88' ' ' PHE . 51.8 tp -57.94 -70.93 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.614 178.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.545 ' HA3' ' OD1' ' A' ' 90' ' ' ASP . . . -175.44 -74.44 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.01 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.859 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 85.6 t 55.72 76.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.971 0.891 . . . . 0.0 109.847 -174.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 118' ' ' LYS . 20.6 pttm -159.34 103.18 1.6 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.469 -174.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -71.25 -40.34 71.07 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.54 8.28 77.51 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.73 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -81.5 93.78 6.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.109 0.48 . . . . 0.0 110.273 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -126.05 108.29 11.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.474 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -83.7 120.96 26.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.127 0.489 . . . . 0.0 110.568 -177.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -90.41 -22.98 21.18 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -76.09 170.6 15.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.367 173.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.08 -174.364 . . . . . . . . 0 0 . 1 stop_ save_